data_1yr1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yr1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 54.7 m95 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.787 0.327 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.03 129.61 48.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -68.65 127.51 33.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.095 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.89 1.18 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.848 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.21 177.02 8.67 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.664 0.268 . . . . 0.0 110.837 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -140.04 173.17 11.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.5 t -133.34 119.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.41 109.52 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.911 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -158.5 137.55 11.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 57.95 42.64 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.61 30.56 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.394 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 89.3 m -147.82 143.0 27.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 0.0 111.001 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.484 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.1 m-85 -92.36 110.25 21.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 110.678 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 11.8 m-30 -83.07 111.57 31.47 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.388 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.14 126.11 11.1 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.546 2.164 . . . . 0.0 113.089 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.404 HD12 ' CG2' ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.14 125.05 51.77 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.708 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.1 mt -84.31 166.04 17.78 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.471 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.45 -30.63 60.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.534 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -91.31 15.61 11.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.357 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.13 7.13 86.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.155 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.287 0.543 . . . . 0.0 110.213 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.425 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.15 119.95 23.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.4 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 3.1 mm? -99.59 94.27 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 22.2 mttt -72.98 -29.43 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -82.2 -21.67 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.95 25.38 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.431 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.39 160.06 53.59 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.433 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.6 t -127.0 155.42 43.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.657 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.76 2.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.81 139.91 28.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.382 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.1 117.99 61.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.83 107.06 2.37 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.146 1.898 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.9 t -67.5 -12.85 61.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.74 -27.0 50.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.707 0.289 . . . . 0.0 111.397 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.1 162.83 45.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.868 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.32 174.09 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.064 1.843 . . . . 0.0 112.733 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.9 t -130.38 153.98 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.939 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 57.4 mt -113.04 97.88 6.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.13 0.49 . . . . 0.0 110.652 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.7 t -82.81 134.67 26.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.361 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.2 87.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.691 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.466 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.8 m95 -148.78 111.72 4.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 111.465 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.76 -26.67 13.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.528 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -97.52 96.18 8.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.301 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.19 -21.27 46.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.999 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.48 97.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.0 70.23 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.532 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.482 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 49.0 mt -62.57 -51.84 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.61 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.58 -27.93 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.384 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.5 mm-40 -71.29 -51.47 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 110.392 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -52.34 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.955 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.63 -33.72 68.56 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.848 0.356 . . . . 0.0 110.352 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.98 97.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.159 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -63.51 -37.77 88.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.1 mp -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.068 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.02 -18.64 61.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.723 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -101.88 -40.49 6.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.685 0.279 . . . . 0.0 111.683 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.16 156.93 91.23 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.774 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.73 124.29 13.26 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.449 2.099 . . . . 0.0 112.466 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.54 -38.48 45.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.24 98.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 51.9 t -59.71 -60.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.7 -24.03 66.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.542 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.81 -22.69 76.6 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.012 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.09 78.27 8.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 ptp 178.55 140.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 m -80.91 -53.88 6.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.3 150.67 20.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.198 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -102.52 135.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.292 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.402 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.2 m170 -109.56 118.8 37.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.769 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.447 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -70.28 110.5 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.955 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -133.01 78.34 65.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 60.8 Cg_endo -74.08 162.77 38.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.256 1.971 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.1 p -140.3 170.23 16.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -57.88 -25.35 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.306 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -104.85 -12.72 16.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.05 83.12 1.73 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 111.335 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.13 -19.08 61.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.546 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -112.42 33.71 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -81.5 115.17 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.66 133.43 63.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.221 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.6 mm -104.69 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.74 151.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.712 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -110.36 101.67 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.4 tpp -55.45 149.43 13.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.513 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -67.05 -20.58 65.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.055 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.79 -13.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.72 20.39 10.09 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.87 165.46 11.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 110.755 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.62 117.43 29.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.1 t -116.54 158.76 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 110.712 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 54.2 p -121.79 149.3 43.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.0 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.32 -177.72 6.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.64 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -127.59 151.88 48.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.297 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.7 mt -65.62 -24.23 34.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.964 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -76.46 -37.72 56.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.394 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -127.84 35.75 4.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.9 t80 -57.69 -42.23 83.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.801 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.73 74.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.768 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.41 -37.33 86.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -58.21 -53.13 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.532 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.99 -20.05 35.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.386 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.6 t -65.68 -36.61 84.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.061 0.457 . . . . 0.0 110.752 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -70.59 -7.73 46.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.069 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.419 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -80.2 112.16 28.21 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 122.356 -0.215 . . . . 0.0 110.786 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.3 -30.64 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.26 1.973 . . . . 0.0 112.542 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.37 -45.34 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.575 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.419 HG13 ' CG ' ' A' ' 221' ' ' TYR . 25.8 mt -63.04 -57.12 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.993 0.425 . . . . 0.0 109.935 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.513 178.57 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 55.6 m95 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.881 0.372 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -98.59 131.87 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.663 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.0 mtt85 -73.12 127.65 33.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.15 -0.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.768 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.03 176.76 10.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.67 0.272 . . . . 0.0 110.926 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.417 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 22.6 m-85 -139.07 173.7 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.16 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.8 t -133.97 117.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.917 0.389 . . . . 0.0 110.858 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 111.45 16.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.097 -179.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 t70 -168.98 144.1 3.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.793 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 40.48 21.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.14 29.45 10.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.616 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 145' ' ' THR . 90.8 m -149.75 142.68 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.326 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.9 m-85 -91.41 109.38 20.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.172 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 17.8 m-85 -79.95 122.94 83.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.31 121.17 9.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.995 1.796 . . . . 0.0 112.372 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.402 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -101.18 125.28 47.79 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.076 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.22 166.17 19.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.397 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -56.6 -30.06 62.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -90.86 15.32 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.445 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.73 4.32 81.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.158 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -61.88 97.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 110.488 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -80.46 116.62 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.23 97.44 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.96 0.41 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 27.5 mttt -71.77 -26.02 62.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.12 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -77.26 -21.0 54.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -103.89 26.69 8.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.562 0.22 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.67 162.86 52.32 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.525 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.413 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -128.05 156.96 41.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.357 . . . . 0.0 110.613 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 26.72 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.83 140.37 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.446 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 118.78 56.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.417 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 67.3 Cg_endo -76.09 106.85 2.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.999 1.799 . . . . 0.0 112.678 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.5 t -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.199 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -26.95 47.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.726 0.298 . . . . 0.0 111.419 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.56 159.98 49.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.52 172.92 13.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.046 1.83 . . . . 0.0 112.587 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.95 154.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.01 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 59.4 mt -112.93 97.79 6.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -82.36 135.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.492 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.62 88.18 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.782 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 71.9 m95 -148.46 110.66 4.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 111.549 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -100.98 -25.25 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.631 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -99.37 96.27 7.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.328 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.94 -20.78 50.34 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.952 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -40.41 97.16 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.31 -34.06 70.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.57 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.476 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 50.4 mt -61.99 -51.93 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.573 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.64 -29.18 51.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.28 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 60.2 mm-40 -71.08 -50.51 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.386 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -52.52 65.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.405 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.56 -33.59 68.3 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 110.248 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.38 -42.72 97.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.181 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -64.33 -37.31 87.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.105 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.402 HD11 ' CE1' ' A' ' 214' ' ' PHE . 7.7 mp -68.93 -27.26 65.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.314 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.15 -20.09 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.522 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -99.1 -40.55 7.95 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.694 0.283 . . . . 0.0 111.381 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.98 155.28 90.58 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.22 125.27 15.95 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.499 2.133 . . . . 0.0 112.443 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.95 -36.86 40.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.797 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.17 97.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 110.355 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.46 -60.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.106 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.44 -26.52 67.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.269 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.63 -22.01 78.83 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.97 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.05 78.07 8.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.911 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 176.88 154.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.1 t -91.98 -46.75 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.159 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -166.0 151.55 8.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -103.92 135.5 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.221 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.417 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 15.7 m170 -107.97 122.8 47.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 18.1 t80 -76.53 102.8 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.744 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -123.39 70.66 44.92 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.411 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 41.1 Cg_endo -67.96 160.07 50.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.35 2.034 . . . . 0.0 112.636 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.5 p -140.12 163.19 33.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.011 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -53.39 -27.33 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.51 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.97 -19.85 14.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -133.29 76.9 1.7 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.941 0.401 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.37 -21.05 33.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.59 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.57 37.88 3.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 111.237 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -83.91 112.76 20.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.836 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.59 132.85 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 198' ' ' ILE . 23.7 mm -104.72 108.14 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.425 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.15 151.82 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -108.75 109.8 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.12 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 149.16 7.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.48 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -61.4 -23.25 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.01 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.5 -13.22 59.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.819 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.94 20.35 9.41 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.792 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -101.28 173.09 6.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.823 0.344 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.57 120.52 36.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.8 t -121.23 159.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 96.8 p -120.14 149.09 42.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.151 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.64 -179.34 6.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.576 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -128.24 155.06 45.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.431 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 11.8 mt -69.87 -23.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.753 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -31.82 57.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -134.1 35.85 3.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 13.1 t80 -56.88 -46.97 81.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.71 99.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.35 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.19 -45.83 89.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.141 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -53.34 -53.04 56.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.604 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.96 -22.43 45.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.079 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.6 m -64.67 -28.28 69.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.797 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.8 8.52 9.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.97 102.65 40.5 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.324 -0.235 . . . . 0.0 110.406 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.93 -34.31 71.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.177 1.918 . . . . 0.0 112.387 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.57 -45.19 84.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 31.7 mt -65.83 -54.76 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.51 178.579 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.5 m95 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.864 0.364 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.6 ptt85 -99.53 132.32 44.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -71.91 127.48 32.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.162 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.41 1.15 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.846 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.15 177.01 8.72 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 120.643 0.259 . . . . 0.0 111.092 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -140.08 173.78 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.393 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -133.54 117.37 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 111.002 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.46 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.49 112.57 17.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.27 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 27.8 t70 -169.18 142.21 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.769 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 41.22 20.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.161 0.505 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.12 28.09 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.672 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 145' ' ' THR . 82.1 m -147.61 142.32 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.317 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.6 m-85 -92.55 110.19 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 17.9 m-85 -79.96 119.35 76.37 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.922 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.31 121.09 9.4 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.92 1.747 . . . . 0.0 112.351 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mt -102.04 125.74 48.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.15 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.7 mt -83.27 165.97 18.92 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.312 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.61 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -90.93 15.65 10.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.51 86.69 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.25 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.62 95.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.327 0.564 . . . . 0.0 110.243 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.438 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -81.03 117.29 21.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.7 mm? -100.77 96.78 7.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.2 mttt -73.25 -25.73 60.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.066 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -84.55 -21.17 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.686 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -100.83 25.47 7.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.649 0.261 . . . . 0.0 111.521 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.45 164.41 54.16 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.659 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.413 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.8 t -127.87 156.66 42.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 26.55 3.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.77 141.47 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.91 118.27 61.68 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 106.59 2.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.04 1.827 . . . . 0.0 112.567 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.48 -12.71 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.257 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.0 -27.42 48.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 111.367 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.97 161.44 53.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.851 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.4 173.28 14.52 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.969 1.779 . . . . 0.0 112.517 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.91 154.47 40.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.899 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.9 mt -113.48 97.97 6.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.026 0.441 . . . . 0.0 110.529 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.9 t -83.88 135.17 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.326 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.46 85.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.69 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.6 m95 -148.57 116.45 6.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.074 0.464 . . . . 0.0 111.452 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.35 -25.68 11.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.464 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.06 95.52 7.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.28 -21.01 46.2 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.071 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.17 96.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.84 -33.59 68.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.589 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.478 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 43.5 mt -62.45 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.587 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.75 55.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.243 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -69.62 -50.43 44.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.234 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -52.31 66.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.737 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.406 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.06 -33.76 69.38 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.911 0.386 . . . . 0.0 110.23 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -40.71 97.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.224 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -66.25 -37.37 85.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.247 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.02 -27.69 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.269 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.59 60.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.552 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.34 -40.44 7.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.309 . . . . 0.0 111.534 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.46 157.34 89.23 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.76 124.01 12.73 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.494 2.129 . . . . 0.0 112.56 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.08 28.72 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.76 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.76 84.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.369 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.22 -59.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.857 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.27 -25.24 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.46 -23.03 77.99 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.951 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.76 78.15 9.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.915 0.388 . . . . 0.0 110.715 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.84 138.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -78.9 -50.36 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -162.73 152.68 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.09 136.46 37.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.303 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 5.3 m170 -108.49 116.17 31.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 48.2 t80 -70.21 105.04 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -126.71 75.48 75.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.416 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 44.4 Cg_endo -68.43 160.55 48.67 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.232 1.955 . . . . 0.0 112.41 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.1 p -139.44 162.38 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -54.24 -26.24 27.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.36 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -103.22 -19.71 14.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.424 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.63 79.6 1.81 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.04 -21.43 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.55 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -113.42 38.59 2.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.678 0.275 . . . . 0.0 111.111 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.19 115.92 22.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.04 132.81 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.275 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.1 mm -105.34 111.69 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.628 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.62 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.55 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -112.2 105.19 13.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.022 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.24 149.09 7.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -67.24 -22.44 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.913 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.5 -10.72 59.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.39 9.15 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.622 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.75 176.17 5.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.853 0.358 . . . . 0.0 110.741 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.93 113.08 11.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.84 159.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 76.5 p -121.3 146.73 46.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.669 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.6 -179.74 7.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.2 147.66 51.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.326 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.82 -24.85 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.615 0.245 . . . . 0.0 111.417 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.95 58.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.553 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -134.21 35.96 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.235 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.05 -50.97 71.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.753 0.311 . . . . 0.0 110.921 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.65 89.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.725 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.77 -41.04 99.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.146 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -55.41 -53.45 56.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.217 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.8 -23.03 49.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.1 t -60.41 -34.26 73.68 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.092 0.472 . . . . 0.0 110.269 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -78.24 0.83 23.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.796 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.53 99.62 6.75 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.53 -20.08 47.9 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.105 1.87 . . . . 0.0 112.41 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.27 12.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.152 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 23.5 mt -63.64 -53.04 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.495 178.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 61.3 m95 . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -95.12 145.81 24.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.519 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -86.92 124.28 32.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 110.456 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.1 OUTLIER -126.98 -0.37 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.869 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.69 176.64 10.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.174 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -139.1 173.18 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.181 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 t -132.95 118.17 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.939 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.459 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.27 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 39.2 t0 -169.31 143.78 2.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.683 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 60.0 40.56 18.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 53.94 27.67 7.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.679 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 86.8 m -148.17 142.23 25.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.459 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 10.5 m-85 -90.41 109.75 20.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 16.5 m-85 -80.28 123.95 82.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.195 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.1 124.09 14.18 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.219 1.946 . . . . 0.0 112.569 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.41 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.3 125.31 50.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.312 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.4 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 19.3 mt -83.35 167.87 17.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.421 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -57.09 -30.87 64.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.5 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -90.94 15.28 11.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.374 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.24 7.86 86.91 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.091 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.4 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.07 96.76 0.05 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.28 0.54 . . . . 0.0 110.282 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.42 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.04 113.33 21.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.969 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.9 mt -104.54 97.93 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 32.6 mttt -69.57 -27.11 64.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.11 -22.09 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.693 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -102.28 25.31 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.483 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.87 163.73 52.63 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.693 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.8 t -127.72 156.22 42.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.55 27.08 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.947 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.77 140.03 26.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.568 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.2 118.56 51.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.38 105.4 2.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.068 1.846 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.9 t -67.61 -12.59 60.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.87 -26.94 44.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.492 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.69 163.44 38.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.79 172.86 15.49 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.915 1.743 . . . . 0.0 112.399 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.9 t -128.96 154.17 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.214 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 61.7 mt -113.54 97.68 6.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.153 0.501 . . . . 0.0 110.614 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.2 t -83.03 134.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.352 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.748 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.2 m95 -147.9 113.89 5.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.1 0.476 . . . . 0.0 111.532 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -104.46 -25.64 12.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.518 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -98.79 95.69 7.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.243 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.58 -20.75 47.47 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.076 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -40.82 97.85 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.86 70.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.538 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.482 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 64.8 mt -62.54 -52.05 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -31.76 61.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.04 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -65.95 -52.08 52.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.057 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -52.28 66.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.812 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.406 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.08 -33.65 69.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.41 97.73 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.321 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -65.62 -36.99 85.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.191 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.7 mp -67.62 -28.23 67.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.2 -18.54 61.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.58 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -103.14 -40.93 6.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -70.3 157.41 90.02 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.27 123.99 13.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.67 -35.74 32.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.97 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.67 92.09 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.427 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 66.9 t -58.66 -55.86 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.652 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.68 -12.74 61.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.65 -12.95 58.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.53 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.67 78.34 3.74 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.991 0.395 . . . . 0.0 111.408 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.14 170.14 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.5 m -103.86 -48.16 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -167.73 154.07 7.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.72 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.9 mt -104.63 134.98 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.224 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -108.96 117.57 34.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -69.21 105.14 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.739 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -128.63 78.61 75.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.39 161.73 43.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.251 1.967 . . . . 0.0 112.479 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.6 p -136.93 163.49 30.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -54.59 -25.77 28.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.456 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.71 -17.11 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -135.16 81.92 1.92 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -58.86 -19.69 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.721 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -113.81 36.93 3.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -83.81 115.09 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.86 136.11 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.37 110.58 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.9 152.14 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.472 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.33 105.97 15.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.84 149.42 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.488 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -64.3 -21.62 66.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.22 -13.32 59.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.74 20.38 9.49 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.815 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.96 168.79 8.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.285 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -119.04 117.01 27.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.08 158.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.716 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 77.3 p -121.76 147.35 46.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.65 147.89 7.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.51 147.46 23.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.694 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.5 mt -59.59 -27.33 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.092 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.76 72.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.551 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -133.07 35.85 3.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.151 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.7 t80 -56.2 -43.88 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.13 73.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -37.08 86.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.865 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.79 -53.91 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.502 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.17 -21.81 33.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.427 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 m -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 110.634 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -72.45 -4.61 31.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.414 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -90.54 110.68 42.86 Favored Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 122.276 -0.265 . . . . 0.0 110.803 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.41 -30.31 44.45 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.184 1.922 . . . . 0.0 112.393 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.92 -44.69 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.392 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.414 HG13 ' CD1' ' A' ' 221' ' ' TYR . 27.9 mt -64.56 -56.49 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 109.805 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 178.5 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 57.8 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -101.36 130.38 47.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -69.36 126.57 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.123 0.487 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.24 -1.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.787 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.79 176.7 10.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -138.09 173.6 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.5 t -134.24 119.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.958 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.414 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 109.46 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.999 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 37.3 t70 -161.31 138.05 8.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 58.59 42.62 20.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 54.17 28.42 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.546 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.414 ' CG2' ' N ' ' A' ' 145' ' ' THR . 89.8 m -145.66 141.97 28.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.414 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.2 m-85 -91.98 109.04 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.405 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 11.7 m-30 -79.73 123.03 84.14 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.784 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 123.89 14.05 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 112.642 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.89 125.01 50.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.4 165.92 17.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.191 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -55.47 -30.33 60.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.505 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.4 15.0 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.368 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.99 6.35 87.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.288 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 95.65 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.246 0.523 . . . . 0.0 110.358 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.411 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -86.1 112.98 21.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.876 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -102.74 98.08 8.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.625 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 17.1 mttp -69.8 -28.85 66.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -74.45 -23.71 58.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.78 25.54 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.451 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.08 162.88 52.94 Favored Glycine 0 CA--C 1.51 -0.246 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.479 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.414 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -127.7 155.3 44.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.794 0.331 . . . . 0.0 110.808 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 27.62 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.57 139.12 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.18 118.32 54.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.064 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.73 105.54 2.04 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.887 . . . . 0.0 112.726 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -67.88 -12.17 60.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.191 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -77.86 -27.17 49.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 111.386 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.83 160.01 51.66 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.76 173.25 12.95 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.103 1.869 . . . . 0.0 112.71 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.6 t -129.48 154.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.943 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 57.7 mt -112.95 97.99 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.9 t -83.04 134.96 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.33 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.75 85.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.842 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 71.1 m95 -148.93 112.7 5.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.41 -25.11 13.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.58 95.41 7.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.236 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.03 -21.46 45.71 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.085 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -40.06 96.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.67 67.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.6 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.483 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 43.7 mt -61.93 -51.74 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.573 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.09 58.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 1.6 mm-40 -68.81 -51.76 37.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -51.74 68.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.734 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -33.72 70.39 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.177 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.73 -41.55 95.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.167 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -65.04 -39.42 93.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.986 0.422 . . . . 0.0 110.03 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.1 mp -67.49 -28.56 67.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -20.49 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.691 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -99.64 -41.32 7.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.506 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.12 157.66 89.31 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.38 123.6 12.4 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.482 2.121 . . . . 0.0 112.539 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.53 18.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.1 81.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.387 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 50.1 t -58.91 -59.88 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.866 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.6 -24.8 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.355 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.14 -23.27 76.41 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.981 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.33 78.15 9.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.918 0.39 . . . . 0.0 110.803 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.31 157.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.507 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 74.0 m -100.8 -55.56 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.172 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.1 149.69 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.0 135.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.266 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.0 m170 -107.77 122.18 46.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 189' ' ' PRO . 17.5 t80 -76.35 105.07 7.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.771 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -124.82 73.76 64.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 187' ' ' TYR . 58.8 Cg_endo -72.21 158.88 51.04 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.307 2.005 . . . . 0.0 112.549 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.6 p -143.71 167.11 23.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -25.8 59.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.294 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -100.95 -17.64 16.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.59 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -143.22 78.7 1.61 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 121.008 0.432 . . . . 0.0 111.146 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.42 -20.17 42.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.633 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.1 36.81 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -84.89 115.57 22.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.2 m -120.51 133.06 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.6 mm -104.47 112.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.1 m -89.04 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -110.82 103.73 12.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.969 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.29 149.03 3.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.652 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -64.76 -22.28 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.963 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.402 ' CB ' ' CE2' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -78.9 -13.33 59.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.42 9.32 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.709 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.402 ' CE2' ' CB ' ' A' ' 203' ' ' ASP . 27.5 m-85 -104.18 164.25 11.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.21 120.77 42.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.0 158.54 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.645 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 39.3 p -121.93 149.21 43.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.91 -178.0 5.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -129.95 154.62 47.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.398 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.7 mt -67.69 -21.88 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.123 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -30.28 30.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.5 35.04 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.6 t80 -59.13 -47.11 86.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.795 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.27 90.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.669 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.16 -37.71 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -59.4 -53.4 58.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.457 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.72 -22.0 43.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.294 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.2 t -63.8 -40.56 96.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.382 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -64.5 -14.65 58.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.805 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -75.91 111.33 14.23 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.467 -0.093 . . . . 0.0 110.886 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.12 -25.76 31.23 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.273 1.982 . . . . 0.0 112.599 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.5 -40.77 25.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.578 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.42 HG13 ' CD1' ' A' ' 221' ' ' TYR . 17.3 mt -69.37 -58.27 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.216 178.274 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 51.8 m95 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.806 0.336 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.5 128.79 45.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.691 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.4 mtm-85 -68.08 127.8 34.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.025 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.53 1.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.84 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.84 176.62 8.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.65 0.262 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 23.1 m-85 -139.66 173.19 11.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.02 118.95 34.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.0 111.038 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.494 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.22 112.0 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.009 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.419 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.1 t70 -156.47 133.86 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 58.16 44.6 18.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.969 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 55.01 28.27 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.433 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.414 ' CG2' ' N ' ' A' ' 145' ' ' THR . 86.5 m -142.08 143.46 33.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.494 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.4 m-85 -95.63 110.7 22.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.43 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 9.2 m-30 -84.05 124.79 74.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.61 127.3 23.2 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.295 1.997 . . . . 0.0 112.841 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.88 125.15 52.49 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.733 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.13 165.15 17.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.513 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -55.25 -29.94 59.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.609 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -91.32 15.6 11.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.357 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.77 3.33 79.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.341 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -61.31 97.58 0.07 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.343 0.572 . . . . 0.0 110.533 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.79 132.27 36.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.001 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.1 mt -111.51 92.71 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.665 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.4 mttt -71.63 -28.49 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -80.23 -23.33 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.495 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -97.85 26.07 5.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.494 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.33 159.94 49.12 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.559 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.414 ' N ' ' CG2' ' A' ' 129' ' ' THR . 3.3 t -130.86 159.44 37.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 20.39 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.297 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.66 142.19 43.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.596 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.21 119.56 76.98 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.406 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.9 Cg_endo -73.71 106.58 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.046 1.831 . . . . 0.0 112.539 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -13.5 61.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.302 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.14 42.94 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.626 0.25 . . . . 0.0 111.554 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.56 161.11 56.41 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.83 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.63 173.42 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.959 1.773 . . . . 0.0 112.673 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.3 t -130.05 153.09 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.7 mt -112.84 97.55 6.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.7 t -82.73 134.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.452 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.56 85.98 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.78 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.473 ' CE3' ' CE2' ' A' ' 187' ' ' TYR . 68.0 m95 -147.1 110.82 4.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 0.0 111.607 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -101.38 -27.11 13.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.95 95.26 8.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.246 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.44 -20.91 47.07 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.983 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -40.7 98.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -34.41 71.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.449 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.475 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 47.6 mt -61.81 -51.95 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.622 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.1 60.02 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -69.46 -51.44 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -52.43 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.958 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.23 -33.61 69.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.856 0.36 . . . . 0.0 110.334 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.89 97.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.346 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -64.94 -37.75 88.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.163 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.415 HD12 ' CE1' ' A' ' 214' ' ' PHE . 7.4 mp -67.88 -27.47 66.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.249 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.13 -19.47 60.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.513 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.49 -40.72 7.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.674 0.273 . . . . 0.0 111.551 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.04 157.1 91.05 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.474 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.08 123.7 12.42 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 112.498 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -34.08 30.23 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.727 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.21 87.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 110.357 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.96 -60.29 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.902 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.42 -25.02 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.47 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.93 -23.1 77.14 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.606 -0.806 . . . . 0.0 111.818 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.23 78.29 8.84 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 110.815 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 178.38 133.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.57 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 m -70.48 -61.64 1.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -154.86 152.32 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -102.76 135.21 41.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -107.75 114.89 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.045 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.473 ' CE2' ' CE3' ' A' ' 158' ' ' TRP . 0.6 OUTLIER -68.47 114.21 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -134.59 76.09 61.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 58.5 Cg_endo -72.21 157.68 53.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.415 2.077 . . . . 0.0 112.659 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.4 p -141.96 161.99 36.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.891 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -55.52 -25.64 38.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.9 -22.13 15.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.108 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -138.46 75.13 1.5 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.02 0.438 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.18 -21.22 21.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.757 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.18 39.26 2.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 111.08 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -87.91 122.92 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.4 mm -104.41 108.77 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -87.58 151.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 0.0 111.54 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.77 105.02 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.073 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.59 149.13 3.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.659 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -64.13 -22.64 67.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.15 -13.3 60.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.36 9.38 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.678 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -105.32 167.67 9.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.933 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -116.39 120.76 39.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.79 158.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.64 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 90.7 p -122.29 148.97 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.125 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.27 -179.17 5.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.663 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.4 p -126.56 152.95 45.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 16.4 mt -68.54 -25.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.802 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -32.08 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.23 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -134.13 35.93 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.002 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 171' ' ' LEU . 12.6 t80 -55.41 -49.39 72.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.443 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.84 -44.56 89.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.262 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -53.7 -50.61 65.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.993 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.42 -21.62 45.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.669 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.7 t -60.62 -33.68 73.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 0.0 110.436 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -78.75 4.72 13.04 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.137 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 99.17 8.9 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 122.238 -0.289 . . . . 0.0 110.257 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.26 -24.89 43.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.174 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.51 -49.15 34.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.8 mt -64.02 -53.46 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.467 178.556 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 49.9 m95 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -98.12 138.25 35.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.324 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -79.68 129.07 34.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.323 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.9 1.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.984 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.88 176.9 9.74 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.238 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.43 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 23.9 m-85 -139.13 173.81 11.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.25 116.63 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.466 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.4 110.43 15.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.009 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -169.01 145.19 3.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.26 39.4 22.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.846 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.27 30.62 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.569 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 90.9 m -151.93 142.78 22.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.466 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.6 m-85 -90.53 109.8 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.133 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.441 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 18.1 m-85 -80.42 118.77 73.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.964 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.47 122.32 11.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.013 1.809 . . . . 0.0 112.351 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.3 mt -103.24 125.28 49.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.171 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 19.9 mt -82.35 166.39 19.5 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -56.68 -30.52 63.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -90.87 15.32 11.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.354 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.65 6.9 87.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.21 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.414 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.0 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.311 0.556 . . . . 0.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.441 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -81.01 117.91 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.76 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.8 mm? -102.19 97.34 7.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 22.8 mttp -72.38 -26.38 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -83.58 -21.15 32.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -100.42 24.31 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.38 164.3 54.63 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.783 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -127.54 156.53 42.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.525 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.9 28.16 3.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.8 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.33 139.37 25.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.618 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.25 118.55 54.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.917 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.43 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 64.8 Cg_endo -76.23 105.71 2.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.06 1.84 . . . . 0.0 112.668 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -67.61 -12.44 60.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -27.24 41.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.709 0.29 . . . . 0.0 111.501 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.17 160.05 53.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.925 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.01 172.88 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.962 1.775 . . . . 0.0 112.743 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.3 154.74 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.921 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 60.9 mt -114.15 97.82 6.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.478 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 77.7 t -83.34 135.11 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.58 86.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.733 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.457 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 72.2 m95 -149.05 111.85 4.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.418 . . . . 0.0 111.492 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -102.27 -25.35 13.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.599 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.43 96.24 7.88 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.479 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.8 -20.65 48.7 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.976 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.45 -40.68 97.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.33 -33.89 70.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.529 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.479 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 51.4 mt -62.38 -51.84 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.591 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.18 -29.7 58.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.53 -51.22 37.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.417 ' HE1' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -58.72 -52.48 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.789 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.7 -33.49 70.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.886 0.374 . . . . 0.0 110.241 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.56 -42.59 96.12 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.402 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -66.1 -38.86 89.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 214' ' ' PHE . 8.1 mp -66.49 -26.24 67.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.3 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.63 59.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.572 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.03 -40.53 7.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.761 0.315 . . . . 0.0 111.461 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -72.41 156.82 90.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.362 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.61 124.48 13.49 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.561 2.174 . . . . 0.0 112.628 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.53 50.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.54 91.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 110.315 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.13 -60.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.926 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.33 -24.48 66.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.381 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.0 -23.21 76.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.852 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.58 78.16 9.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.695 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 177.3 141.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.408 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.8 -50.01 11.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -163.68 153.06 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -104.25 133.9 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.135 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.409 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.6 m170 -106.82 112.51 25.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.029 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.427 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 73.1 t80 -67.53 102.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -125.81 77.48 70.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.048 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.427 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 43.1 Cg_endo -68.16 166.76 23.97 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.223 1.949 . . . . 0.0 112.322 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 p -141.35 173.54 11.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -27.3 68.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.015 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.403 ' HG3' ' CD2' ' A' ' 193' ' ' TYR . 5.6 pt-20 -114.95 10.99 16.43 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 192' ' ' GLU . 71.6 m-85 -155.88 73.49 0.82 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -21.66 23.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.64 39.26 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.235 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 112.66 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.74 134.13 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 198' ' ' ILE . 22.5 mm -105.95 111.37 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.62 152.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.503 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -109.54 105.28 14.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.24 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.53 149.3 8.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -66.65 -22.35 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.97 -12.03 59.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.3 14.68 19.68 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.837 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -100.65 174.26 6.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.849 0.325 . . . . 0.0 110.511 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.41 120.58 27.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 0.0 110.963 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.22 160.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.459 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 96.5 p -118.67 145.13 45.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.792 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.68 151.3 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.87 146.87 27.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.405 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 15.4 mt -58.8 -27.15 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 111.059 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -32.86 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.546 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -133.98 35.8 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.228 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 171' ' ' LEU . 13.5 t80 -55.39 -50.41 69.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.154 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.49 88.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.77 -43.02 99.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.11 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.403 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 10.7 mmtt -51.94 -51.26 58.26 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.016 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.16 -16.56 46.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.958 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.9 t -62.48 -34.91 77.77 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.478 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 1.7 p-80 -81.5 8.12 10.3 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.406 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -101.99 99.31 11.92 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.29 -28.16 40.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.192 1.928 . . . . 0.0 112.175 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.64 -49.06 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.028 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.406 HG13 ' CD1' ' A' ' 221' ' ' TYR . 32.2 mt -65.76 -53.41 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.514 178.464 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 32.2 m95 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.845 0.355 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.55 128.81 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.54 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -69.51 126.74 30.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.035 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.68 -0.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.784 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.44 176.78 10.13 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.736 0.303 . . . . 0.0 110.984 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -138.88 173.34 11.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.9 t -133.71 119.43 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.91 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.15 110.95 16.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.191 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 13.4 t70 -162.09 137.73 7.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 59.16 42.93 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 53.96 26.87 6.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.599 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 145' ' ' THR . 92.2 m -143.49 141.95 30.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.97 0.414 . . . . 0.0 111.007 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.5 m-85 -91.63 110.0 21.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.37 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 12.0 m-30 -81.07 122.69 81.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.879 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.25 123.81 13.9 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.172 1.914 . . . . 0.0 112.684 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.407 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.73 125.19 50.7 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.914 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.9 mt -83.6 165.76 18.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.321 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.84 -30.21 61.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -90.87 14.87 12.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.411 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.28 4.15 83.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.33 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -61.21 97.6 0.07 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.333 0.566 . . . . 0.0 110.482 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.79 117.39 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.068 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.91 97.65 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.423 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.8 mttp -69.96 -29.68 66.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.792 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -71.28 -22.61 61.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -101.8 24.53 9.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.505 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.07 162.2 52.52 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.439 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.411 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.8 t -128.35 156.49 43.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.849 0.357 . . . . 0.0 110.807 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 25.86 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.171 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.93 139.43 30.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.605 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 117.99 53.95 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.3 105.96 2.14 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.114 1.876 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.8 t -67.41 -12.84 61.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.204 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.57 -27.3 51.39 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.39 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.12 164.01 38.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.17 172.94 15.19 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.934 1.756 . . . . 0.0 112.445 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.6 t -129.57 154.88 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.067 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 60.0 mt -113.31 97.9 6.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.424 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.9 t -82.72 134.93 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.473 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.65 86.89 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.803 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.457 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.2 m95 -148.32 113.93 5.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 111.512 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -26.77 12.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.486 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.28 96.07 8.14 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.49 -20.95 47.64 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.026 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -40.7 98.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.49 69.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.497 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 50.0 mt -62.72 -52.37 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.48 47.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.238 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 7.0 mm-40 -68.73 -52.1 34.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -52.83 64.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.99 -33.53 69.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.246 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.44 -42.63 97.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.306 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -64.68 -36.9 85.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.924 0.392 . . . . 0.0 110.107 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.402 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.1 mp -67.81 -27.74 66.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.072 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.65 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.583 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.59 -40.31 6.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.74 0.305 . . . . 0.0 111.726 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.38 156.97 90.94 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.42 124.38 14.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.624 2.216 . . . . 0.0 112.648 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.75 -35.65 32.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.852 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 110.259 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.45 -55.58 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.768 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.45 -12.61 61.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.826 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 -12.69 58.42 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.575 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -93.63 78.05 4.31 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.093 0.447 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.97 176.95 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 p -113.05 -46.22 3.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.88 0.372 . . . . 0.0 110.8 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -167.88 152.43 6.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.882 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -104.74 135.33 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.267 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.403 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 8.2 m170 -107.8 121.91 45.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -75.64 101.82 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -123.42 74.36 51.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.61 160.62 47.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.376 2.051 . . . . 0.0 112.564 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -139.09 163.44 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.985 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -53.96 -26.75 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.42 -18.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -134.09 79.38 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.952 0.406 . . . . 0.0 111.115 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.27 -21.14 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.699 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -114.14 38.28 3.07 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.777 0.322 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 113.89 20.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.58 132.93 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.65 111.26 33.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.63 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -85.0 153.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.467 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -109.09 109.93 21.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.255 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 149.27 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -60.64 -24.37 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -85.37 7.03 23.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.13 -16.32 61.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.915 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.83 173.03 1.12 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -135.02 119.13 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.33 159.54 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.662 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 89.3 p -119.28 149.14 42.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.59 -179.57 6.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -127.92 151.18 49.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.386 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.7 mt -64.94 -25.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.949 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -31.13 62.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.399 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.56 36.13 3.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.13 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 15.7 t80 -56.13 -50.72 70.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.013 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.3 97.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -63.92 -47.64 79.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.042 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -51.83 -51.82 53.79 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.672 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.37 -21.51 42.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.2 m -64.29 -27.74 69.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.753 0.311 . . . . 0.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -85.66 17.1 3.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.061 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.24 103.63 55.0 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.68 -24.46 35.08 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.143 1.895 . . . . 0.0 112.418 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.02 -49.69 42.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.159 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 41.5 mt -63.44 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 178.669 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 60.8 m95 . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.904 0.383 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -96.12 130.14 43.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -71.48 126.33 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.42 0.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.947 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.29 176.79 9.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.086 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.443 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 58.2 m-85 -138.83 173.27 11.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.323 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.08 118.18 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.996 0.426 . . . . 0.0 111.044 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.1 109.4 14.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.961 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -158.73 139.27 12.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 40.96 23.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 55.08 31.13 15.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.332 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 145' ' ' THR . 84.8 m -147.69 144.02 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.994 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.3 m-85 -93.44 110.46 22.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 10.5 m-30 -82.8 127.09 71.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 28.3 Cg_exo -62.18 125.76 17.11 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.329 2.019 . . . . 0.0 112.746 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.8 124.97 50.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.795 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 21.6 mt -85.29 165.44 17.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.408 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -55.22 -30.46 60.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.49 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -91.56 15.82 11.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.85 7.74 86.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.321 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.405 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.89 96.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.332 0.566 . . . . 0.0 110.408 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.6 123.1 29.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.825 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.4 mt -107.77 96.56 6.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.9 mttp -70.98 -26.79 63.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.009 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -79.9 -23.06 42.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.577 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -98.02 25.51 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.515 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.71 159.35 52.14 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.418 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.408 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.5 t -127.09 156.39 41.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 27.32 3.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 139.61 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.74 117.95 55.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.443 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 64.7 Cg_endo -76.12 105.95 2.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.065 1.843 . . . . 0.0 112.643 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.4 t -67.82 -12.32 60.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.263 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -27.39 53.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.714 0.293 . . . . 0.0 111.271 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.34 160.66 50.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.859 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.73 172.72 14.69 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.029 1.819 . . . . 0.0 112.678 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.74 154.87 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.923 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 45.6 mt -113.62 97.72 6.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.546 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 60.5 t -83.6 132.52 31.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.622 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.8 82.77 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.874 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 57.9 m95 -144.55 99.38 3.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.586 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -25.21 21.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -98.35 97.62 8.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.85 -20.88 50.05 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.969 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -40.22 96.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.45 70.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.488 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.478 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 47.1 mt -61.89 -51.72 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.28 -29.17 60.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -71.04 -50.01 38.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.103 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.423 ' HG3' ' CH2' ' A' ' 158' ' ' TRP . 1.2 mmm -57.65 -52.54 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.791 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -60.06 -33.53 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.172 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.24 94.16 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.501 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.74 -39.56 91.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.0 0.429 . . . . 0.0 109.982 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.431 HD12 ' CE1' ' A' ' 214' ' ' PHE . 3.5 mp -66.83 -28.41 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.52 -19.89 60.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.734 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.77 -40.55 7.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 111.473 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.25 156.28 90.71 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.579 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.41 125.56 16.93 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.531 2.154 . . . . 0.0 112.429 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.1 53.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.823 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.86 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.446 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.05 -60.05 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.093 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.61 -23.29 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.551 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -72.79 -24.82 75.38 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.782 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.36 78.06 9.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.775 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 177.16 153.33 0.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.465 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.05 -53.87 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.095 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.67 151.06 25.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.5 mt -106.27 134.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.397 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.3 m170 -106.38 127.47 53.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.24 112.55 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -135.0 78.04 54.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 163.22 32.96 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.351 2.034 . . . . 0.0 112.652 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -144.58 167.92 21.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -57.91 -24.15 56.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.22 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.69 -16.57 15.98 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -144.13 83.06 1.73 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -60.05 -20.5 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.626 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.29 34.32 4.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.71 0.291 . . . . 0.0 111.141 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.69 112.05 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.783 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.7 m -115.4 136.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.243 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.0 mm -106.91 109.75 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -86.45 155.63 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.743 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.04 105.79 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.982 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.55 149.11 6.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.918 0.389 . . . . 0.0 111.636 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -64.49 -23.44 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.918 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -77.58 -13.01 60.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.34 20.39 9.17 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.4 172.63 6.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -126.37 117.11 22.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.4 t -118.8 160.11 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 59.7 p -121.47 146.75 46.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.36 -177.69 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.699 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -126.82 154.38 44.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 4.6 mt -69.31 -25.02 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.776 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -80.96 -28.64 35.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.286 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -132.28 35.5 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.431 ' CE1' HD12 ' A' ' 171' ' ' LEU . 48.7 t80 -60.43 -50.51 73.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.84 82.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.278 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -68.25 -45.68 72.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -53.77 -53.18 55.87 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.46 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.96 -24.95 55.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.818 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.4 m -61.12 -30.46 70.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.878 0.371 . . . . 0.0 110.407 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.66 5.57 12.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.046 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.77 101.72 34.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.56 -24.25 42.19 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.142 1.895 . . . . 0.0 112.326 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.1 -48.73 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.86 -53.67 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.636 178.627 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 68.7 m95 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -97.17 132.45 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.476 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -71.98 126.56 30.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.102 0.477 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.21 1.42 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.886 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.77 176.64 8.6 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -139.88 173.0 11.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.443 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.96 119.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.12 111.67 16.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.109 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 24.3 t0 -158.35 136.29 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.22 43.72 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.004 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 54.85 28.88 11.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.418 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 145' ' ' THR . 86.3 m -144.29 144.08 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.071 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.4 m-85 -94.61 110.4 22.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 111.04 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 10.1 m-30 -82.72 125.23 76.19 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.2 Cg_exo -59.66 126.96 22.0 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.348 2.032 . . . . 0.0 112.853 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.409 HD12 ' CG2' ' A' ' 164' ' ' ILE . 0.8 OUTLIER -109.47 124.82 51.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.703 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.9 mt -85.51 166.5 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.459 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -55.65 -30.68 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.651 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -91.08 15.34 11.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.477 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.45 3.88 83.46 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.326 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.76 97.93 0.06 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.264 0.532 . . . . 0.0 110.548 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.39 129.98 34.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.052 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.5 mt -110.67 94.41 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.652 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 44.2 mttt -71.61 -28.95 64.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -80.12 -21.45 43.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.578 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.56 25.79 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.33 159.0 52.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.53 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.5 t -127.48 156.65 41.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.663 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.56 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.04 141.36 28.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.61 119.1 73.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.29 107.09 2.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.108 1.872 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.2 t -66.78 -13.34 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.286 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.52 -27.16 41.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.61 0.243 . . . . 0.0 111.512 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.82 162.81 48.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.925 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.31 173.16 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.996 1.797 . . . . 0.0 112.627 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 76.7 t -129.43 154.55 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.076 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 51.5 mt -114.17 97.77 6.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 0.0 110.561 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.8 t -82.41 134.84 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.84 87.04 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.878 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.46 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 67.4 m95 -146.97 116.62 7.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 111.545 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -106.68 -27.43 10.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.344 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.74 95.19 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.38 -20.91 46.56 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.03 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -40.64 97.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.13 -34.28 70.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.505 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.483 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 62.0 mt -62.13 -51.63 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.662 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.62 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.99 -50.46 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.401 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -59.64 -52.48 65.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.741 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.408 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.73 68.7 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.847 0.355 . . . . 0.0 110.268 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.98 98.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.366 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -66.84 -35.1 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.193 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.412 HD12 ' CE1' ' A' ' 214' ' ' PHE . 6.5 mp -70.59 -28.97 65.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.059 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.84 -18.13 62.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.68 -40.98 6.38 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.11 157.41 90.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.695 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.21 123.88 12.88 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.629 2.219 . . . . 0.0 112.54 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.74 -36.31 35.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.988 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.51 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.258 0.551 . . . . 0.0 110.309 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.78 -56.12 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.86 -13.64 62.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.766 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.88 -14.29 59.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.585 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.53 78.61 3.82 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 111.609 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.98 153.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.556 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.51 -49.64 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -167.55 156.82 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -104.79 135.48 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.427 ' CD2' ' CE1' ' A' ' 200' ' ' TYR . 13.1 m170 -106.14 127.78 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -80.12 111.63 16.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -133.62 73.55 72.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.854 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.19 160.02 51.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.285 1.99 . . . . 0.0 112.594 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.6 p -140.48 162.1 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -54.74 -25.86 30.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.368 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -102.43 -20.47 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -135.41 77.34 1.67 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.927 0.394 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -55.83 -22.21 23.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.767 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -113.05 39.51 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.314 . . . . 0.0 111.307 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.58 116.09 24.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.49 137.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.08 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.62 110.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.4 m -84.62 153.32 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.639 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.427 ' CE1' ' CD2' ' A' ' 186' ' ' HIS . 6.3 m-85 -111.42 107.37 16.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.78 149.25 14.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.296 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.99 -24.05 66.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.882 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.42 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.3 m-20 -75.84 -13.28 60.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.21 20.3 9.31 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.787 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 51.7 m-85 -104.87 174.06 6.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -127.88 123.95 36.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.044 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.37 159.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 79.4 p -118.92 144.91 46.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.09 149.68 12.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.68 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.25 147.15 24.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.582 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 14.4 mt -58.5 -27.48 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.195 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -32.87 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -130.16 35.8 4.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.074 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.412 ' CE1' HD12 ' A' ' 171' ' ' LEU . 12.3 t80 -57.8 -51.82 68.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.91 87.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.75 -42.67 99.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.0 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -52.31 -53.42 44.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.49 -21.22 42.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.973 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.8 t -60.03 -33.85 72.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.007 0.432 . . . . 0.0 110.447 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.75 3.87 15.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.128 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.36 99.87 14.1 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.25 -26.36 42.01 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.09 1.86 . . . . 0.0 112.126 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.38 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 29.9 mt -64.2 -53.05 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.596 178.586 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.451 ' CG ' ' ND2' ' A' ' 136' ' ' ASN . 44.0 m95 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -99.72 132.84 44.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -72.06 127.81 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.9 0.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.949 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.6 176.75 10.06 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -138.39 173.21 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.364 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.1 t -133.93 117.55 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.967 0.413 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.477 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.59 114.42 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.277 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.4 t70 -169.09 142.01 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.771 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 59.34 41.14 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.497 . . . . 0.0 110.738 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.15 29.65 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.441 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 145' ' ' THR . 46.8 m -148.3 145.09 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.434 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.3 m-85 -95.52 110.53 22.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.701 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 17.9 m-85 -80.84 129.1 69.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.108 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.73 123.92 12.4 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.167 1.911 . . . . 0.0 112.31 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.406 HD12 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -105.57 125.09 50.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.09 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.11 167.09 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.197 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.75 -31.12 62.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.451 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.0 p30 -90.85 14.39 13.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.39 7.68 87.82 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.021 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 95.93 0.04 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.209 0.504 . . . . 0.0 110.27 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.427 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.2 118.62 23.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.017 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.4 mt -103.98 97.34 7.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.565 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.417 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 17.8 mttt -71.16 -25.67 62.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -80.71 -21.1 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.856 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -100.14 26.61 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.71 159.91 52.54 Favored Glycine 0 CA--C 1.506 -0.483 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.722 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.5 t -125.91 156.96 38.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.633 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 29.34 2.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.044 0.449 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.4 143.65 26.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.525 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.7 118.05 67.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.63 109.24 2.72 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.141 1.894 . . . . 0.0 112.54 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.4 t -67.39 -13.11 61.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.28 -27.26 53.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.43 162.56 46.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.868 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.56 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.023 1.815 . . . . 0.0 112.682 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.74 154.25 40.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.7 mt -113.61 97.57 6.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 0.0 110.587 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.5 t -82.26 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.474 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.89 89.42 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.611 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.463 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 71.0 m95 -147.36 97.48 2.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.721 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -93.61 7.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -131.27 93.02 3.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.427 0.156 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -57.86 -21.2 43.65 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.23 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -39.73 95.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.57 -33.56 62.7 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.788 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.48 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 62.6 mt -61.46 -52.05 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.919 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.93 -30.81 62.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.142 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.5 -51.52 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.188 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -52.15 66.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.756 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.412 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.45 -33.63 69.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.872 0.367 . . . . 0.0 110.244 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.43 -41.82 97.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.38 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -66.15 -38.34 87.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.417 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.2 mp -66.34 -27.56 67.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.343 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.5 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.626 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -101.45 -41.06 6.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.645 0.259 . . . . 0.0 111.49 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.42 157.39 90.09 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.13 129.26 24.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.529 2.153 . . . . 0.0 112.841 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.12 67.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.455 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.1 86.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 110.399 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.82 -60.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.838 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.8 -23.89 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.451 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.96 -23.86 75.32 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.771 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.51 78.44 7.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.863 0.364 . . . . 0.0 110.688 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.62 131.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -59.27 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.26 155.43 32.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.415 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.409 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.6 m170 -107.31 118.85 37.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.24 115.0 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -138.7 77.47 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -69.14 162.08 43.23 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.0 p -139.27 161.43 37.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.05 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -25.5 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -103.34 -19.96 14.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.331 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -135.17 81.02 1.87 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -57.09 -21.24 30.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.617 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.04 38.49 2.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.283 . . . . 0.0 111.044 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -85.2 115.73 23.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.2 m -119.76 135.97 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.113 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 20.4 mm -105.33 111.38 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.77 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.84 155.38 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 111.694 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -114.45 99.78 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.956 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.5 tpp -54.18 149.33 9.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.489 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.82 -20.32 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.008 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 5.8 m-20 -76.02 -13.71 60.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.5 20.18 10.49 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.74 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 28.1 m-85 -111.52 155.93 22.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -109.3 118.77 37.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.24 159.52 16.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 110.643 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 51.4 p -121.64 143.68 49.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.791 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.67 150.15 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.43 146.57 24.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 17.9 mt -59.03 -28.15 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.097 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -31.58 69.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.586 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.23 36.11 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.139 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CE1' HD13 ' A' ' 171' ' ' LEU . 12.1 t80 -55.46 -50.77 69.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.481 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.61 -48.27 82.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.976 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -63.07 -38.95 93.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.961 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -55.66 -53.48 56.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.965 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.61 -22.7 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.711 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.8 t -60.49 -34.1 73.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -72.08 -5.47 35.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.855 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.68 100.4 6.18 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 -27.83 46.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.145 1.897 . . . . 0.0 112.105 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.27 80.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 24.8 mt -72.28 -54.93 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.198 178.191 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 56.5 m95 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 130.33 45.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.782 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -70.6 127.73 33.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.251 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.09 3.18 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.708 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.44 176.47 9.01 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.645 0.259 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.418 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 18.9 m-85 -140.12 173.59 11.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.095 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.55 117.46 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.44 107.35 13.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.832 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.6 t0 -164.42 144.17 7.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.725 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.98 40.63 18.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.792 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.16 28.36 8.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.4 m -148.78 146.21 27.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 111.408 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.6 109.03 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 17.5 m-85 -81.15 129.95 64.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.13 124.5 12.68 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.137 1.891 . . . . 0.0 112.287 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.41 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.84 124.77 50.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.861 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.5 mt -83.94 166.63 17.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.234 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -55.85 -30.35 61.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.41 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.52 15.77 11.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.5 9.64 84.6 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.123 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 96.39 0.07 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.244 0.522 . . . . 0.0 110.11 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.423 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.59 119.52 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.079 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.7 mt -105.02 97.63 7.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 40.8 mttt -72.03 -21.92 61.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -84.37 -21.68 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -100.76 29.2 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.498 0.189 . . . . 0.0 111.414 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.53 161.42 54.15 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 t -125.21 160.66 28.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.356 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.36 30.51 4.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.55 133.1 12.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.681 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.95 118.31 37.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.418 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.8 Cg_endo -73.1 111.78 3.36 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.985 1.79 . . . . 0.0 112.477 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -66.61 -13.9 61.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.32 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.24 -26.66 42.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.591 0.234 . . . . 0.0 111.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.86 159.25 47.49 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.87 174.19 11.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.235 1.957 . . . . 0.0 112.902 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 68.6 t -129.0 153.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.836 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 59.6 mt -112.87 98.58 7.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.565 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.81 135.32 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.475 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.63 86.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.469 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.6 m95 -148.11 115.73 6.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 111.468 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -106.26 -27.29 11.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.442 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -96.53 95.78 8.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.41 -20.96 47.01 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.084 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -40.3 96.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.46 68.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.659 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.483 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 58.1 mt -62.91 -52.34 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.625 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.38 57.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.94 -51.2 42.22 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.177 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -52.54 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.414 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.02 -33.71 69.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.286 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.91 97.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.311 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.33 -37.7 87.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.388 . . . . 0.0 110.115 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.75 -27.62 66.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.246 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.73 -19.27 60.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.534 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.04 -40.7 7.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.638 0.256 . . . . 0.0 111.573 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -72.18 157.58 89.07 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.518 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -50.27 124.45 13.01 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.594 2.196 . . . . 0.0 112.681 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.85 53.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.79 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.0 110.3 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.79 -60.21 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.907 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.79 -24.21 67.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.512 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.99 -21.91 77.64 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.145 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.66 78.53 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.069 0.461 . . . . 0.0 110.718 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.03 138.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.502 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.6 t -75.82 -57.27 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.044 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.2 153.9 28.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.073 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.18 136.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.398 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -108.53 125.54 51.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.768 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -77.58 108.88 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.982 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -129.42 77.96 76.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.421 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 67.9 Cg_endo -75.04 163.72 34.7 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.264 1.976 . . . . 0.0 112.827 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.4 p -142.4 164.11 31.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.828 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -54.49 -26.94 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.55 -19.17 14.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -135.87 77.46 1.66 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.13 -21.6 47.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.605 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -111.62 36.16 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.672 0.272 . . . . 0.0 111.337 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.56 114.43 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.416 HG13 ' CH2' ' A' ' 158' ' ' TRP . 34.6 m -117.83 138.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -109.12 111.63 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -84.84 154.72 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -113.59 105.79 13.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.26 149.05 7.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.987 0.422 . . . . 0.0 111.57 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -66.95 -22.93 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.835 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.39 20.51 9.03 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.27 174.24 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -129.77 119.84 24.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.95 159.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 94.4 p -119.59 147.34 44.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.02 150.45 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.7 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.06 147.59 26.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.432 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.97 -27.23 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.641 0.258 . . . . 0.0 111.161 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -30.44 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.469 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.17 35.88 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.34 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.7 -49.62 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.88 -47.19 87.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.47 -42.42 99.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.054 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -53.51 41.18 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.267 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.59 -21.69 41.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.918 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.2 t -59.82 -32.99 71.17 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.999 0.428 . . . . 0.0 110.35 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.81 5.26 14.07 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.037 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.4 100.35 18.15 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.5 -27.29 39.6 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.132 1.888 . . . . 0.0 112.189 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.47 -52.28 47.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.049 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 32.9 mt -63.5 -51.99 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.491 178.582 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.8 m95 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.898 0.38 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -99.89 130.53 46.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.572 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -68.62 127.41 32.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.07 0.462 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.94 0.29 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.834 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.46 176.78 9.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.75 173.46 11.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.334 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.0 t -133.27 117.48 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.967 0.413 . . . . 0.0 111.025 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.52 110.7 16.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.148 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 15.9 t70 -169.15 144.23 3.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.53 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.001 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 53.86 28.65 8.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.679 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 145' ' ' THR . 88.6 m -149.58 141.86 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 14.1 m-85 -89.71 109.84 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.052 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 16.3 m-85 -80.99 123.93 81.72 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.967 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.43 124.24 14.72 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.206 1.937 . . . . 0.0 112.524 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.409 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.82 125.29 50.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.013 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.14 166.7 17.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.179 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.28 -30.26 62.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.291 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -91.38 15.8 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.303 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.26 8.18 85.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.143 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.29 96.18 0.05 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.209 0.504 . . . . 0.0 110.243 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.59 112.88 21.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.853 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.18 98.21 7.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.595 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.4 mttp -69.0 -27.5 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.45 -22.39 60.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.603 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -101.13 23.77 10.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.619 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.17 164.24 52.58 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.733 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.417 ' N ' ' CG2' ' A' ' 129' ' ' THR . 4.0 t -130.26 158.82 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.953 0.406 . . . . 0.0 110.631 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.46 22.56 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.125 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.28 143.87 36.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 110.679 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.36 118.53 72.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.43 108.93 2.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.05 1.833 . . . . 0.0 112.608 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -67.07 -13.52 62.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.274 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.33 -27.54 52.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.667 0.27 . . . . 0.0 111.402 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.61 164.6 38.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.654 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.73 172.72 14.65 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.893 1.729 . . . . 0.0 112.521 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.37 153.57 38.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.939 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 60.4 mt -113.54 97.58 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.06 0.457 . . . . 0.0 110.569 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.2 t -83.44 134.6 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.2 85.78 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.724 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.9 m95 -148.64 110.28 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 111.536 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -101.22 -27.8 13.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.35 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.8 94.08 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.054 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.03 -21.0 44.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.154 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -39.9 95.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.25 -33.83 67.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.577 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 63.4 mt -62.03 -52.24 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.646 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.08 58.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.178 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 12.1 mm-40 -68.8 -50.42 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -52.22 66.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.408 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.48 -33.7 68.27 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.946 0.403 . . . . 0.0 110.235 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.99 97.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.32 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.024 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.418 HD12 ' CE1' ' A' ' 214' ' ' PHE . 7.4 mp -69.23 -28.58 66.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.56 -18.43 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.547 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -102.62 -40.47 6.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.84 157.14 90.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.744 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.3 124.09 13.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.575 2.183 . . . . 0.0 112.631 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.73 26.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.833 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -43.35 89.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.14 0.495 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.53 -55.9 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.757 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.69 -13.55 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.55 -14.54 59.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.519 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -93.62 78.37 4.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.965 0.383 . . . . 0.0 111.54 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.55 155.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.388 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 p -89.32 -48.6 7.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.57 156.1 9.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -105.88 134.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.151 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.435 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.2 m170 -109.12 118.52 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -69.07 110.0 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.57 74.13 75.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.884 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.2 161.78 29.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.267 1.978 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -137.16 162.71 32.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -54.2 -26.37 27.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.369 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -104.41 -18.3 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.572 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.3 87.13 2.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -59.63 -19.56 49.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -115.52 36.05 4.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.741 0.305 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -78.94 108.33 12.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.706 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.9 133.06 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 30.9 mm -106.14 111.55 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.537 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.05 158.32 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.696 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.09 107.12 14.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.174 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.17 149.37 16.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.395 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -65.88 -21.92 66.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -77.07 -13.19 59.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.33 20.3 9.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.721 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -106.43 174.94 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.699 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.64 117.71 21.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.1 t -113.42 160.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 80.3 p -121.14 145.14 48.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.073 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.1 -178.71 7.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.714 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -128.73 154.66 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.369 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.9 mt -69.0 -22.34 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.975 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -32.05 47.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 111.321 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -134.21 35.77 3.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.963 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE1' HD12 ' A' ' 171' ' ' LEU . 12.2 t80 -56.8 -48.09 78.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.07 83.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -62.78 -39.21 93.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.319 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -56.93 -53.31 59.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.49 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.42 -21.35 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.19 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -64.11 -33.61 76.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.601 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -73.61 -2.74 24.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.385 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.36 110.22 43.27 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 122.263 -0.273 . . . . 0.0 110.848 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.28 -31.8 34.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.325 2.017 . . . . 0.0 112.38 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.55 -45.99 64.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.321 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 35.9 mt -64.76 -55.32 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.158 0.504 . . . . 0.0 109.708 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.319 178.53 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 54.3 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.923 0.392 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.59 134.62 38.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -76.78 126.71 31.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.712 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.62 0.72 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.995 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.96 176.89 9.7 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.439 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 55.6 m-85 -138.49 173.29 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.31 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.0 t -134.2 116.61 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 0.0 110.953 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.467 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.39 113.76 18.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.434 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.0 t70 -168.96 144.19 3.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.796 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.65 40.07 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 54.81 31.77 16.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.473 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 145' ' ' THR . 53.6 m -151.47 144.44 24.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 5.0 m-85 -93.55 110.12 21.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 18.3 m-85 -81.15 129.81 65.44 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.119 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.416 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 21.4 Cg_exo -65.09 124.91 13.71 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.189 1.926 . . . . 0.0 112.277 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.86 124.78 50.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.798 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.404 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 21.2 mt -84.95 165.63 17.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.373 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -55.31 -30.74 60.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.697 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -90.92 15.11 12.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.314 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.51 4.05 83.94 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.257 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.404 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 20.6 tpp180 -61.07 98.26 0.07 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.347 0.573 . . . . 0.0 110.476 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.428 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.3 126.97 31.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.079 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 2.9 mm? -106.53 94.24 5.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.426 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 12.5 mttp -70.97 -26.98 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.95 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -84.24 -20.75 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.795 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.09 24.58 6.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.527 0.204 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.31 160.43 53.17 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.825 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.408 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.5 t -126.72 157.21 39.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.599 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 27.72 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.29 140.5 25.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.483 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 117.65 53.29 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.439 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 65.0 Cg_endo -76.21 106.68 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.148 1.898 . . . . 0.0 112.75 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -67.99 -12.26 60.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.241 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.98 -27.22 54.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.759 0.314 . . . . 0.0 111.328 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.06 160.2 50.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.901 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.97 174.18 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.021 1.814 . . . . 0.0 112.722 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.6 t -130.43 155.56 41.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.944 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 57.3 mt -115.06 97.72 6.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.431 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.9 134.32 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.387 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.761 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.4 m95 -147.64 110.43 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 111.631 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -25.24 14.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.86 95.46 7.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.206 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.52 -20.85 47.42 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.057 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.39 -41.11 98.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.22 -34.82 73.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.441 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.482 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 54.5 mt -61.66 -51.68 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.585 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.45 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.292 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.1 mm-40 -70.74 -50.64 33.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.381 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -52.45 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.31 -33.64 67.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.41 98.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.25 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -65.41 -35.97 82.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.847 0.356 . . . . 0.0 110.344 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.0 mp -70.73 -27.88 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.89 -19.47 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.524 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.15 -40.69 7.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.481 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.7 157.2 89.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.375 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.58 123.66 11.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.459 2.106 . . . . 0.0 112.51 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -33.91 39.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.638 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.52 88.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.049 0.452 . . . . 0.0 110.404 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.53 -60.29 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.845 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.26 -24.32 66.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.64 -23.8 76.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.816 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.23 78.3 9.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 110.679 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.2 ptp 178.27 131.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 80.6 p -67.94 -55.4 12.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -161.48 155.64 22.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.9 mt -104.54 136.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.374 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 25.1 m170 -107.19 122.19 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.87 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -75.0 109.77 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -129.37 72.37 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.03 154.77 57.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.439 2.092 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.4 p -140.89 166.9 23.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -26.27 60.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.291 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.75 -17.45 16.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.49 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -143.89 76.78 1.53 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.951 0.405 . . . . 0.0 111.023 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.09 -19.77 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.74 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -113.87 37.09 3.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 111.146 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -87.53 116.94 25.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.025 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.41 HG11 ' CZ2' ' A' ' 158' ' ' TRP . 28.1 m -120.59 133.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.4 mm -103.71 112.1 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.422 HG12 ' CZ ' ' A' ' 214' ' ' PHE . 2.5 m -88.49 151.7 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.391 . . . . 0.0 111.517 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.58 103.78 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.99 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 13.2 tpp -56.25 149.38 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -67.17 -19.78 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.082 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -75.56 -13.51 60.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.05 20.21 10.02 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.772 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.76 167.84 10.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.736 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -119.14 120.7 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.7 t -118.91 159.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.618 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.9 p -118.53 148.77 42.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.911 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.2 150.78 9.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.48 147.55 25.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.526 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.6 mt -59.32 -25.88 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.187 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -29.48 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.2 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -133.96 35.51 3.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CZ ' HG12 ' A' ' 199' ' ' VAL . 12.3 t80 -57.73 -49.55 76.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.018 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.17 82.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.795 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -62.02 -41.23 97.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.11 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -53.1 53.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.298 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.06 -20.8 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.151 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.0 t -61.59 -32.55 72.66 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.005 0.431 . . . . 0.0 110.445 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.84 3.4 14.46 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.418 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -103.1 100.39 17.19 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.03 -26.63 43.13 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.121 1.881 . . . . 0.0 112.059 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.47 -41.58 76.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.418 HG13 ' CD1' ' A' ' 221' ' ' TYR . 36.8 mt -71.62 -54.67 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.159 178.319 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.421 ' CE2' ' ND2' ' A' ' 136' ' ' ASN . 56.0 m95 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.04 130.17 45.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -69.75 127.67 33.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.61 1.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.77 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.66 176.7 9.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.714 0.292 . . . . 0.0 111.04 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -139.72 173.77 11.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.59 117.17 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.42 15.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.291 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.8 t0 -169.28 145.17 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.52 40.9 23.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.97 29.92 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 89.7 m -151.47 142.52 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.425 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.5 m-85 -90.87 109.24 20.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.057 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 15.3 m-85 -79.05 122.74 84.8 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.45 122.11 10.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.13 1.887 . . . . 0.0 112.489 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.3 mt -103.87 125.03 50.0 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.791 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.65 165.91 17.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.474 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -55.72 -30.19 60.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.584 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.421 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.7 p-10 -90.61 14.68 12.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.396 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.27 3.82 82.75 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.583 -0.817 . . . . 0.0 113.254 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -60.6 97.36 0.05 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.276 0.56 . . . . 0.0 110.572 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.408 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -84.49 114.67 22.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.853 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.6 mt -105.07 97.69 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.717 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.2 mttt -69.76 -27.73 65.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -73.28 -23.26 60.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -101.48 25.36 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.547 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.02 163.0 54.08 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.512 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.6 t -127.28 156.12 42.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.661 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 28.43 3.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 138.33 24.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.72 118.36 47.44 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.67 106.21 2.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.077 1.852 . . . . 0.0 112.794 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.0 t -68.0 -12.05 60.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -78.05 -27.26 48.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.59 160.14 48.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.951 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.7 173.29 12.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.031 1.821 . . . . 0.0 112.763 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 68.4 t -129.28 154.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.89 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 54.5 mt -112.94 98.33 7.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.128 0.49 . . . . 0.0 110.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.3 t -82.46 134.89 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.475 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.56 86.73 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.836 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.9 m95 -148.47 112.68 5.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.036 0.446 . . . . 0.0 111.446 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -26.84 12.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.409 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.68 95.82 8.19 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.49 -21.05 47.97 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.964 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.24 97.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.61 -34.18 69.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.524 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.476 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 40.3 mt -61.8 -52.05 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.498 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.97 -30.27 58.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 15.1 mm-40 -69.47 -50.78 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.338 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -52.46 65.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.819 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.79 69.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 110.363 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.11 -40.29 96.95 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.197 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -66.64 -38.11 86.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.404 . . . . 0.0 110.273 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.42 HD12 ' CE1' ' A' ' 214' ' ' PHE . 7.9 mp -67.6 -28.13 67.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.363 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.24 -22.02 59.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.611 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -96.52 -40.75 8.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.283 . . . . 0.0 111.521 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 156.19 92.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -49.31 129.86 23.49 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.651 2.234 . . . . 0.0 112.879 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.63 66.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.699 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.48 87.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.49 . . . . 0.0 110.414 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.86 -59.96 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.75 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.03 -23.82 65.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.384 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.27 -24.76 74.72 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.707 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.19 78.3 8.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.752 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 176.88 140.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.443 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -56.52 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.8 154.41 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.51 136.77 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.32 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.4 m170 -108.06 117.39 34.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 39.2 t80 -73.02 106.62 4.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.783 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -126.92 74.7 76.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.403 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 56.1 Cg_endo -70.41 158.16 56.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.26 1.973 . . . . 0.0 112.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.7 p -140.44 162.9 34.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -26.61 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -102.4 -20.4 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.22 76.61 1.61 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.32 -20.63 29.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.669 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.87 38.37 2.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 111.188 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -85.72 116.87 24.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.06 132.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.38 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.2 mm -105.77 110.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.477 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -85.02 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.0 111.61 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -116.06 106.48 13.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.07 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.82 149.33 11.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.483 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -66.14 -22.36 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.934 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.2 -12.02 59.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.26 20.33 9.26 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -103.14 174.18 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -129.38 116.4 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.1 t -114.87 159.9 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.521 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 85.0 p -121.02 145.33 47.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.066 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.11 -178.44 7.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.778 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.9 153.67 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.1 mt -67.77 -21.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.076 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.47 -35.3 58.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.709 0.29 . . . . 0.0 111.462 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -133.74 35.95 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 171' ' ' LEU . 13.3 t80 -54.38 -48.18 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.69 80.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -62.18 -38.7 90.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -56.44 -51.04 69.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.392 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.66 -20.3 47.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.349 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.5 p -65.49 -36.85 85.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.962 0.411 . . . . 0.0 110.384 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -63.47 -14.93 55.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.795 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 111.21 23.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.535 -0.103 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.3 -24.15 27.54 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.164 1.909 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.23 -41.69 24.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.55 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 18.6 mt -68.78 -57.79 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.325 178.23 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 24.9 m95 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.44 128.67 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.448 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm-85 -68.31 127.22 32.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.09 0.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.024 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.92 177.06 9.55 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.648 0.261 . . . . 0.0 111.042 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -139.34 173.74 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.305 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.8 t -133.45 117.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.454 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.56 114.06 19.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.366 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.9 t70 -169.17 143.12 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 58.95 41.27 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.938 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 54.09 29.99 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.406 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 145' ' ' THR . 51.3 m -149.38 145.42 26.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 111.365 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.454 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.5 m-85 -95.97 110.92 23.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 17.2 m-85 -81.71 127.06 74.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.45 124.81 14.91 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.191 1.927 . . . . 0.0 112.501 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.48 125.16 50.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.35 164.6 17.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.417 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -54.94 -29.88 57.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -91.16 15.36 11.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.72 3.25 78.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.314 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 97.67 0.06 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.362 0.581 . . . . 0.0 110.485 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.406 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -81.09 126.34 31.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.974 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 18.2 mt -107.71 95.69 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.8 mttp -72.54 -25.51 61.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -82.64 -20.91 35.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.791 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -101.1 28.07 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 111.5 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.68 159.8 52.48 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.642 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.405 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.3 t -124.64 155.85 38.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.44 29.71 2.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.85 140.29 22.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 118.25 51.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.02 105.67 2.12 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.122 1.881 . . . . 0.0 112.78 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t -67.89 -12.2 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -78.51 -27.3 46.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.6 0.238 . . . . 0.0 111.316 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.44 159.92 49.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.866 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.46 172.86 13.38 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.961 1.774 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.45 154.19 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.897 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 56.1 mt -113.17 97.84 6.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.422 . . . . 0.0 110.441 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 72.6 t -83.29 134.29 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.37 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.6 85.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.788 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.464 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.2 m95 -148.31 113.05 5.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 111.494 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.84 -26.01 12.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.464 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.93 95.37 7.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.208 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.479 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.59 -20.86 48.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.067 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.2 -40.43 97.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.73 -34.19 69.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.518 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.479 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 48.1 mt -61.42 -51.88 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.612 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.2 61.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.26 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -67.9 -51.15 51.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -52.0 67.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.81 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.47 -33.91 70.28 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.855 0.359 . . . . 0.0 110.252 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.42 96.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.333 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -67.05 -38.06 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 214' ' ' PHE . 8.0 mp -68.06 -28.2 67.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.291 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.95 -18.75 60.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.701 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -101.18 -40.52 7.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 0.0 111.712 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -70.4 157.81 89.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.88 124.23 13.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.542 2.161 . . . . 0.0 112.638 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.73 33.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.65 93.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.17 0.51 . . . . 0.0 110.417 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.24 -60.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.998 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.19 -25.52 67.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.39 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.84 -22.12 77.44 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.022 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.89 78.16 8.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.967 0.413 . . . . 0.0 110.913 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.6 ptp 177.92 140.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.543 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.91 -54.0 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.104 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 152.39 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 110.974 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.1 mt -102.97 135.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.384 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 21.3 m170 -108.05 114.71 28.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -72.14 100.74 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -123.54 79.36 54.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.72 165.93 31.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.35 2.034 . . . . 0.0 112.613 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 p -143.6 176.18 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -62.4 -25.58 68.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.81 5.14 18.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -156.58 78.01 0.92 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.911 0.386 . . . . 0.0 111.008 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -18.4 52.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.518 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.22 34.33 4.75 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.834 0.35 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -80.03 109.13 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.78 132.77 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.402 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.41 107.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.311 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 214' ' ' PHE . 2.2 m -85.0 150.27 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.988 0.423 . . . . 0.0 111.653 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -109.08 109.2 20.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.985 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.81 148.96 9.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.416 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -66.16 -21.86 66.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.6 -10.58 59.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.27 20.52 9.09 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.713 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -100.66 174.25 6.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 110.825 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.03 122.08 29.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.76 158.68 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 81.2 p -121.59 149.19 43.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.079 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.35 -177.14 5.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -129.24 153.75 47.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.4 mt -66.3 -22.43 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.022 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -32.51 57.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 111.381 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -134.16 35.82 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 171' ' ' LEU . 12.3 t80 -57.3 -46.59 83.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.68 79.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.645 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.47 -40.17 95.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -57.03 -52.99 63.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.41 HD21 ' CD1' ' A' ' 214' ' ' PHE . 3.6 mm? -77.3 -21.79 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.445 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 78.7 p -66.4 -33.5 75.84 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 110.361 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.86 -10.29 51.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.914 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.418 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -87.16 110.56 34.31 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 122.485 -0.134 . . . . 0.0 110.865 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.83 -26.35 27.33 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.215 1.943 . . . . 0.0 112.343 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.38 -41.91 46.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.418 HG13 ' CD1' ' A' ' 221' ' ' TYR . 19.7 mt -69.01 -56.83 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.295 178.156 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.447 ' CE2' ' ND2' ' A' ' 136' ' ' ASN . 48.6 m95 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -99.47 129.55 45.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -70.07 127.05 31.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.134 0.492 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.83 1.44 2.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.842 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.93 176.46 9.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 120.695 0.284 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.423 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 20.2 m-85 -140.15 173.85 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.7 t -132.7 117.64 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.424 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.96 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.26 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 38.9 t0 -169.25 143.77 3.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.781 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 59.98 40.46 18.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 53.92 27.58 7.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.586 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 89.6 m -147.87 142.47 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.424 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.9 m-85 -91.1 109.94 21.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 16.4 m-85 -80.0 122.47 83.19 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.25 123.38 13.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.098 1.865 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.406 HD12 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -105.67 125.32 50.85 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.95 166.11 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.339 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -55.7 -29.93 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.447 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.4 p-10 -90.34 13.99 14.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.345 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.18 84.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.17 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -60.15 97.6 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.18 0.514 . . . . 0.0 110.487 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.409 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.68 115.29 22.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.892 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.4 mt -105.29 98.05 7.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.51 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.2 mttt -70.34 -28.16 64.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.79 -22.35 59.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -101.54 25.08 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.82 53.44 Favored Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.603 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -127.5 156.02 42.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.42 139.67 25.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.519 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.37 119.14 50.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.423 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 61.5 Cg_endo -75.8 105.08 2.01 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.98 1.787 . . . . 0.0 112.765 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.6 t -67.64 -12.4 60.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.194 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.98 -26.91 39.77 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.663 0.268 . . . . 0.0 111.568 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.87 159.55 46.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.74 173.66 11.52 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.06 1.84 . . . . 0.0 112.805 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.7 t -129.06 154.44 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.459 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 58.7 mt -112.81 98.36 7.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.66 135.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.476 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.55 86.78 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.876 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.5 m95 -148.4 116.24 6.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.471 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -106.81 -26.53 11.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.459 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -97.41 95.56 7.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.4 -20.86 46.53 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.108 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -40.4 97.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.17 -33.28 67.57 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.621 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 53.1 mt -62.44 -51.86 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.678 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.71 -30.21 55.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.11 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 10.6 mm-40 -68.99 -51.11 42.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.348 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.836 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.408 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.59 -33.7 68.47 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.91 0.386 . . . . 0.0 110.383 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.64 96.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.478 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.1 -39.63 93.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.439 ' CD1' ' CE1' ' A' ' 214' ' ' PHE . 5.1 mp -66.17 -27.77 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.367 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.55 -19.42 60.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.667 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.86 -40.58 7.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.705 0.288 . . . . 0.0 111.633 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.37 157.31 90.29 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.9 128.78 19.75 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.744 2.296 . . . . 0.0 112.92 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.54 67.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.552 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.14 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 0.0 110.327 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.45 -60.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.868 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.56 -24.01 67.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -72.95 -24.44 75.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.628 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.32 78.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.26 137.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 p -80.27 -57.93 3.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.197 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.12 154.12 31.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.971 0.415 . . . . 0.0 111.145 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.06 136.84 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -108.22 123.27 48.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.724 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 55.1 t80 -77.67 107.82 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -131.35 76.4 75.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.744 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 50.2 Cg_endo -69.59 162.67 41.06 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.336 2.024 . . . . 0.0 112.609 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.3 p -140.86 163.37 33.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.9 mtp85 -55.89 -25.89 44.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 -20.64 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.283 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -136.8 82.48 1.94 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.71 -20.76 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.673 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -114.58 37.69 3.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 111.163 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -82.28 112.34 19.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.988 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.51 135.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -106.75 109.27 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.554 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -84.84 154.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.899 0.38 . . . . 0.0 111.654 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -114.5 101.36 9.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.957 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.8 tpp -53.87 149.33 8.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.596 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -66.83 -20.08 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.041 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.76 -13.4 60.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 20.21 9.47 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -109.04 167.86 9.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.68 117.02 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.743 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.3 t -113.85 160.39 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 78.1 p -121.43 144.33 48.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.762 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.32 -177.36 6.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.8 152.35 47.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.321 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 11.5 mt -66.42 -24.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.913 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -29.8 51.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.695 0.283 . . . . 0.0 111.361 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -134.16 36.07 3.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.221 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.439 ' CE1' ' CD1' ' A' ' 171' ' ' LEU . 41.3 t80 -56.88 -50.03 73.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.845 0.355 . . . . 0.0 111.051 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.49 99.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.81 -42.26 95.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -57.08 -53.66 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.346 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.97 -24.0 55.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.5 m -62.8 -32.97 74.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 110.33 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -5.89 39.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.402 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -95.0 100.74 5.95 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.86 -25.85 52.47 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.131 1.887 . . . . 0.0 111.97 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.3 -41.68 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 224' ' ' ILE . 27.3 mt -72.07 -54.88 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.131 178.133 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.454 ' CG ' ' ND2' ' A' ' 136' ' ' ASN . 45.5 m95 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.16 134.24 45.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mtm-85 -73.4 127.46 32.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.136 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.12 -1.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.928 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.83 176.55 11.35 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 120.683 0.278 . . . . 0.0 111.058 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.62 173.05 12.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.503 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.88 120.17 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.927 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.08 109.77 14.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.977 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.413 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.3 t0 -161.38 138.56 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 58.39 42.73 20.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 54.11 28.75 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.625 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 145' ' ' THR . 94.9 m -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 111.103 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.1 m-85 -90.23 110.15 21.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.416 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 13.2 m-30 -81.3 118.23 71.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.999 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.73 124.28 15.88 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.131 1.887 . . . . 0.0 112.563 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -106.24 125.35 50.89 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.117 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -81.67 167.98 18.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.058 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -57.28 -30.78 64.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.463 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.1 p30 -90.6 13.87 14.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.398 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.71 5.61 89.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.121 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 117.392 0.596 . . . . 0.0 110.23 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.416 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -81.33 118.66 22.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.9 mm? -103.74 96.77 6.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.755 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 37.9 mttt -71.84 -26.57 62.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -80.94 -23.74 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.526 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -98.28 22.68 9.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.642 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.2 163.27 54.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.549 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.418 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -128.53 156.38 43.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.586 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 26.12 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.57 139.67 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 118.11 59.89 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.86 106.7 2.3 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.07 1.847 . . . . 0.0 112.501 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.2 t -67.13 -13.24 61.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.74 -27.23 50.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.66 164.96 33.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -78.49 173.33 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.051 1.834 . . . . 0.0 112.757 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.0 t -130.02 154.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.928 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 67.5 mt -112.51 97.59 6.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.65 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 57.6 t -82.55 134.57 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.409 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.09 87.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.709 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.6 m95 -147.57 110.25 4.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 111.597 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -100.2 -25.91 14.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.507 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.43 95.39 7.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.44 -20.83 46.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.044 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.4 -40.56 97.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.88 -34.56 71.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.474 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.478 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 62.1 mt -61.99 -51.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.722 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.79 59.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.188 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -69.25 -51.8 33.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.173 0.511 . . . . 0.0 110.25 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -52.77 64.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.026 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.57 69.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.356 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.06 97.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.434 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.24 -38.48 87.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.913 0.387 . . . . 0.0 110.45 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' A' ' 214' ' ' PHE . 7.6 mp -64.81 -28.21 69.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.634 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -102.82 -40.84 6.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.698 0.285 . . . . 0.0 111.679 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 157.29 89.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.132 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.85 129.79 25.27 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.696 2.264 . . . . 0.0 112.749 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.3 -38.89 66.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 110.314 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.31 -57.07 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.09 -13.19 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.29 -14.68 59.92 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.369 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.39 78.63 3.9 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.918 0.359 . . . . 0.0 111.724 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.35 176.82 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.702 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.9 m -116.55 -44.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -167.51 151.82 6.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.13 135.35 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.407 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -108.42 114.41 28.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.418 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 41.3 t80 -65.85 111.03 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.832 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -132.02 76.96 72.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.418 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 53.5 Cg_endo -70.31 160.66 48.77 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.0 p -140.17 161.46 37.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.04 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -54.73 -25.63 28.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.26 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.25 -21.82 14.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.247 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.448 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.7 m-85 -136.16 80.85 1.85 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.892 0.377 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.28 -21.13 32.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.562 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -112.89 38.09 2.91 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.448 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 3.4 ttm180 -85.89 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.0 138.7 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.23 111.09 34.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.794 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.53 152.89 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 111.645 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -110.55 100.58 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.3 tpp -55.8 149.34 14.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.479 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -67.51 -20.38 65.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.089 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -76.62 -13.54 60.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.18 20.15 10.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.781 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -112.24 156.54 22.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.899 0.38 . . . . 0.0 110.775 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -110.3 117.13 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.04 159.18 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.648 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 49.8 p -121.46 149.09 43.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.22 149.37 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.79 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.688 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.8 mt -58.83 -28.03 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.118 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -32.12 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -134.24 35.97 3.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.152 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.421 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.6 t80 -54.95 -50.22 69.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.516 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.84 -48.78 80.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 0.0 111.195 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -64.92 -32.81 74.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.155 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -61.67 -53.88 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.085 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.408 HD21 ' CD1' ' A' ' 214' ' ' PHE . 3.2 mm? -80.21 -23.67 40.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.4 t -63.29 -38.81 92.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 110.687 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -64.77 -14.38 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.684 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.74 111.39 25.75 Favored Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.567 -0.083 . . . . 0.0 110.828 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.58 -25.56 34.59 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.259 1.972 . . . . 0.0 112.518 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.88 33.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.564 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.07 -56.99 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.212 178.099 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.2 m95 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -95.33 140.59 30.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.478 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -82.38 124.66 30.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 110.561 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.75 0.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.986 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.26 177.02 8.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.42 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 18.9 m-85 -140.46 173.09 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.338 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.44 120.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.985 0.421 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.498 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.45 110.95 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.9 t70 -157.12 135.87 11.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 58.05 43.96 20.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.46 29.22 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.428 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 145' ' ' THR . 85.0 m -144.01 144.04 31.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.0 m-85 -95.27 110.62 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.488 . . . . 0.0 111.048 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 10.1 m-30 -83.29 124.25 76.22 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.185 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.34 127.21 23.14 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.366 2.044 . . . . 0.0 112.82 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.44 124.78 51.6 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.817 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.6 mt -85.66 165.66 16.8 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.546 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.38 -30.71 60.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.594 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -89.71 14.19 12.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.44 3.59 82.91 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.157 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -61.04 97.15 0.06 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.167 0.483 . . . . 0.0 110.589 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -78.15 129.63 35.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.863 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.6 mt -108.06 92.38 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 21.2 mttp -72.64 -28.9 63.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.815 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.32 -21.08 42.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.472 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -101.64 28.02 5.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.505 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.31 159.42 50.2 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.384 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.413 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -128.33 157.56 40.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.952 0.406 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 25.67 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.77 139.34 32.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.483 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.15 111.65 8.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.315 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.42 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 23.3 Cg_exo -63.65 100.41 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.475 2.117 . . . . 0.0 112.196 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -65.61 -14.92 62.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.346 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.64 -27.29 40.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.3 161.86 55.01 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.9 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.97 172.9 14.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.751 1.634 . . . . 0.0 112.539 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.81 154.92 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.133 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 57.5 mt -114.09 97.69 6.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 0.0 110.492 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.68 133.81 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.459 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.45 85.53 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.809 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 68.6 m95 -147.7 115.46 6.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.966 0.413 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.19 -26.4 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.519 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.12 94.77 7.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.479 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.02 -21.26 45.0 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.096 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -39.97 96.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.75 67.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.556 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.479 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 39.6 mt -61.99 -51.76 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.638 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.62 -30.87 61.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 14.7 mm-40 -67.68 -50.77 56.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.172 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.419 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -59.77 -52.25 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -33.55 68.5 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.951 0.405 . . . . 0.0 110.321 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.2 97.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.37 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -64.14 -39.44 94.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.285 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 214' ' ' PHE . 7.6 mp -66.14 -27.53 68.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.259 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.81 -19.87 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.61 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.36 -40.76 7.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 111.483 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.61 156.82 90.99 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.964 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -49.78 129.52 24.3 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 112.864 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.58 -39.6 67.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.574 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.4 85.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.097 0.475 . . . . 0.0 110.536 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.33 -60.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.72 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.86 -24.05 66.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.453 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.26 -24.41 75.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.631 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.19 78.16 6.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.768 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 178.59 138.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.554 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -80.2 -62.01 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.65 152.16 32.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 0.0 111.041 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.23 133.88 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.197 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 33.3 m170 -107.37 111.99 24.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.956 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -65.35 106.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -129.65 79.84 72.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.73 160.86 46.33 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.276 1.984 . . . . 0.0 112.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -138.56 162.58 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -54.75 -25.96 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.279 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -103.9 -18.7 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.515 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . 0.449 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.2 m-85 -136.6 83.44 2.0 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.905 0.383 . . . . 0.0 111.219 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.92 -20.58 38.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.544 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -114.13 38.46 3.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -82.81 117.7 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.78 133.05 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.2 mm -104.09 107.98 23.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.341 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.55 152.4 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.68 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.93 100.77 9.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.013 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 10.2 tpp -54.81 149.5 11.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 111.492 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -65.95 -20.25 66.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.028 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.03 -13.54 60.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.33 20.11 11.53 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.74 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.23 162.64 14.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.666 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -112.44 120.79 42.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.685 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 39.6 t -118.25 158.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.687 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.4 p -121.95 149.44 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.44 -178.15 6.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -127.63 149.76 50.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.119 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.5 mt -64.6 -23.85 34.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.01 -31.22 56.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.445 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.25 35.98 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.1 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.419 ' CE2' ' HE3' ' A' ' 167' ' ' MET . 13.0 t80 -55.75 -50.71 69.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.83 0.348 . . . . 0.0 111.032 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.38 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.93 -41.46 97.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -56.24 -53.37 57.96 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.016 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.409 HD21 ' CD1' ' A' ' 214' ' ' PHE . 3.3 mm? -76.64 -23.19 53.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -61.59 -34.34 75.45 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.072 0.463 . . . . 0.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -71.83 -5.55 35.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 99.96 5.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -28.24 50.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.171 1.914 . . . . 0.0 111.98 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.29 81.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.714 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 25.2 mt -72.13 -54.75 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.281 178.156 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 51.1 m95 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.801 0.334 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 127.93 44.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -69.36 126.62 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.48 -0.16 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.969 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.06 176.68 9.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.963 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.422 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 18.9 m-85 -139.11 173.35 11.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.313 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.59 118.23 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.36 113.37 18.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.145 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 33.3 t0 -164.5 138.87 5.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.798 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.43 42.16 18.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 110.821 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.19 28.26 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.504 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 145' ' ' THR . 63.2 m -145.01 144.28 30.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.6 m-85 -95.16 110.58 22.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 12.3 m-30 -81.97 125.74 76.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.142 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 36.5 Cg_exo -61.29 126.1 18.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.293 1.995 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.407 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -108.14 125.04 51.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.793 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 22.0 mt -85.27 166.13 16.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.384 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.44 -30.26 60.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.499 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -91.29 15.48 11.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.382 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.56 3.63 83.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.228 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.422 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.06 96.73 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.224 0.512 . . . . 0.0 110.581 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.24 122.3 27.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.077 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.2 mt -104.5 96.64 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -72.76 -26.4 61.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -81.73 -22.9 37.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.696 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -97.55 27.25 4.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.383 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -75.26 159.08 51.34 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.801 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.406 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.4 t -126.01 155.54 41.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.684 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 29.6 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.756 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.55 22.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.43 119.05 56.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.422 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.1 Cg_endo -74.44 106.03 2.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.065 1.843 . . . . 0.0 112.68 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -67.28 -12.83 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.63 -27.23 40.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.653 0.263 . . . . 0.0 111.524 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.33 159.69 47.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.86 174.28 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.115 1.877 . . . . 0.0 112.845 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.9 t -129.79 154.61 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.065 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 59.2 mt -113.75 97.76 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.016 0.436 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.22 134.42 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.438 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.18 86.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.811 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.462 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.7 m95 -148.23 113.95 5.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.031 0.443 . . . . 0.0 111.465 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -104.74 -25.38 12.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.589 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.88 95.04 7.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.227 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.43 -21.0 47.35 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.012 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -40.15 96.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.46 -33.77 67.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.606 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 56.2 mt -61.95 -51.9 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.709 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.8 mm-40 -67.57 -50.52 58.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.247 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.4 ' HE2' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -59.63 -52.21 66.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.856 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.41 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.07 -33.69 67.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.843 0.354 . . . . 0.0 110.439 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.38 -44.09 97.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.186 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.24 -38.21 88.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.255 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 214' ' ' PHE . 6.5 mp -67.74 -28.7 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.245 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.6 -22.36 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.399 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.6 -41.15 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.709 0.29 . . . . 0.0 111.385 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.04 156.42 92.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.827 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -49.38 128.53 20.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.621 2.214 . . . . 0.0 112.792 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.14 -40.41 67.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.26 83.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.526 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.03 -60.03 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.15 -23.68 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.477 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -75.17 -22.59 76.05 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.978 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.84 78.32 6.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.871 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.85 132.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -58.29 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.14 153.33 25.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -101.66 135.71 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.438 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -108.68 114.69 28.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -69.29 113.48 6.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -133.73 71.85 74.23 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.94 159.52 51.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.299 2.0 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.4 p -139.59 161.21 38.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.101 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -52.93 -26.54 15.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -103.1 -21.46 13.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.27 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -132.79 76.81 1.71 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -21.68 23.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.652 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.55 39.55 2.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.884 0.374 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -86.3 118.31 25.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.06 133.78 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.8 mm -106.42 109.27 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.39 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.73 152.18 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 0.0 111.775 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -109.74 105.79 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.864 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 11.8 tpp -56.9 149.38 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -58.33 -22.81 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.28 -2.34 48.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.12 -15.22 60.71 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.972 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -66.48 164.87 15.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -119.61 121.38 39.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.675 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 35.7 t -119.48 159.15 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.786 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 98.4 p -121.85 149.32 43.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.021 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.83 -177.49 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.79 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.23 154.61 44.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 11.4 mt -69.76 -21.69 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.097 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.07 -30.38 31.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -133.04 35.06 3.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 171' ' ' LEU . 12.1 t80 -57.68 -47.87 81.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.23 87.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.22 -38.56 91.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -57.86 -53.31 59.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.528 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.73 -20.11 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.382 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 26.1 t -64.92 -37.74 88.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.67 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -67.25 -10.68 53.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.065 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.417 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -81.32 111.7 27.06 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.451 -0.156 . . . . 0.0 110.808 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.94 -27.11 30.88 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.233 1.955 . . . . 0.0 112.389 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.71 -44.75 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.575 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.417 HG13 ' CG ' ' A' ' 221' ' ' TYR . 25.1 mt -64.19 -56.95 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.422 178.426 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 49.3 m95 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 130.83 50.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -68.78 127.88 34.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.118 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.58 -0.2 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.007 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.5 176.82 9.37 Favored 'General case' 0 CA--C 1.523 -0.073 0 CA-C-O 120.655 0.265 . . . . 0.0 111.18 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.74 173.65 11.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.1 t -133.24 117.74 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.444 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.65 111.18 16.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.313 -179.382 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.2 t0 -169.34 144.5 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.37 40.31 21.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 53.96 29.08 9.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.65 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 145' ' ' THR . 85.2 m -150.11 142.19 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.7 m-85 -90.32 109.5 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.149 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 16.2 m-85 -79.86 123.28 83.85 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.095 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.19 123.72 13.74 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.181 1.921 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.403 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -106.29 125.11 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.0 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 18.6 mt -84.23 165.85 18.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.343 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -55.34 -30.45 60.29 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.48 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -91.3 15.1 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.276 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.36 7.13 86.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.292 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.55 95.63 0.04 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.322 0.561 . . . . 0.0 110.32 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.64 112.55 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.711 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.48 98.36 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 26.9 mttt -69.59 -26.39 64.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -74.3 -24.1 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.19 24.81 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.509 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.33 163.03 53.77 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.666 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -127.47 155.49 43.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 110.639 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.15 3.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.73 140.03 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 117.5 44.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 106.28 2.19 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.065 1.844 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -67.71 -12.47 60.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.267 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.46 -27.26 52.03 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.323 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.56 164.09 34.94 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.875 -179.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.02 173.56 14.29 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.913 1.742 . . . . 0.0 112.659 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.24 153.71 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.951 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.1 mt -113.25 97.57 6.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -83.03 135.22 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.52 86.83 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.464 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 72.9 m95 -149.14 111.52 4.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.391 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -102.23 -26.08 13.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.566 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.85 95.09 7.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.397 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.17 -21.13 45.72 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.014 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.34 97.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -33.82 68.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.576 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.48 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 52.8 mt -61.85 -51.88 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.573 178.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.13 -27.99 49.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 29.5 mm-40 -72.08 -50.6 26.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 0.0 110.356 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -52.33 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.55 -33.95 68.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.356 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.283 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -63.89 -38.42 91.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.162 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.03 -28.32 68.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.22 179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -19.27 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.544 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.26 -41.29 6.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 111.505 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.67 157.17 90.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.94 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.16 128.3 19.44 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.35 67.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.552 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.81 85.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.26 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.45 -60.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.774 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.17 -24.82 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.12 -23.75 77.06 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.727 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.43 78.34 6.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 110.746 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.25 130.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.7 m -70.15 -58.31 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.12 154.02 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.07 135.96 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.318 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.8 m170 -109.01 112.6 24.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 63.7 t80 -67.87 109.37 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -132.05 78.24 69.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 43.4 Cg_endo -68.72 160.3 50.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.253 1.968 . . . . 0.0 112.417 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -139.23 162.36 35.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.28 -25.87 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -102.11 -20.07 14.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.505 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -136.38 81.29 1.87 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.66 -21.84 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.636 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.94 39.07 2.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -84.07 115.47 22.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.43 132.98 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.276 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.8 mm -104.89 108.73 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.14 154.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.69 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -111.96 102.15 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.6 tpp -56.71 149.26 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.213 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -67.22 -19.92 65.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.36 -13.43 60.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.19 20.22 10.69 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.797 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -112.0 161.41 16.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.854 0.359 . . . . 0.0 110.691 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.69 120.6 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.806 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.4 t -118.2 158.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.444 . . . . 0.0 110.665 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.4 p -121.88 149.14 43.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.157 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.06 -177.62 6.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.709 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -126.94 151.66 48.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 211' ' ' ILE . 11.0 mt -65.95 -22.74 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -29.17 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.78 35.33 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.4 t80 -57.7 -51.43 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.16 -47.2 86.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.82 -38.69 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.42 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -58.11 -53.41 58.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.497 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.12 -19.79 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.555 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.2 t -64.56 -39.85 94.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -10.65 55.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.851 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.416 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -77.21 111.63 18.1 Favored Pre-proline 0 CA--C 1.535 0.366 0 O-C-N 122.48 -0.138 . . . . 0.0 110.863 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.92 -27.57 30.41 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.251 1.967 . . . . 0.0 112.376 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.13 -45.48 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.523 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.416 HG13 ' CG ' ' A' ' 221' ' ' TYR . 24.9 mt -62.85 -57.18 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.01 0.434 . . . . 0.0 109.944 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.356 178.396 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 57.7 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.894 0.378 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -98.98 132.48 44.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -70.01 126.36 29.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.96 1.14 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.796 179.469 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.0 176.37 9.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.963 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -139.23 173.64 11.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.334 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.3 t -133.98 117.74 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.899 0.381 . . . . 0.0 110.922 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.461 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 113.16 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.14 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.429 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.8 t70 -167.19 139.54 3.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 59.23 42.13 19.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.21 0.529 . . . . 0.0 110.954 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 54.12 27.64 7.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.686 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.409 ' CG2' ' N ' ' A' ' 145' ' ' THR . 86.5 m -145.89 141.59 27.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.461 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.9 m-85 -91.93 109.44 20.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.228 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 10.5 m-30 -79.44 123.1 84.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.872 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.86 123.86 14.14 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.19 1.927 . . . . 0.0 112.678 -179.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.49 124.97 50.4 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.834 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.18 166.27 16.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.378 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -55.64 -30.47 61.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -91.09 15.26 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.389 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.82 86.39 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.269 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 96.28 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.3 0.55 . . . . 0.0 110.36 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -86.71 113.46 22.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.88 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.2 mt -105.62 98.42 8.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 16.5 mttt -69.07 -28.59 66.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -72.39 -27.01 62.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.4 22.17 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.454 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 162.11 54.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.539 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.6 t -127.85 155.71 43.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.382 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 27.99 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.983 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 138.67 25.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.47 117.95 49.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.44 105.79 2.14 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.117 1.878 . . . . 0.0 112.657 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.72 -12.59 60.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.58 -26.94 51.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.673 0.273 . . . . 0.0 111.358 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.5 163.93 36.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.823 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.87 172.77 15.66 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.891 1.727 . . . . 0.0 112.37 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.9 153.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 58.3 mt -112.53 97.69 6.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.431 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.5 t -82.06 134.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.377 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.99 87.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.76 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.503 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.9 m95 -148.67 111.11 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.016 0.436 . . . . 0.0 111.438 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.21 -26.13 13.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.633 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -97.52 95.66 7.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.22 -21.23 46.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.1 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -40.06 96.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.57 -34.21 69.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.572 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.476 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 38.0 mt -61.85 -52.01 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.61 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.43 -28.98 57.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.24 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 6.1 mm-40 -70.89 -51.12 28.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -52.29 66.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.885 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.91 -33.79 69.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.255 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.81 97.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.305 178.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -66.07 -37.39 85.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.248 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.423 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.1 mp -68.01 -29.65 68.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.86 -19.07 62.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.39 -41.07 6.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.751 0.31 . . . . 0.0 111.541 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 156.73 91.26 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.98 130.14 26.7 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 112.792 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.19 -39.78 63.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.45 91.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 110.552 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.6 -55.59 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.686 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 pp -68.74 -12.61 61.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 178.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.69 -14.16 58.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.44 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.68 78.83 3.74 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.975 0.387 . . . . 0.0 111.593 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -178.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.554 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -121.31 -44.36 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -167.66 151.09 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.49 136.15 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.317 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.41 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.5 m170 -109.57 122.52 47.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.503 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -73.53 102.73 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.724 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -122.96 75.08 48.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 55.4 Cg_endo -70.62 161.04 47.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.335 2.023 . . . . 0.0 112.597 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.5 p -139.8 164.95 28.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.885 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -54.28 -27.86 38.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -104.28 -16.59 15.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.65 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -135.32 76.62 1.63 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.3 -21.28 33.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.711 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.76 38.37 2.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -85.77 117.8 24.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.008 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.88 133.67 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -104.53 110.58 31.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.99 156.26 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.686 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.77 106.98 15.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.411 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.17 149.23 20.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -67.29 -21.57 65.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.014 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.411 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.9 m-20 -77.21 -13.08 60.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.19 20.35 9.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.617 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 32.9 m-85 -106.52 173.38 6.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.656 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -127.78 119.73 26.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.77 159.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 94.3 p -119.91 149.11 42.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.23 -179.11 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.808 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -129.93 150.01 51.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.314 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 13.3 mt -63.27 -24.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.156 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -35.96 64.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 0.0 111.553 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -131.95 36.15 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.093 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 171' ' ' LEU . 15.2 t80 -54.84 -51.71 65.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.265 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.01 92.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.7 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.44 -38.38 87.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.144 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 24.1 mmtm -58.94 -53.67 55.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.133 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.35 -22.12 48.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t -60.13 -47.98 83.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.227 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . 0.418 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 1.5 p-80 -62.57 -15.5 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . 0.422 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -71.03 110.59 7.54 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.98 -24.23 28.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.68 -40.84 20.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.613 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.422 HG13 ' CG ' ' A' ' 221' ' ' TYR . 14.2 mt -69.72 -58.57 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.232 178.173 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 39.4 m95 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 130.06 53.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -69.77 124.84 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.0 0.79 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.891 179.639 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -165.5 176.79 7.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.582 0.229 . . . . 0.0 110.869 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 24.2 m-85 -140.47 173.33 11.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.413 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -132.29 119.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.86 0.362 . . . . 0.0 111.116 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.37 111.03 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.965 -179.526 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 43.8 t0 -156.74 134.74 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.796 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 58.52 44.21 18.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.058 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 54.74 27.59 9.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.552 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 145' ' ' THR . 87.0 m -142.12 144.0 33.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.4 m-85 -95.31 110.43 22.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.026 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 9.7 m-30 -82.81 125.34 75.7 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 35.9 Cg_exo -60.23 127.51 23.3 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.218 1.946 . . . . 0.0 112.709 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.22 124.75 52.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.639 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.1 mt -86.37 165.85 16.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.41 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.12 -30.79 60.48 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.576 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.25 12.86 14.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.6 3.45 86.78 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.081 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -60.29 97.41 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.222 0.511 . . . . 0.0 110.436 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -80.45 125.87 30.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.8 mm? -104.0 92.64 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.586 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 11.3 mttm -71.69 -28.55 63.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.858 0.361 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -81.27 -22.9 38.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.405 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -97.27 24.42 6.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.524 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.03 159.22 53.46 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.272 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.406 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -128.93 157.77 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.911 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 26.22 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.41 139.89 31.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.498 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.7 111.67 8.95 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.307 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.421 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 22.3 Cg_exo -64.06 100.59 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.386 2.058 . . . . 0.0 112.146 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -65.75 -14.76 61.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.447 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 -27.27 40.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.5 162.91 48.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.934 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.13 174.36 12.93 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.761 1.641 . . . . 0.0 112.64 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.5 t -130.78 155.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.087 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.3 mt -115.0 97.51 6.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.601 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 66.2 t -83.2 133.95 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.33 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.88 84.96 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.748 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.4 m95 -147.36 111.94 5.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.054 0.454 . . . . 0.0 111.508 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -102.13 -27.08 13.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -96.73 95.67 8.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.39 -21.06 47.24 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.037 178.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.62 98.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.78 -34.48 71.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.476 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 42.1 mt -61.95 -51.8 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.541 178.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.2 -29.62 58.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.264 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 16.3 mm-40 -70.14 -51.78 28.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.3 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -52.54 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.044 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.86 -33.55 68.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.311 179.324 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.55 -42.36 97.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.205 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -65.79 -38.36 88.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.809 0.338 . . . . 0.0 110.311 179.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 214' ' ' PHE . 8.0 mp -66.17 -27.22 67.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.397 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.43 -20.29 60.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.523 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -101.41 -41.11 6.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 156.94 89.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.15 124.93 13.75 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.64 2.227 . . . . 0.0 112.679 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.09 -38.42 65.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.591 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.45 89.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.449 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.31 -60.21 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.866 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.07 -23.5 66.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.473 178.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.23 -24.87 74.59 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.588 178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.18 78.37 7.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.29 134.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -159.53 153.68 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.421 . . . . 0.0 111.102 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.9 mt -105.05 135.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.149 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.3 m170 -109.47 119.57 39.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.31 112.24 5.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.781 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -135.85 79.72 44.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.85 163.46 38.81 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.279 1.986 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -138.73 163.45 32.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -53.54 -27.07 23.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.63 -16.47 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.656 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -134.0 79.78 1.83 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -58.58 -19.93 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.612 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -114.11 36.52 3.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.74 0.305 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.8 116.36 22.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 110.776 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.08 133.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 33.2 mm -106.01 110.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.74 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.57 157.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.599 -179.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -112.53 107.39 16.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.241 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.25 149.29 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 111.309 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -60.58 -24.57 65.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.803 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -85.95 7.07 25.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -16.53 60.91 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.51 177.1 0.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.934 0.367 . . . . 0.0 110.792 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -140.88 115.23 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.98 157.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 83.3 p -121.93 142.78 49.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.123 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.56 -177.27 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.85 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.48 149.06 49.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.476 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.3 mt -61.21 -23.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.378 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -33.68 59.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -132.4 36.19 3.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.008 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CD1' HD23 ' A' ' 218' ' ' LEU . 11.9 t80 -58.12 -39.31 78.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.242 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -69.69 -48.79 58.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.186 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.29 -34.17 76.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.106 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -53.32 56.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.392 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.42 HD23 ' CD1' ' A' ' 214' ' ' PHE . 3.4 mm? -79.31 -22.9 43.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.4 m -64.32 -39.12 93.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.631 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -16.3 52.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.673 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 111.58 13.02 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 122.512 -0.117 . . . . 0.0 110.844 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.98 -27.31 36.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.255 1.97 . . . . 0.0 112.381 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.14 -45.56 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 224' ' ' ILE . 34.6 mt -63.82 -56.28 17.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.066 0.46 . . . . 0.0 109.813 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.457 178.535 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.445 ' CE2' ' ND2' ' A' ' 136' ' ' ASN . 44.9 m95 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.779 0.323 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -101.49 132.2 47.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.673 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -71.49 127.67 33.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.22 -1.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.875 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.3 177.06 9.94 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.025 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.422 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 23.5 m-85 -139.45 173.95 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.387 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.7 t -132.42 118.55 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.45 109.6 15.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.409 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 14.9 t70 -169.2 144.88 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.74 39.65 20.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.36 0.6 . . . . 0.0 110.804 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.92 29.2 9.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.506 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 145' ' ' THR . 90.8 m -150.59 143.0 24.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 111.294 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.71 110.45 21.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.162 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.422 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 18.8 m-85 -80.47 118.55 72.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.04 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.44 121.23 9.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.023 1.816 . . . . 0.0 112.422 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.407 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.4 mt -102.57 125.36 49.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.7 mt -82.98 165.48 19.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.287 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.03 -30.38 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.677 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.445 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 53.0 p-10 -89.89 13.92 13.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.93 86.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.171 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.65 97.34 0.07 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.13 0.491 . . . . 0.0 110.429 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -80.42 121.93 26.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.33 96.6 6.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.586 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.417 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 5.0 mttt -72.71 -25.24 61.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.62 -20.86 30.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.737 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.15 23.35 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.19 163.8 54.5 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.615 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.411 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.8 t -126.68 155.28 42.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.825 0.345 . . . . 0.0 110.533 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 27.12 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.003 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.29 139.06 28.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.43 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.42 3.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.422 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 21.8 Cg_exo -64.54 98.05 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.482 2.122 . . . . 0.0 112.287 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -65.79 -14.49 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.339 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.634 0.254 . . . . 0.0 111.677 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.43 160.34 59.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.866 0.365 . . . . 0.0 111.936 -179.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.42 173.02 13.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.778 1.652 . . . . 0.0 112.668 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.9 t -129.62 154.22 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.157 179.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 59.2 mt -112.92 97.96 6.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 110.551 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.36 135.04 25.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.2 87.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.859 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.3 m95 -148.22 114.9 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.082 0.468 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -105.39 -27.04 11.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.01 95.49 7.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.43 -20.84 46.65 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.014 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -41.06 98.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.03 71.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.463 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 55.3 mt -62.01 -52.08 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.559 178.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.53 -30.93 55.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.3 mm-40 -68.3 -51.0 49.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.223 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.412 ' HE1' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -60.0 -52.05 67.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.87 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.57 -33.73 68.47 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.877 0.37 . . . . 0.0 110.359 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.51 -43.65 97.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.246 178.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.55 -39.46 94.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 214' ' ' PHE . 8.3 mp -66.93 -27.49 67.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.416 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.92 -22.25 58.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -96.94 -41.19 8.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.773 0.32 . . . . 0.0 111.506 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.09 155.55 93.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -49.89 129.82 25.5 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.632 2.222 . . . . 0.0 112.791 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.75 68.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.408 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 110.4 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.66 -60.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.604 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.55 -24.49 66.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 178.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.91 -23.5 76.23 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.872 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.99 78.29 9.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.972 0.415 . . . . 0.0 110.865 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.39 163.65 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.372 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -103.83 -51.9 3.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.41 151.22 18.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 110.943 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.73 135.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.092 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.428 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 7.5 m170 -109.52 125.25 52.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 189' ' ' PRO . 14.0 t80 -75.49 107.37 7.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.526 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -133.24 70.83 77.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.959 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 187' ' ' TYR . 20.5 Cg_exo -65.82 162.75 33.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.339 2.026 . . . . 0.0 112.252 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.9 p -135.88 164.13 28.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -26.05 11.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.445 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -105.35 -20.21 13.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.416 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -129.41 82.05 2.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -16.57 25.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.045 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -121.1 37.22 4.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.645 0.26 . . . . 0.0 111.233 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.8 ttm-85 -81.04 119.86 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.719 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.9 m -119.41 135.14 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.6 mm -105.0 110.78 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.483 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.1 m -89.66 150.71 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.63 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -109.19 108.9 19.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.236 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.48 149.31 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.469 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -64.76 -22.52 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.939 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.67 -13.17 59.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.25 20.35 9.24 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -103.51 172.49 6.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.829 0.347 . . . . 0.0 110.863 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.36 120.05 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.9 t -121.8 160.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 56.9 p -121.63 148.89 43.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.37 -179.26 7.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.72 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.59 151.52 46.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.359 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.1 mt -66.02 -25.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -79.14 -28.24 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.251 . . . . 0.0 111.403 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.05 35.77 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.416 ' CE1' HD13 ' A' ' 171' ' ' LEU . 20.1 t80 -57.89 -51.72 68.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.99 -42.01 97.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.511 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.95 -43.05 93.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -55.03 -52.64 62.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.083 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.39 -22.84 51.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.753 179.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 21.6 t -60.55 -35.47 76.11 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.092 0.472 . . . . 0.0 110.406 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -72.06 -4.94 31.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.007 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 99.4 5.95 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.07 -27.07 50.0 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.156 1.904 . . . . 0.0 111.911 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.27 -45.12 77.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 38.3 mt -70.28 -53.51 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.315 178.376 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' TRP . . . . . 0.459 ' CG ' ' ND2' ' A' ' 136' ' ' ASN . 43.3 m95 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -101.28 132.17 46.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -71.29 127.29 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.72 1.48 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.792 179.668 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.12 176.92 8.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 21.0 m-85 -139.82 173.43 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.226 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.7 t -132.92 118.58 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.57 111.25 16.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.9 t70 -169.09 145.4 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.79 40.86 22.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 54.1 30.62 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.518 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.6 m -152.0 146.42 25.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.424 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.03 109.18 20.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.657 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 18.0 m-85 -80.68 128.75 70.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.501 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.1 Cg_exo -64.16 125.33 14.98 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.162 1.908 . . . . 0.0 112.326 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.416 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.1 124.88 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.993 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.07 166.91 17.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.171 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -55.72 -30.96 62.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.551 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 6.9 p30 -90.49 13.3 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.421 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.0 5.93 89.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.108 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 96.31 0.03 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 117.253 0.526 . . . . 0.0 110.401 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.438 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -80.89 124.15 28.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.184 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.6 mm? -105.5 95.61 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.3 mtpt -72.33 -25.92 61.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.276 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -84.81 -21.14 30.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.695 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -99.31 25.7 6.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.553 0.216 . . . . 0.0 111.418 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -69.38 160.92 52.63 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.574 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 t -124.64 159.82 29.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.36 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.46 30.78 4.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.139 0.495 . . . . 0.0 109.714 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.25 129.62 9.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.483 -178.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.17 109.84 2.35 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.787 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.409 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 35.4 Cg_exo -61.19 105.85 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.225 1.95 . . . . 0.0 112.127 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.68 -15.62 61.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.481 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -81.53 -26.94 34.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.51 162.4 53.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.5 173.69 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.99 1.793 . . . . 0.0 112.749 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.55 153.27 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.886 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 56.5 mt -112.42 97.75 6.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.006 0.431 . . . . 0.0 110.638 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.8 t -82.43 134.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.514 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.74 86.91 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.722 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.8 m95 -148.41 112.93 5.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -103.42 -26.23 12.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.514 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -98.11 96.04 7.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.484 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.55 -20.97 48.14 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.028 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -40.46 97.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.96 -33.77 68.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.697 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.484 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 63.6 mt -62.28 -52.11 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.675 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.24 -30.41 59.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.187 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.7 mm-40 -67.9 -51.14 51.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 110.149 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -52.47 65.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.757 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 168' ' ' THR . . . . . 0.407 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.3 -33.7 67.94 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.268 179.253 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.13 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -66.34 -34.76 78.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.37 . . . . 0.0 110.22 178.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 214' ' ' PHE . 8.1 mp -71.79 -28.18 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -19.23 61.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.482 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.17 -40.24 8.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.8 0.334 . . . . 0.0 111.48 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -73.65 156.0 88.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.41 124.7 14.77 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.02 36.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.925 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.48 95.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.17 -60.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.949 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.58 -24.35 67.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -22.48 77.66 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.101 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.15 78.33 9.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.931 179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.4 ptp 177.86 128.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 m -64.91 -48.78 72.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.47 153.92 8.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.984 0.421 . . . . 0.0 110.997 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -102.89 136.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.269 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -111.06 116.8 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.488 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -66.71 112.02 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.853 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -133.54 78.4 62.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 56.8 Cg_endo -71.38 162.11 43.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.306 2.004 . . . . 0.0 112.53 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.9 p -138.64 161.65 36.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.149 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ptt-85 -53.84 -24.83 17.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.376 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -104.99 -20.19 13.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.429 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -134.91 82.02 1.93 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.07 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.04 -19.34 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.659 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -113.17 35.85 3.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -82.91 115.89 21.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.788 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.92 134.53 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.3 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.3 mm -105.63 110.6 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.622 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.28 153.89 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.452 -179.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -111.5 100.57 9.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.207 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.8 tpp -55.85 149.42 14.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.505 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -66.78 -20.17 65.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.039 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.83 -13.47 60.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.54 20.31 11.09 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.724 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -113.25 153.64 28.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 110.723 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.53 117.55 34.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.8 t -111.96 160.22 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.425 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 88.0 p -121.57 146.36 47.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.005 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.18 179.5 9.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -125.19 152.94 43.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.2 mt -68.37 -23.89 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.897 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -36.58 57.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.46 35.86 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.962 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CE1' HD13 ' A' ' 171' ' ' LEU . 12.2 t80 -56.17 -45.95 79.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.127 -179.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.27 82.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -60.86 -41.47 95.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -52.35 61.29 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.648 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.34 -19.48 36.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.295 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 38.0 t -64.88 -30.72 71.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.942 0.401 . . . . 0.0 110.854 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -81.55 11.26 4.78 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.94 101.85 35.88 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.2 -35.02 87.62 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.241 1.961 . . . . 0.0 112.354 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.14 -44.83 83.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.224 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 42.5 mt -65.58 -54.56 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.383 178.701 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -83.4 162.98 20.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 110.801 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.73 173.22 17.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.961 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 54.7 m95 -87.67 153.01 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.03 129.61 48.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -68.65 127.51 33.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.095 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.89 1.18 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.848 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.21 177.02 8.67 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.664 0.268 . . . . 0.0 110.837 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -140.04 173.17 11.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 19.5 t -133.34 119.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.41 109.52 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.911 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -158.5 137.55 11.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 57.95 42.64 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.61 30.56 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.394 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 89.3 m -147.82 143.0 27.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 0.0 111.001 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.484 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.1 m-85 -92.36 110.25 21.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 110.678 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 11.8 m-30 -83.07 111.57 31.47 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.388 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -47.14 126.11 11.1 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.546 2.164 . . . . 0.0 113.089 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.404 HD12 ' CG2' ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.14 125.05 51.77 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.708 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.1 mt -84.31 166.04 17.78 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.471 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.45 -30.63 60.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.534 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -91.31 15.61 11.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.357 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.13 7.13 86.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.155 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.61 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.287 0.543 . . . . 0.0 110.213 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.425 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.15 119.95 23.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.4 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 3.1 mm? -99.59 94.27 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 22.2 mttt -72.98 -29.43 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -82.2 -21.67 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.95 25.38 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.431 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.39 160.06 53.59 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.433 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.6 t -127.0 155.42 43.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.657 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.76 2.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.81 139.91 28.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.382 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.1 117.99 61.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.83 107.06 2.37 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.146 1.898 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.9 t -67.5 -12.85 61.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.74 -27.0 50.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.707 0.289 . . . . 0.0 111.397 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.1 162.83 45.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.868 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.32 174.09 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.064 1.843 . . . . 0.0 112.733 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.9 t -130.38 153.98 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.939 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.466 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 57.4 mt -113.04 97.88 6.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.13 0.49 . . . . 0.0 110.652 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.7 t -82.81 134.67 26.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.361 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.2 87.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.691 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.466 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.8 m95 -148.78 111.72 4.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 111.465 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.76 -26.67 13.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.528 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -97.52 96.18 8.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.301 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.19 -21.27 46.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.999 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.48 97.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.0 70.23 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.532 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.482 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 49.0 mt -62.57 -51.84 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.61 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.58 -27.93 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.384 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.5 mm-40 -71.29 -51.47 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 110.392 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -52.34 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.955 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.63 -33.72 68.56 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.848 0.356 . . . . 0.0 110.352 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.98 97.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.159 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -63.51 -37.77 88.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.1 mp -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.068 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.02 -18.64 61.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.723 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -101.88 -40.49 6.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.685 0.279 . . . . 0.0 111.683 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.16 156.93 91.23 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.774 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.73 124.29 13.26 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.449 2.099 . . . . 0.0 112.466 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.54 -38.48 45.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.24 98.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 51.9 t -59.71 -60.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.7 -24.03 66.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.542 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.81 -22.69 76.6 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.012 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.09 78.27 8.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 ptp 178.55 140.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 m -80.91 -53.88 6.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.3 150.67 20.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.198 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -102.52 135.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.292 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.402 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.2 m170 -109.56 118.8 37.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.769 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.447 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -70.28 110.5 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.955 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -133.01 78.34 65.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 60.8 Cg_endo -74.08 162.77 38.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.256 1.971 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.1 p -140.3 170.23 16.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -57.88 -25.35 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.306 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -104.85 -12.72 16.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.05 83.12 1.73 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 111.335 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.13 -19.08 61.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.546 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -112.42 33.71 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -81.5 115.17 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.66 133.43 63.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.221 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.6 mm -104.69 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.74 151.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.712 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -110.36 101.67 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.4 tpp -55.45 149.43 13.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.513 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -67.05 -20.58 65.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.055 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.79 -13.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.72 20.39 10.09 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.87 165.46 11.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 110.755 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.62 117.43 29.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 26.1 t -116.54 158.76 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 110.712 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 54.2 p -121.79 149.3 43.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.0 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.32 -177.72 6.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.64 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -127.59 151.88 48.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.297 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.7 mt -65.62 -24.23 34.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.964 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -76.46 -37.72 56.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.394 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -127.84 35.75 4.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.9 t80 -57.69 -42.23 83.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.801 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.73 74.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.768 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.41 -37.33 86.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.9 mmtm -58.21 -53.13 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.532 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.99 -20.05 35.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.386 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.6 t -65.68 -36.61 84.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.061 0.457 . . . . 0.0 110.752 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -70.59 -7.73 46.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.069 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.419 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -80.2 112.16 28.21 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 122.356 -0.215 . . . . 0.0 110.786 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.3 -30.64 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.26 1.973 . . . . 0.0 112.542 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.37 -45.34 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.575 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.419 HG13 ' CG ' ' A' ' 221' ' ' TYR . 25.8 mt -63.04 -57.12 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.993 0.425 . . . . 0.0 109.935 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.01 -28.57 53.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.513 178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.98 -29.04 18.9 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.774 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.36 -28.48 19.69 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.093 0.473 . . . . 0.0 110.285 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.4 mt -76.62 -31.29 57.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.097 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.4 -34.45 65.52 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.984 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -77.6 -49.45 14.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -78.08 76.98 4.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.96 133.44 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.854 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.4 114.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 110.871 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.36 -174.81 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -108.51 152.97 24.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.005 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -98.59 131.87 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.663 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.0 mtt85 -73.12 127.65 33.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.405 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.15 -0.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.768 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.03 176.76 10.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.67 0.272 . . . . 0.0 110.926 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.417 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 22.6 m-85 -139.07 173.7 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.16 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.8 t -133.97 117.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.917 0.389 . . . . 0.0 110.858 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 111.45 16.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.097 -179.498 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 t70 -168.98 144.1 3.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.793 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 40.48 21.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.14 29.45 10.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.616 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 145' ' ' THR . 90.8 m -149.75 142.68 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.326 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.9 m-85 -91.41 109.38 20.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.172 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 17.8 m-85 -79.95 122.94 83.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.31 121.17 9.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.995 1.796 . . . . 0.0 112.372 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.402 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -101.18 125.28 47.79 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.076 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.5 mt -82.22 166.17 19.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.397 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -56.6 -30.06 62.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -90.86 15.32 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.445 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.73 4.32 81.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.158 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.3 tpt85 -61.88 97.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 110.488 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -80.46 116.62 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.23 97.44 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.96 0.41 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.423 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 27.5 mttt -71.77 -26.02 62.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.12 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -77.26 -21.0 54.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -103.89 26.69 8.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.562 0.22 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.67 162.86 52.32 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.525 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.413 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -128.05 156.96 41.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.357 . . . . 0.0 110.613 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 26.72 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.83 140.37 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.446 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 118.78 56.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.417 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 67.3 Cg_endo -76.09 106.85 2.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.999 1.799 . . . . 0.0 112.678 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.5 t -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.199 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -26.95 47.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.726 0.298 . . . . 0.0 111.419 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.56 159.98 49.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -71.52 172.92 13.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.046 1.83 . . . . 0.0 112.587 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.95 154.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.01 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 59.4 mt -112.93 97.79 6.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -82.36 135.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.492 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.62 88.18 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.782 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 71.9 m95 -148.46 110.66 4.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 111.549 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -100.98 -25.25 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.631 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -99.37 96.27 7.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.328 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.94 -20.78 50.34 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.952 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -40.41 97.16 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.31 -34.06 70.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.57 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.476 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 50.4 mt -61.99 -51.93 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.573 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.64 -29.18 51.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.28 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 60.2 mm-40 -71.08 -50.51 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.386 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -52.52 65.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.771 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.405 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.56 -33.59 68.3 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 110.248 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.38 -42.72 97.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.181 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -64.33 -37.31 87.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.105 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.402 HD11 ' CE1' ' A' ' 214' ' ' PHE . 7.7 mp -68.93 -27.26 65.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.314 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.15 -20.09 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.522 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -99.1 -40.55 7.95 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.694 0.283 . . . . 0.0 111.381 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.98 155.28 90.58 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -51.22 125.27 15.95 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.499 2.133 . . . . 0.0 112.443 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.95 -36.86 40.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.797 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.17 97.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 110.355 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.46 -60.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.106 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.44 -26.52 67.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.269 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.63 -22.01 78.83 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.97 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.05 78.07 8.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.911 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 176.88 154.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.1 t -91.98 -46.75 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.159 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -166.0 151.55 8.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -103.92 135.5 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.221 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.417 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 15.7 m170 -107.97 122.8 47.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.411 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 18.1 t80 -76.53 102.8 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.744 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -123.39 70.66 44.92 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.411 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 41.1 Cg_endo -67.96 160.07 50.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.35 2.034 . . . . 0.0 112.636 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.5 p -140.12 163.19 33.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.011 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -53.39 -27.33 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.51 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.97 -19.85 14.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -133.29 76.9 1.7 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.941 0.401 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.37 -21.05 33.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.59 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.57 37.88 3.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 111.237 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -83.91 112.76 20.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.836 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.59 132.85 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.414 HG23 HD13 ' A' ' 198' ' ' ILE . 23.7 mm -104.72 108.14 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.425 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.15 151.82 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -178.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -108.75 109.8 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.12 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 149.16 7.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.48 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -61.4 -23.25 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.01 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.5 -13.22 59.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.819 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.94 20.35 9.41 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.792 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -101.28 173.09 6.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.823 0.344 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.57 120.52 36.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.8 t -121.23 159.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 96.8 p -120.14 149.09 42.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.151 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.64 -179.34 6.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.576 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -128.24 155.06 45.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.431 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 11.8 mt -69.87 -23.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.753 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -31.82 57.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -134.1 35.85 3.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 13.1 t80 -56.88 -46.97 81.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.71 99.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.35 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.19 -45.83 89.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.141 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -53.34 -53.04 56.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.604 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.96 -22.43 45.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.079 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.6 m -64.67 -28.28 69.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.797 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.8 8.52 9.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.97 102.65 40.5 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.324 -0.235 . . . . 0.0 110.406 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.93 -34.31 71.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.177 1.918 . . . . 0.0 112.387 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.57 -45.19 84.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 31.7 mt -65.83 -54.76 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.31 -29.32 47.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.51 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.81 -28.68 16.43 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.95 -28.41 16.55 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.019 0.437 . . . . 0.0 110.325 178.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 5.3 mt -77.23 -31.74 55.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 178.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.43 -22.47 63.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.444 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -53.76 -28.84 36.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.714 0.292 . . . . 0.0 111.424 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -67.31 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.784 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.86 121.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.9 tttm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.9 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -147.76 95.38 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -116.8 -177.01 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.5 m95 -74.76 154.31 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.6 ptt85 -99.53 132.32 44.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -71.91 127.48 32.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.162 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.41 1.15 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.846 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.15 177.01 8.72 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 120.643 0.259 . . . . 0.0 111.092 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -140.08 173.78 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.393 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.6 t -133.54 117.37 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 111.002 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.46 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.49 112.57 17.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.27 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 27.8 t70 -169.18 142.21 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.769 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 41.22 20.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.161 0.505 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.12 28.09 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.672 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 145' ' ' THR . 82.1 m -147.61 142.32 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.317 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.6 m-85 -92.55 110.19 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 17.9 m-85 -79.96 119.35 76.37 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.922 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.31 121.09 9.4 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.92 1.747 . . . . 0.0 112.351 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mt -102.04 125.74 48.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.15 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.7 mt -83.27 165.97 18.92 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.312 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.61 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -90.93 15.65 10.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.51 86.69 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.25 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.62 95.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.327 0.564 . . . . 0.0 110.243 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.438 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -81.03 117.29 21.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.7 mm? -100.77 96.78 7.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.414 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.2 mttt -73.25 -25.73 60.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.066 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -84.55 -21.17 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.686 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -100.83 25.47 7.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.649 0.261 . . . . 0.0 111.521 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.45 164.41 54.16 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.659 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.413 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.8 t -127.87 156.66 42.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 26.55 3.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -144.77 141.47 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.91 118.27 61.68 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 106.59 2.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.04 1.827 . . . . 0.0 112.567 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.48 -12.71 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.257 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.0 -27.42 48.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 111.367 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.97 161.44 53.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.851 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.4 173.28 14.52 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.969 1.779 . . . . 0.0 112.517 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.91 154.47 40.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.899 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.9 mt -113.48 97.97 6.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.026 0.441 . . . . 0.0 110.529 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.9 t -83.88 135.17 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.326 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.46 85.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.69 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.6 m95 -148.57 116.45 6.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.074 0.464 . . . . 0.0 111.452 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.35 -25.68 11.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.464 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.06 95.52 7.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.28 -21.01 46.2 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.071 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.17 96.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.84 -33.59 68.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.589 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.478 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 43.5 mt -62.45 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.587 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.75 55.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.243 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -69.62 -50.43 44.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.234 179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.73 -52.31 66.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.737 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.406 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.06 -33.76 69.38 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.911 0.386 . . . . 0.0 110.23 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -40.71 97.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.224 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -66.25 -37.37 85.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.247 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.7 mp -69.02 -27.69 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.269 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.59 60.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.552 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.34 -40.44 7.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.309 . . . . 0.0 111.534 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.46 157.34 89.23 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -50.76 124.01 12.73 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.494 2.129 . . . . 0.0 112.56 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.08 28.72 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.76 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.76 84.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.369 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.22 -59.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.857 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.27 -25.24 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 178.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.46 -23.03 77.99 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.951 179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.76 78.15 9.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.915 0.388 . . . . 0.0 110.715 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.84 138.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -78.9 -50.36 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -162.73 152.68 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.09 136.46 37.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.303 179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 5.3 m170 -108.49 116.17 31.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.416 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 48.2 t80 -70.21 105.04 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -126.71 75.48 75.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.416 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 44.4 Cg_endo -68.43 160.55 48.67 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.232 1.955 . . . . 0.0 112.41 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.1 p -139.44 162.38 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -54.24 -26.24 27.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.36 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -103.22 -19.71 14.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.424 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.63 79.6 1.81 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.04 -21.43 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.55 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -113.42 38.59 2.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.678 0.275 . . . . 0.0 111.111 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.19 115.92 22.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.04 132.81 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.275 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.1 mm -105.34 111.69 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.628 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.62 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.55 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -112.2 105.19 13.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.022 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.24 149.09 7.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -67.24 -22.44 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.913 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.5 -10.72 59.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.39 9.15 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.622 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.75 176.17 5.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.853 0.358 . . . . 0.0 110.741 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.93 113.08 11.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.0 t -109.84 159.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 76.5 p -121.3 146.73 46.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.669 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.6 -179.74 7.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.2 147.66 51.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.326 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 10.7 mt -58.82 -24.85 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.615 0.245 . . . . 0.0 111.417 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.95 58.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.553 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -134.21 35.96 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.235 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.05 -50.97 71.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.753 0.311 . . . . 0.0 110.921 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.65 89.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.725 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.77 -41.04 99.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.146 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 26.7 mmtt -55.41 -53.45 56.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.217 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.8 -23.03 49.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.1 t -60.41 -34.26 73.68 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.092 0.472 . . . . 0.0 110.269 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -78.24 0.83 23.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.796 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.53 99.62 6.75 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.53 -20.08 47.9 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.105 1.87 . . . . 0.0 112.41 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.27 12.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.152 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 23.5 mt -63.64 -53.04 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.38 -29.43 48.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.495 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.46 -28.45 13.17 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.66 -27.32 11.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.384 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.2 mt -79.55 -31.68 42.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.223 178.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -108.82 26.44 10.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.269 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -55.87 -57.76 10.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -176.48 -40.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.029 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.51 119.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.619 -0.193 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.3 m -91.47 147.95 22.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -135.34 179.97 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 61.3 m95 -96.93 154.96 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.161 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -95.12 145.81 24.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.519 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -86.92 124.28 32.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 110.456 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.406 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.1 OUTLIER -126.98 -0.37 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.869 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.69 176.64 10.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.174 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -139.1 173.18 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.181 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.5 t -132.95 118.17 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.939 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.459 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.27 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.433 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 39.2 t0 -169.31 143.78 2.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.683 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 60.0 40.56 18.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 53.94 27.67 7.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.679 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 86.8 m -148.17 142.23 25.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.459 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 10.5 m-85 -90.41 109.75 20.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 16.5 m-85 -80.28 123.95 82.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.195 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.1 124.09 14.18 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.219 1.946 . . . . 0.0 112.569 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.41 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.3 125.31 50.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.312 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.4 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 19.3 mt -83.35 167.87 17.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.421 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -57.09 -30.87 64.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.5 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -90.94 15.28 11.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.374 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.24 7.86 86.91 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.091 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.4 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.07 96.76 0.05 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.28 0.54 . . . . 0.0 110.282 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.42 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.04 113.33 21.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.969 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.9 mt -104.54 97.93 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 32.6 mttt -69.57 -27.11 64.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.11 -22.09 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.693 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -102.28 25.31 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.483 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.87 163.73 52.63 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.693 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.8 t -127.72 156.22 42.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.55 27.08 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.947 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.77 140.03 26.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.568 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.2 118.56 51.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.38 105.4 2.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.068 1.846 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.9 t -67.61 -12.59 60.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.87 -26.94 44.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.492 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.69 163.44 38.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.79 172.86 15.49 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.915 1.743 . . . . 0.0 112.399 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 74.9 t -128.96 154.17 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.214 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 61.7 mt -113.54 97.68 6.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.153 0.501 . . . . 0.0 110.614 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.2 t -83.03 134.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.352 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.748 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.2 m95 -147.9 113.89 5.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.1 0.476 . . . . 0.0 111.532 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -104.46 -25.64 12.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.518 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -98.79 95.69 7.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.243 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.58 -20.75 47.47 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.076 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -40.82 97.85 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.86 70.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.538 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.482 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 64.8 mt -62.54 -52.05 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -31.76 61.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.04 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -65.95 -52.08 52.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.057 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -52.28 66.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.812 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.406 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.08 -33.65 69.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.41 97.73 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.321 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -65.62 -36.99 85.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.191 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.418 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.7 mp -67.62 -28.23 67.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.2 -18.54 61.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.58 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -103.14 -40.93 6.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -70.3 157.41 90.02 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.68 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.27 123.99 13.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.67 -35.74 32.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.97 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.402 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -65.7 -41.67 92.09 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.427 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 66.9 t -58.66 -55.86 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.652 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -68.68 -12.74 61.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.65 -12.95 58.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.53 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.67 78.34 3.74 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.991 0.395 . . . . 0.0 111.408 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.14 170.14 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.5 m -103.86 -48.16 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -167.73 154.07 7.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.72 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.9 mt -104.63 134.98 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.224 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -108.96 117.57 34.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -69.21 105.14 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.739 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -128.63 78.61 75.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.39 161.73 43.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.251 1.967 . . . . 0.0 112.479 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.6 p -136.93 163.49 30.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -54.59 -25.77 28.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.456 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.71 -17.11 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -135.16 81.92 1.92 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -58.86 -19.69 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.721 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -113.81 36.93 3.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -83.81 115.09 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.6 m -116.86 136.11 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.4 mm -105.37 110.58 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.9 152.14 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.472 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.33 105.97 15.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.84 149.42 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.488 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -64.3 -21.62 66.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.22 -13.32 59.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.74 20.38 9.49 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.815 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.96 168.79 8.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.285 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -119.04 117.01 27.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.08 158.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.716 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 77.3 p -121.76 147.35 46.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.65 147.89 7.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.51 147.46 23.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.694 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.5 mt -59.59 -27.33 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.092 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.76 72.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.551 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -133.07 35.85 3.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.151 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE1' HD13 ' A' ' 171' ' ' LEU . 11.7 t80 -56.2 -43.88 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.87 -49.13 73.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -37.08 86.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.865 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.79 -53.91 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.502 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.17 -21.81 33.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.427 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 m -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 110.634 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -72.45 -4.61 31.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.414 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -90.54 110.68 42.86 Favored Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 122.276 -0.265 . . . . 0.0 110.803 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.41 -30.31 44.45 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.184 1.922 . . . . 0.0 112.393 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.92 -44.69 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.392 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.414 HG13 ' CD1' ' A' ' 221' ' ' TYR . 27.9 mt -64.56 -56.49 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 109.805 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.31 -28.83 60.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 178.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.31 -29.1 13.92 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.64 -27.4 11.28 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.402 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 3.4 mt -78.29 -32.18 49.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.8 -37.11 56.37 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -66.27 -75.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -96.9 78.8 2.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.6 p -90.59 141.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.949 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -37.54 60.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.831 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.42 -171.45 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 57.8 m95 -78.29 153.87 31.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -101.36 130.38 47.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -69.36 126.57 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.123 0.487 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.24 -1.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.787 179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.79 176.7 10.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.1 m-85 -138.09 173.6 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.5 t -134.24 119.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.958 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.414 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 109.46 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.999 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 37.3 t70 -161.31 138.05 8.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 58.59 42.62 20.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 54.17 28.42 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.546 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.414 ' CG2' ' N ' ' A' ' 145' ' ' THR . 89.8 m -145.66 141.97 28.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.414 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.2 m-85 -91.98 109.04 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.405 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.42 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 11.7 m-30 -79.73 123.03 84.14 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.784 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 123.89 14.05 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 112.642 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 mt -105.89 125.01 50.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.946 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.7 mt -84.4 165.92 17.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.191 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -55.47 -30.33 60.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.505 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.4 15.0 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.368 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.99 6.35 87.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.288 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.95 95.65 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.246 0.523 . . . . 0.0 110.358 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.411 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -86.1 112.98 21.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.876 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -102.74 98.08 8.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.625 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 17.1 mttp -69.8 -28.85 66.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -74.45 -23.71 58.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.78 25.54 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.451 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.08 162.88 52.94 Favored Glycine 0 CA--C 1.51 -0.246 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.479 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.414 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -127.7 155.3 44.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.794 0.331 . . . . 0.0 110.808 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 27.62 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.57 139.12 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.18 118.32 54.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.064 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -77.73 105.54 2.04 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.887 . . . . 0.0 112.726 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -67.88 -12.17 60.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.191 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -77.86 -27.17 49.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 111.386 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.83 160.01 51.66 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -71.76 173.25 12.95 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.103 1.869 . . . . 0.0 112.71 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 72.6 t -129.48 154.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.943 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.455 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 57.7 mt -112.95 97.99 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.9 t -83.04 134.96 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.33 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.75 85.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.842 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.455 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 71.1 m95 -148.93 112.7 5.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.41 -25.11 13.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.58 95.41 7.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.236 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.03 -21.46 45.71 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.085 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -40.06 96.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.67 67.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.6 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.483 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 43.7 mt -61.93 -51.74 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.573 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.09 58.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 1.6 mm-40 -68.81 -51.76 37.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.95 -51.74 68.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.734 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -33.72 70.39 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.177 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.73 -41.55 95.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.167 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -65.04 -39.42 93.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.986 0.422 . . . . 0.0 110.03 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.1 mp -67.49 -28.56 67.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -20.49 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.691 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -99.64 -41.32 7.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.506 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -70.12 157.66 89.31 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -51.38 123.6 12.4 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.482 2.121 . . . . 0.0 112.539 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.53 18.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.1 81.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.387 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 50.1 t -58.91 -59.88 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.866 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.6 -24.8 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.355 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.14 -23.27 76.41 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.981 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.33 78.15 9.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.918 0.39 . . . . 0.0 110.803 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.31 157.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.507 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 74.0 m -100.8 -55.56 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.172 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.1 149.69 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.0 135.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.266 179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.0 m170 -107.77 122.18 46.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.414 ' CZ ' ' HG3' ' A' ' 189' ' ' PRO . 17.5 t80 -76.35 105.07 7.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.771 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -124.82 73.76 64.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.414 ' HG3' ' CZ ' ' A' ' 187' ' ' TYR . 58.8 Cg_endo -72.21 158.88 51.04 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.307 2.005 . . . . 0.0 112.549 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.6 p -143.71 167.11 23.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -25.8 59.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.294 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -100.95 -17.64 16.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.59 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -143.22 78.7 1.61 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 121.008 0.432 . . . . 0.0 111.146 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.42 -20.17 42.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.633 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.1 36.81 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -84.89 115.57 22.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.2 m -120.51 133.06 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.6 mm -104.47 112.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 3.1 m -89.04 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -110.82 103.73 12.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.969 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.29 149.03 3.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.652 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -64.76 -22.28 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.963 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.402 ' CB ' ' CE2' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -78.9 -13.33 59.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.42 9.32 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.709 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.402 ' CE2' ' CB ' ' A' ' 203' ' ' ASP . 27.5 m-85 -104.18 164.25 11.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.21 120.77 42.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 40.4 t -122.0 158.54 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.645 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 39.3 p -121.93 149.21 43.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.91 -178.0 5.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -129.95 154.62 47.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.398 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.7 mt -67.69 -21.88 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.123 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -30.28 30.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.5 35.04 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.6 t80 -59.13 -47.11 86.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.795 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.71 -46.27 90.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.669 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.16 -37.71 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -59.4 -53.4 58.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.457 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.72 -22.0 43.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.294 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.2 t -63.8 -40.56 96.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.382 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -64.5 -14.65 58.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.805 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -75.91 111.33 14.23 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.467 -0.093 . . . . 0.0 110.886 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.12 -25.76 31.23 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.273 1.982 . . . . 0.0 112.599 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.5 -40.77 25.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.578 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.42 HG13 ' CD1' ' A' ' 221' ' ' TYR . 17.3 mt -69.37 -58.27 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.83 -29.12 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.216 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.49 -28.23 19.55 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.561 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.72 -27.31 11.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.5 mt -79.97 -31.96 39.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.132 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.28 18.99 15.07 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.521 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -91.13 -31.74 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 17.5 t 61.51 31.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.5 mttt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.851 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.0 m 60.21 80.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -153.29 -176.76 5.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -79.82 151.09 30.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.5 128.79 45.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.691 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.4 mtm-85 -68.08 127.8 34.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.025 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.53 1.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.84 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.84 176.62 8.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.65 0.262 . . . . 0.0 110.863 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.406 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 23.1 m-85 -139.66 173.19 11.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.02 118.95 34.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.0 111.038 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.494 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.22 112.0 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.009 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.419 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.1 t70 -156.47 133.86 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 58.16 44.6 18.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.969 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 55.01 28.27 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.433 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.414 ' CG2' ' N ' ' A' ' 145' ' ' THR . 86.5 m -142.08 143.46 33.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.494 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.4 m-85 -95.63 110.7 22.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.43 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 9.2 m-30 -84.05 124.79 74.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.61 127.3 23.2 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.295 1.997 . . . . 0.0 112.841 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.88 125.15 52.49 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.733 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 21.3 mt -85.13 165.15 17.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.513 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -55.25 -29.94 59.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.609 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -91.32 15.6 11.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.357 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.77 3.33 79.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.341 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -61.31 97.58 0.07 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.343 0.572 . . . . 0.0 110.533 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.1 tt -78.79 132.27 36.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.001 -179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.1 mt -111.51 92.71 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.665 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.43 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.4 mttt -71.63 -28.49 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -80.23 -23.33 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.495 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -97.85 26.07 5.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.494 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.33 159.94 49.12 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.559 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.414 ' N ' ' CG2' ' A' ' 129' ' ' THR . 3.3 t -130.86 159.44 37.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 20.39 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.297 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -136.66 142.19 43.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.596 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.21 119.56 76.98 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.406 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.9 Cg_endo -73.71 106.58 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.046 1.831 . . . . 0.0 112.539 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -13.5 61.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.302 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.14 42.94 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.626 0.25 . . . . 0.0 111.554 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.56 161.11 56.41 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.83 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -73.63 173.42 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.959 1.773 . . . . 0.0 112.673 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.3 t -130.05 153.09 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.7 mt -112.84 97.55 6.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.7 t -82.73 134.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.452 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.56 85.98 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.78 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.473 ' CE3' ' CE2' ' A' ' 187' ' ' TYR . 68.0 m95 -147.1 110.82 4.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 0.0 111.607 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -101.38 -27.11 13.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.95 95.26 8.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.246 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.475 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.44 -20.91 47.07 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.983 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -40.7 98.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -34.41 71.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.449 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.475 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 47.6 mt -61.81 -51.95 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.622 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.1 60.02 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -69.46 -51.44 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.9 -52.43 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.958 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.23 -33.61 69.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.856 0.36 . . . . 0.0 110.334 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.89 97.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.346 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -64.94 -37.75 88.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.163 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD12 ' CE1' ' A' ' 214' ' ' PHE . 7.4 mp -67.88 -27.47 66.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.249 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.13 -19.47 60.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.513 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.49 -40.72 7.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.674 0.273 . . . . 0.0 111.551 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.04 157.1 91.05 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.474 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -51.08 123.7 12.42 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 112.498 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -34.08 30.23 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.727 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.21 87.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 110.357 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 49.1 t -58.96 -60.29 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.902 179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.42 -25.02 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.47 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.93 -23.1 77.14 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.606 -0.806 . . . . 0.0 111.818 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.23 78.29 8.84 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 110.815 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 178.38 133.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.57 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 m -70.48 -61.64 1.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -154.86 152.32 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -102.76 135.21 41.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -107.75 114.89 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.045 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.473 ' CE2' ' CE3' ' A' ' 158' ' ' TRP . 0.6 OUTLIER -68.47 114.21 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -134.59 76.09 61.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.42 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 58.5 Cg_endo -72.21 157.68 53.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.415 2.077 . . . . 0.0 112.659 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.4 p -141.96 161.99 36.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.891 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -55.52 -25.64 38.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.9 -22.13 15.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.108 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -138.46 75.13 1.5 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.02 0.438 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.18 -21.22 21.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.757 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.18 39.26 2.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 111.08 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -87.91 122.92 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.4 mm -104.41 108.77 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -87.58 151.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 0.0 111.54 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.77 105.02 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.073 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.59 149.13 3.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.659 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -64.13 -22.64 67.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.15 -13.3 60.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.36 9.38 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.678 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -105.32 167.67 9.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.933 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -116.39 120.76 39.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 46.2 t -120.79 158.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.64 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 90.7 p -122.29 148.97 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.125 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -164.27 -179.17 5.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.663 179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.4 p -126.56 152.95 45.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 16.4 mt -68.54 -25.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.802 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -32.08 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.23 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -134.13 35.93 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.002 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.415 ' CE1' HD12 ' A' ' 171' ' ' LEU . 12.6 t80 -55.41 -49.39 72.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.443 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.84 -44.56 89.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.262 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -53.7 -50.61 65.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.993 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -79.42 -21.62 45.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.669 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.7 t -60.62 -33.68 73.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 0.0 110.436 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -78.75 4.72 13.04 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.137 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -100.19 99.17 8.9 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 122.238 -0.289 . . . . 0.0 110.257 179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.26 -24.89 43.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.174 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.51 -49.15 34.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 49.8 mt -64.02 -53.46 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.01 -29.15 59.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.467 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.4 -29.0 14.23 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.59 -27.68 11.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.373 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.3 mt -78.27 -31.89 49.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.201 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.6 -41.68 53.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -91.25 -70.98 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.21 85.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.6 m -104.35 80.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.884 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -125.71 -175.68 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.66 -173.31 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 49.9 m95 -92.31 150.12 21.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.099 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 10.7 ttp180 -98.12 138.25 35.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.324 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 33.3 mtm180 -79.68 129.07 34.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.323 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.9 1.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.984 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.88 176.9 9.74 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.238 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.43 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 23.9 m-85 -139.13 173.81 11.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.6 t -134.25 116.63 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.466 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.4 110.43 15.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.009 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -169.01 145.19 3.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.26 39.4 22.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.846 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.27 30.62 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.569 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 90.9 m -151.93 142.78 22.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.466 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.6 m-85 -90.53 109.8 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.133 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.441 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 18.1 m-85 -80.42 118.77 73.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.964 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.47 122.32 11.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.013 1.809 . . . . 0.0 112.351 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.3 mt -103.24 125.28 49.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.171 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.414 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 19.9 mt -82.35 166.39 19.5 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -56.68 -30.52 63.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -90.87 15.32 11.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.354 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.65 6.9 87.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.21 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.414 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.0 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.311 0.556 . . . . 0.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.441 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -81.01 117.91 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.76 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.413 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.8 mm? -102.19 97.34 7.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 22.8 mttp -72.38 -26.38 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -83.58 -21.15 32.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -100.42 24.31 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.38 164.3 54.63 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.783 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -127.54 156.53 42.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.525 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.9 28.16 3.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.8 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.33 139.37 25.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.618 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.25 118.55 54.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.917 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.43 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 64.8 Cg_endo -76.23 105.71 2.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.06 1.84 . . . . 0.0 112.668 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -67.61 -12.44 60.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -27.24 41.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.709 0.29 . . . . 0.0 111.501 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.17 160.05 53.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.925 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.01 172.88 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.962 1.775 . . . . 0.0 112.743 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.3 154.74 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.921 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 60.9 mt -114.15 97.82 6.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.478 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 77.7 t -83.34 135.11 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.58 86.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.733 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.457 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 72.2 m95 -149.05 111.85 4.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.418 . . . . 0.0 111.492 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -102.27 -25.35 13.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.599 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.43 96.24 7.88 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.479 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.8 -20.65 48.7 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.976 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.45 -40.68 97.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.33 -33.89 70.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.529 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.479 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 51.4 mt -62.38 -51.84 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.591 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.18 -29.7 58.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.53 -51.22 37.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.417 ' HE1' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -58.72 -52.48 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.789 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.7 -33.49 70.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.886 0.374 . . . . 0.0 110.241 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.56 -42.59 96.12 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.402 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -66.1 -38.86 89.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 214' ' ' PHE . 8.1 mp -66.49 -26.24 67.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.3 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.63 59.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.572 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.03 -40.53 7.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.761 0.315 . . . . 0.0 111.461 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -72.41 156.82 90.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.362 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -50.61 124.48 13.49 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.561 2.174 . . . . 0.0 112.628 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.53 50.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.54 91.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 110.315 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.9 t -60.13 -60.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.926 179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.33 -24.48 66.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.381 178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.0 -23.21 76.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.852 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -84.58 78.16 9.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.695 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 177.3 141.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.408 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.8 -50.01 11.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -163.68 153.06 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -104.25 133.9 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.135 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.409 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.6 m170 -106.82 112.51 25.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.029 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.427 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 73.1 t80 -67.53 102.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -125.81 77.48 70.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.048 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.427 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 43.1 Cg_endo -68.16 166.76 23.97 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.223 1.949 . . . . 0.0 112.322 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 p -141.35 173.54 11.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -27.3 68.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.015 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.403 ' HG3' ' CD2' ' A' ' 193' ' ' TYR . 5.6 pt-20 -114.95 10.99 16.43 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.403 ' CD2' ' HG3' ' A' ' 192' ' ' GLU . 71.6 m-85 -155.88 73.49 0.82 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -21.66 23.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.64 39.26 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.235 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 112.66 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.74 134.13 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 198' ' ' ILE . 22.5 mm -105.95 111.37 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.62 152.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.503 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -109.54 105.28 14.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.24 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.53 149.3 8.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -66.65 -22.35 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.97 -12.03 59.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.3 14.68 19.68 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.837 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -100.65 174.26 6.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.849 0.325 . . . . 0.0 110.511 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.41 120.58 27.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 0.0 110.963 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.2 t -117.22 160.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.459 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 96.5 p -118.67 145.13 45.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.792 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.68 151.3 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.823 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.87 146.87 27.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.405 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 15.4 mt -58.8 -27.15 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 111.059 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -32.86 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.546 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -133.98 35.8 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.228 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 171' ' ' LEU . 13.5 t80 -55.39 -50.41 69.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.154 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.49 88.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.77 -43.02 99.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.11 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.403 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 10.7 mmtt -51.94 -51.26 58.26 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.016 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.16 -16.56 46.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.958 179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.9 t -62.48 -34.91 77.77 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.478 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 1.7 p-80 -81.5 8.12 10.3 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.406 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -101.99 99.31 11.92 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.29 -28.16 40.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.192 1.928 . . . . 0.0 112.175 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.64 -49.06 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.028 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.406 HG13 ' CD1' ' A' ' 221' ' ' TYR . 32.2 mt -65.76 -53.41 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.13 -29.83 46.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.514 178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.48 -29.21 15.63 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.682 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.87 -28.06 14.8 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.9 mt -78.05 -31.06 50.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.31 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.0 -31.97 72.88 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 8.6 mtt85 -62.71 -33.5 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -113.93 84.68 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 15.4 t -101.28 36.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.5 tttm . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.862 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.58 -77.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.712 0.291 . . . . 0.0 111.027 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -97.69 -177.36 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -129.05 153.8 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.55 128.81 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.54 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -69.51 126.74 30.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.035 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.68 -0.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.784 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.44 176.78 10.13 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.736 0.303 . . . . 0.0 110.984 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -138.88 173.34 11.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.9 t -133.71 119.43 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.91 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.15 110.95 16.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.191 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.416 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 13.4 t70 -162.09 137.73 7.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 59.16 42.93 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 53.96 26.87 6.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.599 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 145' ' ' THR . 92.2 m -143.49 141.95 30.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.97 0.414 . . . . 0.0 111.007 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.5 m-85 -91.63 110.0 21.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.37 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.423 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 12.0 m-30 -81.07 122.69 81.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.879 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.25 123.81 13.9 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.172 1.914 . . . . 0.0 112.684 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.407 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.73 125.19 50.7 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.914 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.9 mt -83.6 165.76 18.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.321 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.84 -30.21 61.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -90.87 14.87 12.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.411 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.28 4.15 83.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.33 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.6 tpp85 -61.21 97.6 0.07 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.333 0.566 . . . . 0.0 110.482 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.79 117.39 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.068 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.91 97.65 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.423 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.8 mttp -69.96 -29.68 66.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.792 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -71.28 -22.61 61.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -101.8 24.53 9.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.505 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.07 162.2 52.52 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.439 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.411 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.8 t -128.35 156.49 43.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.849 0.357 . . . . 0.0 110.807 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 25.86 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.171 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.93 139.43 30.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.605 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 117.99 53.95 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.3 105.96 2.14 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.114 1.876 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.8 t -67.41 -12.84 61.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.204 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.57 -27.3 51.39 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.39 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.12 164.01 38.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -77.17 172.94 15.19 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.934 1.756 . . . . 0.0 112.445 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.6 t -129.57 154.88 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.067 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 60.0 mt -113.31 97.9 6.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.424 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.403 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.9 t -82.72 134.93 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.473 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.65 86.89 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.803 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.457 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.2 m95 -148.32 113.93 5.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 111.512 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -26.77 12.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.486 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.28 96.07 8.14 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.49 -20.95 47.64 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.026 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -40.7 98.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.49 69.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.497 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 50.0 mt -62.72 -52.37 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.48 47.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.238 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 7.0 mm-40 -68.73 -52.1 34.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -52.83 64.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.99 -33.53 69.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.246 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.44 -42.63 97.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.306 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -64.68 -36.9 85.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.924 0.392 . . . . 0.0 110.107 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.402 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.1 mp -67.81 -27.74 66.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.072 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.65 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.583 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.59 -40.31 6.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.74 0.305 . . . . 0.0 111.726 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -71.38 156.97 90.94 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.42 124.38 14.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.624 2.216 . . . . 0.0 112.648 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.75 -35.65 32.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.852 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 110.259 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 57.9 t -58.45 -55.58 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.768 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.45 -12.61 61.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.826 178.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 -12.69 58.42 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.575 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -93.63 78.05 4.31 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.093 0.447 . . . . 0.0 111.205 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.97 176.95 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 p -113.05 -46.22 3.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.88 0.372 . . . . 0.0 110.8 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -167.88 152.43 6.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.882 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -104.74 135.33 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.267 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.403 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 8.2 m170 -107.8 121.91 45.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -75.64 101.82 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -123.42 74.36 51.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.61 160.62 47.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.376 2.051 . . . . 0.0 112.564 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -139.09 163.44 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.985 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -53.96 -26.75 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.42 -18.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -134.09 79.38 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.952 0.406 . . . . 0.0 111.115 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.27 -21.14 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.699 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -114.14 38.28 3.07 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.777 0.322 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 113.89 20.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.58 132.93 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.65 111.26 33.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.63 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -85.0 153.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.467 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -109.09 109.93 21.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.255 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 149.27 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -60.64 -24.37 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -85.37 7.03 23.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.13 -16.32 61.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.915 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.83 173.03 1.12 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -135.02 119.13 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 16.3 t -115.33 159.54 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.662 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 89.3 p -119.28 149.14 42.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.59 -179.57 6.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -127.92 151.18 49.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.386 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.7 mt -64.94 -25.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.949 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -31.13 62.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.399 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.56 36.13 3.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.13 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 15.7 t80 -56.13 -50.72 70.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.013 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.3 97.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -63.92 -47.64 79.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.042 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 21.8 mmtm -51.83 -51.82 53.79 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.672 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.37 -21.51 42.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.2 m -64.29 -27.74 69.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.753 0.311 . . . . 0.0 110.757 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -85.66 17.1 3.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.061 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.24 103.63 55.0 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.68 -24.46 35.08 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.143 1.895 . . . . 0.0 112.418 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.02 -49.69 42.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.159 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 41.5 mt -63.44 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.7 53.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -50.64 -28.36 8.71 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.56 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.03 -27.33 13.29 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.294 178.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.8 mt -77.03 -32.6 57.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.48 -30.82 33.21 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.083 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -59.91 -37.53 79.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -107.72 92.82 4.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.7 p -168.97 140.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 26.0 pttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.884 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.52 163.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -127.4 -176.04 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -69.73 150.67 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 0.0 110.617 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -96.12 130.14 43.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -71.48 126.33 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.42 0.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.947 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.29 176.79 9.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.086 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.443 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 58.2 m-85 -138.83 173.27 11.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.323 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.8 t -134.08 118.18 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.996 0.426 . . . . 0.0 111.044 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.1 109.4 14.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.961 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -158.73 139.27 12.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 40.96 23.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 55.08 31.13 15.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.332 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 145' ' ' THR . 84.8 m -147.69 144.02 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.994 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.3 m-85 -93.44 110.46 22.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 10.5 m-30 -82.8 127.09 71.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.412 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 28.3 Cg_exo -62.18 125.76 17.11 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.329 2.019 . . . . 0.0 112.746 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -107.8 124.97 50.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.795 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.405 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 21.6 mt -85.29 165.44 17.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.408 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -55.22 -30.46 60.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.49 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -91.56 15.82 11.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.85 7.74 86.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.321 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.405 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.89 96.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.332 0.566 . . . . 0.0 110.408 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.6 123.1 29.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.825 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.4 mt -107.77 96.56 6.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.9 mttp -70.98 -26.79 63.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.009 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -79.9 -23.06 42.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.577 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -98.02 25.51 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.515 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.71 159.35 52.14 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.418 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.408 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.5 t -127.09 156.39 41.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 27.32 3.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 139.61 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.74 117.95 55.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.443 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 64.7 Cg_endo -76.12 105.95 2.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.065 1.843 . . . . 0.0 112.643 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.4 t -67.82 -12.32 60.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.263 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -27.39 53.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.714 0.293 . . . . 0.0 111.271 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -143.34 160.66 50.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.859 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.73 172.72 14.69 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.029 1.819 . . . . 0.0 112.678 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 78.8 t -128.74 154.87 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.923 179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 45.6 mt -113.62 97.72 6.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.546 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 60.5 t -83.6 132.52 31.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.622 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.8 82.77 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.874 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 57.9 m95 -144.55 99.38 3.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.586 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -25.21 21.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -98.35 97.62 8.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.85 -20.88 50.05 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.969 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -40.22 96.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.45 70.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.488 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.478 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 47.1 mt -61.89 -51.72 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -56.28 -29.17 60.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -71.04 -50.01 38.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.103 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.423 ' HG3' ' CH2' ' A' ' 158' ' ' TRP . 1.2 mmm -57.65 -52.54 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.791 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -60.06 -33.53 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.172 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.24 94.16 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.501 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.74 -39.56 91.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.0 0.429 . . . . 0.0 109.982 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.431 HD12 ' CE1' ' A' ' 214' ' ' PHE . 3.5 mp -66.83 -28.41 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.52 -19.89 60.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.734 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.77 -40.55 7.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 111.473 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.2 pp -72.25 156.28 90.71 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.579 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -51.41 125.56 16.93 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.531 2.154 . . . . 0.0 112.429 179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.1 53.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.823 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.86 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.446 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.5 t -59.05 -60.05 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.093 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.61 -23.29 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.551 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -72.79 -24.82 75.38 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.782 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -82.36 78.06 9.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.775 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 177.16 153.33 0.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.465 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.05 -53.87 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.095 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.67 151.06 25.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.5 mt -106.27 134.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.397 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.3 m170 -106.38 127.47 53.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.24 112.55 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -135.0 78.04 54.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 163.22 32.96 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.351 2.034 . . . . 0.0 112.652 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -144.58 167.92 21.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -57.91 -24.15 56.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.22 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.69 -16.57 15.98 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -144.13 83.06 1.73 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -60.05 -20.5 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.626 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.29 34.32 4.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.71 0.291 . . . . 0.0 111.141 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.69 112.05 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.783 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.7 m -115.4 136.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.243 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.0 mm -106.91 109.75 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -86.45 155.63 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.743 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.04 105.79 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.982 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.55 149.11 6.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.918 0.389 . . . . 0.0 111.636 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -64.49 -23.44 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.918 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -77.58 -13.01 60.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.34 20.39 9.17 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.4 172.63 6.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -126.37 117.11 22.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.4 t -118.8 160.11 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 59.7 p -121.47 146.75 46.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.36 -177.69 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.699 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -126.82 154.38 44.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 4.6 mt -69.31 -25.02 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.776 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -80.96 -28.64 35.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.286 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -132.28 35.5 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.431 ' CE1' HD12 ' A' ' 171' ' ' LEU . 48.7 t80 -60.43 -50.51 73.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.98 -36.84 82.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.278 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -68.25 -45.68 72.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.1 mmpt? -53.77 -53.18 55.87 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.46 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.96 -24.95 55.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.818 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.4 m -61.12 -30.46 70.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.878 0.371 . . . . 0.0 110.407 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.66 5.57 12.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.046 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.77 101.72 34.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.56 -24.25 42.19 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.142 1.895 . . . . 0.0 112.326 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.1 -48.73 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 36.2 mt -64.86 -53.67 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -53.7 -29.32 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.636 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.53 -29.19 23.99 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.65 11.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.115 0.483 . . . . 0.0 110.502 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.0 mt -77.86 -32.81 52.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.158 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.67 -30.54 32.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.875 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -24.22 67.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.404 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -55.08 -51.02 67.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.687 0.28 . . . . 0.0 111.425 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 6.9 m -64.54 128.37 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.897 0.38 . . . . 0.0 111.098 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.968 -179.909 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 m -134.25 -48.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.38 -177.7 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -72.23 155.11 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -97.17 132.45 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.476 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -71.98 126.56 30.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.102 0.477 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.21 1.42 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.886 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.77 176.64 8.6 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.997 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -139.88 173.0 11.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.443 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 25.2 t -132.96 119.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.12 111.67 16.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.109 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 24.3 t0 -158.35 136.29 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.22 43.72 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.004 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 54.85 28.88 11.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.418 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 145' ' ' THR . 86.3 m -144.29 144.08 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.071 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.4 m-85 -94.61 110.4 22.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 111.04 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 10.1 m-30 -82.72 125.23 76.19 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.2 Cg_exo -59.66 126.96 22.0 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.348 2.032 . . . . 0.0 112.853 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.409 HD12 ' CG2' ' A' ' 164' ' ' ILE . 0.8 OUTLIER -109.47 124.82 51.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.703 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.9 mt -85.51 166.5 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.459 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -55.65 -30.68 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.651 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -91.08 15.34 11.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.477 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.45 3.88 83.46 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.326 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.76 97.93 0.06 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.264 0.532 . . . . 0.0 110.548 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.39 129.98 34.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.052 -179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 24.5 mt -110.67 94.41 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.652 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 44.2 mttt -71.61 -28.95 64.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -80.12 -21.45 43.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.578 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -99.56 25.79 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.33 159.0 52.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.53 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.5 t -127.48 156.65 41.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.663 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.56 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.04 141.36 28.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.61 119.1 73.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.29 107.09 2.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.108 1.872 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.2 t -66.78 -13.34 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.286 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.52 -27.16 41.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.61 0.243 . . . . 0.0 111.512 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.82 162.81 48.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.925 -179.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -77.31 173.16 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.996 1.797 . . . . 0.0 112.627 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 76.7 t -129.43 154.55 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.076 179.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 51.5 mt -114.17 97.77 6.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 0.0 110.561 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.8 t -82.41 134.84 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.84 87.04 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.878 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.46 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 67.4 m95 -146.97 116.62 7.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 111.545 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -106.68 -27.43 10.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.344 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.74 95.19 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.38 -20.91 46.56 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.03 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -40.64 97.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.13 -34.28 70.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.505 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.483 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 62.0 mt -62.13 -51.63 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.662 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.62 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -66.99 -50.46 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.401 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -59.64 -52.48 65.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.741 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.408 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.73 68.7 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.847 0.355 . . . . 0.0 110.268 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.98 98.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.366 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -66.84 -35.1 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.193 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.412 HD12 ' CE1' ' A' ' 214' ' ' PHE . 6.5 mp -70.59 -28.97 65.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.059 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.84 -18.13 62.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.68 -40.98 6.38 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -71.11 157.41 90.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.695 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -51.21 123.88 12.88 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.629 2.219 . . . . 0.0 112.54 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.74 -36.31 35.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.988 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.4 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -64.05 -42.51 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.258 0.551 . . . . 0.0 110.309 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 78.5 t -58.78 -56.12 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -67.86 -13.64 62.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.766 178.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.88 -14.29 59.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.585 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.53 78.61 3.82 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 111.609 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.98 153.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.556 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.51 -49.64 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -167.55 156.82 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -104.79 135.48 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.406 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.427 ' CD2' ' CE1' ' A' ' 200' ' ' TYR . 13.1 m170 -106.14 127.78 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -80.12 111.63 16.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -133.62 73.55 72.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.854 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.19 160.02 51.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.285 1.99 . . . . 0.0 112.594 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.6 p -140.48 162.1 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -54.74 -25.86 30.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.368 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -102.43 -20.47 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -135.41 77.34 1.67 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.927 0.394 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -55.83 -22.21 23.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.767 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -113.05 39.51 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.314 . . . . 0.0 111.307 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.58 116.09 24.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.8 m -121.49 137.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.08 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.62 110.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.4 m -84.62 153.32 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.639 -178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.427 ' CE1' ' CD2' ' A' ' 186' ' ' HIS . 6.3 m-85 -111.42 107.37 16.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.78 149.25 14.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.296 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.99 -24.05 66.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.882 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.42 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.3 m-20 -75.84 -13.28 60.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.21 20.3 9.31 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.787 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.42 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 51.7 m-85 -104.87 174.06 6.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -127.88 123.95 36.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.044 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 20.3 t -124.37 159.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 79.4 p -118.92 144.91 46.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.09 149.68 12.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.68 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.25 147.15 24.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.582 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 14.4 mt -58.5 -27.48 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.195 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -32.87 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -130.16 35.8 4.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.074 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.412 ' CE1' HD12 ' A' ' 171' ' ' LEU . 12.3 t80 -57.8 -51.82 68.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.91 87.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.75 -42.67 99.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.0 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 2.3 mmpt? -52.31 -53.42 44.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.49 -21.22 42.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.973 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.8 t -60.03 -33.85 72.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.007 0.432 . . . . 0.0 110.447 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.75 3.87 15.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.128 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.36 99.87 14.1 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.25 -26.36 42.01 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.09 1.86 . . . . 0.0 112.126 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.38 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 29.9 mt -64.2 -53.05 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.36 -29.26 47.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.596 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.69 -28.55 15.15 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.93 -27.48 13.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.103 0.477 . . . . 0.0 110.401 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 3.8 mt -77.14 -32.53 56.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.137 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.22 -57.51 8.31 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 56.82 26.42 11.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -144.78 -55.21 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.25 143.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 tptt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.915 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -71.31 -38.89 71.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.77 0.319 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 60.79 -178.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.451 ' CG ' ' ND2' ' A' ' 136' ' ' ASN . 44.0 m95 -94.48 148.57 22.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -99.72 132.84 44.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -72.06 127.81 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.9 0.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.949 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.6 176.75 10.06 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.094 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -138.39 173.21 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.364 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.1 t -133.93 117.55 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.967 0.413 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.477 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.59 114.42 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.277 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.437 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.4 t70 -169.09 142.01 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.771 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 59.34 41.14 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.497 . . . . 0.0 110.738 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.15 29.65 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.441 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.407 ' CG2' ' N ' ' A' ' 145' ' ' THR . 46.8 m -148.3 145.09 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.434 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.3 m-85 -95.52 110.53 22.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.701 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.437 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 17.9 m-85 -80.84 129.1 69.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.108 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.73 123.92 12.4 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.167 1.911 . . . . 0.0 112.31 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.406 HD12 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -105.57 125.09 50.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.09 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.3 mt -84.11 167.09 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.197 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -55.75 -31.12 62.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.451 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.0 p30 -90.85 14.39 13.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.39 7.68 87.82 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.021 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.1 95.93 0.04 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.209 0.504 . . . . 0.0 110.27 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.427 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.2 118.62 23.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.017 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.4 mt -103.98 97.34 7.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.565 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.417 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 17.8 mttt -71.16 -25.67 62.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -80.71 -21.1 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.856 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -100.14 26.61 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.71 159.91 52.54 Favored Glycine 0 CA--C 1.506 -0.483 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.722 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.407 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.5 t -125.91 156.96 38.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.633 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 29.34 2.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.044 0.449 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.4 143.65 26.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.525 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.7 118.05 67.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.63 109.24 2.72 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.141 1.894 . . . . 0.0 112.54 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.4 t -67.39 -13.11 61.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.28 -27.26 53.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -141.43 162.56 46.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.868 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -76.56 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.023 1.815 . . . . 0.0 112.682 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 62.3 t -130.74 154.25 40.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 179.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.7 mt -113.61 97.57 6.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 0.0 110.587 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.5 t -82.26 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.474 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.89 89.42 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.611 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.463 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 71.0 m95 -147.36 97.48 2.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.721 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -93.61 7.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -131.27 93.02 3.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.427 0.156 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -57.86 -21.2 43.65 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.23 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -39.73 95.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.57 -33.56 62.7 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.788 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.48 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 62.6 mt -61.46 -52.05 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.919 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.93 -30.81 62.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.142 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.5 -51.52 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.188 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.31 -52.15 66.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.756 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.412 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.45 -33.63 69.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.872 0.367 . . . . 0.0 110.244 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.43 -41.82 97.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.38 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -66.15 -38.34 87.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.417 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.2 mp -66.34 -27.56 67.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.343 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.5 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.626 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -101.45 -41.06 6.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.645 0.259 . . . . 0.0 111.49 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.42 157.39 90.09 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.13 129.26 24.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.529 2.153 . . . . 0.0 112.841 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.12 67.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.455 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.1 86.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 110.399 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 55.6 t -61.82 -60.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.838 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.8 -23.89 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.451 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.96 -23.86 75.32 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.771 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.51 78.44 7.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.863 0.364 . . . . 0.0 110.688 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.62 131.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -59.27 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.26 155.43 32.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.415 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.409 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.6 m170 -107.31 118.85 37.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.24 115.0 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -138.7 77.47 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -69.14 162.08 43.23 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.0 p -139.27 161.43 37.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.05 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -25.5 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -103.34 -19.96 14.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.331 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -135.17 81.02 1.87 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -57.09 -21.24 30.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.617 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.04 38.49 2.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.283 . . . . 0.0 111.044 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -85.2 115.73 23.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 32.2 m -119.76 135.97 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.113 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 20.4 mm -105.33 111.38 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.77 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.84 155.38 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 111.694 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -114.45 99.78 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.956 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.5 tpp -54.18 149.33 9.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.489 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.82 -20.32 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.008 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 5.8 m-20 -76.02 -13.71 60.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.5 20.18 10.49 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.74 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.407 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 28.1 m-85 -111.52 155.93 22.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -109.3 118.77 37.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 15.7 t -116.24 159.52 16.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 110.643 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 51.4 p -121.64 143.68 49.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.791 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.67 150.15 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.43 146.57 24.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 17.9 mt -59.03 -28.15 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.097 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -31.58 69.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.586 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.23 36.11 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.139 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CE1' HD13 ' A' ' 171' ' ' LEU . 12.1 t80 -55.46 -50.77 69.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.481 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.61 -48.27 82.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.976 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -63.07 -38.95 93.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.961 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -55.66 -53.48 56.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.965 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.61 -22.7 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.711 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.8 t -60.49 -34.1 73.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -72.08 -5.47 35.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.855 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.68 100.4 6.18 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 -27.83 46.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.145 1.897 . . . . 0.0 112.105 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.27 80.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 24.8 mt -72.28 -54.93 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.61 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.198 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.78 -27.97 13.89 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.431 178.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.26 -27.91 10.44 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.376 178.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.62 -32.77 47.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.221 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 20.45 18.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -127.39 -75.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 110.975 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -129.73 106.59 8.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 15.8 t -101.57 31.23 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.007 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.864 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.2 m -69.33 112.89 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -146.63 -175.99 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -74.38 151.06 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.794 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 130.33 45.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.782 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -70.6 127.73 33.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.251 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.414 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.09 3.18 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.708 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.44 176.47 9.01 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.645 0.259 . . . . 0.0 110.894 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.418 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 18.9 m-85 -140.12 173.59 11.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.095 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.6 t -133.55 117.46 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.44 107.35 13.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.832 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.6 t0 -164.42 144.17 7.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.725 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.98 40.63 18.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.792 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.16 28.36 8.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 40.4 m -148.78 146.21 27.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 111.408 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.6 109.03 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.428 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 17.5 m-85 -81.15 129.95 64.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.13 124.5 12.68 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.137 1.891 . . . . 0.0 112.287 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.41 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.84 124.77 50.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.861 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.5 mt -83.94 166.63 17.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.234 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -55.85 -30.35 61.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.41 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.52 15.77 11.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.5 9.64 84.6 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.123 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.96 96.39 0.07 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.244 0.522 . . . . 0.0 110.11 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.423 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.59 119.52 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.079 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.7 mt -105.02 97.63 7.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 40.8 mttt -72.03 -21.92 61.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -84.37 -21.68 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -100.76 29.2 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.498 0.189 . . . . 0.0 111.414 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -73.53 161.42 54.15 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 t -125.21 160.66 28.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.356 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.36 30.51 4.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.55 133.1 12.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.681 -178.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.95 118.31 37.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.418 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.8 Cg_endo -73.1 111.78 3.36 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.985 1.79 . . . . 0.0 112.477 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -66.61 -13.9 61.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.32 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.24 -26.66 42.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.591 0.234 . . . . 0.0 111.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.86 159.25 47.49 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.87 174.19 11.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.235 1.957 . . . . 0.0 112.902 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 68.6 t -129.0 153.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.836 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.457 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 59.6 mt -112.87 98.58 7.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.565 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 59.5 t -82.81 135.32 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.475 -179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.63 86.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.469 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.6 m95 -148.11 115.73 6.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 111.468 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -106.26 -27.29 11.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.442 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -96.53 95.78 8.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.483 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.41 -20.96 47.01 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.084 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -40.3 96.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.46 68.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.659 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.483 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 58.1 mt -62.91 -52.34 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.625 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.38 57.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -68.94 -51.2 42.22 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.177 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.67 -52.54 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.414 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.02 -33.71 69.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.286 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.91 97.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.311 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.33 -37.7 87.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.388 . . . . 0.0 110.115 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.4 mp -67.75 -27.62 66.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.246 179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.73 -19.27 60.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.534 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.04 -40.7 7.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.638 0.256 . . . . 0.0 111.573 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.0 pp -72.18 157.58 89.07 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.518 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -50.27 124.45 13.01 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.594 2.196 . . . . 0.0 112.681 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.85 53.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.79 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.402 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -64.9 -40.06 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.0 110.3 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.1 t -59.79 -60.21 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.907 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.79 -24.21 67.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.512 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.99 -21.91 77.64 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.145 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.66 78.53 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.069 0.461 . . . . 0.0 110.718 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.03 138.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.502 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.6 t -75.82 -57.27 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.044 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.2 153.9 28.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.073 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.18 136.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.398 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -108.53 125.54 51.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.768 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -77.58 108.88 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.982 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -129.42 77.96 76.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.421 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 67.9 Cg_endo -75.04 163.72 34.7 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.264 1.976 . . . . 0.0 112.827 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.4 p -142.4 164.11 31.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.828 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -54.49 -26.94 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.55 -19.17 14.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -135.87 77.46 1.66 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.13 -21.6 47.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.605 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -111.62 36.16 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.672 0.272 . . . . 0.0 111.337 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.56 114.43 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.937 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.416 HG13 ' CH2' ' A' ' 158' ' ' TRP . 34.6 m -117.83 138.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -109.12 111.63 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -84.84 154.72 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -113.59 105.79 13.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.26 149.05 7.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.987 0.422 . . . . 0.0 111.57 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -66.95 -22.93 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.835 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.39 20.51 9.03 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.27 174.24 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -129.77 119.84 24.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.0 t -121.95 159.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 94.4 p -119.59 147.34 44.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.02 150.45 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.7 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -101.06 147.59 26.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.432 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 10.0 mt -57.97 -27.23 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.641 0.258 . . . . 0.0 111.161 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -30.44 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.469 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.17 35.88 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.34 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.7 -49.62 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.88 -47.19 87.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.47 -42.42 99.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.054 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -53.51 41.18 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.267 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.59 -21.69 41.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.918 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.2 t -59.82 -32.99 71.17 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.999 0.428 . . . . 0.0 110.35 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.81 5.26 14.07 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.037 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.4 100.35 18.15 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.5 -27.29 39.6 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.132 1.888 . . . . 0.0 112.189 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.47 -52.28 47.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.049 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 32.9 mt -63.5 -51.99 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.39 -29.84 50.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.491 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.46 -28.31 12.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.721 178.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.99 -28.75 17.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.252 178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.402 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 5.0 mt -76.33 -32.11 58.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.083 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -26.18 68.57 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.199 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -97.09 28.61 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.346 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -106.32 -44.38 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.36 116.12 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.38 161.55 34.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.795 0.331 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.68 -179.59 7.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.04 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -69.76 155.09 41.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -99.89 130.53 46.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.572 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -68.62 127.41 32.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.07 0.462 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.94 0.29 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.834 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.46 176.78 9.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.75 173.46 11.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.334 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 15.0 t -133.27 117.48 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.967 0.413 . . . . 0.0 111.025 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.52 110.7 16.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.148 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 15.9 t70 -169.15 144.23 3.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.53 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.001 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 53.86 28.65 8.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.679 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.417 ' CG2' ' N ' ' A' ' 145' ' ' THR . 88.6 m -149.58 141.86 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 14.1 m-85 -89.71 109.84 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.052 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 16.3 m-85 -80.99 123.93 81.72 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.967 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.43 124.24 14.72 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.206 1.937 . . . . 0.0 112.524 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.409 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.82 125.29 50.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.013 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.7 mt -84.14 166.7 17.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.179 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -56.28 -30.26 62.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.291 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -91.38 15.8 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.303 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.26 8.18 85.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.143 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.29 96.18 0.05 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.209 0.504 . . . . 0.0 110.243 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.59 112.88 21.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.853 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.18 98.21 7.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.595 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.4 mttp -69.0 -27.5 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.45 -22.39 60.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.603 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -101.13 23.77 10.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.619 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.17 164.24 52.58 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.733 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.417 ' N ' ' CG2' ' A' ' 129' ' ' THR . 4.0 t -130.26 158.82 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.953 0.406 . . . . 0.0 110.631 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.46 22.56 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.125 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -140.28 143.87 36.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 110.679 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.36 118.53 72.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.43 108.93 2.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.05 1.833 . . . . 0.0 112.608 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -67.07 -13.52 62.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.274 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.33 -27.54 52.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.667 0.27 . . . . 0.0 111.402 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.61 164.6 38.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.654 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.73 172.72 14.65 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.893 1.729 . . . . 0.0 112.521 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.1 t -129.37 153.57 38.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.939 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 60.4 mt -113.54 97.58 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.06 0.457 . . . . 0.0 110.569 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.2 t -83.44 134.6 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.2 85.78 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.724 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.9 m95 -148.64 110.28 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 111.536 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -101.22 -27.8 13.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.35 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.8 94.08 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.054 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.03 -21.0 44.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.154 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -39.9 95.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.25 -33.83 67.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.577 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 63.4 mt -62.03 -52.24 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.646 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.08 58.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.178 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 12.1 mm-40 -68.8 -50.42 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.94 -52.22 66.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.408 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.48 -33.7 68.27 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.946 0.403 . . . . 0.0 110.235 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.99 97.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.32 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.024 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.418 HD12 ' CE1' ' A' ' 214' ' ' PHE . 7.4 mp -69.23 -28.58 66.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.56 -18.43 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.547 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -102.62 -40.47 6.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 1.9 pp -70.84 157.14 90.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.744 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -51.3 124.09 13.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.575 2.183 . . . . 0.0 112.631 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.73 26.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.833 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -43.35 89.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.14 0.495 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.8 t -58.53 -55.9 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.757 179.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -67.69 -13.55 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.55 -14.54 59.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.519 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -93.62 78.37 4.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.965 0.383 . . . . 0.0 111.54 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.55 155.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.388 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 p -89.32 -48.6 7.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.57 156.1 9.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -105.88 134.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.151 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.435 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.2 m170 -109.12 118.52 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -69.07 110.0 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -132.57 74.13 75.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.884 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.2 161.78 29.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.267 1.978 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -137.16 162.71 32.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -54.2 -26.37 27.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.369 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -104.41 -18.3 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.572 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.3 87.13 2.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -59.63 -19.56 49.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -115.52 36.05 4.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.741 0.305 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -78.94 108.33 12.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.706 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.9 133.06 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 30.9 mm -106.14 111.55 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.537 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -87.05 158.32 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.696 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.09 107.12 14.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.174 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.17 149.37 16.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.395 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -65.88 -21.92 66.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -77.07 -13.19 59.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.33 20.3 9.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.721 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -106.43 174.94 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.699 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.64 117.71 21.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 12.1 t -113.42 160.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 80.3 p -121.14 145.14 48.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.073 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.1 -178.71 7.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.714 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -128.73 154.66 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.369 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.404 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.9 mt -69.0 -22.34 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.975 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -32.05 47.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 111.321 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -134.21 35.77 3.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.963 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.418 ' CE1' HD12 ' A' ' 171' ' ' LEU . 12.2 t80 -56.8 -48.09 78.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.07 83.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -62.78 -39.21 93.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.319 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 13.0 mmtt -56.93 -53.31 59.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.49 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.42 -21.35 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.19 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -64.11 -33.61 76.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.601 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -73.61 -2.74 24.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.385 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.36 110.22 43.27 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 122.263 -0.273 . . . . 0.0 110.848 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.28 -31.8 34.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.325 2.017 . . . . 0.0 112.38 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.55 -45.99 64.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.321 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 35.9 mt -64.76 -55.32 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.158 0.504 . . . . 0.0 109.708 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.67 -29.16 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.319 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.33 -29.13 14.16 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.752 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.68 -27.5 11.85 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 178.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 3.2 mt -77.2 -33.11 56.34 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.014 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.74 19.14 14.16 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.653 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -53.86 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 111.033 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -143.28 96.87 2.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.65 139.94 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.882 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.95 69.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 0.0 110.859 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -129.72 177.43 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -70.47 152.0 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.59 134.62 38.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -76.78 126.71 31.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.712 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.62 0.72 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.995 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.96 176.89 9.7 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.098 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.439 ' CD1' ' CG ' ' A' ' 149' ' ' PRO . 55.6 m-85 -138.49 173.29 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.31 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 20.0 t -134.2 116.61 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 0.0 110.953 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.467 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.39 113.76 18.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.434 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.0 t70 -168.96 144.19 3.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.796 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.65 40.07 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 54.81 31.77 16.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.473 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.408 ' CG2' ' N ' ' A' ' 145' ' ' THR . 53.6 m -151.47 144.44 24.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 5.0 m-85 -93.55 110.12 21.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.434 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 18.3 m-85 -81.15 129.81 65.44 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.119 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.416 ' HA ' ' CD2' ' A' ' 123' ' ' TYR . 21.4 Cg_exo -65.09 124.91 13.71 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.189 1.926 . . . . 0.0 112.277 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -105.86 124.78 50.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.798 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.404 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 21.2 mt -84.95 165.63 17.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.373 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -55.31 -30.74 60.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.697 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -90.92 15.11 12.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.314 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.51 4.05 83.94 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.257 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.404 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 20.6 tpp180 -61.07 98.26 0.07 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.347 0.573 . . . . 0.0 110.476 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.428 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.3 126.97 31.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.079 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.412 ' CD2' ' N ' ' A' ' 140' ' ' LEU . 2.9 mm? -106.53 94.24 5.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.426 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 12.5 mttp -70.97 -26.98 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.95 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -84.24 -20.75 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.795 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.09 24.58 6.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.527 0.204 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.31 160.43 53.17 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.825 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.408 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.5 t -126.72 157.21 39.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.599 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 27.72 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.29 140.5 25.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.483 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 117.65 53.29 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.439 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 65.0 Cg_endo -76.21 106.68 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.148 1.898 . . . . 0.0 112.75 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -67.99 -12.26 60.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.241 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.98 -27.22 54.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.759 0.314 . . . . 0.0 111.328 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.06 160.2 50.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.901 -179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -71.97 174.18 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.021 1.814 . . . . 0.0 112.722 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 63.6 t -130.43 155.56 41.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.944 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 57.3 mt -115.06 97.72 6.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.431 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.414 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.9 134.32 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.387 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.761 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.4 m95 -147.64 110.43 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 111.631 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -25.24 14.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.86 95.46 7.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.206 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.482 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.52 -20.85 47.42 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.057 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.39 -41.11 98.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.22 -34.82 73.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.441 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.482 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 54.5 mt -61.66 -51.68 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.585 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.45 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.292 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.1 mm-40 -70.74 -50.64 33.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.381 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.97 -52.45 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.952 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.31 -33.64 67.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.41 98.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.25 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -65.41 -35.97 82.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.847 0.356 . . . . 0.0 110.344 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 8.0 mp -70.73 -27.88 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.89 -19.47 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.524 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.15 -40.69 7.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.481 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -72.7 157.2 89.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.375 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.58 123.66 11.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.459 2.106 . . . . 0.0 112.51 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -33.91 39.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.638 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.52 88.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.049 0.452 . . . . 0.0 110.404 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 53.6 t -59.53 -60.29 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.845 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.26 -24.32 66.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.64 -23.8 76.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.816 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -86.23 78.3 9.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 110.679 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.2 ptp 178.27 131.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 80.6 p -67.94 -55.4 12.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -161.48 155.64 22.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.9 mt -104.54 136.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.374 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 25.1 m170 -107.19 122.19 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.87 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -75.0 109.77 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -129.37 72.37 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.03 154.77 57.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.439 2.092 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.4 p -140.89 166.9 23.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -26.27 60.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.291 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.75 -17.45 16.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.49 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -143.89 76.78 1.53 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.951 0.405 . . . . 0.0 111.023 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.09 -19.77 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.74 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -113.87 37.09 3.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 111.146 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.4 ttt180 -87.53 116.94 25.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.025 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.41 HG11 ' CZ2' ' A' ' 158' ' ' TRP . 28.1 m -120.59 133.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.4 mm -103.71 112.1 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.422 HG12 ' CZ ' ' A' ' 214' ' ' PHE . 2.5 m -88.49 151.7 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.391 . . . . 0.0 111.517 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.58 103.78 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.99 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 13.2 tpp -56.25 149.38 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -67.17 -19.78 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.082 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -75.56 -13.51 60.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.05 20.21 10.02 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.772 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.76 167.84 10.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.736 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -119.14 120.7 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 22.7 t -118.91 159.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.618 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 6.9 p -118.53 148.77 42.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.911 -179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -165.2 150.78 9.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.48 147.55 25.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.526 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.6 mt -59.32 -25.88 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.187 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -29.48 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.2 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -133.96 35.51 3.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.422 ' CZ ' HG12 ' A' ' 199' ' ' VAL . 12.3 t80 -57.73 -49.55 76.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.018 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.17 82.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.795 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -62.02 -41.23 97.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.11 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -53.1 53.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.298 179.455 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.06 -20.8 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.151 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.0 t -61.59 -32.55 72.66 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.005 0.431 . . . . 0.0 110.445 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.84 3.4 14.46 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.418 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -103.1 100.39 17.19 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.03 -26.63 43.13 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.121 1.881 . . . . 0.0 112.059 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.47 -41.58 76.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.418 HG13 ' CD1' ' A' ' 221' ' ' TYR . 36.8 mt -71.62 -54.67 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.32 -29.06 63.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.159 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.22 -28.02 10.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.61 -28.04 13.01 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.293 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.9 mt -77.69 -32.38 52.99 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.184 178.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -26.95 39.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -28.82 55.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 111.458 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -62.95 -49.86 73.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.9 m -95.49 82.05 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.1 ttpp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.861 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -55.86 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -176.33 -168.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.421 ' CE2' ' ND2' ' A' ' 136' ' ' ASN . 56.0 m95 -80.22 150.64 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.04 130.17 45.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 52.1 mtt180 -69.75 127.67 33.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.61 1.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.77 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.66 176.7 9.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.714 0.292 . . . . 0.0 111.04 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -139.72 173.77 11.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.59 117.17 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.42 15.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.291 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.8 t0 -169.28 145.17 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.52 40.9 23.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.97 29.92 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 89.7 m -151.47 142.52 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.425 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.5 m-85 -90.87 109.24 20.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.057 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 141' ' ' LYS . 15.3 m-85 -79.05 122.74 84.8 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.45 122.11 10.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.13 1.887 . . . . 0.0 112.489 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.3 mt -103.87 125.03 50.0 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.791 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.65 165.91 17.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.474 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -55.72 -30.19 60.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.584 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.421 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.7 p-10 -90.61 14.68 12.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.396 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.27 3.82 82.75 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.583 -0.817 . . . . 0.0 113.254 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.1 tpp180 -60.6 97.36 0.05 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.276 0.56 . . . . 0.0 110.572 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.408 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -84.49 114.67 22.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.853 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.6 mt -105.07 97.69 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.717 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.2 mttt -69.76 -27.73 65.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -73.28 -23.26 60.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -101.48 25.36 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.547 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.02 163.0 54.08 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.512 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.6 t -127.28 156.12 42.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.661 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 28.43 3.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 138.33 24.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.72 118.36 47.44 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.67 106.21 2.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.077 1.852 . . . . 0.0 112.794 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.0 t -68.0 -12.05 60.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -78.05 -27.26 48.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.59 160.14 48.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.951 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -71.7 173.29 12.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.031 1.821 . . . . 0.0 112.763 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 68.4 t -129.28 154.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.89 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 54.5 mt -112.94 98.33 7.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.128 0.49 . . . . 0.0 110.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.401 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.3 t -82.46 134.89 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.475 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.56 86.73 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.836 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.9 m95 -148.47 112.68 5.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.036 0.446 . . . . 0.0 111.446 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -26.84 12.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.409 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.68 95.82 8.19 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.49 -21.05 47.97 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.964 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.24 97.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.61 -34.18 69.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.524 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.476 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 40.3 mt -61.8 -52.05 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.498 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.97 -30.27 58.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.401 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 15.1 mm-40 -69.47 -50.78 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.338 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.34 -52.46 65.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.819 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.79 69.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 110.363 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.11 -40.29 96.95 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.197 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -66.64 -38.11 86.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.404 . . . . 0.0 110.273 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.42 HD12 ' CE1' ' A' ' 214' ' ' PHE . 7.9 mp -67.6 -28.13 67.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.363 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.24 -22.02 59.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.611 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -96.52 -40.75 8.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.283 . . . . 0.0 111.521 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.84 156.19 92.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -49.31 129.86 23.49 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.651 2.234 . . . . 0.0 112.879 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.63 66.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.699 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.48 87.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.49 . . . . 0.0 110.414 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.86 -59.96 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.75 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.03 -23.82 65.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.384 178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.27 -24.76 74.72 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.707 179.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -88.19 78.3 8.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.752 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 176.88 140.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.443 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -56.52 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.8 154.41 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.5 mt -107.51 136.77 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.32 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.4 m170 -108.06 117.39 34.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.403 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 39.2 t80 -73.02 106.62 4.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.783 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -126.92 74.7 76.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.403 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 56.1 Cg_endo -70.41 158.16 56.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.26 1.973 . . . . 0.0 112.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.7 p -140.44 162.9 34.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -26.61 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -102.4 -20.4 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.22 76.61 1.61 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.32 -20.63 29.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.669 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.87 38.37 2.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 111.188 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -85.72 116.87 24.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.06 132.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.38 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.2 mm -105.77 110.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.477 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -85.02 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.0 111.61 -179.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -116.06 106.48 13.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.07 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.82 149.33 11.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.483 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -66.14 -22.36 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.934 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.2 -12.02 59.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.26 20.33 9.26 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -103.14 174.18 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -129.38 116.4 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.1 t -114.87 159.9 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.521 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 85.0 p -121.02 145.33 47.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.066 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.11 -178.44 7.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.778 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.9 153.67 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.401 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.1 mt -67.77 -21.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.076 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.47 -35.3 58.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.709 0.29 . . . . 0.0 111.462 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -133.74 35.95 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 171' ' ' LEU . 13.3 t80 -54.38 -48.18 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 -179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.69 80.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -62.18 -38.7 90.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -56.44 -51.04 69.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.392 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -79.66 -20.3 47.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.349 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.5 p -65.49 -36.85 85.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.962 0.411 . . . . 0.0 110.384 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -63.47 -14.93 55.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.795 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 111.21 23.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.535 -0.103 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.3 -24.15 27.54 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.164 1.909 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.23 -41.69 24.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.55 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 18.6 mt -68.78 -57.79 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.35 -29.4 58.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.325 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.81 -28.24 21.73 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.545 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.36 -28.03 11.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.368 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.2 mt -77.82 -33.51 52.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.01 178.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.92 21.61 11.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.438 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -40.95 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.318 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.94 -61.68 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.3 p -176.53 140.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.971 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.932 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.6 m -136.63 -170.77 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 61.14 -172.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -131.03 151.92 50.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.44 128.67 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.448 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm-85 -68.31 127.22 32.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.09 0.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.024 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.92 177.06 9.55 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.648 0.261 . . . . 0.0 111.042 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -139.34 173.74 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.305 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.8 t -133.45 117.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 111.073 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.454 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.56 114.06 19.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.366 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.9 t70 -169.17 143.12 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 58.95 41.27 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.938 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 54.09 29.99 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.406 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.405 ' CG2' ' N ' ' A' ' 145' ' ' THR . 51.3 m -149.38 145.42 26.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 111.365 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.454 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.5 m-85 -95.97 110.92 23.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 17.2 m-85 -81.71 127.06 74.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.45 124.81 14.91 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.191 1.927 . . . . 0.0 112.501 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.1 mt -106.48 125.16 50.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.3 mt -85.35 164.6 17.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.417 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -54.94 -29.88 57.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -91.16 15.36 11.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.72 3.25 78.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.314 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.68 97.67 0.06 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.362 0.581 . . . . 0.0 110.485 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.406 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -81.09 126.34 31.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.974 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 18.2 mt -107.71 95.69 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.416 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.8 mttp -72.54 -25.51 61.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -82.64 -20.91 35.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.791 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -101.1 28.07 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 111.5 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.68 159.8 52.48 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.642 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.405 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.3 t -124.64 155.85 38.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.44 29.71 2.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.85 140.29 22.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 118.25 51.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.02 105.67 2.12 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.122 1.881 . . . . 0.0 112.78 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t -67.89 -12.2 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -78.51 -27.3 46.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.6 0.238 . . . . 0.0 111.316 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -144.44 159.92 49.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.866 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -71.46 172.86 13.38 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.961 1.774 . . . . 0.0 112.6 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.6 t -129.45 154.19 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.897 179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 56.1 mt -113.17 97.84 6.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.422 . . . . 0.0 110.441 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 72.6 t -83.29 134.29 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.37 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.6 85.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.788 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.464 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.2 m95 -148.31 113.05 5.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 111.494 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.84 -26.01 12.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.464 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.93 95.37 7.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.208 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.479 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.59 -20.86 48.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.067 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.2 -40.43 97.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.73 -34.19 69.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.518 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.479 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 48.1 mt -61.42 -51.88 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.612 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.46 -31.2 61.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.26 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -67.9 -51.15 51.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.24 -52.0 67.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.81 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.47 -33.91 70.28 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.855 0.359 . . . . 0.0 110.252 179.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.42 96.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.333 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -67.05 -38.06 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 214' ' ' PHE . 8.0 mp -68.06 -28.2 67.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.291 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.95 -18.75 60.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.701 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -101.18 -40.52 7.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 0.0 111.712 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -70.4 157.81 89.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 -179.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.88 124.23 13.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.542 2.161 . . . . 0.0 112.638 179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.73 33.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.65 93.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.17 0.51 . . . . 0.0 110.417 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 42.8 t -60.24 -60.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.998 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.19 -25.52 67.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.39 178.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.84 -22.12 77.44 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.022 179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -87.89 78.16 8.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.967 0.413 . . . . 0.0 110.913 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.6 ptp 177.92 140.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.543 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.91 -54.0 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.104 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 152.39 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 110.974 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.1 mt -102.97 135.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.384 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 21.3 m170 -108.05 114.71 28.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -72.14 100.74 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -123.54 79.36 54.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.72 165.93 31.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.35 2.034 . . . . 0.0 112.613 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 p -143.6 176.18 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -62.4 -25.58 68.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.81 5.14 18.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -156.58 78.01 0.92 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.911 0.386 . . . . 0.0 111.008 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -18.4 52.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.518 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.22 34.33 4.75 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.834 0.35 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -80.03 109.13 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.78 132.77 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.402 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.41 107.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.311 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . 0.415 HG11 ' CZ ' ' A' ' 214' ' ' PHE . 2.2 m -85.0 150.27 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.988 0.423 . . . . 0.0 111.653 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -109.08 109.2 20.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.985 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.81 148.96 9.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.416 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -66.16 -21.86 66.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.6 -10.58 59.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.27 20.52 9.09 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.713 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -100.66 174.25 6.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 110.825 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.03 122.08 29.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 38.6 t -125.76 158.68 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 81.2 p -121.59 149.19 43.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.079 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.35 -177.14 5.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -129.24 153.75 47.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.4 mt -66.3 -22.43 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.022 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -32.51 57.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 111.381 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -134.16 35.82 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 171' ' ' LEU . 12.3 t80 -57.3 -46.59 83.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.99 -48.68 79.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.645 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.47 -40.17 95.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -57.03 -52.99 63.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.41 HD21 ' CD1' ' A' ' 214' ' ' PHE . 3.6 mm? -77.3 -21.79 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.445 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 78.7 p -66.4 -33.5 75.84 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 110.361 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.86 -10.29 51.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.914 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.418 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -87.16 110.56 34.31 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 122.485 -0.134 . . . . 0.0 110.865 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.83 -26.35 27.33 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.215 1.943 . . . . 0.0 112.343 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.38 -41.91 46.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.418 HG13 ' CD1' ' A' ' 221' ' ' TYR . 19.7 mt -69.01 -56.83 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.295 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.5 -28.46 20.52 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.85 -27.55 13.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.1 0.476 . . . . 0.0 110.328 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 2.7 mt -78.42 -32.23 48.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.094 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.63 -17.4 57.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.757 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -53.89 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 111.45 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -147.21 -74.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.154 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 18.1 t 64.45 33.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.978 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.865 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 p -159.8 132.58 6.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.35 -179.11 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.447 ' CE2' ' ND2' ' A' ' 136' ' ' ASN . 48.6 m95 -80.57 150.61 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -99.47 129.55 45.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -70.07 127.05 31.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.134 0.492 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.408 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.83 1.44 2.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.842 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.93 176.46 9.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 120.695 0.284 . . . . 0.0 110.893 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.423 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 20.2 m-85 -140.15 173.85 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.7 t -132.7 117.64 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.883 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.424 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.96 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.26 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 38.9 t0 -169.25 143.77 3.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.781 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 59.98 40.46 18.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 53.92 27.58 7.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.586 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 145' ' ' THR . 89.6 m -147.87 142.47 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.424 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.9 m-85 -91.1 109.94 21.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.43 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 16.4 m-85 -80.0 122.47 83.19 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.25 123.38 13.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.098 1.865 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.406 HD12 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -105.67 125.32 50.85 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.2 mt -84.95 166.11 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.339 179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -55.7 -29.93 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.447 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.4 p-10 -90.34 13.99 14.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.345 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.18 84.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.17 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.9 tpt180 -60.15 97.6 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.18 0.514 . . . . 0.0 110.487 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.409 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.68 115.29 22.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.892 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.4 mt -105.29 98.05 7.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.51 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.2 mttt -70.34 -28.16 64.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.79 -22.35 59.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -101.54 25.08 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.82 53.44 Favored Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.603 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.415 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -127.5 156.02 42.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.42 139.67 25.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.519 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.37 119.14 50.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.423 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 61.5 Cg_endo -75.8 105.08 2.01 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.98 1.787 . . . . 0.0 112.765 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.6 t -67.64 -12.4 60.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.194 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.98 -26.91 39.77 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.663 0.268 . . . . 0.0 111.568 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.87 159.55 46.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -70.74 173.66 11.52 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.06 1.84 . . . . 0.0 112.805 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.7 t -129.06 154.44 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.023 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.459 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 58.7 mt -112.81 98.36 7.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.2 t -82.66 135.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.476 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.55 86.78 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.876 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.5 m95 -148.4 116.24 6.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.471 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -106.81 -26.53 11.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.459 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -97.41 95.56 7.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.4 -20.86 46.53 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.108 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -40.4 97.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.17 -33.28 67.57 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.621 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 53.1 mt -62.44 -51.86 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.678 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.71 -30.21 55.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.11 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 10.6 mm-40 -68.99 -51.11 42.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.348 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.836 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.408 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.59 -33.7 68.47 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.91 0.386 . . . . 0.0 110.383 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.64 96.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.478 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.1 -39.63 93.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.439 ' CD1' ' CE1' ' A' ' 214' ' ' PHE . 5.1 mp -66.17 -27.77 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.367 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.55 -19.42 60.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.667 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.86 -40.58 7.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.705 0.288 . . . . 0.0 111.633 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.37 157.31 90.29 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -48.9 128.78 19.75 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.744 2.296 . . . . 0.0 112.92 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.54 67.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.552 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.4 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -63.4 -37.14 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 44.9 t -61.45 -60.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.868 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.56 -24.01 67.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -72.95 -24.44 75.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.628 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.32 78.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.26 137.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 p -80.27 -57.93 3.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.197 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.12 154.12 31.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.971 0.415 . . . . 0.0 111.145 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -106.06 136.84 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -108.22 123.27 48.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.724 -179.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.417 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 55.1 t80 -77.67 107.82 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -131.35 76.4 75.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.744 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 50.2 Cg_endo -69.59 162.67 41.06 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.336 2.024 . . . . 0.0 112.609 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.3 p -140.86 163.37 33.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.9 mtp85 -55.89 -25.89 44.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 -20.64 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.283 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -136.8 82.48 1.94 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.71 -20.76 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.673 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -114.58 37.69 3.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 111.163 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -82.28 112.34 19.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.988 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.51 135.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -106.75 109.27 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.554 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.6 m -84.84 154.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.899 0.38 . . . . 0.0 111.654 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -114.5 101.36 9.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.957 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 7.8 tpp -53.87 149.33 8.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.596 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -66.83 -20.08 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.041 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.76 -13.4 60.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 20.21 9.47 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -109.04 167.86 9.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.68 117.02 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.743 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 9.3 t -113.85 160.39 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 78.1 p -121.43 144.33 48.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.762 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.32 -177.36 6.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.8 152.35 47.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.321 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 11.5 mt -66.42 -24.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.913 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -29.8 51.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.695 0.283 . . . . 0.0 111.361 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -134.16 36.07 3.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.221 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.439 ' CE1' ' CD1' ' A' ' 171' ' ' LEU . 41.3 t80 -56.88 -50.03 73.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.845 0.355 . . . . 0.0 111.051 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.16 -42.49 99.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.81 -42.26 95.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 45.6 mmtt -57.08 -53.66 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.346 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.97 -24.0 55.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.5 m -62.8 -32.97 74.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 110.33 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -5.89 39.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.402 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -95.0 100.74 5.95 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.86 -25.85 52.47 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.131 1.887 . . . . 0.0 111.97 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.3 -41.68 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.406 HD12 HG23 ' A' ' 224' ' ' ILE . 27.3 mt -72.07 -54.88 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.19 -29.28 63.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.131 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.08 -28.31 10.21 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 178.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.59 -27.41 11.04 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.413 178.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 2.2 mt -78.67 -32.01 46.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.226 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.19 -28.72 65.06 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.26 -28.64 63.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.204 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.78 -55.08 2.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.4 t -147.77 159.02 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 9.3 mtmt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.01 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.7 p -83.26 133.86 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.06 -174.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.454 ' CG ' ' ND2' ' A' ' 136' ' ' ASN . 45.5 m95 -103.58 149.24 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.16 134.24 45.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mtm-85 -73.4 127.46 32.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.136 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.12 -1.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.928 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -160.83 176.55 11.35 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 120.683 0.278 . . . . 0.0 111.058 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 33.9 m-85 -138.62 173.05 12.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.503 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.6 t -133.88 120.17 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.927 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.08 109.77 14.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.977 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.413 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.3 t0 -161.38 138.56 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 58.39 42.73 20.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 54.11 28.75 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.625 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.418 ' CG2' ' N ' ' A' ' 145' ' ' THR . 94.9 m -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 111.103 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.1 m-85 -90.23 110.15 21.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.416 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 13.2 m-30 -81.3 118.23 71.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.999 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -56.73 124.28 15.88 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.131 1.887 . . . . 0.0 112.563 -179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.408 HD12 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -106.24 125.35 50.89 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.117 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.4 mt -81.67 167.98 18.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.058 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -57.28 -30.78 64.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.463 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.1 p30 -90.6 13.87 14.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.398 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 79.71 5.61 89.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.121 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 117.392 0.596 . . . . 0.0 110.23 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.416 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -81.33 118.66 22.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.9 mm? -103.74 96.77 6.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.755 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.409 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 37.9 mttt -71.84 -26.57 62.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -80.94 -23.74 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.526 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -98.28 22.68 9.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.642 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.2 163.27 54.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.549 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.418 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -128.53 156.38 43.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.586 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 26.12 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -143.57 139.67 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 118.11 59.89 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.86 106.7 2.3 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.07 1.847 . . . . 0.0 112.501 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.2 t -67.13 -13.24 61.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.74 -27.23 50.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.66 164.96 33.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -78.49 173.33 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.051 1.834 . . . . 0.0 112.757 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.0 t -130.02 154.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.928 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 67.5 mt -112.51 97.59 6.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.65 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 57.6 t -82.55 134.57 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.409 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.09 87.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.709 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.6 m95 -147.57 110.25 4.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 111.597 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -100.2 -25.91 14.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.507 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.43 95.39 7.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.478 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.44 -20.83 46.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.044 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.4 -40.56 97.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.88 -34.56 71.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.474 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.478 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 62.1 mt -61.99 -51.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.722 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.57 -29.79 59.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.188 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -69.25 -51.8 33.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.173 0.511 . . . . 0.0 110.25 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.42 -52.77 64.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.026 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.57 69.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.356 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.06 97.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.434 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.24 -38.48 87.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.913 0.387 . . . . 0.0 110.45 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.421 HD11 ' CE1' ' A' ' 214' ' ' PHE . 7.6 mp -64.81 -28.21 69.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.634 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -102.82 -40.84 6.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.698 0.285 . . . . 0.0 111.679 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.91 157.29 89.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.132 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -49.85 129.79 25.27 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.696 2.264 . . . . 0.0 112.749 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.3 -38.89 66.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -63.05 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 110.314 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 54.4 t -60.31 -57.07 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -68.09 -13.19 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.29 -14.68 59.92 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.369 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.39 78.63 3.9 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.918 0.359 . . . . 0.0 111.724 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.35 176.82 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.702 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.9 m -116.55 -44.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -167.51 151.82 6.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.13 135.35 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.407 179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 9.7 m170 -108.42 114.41 28.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.418 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 41.3 t80 -65.85 111.03 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.832 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -132.02 76.96 72.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.418 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 53.5 Cg_endo -70.31 160.66 48.77 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.0 p -140.17 161.46 37.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.04 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -54.73 -25.63 28.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.26 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.25 -21.82 14.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.247 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.448 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.7 m-85 -136.16 80.85 1.85 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.892 0.377 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.28 -21.13 32.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.562 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -112.89 38.09 2.91 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.448 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 3.4 ttm180 -85.89 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 35.8 m -120.0 138.7 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.23 111.09 34.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.794 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.9 m -86.53 152.89 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 111.645 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -110.55 100.58 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.3 tpp -55.8 149.34 14.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.479 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -67.51 -20.38 65.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.089 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -76.62 -13.54 60.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.18 20.15 10.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.781 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -112.24 156.54 22.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.899 0.38 . . . . 0.0 110.775 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -110.3 117.13 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 41.2 t -114.04 159.18 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.648 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 49.8 p -121.46 149.09 43.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -167.22 149.37 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.918 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.79 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.688 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . . . . . . . . . 13.8 mt -58.83 -28.03 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.118 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -32.12 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -134.24 35.97 3.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.152 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.421 ' CE1' HD11 ' A' ' 171' ' ' LEU . 11.6 t80 -54.95 -50.22 69.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.516 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.84 -48.78 80.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 0.0 111.195 -179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -64.92 -32.81 74.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.155 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -61.67 -53.88 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.085 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.408 HD21 ' CD1' ' A' ' 214' ' ' PHE . 3.2 mm? -80.21 -23.67 40.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.4 t -63.29 -38.81 92.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 110.687 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -64.77 -14.38 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.684 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.74 111.39 25.75 Favored Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.567 -0.083 . . . . 0.0 110.828 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.58 -25.56 34.59 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.259 1.972 . . . . 0.0 112.518 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.88 33.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.564 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 22.9 mt -70.07 -56.99 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.97 -29.04 62.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.212 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.17 -28.25 10.65 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.5 -27.7 11.37 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.214 178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.405 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 4.4 mt -76.26 -34.22 59.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.007 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -97.49 17.32 17.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.686 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 54.64 24.66 5.67 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 59.32 84.14 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.043 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.72 150.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 11.5 tttp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.872 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 m -108.48 83.42 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 60.37 175.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -74.87 153.91 38.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.049 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -95.33 140.59 30.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.478 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -82.38 124.66 30.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 110.561 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -127.75 0.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.986 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.26 177.02 8.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.42 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 18.9 m-85 -140.46 173.09 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.338 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 24.7 t -132.44 120.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.985 0.421 . . . . 0.0 111.079 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.498 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.45 110.95 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.9 t70 -157.12 135.87 11.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 58.05 43.96 20.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.46 29.22 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.428 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.413 ' CG2' ' N ' ' A' ' 145' ' ' THR . 85.0 m -144.01 144.04 31.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.0 m-85 -95.27 110.62 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.488 . . . . 0.0 111.048 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.433 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 10.1 m-30 -83.29 124.25 76.22 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.185 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.34 127.21 23.14 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.366 2.044 . . . . 0.0 112.82 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.44 124.78 51.6 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.817 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.6 mt -85.66 165.66 16.8 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.546 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -55.38 -30.71 60.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.594 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -89.71 14.19 12.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.44 3.59 82.91 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.157 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -61.04 97.15 0.06 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.167 0.483 . . . . 0.0 110.589 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.4 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -78.15 129.63 35.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.863 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 81.6 mt -108.06 92.38 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 21.2 mttp -72.64 -28.9 63.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.815 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.32 -21.08 42.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.472 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -101.64 28.02 5.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.505 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.31 159.42 50.2 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.384 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.413 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -128.33 157.56 40.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.952 0.406 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 25.67 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.77 139.34 32.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.483 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.15 111.65 8.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.315 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.42 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 23.3 Cg_exo -63.65 100.41 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.475 2.117 . . . . 0.0 112.196 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -65.61 -14.92 62.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.346 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.64 -27.29 40.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.3 161.86 55.01 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.9 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.97 172.9 14.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.751 1.634 . . . . 0.0 112.539 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 76.5 t -129.81 154.92 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.133 179.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.465 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 57.5 mt -114.09 97.69 6.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 0.0 110.492 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.68 133.81 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.459 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.45 85.53 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.809 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.465 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 68.6 m95 -147.7 115.46 6.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.966 0.413 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.19 -26.4 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.519 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.12 94.77 7.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.479 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.02 -21.26 45.0 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.096 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -39.97 96.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.75 67.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.556 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.479 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 39.6 mt -61.99 -51.76 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.638 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.62 -30.87 61.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 14.7 mm-40 -67.68 -50.77 56.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.172 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.419 ' HE3' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -59.77 -52.25 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.7 -33.55 68.5 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.951 0.405 . . . . 0.0 110.321 179.217 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.2 97.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.37 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -64.14 -39.44 94.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.285 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.414 HD12 ' CE1' ' A' ' 214' ' ' PHE . 7.6 mp -66.14 -27.53 68.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.259 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.81 -19.87 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.61 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.36 -40.76 7.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 111.483 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.61 156.82 90.99 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.964 -179.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -49.78 129.52 24.3 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 112.864 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.58 -39.6 67.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.574 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.402 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -62.34 -37.4 85.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.097 0.475 . . . . 0.0 110.536 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 52.5 t -61.33 -60.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.72 179.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.86 -24.05 66.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.453 178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.26 -24.41 75.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.631 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.19 78.16 6.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.768 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 178.59 138.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.554 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -80.2 -62.01 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.65 152.16 32.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 0.0 111.041 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.23 133.88 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.197 179.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.407 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 33.3 m170 -107.37 111.99 24.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.956 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -65.35 106.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -129.65 79.84 72.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.73 160.86 46.33 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.276 1.984 . . . . 0.0 112.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -138.56 162.58 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -54.75 -25.96 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.279 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -103.9 -18.7 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.515 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . 0.449 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.2 m-85 -136.6 83.44 2.0 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.905 0.383 . . . . 0.0 111.219 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.92 -20.58 38.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.544 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -114.13 38.46 3.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -82.81 117.7 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.78 133.05 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 25.2 mm -104.09 107.98 23.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.341 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.55 152.4 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.68 -178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.93 100.77 9.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.013 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 10.2 tpp -54.81 149.5 11.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 111.492 -179.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -65.95 -20.25 66.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.028 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.03 -13.54 60.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.33 20.11 11.53 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.74 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.23 162.64 14.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.666 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -112.44 120.79 42.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.685 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 39.6 t -118.25 158.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.687 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 44.4 p -121.95 149.44 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.44 -178.15 6.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.812 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -127.63 149.76 50.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.119 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.5 mt -64.6 -23.85 34.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.01 -31.22 56.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.445 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.25 35.98 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.1 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.419 ' CE2' ' HE3' ' A' ' 167' ' ' MET . 13.0 t80 -55.75 -50.71 69.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.83 0.348 . . . . 0.0 111.032 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.57 -44.38 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.93 -41.46 97.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 57.2 mmtt -56.24 -53.37 57.96 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.016 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.409 HD21 ' CD1' ' A' ' 214' ' ' PHE . 3.3 mm? -76.64 -23.19 53.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -61.59 -34.34 75.45 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.072 0.463 . . . . 0.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -71.83 -5.55 35.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 99.96 5.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -28.24 50.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.171 1.914 . . . . 0.0 111.98 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.29 81.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.714 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 25.2 mt -72.13 -54.75 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.05 -29.43 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.81 -28.13 14.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.459 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.55 -27.87 12.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.27 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.402 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 3.6 mt -77.66 -33.21 53.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.8 19.86 11.89 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.649 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -85.95 -62.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.828 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -100.97 72.39 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.84 136.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.9 tptt . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.833 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -112.0 122.31 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 60.97 172.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.024 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 51.1 m95 -68.35 155.3 40.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.0 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 127.93 44.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -69.36 126.62 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.41 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.48 -0.16 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.969 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.06 176.68 9.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.963 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.422 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 18.9 m-85 -139.11 173.35 11.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.313 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 21.4 t -132.59 118.23 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.36 113.37 18.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.145 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.424 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 33.3 t0 -164.5 138.87 5.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.798 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.43 42.16 18.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 110.821 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.19 28.26 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.504 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 145' ' ' THR . 63.2 m -145.01 144.28 30.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.6 m-85 -95.16 110.58 22.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 12.3 m-30 -81.97 125.74 76.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.142 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 36.5 Cg_exo -61.29 126.1 18.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.293 1.995 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.407 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -108.14 125.04 51.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.793 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.422 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 22.0 mt -85.27 166.13 16.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.384 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -55.44 -30.26 60.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.499 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -91.29 15.48 11.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.382 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.56 3.63 83.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.228 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.422 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.06 96.73 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.224 0.512 . . . . 0.0 110.581 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.24 122.3 27.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.077 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 16.2 mt -104.5 96.64 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -72.76 -26.4 61.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -81.73 -22.9 37.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.696 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -97.55 27.25 4.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.383 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -75.26 159.08 51.34 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.801 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.406 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.4 t -126.01 155.54 41.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.684 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 29.6 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.756 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.55 22.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.43 119.05 56.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.422 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.1 Cg_endo -74.44 106.03 2.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.065 1.843 . . . . 0.0 112.68 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -67.28 -12.83 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.63 -27.23 40.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.653 0.263 . . . . 0.0 111.524 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -145.33 159.69 47.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.86 174.28 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.115 1.877 . . . . 0.0 112.845 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.9 t -129.79 154.61 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.065 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 59.2 mt -113.75 97.76 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.016 0.436 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.8 t -82.22 134.42 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.438 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.18 86.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.811 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.462 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.7 m95 -148.23 113.95 5.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.031 0.443 . . . . 0.0 111.465 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -104.74 -25.38 12.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.589 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.88 95.04 7.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.227 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.43 -21.0 47.35 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.012 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -40.15 96.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.46 -33.77 67.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.606 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 56.2 mt -61.95 -51.9 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.709 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.8 mm-40 -67.57 -50.52 58.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.247 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.4 ' HE2' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -59.63 -52.21 66.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.856 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.41 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.07 -33.69 67.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.843 0.354 . . . . 0.0 110.439 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.38 -44.09 97.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.186 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.24 -38.21 88.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.255 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.417 HD11 ' CE1' ' A' ' 214' ' ' PHE . 6.5 mp -67.74 -28.7 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.245 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.6 -22.36 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.399 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.6 -41.15 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.709 0.29 . . . . 0.0 111.385 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.04 156.42 92.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.827 -179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -49.38 128.53 20.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.621 2.214 . . . . 0.0 112.792 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.14 -40.41 67.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.405 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -61.9 -37.26 83.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.526 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 42.4 t -61.03 -60.03 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.15 -23.68 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.477 178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -75.17 -22.59 76.05 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.978 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.84 78.32 6.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.871 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.85 132.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -58.29 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.14 153.33 25.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -101.66 135.71 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.438 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -108.68 114.69 28.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -69.29 113.48 6.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -133.73 71.85 74.23 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.94 159.52 51.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.299 2.0 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.4 p -139.59 161.21 38.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.101 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -52.93 -26.54 15.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -103.1 -21.46 13.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.27 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -132.79 76.81 1.71 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -21.68 23.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.652 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.55 39.55 2.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.884 0.374 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -86.3 118.31 25.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.06 133.78 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.8 mm -106.42 109.27 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.39 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.73 152.18 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 0.0 111.775 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -109.74 105.79 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.864 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 11.8 tpp -56.9 149.38 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -58.33 -22.81 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.28 -2.34 48.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.12 -15.22 60.71 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.972 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -66.48 164.87 15.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -119.61 121.38 39.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.675 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 35.7 t -119.48 159.15 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.786 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 98.4 p -121.85 149.32 43.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.021 -179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.83 -177.49 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.79 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.23 154.61 44.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 11.4 mt -69.76 -21.69 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.097 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.07 -30.38 31.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -133.04 35.06 3.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 171' ' ' LEU . 12.1 t80 -57.68 -47.87 81.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.66 -47.23 87.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.22 -38.56 91.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.4 mmpt? -57.86 -53.31 59.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.528 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -81.73 -20.11 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.382 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 26.1 t -64.92 -37.74 88.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.67 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -67.25 -10.68 53.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.065 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.417 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -81.32 111.7 27.06 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.451 -0.156 . . . . 0.0 110.808 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.94 -27.11 30.88 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.233 1.955 . . . . 0.0 112.389 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.71 -44.75 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.575 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.417 HG13 ' CG ' ' A' ' 221' ' ' TYR . 25.1 mt -64.19 -56.95 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.98 -28.74 58.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.422 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.29 -28.8 12.91 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.706 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.19 -26.72 12.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.397 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.405 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 6.1 mt -76.76 -33.44 58.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.967 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.52 -59.23 5.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.21 25.23 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.6 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -130.89 36.58 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.2 m -109.8 77.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.894 -179.98 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 81.5 p -154.29 -73.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -98.79 -178.17 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -99.18 150.73 21.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 130.83 50.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -68.78 127.88 34.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.118 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.58 -0.2 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.007 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -163.5 176.82 9.37 Favored 'General case' 0 CA--C 1.523 -0.073 0 CA-C-O 120.655 0.265 . . . . 0.0 111.18 -179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -138.74 173.65 11.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 17.1 t -133.24 117.74 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.444 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.65 111.18 16.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.313 -179.382 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.2 t0 -169.34 144.5 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.37 40.31 21.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 53.96 29.08 9.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.65 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.412 ' CG2' ' N ' ' A' ' 145' ' ' THR . 85.2 m -150.11 142.19 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.7 m-85 -90.32 109.5 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.149 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.432 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 16.2 m-85 -79.86 123.28 83.85 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.095 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.19 123.72 13.74 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.181 1.921 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.403 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -106.29 125.11 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.0 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 138' ' ' ARG . 18.6 mt -84.23 165.85 18.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.343 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -55.34 -30.45 60.29 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.48 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -91.3 15.1 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.276 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.36 7.13 86.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.292 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HB3' ' CD1' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.55 95.63 0.04 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.322 0.561 . . . . 0.0 110.32 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.413 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.64 112.55 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.711 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.48 98.36 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 26.9 mttt -69.59 -26.39 64.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -74.3 -24.1 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.19 24.81 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.509 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.33 163.03 53.77 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.666 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.412 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -127.47 155.49 43.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 110.639 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.15 3.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.73 140.03 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 117.5 44.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 106.28 2.19 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.065 1.844 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -67.71 -12.47 60.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.267 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.46 -27.26 52.03 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.323 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.56 164.09 34.94 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.875 -179.245 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -76.02 173.56 14.29 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.913 1.742 . . . . 0.0 112.659 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.24 153.71 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.951 179.338 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.464 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.1 mt -113.25 97.57 6.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -83.03 135.22 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.52 86.83 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.464 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 72.9 m95 -149.14 111.52 4.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.391 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -102.23 -26.08 13.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.566 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.85 95.09 7.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.397 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.17 -21.13 45.72 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.014 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.34 97.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -33.82 68.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.576 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.48 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 52.8 mt -61.85 -51.88 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.573 178.547 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.13 -27.99 49.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 179.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 29.5 mm-40 -72.08 -50.6 26.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 0.0 110.356 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.15 -52.33 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 179.661 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.55 -33.95 68.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.356 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.283 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -63.89 -38.42 91.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.162 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.03 -28.32 68.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.22 179.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -19.27 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.544 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.26 -41.29 6.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 111.505 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.67 157.17 90.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.94 -179.623 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -49.16 128.3 19.44 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.35 67.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.552 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.404 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -65.16 -36.81 85.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.26 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 41.7 t -61.45 -60.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.774 179.403 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.17 -24.82 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.12 -23.75 77.06 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.727 179.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -90.43 78.34 6.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 110.746 179.709 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.25 130.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.7 m -70.15 -58.31 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.12 154.02 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 5.0 mt -104.07 135.96 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.318 179.739 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.411 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.8 m170 -109.01 112.6 24.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 63.7 t80 -67.87 109.37 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -132.05 78.24 69.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 43.4 Cg_endo -68.72 160.3 50.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.253 1.968 . . . . 0.0 112.417 -179.833 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -139.23 162.36 35.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.28 -25.87 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -102.11 -20.07 14.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.505 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -136.38 81.29 1.87 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.66 -21.84 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.636 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.94 39.07 2.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -84.07 115.47 22.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.43 132.98 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.276 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.8 mm -104.89 108.73 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.4 m -86.14 154.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.69 -178.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -111.96 102.15 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 6.6 tpp -56.71 149.26 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.213 -179.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -67.22 -19.92 65.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.36 -13.43 60.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.19 20.22 10.69 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.797 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -112.0 161.41 16.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.854 0.359 . . . . 0.0 110.691 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.69 120.6 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.806 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 27.4 t -118.2 158.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.444 . . . . 0.0 110.665 179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 52.4 p -121.88 149.14 43.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.157 -179.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -161.06 -177.62 6.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.709 179.727 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -126.94 151.66 48.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.408 HD12 HG21 ' A' ' 211' ' ' ILE . 11.0 mt -65.95 -22.74 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -29.17 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.78 35.33 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.4 t80 -57.7 -51.43 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.16 -47.2 86.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.996 179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.82 -38.69 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.42 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 53.4 mmtt -58.11 -53.41 58.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.497 179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -82.12 -19.79 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.555 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.2 t -64.56 -39.85 94.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -10.65 55.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.851 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.416 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -77.21 111.63 18.1 Favored Pre-proline 0 CA--C 1.535 0.366 0 O-C-N 122.48 -0.138 . . . . 0.0 110.863 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.92 -27.57 30.41 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.251 1.967 . . . . 0.0 112.376 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.13 -45.48 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.523 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.416 HG13 ' CG ' ' A' ' 221' ' ' TYR . 24.9 mt -62.85 -57.18 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.01 0.434 . . . . 0.0 109.944 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.45 -29.05 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.356 178.396 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -50.9 -28.85 10.54 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 178.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.95 -27.54 13.57 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.086 0.469 . . . . 0.0 110.203 178.347 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.404 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 4.3 mt -73.9 -34.81 64.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.66 15.47 26.84 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.883 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -67.65 -33.63 75.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.001 0.429 . . . . 0.0 110.365 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -140.25 -67.58 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.356 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.83 179.63 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.927 -179.997 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 p 68.98 -62.82 0.39 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 111.394 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.11 -170.9 3.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -77.61 151.8 34.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -98.98 132.48 44.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -70.01 126.36 29.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.402 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.96 1.14 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.796 179.469 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.0 176.37 9.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.963 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 27.5 m-85 -139.23 173.64 11.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.334 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.3 t -133.98 117.74 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.899 0.381 . . . . 0.0 110.922 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.461 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 113.16 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.14 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.429 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.8 t70 -167.19 139.54 3.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 59.23 42.13 19.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.21 0.529 . . . . 0.0 110.954 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 54.12 27.64 7.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.686 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.409 ' CG2' ' N ' ' A' ' 145' ' ' THR . 86.5 m -145.89 141.59 27.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.461 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.9 m-85 -91.93 109.44 20.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.228 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 126' ' ' ASP . 10.5 m-30 -79.44 123.1 84.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.872 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.86 123.86 14.14 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.19 1.927 . . . . 0.0 112.678 -179.663 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.2 mt -106.49 124.97 50.4 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.834 -179.952 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.18 166.27 16.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.378 179.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -55.64 -30.47 61.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 -179.982 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -91.09 15.26 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.389 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.82 86.39 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.269 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.2 96.28 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.3 0.55 . . . . 0.0 110.36 179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.402 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -86.71 113.46 22.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.88 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.2 mt -105.62 98.42 8.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.421 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 16.5 mttt -69.07 -28.59 66.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -72.39 -27.01 62.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.4 22.17 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.454 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 162.11 54.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.539 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.409 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.6 t -127.85 155.71 43.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.382 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 27.99 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.983 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 138.67 25.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.47 117.95 49.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -76.44 105.79 2.14 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.117 1.878 . . . . 0.0 112.657 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.72 -12.59 60.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.58 -26.94 51.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.673 0.273 . . . . 0.0 111.358 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -142.5 163.93 36.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.823 -179.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -75.87 172.77 15.66 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.891 1.727 . . . . 0.0 112.37 179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.3 t -128.9 153.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 58.3 mt -112.53 97.69 6.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.431 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.5 t -82.06 134.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.377 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.99 87.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.76 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.503 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.9 m95 -148.67 111.11 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.016 0.436 . . . . 0.0 111.438 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.21 -26.13 13.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.633 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -97.52 95.66 7.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.22 -21.23 46.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.1 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -40.06 96.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.57 -34.21 69.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.572 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.476 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 38.0 mt -61.85 -52.01 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.61 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.43 -28.98 57.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.24 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.4 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 6.1 mm-40 -70.89 -51.12 28.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -52.29 66.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.885 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.402 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.91 -33.79 69.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.255 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.81 97.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.305 178.758 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -66.07 -37.39 85.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.248 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.423 HD13 ' CE1' ' A' ' 214' ' ' PHE . 7.1 mp -68.01 -29.65 68.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.86 -19.07 62.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.39 -41.07 6.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.751 0.31 . . . . 0.0 111.541 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.89 156.73 91.26 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.98 130.14 26.7 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 112.792 -179.766 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.19 -39.78 63.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.45 91.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 110.552 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 58.1 t -59.6 -55.59 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.686 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.5 pp -68.74 -12.61 61.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 178.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.69 -14.16 58.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.44 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.68 78.83 3.74 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.975 0.387 . . . . 0.0 111.593 -179.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -178.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.554 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -121.31 -44.36 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -167.66 151.09 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -105.49 136.15 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.317 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.41 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.5 m170 -109.57 122.52 47.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.503 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -73.53 102.73 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.724 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -122.96 75.08 48.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 55.4 Cg_endo -70.62 161.04 47.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.335 2.023 . . . . 0.0 112.597 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.5 p -139.8 164.95 28.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.885 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -54.28 -27.86 38.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -104.28 -16.59 15.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.65 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -135.32 76.62 1.63 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.3 -21.28 33.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.711 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.76 38.37 2.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -85.77 117.8 24.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.008 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.88 133.67 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -104.53 110.58 31.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.3 m -84.99 156.26 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.686 -179.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.77 106.98 15.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.411 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.17 149.23 20.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -67.29 -21.57 65.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.014 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.411 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.9 m-20 -77.21 -13.08 60.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.19 20.35 9.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.617 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 32.9 m-85 -106.52 173.38 6.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.656 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -127.78 119.73 26.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 18.6 t -116.77 159.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 179.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 94.3 p -119.91 149.11 42.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -162.23 -179.11 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.808 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -129.93 150.01 51.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.314 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.4 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 13.3 mt -63.27 -24.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.156 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -35.96 64.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 0.0 111.553 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -131.95 36.15 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.093 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' CE1' HD13 ' A' ' 171' ' ' LEU . 15.2 t80 -54.84 -51.71 65.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.265 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.3 -43.01 92.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.7 179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.44 -38.38 87.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.144 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 24.1 mmtm -58.94 -53.67 55.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.133 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -78.35 -22.12 48.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 179.741 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t -60.13 -47.98 83.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.227 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . 0.418 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 1.5 p-80 -62.57 -15.5 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.422 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -71.03 110.59 7.54 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.98 -24.23 28.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.68 -40.84 20.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.613 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.422 HG13 ' CG ' ' A' ' 221' ' ' TYR . 14.2 mt -69.72 -58.57 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.28 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.232 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.46 -28.45 20.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.506 178.658 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.61 -27.6 11.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.377 178.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 4.7 mt -79.53 -31.9 42.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.23 178.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.45 17.9 23.03 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.672 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.48 -32.51 58.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.62 -37.34 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.788 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.7 m -89.38 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.065 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.948 -179.947 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -95.51 128.53 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.832 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.3 -179.04 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -83.85 158.05 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 130.06 53.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -69.77 124.84 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.0 0.79 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.891 179.639 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -165.5 176.79 7.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.582 0.229 . . . . 0.0 110.869 179.933 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 24.2 m-85 -140.47 173.33 11.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.413 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 22.8 t -132.29 119.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.86 0.362 . . . . 0.0 111.116 179.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.37 111.03 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.965 -179.526 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 43.8 t0 -156.74 134.74 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.796 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 58.52 44.21 18.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.058 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 54.74 27.59 9.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.552 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 145' ' ' THR . 87.0 m -142.12 144.0 33.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.4 m-85 -95.31 110.43 22.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.026 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CG ' ' HA ' ' A' ' 141' ' ' LYS . 9.7 m-30 -82.81 125.34 75.7 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 35.9 Cg_exo -60.23 127.51 23.3 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.218 1.946 . . . . 0.0 112.709 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.22 124.75 52.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.639 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 19.1 mt -86.37 165.85 16.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.41 -179.755 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -55.12 -30.79 60.48 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.576 -179.715 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.25 12.86 14.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.6 3.45 86.78 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.081 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -60.29 97.41 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.222 0.511 . . . . 0.0 110.436 179.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.401 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -80.45 125.87 30.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.8 mm? -104.0 92.64 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.586 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.425 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 11.3 mttm -71.69 -28.55 63.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.858 0.361 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -81.27 -22.9 38.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.405 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -97.27 24.42 6.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.524 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.4 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.03 159.22 53.46 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.272 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.406 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.7 t -128.93 157.77 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.911 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 26.22 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.41 139.89 31.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.498 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.7 111.67 8.95 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.307 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.421 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 22.3 Cg_exo -64.06 100.59 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.386 2.058 . . . . 0.0 112.146 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -65.75 -14.76 61.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.447 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 -27.27 40.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -139.5 162.91 48.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.934 -179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -75.13 174.36 12.93 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.761 1.641 . . . . 0.0 112.64 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 73.5 t -130.78 155.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.087 179.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 62.3 mt -115.0 97.51 6.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.601 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 66.2 t -83.2 133.95 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.33 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.88 84.96 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.748 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.467 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.4 m95 -147.36 111.94 5.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.054 0.454 . . . . 0.0 111.508 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -102.13 -27.08 13.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -96.73 95.67 8.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.39 -21.06 47.24 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.037 178.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.62 98.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.737 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.78 -34.48 71.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.476 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 42.1 mt -61.95 -51.8 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.541 178.528 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.2 -29.62 58.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.264 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 16.3 mm-40 -70.14 -51.78 28.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.3 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.56 -52.54 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.044 179.917 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.4 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.86 -33.55 68.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.311 179.324 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.55 -42.36 97.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.205 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -65.79 -38.36 88.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.809 0.338 . . . . 0.0 110.311 179.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.419 HD12 ' CE1' ' A' ' 214' ' ' PHE . 8.0 mp -66.17 -27.22 67.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.397 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.43 -20.29 60.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.523 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -101.41 -41.11 6.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.57 156.94 89.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -50.15 124.93 13.75 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.64 2.227 . . . . 0.0 112.679 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.09 -38.42 65.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.591 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.407 ' CB ' ' CD2' ' A' ' 228' ' ' LEU . . . -62.5 -38.45 89.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.449 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 50.5 t -61.31 -60.21 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.866 179.555 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.07 -23.5 66.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.473 178.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.23 -24.87 74.59 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.588 178.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.18 78.37 7.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.29 134.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -159.53 153.68 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.421 . . . . 0.0 111.102 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.9 mt -105.05 135.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.149 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.3 m170 -109.47 119.57 39.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.31 112.24 5.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.781 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -135.85 79.72 44.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.85 163.46 38.81 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.279 1.986 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -138.73 163.45 32.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -53.54 -27.07 23.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.63 -16.47 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.656 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -134.0 79.78 1.83 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -58.58 -19.93 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.612 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -114.11 36.52 3.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.74 0.305 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.8 116.36 22.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 110.776 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.08 133.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 33.2 mm -106.01 110.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.74 179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.8 m -84.57 157.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.599 -179.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -112.53 107.39 16.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.241 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.25 149.29 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 111.309 -179.491 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -60.58 -24.57 65.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.803 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -85.95 7.07 25.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -16.53 60.91 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.51 177.1 0.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.934 0.367 . . . . 0.0 110.792 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -140.88 115.23 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.98 157.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 83.3 p -121.93 142.78 49.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.123 -179.608 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.56 -177.27 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.85 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.48 149.06 49.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.476 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.403 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 12.3 mt -61.21 -23.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.378 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -33.68 59.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -132.4 36.19 3.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.008 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CD1' HD23 ' A' ' 218' ' ' LEU . 11.9 t80 -58.12 -39.31 78.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.242 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -69.69 -48.79 58.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.186 -179.685 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.29 -34.17 76.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.106 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -53.32 56.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.392 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.42 HD23 ' CD1' ' A' ' 214' ' ' PHE . 3.4 mm? -79.31 -22.9 43.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.4 m -64.32 -39.12 93.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.631 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -16.3 52.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.673 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 111.58 13.02 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 122.512 -0.117 . . . . 0.0 110.844 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.98 -27.31 36.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.255 1.97 . . . . 0.0 112.381 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.14 -45.56 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.401 HG22 HD11 ' A' ' 224' ' ' ILE . 34.6 mt -63.82 -56.28 17.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.066 0.46 . . . . 0.0 109.813 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.3 58.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.457 178.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -51.2 -29.26 13.49 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.65 178.918 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.98 -27.33 12.99 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.041 0.448 . . . . 0.0 110.347 178.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.407 ' CD2' ' CB ' ' A' ' 177' ' ' ALA . 3.3 mt -76.99 -32.49 57.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.06 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.17 -31.06 65.59 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -72.5 -33.53 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.79 81.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.83 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.38 117.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.904 179.989 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.0 m -93.77 85.9 4.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.84 174.99 7.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.445 ' CE2' ' ND2' ' A' ' 136' ' ' ASN . 44.9 m95 -90.64 150.46 21.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -101.49 132.2 47.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.673 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -71.49 127.67 33.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 -179.81 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.404 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.22 -1.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.875 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -162.3 177.06 9.94 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.025 179.965 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.422 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 23.5 m-85 -139.45 173.95 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.387 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 16.7 t -132.42 118.55 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.45 109.6 15.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.409 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 14.9 t70 -169.2 144.88 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.74 39.65 20.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.36 0.6 . . . . 0.0 110.804 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.92 29.2 9.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.506 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.411 ' CG2' ' N ' ' A' ' 145' ' ' THR . 90.8 m -150.59 143.0 24.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 111.294 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -90.71 110.45 21.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.162 178.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.422 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 18.8 m-85 -80.47 118.55 72.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.04 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.44 121.23 9.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.023 1.816 . . . . 0.0 112.422 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.407 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.4 mt -102.57 125.36 49.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 18.7 mt -82.98 165.48 19.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.287 179.77 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.03 -30.38 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.677 -179.626 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.445 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 53.0 p-10 -89.89 13.92 13.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.93 86.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.171 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.65 97.34 0.07 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.13 0.491 . . . . 0.0 110.429 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 1.1 tt -80.42 121.93 26.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.33 96.6 6.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.586 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.417 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 5.0 mttt -72.71 -25.24 61.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.62 -20.86 30.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.737 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.15 23.35 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.19 163.8 54.5 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.615 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.411 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.8 t -126.68 155.28 42.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.825 0.345 . . . . 0.0 110.533 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 27.12 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.003 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.29 139.06 28.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.43 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.42 3.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.422 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 21.8 Cg_exo -64.54 98.05 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.482 2.122 . . . . 0.0 112.287 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -65.79 -14.49 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.339 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.634 0.254 . . . . 0.0 111.677 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -140.43 160.34 59.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.866 0.365 . . . . 0.0 111.936 -179.178 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -72.42 173.02 13.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.778 1.652 . . . . 0.0 112.668 -179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 75.9 t -129.62 154.22 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.157 179.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.461 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 59.2 mt -112.92 97.96 6.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 110.551 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.36 135.04 25.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.2 87.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.859 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.461 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.3 m95 -148.22 114.9 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.082 0.468 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -105.39 -27.04 11.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.01 95.49 7.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.481 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.43 -20.84 46.65 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.014 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -41.06 98.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.788 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.03 71.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.463 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.481 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 55.3 mt -62.01 -52.08 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.559 178.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.53 -30.93 55.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.402 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.3 mm-40 -68.3 -51.0 49.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.223 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.412 ' HE1' ' CE2' ' A' ' 214' ' ' PHE . 0.0 OUTLIER -60.0 -52.05 67.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.87 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.404 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.57 -33.73 68.47 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.877 0.37 . . . . 0.0 110.359 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.51 -43.65 97.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.246 178.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.55 -39.46 94.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.416 HD13 ' CE1' ' A' ' 214' ' ' PHE . 8.3 mp -66.93 -27.49 67.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.416 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.92 -22.25 58.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -96.94 -41.19 8.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.773 0.32 . . . . 0.0 111.506 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.09 155.55 93.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -49.89 129.82 25.5 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.632 2.222 . . . . 0.0 112.791 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.75 68.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.408 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 110.4 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 42.2 t -61.66 -60.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.604 179.489 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.55 -24.49 66.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 178.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.91 -23.5 76.23 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.872 179.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.99 78.29 9.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.972 0.415 . . . . 0.0 110.865 179.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.39 163.65 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.372 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -103.83 -51.9 3.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.41 151.22 18.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 110.943 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.7 mt -104.73 135.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.092 179.528 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.428 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 7.5 m170 -109.52 125.25 52.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.419 ' CZ ' ' HG3' ' A' ' 189' ' ' PRO . 14.0 t80 -75.49 107.37 7.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.526 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -133.24 70.83 77.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.959 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.419 ' HG3' ' CZ ' ' A' ' 187' ' ' TYR . 20.5 Cg_exo -65.82 162.75 33.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.339 2.026 . . . . 0.0 112.252 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.9 p -135.88 164.13 28.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -26.05 11.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.445 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -105.35 -20.21 13.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.416 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -129.41 82.05 2.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -16.57 25.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.045 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -121.1 37.22 4.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.645 0.26 . . . . 0.0 111.233 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.8 ttm-85 -81.04 119.86 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.719 179.658 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.9 m -119.41 135.14 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.6 mm -105.0 110.78 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.483 179.599 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.1 m -89.66 150.71 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.63 -178.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -109.19 108.9 19.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.236 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.48 149.31 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.469 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -64.76 -22.52 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.939 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.67 -13.17 59.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.25 20.35 9.24 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -103.51 172.49 6.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.829 0.347 . . . . 0.0 110.863 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.36 120.05 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 13.9 t -121.8 160.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.754 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 56.9 p -121.63 148.89 43.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -160.37 -179.26 7.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.72 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.59 151.52 46.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.359 179.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.1 mt -66.02 -25.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -79.14 -28.24 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.251 . . . . 0.0 111.403 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.05 35.77 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.416 ' CE1' HD13 ' A' ' 171' ' ' LEU . 20.1 t80 -57.89 -51.72 68.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.99 -42.01 97.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.511 179.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.95 -43.05 93.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 16.1 mmtm -55.03 -52.64 62.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.083 179.389 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -77.39 -22.84 51.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.753 179.343 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 21.6 t -60.55 -35.47 76.11 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.092 0.472 . . . . 0.0 110.406 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -72.06 -4.94 31.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.007 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 99.4 5.95 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.07 -27.07 50.0 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.156 1.904 . . . . 0.0 111.911 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.27 -45.12 77.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 38.3 mt -70.28 -53.51 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.53 60.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.315 178.376 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -52.24 -27.69 15.81 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.606 178.696 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.65 -27.75 12.41 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.134 0.493 . . . . 0.0 110.321 178.377 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 6.1 mt -78.54 -32.77 48.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.07 178.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.34 20.11 8.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.563 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.79 28.26 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.244 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -121.12 37.91 4.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.73 139.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.866 179.984 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -140.28 31.91 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 -175.04 4.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' TRP . . . . . 0.459 ' CG ' ' ND2' ' A' ' 136' ' ' ASN . 43.3 m95 -104.89 149.51 25.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.822 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -101.28 132.17 46.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -71.29 127.29 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.407 ' CD1' ' CG2' ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.72 1.48 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.792 179.668 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -164.12 176.92 8.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.409 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 21.0 m-85 -139.82 173.43 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.226 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 18.7 t -132.92 118.58 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.57 111.25 16.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.9 t70 -169.09 145.4 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.79 40.86 22.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 54.1 30.62 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.518 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.6 m -152.0 146.42 25.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.424 -179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.03 109.18 20.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.657 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.438 ' CB ' ' CD2' ' A' ' 139' ' ' LEU . 18.0 m-85 -80.68 128.75 70.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.501 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.1 Cg_exo -64.16 125.33 14.98 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.162 1.908 . . . . 0.0 112.326 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.416 HD13 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.1 124.88 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.993 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 17.3 mt -84.07 166.91 17.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.171 179.735 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -55.72 -30.96 62.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.551 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 6.9 p30 -90.49 13.3 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.421 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 80.0 5.93 89.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.108 -179.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.46 96.31 0.03 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 117.253 0.526 . . . . 0.0 110.401 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.438 ' CD2' ' CB ' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -80.89 124.15 28.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.184 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.418 ' N ' ' CD2' ' A' ' 140' ' ' LEU . 2.6 mm? -105.5 95.61 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . 0.422 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.3 mtpt -72.33 -25.92 61.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.276 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -84.81 -21.14 30.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.695 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -99.31 25.7 6.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.553 0.216 . . . . 0.0 111.418 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -69.38 160.92 52.63 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.574 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 1.4 t -124.64 159.82 29.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.36 179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.46 30.78 4.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.139 0.495 . . . . 0.0 109.714 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.25 129.62 9.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.483 -178.215 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.17 109.84 2.35 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.787 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.409 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 35.4 Cg_exo -61.19 105.85 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.225 1.95 . . . . 0.0 112.127 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.68 -15.62 61.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.481 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -81.53 -26.94 34.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -138.51 162.4 53.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.04 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -76.5 173.69 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.99 1.793 . . . . 0.0 112.749 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.0 t -129.55 153.27 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.886 179.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' A' ' 158' ' ' TRP . 56.5 mt -112.42 97.75 6.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.006 0.431 . . . . 0.0 110.638 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.8 t -82.43 134.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.514 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.74 86.91 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.722 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.8 m95 -148.41 112.93 5.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -103.42 -26.23 12.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.514 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -98.11 96.04 7.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.484 ' HA2' ' CD1' ' A' ' 164' ' ' ILE . . . -58.55 -20.97 48.14 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.028 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -40.46 97.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.96 -33.77 68.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.697 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.484 ' CD1' ' HA2' ' A' ' 161' ' ' GLY . 63.6 mt -62.28 -52.11 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.675 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.24 -30.41 59.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.187 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.7 mm-40 -67.9 -51.14 51.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 110.149 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.9 -52.47 65.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.757 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 168' ' ' THR . . . . . 0.407 ' CG2' ' CD1' ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.3 -33.7 67.94 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.268 179.253 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.13 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -66.34 -34.76 78.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.37 . . . . 0.0 110.22 178.752 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 214' ' ' PHE . 8.1 mp -71.79 -28.18 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -19.23 61.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.482 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.17 -40.24 8.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.8 0.334 . . . . 0.0 111.48 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 2.1 pp -73.65 156.0 88.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 -179.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.41 124.7 14.77 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 179.711 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.02 36.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.925 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.48 95.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 48.3 t -59.17 -60.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.949 179.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.58 -24.35 67.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -22.48 77.66 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.101 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -85.15 78.33 9.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.931 179.834 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.4 ptp 177.86 128.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 m -64.91 -48.78 72.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.47 153.92 8.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.984 0.421 . . . . 0.0 110.997 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 4.8 mt -102.89 136.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.269 179.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -111.06 116.8 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.488 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -66.71 112.02 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.853 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -133.54 78.4 62.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 56.8 Cg_endo -71.38 162.11 43.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.306 2.004 . . . . 0.0 112.53 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.9 p -138.64 161.65 36.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.149 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ptt-85 -53.84 -24.83 17.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.376 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -104.99 -20.19 13.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.429 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -134.91 82.02 1.93 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.07 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.04 -19.34 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.659 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -113.17 35.85 3.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -82.91 115.89 21.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.788 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.92 134.53 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.3 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.3 mm -105.63 110.6 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.622 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 2.5 m -86.28 153.89 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.452 -179.145 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -111.5 100.57 9.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.207 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.8 tpp -55.85 149.42 14.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.505 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -66.78 -20.17 65.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.039 179.455 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.83 -13.47 60.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.54 20.31 11.09 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.724 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -113.25 153.64 28.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 110.723 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.53 117.55 34.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 10.8 t -111.96 160.22 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.425 179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 88.0 p -121.57 146.36 47.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.005 -179.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.18 179.5 9.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -125.19 152.94 43.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' ILE . . . . . 0.405 ' CG2' ' HB3' ' A' ' 166' ' ' GLU . 10.2 mt -68.37 -23.89 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.897 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -36.58 57.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.46 35.86 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.962 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' PHE . . . . . 0.42 ' CE1' HD13 ' A' ' 171' ' ' LEU . 12.2 t80 -56.17 -45.95 79.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.127 -179.598 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.27 82.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -60.86 -41.47 95.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -52.35 61.29 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.648 179.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.34 -19.48 36.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.295 179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 38.0 t -64.88 -30.72 71.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.942 0.401 . . . . 0.0 110.854 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -81.55 11.26 4.78 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.94 101.85 35.88 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.2 -35.02 87.62 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.241 1.961 . . . . 0.0 112.354 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.14 -44.83 83.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.224 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 42.5 mt -65.58 -54.56 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.14 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.66 -29.37 59.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.383 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -50.97 -28.93 10.93 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.487 178.839 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -52.77 -25.22 10.6 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.491 178.209 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . . . . . . . . . 1.2 mt -80.91 -30.08 35.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.405 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.1 -31.23 65.86 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.809 0.338 . . . . 0.0 111.078 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 74.55 -61.05 0.5 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.024 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -177.11 37.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.79 121.95 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.915 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.819 ' HB2' HD13 ' A' ' 134' ' ' LEU . 54.7 m95 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.787 0.327 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.03 129.61 48.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -68.65 127.51 33.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.095 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.0 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.89 1.18 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.848 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.21 177.02 8.67 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.664 0.268 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' HB2' HG22 ' A' ' 154' ' ' VAL . 25.1 m-85 -140.04 173.17 11.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.662 HG21 ' HG ' ' A' ' 139' ' ' LEU . 19.5 t -133.34 119.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.41 109.52 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.911 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -158.5 137.55 11.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 57.95 42.64 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.61 30.56 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.394 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 145' ' ' THR . 89.3 m -147.82 143.0 27.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 0.0 111.001 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.484 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.1 m-85 -92.36 110.25 21.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 110.678 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.7 ' HB2' HD21 ' A' ' 139' ' ' LEU . 11.8 m-30 -83.07 111.57 31.47 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.388 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 82.6 Cg_exo -47.14 126.11 11.1 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.546 2.164 . . . . 0.0 113.089 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.981 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.14 125.05 51.77 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.708 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.1 mt -84.31 166.04 17.78 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.9 pt-20 -55.45 -30.63 60.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.534 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -91.31 15.61 11.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.357 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.429 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.13 7.13 86.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.155 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.608 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -60.61 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.287 0.543 . . . . 0.0 110.213 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.15 119.95 23.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 140' ' ' LEU . 3.1 mm? -99.59 94.27 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 22.2 mttt -72.98 -29.43 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -82.2 -21.67 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.95 25.38 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.431 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.39 160.06 53.59 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.433 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.0 155.42 43.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.657 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.76 2.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.404 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -144.81 139.91 28.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.382 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.1 117.99 61.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.83 107.06 2.37 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.146 1.898 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.9 t -67.5 -12.85 61.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.74 -27.0 50.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.707 0.289 . . . . 0.0 111.397 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.1 162.83 45.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.868 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.4 Cg_endo -76.32 174.09 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.064 1.843 . . . . 0.0 112.733 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 130' ' ' PHE . 72.9 t -130.38 153.98 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.939 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.569 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.4 mt -113.04 97.88 6.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.13 0.49 . . . . 0.0 110.652 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.7 t -82.81 134.67 26.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.361 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.2 87.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.691 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.8 m95 -148.78 111.72 4.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 111.465 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.76 -26.67 13.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.528 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -97.52 96.18 8.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.301 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.906 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.19 -21.27 46.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.999 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.48 97.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.0 70.23 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.532 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.981 HG23 HD11 ' A' ' 133' ' ' LEU . 49.0 mt -62.57 -51.84 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.61 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.58 -27.93 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.384 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.5 mm-40 -71.29 -51.47 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 110.392 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.452 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.92 -52.34 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.955 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.0 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.63 -33.72 68.56 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.848 0.356 . . . . 0.0 110.352 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.98 97.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.159 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -63.51 -37.77 88.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.682 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.1 mp -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.068 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.02 -18.64 61.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.723 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -101.88 -40.49 6.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.685 0.279 . . . . 0.0 111.683 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.3 pp -71.16 156.93 91.23 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.774 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.679 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.9 Cg_exo -50.73 124.29 13.26 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.449 2.099 . . . . 0.0 112.466 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.54 -38.48 45.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.24 98.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 51.9 t -59.71 -60.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.789 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.7 -24.03 66.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.542 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.513 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.81 -22.69 76.6 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.012 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.09 78.27 8.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 ptp 178.55 140.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 m -80.91 -53.88 6.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.3 150.67 20.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.198 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.527 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -102.52 135.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.292 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.2 m170 -109.56 118.8 37.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.769 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.447 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -70.28 110.5 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.955 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -133.01 78.34 65.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.423 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 60.8 Cg_endo -74.08 162.77 38.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.256 1.971 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.1 p -140.3 170.23 16.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -57.88 -25.35 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.306 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -104.85 -12.72 16.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.05 83.12 1.73 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 111.335 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.13 -19.08 61.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.546 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -112.42 33.71 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -81.5 115.17 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.66 133.43 63.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.221 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.6 mm -104.69 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -87.74 151.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.712 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -110.36 101.67 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.552 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.4 tpp -55.45 149.43 13.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.513 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -67.05 -20.58 65.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.055 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.79 -13.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.72 20.39 10.09 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.87 165.46 11.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 110.755 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.62 117.43 29.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 201' ' ' MET . 26.1 t -116.54 158.76 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 110.712 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 207' ' ' VAL . 54.2 p -121.79 149.3 43.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.0 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.32 -177.72 6.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -127.59 151.88 48.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.297 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.501 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -65.62 -24.23 34.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.964 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -76.46 -37.72 56.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.394 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -127.84 35.75 4.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.9 t80 -57.69 -42.23 83.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.801 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -64.12 -48.73 74.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.768 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.41 -37.33 86.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 13.9 mmtm -58.21 -53.13 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.532 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.477 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -82.99 -20.05 35.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.386 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.6 t -65.68 -36.61 84.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.061 0.457 . . . . 0.0 110.752 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -70.59 -7.73 46.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.069 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.411 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -80.2 112.16 28.21 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 122.356 -0.215 . . . . 0.0 110.786 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.3 -30.64 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.26 1.973 . . . . 0.0 112.542 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.37 -45.34 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.575 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.8 mt -63.04 -57.12 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.993 0.425 . . . . 0.0 109.935 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.423 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.513 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.825 ' HB2' HD13 ' A' ' 134' ' ' LEU . 55.6 m95 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.881 0.372 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -98.59 131.87 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.663 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HG2' HD23 ' A' ' 134' ' ' LEU . 8.0 mtt85 -73.12 127.65 33.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.15 -0.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.768 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.687 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.03 176.76 10.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.67 0.272 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 22.6 m-85 -139.07 173.7 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.16 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.645 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.8 t -133.97 117.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.917 0.389 . . . . 0.0 110.858 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 111.45 16.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.097 -179.498 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 t70 -168.98 144.1 3.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.793 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 40.48 21.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.14 29.45 10.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.616 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 145' ' ' THR . 90.8 m -149.75 142.68 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.326 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.9 m-85 -91.41 109.38 20.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.172 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.734 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.8 m-85 -79.95 122.94 83.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.31 121.17 9.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.995 1.796 . . . . 0.0 112.372 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.916 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -101.18 125.28 47.79 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.076 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.5 mt -82.22 166.17 19.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.397 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.4 pt-20 -56.6 -30.06 62.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -90.86 15.32 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.445 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 76.73 4.32 81.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.158 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.591 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt85 -61.88 97.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 110.488 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.46 116.62 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.23 97.44 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.96 0.41 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 27.5 mttt -71.77 -26.02 62.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.12 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -77.26 -21.0 54.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -103.89 26.69 8.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.562 0.22 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.67 162.86 52.32 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.525 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.05 156.96 41.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.357 . . . . 0.0 110.613 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 26.72 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.401 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -145.83 140.37 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.446 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 118.78 56.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 67.3 Cg_endo -76.09 106.85 2.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.999 1.799 . . . . 0.0 112.678 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.5 t -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.199 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -26.95 47.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.726 0.298 . . . . 0.0 111.419 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.56 159.98 49.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 54.5 Cg_endo -71.52 172.92 13.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.046 1.83 . . . . 0.0 112.587 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.6 t -128.95 154.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.01 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.4 mt -112.93 97.79 6.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -82.36 135.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.492 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.62 88.18 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.782 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.9 m95 -148.46 110.66 4.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 111.549 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -100.98 -25.25 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.631 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -99.37 96.27 7.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.328 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.906 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.94 -20.78 50.34 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.952 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -40.41 97.16 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.31 -34.06 70.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.57 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.916 HG23 HD11 ' A' ' 133' ' ' LEU . 50.4 mt -61.99 -51.93 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.573 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.64 -29.18 51.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.28 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 60.2 mm-40 -71.08 -50.51 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.386 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.459 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.87 -52.52 65.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.771 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.026 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.56 -33.59 68.3 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 110.248 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.38 -42.72 97.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.181 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -64.33 -37.31 87.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.105 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.652 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -68.93 -27.26 65.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.314 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.15 -20.09 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.522 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -99.1 -40.55 7.95 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.694 0.283 . . . . 0.0 111.381 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.98 155.28 90.58 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.673 ' O ' HD12 ' A' ' 174' ' ' LEU . 54.2 Cg_exo -51.22 125.27 15.95 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.499 2.133 . . . . 0.0 112.443 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.95 -36.86 40.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.797 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.17 97.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 110.355 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.772 ' HA ' HG22 ' A' ' 224' ' ' ILE . 40.3 t -59.46 -60.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.106 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.776 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.7 pp -61.44 -26.52 67.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.269 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.505 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.63 -22.01 78.83 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.97 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.855 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -82.05 78.07 8.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.911 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 176.88 154.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.1 t -91.98 -46.75 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.159 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -166.0 151.55 8.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -103.92 135.5 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.221 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 15.7 m170 -107.97 122.8 47.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 18.1 t80 -76.53 102.8 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.744 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -123.39 70.66 44.92 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.409 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 41.1 Cg_endo -67.96 160.07 50.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.35 2.034 . . . . 0.0 112.636 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.5 p -140.12 163.19 33.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.011 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -53.39 -27.33 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.51 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.97 -19.85 14.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -133.29 76.9 1.7 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.941 0.401 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.37 -21.05 33.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.59 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.57 37.88 3.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 111.237 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -83.91 112.76 20.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.836 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.59 132.85 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 207' ' ' VAL . 23.7 mm -104.72 108.14 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.425 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.496 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.15 151.82 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -108.75 109.8 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.12 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 149.16 7.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.48 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.441 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 4.0 p-10 -61.4 -23.25 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.01 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.5 -13.22 59.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.819 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.94 20.35 9.41 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.792 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -101.28 173.09 6.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.823 0.344 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.57 120.52 36.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 208' ' ' SER . 40.8 t -121.23 159.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.479 ' N ' HG12 ' A' ' 207' ' ' VAL . 96.8 p -120.14 149.09 42.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.151 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -163.64 -179.34 6.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.576 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -128.24 155.06 45.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.431 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.501 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.8 mt -69.87 -23.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.753 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -31.82 57.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -134.1 35.85 3.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 13.1 t80 -56.88 -46.97 81.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.71 99.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.35 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.19 -45.83 89.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.141 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.5 mmpt? -53.34 -53.04 56.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.604 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.489 HD12 HD13 ' A' ' 224' ' ' ILE . 3.5 mm? -78.96 -22.43 45.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.079 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.6 m -64.67 -28.28 69.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.797 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.8 8.52 9.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.425 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -105.97 102.65 40.5 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.324 -0.235 . . . . 0.0 110.406 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.93 -34.31 71.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.177 1.918 . . . . 0.0 112.387 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.57 -45.19 84.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.855 HG23 ' HB3' ' A' ' 181' ' ' ALA . 31.7 mt -65.83 -54.76 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.51 178.579 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.787 ' HB2' HD13 ' A' ' 134' ' ' LEU . 66.5 m95 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.864 0.364 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.6 ptt85 -99.53 132.32 44.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HG2' HD23 ' A' ' 134' ' ' LEU . 18.2 mtm180 -71.91 127.48 32.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.162 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.02 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.41 1.15 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.846 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.675 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.15 177.01 8.72 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 120.643 0.259 . . . . 0.0 111.092 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HB2' HG22 ' A' ' 154' ' ' VAL . 28.8 m-85 -140.08 173.78 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.663 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.6 t -133.54 117.37 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 111.002 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.46 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.49 112.57 17.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.27 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 27.8 t70 -169.18 142.21 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.769 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 41.22 20.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.161 0.505 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.12 28.09 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.672 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 145' ' ' THR . 82.1 m -147.61 142.32 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.317 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.6 m-85 -92.55 110.19 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.9 m-85 -79.96 119.35 76.37 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.922 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 11.8 Cg_endo -58.31 121.09 9.4 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.92 1.747 . . . . 0.0 112.351 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.919 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -102.04 125.74 48.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.15 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.787 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.7 mt -83.27 165.97 18.92 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.312 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' ' 121' ' ' ILE . 9.1 pt-20 -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.61 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -90.93 15.65 10.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.51 86.69 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.25 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.62 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -60.62 95.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.327 0.564 . . . . 0.0 110.243 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -81.03 117.29 21.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.482 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.7 mm? -100.77 96.78 7.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.2 mttt -73.25 -25.73 60.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.066 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -84.55 -21.17 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.686 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -100.83 25.47 7.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.649 0.261 . . . . 0.0 111.521 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.45 164.41 54.16 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.659 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -127.87 156.66 42.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 26.55 3.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.424 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -144.77 141.47 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.91 118.27 61.68 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 106.59 2.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.04 1.827 . . . . 0.0 112.567 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.48 -12.71 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.257 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.0 -27.42 48.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 111.367 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.97 161.44 53.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.851 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.8 Cg_endo -74.4 173.28 14.52 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.969 1.779 . . . . 0.0 112.517 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.3 t -129.91 154.47 40.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.9 mt -113.48 97.97 6.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.026 0.441 . . . . 0.0 110.529 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.9 t -83.88 135.17 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.326 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.46 85.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.69 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.537 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.6 m95 -148.57 116.45 6.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.074 0.464 . . . . 0.0 111.452 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.35 -25.68 11.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.464 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.06 95.52 7.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.919 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.28 -21.01 46.2 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.071 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.17 96.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.84 -33.59 68.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.589 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.919 HG23 HD11 ' A' ' 133' ' ' LEU . 43.5 mt -62.45 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.587 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.75 55.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.243 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.2 mm-40 -69.62 -50.43 44.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.234 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.73 -52.31 66.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.737 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.02 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.06 -33.76 69.38 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.911 0.386 . . . . 0.0 110.23 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -40.71 97.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.224 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -66.25 -37.37 85.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.247 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.568 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -69.02 -27.69 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.269 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.59 60.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.552 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.34 -40.44 7.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.309 . . . . 0.0 111.534 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.46 157.34 89.23 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.656 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.6 Cg_exo -50.76 124.01 12.73 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.494 2.129 . . . . 0.0 112.56 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.08 28.72 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.76 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.76 84.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.369 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.751 ' HA ' HG22 ' A' ' 224' ' ' ILE . 45.0 t -59.22 -59.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.8 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.2 pp -61.27 -25.24 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.46 -23.03 77.99 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.951 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.76 78.15 9.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.915 0.388 . . . . 0.0 110.715 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.84 138.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -78.9 -50.36 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -162.73 152.68 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.53 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.09 136.46 37.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.303 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 5.3 m170 -108.49 116.17 31.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 48.2 t80 -70.21 105.04 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -126.71 75.48 75.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 44.4 Cg_endo -68.43 160.55 48.67 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.232 1.955 . . . . 0.0 112.41 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.1 p -139.44 162.38 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -54.24 -26.24 27.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.36 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -103.22 -19.71 14.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.424 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.63 79.6 1.81 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.04 -21.43 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.55 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -113.42 38.59 2.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.678 0.275 . . . . 0.0 111.111 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.19 115.92 22.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.04 132.81 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.275 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.1 mm -105.34 111.69 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.628 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.5 m -86.62 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.55 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -112.2 105.19 13.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.022 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.24 149.09 7.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -67.24 -22.44 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.913 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.5 -10.72 59.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.39 9.15 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.622 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.75 176.17 5.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.853 0.358 . . . . 0.0 110.741 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.93 113.08 11.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 199' ' ' VAL . 15.0 t -109.84 159.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 207' ' ' VAL . 76.5 p -121.3 146.73 46.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.669 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.493 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.6 -179.74 7.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.2 147.66 51.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.326 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.537 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -58.82 -24.85 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.615 0.245 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.95 58.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.553 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -134.21 35.96 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.235 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.05 -50.97 71.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.753 0.311 . . . . 0.0 110.921 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.65 89.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.725 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.77 -41.04 99.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.146 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.493 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 26.7 mmtt -55.41 -53.45 56.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.217 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -77.8 -23.03 49.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.1 t -60.41 -34.26 73.68 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.092 0.472 . . . . 0.0 110.269 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -78.24 0.83 23.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.796 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.53 99.62 6.75 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.53 -20.08 47.9 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.105 1.87 . . . . 0.0 112.41 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.27 12.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.152 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.787 HG23 ' HB3' ' A' ' 181' ' ' ALA . 23.5 mt -63.64 -53.04 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.449 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.495 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.801 ' HB2' HD13 ' A' ' 134' ' ' LEU . 61.3 m95 . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -95.12 145.81 24.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.519 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HG2' HD23 ' A' ' 134' ' ' LEU . 14.3 mtm180 -86.92 124.28 32.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 110.456 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 168' ' ' THR . 0.1 OUTLIER -126.98 -0.37 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.869 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.69 176.64 10.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HB2' HG22 ' A' ' 154' ' ' VAL . 19.8 m-85 -139.1 173.18 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.181 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.632 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.5 t -132.95 118.17 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.939 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.459 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.27 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 39.2 t0 -169.31 143.78 2.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.683 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 60.0 40.56 18.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 53.94 27.67 7.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.679 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 86.8 m -148.17 142.23 25.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.459 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 10.5 m-85 -90.41 109.75 20.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.5 m-85 -80.28 123.95 82.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.195 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.1 124.09 14.18 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.219 1.946 . . . . 0.0 112.569 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.923 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.3 125.31 50.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.312 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.3 mt -83.35 167.87 17.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.421 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.3 pt-20 -57.09 -30.87 64.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.5 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -90.94 15.28 11.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.374 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.452 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.24 7.86 86.91 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.091 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.624 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.07 96.76 0.05 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.28 0.54 . . . . 0.0 110.282 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.04 113.33 21.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.969 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.9 mt -104.54 97.93 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 32.6 mttt -69.57 -27.11 64.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.11 -22.09 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.693 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -102.28 25.31 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.483 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.87 163.73 52.63 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.693 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -127.72 156.22 42.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.55 27.08 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.947 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.77 140.03 26.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.568 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.2 118.56 51.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.38 105.4 2.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.068 1.846 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.9 t -67.61 -12.59 60.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.87 -26.94 44.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.492 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.69 163.44 38.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 59.9 Cg_endo -75.79 172.86 15.49 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.915 1.743 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 130' ' ' PHE . 74.9 t -128.96 154.17 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.214 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.57 HD12 ' CD1' ' A' ' 133' ' ' LEU . 61.7 mt -113.54 97.68 6.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.153 0.501 . . . . 0.0 110.614 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.2 t -83.03 134.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.352 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.748 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -147.9 113.89 5.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.1 0.476 . . . . 0.0 111.532 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -104.46 -25.64 12.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.518 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -98.79 95.69 7.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.243 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.878 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.58 -20.75 47.47 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.076 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -40.82 97.85 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.86 70.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.538 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.923 ' CG2' HD11 ' A' ' 133' ' ' LEU . 64.8 mt -62.54 -52.05 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -31.76 61.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.04 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 9.0 mm-40 -65.95 -52.08 52.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.057 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.61 -52.28 66.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.812 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.026 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.08 -33.65 69.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.41 97.73 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.321 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -65.62 -36.99 85.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.191 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.607 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -67.62 -28.23 67.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.2 -18.54 61.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.58 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -103.14 -40.93 6.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -70.3 157.41 90.02 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.666 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.4 Cg_exo -51.27 123.99 13.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.67 -35.74 32.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.97 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.67 92.09 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.427 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.803 ' HA ' HG22 ' A' ' 224' ' ' ILE . 66.9 t -58.66 -55.86 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -68.68 -12.74 61.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.65 -12.95 58.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.53 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.67 78.34 3.74 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.991 0.395 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.14 170.14 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.5 m -103.86 -48.16 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -167.73 154.07 7.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.72 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.581 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -104.63 134.98 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.224 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -108.96 117.57 34.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -69.21 105.14 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.739 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -128.63 78.61 75.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.39 161.73 43.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.251 1.967 . . . . 0.0 112.479 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.6 p -136.93 163.49 30.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -54.59 -25.77 28.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.456 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.71 -17.11 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.421 ' HD1' HG21 ' A' ' 210' ' ' THR . 89.5 m-85 -135.16 81.92 1.92 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -58.86 -19.69 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.721 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -113.81 36.93 3.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -83.81 115.09 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.6 m -116.86 136.11 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 207' ' ' VAL . 25.4 mm -105.37 110.58 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.581 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.9 152.14 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.472 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.33 105.97 15.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -53.84 149.42 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.488 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -64.3 -21.62 66.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.22 -13.32 59.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.74 20.38 9.49 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.815 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.96 168.79 8.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.285 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -119.04 117.01 27.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 208' ' ' SER . 40.9 t -118.08 158.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.716 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 207' ' ' VAL . 77.3 p -121.76 147.35 46.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.65 147.89 7.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.421 HG21 ' HD1' ' A' ' 193' ' ' TYR . 0.9 OUTLIER -95.51 147.46 23.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.694 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.492 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.5 mt -59.59 -27.33 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.092 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.76 72.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.551 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -133.07 35.85 3.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.151 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -56.2 -43.88 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -63.87 -49.13 73.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.935 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -37.08 86.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.865 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.79 -53.91 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.502 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.4 mm? -83.17 -21.81 33.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.427 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 m -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 110.634 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -72.45 -4.61 31.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -90.54 110.68 42.86 Favored Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 122.276 -0.265 . . . . 0.0 110.803 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.41 -30.31 44.45 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.184 1.922 . . . . 0.0 112.393 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.92 -44.69 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.392 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.803 HG22 ' HA ' ' A' ' 178' ' ' VAL . 27.9 mt -64.56 -56.49 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 109.805 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.796 ' HB2' HD13 ' A' ' 134' ' ' LEU . 57.8 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -101.36 130.38 47.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HG2' HD23 ' A' ' 134' ' ' LEU . 25.0 mtm180 -69.36 126.57 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.123 0.487 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.057 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.24 -1.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.787 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 171' ' ' LEU . . . -161.79 176.7 10.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.1 m-85 -138.09 173.6 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.641 HG21 ' HG ' ' A' ' 139' ' ' LEU . 13.5 t -134.24 119.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.414 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 109.46 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.999 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 37.3 t70 -161.31 138.05 8.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 58.59 42.62 20.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 54.17 28.42 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.546 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 145' ' ' THR . 89.8 m -145.66 141.97 28.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.424 ' CD2' HG21 ' A' ' 154' ' ' VAL . 8.2 m-85 -91.98 109.04 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.405 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.725 ' HB2' HD21 ' A' ' 139' ' ' LEU . 11.7 m-30 -79.73 123.03 84.14 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.784 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 123.89 14.05 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 112.642 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 164' ' ' ILE . 1.5 mt -105.89 125.01 50.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.946 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.7 mt -84.4 165.92 17.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.191 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 121' ' ' ILE . 4.8 pt-20 -55.47 -30.33 60.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.505 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.4 15.0 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.368 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.99 6.35 87.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.288 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.61 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.95 95.65 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.246 0.523 . . . . 0.0 110.358 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.725 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -86.1 112.98 21.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.876 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -102.74 98.08 8.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.625 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 17.1 mttp -69.8 -28.85 66.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -74.45 -23.71 58.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.78 25.54 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.451 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.08 162.88 52.94 Favored Glycine 0 CA--C 1.51 -0.246 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.479 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.7 155.3 44.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.794 0.331 . . . . 0.0 110.808 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 27.62 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.57 139.12 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.18 118.32 54.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.064 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -77.73 105.54 2.04 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.887 . . . . 0.0 112.726 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -67.88 -12.17 60.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.191 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -77.86 -27.17 49.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 111.386 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -143.83 160.01 51.66 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 47.5 Cg_endo -71.76 173.25 12.95 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.103 1.869 . . . . 0.0 112.71 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 123' ' ' TYR . 72.6 t -129.48 154.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.943 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.611 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.7 mt -112.95 97.99 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.9 t -83.04 134.96 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.33 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.75 85.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.842 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.562 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.1 m95 -148.93 112.7 5.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.41 -25.11 13.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.58 95.41 7.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.236 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.92 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.03 -21.46 45.71 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.085 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -40.06 96.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.67 67.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.6 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.946 HG23 HD11 ' A' ' 133' ' ' LEU . 43.7 mt -61.93 -51.74 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.573 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.09 58.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 1.6 mm-40 -68.81 -51.76 37.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.439 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -57.95 -51.74 68.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.734 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.057 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.65 -33.72 70.39 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.177 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.73 -41.55 95.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.167 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -65.04 -39.42 93.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.986 0.422 . . . . 0.0 110.03 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.608 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.1 mp -67.49 -28.56 67.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -20.49 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.691 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -99.64 -41.32 7.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.506 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.2 pp -70.12 157.66 89.31 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.66 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.4 Cg_exo -51.38 123.6 12.4 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.482 2.121 . . . . 0.0 112.539 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.53 18.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.1 81.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.387 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 50.1 t -58.91 -59.88 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.866 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -60.6 -24.8 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.355 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.421 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.14 -23.27 76.41 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.981 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.857 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.33 78.15 9.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.918 0.39 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.31 157.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.507 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 74.0 m -100.8 -55.56 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.172 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.1 149.69 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 199' ' ' VAL . 4.6 mt -106.0 135.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.266 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.0 m170 -107.77 122.18 46.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -76.35 105.07 7.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.771 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -124.82 73.76 64.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.21 158.88 51.04 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.307 2.005 . . . . 0.0 112.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.6 p -143.71 167.11 23.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -25.8 59.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.294 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -100.95 -17.64 16.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.59 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -143.22 78.7 1.61 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 121.008 0.432 . . . . 0.0 111.146 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.42 -20.17 42.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.633 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.1 36.81 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -84.89 115.57 22.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.2 m -120.51 133.06 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 207' ' ' VAL . 21.6 mm -104.47 112.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 185' ' ' ILE . 3.1 m -89.04 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -110.82 103.73 12.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.969 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.572 ' SD ' HD11 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -50.29 149.03 3.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.652 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -64.76 -22.28 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.963 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -78.9 -13.33 59.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.42 9.32 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.709 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 27.5 m-85 -104.18 164.25 11.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.21 120.77 42.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 208' ' ' SER . 40.4 t -122.0 158.54 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.645 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 207' ' ' VAL . 39.3 p -121.93 149.21 43.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.91 -178.0 5.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -129.95 154.62 47.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.398 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.562 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -67.69 -21.88 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.123 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -30.28 30.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.5 35.04 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.43 ' CD1' HD23 ' A' ' 218' ' ' LEU . 12.6 t80 -59.13 -47.11 86.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.795 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.71 -46.27 90.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.16 -37.71 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -59.4 -53.4 58.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.457 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -79.72 -22.0 43.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.2 t -63.8 -40.56 96.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.382 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -64.5 -14.65 58.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.805 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.422 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -75.91 111.33 14.23 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.467 -0.093 . . . . 0.0 110.886 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.12 -25.76 31.23 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.273 1.982 . . . . 0.0 112.599 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.5 -40.77 25.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.578 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.857 HG23 ' HB3' ' A' ' 181' ' ' ALA . 17.3 mt -69.37 -58.27 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.436 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.216 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.809 ' HB2' HD13 ' A' ' 134' ' ' LEU . 51.8 m95 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.806 0.336 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.5 128.79 45.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.691 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.4 mtm-85 -68.08 127.8 34.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.025 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.53 1.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.84 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.84 176.62 8.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.65 0.262 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.435 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 23.1 m-85 -139.66 173.19 11.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.588 HG21 ' HG ' ' A' ' 139' ' ' LEU . 22.4 t -133.02 118.95 34.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.0 111.038 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.494 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.22 112.0 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.009 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.1 t70 -156.47 133.86 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 58.16 44.6 18.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.969 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 55.01 28.27 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.433 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 86.5 m -142.08 143.46 33.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.494 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.4 m-85 -95.63 110.7 22.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.721 ' HB2' HD21 ' A' ' 139' ' ' LEU . 9.2 m-30 -84.05 124.79 74.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.463 ' HB2' HD12 ' A' ' 140' ' ' LEU . 31.3 Cg_exo -59.61 127.3 23.2 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.295 1.997 . . . . 0.0 112.841 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 1.001 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.88 125.15 52.49 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.733 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.3 mt -85.13 165.15 17.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.513 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.5 pt-20 -55.25 -29.94 59.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.609 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -91.32 15.6 11.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.357 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.77 3.33 79.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.341 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.591 ' HB3' HD12 ' A' ' 134' ' ' LEU . 3.3 tpt180 -61.31 97.58 0.07 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.343 0.572 . . . . 0.0 110.533 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -78.79 132.27 36.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.58 ' N ' HD23 ' A' ' 139' ' ' LEU . 75.1 mt -111.51 92.71 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.4 mttt -71.63 -28.49 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -80.23 -23.33 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.495 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.467 ' HG3' HD13 ' A' ' 140' ' ' LEU . 46.7 mm-40 -97.85 26.07 5.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.494 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -77.33 159.94 49.12 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.559 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 3.3 t -130.86 159.44 37.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 20.39 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.297 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.471 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -136.66 142.19 43.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.596 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.21 119.56 76.98 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.9 Cg_endo -73.71 106.58 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.046 1.831 . . . . 0.0 112.539 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -13.5 61.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.302 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.14 42.94 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.626 0.25 . . . . 0.0 111.554 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.56 161.11 56.41 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.83 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.518 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 57.7 Cg_endo -73.63 173.42 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.959 1.773 . . . . 0.0 112.673 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 130' ' ' PHE . 65.3 t -130.05 153.09 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.7 mt -112.84 97.55 6.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.7 t -82.73 134.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.452 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.56 85.98 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.78 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.509 ' CH2' HD11 ' A' ' 211' ' ' ILE . 68.0 m95 -147.1 110.82 4.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 0.0 111.607 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -101.38 -27.11 13.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.95 95.26 8.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.246 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.44 -20.91 47.07 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.983 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -40.7 98.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -34.41 71.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.449 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.001 HG23 HD11 ' A' ' 133' ' ' LEU . 47.6 mt -61.81 -51.95 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.622 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.1 60.02 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -69.46 -51.44 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.9 -52.43 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.958 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.01 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.23 -33.61 69.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.856 0.36 . . . . 0.0 110.334 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.89 97.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.346 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -64.94 -37.75 88.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.163 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.589 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.4 mp -67.88 -27.47 66.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.249 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.13 -19.47 60.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.513 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.49 -40.72 7.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.674 0.273 . . . . 0.0 111.551 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -71.04 157.1 91.05 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.474 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.657 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.0 Cg_exo -51.08 123.7 12.42 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 112.498 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -34.08 30.23 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.727 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.21 87.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 110.357 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.765 ' HA ' HG22 ' A' ' 224' ' ' ILE . 49.1 t -58.96 -60.29 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.902 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -60.42 -25.02 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.47 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.93 -23.1 77.14 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.606 -0.806 . . . . 0.0 111.818 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.685 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.23 78.29 8.84 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 110.815 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 178.38 133.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.57 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 m -70.48 -61.64 1.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -154.86 152.32 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -102.76 135.21 41.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.433 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -107.75 114.89 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.045 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.473 ' CE2' ' CE3' ' A' ' 158' ' ' TRP . 0.6 OUTLIER -68.47 114.21 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -134.59 76.09 61.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 58.5 Cg_endo -72.21 157.68 53.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.415 2.077 . . . . 0.0 112.659 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.4 p -141.96 161.99 36.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.891 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -55.52 -25.64 38.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.9 -22.13 15.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.108 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -138.46 75.13 1.5 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.02 0.438 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.18 -21.22 21.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.757 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.18 39.26 2.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 111.08 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -87.91 122.92 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.4 mm -104.41 108.77 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.534 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -87.58 151.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 0.0 111.54 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.77 105.02 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.073 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.59 149.13 3.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.659 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -64.13 -22.64 67.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.15 -13.3 60.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.36 9.38 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.678 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -105.32 167.67 9.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.933 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -116.39 120.76 39.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 208' ' ' SER . 46.2 t -120.79 158.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 207' ' ' VAL . 90.7 p -122.29 148.97 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.125 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -164.27 -179.17 5.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.663 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.4 p -126.56 152.95 45.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.509 HD11 ' CH2' ' A' ' 158' ' ' TRP . 16.4 mt -68.54 -25.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.802 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -32.08 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.23 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -134.13 35.93 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.002 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.6 t80 -55.41 -49.39 72.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.443 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.84 -44.56 89.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.262 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.425 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 1.8 mmpt? -53.7 -50.61 65.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.993 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.536 HD12 HD13 ' A' ' 224' ' ' ILE . 3.6 mm? -79.42 -21.62 45.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.669 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.7 t -60.62 -33.68 73.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 0.0 110.436 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -78.75 4.72 13.04 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.137 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.428 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -100.19 99.17 8.9 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 122.238 -0.289 . . . . 0.0 110.257 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.26 -24.89 43.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.174 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.51 -49.15 34.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.765 HG22 ' HA ' ' A' ' 178' ' ' VAL . 49.8 mt -64.02 -53.46 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.467 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.847 ' HB2' HD13 ' A' ' 134' ' ' LEU . 49.9 m95 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ARG . . . . . 0.516 ' NH2' HG21 ' A' ' 121' ' ' ILE . 10.7 ttp180 -98.12 138.25 35.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.324 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.434 ' HG2' HD23 ' A' ' 134' ' ' LEU . 33.3 mtm180 -79.68 129.07 34.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.323 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.007 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.9 1.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.984 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.88 176.9 9.74 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.472 ' HB2' HG22 ' A' ' 154' ' ' VAL . 23.9 m-85 -139.13 173.81 11.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.696 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.6 t -134.25 116.63 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.466 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.4 110.43 15.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.009 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.405 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 10.3 t70 -169.01 145.19 3.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.26 39.4 22.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.846 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.27 30.62 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.569 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 90.9 m -151.93 142.78 22.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.466 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.6 m-85 -90.53 109.8 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.133 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -80.42 118.77 73.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.964 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.47 122.32 11.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.013 1.809 . . . . 0.0 112.351 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.91 HD11 HG23 ' A' ' 164' ' ' ILE . 1.3 mt -103.24 125.28 49.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.171 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.847 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.9 mt -82.35 166.39 19.5 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.2 pt-20 -56.68 -30.52 63.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -90.87 15.32 11.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.354 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.65 6.9 87.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.21 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.628 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.0 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.311 0.556 . . . . 0.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -81.01 117.91 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.76 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.488 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.8 mm? -102.19 97.34 7.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 22.8 mttp -72.38 -26.38 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -83.58 -21.15 32.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -100.42 24.31 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.38 164.3 54.63 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.783 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.54 156.53 42.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.525 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.9 28.16 3.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.8 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.33 139.37 25.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.618 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.25 118.55 54.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.917 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 64.8 Cg_endo -76.23 105.71 2.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.06 1.84 . . . . 0.0 112.668 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -67.61 -12.44 60.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -27.24 41.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.709 0.29 . . . . 0.0 111.501 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -143.17 160.05 53.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.925 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.9 Cg_endo -72.01 172.88 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.962 1.775 . . . . 0.0 112.743 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 123' ' ' TYR . 57.9 t -129.3 154.74 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.921 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.9 mt -114.15 97.82 6.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.478 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 77.7 t -83.34 135.11 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.58 86.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.733 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.576 ' CH2' HD11 ' A' ' 211' ' ' ILE . 72.2 m95 -149.05 111.85 4.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.418 . . . . 0.0 111.492 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -102.27 -25.35 13.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.599 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.43 96.24 7.88 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.895 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.8 -20.65 48.7 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.976 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.45 -40.68 97.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.33 -33.89 70.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.529 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.91 HG23 HD11 ' A' ' 133' ' ' LEU . 51.4 mt -62.38 -51.84 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.591 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.18 -29.7 58.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.9 mm-40 -69.53 -51.22 37.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.72 -52.48 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.789 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.007 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.7 -33.49 70.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.886 0.374 . . . . 0.0 110.241 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.56 -42.59 96.12 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.402 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -66.1 -38.86 89.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.648 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.1 mp -66.49 -26.24 67.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.3 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.63 59.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.572 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.03 -40.53 7.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.761 0.315 . . . . 0.0 111.461 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.746 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -72.41 156.82 90.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.362 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.654 ' O ' HD12 ' A' ' 174' ' ' LEU . 53.1 Cg_exo -50.61 124.48 13.49 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.561 2.174 . . . . 0.0 112.628 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.53 50.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.54 91.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 110.315 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.845 ' HA ' HG22 ' A' ' 224' ' ' ILE . 55.9 t -60.13 -60.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.926 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.746 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.33 -24.48 66.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.381 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.4 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.0 -23.21 76.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.852 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.909 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -84.58 78.16 9.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.695 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 177.3 141.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.408 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.8 -50.01 11.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -163.68 153.06 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.505 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -104.25 133.9 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.135 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.6 m170 -106.82 112.51 25.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.029 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.444 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 73.1 t80 -67.53 102.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -125.81 77.48 70.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.048 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.444 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 43.1 Cg_endo -68.16 166.76 23.97 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.223 1.949 . . . . 0.0 112.322 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 p -141.35 173.54 11.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -27.3 68.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.015 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 193' ' ' TYR . 5.6 pt-20 -114.95 10.99 16.43 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 192' ' ' GLU . 71.6 m-85 -155.88 73.49 0.82 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -21.66 23.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.64 39.26 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.235 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.403 ' HB3' ' HA ' ' A' ' 189' ' ' PRO . 0.0 OUTLIER -85.8 112.66 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 209' ' ' ALA . 34.8 m -116.74 134.13 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 207' ' ' VAL . 22.5 mm -105.95 111.37 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.505 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -84.62 152.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.503 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -109.54 105.28 14.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.24 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.53 149.3 8.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -66.65 -22.35 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.97 -12.03 59.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.3 14.68 19.68 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.837 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -100.65 174.26 6.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.849 0.325 . . . . 0.0 110.511 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.41 120.58 27.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 0.0 110.963 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.491 ' HB ' HG22 ' A' ' 199' ' ' VAL . 15.2 t -117.22 160.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.459 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 207' ' ' VAL . 96.5 p -118.67 145.13 45.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.5 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -162.68 151.3 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.823 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.87 146.87 27.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.405 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' CH2' ' A' ' 158' ' ' TRP . 15.4 mt -58.8 -27.15 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 111.059 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -32.86 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.546 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -133.98 35.8 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.228 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -55.39 -50.41 69.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.154 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.49 88.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.77 -43.02 99.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.11 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.556 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 10.7 mmtt -51.94 -51.26 58.26 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.016 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -83.16 -16.56 46.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.958 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.9 t -62.48 -34.91 77.77 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.478 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.556 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 0.9 OUTLIER -81.5 8.12 10.3 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -101.99 99.31 11.92 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.29 -28.16 40.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.192 1.928 . . . . 0.0 112.175 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.64 -49.06 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.028 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.909 HG23 ' HB3' ' A' ' 181' ' ' ALA . 32.2 mt -65.76 -53.41 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.514 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.82 ' HB2' HD13 ' A' ' 134' ' ' LEU . 32.2 m95 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.845 0.355 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.55 128.81 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.54 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -69.51 126.74 30.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.035 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.023 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.68 -0.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.784 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.738 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.44 176.78 10.13 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.736 0.303 . . . . 0.0 110.984 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.437 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.5 m-85 -138.88 173.34 11.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 139' ' ' LEU . 18.9 t -133.71 119.43 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.91 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.15 110.95 16.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.191 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 13.4 t70 -162.09 137.73 7.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 59.16 42.93 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 53.96 26.87 6.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.599 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 145' ' ' THR . 92.2 m -143.49 141.95 30.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.97 0.414 . . . . 0.0 111.007 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.5 m-85 -91.63 110.0 21.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.37 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.712 ' HB2' HD21 ' A' ' 139' ' ' LEU . 12.0 m-30 -81.07 122.69 81.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.879 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.25 123.81 13.9 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.172 1.914 . . . . 0.0 112.684 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.925 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.73 125.19 50.7 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.914 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.9 mt -83.6 165.76 18.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.321 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.514 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.0 pt-20 -55.84 -30.21 61.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -90.87 14.87 12.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.411 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.28 4.15 83.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.33 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.587 ' HB3' HD12 ' A' ' 134' ' ' LEU . 19.6 tpp85 -61.21 97.6 0.07 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.333 0.566 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.712 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -83.79 117.39 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.068 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.91 97.65 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.8 mttp -69.96 -29.68 66.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.792 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -71.28 -22.61 61.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -101.8 24.53 9.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.505 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.07 162.2 52.52 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.439 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -128.35 156.49 43.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.849 0.357 . . . . 0.0 110.807 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 25.86 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.171 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.421 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.4 OUTLIER -142.93 139.43 30.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.605 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 117.99 53.95 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.3 105.96 2.14 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.114 1.876 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.8 t -67.41 -12.84 61.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.204 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.57 -27.3 51.39 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.39 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.12 164.01 38.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.9 Cg_endo -77.17 172.94 15.19 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.934 1.756 . . . . 0.0 112.445 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.6 t -129.57 154.88 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.067 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.567 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.0 mt -113.31 97.9 6.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.424 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.9 t -82.72 134.93 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.473 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.65 86.89 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.803 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.506 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -148.32 113.93 5.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 111.512 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -26.77 12.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.486 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.28 96.07 8.14 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.893 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.49 -20.95 47.64 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.026 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -40.7 98.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.49 69.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.497 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.925 HG23 HD11 ' A' ' 133' ' ' LEU . 50.0 mt -62.72 -52.37 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.48 47.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.238 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 7.0 mm-40 -68.73 -52.1 34.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.21 -52.83 64.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.023 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.99 -33.53 69.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.246 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.44 -42.63 97.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.306 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -64.68 -36.9 85.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.924 0.392 . . . . 0.0 110.107 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.628 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.1 mp -67.81 -27.74 66.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.072 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.65 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.583 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.59 -40.31 6.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.74 0.305 . . . . 0.0 111.726 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.781 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -71.38 156.97 90.94 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.66 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -51.42 124.38 14.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.624 2.216 . . . . 0.0 112.648 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.75 -35.65 32.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.852 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 110.259 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 224' ' ' ILE . 57.9 t -58.45 -55.58 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.768 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.781 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -68.45 -12.61 61.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.826 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 -12.69 58.42 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.575 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -93.63 78.05 4.31 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.093 0.447 . . . . 0.0 111.205 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.97 176.95 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 p -113.05 -46.22 3.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.88 0.372 . . . . 0.0 110.8 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -167.88 152.43 6.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.882 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -104.74 135.33 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.267 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.423 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 1.6 m80 -107.8 121.91 45.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -75.64 101.82 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -123.42 74.36 51.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.61 160.62 47.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.376 2.051 . . . . 0.0 112.564 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -139.09 163.44 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.985 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -53.96 -26.75 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.42 -18.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -134.09 79.38 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.952 0.406 . . . . 0.0 111.115 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.27 -21.14 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.699 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -114.14 38.28 3.07 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.777 0.322 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 113.89 20.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.58 132.93 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.65 111.26 33.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.63 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.521 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.5 m -85.0 153.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.467 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -109.09 109.93 21.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.255 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 149.27 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.402 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 3.8 p-10 -60.64 -24.37 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -85.37 7.03 23.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.13 -16.32 61.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.915 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.83 173.03 1.12 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -135.02 119.13 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.521 ' HB ' HG22 ' A' ' 199' ' ' VAL . 16.3 t -115.33 159.54 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.662 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 207' ' ' VAL . 89.3 p -119.28 149.14 42.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -163.59 -179.57 6.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -127.92 151.18 49.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.386 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.506 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.7 mt -64.94 -25.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.949 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -31.13 62.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.399 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.56 36.13 3.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.13 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 15.7 t80 -56.13 -50.72 70.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.013 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.3 97.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.411 ' HA ' ' HB2' ' A' ' 219' ' ' SER . 5.4 t70 -63.92 -47.64 79.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.042 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 21.8 mmtm -51.83 -51.82 53.79 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.672 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 224' ' ' ILE . 3.4 mm? -80.37 -21.51 42.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' SER . . . . . 0.411 ' HB2' ' HA ' ' A' ' 216' ' ' ASP . 3.2 m -64.29 -27.74 69.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.753 0.311 . . . . 0.0 110.757 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -85.66 17.1 3.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.061 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.24 103.63 55.0 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.68 -24.46 35.08 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.143 1.895 . . . . 0.0 112.418 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.02 -49.69 42.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.159 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' A' ' 178' ' ' VAL . 41.5 mt -63.44 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 178.669 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.811 ' HB2' HD13 ' A' ' 134' ' ' LEU . 60.8 m95 . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.904 0.383 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -96.12 130.14 43.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -71.48 126.33 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.983 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.42 0.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.947 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.727 ' HB2' HD23 ' A' ' 171' ' ' LEU . . . -163.29 176.79 9.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 152' ' ' ALA . 58.2 m-85 -138.83 173.27 11.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.323 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.655 HG11 HD11 ' A' ' 139' ' ' LEU . 21.8 t -134.08 118.18 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.996 0.426 . . . . 0.0 111.044 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.1 109.4 14.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.961 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -158.73 139.27 12.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 40.96 23.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 55.08 31.13 15.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.332 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 145' ' ' THR . 84.8 m -147.69 144.02 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.994 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.3 m-85 -93.44 110.46 22.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.708 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.5 m-30 -82.8 127.09 71.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 28.3 Cg_exo -62.18 125.76 17.11 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.329 2.019 . . . . 0.0 112.746 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 1.049 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.8 124.97 50.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.795 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.6 mt -85.29 165.44 17.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.408 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.7 pt-20 -55.22 -30.46 60.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.49 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -91.56 15.82 11.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 76.85 7.74 86.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.321 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.61 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.89 96.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.332 0.566 . . . . 0.0 110.408 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.708 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -83.6 123.1 29.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.825 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.4 mt -107.77 96.56 6.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.9 mttp -70.98 -26.79 63.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.009 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -79.9 -23.06 42.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.577 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -98.02 25.51 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.515 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.71 159.35 52.14 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.418 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -127.09 156.39 41.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 27.32 3.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 139.61 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.74 117.95 55.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 64.7 Cg_endo -76.12 105.95 2.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.065 1.843 . . . . 0.0 112.643 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.4 t -67.82 -12.32 60.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.263 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -27.39 53.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.714 0.293 . . . . 0.0 111.271 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.646 ' HB3' ' HE1' ' A' ' 123' ' ' TYR . . . -143.34 160.66 50.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.859 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.9 Cg_endo -72.73 172.72 14.69 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.029 1.819 . . . . 0.0 112.678 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 123' ' ' TYR . 78.8 t -128.74 154.87 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.923 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.614 HD12 ' CD1' ' A' ' 133' ' ' LEU . 45.6 mt -113.62 97.72 6.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.546 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 60.5 t -83.6 132.52 31.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.622 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.8 82.77 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.874 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.543 ' CZ2' HD22 ' A' ' 155' ' ' LEU . 57.9 m95 -144.55 99.38 3.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.586 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -25.21 21.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -98.35 97.62 8.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.894 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.85 -20.88 50.05 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.969 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -40.22 96.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.45 70.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.488 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.049 HG23 HD11 ' A' ' 133' ' ' LEU . 47.1 mt -61.89 -51.72 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.403 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -56.28 -29.17 60.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.8 mm-40 -71.04 -50.01 38.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.103 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.501 ' HE2' HD21 ' A' ' 155' ' ' LEU . 1.2 mmm -57.65 -52.54 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.791 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.983 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -60.06 -33.53 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.172 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.24 94.16 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.501 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.74 -39.56 91.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.0 0.429 . . . . 0.0 109.982 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 122' ' ' ALA . 3.5 mp -66.83 -28.41 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.52 -19.89 60.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.734 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.77 -40.55 7.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 111.473 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.2 pp -72.25 156.28 90.71 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.579 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.674 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.0 Cg_exo -51.41 125.56 16.93 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.531 2.154 . . . . 0.0 112.429 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.1 53.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.823 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.86 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.446 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.789 ' HA ' HG22 ' A' ' 224' ' ' ILE . 44.5 t -59.05 -60.05 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.729 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -62.61 -23.29 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.551 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -72.79 -24.82 75.38 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.782 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.792 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -82.36 78.06 9.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.775 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 177.16 153.33 0.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.465 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.05 -53.87 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.095 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.67 151.06 25.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.477 HG12 HG12 ' A' ' 199' ' ' VAL . 4.5 mt -106.27 134.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.397 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.3 m170 -106.38 127.47 53.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.24 112.55 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -135.0 78.04 54.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 163.22 32.96 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.351 2.034 . . . . 0.0 112.652 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -144.58 167.92 21.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -57.91 -24.15 56.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.22 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.69 -16.57 15.98 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -144.13 83.06 1.73 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -60.05 -20.5 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.626 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.29 34.32 4.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.71 0.291 . . . . 0.0 111.141 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.69 112.05 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.783 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.7 m -115.4 136.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.243 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.0 mm -106.91 109.75 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -86.45 155.63 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.743 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.04 105.79 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.982 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.55 149.11 6.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.918 0.389 . . . . 0.0 111.636 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -64.49 -23.44 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.918 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -77.58 -13.01 60.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.34 20.39 9.17 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.4 172.63 6.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -126.37 117.11 22.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 208' ' ' SER . 13.4 t -118.8 160.11 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 207' ' ' VAL . 59.7 p -121.47 146.75 46.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.36 -177.69 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.699 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -126.82 154.38 44.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.434 HD11 ' CH2' ' A' ' 158' ' ' TRP . 4.6 mt -69.31 -25.02 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.776 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -80.96 -28.64 35.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.286 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -132.28 35.5 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 171' ' ' LEU . 48.7 t80 -60.43 -50.51 73.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.98 -36.84 82.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.278 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -68.25 -45.68 72.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.1 mmpt? -53.77 -53.18 55.87 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.46 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.574 HD12 HD13 ' A' ' 224' ' ' ILE . 3.5 mm? -75.96 -24.95 55.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.818 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.4 m -61.12 -30.46 70.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.878 0.371 . . . . 0.0 110.407 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.66 5.57 12.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.046 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.77 101.72 34.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.56 -24.25 42.19 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.142 1.895 . . . . 0.0 112.326 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.1 -48.73 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.792 HG23 ' HB3' ' A' ' 181' ' ' ALA . 36.2 mt -64.86 -53.67 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.636 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.79 ' HB2' HD13 ' A' ' 134' ' ' LEU . 68.7 m95 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -97.17 132.45 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.476 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -71.98 126.56 30.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.102 0.477 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.017 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.21 1.42 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.886 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.677 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.77 176.64 8.6 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.413 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.6 m-85 -139.88 173.0 11.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.443 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 139' ' ' LEU . 25.2 t -132.96 119.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.12 111.67 16.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.109 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 24.3 t0 -158.35 136.29 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.22 43.72 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.004 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 54.85 28.88 11.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.418 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 86.3 m -144.29 144.08 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.071 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.4 m-85 -94.61 110.4 22.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 111.04 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.717 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.1 m-30 -82.72 125.23 76.19 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.438 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.2 Cg_exo -59.66 126.96 22.0 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.348 2.032 . . . . 0.0 112.853 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.924 HD11 HG23 ' A' ' 164' ' ' ILE . 0.8 OUTLIER -109.47 124.82 51.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.703 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.9 mt -85.51 166.5 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.459 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.446 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.0 pt-20 -55.65 -30.68 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.651 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -91.08 15.34 11.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.477 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.404 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.45 3.88 83.46 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.326 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.603 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -60.76 97.93 0.06 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.264 0.532 . . . . 0.0 110.548 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.717 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.39 129.98 34.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.052 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.515 ' N ' HD23 ' A' ' 139' ' ' LEU . 24.5 mt -110.67 94.41 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.652 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 44.2 mttt -71.61 -28.95 64.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -80.12 -21.45 43.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.578 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.431 ' HG3' HD13 ' A' ' 140' ' ' LEU . 2.7 mm-40 -99.56 25.79 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.33 159.0 52.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.53 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -127.48 156.65 41.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.663 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.56 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.416 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -145.04 141.36 28.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.61 119.1 73.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.29 107.09 2.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.108 1.872 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.2 t -66.78 -13.34 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.286 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.52 -27.16 41.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.61 0.243 . . . . 0.0 111.512 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.82 162.81 48.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.925 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.4 Cg_endo -77.31 173.16 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.996 1.797 . . . . 0.0 112.627 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 130' ' ' PHE . 76.7 t -129.43 154.55 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.076 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.571 HD12 ' CD1' ' A' ' 133' ' ' LEU . 51.5 mt -114.17 97.77 6.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 0.0 110.561 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.8 t -82.41 134.84 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.84 87.04 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.878 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.502 ' CH2' HD11 ' A' ' 211' ' ' ILE . 67.4 m95 -146.97 116.62 7.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 111.545 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -106.68 -27.43 10.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.344 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.74 95.19 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.893 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.38 -20.91 46.56 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.03 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -40.64 97.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.13 -34.28 70.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.505 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.924 HG23 HD11 ' A' ' 133' ' ' LEU . 62.0 mt -62.13 -51.63 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.662 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.62 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.8 mm-40 -66.99 -50.46 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.64 -52.48 65.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.741 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.73 68.7 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.847 0.355 . . . . 0.0 110.268 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.98 98.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.366 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -66.84 -35.1 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.193 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.609 ' HB3' HD22 ' A' ' 179' ' ' LEU . 6.5 mp -70.59 -28.97 65.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.059 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.84 -18.13 62.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.68 -40.98 6.38 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -71.11 157.41 90.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.695 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.7 Cg_exo -51.21 123.88 12.88 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.629 2.219 . . . . 0.0 112.54 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.74 -36.31 35.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.988 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.51 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.258 0.551 . . . . 0.0 110.309 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.782 ' HA ' HG22 ' A' ' 224' ' ' ILE . 78.5 t -58.78 -56.12 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.773 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -67.86 -13.64 62.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.766 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.88 -14.29 59.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.585 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.639 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.53 78.61 3.82 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 111.609 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.98 153.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.556 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.51 -49.64 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -167.55 156.82 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 153' ' ' PRO . 4.8 mt -104.79 135.48 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.406 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.427 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 13.1 m170 -106.14 127.78 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -80.12 111.63 16.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -133.62 73.55 72.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.854 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.19 160.02 51.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.285 1.99 . . . . 0.0 112.594 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.6 p -140.48 162.1 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -54.74 -25.86 30.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.368 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -102.43 -20.47 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -135.41 77.34 1.67 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.927 0.394 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -55.83 -22.21 23.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.767 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -113.05 39.51 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.314 . . . . 0.0 111.307 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.58 116.09 24.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.8 m -121.49 137.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.08 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 207' ' ' VAL . 19.1 mm -106.62 110.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.44 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.4 m -84.62 153.32 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.639 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.427 ' CE1' ' CD2' ' A' ' 186' ' ' HIS . 6.3 m-85 -111.42 107.37 16.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.449 ' SD ' HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -55.78 149.25 14.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.99 -24.05 66.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.882 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.3 m-20 -75.84 -13.28 60.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.21 20.3 9.31 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.787 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 51.7 m-85 -104.87 174.06 6.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -127.88 123.95 36.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.044 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 208' ' ' SER . 20.3 t -124.37 159.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 207' ' ' VAL . 79.4 p -118.92 144.91 46.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.99 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -163.09 149.68 12.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.68 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.25 147.15 24.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.582 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.502 HD11 ' CH2' ' A' ' 158' ' ' TRP . 14.4 mt -58.5 -27.48 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -32.87 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -130.16 35.8 4.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.074 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.8 -51.82 68.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.91 87.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.75 -42.67 99.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.0 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.415 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.3 mmpt? -52.31 -53.42 44.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.587 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -80.49 -21.22 42.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.973 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.8 t -60.03 -33.85 72.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.007 0.432 . . . . 0.0 110.447 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.75 3.87 15.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.128 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.36 99.87 14.1 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.25 -26.36 42.01 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.09 1.86 . . . . 0.0 112.126 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.38 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.782 HG22 ' HA ' ' A' ' 178' ' ' VAL . 29.9 mt -64.2 -53.05 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.596 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.846 ' HB2' HD13 ' A' ' 134' ' ' LEU . 44.0 m95 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -99.72 132.84 44.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -72.06 127.81 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.016 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.9 0.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.949 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.707 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.6 176.75 10.06 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.094 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.483 ' HB2' HG22 ' A' ' 154' ' ' VAL . 28.4 m-85 -138.39 173.21 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.696 HG21 ' HG ' ' A' ' 139' ' ' LEU . 15.1 t -133.93 117.55 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.967 0.413 . . . . 0.0 111.101 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.477 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.59 114.42 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.277 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.449 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.4 t70 -169.09 142.01 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.771 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 59.34 41.14 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.497 . . . . 0.0 110.738 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.15 29.65 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.441 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 145' ' ' THR . 46.8 m -148.3 145.09 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.434 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.3 m-85 -95.52 110.53 22.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.701 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.715 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.9 m-85 -80.84 129.1 69.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.108 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 22.3 Cg_exo -64.73 123.92 12.4 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.167 1.911 . . . . 0.0 112.31 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.911 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -105.57 125.09 50.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.09 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.846 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.3 mt -84.11 167.09 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.197 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.4 pt-20 -55.75 -31.12 62.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.451 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.0 p30 -90.85 14.39 13.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.48 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 78.39 7.68 87.82 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.021 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.592 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.1 95.93 0.04 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.209 0.504 . . . . 0.0 110.27 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.715 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.2 118.62 23.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.017 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.4 mt -103.98 97.34 7.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.565 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 17.8 mttt -71.16 -25.67 62.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -80.71 -21.1 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.856 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -100.14 26.61 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.71 159.91 52.54 Favored Glycine 0 CA--C 1.506 -0.483 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.722 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.671 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -125.91 156.96 38.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.633 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 29.34 2.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.044 0.449 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.4 143.65 26.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.525 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.7 118.05 67.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.63 109.24 2.72 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.141 1.894 . . . . 0.0 112.54 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.4 t -67.39 -13.11 61.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.28 -27.26 53.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.43 162.56 46.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.868 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 68.0 Cg_endo -76.56 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.023 1.815 . . . . 0.0 112.682 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 123' ' ' TYR . 62.3 t -130.74 154.25 40.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.7 mt -113.61 97.57 6.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 0.0 110.587 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.5 t -82.26 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.474 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.89 89.42 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.611 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.0 m95 -147.36 97.48 2.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.721 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -93.61 7.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -131.27 93.02 3.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.427 0.156 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.877 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.86 -21.2 43.65 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.23 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -39.73 95.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.57 -33.56 62.7 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.788 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.911 HG23 HD11 ' A' ' 133' ' ' LEU . 62.6 mt -61.46 -52.05 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.919 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.93 -30.81 62.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.142 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.5 -51.52 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.188 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.31 -52.15 66.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.756 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.016 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.45 -33.63 69.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.872 0.367 . . . . 0.0 110.244 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.43 -41.82 97.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.38 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -66.15 -38.34 87.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.781 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.2 mp -66.34 -27.56 67.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.343 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.5 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.626 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -101.45 -41.06 6.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.645 0.259 . . . . 0.0 111.49 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.42 157.39 90.09 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.627 ' HB2' HG23 ' A' ' 178' ' ' VAL . 52.2 Cg_exo -50.13 129.26 24.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.529 2.153 . . . . 0.0 112.841 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.12 67.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.455 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.1 86.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 110.399 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.706 ' HA ' HG22 ' A' ' 224' ' ' ILE . 55.6 t -61.82 -60.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.838 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -62.8 -23.89 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.451 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.96 -23.86 75.32 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.771 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -89.51 78.44 7.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.863 0.364 . . . . 0.0 110.688 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.62 131.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -59.27 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.26 155.43 32.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.415 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.6 m170 -107.31 118.85 37.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.24 115.0 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -138.7 77.47 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -69.14 162.08 43.23 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.0 p -139.27 161.43 37.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.05 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -25.5 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -103.34 -19.96 14.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.331 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -135.17 81.02 1.87 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -57.09 -21.24 30.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.617 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ASP . . . . . 0.422 ' OD2' HD12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -113.04 38.49 2.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.283 . . . . 0.0 111.044 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -85.2 115.73 23.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 209' ' ' ALA . 32.2 m -119.76 135.97 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.113 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 208' ' ' SER . 20.4 mm -105.33 111.38 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.52 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.84 155.38 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 111.694 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -114.45 99.78 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.956 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.501 ' HE3' HG21 ' A' ' 207' ' ' VAL . 7.5 tpp -54.18 149.33 9.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.489 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.82 -20.32 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.008 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 5.8 m-20 -76.02 -13.71 60.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.5 20.18 10.49 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.74 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 28.1 m-85 -111.52 155.93 22.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -109.3 118.77 37.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.501 HG21 ' HE3' ' A' ' 201' ' ' MET . 15.7 t -116.24 159.52 16.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 110.643 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 198' ' ' ILE . 51.4 p -121.64 143.68 49.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.791 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -162.67 150.15 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.43 146.57 24.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.523 HD11 ' CH2' ' A' ' 158' ' ' TRP . 17.9 mt -59.03 -28.15 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.097 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -31.58 69.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.586 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.23 36.11 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.139 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -55.46 -50.77 69.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.481 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.61 -48.27 82.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.976 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -63.07 -38.95 93.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.961 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -55.66 -53.48 56.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.965 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.515 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.6 mm? -78.61 -22.7 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.711 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.8 t -60.49 -34.1 73.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -72.08 -5.47 35.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.855 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.68 100.4 6.18 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 -27.83 46.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.145 1.897 . . . . 0.0 112.105 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.27 80.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.706 HG22 ' HA ' ' A' ' 178' ' ' VAL . 24.8 mt -72.28 -54.93 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.198 178.191 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.829 ' HB2' HD13 ' A' ' 134' ' ' LEU . 56.5 m95 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 130.33 45.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.782 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -70.6 127.73 33.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.251 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.995 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.09 3.18 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.708 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.798 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.44 176.47 9.01 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.645 0.259 . . . . 0.0 110.894 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.457 ' HB2' HG22 ' A' ' 154' ' ' VAL . 18.9 m-85 -140.12 173.59 11.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.095 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.65 HG21 ' HG ' ' A' ' 139' ' ' LEU . 21.6 t -133.55 117.46 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.511 ' HD2' HG22 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -80.44 107.35 13.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.832 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.434 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.6 t0 -164.42 144.17 7.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.725 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.98 40.63 18.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.792 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.16 28.36 8.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 145' ' ' THR . 40.4 m -148.78 146.21 27.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.6 109.03 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.5 m-85 -81.15 129.95 64.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 19.5 Cg_exo -66.13 124.5 12.68 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.137 1.891 . . . . 0.0 112.287 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.922 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.84 124.77 50.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.861 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.5 mt -83.94 166.63 17.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.1 pt-20 -55.85 -30.35 61.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.41 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.52 15.77 11.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.497 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 75.5 9.64 84.6 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.123 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.609 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.96 96.39 0.07 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.244 0.522 . . . . 0.0 110.11 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.59 119.52 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.079 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.7 mt -105.02 97.63 7.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.439 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 40.8 mttt -72.03 -21.92 61.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -84.37 -21.68 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -100.76 29.2 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.498 0.189 . . . . 0.0 111.414 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.53 161.42 54.15 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -125.21 160.66 28.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.36 30.51 4.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.406 HG23 ' OG1' ' A' ' 145' ' ' THR . 0.0 OUTLIER -154.55 133.1 12.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.681 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.95 118.31 37.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.8 Cg_endo -73.1 111.78 3.36 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.985 1.79 . . . . 0.0 112.477 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -66.61 -13.9 61.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.32 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.24 -26.66 42.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.591 0.234 . . . . 0.0 111.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.86 159.25 47.49 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.2 Cg_endo -71.87 174.19 11.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.235 1.957 . . . . 0.0 112.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 123' ' ' TYR . 68.6 t -129.0 153.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.836 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.6 mt -112.87 98.58 7.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.565 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.511 HG22 ' HD2' ' A' ' 125' ' ' TYR . 59.5 t -82.81 135.32 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.475 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.63 86.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.6 m95 -148.11 115.73 6.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 111.468 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -106.26 -27.29 11.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.442 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -96.53 95.78 8.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.89 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.41 -20.96 47.01 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.084 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -40.3 96.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.46 68.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.659 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.922 ' CG2' HD11 ' A' ' 133' ' ' LEU . 58.1 mt -62.91 -52.34 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.625 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.38 57.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -68.94 -51.2 42.22 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.177 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.67 -52.54 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.995 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.02 -33.71 69.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.286 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.91 97.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.311 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.33 -37.7 87.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.388 . . . . 0.0 110.115 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.654 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.4 mp -67.75 -27.62 66.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.246 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.73 -19.27 60.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.534 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.04 -40.7 7.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.638 0.256 . . . . 0.0 111.573 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.68 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -72.18 157.58 89.07 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.518 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.646 ' O ' HD12 ' A' ' 174' ' ' LEU . 56.8 Cg_exo -50.27 124.45 13.01 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.594 2.196 . . . . 0.0 112.681 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.85 53.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.79 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.0 110.3 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 224' ' ' ILE . 47.1 t -59.79 -60.21 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.907 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.68 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -62.79 -24.21 67.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.512 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.99 -21.91 77.64 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.145 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -88.66 78.53 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.069 0.461 . . . . 0.0 110.718 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.03 138.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.502 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.6 t -75.82 -57.27 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.044 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.2 153.9 28.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.073 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.18 136.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.398 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 19.3 m170 -108.53 125.54 51.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.768 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -77.58 108.88 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.982 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -129.42 77.96 76.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 67.9 Cg_endo -75.04 163.72 34.7 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.264 1.976 . . . . 0.0 112.827 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.4 p -142.4 164.11 31.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.828 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -54.49 -26.94 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.55 -19.17 14.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -135.87 77.46 1.66 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.13 -21.6 47.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.605 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -111.62 36.16 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.672 0.272 . . . . 0.0 111.337 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.726 ' NH1' HG23 ' A' ' 210' ' ' THR . 0.0 OUTLIER -85.56 114.43 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 209' ' ' ALA . 34.6 m -117.83 138.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -109.12 111.63 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.533 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -84.84 154.72 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -113.59 105.79 13.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.26 149.05 7.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.987 0.422 . . . . 0.0 111.57 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -66.95 -22.93 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.835 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.39 20.51 9.03 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.27 174.24 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -129.77 119.84 24.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 208' ' ' SER . 21.0 t -121.95 159.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 207' ' ' VAL . 94.4 p -119.59 147.34 44.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.02 150.45 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.7 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.726 HG23 ' NH1' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -101.06 147.59 26.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.432 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.0 mt -57.97 -27.23 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.641 0.258 . . . . 0.0 111.161 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -30.44 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.469 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.17 35.88 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.34 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.7 -49.62 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.88 -47.19 87.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.47 -42.42 99.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.054 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.411 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -52.05 -53.51 41.18 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.267 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.5 mm? -80.59 -21.69 41.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.918 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.2 t -59.82 -32.99 71.17 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.999 0.428 . . . . 0.0 110.35 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.81 5.26 14.07 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.037 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.4 100.35 18.15 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.5 -27.29 39.6 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.132 1.888 . . . . 0.0 112.189 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.47 -52.28 47.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.049 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.785 HG22 ' HA ' ' A' ' 178' ' ' VAL . 32.9 mt -63.5 -51.99 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.491 178.582 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.792 ' HB2' HD13 ' A' ' 134' ' ' LEU . 66.8 m95 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.898 0.38 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -99.89 130.53 46.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.572 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -68.62 127.41 32.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.07 0.462 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.015 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.94 0.29 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.834 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.661 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.46 176.78 9.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.488 ' HB2' HG22 ' A' ' 154' ' ' VAL . 33.9 m-85 -138.75 173.46 11.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.334 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.656 HG21 ' HG ' ' A' ' 139' ' ' LEU . 15.0 t -133.27 117.48 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.967 0.413 . . . . 0.0 111.025 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.52 110.7 16.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.148 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.441 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 15.9 t70 -169.15 144.23 3.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.53 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.001 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 53.86 28.65 8.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.679 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 145' ' ' THR . 88.6 m -149.58 141.86 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 14.1 m-85 -89.71 109.84 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.052 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.732 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.3 m-85 -80.99 123.93 81.72 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.967 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.43 124.24 14.72 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.206 1.937 . . . . 0.0 112.524 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.915 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.82 125.29 50.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.013 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.7 mt -84.14 166.7 17.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.179 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.7 pt-20 -56.28 -30.26 62.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.291 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -91.38 15.8 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.303 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 76.26 8.18 85.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.143 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.609 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.29 96.18 0.05 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.209 0.504 . . . . 0.0 110.243 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.59 112.88 21.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.853 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.18 98.21 7.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.595 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.4 mttp -69.0 -27.5 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.45 -22.39 60.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.603 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -101.13 23.77 10.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.619 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.17 164.24 52.58 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.733 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 129' ' ' THR . 4.0 t -130.26 158.82 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.953 0.406 . . . . 0.0 110.631 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.46 22.56 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.125 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.463 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -140.28 143.87 36.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 110.679 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.36 118.53 72.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.43 108.93 2.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.05 1.833 . . . . 0.0 112.608 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -67.07 -13.52 62.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.274 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.33 -27.54 52.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.667 0.27 . . . . 0.0 111.402 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.61 164.6 38.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.654 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 72.7 Cg_endo -78.73 172.72 14.65 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.893 1.729 . . . . 0.0 112.521 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 123' ' ' TYR . 60.1 t -129.37 153.57 38.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.939 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.611 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.4 mt -113.54 97.58 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.06 0.457 . . . . 0.0 110.569 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.2 t -83.44 134.6 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.2 85.78 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.724 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.505 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.64 110.28 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 111.536 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -101.22 -27.8 13.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.35 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.8 94.08 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.054 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.897 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.03 -21.0 44.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.154 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -39.9 95.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.25 -33.83 67.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.577 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.915 ' CG2' HD11 ' A' ' 133' ' ' LEU . 63.4 mt -62.03 -52.24 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.646 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.08 58.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.178 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 12.1 mm-40 -68.8 -50.42 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.94 -52.22 66.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.015 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.48 -33.7 68.27 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.946 0.403 . . . . 0.0 110.235 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.99 97.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.32 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.024 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.533 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.4 mp -69.23 -28.58 66.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.56 -18.43 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.547 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -102.62 -40.47 6.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 179' ' ' LEU . 1.9 pp -70.84 157.14 90.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.744 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.659 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.4 Cg_exo -51.3 124.09 13.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.575 2.183 . . . . 0.0 112.631 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.73 26.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.833 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -43.35 89.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.14 0.495 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 53.8 t -58.53 -55.9 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.757 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -67.69 -13.55 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.55 -14.54 59.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.519 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -93.62 78.37 4.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.965 0.383 . . . . 0.0 111.54 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.55 155.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.388 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 p -89.32 -48.6 7.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.57 156.1 9.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -105.88 134.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.151 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.456 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.2 m170 -109.12 118.52 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -69.07 110.0 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.424 ' HD3' HG12 ' A' ' 198' ' ' ILE . 1.0 OUTLIER -132.57 74.13 75.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.884 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.2 161.78 29.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.267 1.978 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -137.16 162.71 32.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -54.2 -26.37 27.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.369 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -104.41 -18.3 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.572 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.3 87.13 2.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -59.63 -19.56 49.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -115.52 36.05 4.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.741 0.305 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -78.94 108.33 12.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.706 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.9 133.06 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.424 HG12 ' HD3' ' A' ' 188' ' ' LYS . 30.9 mm -106.14 111.55 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.537 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.524 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -87.05 158.32 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.696 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.09 107.12 14.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.174 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.17 149.37 16.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.395 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -65.88 -21.92 66.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -77.07 -13.19 59.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.33 20.3 9.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.721 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -106.43 174.94 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.699 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.64 117.71 21.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 199' ' ' VAL . 12.1 t -113.42 160.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 207' ' ' VAL . 80.3 p -121.14 145.14 48.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.073 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.1 -178.71 7.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -128.73 154.66 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.369 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.505 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.9 mt -69.0 -22.34 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.975 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -32.05 47.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 111.321 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -134.21 35.77 3.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.963 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.2 t80 -56.8 -48.09 78.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -59.47 -48.07 83.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -62.78 -39.21 93.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.319 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.406 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 13.0 mmtt -56.93 -53.31 59.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.49 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.3 mm? -81.42 -21.35 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.19 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -64.11 -33.61 76.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.601 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -73.61 -2.74 24.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.385 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.36 110.22 43.27 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 122.263 -0.273 . . . . 0.0 110.848 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.28 -31.8 34.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.325 2.017 . . . . 0.0 112.38 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.55 -45.99 64.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.321 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 178' ' ' VAL . 35.9 mt -64.76 -55.32 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.158 0.504 . . . . 0.0 109.708 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.319 178.53 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.808 ' HB2' HD13 ' A' ' 134' ' ' LEU . 54.3 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.923 0.392 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.59 134.62 38.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -76.78 126.71 31.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.712 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.0 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.62 0.72 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.995 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.69 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.96 176.89 9.7 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.624 ' HE1' ' HB3' ' A' ' 152' ' ' ALA . 55.6 m-85 -138.49 173.29 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.31 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.678 HG21 ' HG ' ' A' ' 139' ' ' LEU . 20.0 t -134.2 116.61 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 0.0 110.953 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.467 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.39 113.76 18.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.442 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.0 t70 -168.96 144.19 3.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.796 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.65 40.07 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 54.81 31.77 16.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.473 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 53.6 m -151.47 144.44 24.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 5.0 m-85 -93.55 110.12 21.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.3 m-85 -81.15 129.81 65.44 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.119 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.4 Cg_exo -65.09 124.91 13.71 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.189 1.926 . . . . 0.0 112.277 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.985 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.86 124.78 50.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.798 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.2 mt -84.95 165.63 17.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.373 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.2 pt-20 -55.31 -30.74 60.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.697 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -90.92 15.11 12.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.314 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 77.51 4.05 83.94 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.257 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.609 ' HB3' HD12 ' A' ' 134' ' ' LEU . 20.6 tpp180 -61.07 98.26 0.07 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.347 0.573 . . . . 0.0 110.476 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.3 126.97 31.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.079 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.497 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.9 mm? -106.53 94.24 5.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 12.5 mttp -70.97 -26.98 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.95 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -84.24 -20.75 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.795 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.09 24.58 6.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.527 0.204 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.31 160.43 53.17 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.825 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -126.72 157.21 39.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.599 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 27.72 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.29 140.5 25.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.483 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 117.65 53.29 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.439 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 65.0 Cg_endo -76.21 106.68 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.148 1.898 . . . . 0.0 112.75 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -67.99 -12.26 60.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.241 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.98 -27.22 54.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.759 0.314 . . . . 0.0 111.328 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.624 ' HB3' ' HE1' ' A' ' 123' ' ' TYR . . . -144.06 160.2 50.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.901 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.509 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.5 Cg_endo -71.97 174.18 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.021 1.814 . . . . 0.0 112.722 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 123' ' ' TYR . 63.6 t -130.43 155.56 41.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.944 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.3 mt -115.06 97.72 6.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.431 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.9 134.32 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.387 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.761 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.533 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.4 m95 -147.64 110.43 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 111.631 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -25.24 14.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.86 95.46 7.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.206 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.907 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.52 -20.85 47.42 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.057 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.39 -41.11 98.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.22 -34.82 73.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.441 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.985 HG23 HD11 ' A' ' 133' ' ' LEU . 54.5 mt -61.66 -51.68 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.585 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.409 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.33 -29.45 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.292 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.1 mm-40 -70.74 -50.64 33.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.381 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.453 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.97 -52.45 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.952 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.0 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.31 -33.64 67.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.41 98.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.25 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -65.41 -35.97 82.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.847 0.356 . . . . 0.0 110.344 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.662 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.0 mp -70.73 -27.88 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.89 -19.47 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.524 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.15 -40.69 7.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.481 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.81 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.7 157.2 89.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.375 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.658 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.0 Cg_exo -50.58 123.66 11.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.459 2.106 . . . . 0.0 112.51 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -33.91 39.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.638 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.52 88.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.049 0.452 . . . . 0.0 110.404 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.675 ' HA ' HG22 ' A' ' 224' ' ' ILE . 53.6 t -59.53 -60.29 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.845 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.81 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.26 -24.32 66.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.64 -23.8 76.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.816 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -86.23 78.3 9.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 110.679 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.2 ptp 178.27 131.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 80.6 p -67.94 -55.4 12.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -161.48 155.64 22.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -104.54 136.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.436 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 25.1 m170 -107.19 122.19 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.87 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.544 ' HD1' HG12 ' A' ' 197' ' ' VAL . 9.2 t80 -75.0 109.77 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.811 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -129.37 72.37 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.03 154.77 57.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.439 2.092 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.4 p -140.89 166.9 23.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -26.27 60.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.291 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.75 -17.45 16.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.49 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.401 ' CB ' ' HB2' ' A' ' 196' ' ' ARG . 46.8 m-85 -143.89 76.78 1.53 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.951 0.405 . . . . 0.0 111.023 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.09 -19.77 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.74 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -113.87 37.09 3.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 111.146 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.401 ' HB2' ' CB ' ' A' ' 193' ' ' TYR . 6.4 ttt180 -87.53 116.94 25.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.025 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.544 HG12 ' HD1' ' A' ' 187' ' ' TYR . 28.1 m -120.59 133.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 208' ' ' SER . 23.4 mm -103.71 112.1 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.531 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -88.49 151.7 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.391 . . . . 0.0 111.517 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.58 103.78 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.99 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 13.2 tpp -56.25 149.38 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -67.17 -19.78 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.082 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -75.56 -13.51 60.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.05 20.21 10.02 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.772 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.76 167.84 10.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.736 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -119.14 120.7 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 208' ' ' SER . 22.7 t -118.91 159.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.618 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.577 ' HB3' HD12 ' A' ' 198' ' ' ILE . 6.9 p -118.53 148.77 42.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.911 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.2 150.78 9.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.48 147.55 25.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.526 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.533 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.6 mt -59.32 -25.88 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.187 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -29.48 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.2 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -133.96 35.51 3.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.73 -49.55 76.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.018 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.17 82.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.795 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -62.02 -41.23 97.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.11 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.436 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -52.88 -53.1 53.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.298 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.484 HD12 HD13 ' A' ' 224' ' ' ILE . 3.4 mm? -82.06 -20.8 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.151 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.0 t -61.59 -32.55 72.66 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.005 0.431 . . . . 0.0 110.445 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.84 3.4 14.46 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.502 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -103.1 100.39 17.19 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.03 -26.63 43.13 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.121 1.881 . . . . 0.0 112.059 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.47 -41.58 76.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 178' ' ' VAL . 36.8 mt -71.62 -54.67 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.159 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.829 ' HB2' HD13 ' A' ' 134' ' ' LEU . 56.0 m95 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.04 130.17 45.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HG2' HD23 ' A' ' 134' ' ' LEU . 52.1 mtt180 -69.75 127.67 33.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.61 1.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.77 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.678 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.66 176.7 9.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.714 0.292 . . . . 0.0 111.04 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.468 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.0 m-85 -139.72 173.77 11.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.629 HG21 ' CD1' ' A' ' 139' ' ' LEU . 16.6 t -133.59 117.17 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.42 15.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.291 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.435 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.8 t0 -169.28 145.17 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.52 40.9 23.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.97 29.92 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 145' ' ' THR . 89.7 m -151.47 142.52 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.425 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.5 m-85 -90.87 109.24 20.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.057 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.742 ' HB2' HD21 ' A' ' 139' ' ' LEU . 15.3 m-85 -79.05 122.74 84.8 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.45 122.11 10.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.13 1.887 . . . . 0.0 112.489 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.962 HD11 HG23 ' A' ' 164' ' ' ILE . 1.3 mt -103.87 125.03 50.0 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.791 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.2 mt -84.65 165.91 17.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.474 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HA ' HD12 ' A' ' 121' ' ' ILE . 4.8 pt-20 -55.72 -30.19 60.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.584 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.421 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.7 p-10 -90.61 14.68 12.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.396 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.27 3.82 82.75 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.583 -0.817 . . . . 0.0 113.254 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.578 ' HB3' HD12 ' A' ' 134' ' ' LEU . 16.1 tpp180 -60.6 97.36 0.05 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.276 0.56 . . . . 0.0 110.572 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.742 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -84.49 114.67 22.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.853 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.6 mt -105.07 97.69 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.717 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.2 mttt -69.76 -27.73 65.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -73.28 -23.26 60.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -101.48 25.36 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.547 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.02 163.0 54.08 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.512 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.28 156.12 42.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.661 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 28.43 3.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 138.33 24.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.72 118.36 47.44 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.407 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.5 Cg_endo -77.67 106.21 2.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.077 1.852 . . . . 0.0 112.794 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.0 t -68.0 -12.05 60.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -78.05 -27.26 48.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.59 160.14 48.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.951 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.0 Cg_endo -71.7 173.29 12.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.031 1.821 . . . . 0.0 112.763 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 123' ' ' TYR . 68.4 t -129.28 154.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.89 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.61 HD12 ' CD1' ' A' ' 133' ' ' LEU . 54.5 mt -112.94 98.33 7.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.128 0.49 . . . . 0.0 110.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.3 t -82.46 134.89 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.475 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.56 86.73 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.836 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.47 112.68 5.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.036 0.446 . . . . 0.0 111.446 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -26.84 12.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.409 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.68 95.82 8.19 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.914 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.49 -21.05 47.97 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.964 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.24 97.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.61 -34.18 69.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.524 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.962 HG23 HD11 ' A' ' 133' ' ' LEU . 40.3 mt -61.8 -52.05 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.498 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.97 -30.27 58.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 15.1 mm-40 -69.47 -50.78 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.338 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.459 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.34 -52.46 65.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.819 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.019 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.79 69.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 110.363 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.11 -40.29 96.95 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.197 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -66.64 -38.11 86.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.404 . . . . 0.0 110.273 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.732 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.9 mp -67.6 -28.13 67.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.363 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.24 -22.02 59.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.611 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -96.52 -40.75 8.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.283 . . . . 0.0 111.521 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.732 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -70.84 156.19 92.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.611 ' HB2' HG23 ' A' ' 178' ' ' VAL . 68.5 Cg_exo -49.31 129.86 23.49 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.651 2.234 . . . . 0.0 112.879 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.63 66.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.699 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.48 87.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.49 . . . . 0.0 110.414 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.756 ' HA ' HG22 ' A' ' 224' ' ' ILE . 52.1 t -60.86 -59.96 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.75 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.677 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -61.03 -23.82 65.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.384 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.59 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.27 -24.76 74.72 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.707 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.804 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -88.19 78.3 8.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.752 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 176.88 140.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.443 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -56.52 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.8 154.41 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 199' ' ' VAL . 4.5 mt -107.51 136.77 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.32 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.423 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.4 m170 -108.06 117.39 34.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 39.2 t80 -73.02 106.62 4.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.783 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -126.92 74.7 76.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 56.1 Cg_endo -70.41 158.16 56.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.26 1.973 . . . . 0.0 112.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.7 p -140.44 162.9 34.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -26.61 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -102.4 -20.4 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.22 76.61 1.61 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.32 -20.63 29.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.669 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.87 38.37 2.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 111.188 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -85.72 116.87 24.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.06 132.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.38 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.405 HG21 ' OE2' ' A' ' 206' ' ' GLU . 21.2 mm -105.77 110.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.477 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.526 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.6 m -85.02 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.0 111.61 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -116.06 106.48 13.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.07 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.82 149.33 11.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.483 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -66.14 -22.36 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.934 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.2 -12.02 59.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.26 20.33 9.26 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -103.14 174.18 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' GLU . . . . . 0.405 ' OE2' HG21 ' A' ' 198' ' ' ILE . 35.5 tt0 -129.38 116.4 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 199' ' ' VAL . 13.1 t -114.87 159.9 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.521 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.462 ' N ' HG12 ' A' ' 207' ' ' VAL . 85.0 p -121.02 145.33 47.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.11 -178.44 7.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.778 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.9 153.67 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.1 mt -67.77 -21.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.076 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.47 -35.3 58.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.709 0.29 . . . . 0.0 111.462 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -133.74 35.95 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -54.38 -48.18 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.61 -48.69 80.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -62.18 -38.7 90.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 19.7 mmtt -56.44 -51.04 69.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.392 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.411 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.4 mm? -79.66 -20.3 47.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.349 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.5 p -65.49 -36.85 85.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.962 0.411 . . . . 0.0 110.384 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -63.47 -14.93 55.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.795 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 111.21 23.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.535 -0.103 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.3 -24.15 27.54 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.164 1.909 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.23 -41.69 24.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.55 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.804 HG23 ' HB3' ' A' ' 181' ' ' ALA . 18.6 mt -68.78 -57.79 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.325 178.23 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.803 ' HB2' HD13 ' A' ' 134' ' ' LEU . 24.9 m95 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.44 128.67 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.448 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm-85 -68.31 127.22 32.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.013 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.09 0.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.024 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.605 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.92 177.06 9.55 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.648 0.261 . . . . 0.0 111.042 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.438 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.4 m-85 -139.34 173.74 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.8 t -133.45 117.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 111.073 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.454 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.56 114.06 19.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.366 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.9 t70 -169.17 143.12 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 58.95 41.27 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.938 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 54.09 29.99 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.406 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 145' ' ' THR . 51.3 m -149.38 145.42 26.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 111.365 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.454 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.5 m-85 -95.97 110.92 23.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.735 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.2 m-85 -81.71 127.06 74.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 26.3 Cg_exo -62.45 124.81 14.91 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.191 1.927 . . . . 0.0 112.501 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.95 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -106.48 125.16 50.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.803 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.3 mt -85.35 164.6 17.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.417 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.6 pt-20 -54.94 -29.88 57.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -91.16 15.36 11.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 76.72 3.25 78.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.314 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.589 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.68 97.67 0.06 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.362 0.581 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -81.09 126.34 31.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.974 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.475 ' N ' HD23 ' A' ' 139' ' ' LEU . 18.2 mt -107.71 95.69 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.8 mttp -72.54 -25.51 61.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -82.64 -20.91 35.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.791 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -101.1 28.07 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 111.5 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.68 159.8 52.48 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.642 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 129' ' ' THR . 1.3 t -124.64 155.85 38.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.44 29.71 2.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.85 140.29 22.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 118.25 51.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.02 105.67 2.12 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.122 1.881 . . . . 0.0 112.78 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t -67.89 -12.2 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -78.51 -27.3 46.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.6 0.238 . . . . 0.0 111.316 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.44 159.92 49.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.866 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 53.2 Cg_endo -71.46 172.86 13.38 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.961 1.774 . . . . 0.0 112.6 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 123' ' ' TYR . 58.6 t -129.45 154.19 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.897 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.62 HD12 ' CD1' ' A' ' 133' ' ' LEU . 56.1 mt -113.17 97.84 6.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.422 . . . . 0.0 110.441 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 72.6 t -83.29 134.29 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.37 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.6 85.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.788 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.563 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -148.31 113.05 5.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 111.494 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.84 -26.01 12.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.464 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.93 95.37 7.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.208 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.59 -20.86 48.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.067 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.2 -40.43 97.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.73 -34.19 69.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.518 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.95 HG23 HD11 ' A' ' 133' ' ' LEU . 48.1 mt -61.42 -51.88 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.612 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.401 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.46 -31.2 61.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.26 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 9.7 mm-40 -67.9 -51.15 51.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.456 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.24 -52.0 67.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.81 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.013 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.47 -33.91 70.28 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.855 0.359 . . . . 0.0 110.252 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.42 96.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.333 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -67.05 -38.06 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 8.0 mp -68.06 -28.2 67.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.291 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.95 -18.75 60.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.701 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -101.18 -40.52 7.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 0.0 111.712 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -70.4 157.81 89.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.665 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.9 Cg_exo -50.88 124.23 13.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.542 2.161 . . . . 0.0 112.638 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.73 33.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.65 93.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.17 0.51 . . . . 0.0 110.417 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.8 t -60.24 -60.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.998 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.757 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.2 pp -61.19 -25.52 67.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.39 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.449 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.84 -22.12 77.44 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.022 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.697 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.89 78.16 8.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.967 0.413 . . . . 0.0 110.913 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.6 ptp 177.92 140.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.543 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.91 -54.0 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.104 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 152.39 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 110.974 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.43 HG12 HG12 ' A' ' 199' ' ' VAL . 5.1 mt -102.97 135.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.384 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.428 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 21.3 m170 -108.05 114.71 28.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -72.14 100.74 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -123.54 79.36 54.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.72 165.93 31.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.35 2.034 . . . . 0.0 112.613 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 p -143.6 176.18 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -62.4 -25.58 68.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.81 5.14 18.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -156.58 78.01 0.92 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.911 0.386 . . . . 0.0 111.008 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -18.4 52.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.518 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.22 34.33 4.75 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.834 0.35 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -80.03 109.13 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.78 132.77 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.402 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.41 107.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.311 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.46 HG21 HD11 ' A' ' 218' ' ' LEU . 2.2 m -85.0 150.27 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.988 0.423 . . . . 0.0 111.653 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -109.08 109.2 20.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.985 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.81 148.96 9.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.416 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -66.16 -21.86 66.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.6 -10.58 59.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.27 20.52 9.09 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.713 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -100.66 174.25 6.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 110.825 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.03 122.08 29.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 208' ' ' SER . 38.6 t -125.76 158.68 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.478 ' N ' HG12 ' A' ' 207' ' ' VAL . 81.2 p -121.59 149.19 43.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.079 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.35 -177.14 5.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -129.24 153.75 47.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.563 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.4 mt -66.3 -22.43 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.022 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -32.51 57.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 111.381 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -134.16 35.82 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.408 ' CD1' HD23 ' A' ' 218' ' ' LEU . 12.3 t80 -57.3 -46.59 83.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.99 -48.68 79.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.645 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.47 -40.17 95.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -57.03 -52.99 63.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.6 mm? -77.3 -21.79 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.445 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 78.7 p -66.4 -33.5 75.84 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 110.361 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.86 -10.29 51.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.914 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.419 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -87.16 110.56 34.31 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 122.485 -0.134 . . . . 0.0 110.865 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.83 -26.35 27.33 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.215 1.943 . . . . 0.0 112.343 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.38 -41.91 46.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 178' ' ' VAL . 19.7 mt -69.01 -56.83 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.295 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.834 ' HB2' HD13 ' A' ' 134' ' ' LEU . 48.6 m95 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -99.47 129.55 45.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -70.07 127.05 31.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.134 0.492 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.986 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.83 1.44 2.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.842 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.72 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.93 176.46 9.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 120.695 0.284 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.45 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 20.2 m-85 -140.15 173.85 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.635 HG21 ' CD1' ' A' ' 139' ' ' LEU . 18.7 t -132.7 117.64 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.883 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.424 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.96 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.26 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 38.9 t0 -169.25 143.77 3.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.781 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 59.98 40.46 18.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 53.92 27.58 7.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.586 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 145' ' ' THR . 89.6 m -147.87 142.47 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 154' ' ' VAL . 8.9 m-85 -91.1 109.94 21.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.73 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.4 m-85 -80.0 122.47 83.19 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.25 123.38 13.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.098 1.865 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.913 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -105.67 125.32 50.85 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.834 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.2 mt -84.95 166.11 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.339 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.1 pt-20 -55.7 -29.93 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.447 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.4 p-10 -90.34 13.99 14.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.345 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.53 4.18 84.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.17 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.579 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.9 tpt180 -60.15 97.6 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.18 0.514 . . . . 0.0 110.487 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.73 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.68 115.29 22.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.892 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.4 mt -105.29 98.05 7.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.51 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.2 mttt -70.34 -28.16 64.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.79 -22.35 59.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -101.54 25.08 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.82 53.44 Favored Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.603 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.5 156.02 42.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.42 139.67 25.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.519 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.37 119.14 50.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.45 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 61.5 Cg_endo -75.8 105.08 2.01 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.98 1.787 . . . . 0.0 112.765 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.6 t -67.64 -12.4 60.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.194 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.98 -26.91 39.77 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.663 0.268 . . . . 0.0 111.568 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.87 159.55 46.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 44.5 Cg_endo -70.74 173.66 11.52 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.06 1.84 . . . . 0.0 112.805 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 130' ' ' PHE . 77.7 t -129.06 154.44 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.023 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.587 HD12 ' CD1' ' A' ' 133' ' ' LEU . 58.7 mt -112.81 98.36 7.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.2 t -82.66 135.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.476 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.55 86.78 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.876 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.5 m95 -148.4 116.24 6.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.471 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -106.81 -26.53 11.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.459 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -97.41 95.56 7.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.4 -20.86 46.53 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.108 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -40.4 97.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.17 -33.28 67.57 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.621 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.913 HG23 HD11 ' A' ' 133' ' ' LEU . 53.1 mt -62.44 -51.86 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.678 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.71 -30.21 55.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.11 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 10.6 mm-40 -68.99 -51.11 42.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.348 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.836 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.986 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.59 -33.7 68.47 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.91 0.386 . . . . 0.0 110.383 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.64 96.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.478 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.1 -39.63 93.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.738 ' HA ' HD22 ' A' ' 174' ' ' LEU . 5.1 mp -66.17 -27.77 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.367 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.55 -19.42 60.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.667 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.86 -40.58 7.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.705 0.288 . . . . 0.0 111.633 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.738 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -70.37 157.31 90.29 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' A' ' 178' ' ' VAL . 72.9 Cg_exo -48.9 128.78 19.75 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.744 2.296 . . . . 0.0 112.92 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.54 67.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.552 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.14 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 0.0 110.327 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 224' ' ' ILE . 44.9 t -61.45 -60.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.868 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.6 pp -62.56 -24.01 67.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -72.95 -24.44 75.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.628 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' A' ' 202' ' ' ASN . . . -90.32 78.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.26 137.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 p -80.27 -57.93 3.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.197 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.12 154.12 31.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.971 0.415 . . . . 0.0 111.145 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -106.06 136.84 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.6 m170 -108.22 123.27 48.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.724 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 55.1 t80 -77.67 107.82 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -131.35 76.4 75.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.744 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.406 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 50.2 Cg_endo -69.59 162.67 41.06 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.336 2.024 . . . . 0.0 112.609 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.3 p -140.86 163.37 33.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.9 mtp85 -55.89 -25.89 44.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 -20.64 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.283 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -136.8 82.48 1.94 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.71 -20.76 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.673 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -114.58 37.69 3.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 111.163 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -82.28 112.34 19.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.988 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.51 135.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -106.75 109.27 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.554 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.6 m -84.84 154.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.899 0.38 . . . . 0.0 111.654 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -114.5 101.36 9.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.957 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.436 ' HE3' HG21 ' A' ' 207' ' ' VAL . 7.8 tpp -53.87 149.33 8.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.596 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.502 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 11.5 p-10 -66.83 -20.08 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.041 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.76 -13.4 60.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 20.21 9.47 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -109.04 167.86 9.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.68 117.02 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.743 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 199' ' ' VAL . 9.3 t -113.85 160.39 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 207' ' ' VAL . 78.1 p -121.43 144.33 48.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.762 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -158.32 -177.36 6.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.8 152.35 47.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.321 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.5 mt -66.42 -24.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.913 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -29.8 51.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.695 0.283 . . . . 0.0 111.361 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -134.16 36.07 3.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.221 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.672 ' CE1' HD11 ' A' ' 171' ' ' LEU . 41.3 t80 -56.88 -50.03 73.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.845 0.355 . . . . 0.0 111.051 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -62.16 -42.49 99.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.81 -42.26 95.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.414 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 45.6 mmtt -57.08 -53.66 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.346 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.48 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -75.97 -24.0 55.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.5 m -62.8 -32.97 74.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 110.33 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -5.89 39.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.406 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -95.0 100.74 5.95 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.86 -25.85 52.47 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.131 1.887 . . . . 0.0 111.97 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.3 -41.68 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 178' ' ' VAL . 27.3 mt -72.07 -54.88 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.131 178.133 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.841 ' HB2' HD13 ' A' ' 134' ' ' LEU . 45.5 m95 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.16 134.24 45.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.466 ' HG2' HD23 ' A' ' 134' ' ' LEU . 13.9 mtm-85 -73.4 127.46 32.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.136 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.009 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.12 -1.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.928 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.728 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -160.83 176.55 11.35 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 120.683 0.278 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.448 ' HB2' HG22 ' A' ' 154' ' ' VAL . 33.9 m-85 -138.62 173.05 12.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.503 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.651 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.6 t -133.88 120.17 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.927 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.08 109.77 14.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.977 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.418 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.3 t0 -161.38 138.56 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 58.39 42.73 20.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 54.11 28.75 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.625 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 145' ' ' THR . 94.9 m -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 111.103 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.1 m-85 -90.23 110.15 21.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.697 ' HB2' HD21 ' A' ' 139' ' ' LEU . 13.2 m-30 -81.3 118.23 71.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.999 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 10.8 Cg_endo -56.73 124.28 15.88 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.131 1.887 . . . . 0.0 112.563 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.926 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -106.24 125.35 50.89 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.117 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 118' ' ' TRP . 17.4 mt -81.67 167.98 18.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.058 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.6 pt-20 -57.28 -30.78 64.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.463 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.1 p30 -90.6 13.87 14.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.398 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.503 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 79.71 5.61 89.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.121 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.589 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -59.44 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 117.392 0.596 . . . . 0.0 110.23 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -81.33 118.66 22.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.491 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.9 mm? -103.74 96.77 6.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.755 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 37.9 mttt -71.84 -26.57 62.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -80.94 -23.74 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.526 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -98.28 22.68 9.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.642 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.2 163.27 54.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.549 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.712 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.53 156.38 43.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.586 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 26.12 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.42 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -143.57 139.67 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 118.11 59.89 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.86 106.7 2.3 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.07 1.847 . . . . 0.0 112.501 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.2 t -67.13 -13.24 61.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.74 -27.23 50.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.66 164.96 33.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.6 Cg_endo -78.49 173.33 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.051 1.834 . . . . 0.0 112.757 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.0 t -130.02 154.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.928 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 133' ' ' LEU . 67.5 mt -112.51 97.59 6.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.65 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.6 t -82.55 134.57 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.409 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.09 87.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.709 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.6 m95 -147.57 110.25 4.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 111.597 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -100.2 -25.91 14.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.507 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.43 95.39 7.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.915 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.44 -20.83 46.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.044 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.4 -40.56 97.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.88 -34.56 71.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.474 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.926 ' CG2' HD11 ' A' ' 133' ' ' LEU . 62.1 mt -61.99 -51.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.722 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.408 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.57 -29.79 59.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.188 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 27.3 mm-40 -69.25 -51.8 33.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.173 0.511 . . . . 0.0 110.25 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.47 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.42 -52.77 64.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.026 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.009 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.57 69.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.356 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.06 97.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.434 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.24 -38.48 87.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.913 0.387 . . . . 0.0 110.45 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.775 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.6 mp -64.81 -28.21 69.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.634 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -102.82 -40.84 6.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.698 0.285 . . . . 0.0 111.679 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.775 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -68.91 157.29 89.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.132 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.63 ' HB2' HG23 ' A' ' 178' ' ' VAL . 56.2 Cg_exo -49.85 129.79 25.27 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.696 2.264 . . . . 0.0 112.749 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.3 -38.89 66.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 110.314 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 175' ' ' PRO . 54.4 t -60.31 -57.07 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.679 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.4 pp -68.09 -13.19 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.29 -14.68 59.92 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.369 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.39 78.63 3.9 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.918 0.359 . . . . 0.0 111.724 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.35 176.82 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.702 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.9 m -116.55 -44.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -167.51 151.82 6.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -105.13 135.35 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.407 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -108.42 114.41 28.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 41.3 t80 -65.85 111.03 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.832 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -132.02 76.96 72.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 53.5 Cg_endo -70.31 160.66 48.77 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.0 p -140.17 161.46 37.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.04 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -54.73 -25.63 28.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.26 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.25 -21.82 14.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.247 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.448 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.7 m-85 -136.16 80.85 1.85 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.892 0.377 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.28 -21.13 32.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.562 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -112.89 38.09 2.91 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.448 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 3.4 ttm180 -85.89 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.8 m -120.0 138.7 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.23 111.09 34.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.794 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.607 HG12 HG12 ' A' ' 185' ' ' ILE . 2.9 m -86.53 152.89 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -110.55 100.58 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.535 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.3 tpp -55.8 149.34 14.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.479 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -67.51 -20.38 65.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.089 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -76.62 -13.54 60.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.18 20.15 10.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.781 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -112.24 156.54 22.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.899 0.38 . . . . 0.0 110.775 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -110.3 117.13 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.535 HG21 ' HE3' ' A' ' 201' ' ' MET . 41.2 t -114.04 159.18 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.648 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 207' ' ' VAL . 49.8 p -121.46 149.09 43.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.569 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -167.22 149.37 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.79 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.688 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.476 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.8 mt -58.83 -28.03 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.118 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -32.12 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -134.24 35.97 3.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.152 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.455 ' CD1' HD23 ' A' ' 218' ' ' LEU . 11.6 t80 -54.95 -50.22 69.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.516 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.84 -48.78 80.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 0.0 111.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -64.92 -32.81 74.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.155 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.409 ' CB ' ' HB1' ' A' ' 209' ' ' ALA . 1.9 mmpt? -61.67 -53.88 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.085 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.2 mm? -80.21 -23.67 40.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.4 t -63.29 -38.81 92.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 110.687 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -64.77 -14.38 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.684 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.74 111.39 25.75 Favored Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.567 -0.083 . . . . 0.0 110.828 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.58 -25.56 34.59 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.259 1.972 . . . . 0.0 112.518 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.88 33.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.564 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 178' ' ' VAL . 22.9 mt -70.07 -56.99 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.212 178.099 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.79 ' HB2' HD13 ' A' ' 134' ' ' LEU . 58.2 m95 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -95.33 140.59 30.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.478 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -82.38 124.66 30.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 110.561 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.988 HD11 HG22 ' A' ' 168' ' ' THR . 0.1 OUTLIER -127.75 0.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.986 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.26 177.02 8.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.432 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 18.9 m-85 -140.46 173.09 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.338 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 139' ' ' LEU . 24.7 t -132.44 120.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.985 0.421 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.498 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.45 110.95 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.42 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.9 t70 -157.12 135.87 11.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 58.05 43.96 20.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.46 29.22 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.428 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 145' ' ' THR . 85.0 m -144.01 144.04 31.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.0 m-85 -95.27 110.62 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.488 . . . . 0.0 111.048 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.716 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.1 m-30 -83.29 124.25 76.22 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.185 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.546 ' HB2' HD12 ' A' ' 140' ' ' LEU . 31.4 Cg_exo -59.34 127.21 23.14 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.366 2.044 . . . . 0.0 112.82 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.994 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.44 124.78 51.6 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.817 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.6 mt -85.66 165.66 16.8 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.546 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 121' ' ' ILE . 9.3 pt-20 -55.38 -30.71 60.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -89.71 14.19 12.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 77.44 3.59 82.91 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.157 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.603 ' HB3' HD12 ' A' ' 134' ' ' LEU . 19.4 tpp180 -61.04 97.15 0.06 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.167 0.483 . . . . 0.0 110.589 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -78.15 129.63 35.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.863 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 132' ' ' PRO . 81.6 mt -108.06 92.38 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 21.2 mttp -72.64 -28.9 63.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.815 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.32 -21.08 42.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.472 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -101.64 28.02 5.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.505 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -76.31 159.42 50.2 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.384 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.33 157.56 40.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.952 0.406 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 25.67 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.4 OUTLIER -141.77 139.34 32.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.483 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.15 111.65 8.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.315 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.432 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 23.3 Cg_exo -63.65 100.41 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.475 2.117 . . . . 0.0 112.196 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -65.61 -14.92 62.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.346 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.64 -27.29 40.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.3 161.86 55.01 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.9 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.534 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 56.9 Cg_endo -73.97 172.9 14.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.751 1.634 . . . . 0.0 112.539 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.417 HG21 ' CD2' ' A' ' 130' ' ' PHE . 76.5 t -129.81 154.92 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.133 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.5 mt -114.09 97.69 6.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 0.0 110.492 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.68 133.81 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.459 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.45 85.53 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.809 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 68.6 m95 -147.7 115.46 6.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.966 0.413 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.19 -26.4 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.519 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.12 94.77 7.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.923 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.02 -21.26 45.0 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.096 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -39.97 96.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.75 67.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.556 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.994 HG23 HD11 ' A' ' 133' ' ' LEU . 39.6 mt -61.99 -51.76 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.638 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.418 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.62 -30.87 61.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 14.7 mm-40 -67.68 -50.77 56.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.172 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.446 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.77 -52.25 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.988 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.55 68.5 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.951 0.405 . . . . 0.0 110.321 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.2 97.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.37 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -64.14 -39.44 94.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.285 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.741 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.6 mp -66.14 -27.53 68.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.259 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.81 -19.87 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.61 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.36 -40.76 7.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 111.483 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.61 156.82 90.99 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.964 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.614 ' HB2' HG23 ' A' ' 178' ' ' VAL . 57.4 Cg_exo -49.78 129.52 24.3 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 112.864 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.58 -39.6 67.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.574 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.4 85.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.097 0.475 . . . . 0.0 110.536 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.678 ' HA ' HG22 ' A' ' 224' ' ' ILE . 52.5 t -61.33 -60.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.72 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.667 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -61.86 -24.05 66.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.453 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.26 -24.41 75.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.631 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.563 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -90.19 78.16 6.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.768 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 178.59 138.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.554 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -80.2 -62.01 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.65 152.16 32.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 0.0 111.041 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.23 133.88 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.429 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 33.3 m170 -107.37 111.99 24.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.956 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -65.35 106.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -129.65 79.84 72.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.73 160.86 46.33 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.276 1.984 . . . . 0.0 112.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -138.56 162.58 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -54.75 -25.96 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.279 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -103.9 -18.7 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.515 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' TYR . . . . . 0.449 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.2 m-85 -136.6 83.44 2.0 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.905 0.383 . . . . 0.0 111.219 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.92 -20.58 38.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.544 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -114.13 38.46 3.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -82.81 117.7 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.78 133.05 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.517 HD12 ' HB3' ' A' ' 208' ' ' SER . 25.2 mm -104.09 107.98 23.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.341 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.542 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.55 152.4 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.68 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.93 100.77 9.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.013 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.42 ' HE3' HG21 ' A' ' 207' ' ' VAL . 10.2 tpp -54.81 149.5 11.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 111.492 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -65.95 -20.25 66.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.028 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.03 -13.54 60.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.33 20.11 11.53 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.74 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.23 162.64 14.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.666 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -112.44 120.79 42.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.685 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 208' ' ' SER . 39.6 t -118.25 158.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.687 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.517 ' HB3' HD12 ' A' ' 198' ' ' ILE . 44.4 p -121.95 149.44 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.44 -178.15 6.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.812 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -127.63 149.76 50.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.119 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.465 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.5 mt -64.6 -23.85 34.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.01 -31.22 56.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.445 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.25 35.98 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.1 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.427 ' CD1' HD23 ' A' ' 218' ' ' LEU . 13.0 t80 -55.75 -50.71 69.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.83 0.348 . . . . 0.0 111.032 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.57 -44.38 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.93 -41.46 97.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.43 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 57.2 mmtt -56.24 -53.37 57.96 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.016 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.427 HD23 ' CD1' ' A' ' 214' ' ' PHE . 3.3 mm? -76.64 -23.19 53.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -61.59 -34.34 75.45 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.072 0.463 . . . . 0.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -71.83 -5.55 35.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 99.96 5.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -28.24 50.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.171 1.914 . . . . 0.0 111.98 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.29 81.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.714 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.2 mt -72.13 -54.75 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.281 178.156 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.798 ' HB2' HD13 ' A' ' 134' ' ' LEU . 51.1 m95 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.801 0.334 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 127.93 44.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -69.36 126.62 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.017 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.48 -0.16 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.969 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.06 176.68 9.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.963 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.449 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 18.9 m-85 -139.11 173.35 11.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.313 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.63 HG21 ' HG ' ' A' ' 139' ' ' LEU . 21.4 t -132.59 118.23 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.36 113.37 18.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.145 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 33.3 t0 -164.5 138.87 5.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.798 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.43 42.16 18.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 110.821 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.19 28.26 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.504 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 145' ' ' THR . 63.2 m -145.01 144.28 30.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.6 m-85 -95.16 110.58 22.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.718 ' HB2' HD21 ' A' ' 139' ' ' LEU . 12.3 m-30 -81.97 125.74 76.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.142 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.571 ' HB2' HD12 ' A' ' 140' ' ' LEU . 36.5 Cg_exo -61.29 126.1 18.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.293 1.995 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.949 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -108.14 125.04 51.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.793 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 118' ' ' TRP . 22.0 mt -85.27 166.13 16.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.384 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.9 pt-20 -55.44 -30.26 60.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.499 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -91.29 15.48 11.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.382 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.56 3.63 83.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.228 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.548 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.06 96.73 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.224 0.512 . . . . 0.0 110.581 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -82.24 122.3 27.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.077 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 132' ' ' PRO . 16.2 mt -104.5 96.64 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -72.76 -26.4 61.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -81.73 -22.9 37.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.696 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -97.55 27.25 4.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.383 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -75.26 159.08 51.34 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.801 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -126.01 155.54 41.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.684 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 29.6 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.756 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.55 22.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.43 119.05 56.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.1 Cg_endo -74.44 106.03 2.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.065 1.843 . . . . 0.0 112.68 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -67.28 -12.83 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.63 -27.23 40.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.653 0.263 . . . . 0.0 111.524 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.33 159.69 47.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 44.2 Cg_endo -70.86 174.28 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.115 1.877 . . . . 0.0 112.845 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' A' ' 130' ' ' PHE . 75.9 t -129.79 154.61 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.065 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.2 mt -113.75 97.76 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.016 0.436 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.22 134.42 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.438 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.18 86.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.811 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.7 m95 -148.23 113.95 5.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.031 0.443 . . . . 0.0 111.465 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -104.74 -25.38 12.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.589 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.88 95.04 7.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.227 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.885 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.43 -21.0 47.35 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.012 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -40.15 96.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.46 -33.77 67.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.606 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.949 HG23 HD11 ' A' ' 133' ' ' LEU . 56.2 mt -61.95 -51.9 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.709 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.8 mm-40 -67.57 -50.52 58.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.247 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.63 -52.21 66.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.856 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.07 -33.69 67.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.843 0.354 . . . . 0.0 110.439 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.38 -44.09 97.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.186 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.24 -38.21 88.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.255 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.779 ' HA ' HD22 ' A' ' 174' ' ' LEU . 6.5 mp -67.74 -28.7 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.245 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.6 -22.36 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.399 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.6 -41.15 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.709 0.29 . . . . 0.0 111.385 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.779 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.04 156.42 92.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.827 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' A' ' 178' ' ' VAL . 67.9 Cg_exo -49.38 128.53 20.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.621 2.214 . . . . 0.0 112.792 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.14 -40.41 67.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.26 83.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.526 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.648 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.4 t -61.03 -60.03 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 171' ' ' LEU . 4.4 pp -62.15 -23.68 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.477 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.61 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -75.17 -22.59 76.05 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.978 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -90.84 78.32 6.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.85 132.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -58.29 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.14 153.33 25.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.51 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -101.66 135.71 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.438 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.419 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 8.0 m170 -108.68 114.69 28.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -69.29 113.48 6.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -133.73 71.85 74.23 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.94 159.52 51.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.299 2.0 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.4 p -139.59 161.21 38.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.101 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -52.93 -26.54 15.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -103.1 -21.46 13.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.27 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -132.79 76.81 1.71 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -21.68 23.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.652 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.55 39.55 2.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.884 0.374 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -86.3 118.31 25.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.06 133.78 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.8 mm -106.42 109.27 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.39 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.73 152.18 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 0.0 111.775 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -109.74 105.79 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.864 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.401 ' HE1' HD13 ' A' ' 224' ' ' ILE . 11.8 tpp -56.9 149.38 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -58.33 -22.81 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.28 -2.34 48.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.12 -15.22 60.71 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.972 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -66.48 164.87 15.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -119.61 121.38 39.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.675 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 208' ' ' SER . 35.7 t -119.48 159.15 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.786 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 207' ' ' VAL . 98.4 p -121.85 149.32 43.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.021 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.83 -177.49 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.79 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.23 154.61 44.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.4 mt -69.76 -21.69 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.097 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.07 -30.38 31.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -133.04 35.06 3.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.68 -47.87 81.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.66 -47.23 87.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.22 -38.56 91.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 1.4 mmpt? -57.86 -53.31 59.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.528 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.3 mm? -81.73 -20.11 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.382 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 26.1 t -64.92 -37.74 88.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.67 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -67.25 -10.68 53.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.065 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -81.32 111.7 27.06 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.451 -0.156 . . . . 0.0 110.808 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.94 -27.11 30.88 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.233 1.955 . . . . 0.0 112.389 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.71 -44.75 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.575 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.648 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.1 mt -64.19 -56.95 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.422 178.426 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.83 ' HB2' HD13 ' A' ' 134' ' ' LEU . 49.3 m95 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 130.83 50.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -68.78 127.88 34.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.118 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.018 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.58 -0.2 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.007 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.65 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.5 176.82 9.37 Favored 'General case' 0 CA--C 1.523 -0.073 0 CA-C-O 120.655 0.265 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.443 ' HB2' HG22 ' A' ' 154' ' ' VAL . 26.8 m-85 -138.74 173.65 11.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.431 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.627 HG21 ' HG ' ' A' ' 139' ' ' LEU . 17.1 t -133.24 117.74 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.444 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.65 111.18 16.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.313 -179.382 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.2 t0 -169.34 144.5 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.37 40.31 21.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 53.96 29.08 9.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.65 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 145' ' ' THR . 85.2 m -150.11 142.19 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.7 m-85 -90.32 109.5 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.149 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.728 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.2 m-85 -79.86 123.28 83.85 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.095 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.19 123.72 13.74 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.181 1.921 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.926 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -106.29 125.11 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.0 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.83 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.6 mt -84.23 165.85 18.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.343 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.7 pt-20 -55.34 -30.45 60.29 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.48 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -91.3 15.1 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.276 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.425 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.36 7.13 86.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.292 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.595 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.55 95.63 0.04 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.322 0.561 . . . . 0.0 110.32 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.64 112.55 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.711 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.48 98.36 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 26.9 mttt -69.59 -26.39 64.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -74.3 -24.1 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.19 24.81 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.509 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.33 163.03 53.77 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.666 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.47 155.49 43.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 110.639 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.15 3.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.73 140.03 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 117.5 44.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 106.28 2.19 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.065 1.844 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -67.71 -12.47 60.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.267 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.46 -27.26 52.03 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.323 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.56 164.09 34.94 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.875 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.6 Cg_endo -76.02 173.56 14.29 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.913 1.742 . . . . 0.0 112.659 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 123' ' ' TYR . 57.9 t -130.24 153.71 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.951 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.589 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.1 mt -113.25 97.57 6.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -83.03 135.22 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.52 86.83 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.494 ' CH2' HD11 ' A' ' 211' ' ' ILE . 72.9 m95 -149.14 111.52 4.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.391 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -102.23 -26.08 13.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.566 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.85 95.09 7.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.397 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.897 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.17 -21.13 45.72 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.014 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.34 97.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -33.82 68.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.576 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.926 HG23 HD11 ' A' ' 133' ' ' LEU . 52.8 mt -61.85 -51.88 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.573 178.547 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.13 -27.99 49.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 29.5 mm-40 -72.08 -50.6 26.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 0.0 110.356 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.15 -52.33 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 179.661 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.018 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.55 -33.95 68.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.356 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.283 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -63.89 -38.42 91.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.162 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.763 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.3 mp -67.03 -28.32 68.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.22 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -19.27 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.544 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.26 -41.29 6.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 111.505 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.67 157.17 90.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.94 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.586 ' HB2' HG23 ' A' ' 178' ' ' VAL . 74.9 Cg_exo -49.16 128.3 19.44 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.35 67.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.552 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.81 85.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.26 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 175' ' ' PRO . 41.7 t -61.45 -60.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.774 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.667 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.6 pp -62.17 -24.82 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.12 -23.75 77.06 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.727 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.446 ' HB1' ' OD1' ' A' ' 202' ' ' ASN . . . -90.43 78.34 6.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 110.746 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.25 130.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.7 m -70.15 -58.31 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.12 154.02 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.07 135.96 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.318 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.434 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.8 m170 -109.01 112.6 24.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.87 109.37 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -132.05 78.24 69.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.72 160.3 50.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.253 1.968 . . . . 0.0 112.417 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -139.23 162.36 35.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.28 -25.87 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -102.11 -20.07 14.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.505 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -136.38 81.29 1.87 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.66 -21.84 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.636 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.94 39.07 2.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -84.07 115.47 22.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.43 132.98 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.276 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.8 mm -104.89 108.73 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.487 HG12 HG12 ' A' ' 185' ' ' ILE . 2.4 m -86.14 154.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.69 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -111.96 102.15 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.507 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.6 tpp -56.71 149.26 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.213 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.446 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 3.9 p-10 -67.22 -19.92 65.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.36 -13.43 60.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.19 20.22 10.69 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.797 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -112.0 161.41 16.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.854 0.359 . . . . 0.0 110.691 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.69 120.6 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.806 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 201' ' ' MET . 27.4 t -118.2 158.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.444 . . . . 0.0 110.665 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 207' ' ' VAL . 52.4 p -121.88 149.14 43.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.157 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.06 -177.62 6.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.709 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -126.94 151.66 48.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.494 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.0 mt -65.95 -22.74 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -29.17 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.78 35.33 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.4 t80 -57.7 -51.43 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.16 -47.2 86.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.996 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.82 -38.69 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.42 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.503 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 53.4 mmtt -58.11 -53.41 58.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.497 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.1 mm? -82.12 -19.79 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.555 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.2 t -64.56 -39.85 94.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -10.65 55.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.851 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.415 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -77.21 111.63 18.1 Favored Pre-proline 0 CA--C 1.535 0.366 0 O-C-N 122.48 -0.138 . . . . 0.0 110.863 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.92 -27.57 30.41 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.251 1.967 . . . . 0.0 112.376 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.13 -45.48 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.523 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 178' ' ' VAL . 24.9 mt -62.85 -57.18 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.01 0.434 . . . . 0.0 109.944 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.356 178.396 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.791 ' HB2' HD13 ' A' ' 134' ' ' LEU . 57.7 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.894 0.378 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -98.98 132.48 44.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -70.01 126.36 29.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.011 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.96 1.14 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.796 179.469 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.657 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.0 176.37 9.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.445 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.5 m-85 -139.23 173.64 11.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.334 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 139' ' ' LEU . 16.3 t -133.98 117.74 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.899 0.381 . . . . 0.0 110.922 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.461 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 113.16 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.14 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.435 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.8 t70 -167.19 139.54 3.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 59.23 42.13 19.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.21 0.529 . . . . 0.0 110.954 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 54.12 27.64 7.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.686 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 145' ' ' THR . 86.5 m -145.89 141.59 27.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.461 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.9 m-85 -91.93 109.44 20.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.228 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.5 m-30 -79.44 123.1 84.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.872 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.86 123.86 14.14 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.19 1.927 . . . . 0.0 112.678 -179.663 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.963 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -106.49 124.97 50.4 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.791 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.2 mt -85.18 166.27 16.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.378 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.3 pt-20 -55.64 -30.47 61.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -91.09 15.26 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.389 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.82 86.39 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.269 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.614 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.2 96.28 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.3 0.55 . . . . 0.0 110.36 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -86.71 113.46 22.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.88 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.2 mt -105.62 98.42 8.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.431 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 16.5 mttt -69.07 -28.59 66.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -72.39 -27.01 62.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.4 22.17 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.454 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 162.11 54.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.539 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.702 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.85 155.71 43.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.382 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 27.99 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.983 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 138.67 25.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.47 117.95 49.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.425 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 66.9 Cg_endo -76.44 105.79 2.14 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.117 1.878 . . . . 0.0 112.657 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.72 -12.59 60.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.58 -26.94 51.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.673 0.273 . . . . 0.0 111.358 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.5 163.93 36.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.823 -179.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.6 Cg_endo -75.87 172.77 15.66 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.891 1.727 . . . . 0.0 112.37 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 123' ' ' TYR . 58.3 t -128.9 153.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.618 HD12 ' CD1' ' A' ' 133' ' ' LEU . 58.3 mt -112.53 97.69 6.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.431 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.5 t -82.06 134.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.377 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.99 87.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.76 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.555 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.67 111.11 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.016 0.436 . . . . 0.0 111.438 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.21 -26.13 13.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.633 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -97.52 95.66 7.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.919 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.22 -21.23 46.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.1 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -40.06 96.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.57 -34.21 69.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.572 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.963 HG23 HD11 ' A' ' 133' ' ' LEU . 38.0 mt -61.85 -52.01 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.61 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.43 -28.98 57.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.24 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 6.1 mm-40 -70.89 -51.12 28.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.32 -52.29 66.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.885 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.011 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.91 -33.79 69.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.255 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.81 97.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.305 178.758 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -66.07 -37.39 85.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.248 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.765 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.1 mp -68.01 -29.65 68.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.86 -19.07 62.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.39 -41.07 6.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.751 0.31 . . . . 0.0 111.541 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.765 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.89 156.73 91.26 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 -179.593 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.654 ' HB2' HG23 ' A' ' 178' ' ' VAL . 53.2 Cg_exo -49.98 130.14 26.7 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 112.792 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.19 -39.78 63.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.45 91.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 110.552 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.766 ' HA ' HG22 ' A' ' 224' ' ' ILE . 58.1 t -59.6 -55.59 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.686 179.397 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.652 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -68.74 -12.61 61.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 178.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.69 -14.16 58.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.44 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.665 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.68 78.83 3.74 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.975 0.387 . . . . 0.0 111.593 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -178.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.554 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -121.31 -44.36 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -167.66 151.09 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.469 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -105.49 136.15 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.317 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.5 m170 -109.57 122.52 47.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.503 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -73.53 102.73 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.724 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -122.96 75.08 48.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.415 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 55.4 Cg_endo -70.62 161.04 47.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.335 2.023 . . . . 0.0 112.597 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.5 p -139.8 164.95 28.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.885 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -54.28 -27.86 38.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -104.28 -16.59 15.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.65 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -135.32 76.62 1.63 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.3 -21.28 33.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.711 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.76 38.37 2.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -85.77 117.8 24.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.008 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.88 133.67 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -104.53 110.58 31.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.497 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.3 m -84.99 156.26 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.686 -179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.77 106.98 15.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.411 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.17 149.23 20.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -67.29 -21.57 65.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.014 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.433 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.9 m-20 -77.21 -13.08 60.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.19 20.35 9.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.617 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 32.9 m-85 -106.52 173.38 6.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.656 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -127.78 119.73 26.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 199' ' ' VAL . 18.6 t -116.77 159.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 207' ' ' VAL . 94.3 p -119.91 149.11 42.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.413 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.23 -179.11 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.808 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -129.93 150.01 51.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.314 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.555 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.3 mt -63.27 -24.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.156 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -35.96 64.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 0.0 111.553 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -131.95 36.15 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.093 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.456 ' CD1' HD23 ' A' ' 218' ' ' LEU . 15.2 t80 -54.84 -51.71 65.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.265 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.3 -43.01 92.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.7 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.44 -38.38 87.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.144 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.522 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 24.1 mmtm -58.94 -53.67 55.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.133 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.523 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.1 mm? -78.35 -22.12 48.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t -60.13 -47.98 83.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.227 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' HIS . . . . . 0.522 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 0.6 OUTLIER -62.57 -15.5 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.605 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -71.03 110.59 7.54 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.98 -24.23 28.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.68 -40.84 20.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.613 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 178' ' ' VAL . 14.2 mt -69.72 -58.57 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.232 178.173 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.8 ' HB2' HD13 ' A' ' 134' ' ' LEU . 39.4 m95 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 130.06 53.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.401 ' HG2' ' CD2' ' A' ' 134' ' ' LEU . 3.5 mtm180 -69.77 124.84 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.999 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.0 0.79 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.891 179.639 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.669 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -165.5 176.79 7.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.582 0.229 . . . . 0.0 110.869 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 24.2 m-85 -140.47 173.33 11.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.413 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.604 HG21 ' CD1' ' A' ' 139' ' ' LEU . 22.8 t -132.29 119.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.86 0.362 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.37 111.03 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.965 -179.526 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 43.8 t0 -156.74 134.74 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.796 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 58.52 44.21 18.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.058 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 54.74 27.59 9.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.552 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 87.0 m -142.12 144.0 33.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.4 m-85 -95.31 110.43 22.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.026 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HB2' HD21 ' A' ' 139' ' ' LEU . 9.7 m-30 -82.81 125.34 75.7 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 35.9 Cg_exo -60.23 127.51 23.3 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.218 1.946 . . . . 0.0 112.709 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 1.0 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -110.22 124.75 52.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.1 mt -86.37 165.85 16.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.41 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' A' ' 121' ' ' ILE . 8.8 pt-20 -55.12 -30.79 60.48 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.576 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.25 12.86 14.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 78.6 3.45 86.78 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.081 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.59 ' HB3' HD12 ' A' ' 134' ' ' LEU . 2.0 tpt180 -60.29 97.41 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.222 0.511 . . . . 0.0 110.436 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.45 125.87 30.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.494 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.8 mm? -104.0 92.64 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.586 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 11.3 mttm -71.69 -28.55 63.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.858 0.361 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -81.27 -22.9 38.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.405 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -97.27 24.42 6.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.524 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.03 159.22 53.46 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.272 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.93 157.77 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.911 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 26.22 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -142.41 139.89 31.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.498 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.7 111.67 8.95 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.307 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 22.3 Cg_exo -64.06 100.59 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.386 2.058 . . . . 0.0 112.146 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -65.75 -14.76 61.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.447 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 -27.27 40.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.5 162.91 48.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.934 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 57.6 Cg_endo -75.13 174.36 12.93 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.761 1.641 . . . . 0.0 112.64 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.405 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.5 t -130.78 155.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.087 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.3 mt -115.0 97.51 6.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.601 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 66.2 t -83.2 133.95 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.33 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.88 84.96 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.748 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.484 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.4 m95 -147.36 111.94 5.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.054 0.454 . . . . 0.0 111.508 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -102.13 -27.08 13.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -96.73 95.67 8.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.911 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.39 -21.06 47.24 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.037 178.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.62 98.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.737 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.78 -34.48 71.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 1.0 HG23 HD11 ' A' ' 133' ' ' LEU . 42.1 mt -61.95 -51.8 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.541 178.528 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.2 -29.62 58.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.264 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 16.3 mm-40 -70.14 -51.78 28.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.3 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.458 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.56 -52.54 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.044 179.917 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.999 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.86 -33.55 68.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.311 179.324 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.55 -42.36 97.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.205 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -65.79 -38.36 88.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.809 0.338 . . . . 0.0 110.311 179.003 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.817 ' HA ' HD22 ' A' ' 174' ' ' LEU . 8.0 mp -66.17 -27.22 67.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.397 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.43 -20.29 60.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.523 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -101.41 -41.11 6.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.817 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -68.57 156.94 89.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 178' ' ' VAL . 54.2 Cg_exo -50.15 124.93 13.75 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.64 2.227 . . . . 0.0 112.679 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.09 -38.42 65.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.591 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.45 89.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.449 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.668 ' HA ' HG22 ' A' ' 224' ' ' ILE . 50.5 t -61.31 -60.21 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.794 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -62.07 -23.5 66.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.473 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.23 -24.87 74.59 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.588 178.798 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.18 78.37 7.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.29 134.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -159.53 153.68 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.421 . . . . 0.0 111.102 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -105.05 135.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.149 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.452 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.3 m170 -109.47 119.57 39.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.31 112.24 5.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.781 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 186' ' ' HIS . 1.1 mptp? -135.85 79.72 44.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.85 163.46 38.81 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.279 1.986 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -138.73 163.45 32.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -53.54 -27.07 23.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.63 -16.47 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.656 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -134.0 79.78 1.83 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -58.58 -19.93 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.612 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -114.11 36.52 3.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.74 0.305 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.8 116.36 22.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 110.776 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.08 133.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.402 HG12 ' HD3' ' A' ' 188' ' ' LYS . 33.2 mm -106.01 110.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.74 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.8 m -84.57 157.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.599 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -112.53 107.39 16.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.241 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' MET . . . . . 0.493 ' HE1' HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -56.25 149.29 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 111.309 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -60.58 -24.57 65.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.803 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -85.95 7.07 25.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -16.53 60.91 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.51 177.1 0.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.934 0.367 . . . . 0.0 110.792 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -140.88 115.23 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 199' ' ' VAL . 21.7 t -106.98 157.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 207' ' ' VAL . 83.3 p -121.93 142.78 49.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.123 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.56 -177.27 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.85 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.48 149.06 49.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.476 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.484 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.3 mt -61.21 -23.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.378 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -33.68 59.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -132.4 36.19 3.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.008 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 218' ' ' LEU . 11.9 t80 -58.12 -39.31 78.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.242 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -69.69 -48.79 58.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.186 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.29 -34.17 76.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.106 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -53.32 56.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.392 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -79.31 -22.9 43.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.4 m -64.32 -39.12 93.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.631 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -16.3 52.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.673 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 111.58 13.02 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 122.512 -0.117 . . . . 0.0 110.844 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.98 -27.31 36.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.255 1.97 . . . . 0.0 112.381 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.14 -45.56 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 178' ' ' VAL . 34.6 mt -63.82 -56.28 17.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.066 0.46 . . . . 0.0 109.813 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 225' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.457 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.841 ' HB2' HD13 ' A' ' 134' ' ' LEU . 44.9 m95 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.779 0.323 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -101.49 132.2 47.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.673 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.435 ' HG2' HD23 ' A' ' 134' ' ' LEU . 72.5 mtm180 -71.49 127.67 33.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 1.012 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.22 -1.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.875 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.3 177.06 9.94 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.025 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.435 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 23.5 m-85 -139.45 173.95 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.387 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.655 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.7 t -132.42 118.55 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.45 109.6 15.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 14.9 t70 -169.2 144.88 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.74 39.65 20.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.36 0.6 . . . . 0.0 110.804 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.92 29.2 9.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.506 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 145' ' ' THR . 90.8 m -150.59 143.0 24.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 111.294 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' PHE . . . . . 0.431 ' CD2' HG21 ' A' ' 154' ' ' VAL . 7.1 m-85 -90.71 110.45 21.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.734 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.8 m-85 -80.47 118.55 72.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.04 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 11.2 Cg_endo -57.44 121.23 9.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.023 1.816 . . . . 0.0 112.422 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.901 HD11 HG23 ' A' ' 164' ' ' ILE . 1.4 mt -102.57 125.36 49.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.7 mt -82.98 165.48 19.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.516 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.0 pt-20 -56.03 -30.38 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.677 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.445 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 53.0 p-10 -89.89 13.92 13.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.93 86.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.171 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.586 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -61.65 97.34 0.07 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.13 0.491 . . . . 0.0 110.429 179.649 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.42 121.93 26.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.51 ' N ' HD22 ' A' ' 140' ' ' LEU . 3.2 mm? -104.33 96.6 6.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.586 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 5.0 mttt -72.71 -25.24 61.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.62 -20.86 30.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.737 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.15 23.35 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.19 163.8 54.5 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.615 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -126.68 155.28 42.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.825 0.345 . . . . 0.0 110.533 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 27.12 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.003 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.29 139.06 28.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.43 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.42 3.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.435 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 21.8 Cg_exo -64.54 98.05 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.482 2.122 . . . . 0.0 112.287 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -65.79 -14.49 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.339 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.634 0.254 . . . . 0.0 111.677 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.43 160.34 59.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.866 0.365 . . . . 0.0 111.936 -179.178 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -72.42 173.02 13.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.778 1.652 . . . . 0.0 112.668 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 130' ' ' PHE . 75.9 t -129.62 154.22 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.157 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.609 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.2 mt -112.92 97.96 6.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 110.551 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.36 135.04 25.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.2 87.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.859 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.477 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.3 m95 -148.22 114.9 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.082 0.468 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -105.39 -27.04 11.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.01 95.49 7.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.888 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.43 -20.84 46.65 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.014 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -41.06 98.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.788 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.03 71.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.463 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.901 HG23 HD11 ' A' ' 133' ' ' LEU . 55.3 mt -62.01 -52.08 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.559 178.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.53 -30.93 55.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.3 mm-40 -68.3 -51.0 49.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.223 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.445 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.0 -52.05 67.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.87 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 168' ' ' THR . . . . . 1.012 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.57 -33.73 68.47 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.877 0.37 . . . . 0.0 110.359 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.51 -43.65 97.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.246 178.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.55 -39.46 94.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.751 ' HA ' HD22 ' A' ' 174' ' ' LEU . 8.3 mp -66.93 -27.49 67.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.416 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.92 -22.25 58.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -96.94 -41.19 8.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.773 0.32 . . . . 0.0 111.506 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.751 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.09 155.55 93.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 -179.614 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.575 ' HB2' HG23 ' A' ' 178' ' ' VAL . 61.9 Cg_exo -49.89 129.82 25.5 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.632 2.222 . . . . 0.0 112.791 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.75 68.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.408 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 110.4 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.759 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.2 t -61.66 -60.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.604 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.669 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -61.55 -24.49 66.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 178.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.47 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.91 -23.5 76.23 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.872 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.99 78.29 9.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.972 0.415 . . . . 0.0 110.865 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.39 163.65 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.372 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -103.83 -51.9 3.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.41 151.22 18.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 110.943 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -104.73 135.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.092 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.449 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 7.5 m170 -109.52 125.25 52.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 189' ' ' PRO . 14.0 t80 -75.49 107.37 7.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.526 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -133.24 70.83 77.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.959 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 187' ' ' TYR . 20.5 Cg_exo -65.82 162.75 33.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.339 2.026 . . . . 0.0 112.252 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.9 p -135.88 164.13 28.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -26.05 11.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.445 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -105.35 -20.21 13.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.416 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -129.41 82.05 2.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -16.57 25.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.045 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -121.1 37.22 4.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.645 0.26 . . . . 0.0 111.233 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 196' ' ' ARG . . . . . 0.781 ' NH2' HG23 ' A' ' 210' ' ' THR . 3.8 ttm-85 -81.04 119.86 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.719 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.9 m -119.41 135.14 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 208' ' ' SER . 22.6 mm -105.0 110.78 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.483 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 185' ' ' ILE . 2.1 m -89.66 150.71 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.63 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -109.19 108.9 19.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.236 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.48 149.31 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.469 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -64.76 -22.52 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.939 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.67 -13.17 59.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.25 20.35 9.24 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -103.51 172.49 6.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.829 0.347 . . . . 0.0 110.863 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.36 120.05 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 208' ' ' SER . 13.9 t -121.8 160.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.457 ' N ' HG12 ' A' ' 207' ' ' VAL . 56.9 p -121.63 148.89 43.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -160.37 -179.26 7.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.72 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.781 HG23 ' NH2' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -125.59 151.52 46.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.359 179.781 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.459 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.1 mt -66.02 -25.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -79.14 -28.24 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.251 . . . . 0.0 111.403 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.05 35.77 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -57.89 -51.72 68.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.99 -42.01 97.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.511 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.95 -43.05 93.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.429 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 16.1 mmtm -55.03 -52.64 62.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.083 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.51 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.5 mm? -77.39 -22.84 51.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 21.6 t -60.55 -35.47 76.11 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.092 0.472 . . . . 0.0 110.406 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -72.06 -4.94 31.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.007 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 99.4 5.95 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.07 -27.07 50.0 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.156 1.904 . . . . 0.0 111.911 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.27 -45.12 77.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.783 HG23 ' HB3' ' A' ' 181' ' ' ALA . 38.3 mt -70.28 -53.51 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.636 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.315 178.376 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 118' ' ' TRP . . . . . 0.844 ' HB2' HD13 ' A' ' 134' ' ' LEU . 43.3 m95 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -101.28 132.17 46.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -71.29 127.29 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.999 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.72 1.48 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.792 179.668 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.698 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.12 176.92 8.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 21.0 m-85 -139.82 173.43 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.226 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.68 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.7 t -132.92 118.58 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.57 111.25 16.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.9 t70 -169.09 145.4 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.79 40.86 22.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 54.1 30.62 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.518 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 145' ' ' THR . 41.6 m -152.0 146.42 25.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.424 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.03 109.18 20.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.657 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.0 m-85 -80.68 128.75 70.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.501 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.1 Cg_exo -64.16 125.33 14.98 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.162 1.908 . . . . 0.0 112.326 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.921 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.1 124.88 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.993 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' A' ' 118' ' ' TRP . 17.3 mt -84.07 166.91 17.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.171 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.2 pt-20 -55.72 -30.96 62.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.551 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 6.9 p30 -90.49 13.3 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.421 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.468 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 80.0 5.93 89.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.601 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.46 96.31 0.03 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 117.253 0.526 . . . . 0.0 110.401 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -80.89 124.15 28.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.184 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.6 mm? -105.5 95.61 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.3 mtpt -72.33 -25.92 61.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.276 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -84.81 -21.14 30.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.695 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -99.31 25.7 6.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.553 0.216 . . . . 0.0 111.418 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -69.38 160.92 52.63 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.574 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -124.64 159.82 29.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.36 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.46 30.78 4.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.139 0.495 . . . . 0.0 109.714 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' THR . . . . . 0.464 HG23 ' OG1' ' A' ' 145' ' ' THR . 0.0 OUTLIER -154.25 129.62 9.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.483 -178.215 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.17 109.84 2.35 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.787 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.421 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 35.4 Cg_exo -61.19 105.85 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.225 1.95 . . . . 0.0 112.127 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.68 -15.62 61.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.481 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -81.53 -26.94 34.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.51 162.4 53.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.04 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.9 Cg_endo -76.5 173.69 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.99 1.793 . . . . 0.0 112.749 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.0 t -129.55 153.27 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.886 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 133' ' ' LEU . 56.5 mt -112.42 97.75 6.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.006 0.431 . . . . 0.0 110.638 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.8 t -82.43 134.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.514 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.74 86.91 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.722 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.8 m95 -148.41 112.93 5.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -103.42 -26.23 12.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.514 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -98.11 96.04 7.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.903 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.55 -20.97 48.14 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.028 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -40.46 97.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.96 -33.77 68.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.697 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.921 ' CG2' HD11 ' A' ' 133' ' ' LEU . 63.6 mt -62.28 -52.11 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.675 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.24 -30.41 59.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.187 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.7 mm-40 -67.9 -51.14 51.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 110.149 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.9 -52.47 65.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.757 179.609 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.999 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.3 -33.7 67.94 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.268 179.253 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.13 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -66.34 -34.76 78.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.37 . . . . 0.0 110.22 178.752 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.625 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.1 mp -71.79 -28.18 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -19.23 61.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.482 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.17 -40.24 8.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.8 0.334 . . . . 0.0 111.48 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.816 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -73.65 156.0 88.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 175' ' ' PRO . . . . . 0.67 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.5 Cg_exo -51.41 124.7 14.77 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.02 36.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.925 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.48 95.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 224' ' ' ILE . 48.3 t -59.17 -60.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.949 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 179' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -62.58 -24.35 67.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -22.48 77.66 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.101 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 181' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.15 78.33 9.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.931 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.4 ptp 177.86 128.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 m -64.91 -48.78 72.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.47 153.92 8.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.984 0.421 . . . . 0.0 110.997 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -102.89 136.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.269 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 186' ' ' HIS . . . . . 0.438 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -111.06 116.8 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.488 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -66.71 112.02 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.853 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -133.54 78.4 62.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 56.8 Cg_endo -71.38 162.11 43.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.306 2.004 . . . . 0.0 112.53 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.9 p -138.64 161.65 36.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.149 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ptt-85 -53.84 -24.83 17.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.376 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -104.99 -20.19 13.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.429 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -134.91 82.02 1.93 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.07 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.04 -19.34 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.659 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -113.17 35.85 3.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -82.91 115.89 21.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.788 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.92 134.53 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.3 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 207' ' ' VAL . 24.3 mm -105.63 110.6 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.622 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 199' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.28 153.89 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.452 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -111.5 100.57 9.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.207 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.8 tpp -55.85 149.42 14.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.505 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.467 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 3.8 p-10 -66.78 -20.17 65.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.039 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.83 -13.47 60.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.54 20.31 11.09 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.724 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -113.25 153.64 28.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 110.723 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.53 117.55 34.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' VAL . . . . . 0.48 ' HB ' HG22 ' A' ' 199' ' ' VAL . 10.8 t -111.96 160.22 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.425 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 208' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 207' ' ' VAL . 88.0 p -121.57 146.36 47.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.005 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 209' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -158.18 179.5 9.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -125.19 152.94 43.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 211' ' ' ILE . . . . . 0.439 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.2 mt -68.37 -23.89 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.897 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -36.58 57.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.46 35.86 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.962 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.2 t80 -56.17 -45.95 79.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.127 -179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.27 82.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -60.86 -41.47 95.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' LYS . . . . . 0.431 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -54.11 -52.35 61.29 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.648 179.713 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.4 mm? -83.34 -19.48 36.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 38.0 t -64.88 -30.72 71.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.942 0.401 . . . . 0.0 110.854 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -81.55 11.26 4.78 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 221' ' ' TYR . . . . . 0.49 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -105.94 101.85 35.88 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.2 -35.02 87.62 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.241 1.961 . . . . 0.0 112.354 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.14 -44.83 83.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.224 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 178' ' ' VAL . 42.5 mt -65.58 -54.56 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.14 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.383 178.701 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -83.4 162.98 20.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 110.801 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.73 173.22 17.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.961 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.819 ' HB2' HD13 ' A' ' 134' ' ' LEU . 54.7 m95 -87.67 153.01 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.03 129.61 48.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -68.65 127.51 33.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.095 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.0 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.89 1.18 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.848 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.21 177.02 8.67 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.664 0.268 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' HB2' HG22 ' A' ' 154' ' ' VAL . 25.1 m-85 -140.04 173.17 11.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.662 HG21 ' HG ' ' A' ' 139' ' ' LEU . 19.5 t -133.34 119.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.41 109.52 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.911 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -158.5 137.55 11.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 57.95 42.64 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.61 30.56 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.394 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 145' ' ' THR . 89.3 m -147.82 143.0 27.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 0.0 111.001 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.484 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.1 m-85 -92.36 110.25 21.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 110.678 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.7 ' HB2' HD21 ' A' ' 139' ' ' LEU . 11.8 m-30 -83.07 111.57 31.47 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.388 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 82.6 Cg_exo -47.14 126.11 11.1 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.546 2.164 . . . . 0.0 113.089 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.981 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.14 125.05 51.77 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.708 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.1 mt -84.31 166.04 17.78 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.9 pt-20 -55.45 -30.63 60.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.534 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -91.31 15.61 11.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.357 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.429 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.13 7.13 86.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.155 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.608 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -60.61 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.287 0.543 . . . . 0.0 110.213 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.15 119.95 23.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.511 ' N ' HD22 ' A' ' 140' ' ' LEU . 3.1 mm? -99.59 94.27 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 22.2 mttt -72.98 -29.43 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -82.2 -21.67 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.95 25.38 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.431 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.39 160.06 53.59 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.433 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.0 155.42 43.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.657 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.76 2.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.404 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -144.81 139.91 28.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.382 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.1 117.99 61.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.83 107.06 2.37 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.146 1.898 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.9 t -67.5 -12.85 61.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.74 -27.0 50.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.707 0.289 . . . . 0.0 111.397 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.1 162.83 45.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.868 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.4 Cg_endo -76.32 174.09 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.064 1.843 . . . . 0.0 112.733 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 130' ' ' PHE . 72.9 t -130.38 153.98 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.939 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.569 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.4 mt -113.04 97.88 6.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.13 0.49 . . . . 0.0 110.652 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.7 t -82.81 134.67 26.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.361 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.2 87.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.691 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.8 m95 -148.78 111.72 4.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 111.465 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.76 -26.67 13.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.528 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -97.52 96.18 8.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.301 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.906 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.19 -21.27 46.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.999 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.48 97.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.0 70.23 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.532 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.981 HG23 HD11 ' A' ' 133' ' ' LEU . 49.0 mt -62.57 -51.84 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.61 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.58 -27.93 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.384 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.5 mm-40 -71.29 -51.47 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 110.392 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.452 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.92 -52.34 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.955 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.0 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.63 -33.72 68.56 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.848 0.356 . . . . 0.0 110.352 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.98 97.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.159 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -63.51 -37.77 88.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.682 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.1 mp -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.068 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.02 -18.64 61.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.723 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -101.88 -40.49 6.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.685 0.279 . . . . 0.0 111.683 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.3 pp -71.16 156.93 91.23 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.774 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.679 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.9 Cg_exo -50.73 124.29 13.26 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.449 2.099 . . . . 0.0 112.466 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.54 -38.48 45.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.703 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -62.68 -41.24 98.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 110.593 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 51.9 t -59.71 -60.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.789 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.7 -24.03 66.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.542 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.513 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.81 -22.69 76.6 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.012 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.09 78.27 8.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 ptp 178.55 140.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 m -80.91 -53.88 6.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.3 150.67 20.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.198 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.527 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -102.52 135.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.292 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.2 m170 -109.56 118.8 37.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.769 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.447 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -70.28 110.5 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.955 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -133.01 78.34 65.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.423 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 60.8 Cg_endo -74.08 162.77 38.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.256 1.971 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.1 p -140.3 170.23 16.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -57.88 -25.35 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.306 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -104.85 -12.72 16.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.05 83.12 1.73 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 111.335 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.13 -19.08 61.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.546 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -112.42 33.71 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -81.5 115.17 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.66 133.43 63.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.221 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.6 mm -104.69 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -87.74 151.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.712 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -110.36 101.67 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.552 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.4 tpp -55.45 149.43 13.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.513 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -67.05 -20.58 65.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.055 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.79 -13.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.72 20.39 10.09 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.87 165.46 11.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 110.755 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.62 117.43 29.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 201' ' ' MET . 26.1 t -116.54 158.76 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 110.712 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 207' ' ' VAL . 54.2 p -121.79 149.3 43.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.0 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.32 -177.72 6.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -127.59 151.88 48.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.297 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.501 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -65.62 -24.23 34.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.964 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -76.46 -37.72 56.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.394 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -127.84 35.75 4.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.9 t80 -57.69 -42.23 83.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.801 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -64.12 -48.73 74.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.768 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.41 -37.33 86.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 13.9 mmtm -58.21 -53.13 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.532 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.477 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -82.99 -20.05 35.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.386 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.6 t -65.68 -36.61 84.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.061 0.457 . . . . 0.0 110.752 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -70.59 -7.73 46.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.069 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -80.2 112.16 28.21 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 122.356 -0.215 . . . . 0.0 110.786 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 17.0 Cg_exo -67.3 -30.64 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.26 1.973 . . . . 0.0 112.542 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -77.37 -45.34 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.575 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.8 mt -63.04 -57.12 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.993 0.425 . . . . 0.0 109.935 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.423 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -55.01 -28.57 53.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.513 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.98 -29.04 18.9 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.774 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.566 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -52.36 -28.48 19.69 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.093 0.473 . . . . 0.0 110.285 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.703 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.4 mt -76.62 -31.29 57.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.097 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.4 -34.45 65.52 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.984 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -77.6 -49.45 14.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -78.08 76.98 4.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.96 133.44 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.854 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.4 114.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 110.871 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.36 -174.81 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.825 ' HB2' HD13 ' A' ' 134' ' ' LEU . 55.6 m95 -108.51 152.97 24.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.005 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -98.59 131.87 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.663 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HG2' HD23 ' A' ' 134' ' ' LEU . 8.0 mtt85 -73.12 127.65 33.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.15 -0.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.768 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.687 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.03 176.76 10.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.67 0.272 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 22.6 m-85 -139.07 173.7 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.16 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.645 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.8 t -133.97 117.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.917 0.389 . . . . 0.0 110.858 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 111.45 16.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.097 -179.498 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 t70 -168.98 144.1 3.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.793 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 40.48 21.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.14 29.45 10.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.616 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 145' ' ' THR . 90.8 m -149.75 142.68 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.326 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.9 m-85 -91.41 109.38 20.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.172 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.734 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.8 m-85 -79.95 122.94 83.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.31 121.17 9.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.995 1.796 . . . . 0.0 112.372 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.916 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -101.18 125.28 47.79 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.076 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.5 mt -82.22 166.17 19.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.397 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.4 pt-20 -56.6 -30.06 62.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -90.86 15.32 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.445 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 76.73 4.32 81.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.158 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.591 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt85 -61.88 97.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 110.488 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.46 116.62 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.23 97.44 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.96 0.41 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 27.5 mttt -71.77 -26.02 62.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.12 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -77.26 -21.0 54.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -103.89 26.69 8.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.562 0.22 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.67 162.86 52.32 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.525 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.05 156.96 41.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.357 . . . . 0.0 110.613 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 26.72 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.401 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -145.83 140.37 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.446 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 118.78 56.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 67.3 Cg_endo -76.09 106.85 2.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.999 1.799 . . . . 0.0 112.678 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.5 t -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.199 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -26.95 47.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.726 0.298 . . . . 0.0 111.419 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.56 159.98 49.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 54.5 Cg_endo -71.52 172.92 13.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.046 1.83 . . . . 0.0 112.587 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.6 t -128.95 154.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.01 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.4 mt -112.93 97.79 6.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -82.36 135.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.492 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.62 88.18 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.782 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.9 m95 -148.46 110.66 4.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 111.549 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -100.98 -25.25 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.631 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -99.37 96.27 7.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.328 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.906 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.94 -20.78 50.34 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.952 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -40.41 97.16 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.31 -34.06 70.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.57 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.916 HG23 HD11 ' A' ' 133' ' ' LEU . 50.4 mt -61.99 -51.93 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.573 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.64 -29.18 51.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.28 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 60.2 mm-40 -71.08 -50.51 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.386 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.459 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.87 -52.52 65.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.771 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.026 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.56 -33.59 68.3 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 110.248 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.38 -42.72 97.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.181 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -64.33 -37.31 87.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.105 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.652 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -68.93 -27.26 65.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.314 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.15 -20.09 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.522 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -99.1 -40.55 7.95 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.694 0.283 . . . . 0.0 111.381 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.98 155.28 90.58 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.673 ' O ' HD12 ' A' ' 174' ' ' LEU . 54.2 Cg_exo -51.22 125.27 15.95 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.499 2.133 . . . . 0.0 112.443 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.95 -36.86 40.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.797 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.714 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.97 -41.17 97.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 110.355 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.772 ' HA ' HG22 ' A' ' 224' ' ' ILE . 40.3 t -59.46 -60.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.106 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.776 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.7 pp -61.44 -26.52 67.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.269 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.505 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.63 -22.01 78.83 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.97 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.855 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -82.05 78.07 8.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.911 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 176.88 154.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.1 t -91.98 -46.75 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.159 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -166.0 151.55 8.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -103.92 135.5 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.221 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 15.7 m170 -107.97 122.8 47.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 18.1 t80 -76.53 102.8 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.744 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -123.39 70.66 44.92 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.409 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 41.1 Cg_endo -67.96 160.07 50.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.35 2.034 . . . . 0.0 112.636 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.5 p -140.12 163.19 33.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.011 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -53.39 -27.33 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.51 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.97 -19.85 14.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -133.29 76.9 1.7 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.941 0.401 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.37 -21.05 33.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.59 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.57 37.88 3.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 111.237 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -83.91 112.76 20.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.836 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.59 132.85 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 207' ' ' VAL . 23.7 mm -104.72 108.14 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.425 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.496 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.15 151.82 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -108.75 109.8 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.12 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 149.16 7.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.48 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.441 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 4.0 p-10 -61.4 -23.25 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.01 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.5 -13.22 59.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.819 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.94 20.35 9.41 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.792 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -101.28 173.09 6.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.823 0.344 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.57 120.52 36.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 208' ' ' SER . 40.8 t -121.23 159.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.479 ' N ' HG12 ' A' ' 207' ' ' VAL . 96.8 p -120.14 149.09 42.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.151 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -163.64 -179.34 6.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.576 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -128.24 155.06 45.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.431 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.501 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.8 mt -69.87 -23.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.753 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -31.82 57.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -134.1 35.85 3.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 13.1 t80 -56.88 -46.97 81.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.71 99.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.35 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.19 -45.83 89.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.141 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.5 mmpt? -53.34 -53.04 56.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.604 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.489 HD12 HD13 ' A' ' 224' ' ' ILE . 3.5 mm? -78.96 -22.43 45.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.079 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.6 m -64.67 -28.28 69.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.797 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.8 8.52 9.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.425 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -105.97 102.65 40.5 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.324 -0.235 . . . . 0.0 110.406 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.93 -34.31 71.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.177 1.918 . . . . 0.0 112.387 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -65.57 -45.19 84.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.855 HG23 ' HB3' ' A' ' 181' ' ' ALA . 31.7 mt -65.83 -54.76 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.31 -29.32 47.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.51 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.81 -28.68 16.43 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.573 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.95 -28.41 16.55 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.019 0.437 . . . . 0.0 110.325 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.714 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 5.3 mt -77.23 -31.74 55.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.43 -22.47 63.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.444 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -53.76 -28.84 36.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.714 0.292 . . . . 0.0 111.424 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -67.31 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.784 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.86 121.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.9 tttm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.9 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -147.76 95.38 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -116.8 -177.01 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.787 ' HB2' HD13 ' A' ' 134' ' ' LEU . 66.5 m95 -74.76 154.31 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.6 ptt85 -99.53 132.32 44.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HG2' HD23 ' A' ' 134' ' ' LEU . 18.2 mtm180 -71.91 127.48 32.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.162 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.02 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.41 1.15 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.846 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.675 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.15 177.01 8.72 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 120.643 0.259 . . . . 0.0 111.092 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HB2' HG22 ' A' ' 154' ' ' VAL . 28.8 m-85 -140.08 173.78 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.663 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.6 t -133.54 117.37 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 111.002 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.46 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.49 112.57 17.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.27 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 27.8 t70 -169.18 142.21 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.769 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 41.22 20.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.161 0.505 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.12 28.09 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.672 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 145' ' ' THR . 82.1 m -147.61 142.32 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.317 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.6 m-85 -92.55 110.19 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.9 m-85 -79.96 119.35 76.37 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.922 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 11.8 Cg_endo -58.31 121.09 9.4 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.92 1.747 . . . . 0.0 112.351 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.919 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -102.04 125.74 48.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.15 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.787 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.7 mt -83.27 165.97 18.92 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.312 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' ' 121' ' ' ILE . 9.1 pt-20 -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.61 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -90.93 15.65 10.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.51 86.69 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.25 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.62 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -60.62 95.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.327 0.564 . . . . 0.0 110.243 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -81.03 117.29 21.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.482 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.7 mm? -100.77 96.78 7.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.2 mttt -73.25 -25.73 60.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.066 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -84.55 -21.17 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.686 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -100.83 25.47 7.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.649 0.261 . . . . 0.0 111.521 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.45 164.41 54.16 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.659 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -127.87 156.66 42.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 26.55 3.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.424 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -144.77 141.47 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.91 118.27 61.68 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 106.59 2.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.04 1.827 . . . . 0.0 112.567 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.48 -12.71 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.257 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.0 -27.42 48.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 111.367 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.97 161.44 53.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.851 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.8 Cg_endo -74.4 173.28 14.52 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.969 1.779 . . . . 0.0 112.517 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.3 t -129.91 154.47 40.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.9 mt -113.48 97.97 6.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.026 0.441 . . . . 0.0 110.529 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.9 t -83.88 135.17 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.326 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.46 85.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.69 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.537 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.6 m95 -148.57 116.45 6.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.074 0.464 . . . . 0.0 111.452 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.35 -25.68 11.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.464 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.06 95.52 7.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.919 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.28 -21.01 46.2 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.071 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.17 96.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.84 -33.59 68.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.589 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.919 HG23 HD11 ' A' ' 133' ' ' LEU . 43.5 mt -62.45 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.587 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.75 55.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.243 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.2 mm-40 -69.62 -50.43 44.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.234 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.73 -52.31 66.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.737 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.02 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.06 -33.76 69.38 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.911 0.386 . . . . 0.0 110.23 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -40.71 97.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.224 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -66.25 -37.37 85.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.247 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.568 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -69.02 -27.69 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.269 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.59 60.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.552 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.34 -40.44 7.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.309 . . . . 0.0 111.534 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.46 157.34 89.23 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.656 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.6 Cg_exo -50.76 124.01 12.73 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.494 2.129 . . . . 0.0 112.56 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.08 28.72 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.76 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.716 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -67.42 -41.76 84.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.369 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.751 ' HA ' HG22 ' A' ' 224' ' ' ILE . 45.0 t -59.22 -59.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.8 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.2 pp -61.27 -25.24 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.46 -23.03 77.99 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.951 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.76 78.15 9.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.915 0.388 . . . . 0.0 110.715 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.84 138.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -78.9 -50.36 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -162.73 152.68 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.53 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.09 136.46 37.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.303 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 5.3 m170 -108.49 116.17 31.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 48.2 t80 -70.21 105.04 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -126.71 75.48 75.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 44.4 Cg_endo -68.43 160.55 48.67 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.232 1.955 . . . . 0.0 112.41 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.1 p -139.44 162.38 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -54.24 -26.24 27.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.36 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -103.22 -19.71 14.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.424 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.63 79.6 1.81 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.04 -21.43 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.55 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -113.42 38.59 2.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.678 0.275 . . . . 0.0 111.111 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.19 115.92 22.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.04 132.81 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.275 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.1 mm -105.34 111.69 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.628 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.5 m -86.62 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.55 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -112.2 105.19 13.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.022 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.24 149.09 7.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -67.24 -22.44 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.913 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.5 -10.72 59.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.39 9.15 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.622 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.75 176.17 5.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.853 0.358 . . . . 0.0 110.741 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.93 113.08 11.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 199' ' ' VAL . 15.0 t -109.84 159.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 207' ' ' VAL . 76.5 p -121.3 146.73 46.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.669 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.493 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.6 -179.74 7.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.2 147.66 51.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.326 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.537 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -58.82 -24.85 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.615 0.245 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.95 58.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.553 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -134.21 35.96 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.235 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.05 -50.97 71.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.753 0.311 . . . . 0.0 110.921 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.65 89.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.725 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.77 -41.04 99.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.146 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.493 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 26.7 mmtt -55.41 -53.45 56.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.217 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -77.8 -23.03 49.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.1 t -60.41 -34.26 73.68 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.092 0.472 . . . . 0.0 110.269 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -78.24 0.83 23.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.796 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.53 99.62 6.75 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.53 -20.08 47.9 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.105 1.87 . . . . 0.0 112.41 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -74.2 -52.27 12.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.787 HG23 ' HB3' ' A' ' 181' ' ' ALA . 23.5 mt -63.64 -53.04 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.449 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -54.38 -29.43 48.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.495 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.46 -28.45 13.17 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.66 -27.32 11.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.384 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.716 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.2 mt -79.55 -31.68 42.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.223 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -108.82 26.44 10.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.269 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -55.87 -57.76 10.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -176.48 -40.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.029 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.51 119.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.619 -0.193 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.3 m -91.47 147.95 22.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -135.34 179.97 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.801 ' HB2' HD13 ' A' ' 134' ' ' LEU . 61.3 m95 -96.93 154.96 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.161 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -95.12 145.81 24.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.519 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HG2' HD23 ' A' ' 134' ' ' LEU . 14.3 mtm180 -86.92 124.28 32.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 110.456 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 168' ' ' THR . 0.1 OUTLIER -126.98 -0.37 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.869 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.69 176.64 10.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HB2' HG22 ' A' ' 154' ' ' VAL . 19.8 m-85 -139.1 173.18 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.181 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.632 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.5 t -132.95 118.17 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.939 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.459 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.27 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 39.2 t0 -169.31 143.78 2.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.683 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 60.0 40.56 18.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 53.94 27.67 7.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.679 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 86.8 m -148.17 142.23 25.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.459 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 10.5 m-85 -90.41 109.75 20.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.5 m-85 -80.28 123.95 82.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.195 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.1 124.09 14.18 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.219 1.946 . . . . 0.0 112.569 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.923 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.3 125.31 50.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.312 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.3 mt -83.35 167.87 17.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.421 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.3 pt-20 -57.09 -30.87 64.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.5 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -90.94 15.28 11.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.374 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.452 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.24 7.86 86.91 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.091 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.624 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.07 96.76 0.05 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.28 0.54 . . . . 0.0 110.282 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.04 113.33 21.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.969 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.9 mt -104.54 97.93 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 32.6 mttt -69.57 -27.11 64.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.11 -22.09 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.693 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -102.28 25.31 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.483 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.87 163.73 52.63 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.693 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -127.72 156.22 42.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.55 27.08 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.947 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.77 140.03 26.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.568 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.2 118.56 51.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.38 105.4 2.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.068 1.846 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.9 t -67.61 -12.59 60.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.87 -26.94 44.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.492 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.69 163.44 38.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 59.9 Cg_endo -75.79 172.86 15.49 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.915 1.743 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 130' ' ' PHE . 74.9 t -128.96 154.17 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.214 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.57 HD12 ' CD1' ' A' ' 133' ' ' LEU . 61.7 mt -113.54 97.68 6.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.153 0.501 . . . . 0.0 110.614 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.2 t -83.03 134.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.352 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.748 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -147.9 113.89 5.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.1 0.476 . . . . 0.0 111.532 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -104.46 -25.64 12.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.518 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -98.79 95.69 7.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.243 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.878 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.58 -20.75 47.47 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.076 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -40.82 97.85 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.86 70.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.538 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.923 ' CG2' HD11 ' A' ' 133' ' ' LEU . 64.8 mt -62.54 -52.05 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -31.76 61.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.04 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 9.0 mm-40 -65.95 -52.08 52.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.057 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.61 -52.28 66.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.812 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.026 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.08 -33.65 69.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.41 97.73 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.321 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -65.62 -36.99 85.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.191 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.607 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -67.62 -28.23 67.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.2 -18.54 61.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.58 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -103.14 -40.93 6.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -70.3 157.41 90.02 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.666 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.4 Cg_exo -51.27 123.99 13.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.67 -35.74 32.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.97 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.654 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.7 -41.67 92.09 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.427 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.803 ' HA ' HG22 ' A' ' 224' ' ' ILE . 66.9 t -58.66 -55.86 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -68.68 -12.74 61.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.65 -12.95 58.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.53 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.67 78.34 3.74 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.991 0.395 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.14 170.14 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.5 m -103.86 -48.16 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -167.73 154.07 7.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.72 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.581 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -104.63 134.98 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.224 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -108.96 117.57 34.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -69.21 105.14 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.739 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -128.63 78.61 75.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.39 161.73 43.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.251 1.967 . . . . 0.0 112.479 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.6 p -136.93 163.49 30.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -54.59 -25.77 28.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.456 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.71 -17.11 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.421 ' HD1' HG21 ' A' ' 210' ' ' THR . 89.5 m-85 -135.16 81.92 1.92 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -58.86 -19.69 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.721 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -113.81 36.93 3.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -83.81 115.09 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.6 m -116.86 136.11 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 207' ' ' VAL . 25.4 mm -105.37 110.58 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.581 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.9 152.14 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.472 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.33 105.97 15.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -53.84 149.42 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.488 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -64.3 -21.62 66.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.22 -13.32 59.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.74 20.38 9.49 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.815 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.96 168.79 8.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.285 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -119.04 117.01 27.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 208' ' ' SER . 40.9 t -118.08 158.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.716 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 207' ' ' VAL . 77.3 p -121.76 147.35 46.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.65 147.89 7.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.421 HG21 ' HD1' ' A' ' 193' ' ' TYR . 0.9 OUTLIER -95.51 147.46 23.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.694 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.492 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.5 mt -59.59 -27.33 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.092 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.76 72.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.551 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -133.07 35.85 3.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.151 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -56.2 -43.88 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -63.87 -49.13 73.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.935 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -37.08 86.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.865 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.79 -53.91 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.502 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.4 mm? -83.17 -21.81 33.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.427 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 m -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 110.634 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -72.45 -4.61 31.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -90.54 110.68 42.86 Favored Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 122.276 -0.265 . . . . 0.0 110.803 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 18.3 Cg_exo -66.41 -30.31 44.45 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.184 1.922 . . . . 0.0 112.393 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -73.92 -44.69 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.392 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.803 HG22 ' HA ' ' A' ' 178' ' ' VAL . 27.9 mt -64.56 -56.49 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 109.805 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -56.31 -28.83 60.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.31 -29.1 13.92 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.579 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.64 -27.4 11.28 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.654 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.4 mt -78.29 -32.18 49.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.8 -37.11 56.37 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -66.27 -75.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -96.9 78.8 2.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.6 p -90.59 141.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.949 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -37.54 60.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.831 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.42 -171.45 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.796 ' HB2' HD13 ' A' ' 134' ' ' LEU . 57.8 m95 -78.29 153.87 31.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -101.36 130.38 47.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HG2' HD23 ' A' ' 134' ' ' LEU . 25.0 mtm180 -69.36 126.57 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.123 0.487 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.057 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.24 -1.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.787 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 171' ' ' LEU . . . -161.79 176.7 10.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.1 m-85 -138.09 173.6 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.641 HG21 ' HG ' ' A' ' 139' ' ' LEU . 13.5 t -134.24 119.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.414 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 109.46 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.999 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 37.3 t70 -161.31 138.05 8.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 58.59 42.62 20.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 54.17 28.42 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.546 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 145' ' ' THR . 89.8 m -145.66 141.97 28.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.424 ' CD2' HG21 ' A' ' 154' ' ' VAL . 8.2 m-85 -91.98 109.04 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.405 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.725 ' HB2' HD21 ' A' ' 139' ' ' LEU . 11.7 m-30 -79.73 123.03 84.14 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.784 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 123.89 14.05 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 112.642 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 164' ' ' ILE . 1.5 mt -105.89 125.01 50.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.946 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.7 mt -84.4 165.92 17.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.191 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 121' ' ' ILE . 4.8 pt-20 -55.47 -30.33 60.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.505 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.4 15.0 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.368 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.99 6.35 87.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.288 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.61 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.95 95.65 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.246 0.523 . . . . 0.0 110.358 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.725 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -86.1 112.98 21.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.876 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -102.74 98.08 8.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.625 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 17.1 mttp -69.8 -28.85 66.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -74.45 -23.71 58.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.78 25.54 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.451 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.08 162.88 52.94 Favored Glycine 0 CA--C 1.51 -0.246 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.479 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.7 155.3 44.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.794 0.331 . . . . 0.0 110.808 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 27.62 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.57 139.12 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.18 118.32 54.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.064 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -77.73 105.54 2.04 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.887 . . . . 0.0 112.726 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -67.88 -12.17 60.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.191 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -77.86 -27.17 49.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 111.386 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -143.83 160.01 51.66 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 47.5 Cg_endo -71.76 173.25 12.95 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.103 1.869 . . . . 0.0 112.71 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 123' ' ' TYR . 72.6 t -129.48 154.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.943 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.611 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.7 mt -112.95 97.99 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.9 t -83.04 134.96 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.33 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.75 85.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.842 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.562 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.1 m95 -148.93 112.7 5.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.41 -25.11 13.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.58 95.41 7.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.236 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.92 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.03 -21.46 45.71 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.085 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -40.06 96.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.67 67.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.6 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.946 HG23 HD11 ' A' ' 133' ' ' LEU . 43.7 mt -61.93 -51.74 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.573 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.09 58.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 1.6 mm-40 -68.81 -51.76 37.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.439 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -57.95 -51.74 68.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.734 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.057 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.65 -33.72 70.39 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.177 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.73 -41.55 95.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.167 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -65.04 -39.42 93.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.986 0.422 . . . . 0.0 110.03 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.608 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.1 mp -67.49 -28.56 67.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -20.49 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.691 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -99.64 -41.32 7.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.506 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.2 pp -70.12 157.66 89.31 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.66 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.4 Cg_exo -51.38 123.6 12.4 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.482 2.121 . . . . 0.0 112.539 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.53 18.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.662 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -67.58 -43.1 81.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.387 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 50.1 t -58.91 -59.88 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.866 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -60.6 -24.8 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.355 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.421 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.14 -23.27 76.41 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.981 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.857 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.33 78.15 9.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.918 0.39 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.31 157.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.507 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 74.0 m -100.8 -55.56 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.172 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.1 149.69 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 199' ' ' VAL . 4.6 mt -106.0 135.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.266 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.0 m170 -107.77 122.18 46.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -76.35 105.07 7.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.771 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -124.82 73.76 64.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.21 158.88 51.04 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.307 2.005 . . . . 0.0 112.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.6 p -143.71 167.11 23.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -25.8 59.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.294 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -100.95 -17.64 16.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.59 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -143.22 78.7 1.61 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 121.008 0.432 . . . . 0.0 111.146 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.42 -20.17 42.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.633 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.1 36.81 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -84.89 115.57 22.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.2 m -120.51 133.06 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 207' ' ' VAL . 21.6 mm -104.47 112.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 185' ' ' ILE . 3.1 m -89.04 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -110.82 103.73 12.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.969 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.572 ' SD ' HD11 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -50.29 149.03 3.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.652 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -64.76 -22.28 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.963 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -78.9 -13.33 59.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.42 9.32 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.709 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 27.5 m-85 -104.18 164.25 11.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.21 120.77 42.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 208' ' ' SER . 40.4 t -122.0 158.54 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.645 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 207' ' ' VAL . 39.3 p -121.93 149.21 43.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.91 -178.0 5.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -129.95 154.62 47.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.398 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.562 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -67.69 -21.88 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.123 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -30.28 30.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.5 35.04 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.43 ' CD1' HD23 ' A' ' 218' ' ' LEU . 12.6 t80 -59.13 -47.11 86.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.795 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.71 -46.27 90.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.16 -37.71 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -59.4 -53.4 58.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.457 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -79.72 -22.0 43.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.2 t -63.8 -40.56 96.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.382 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -64.5 -14.65 58.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.805 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.422 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -75.91 111.33 14.23 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.467 -0.093 . . . . 0.0 110.886 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.753 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 14.8 Cg_exo -69.12 -25.76 31.23 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.273 1.982 . . . . 0.0 112.599 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -80.5 -40.77 25.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.578 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.857 HG23 ' HB3' ' A' ' 181' ' ' ALA . 17.3 mt -69.37 -58.27 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.436 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -55.83 -29.12 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.216 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.49 -28.23 19.55 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.561 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.414 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.72 -27.31 11.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.662 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.5 mt -79.97 -31.96 39.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.132 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.28 18.99 15.07 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.521 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -91.13 -31.74 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 232' ' ' VAL . 17.5 t 61.51 31.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.5 mttt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.851 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.0 m 60.21 80.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -153.29 -176.76 5.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.809 ' HB2' HD13 ' A' ' 134' ' ' LEU . 51.8 m95 -79.82 151.09 30.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.5 128.79 45.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.691 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.4 mtm-85 -68.08 127.8 34.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.025 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.53 1.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.84 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.84 176.62 8.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.65 0.262 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.435 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 23.1 m-85 -139.66 173.19 11.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.588 HG21 ' HG ' ' A' ' 139' ' ' LEU . 22.4 t -133.02 118.95 34.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.0 111.038 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.494 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.22 112.0 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.009 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.1 t70 -156.47 133.86 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 58.16 44.6 18.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.969 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 55.01 28.27 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.433 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 86.5 m -142.08 143.46 33.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.494 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.4 m-85 -95.63 110.7 22.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.721 ' HB2' HD21 ' A' ' 139' ' ' LEU . 9.2 m-30 -84.05 124.79 74.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.463 ' HB2' HD12 ' A' ' 140' ' ' LEU . 31.3 Cg_exo -59.61 127.3 23.2 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.295 1.997 . . . . 0.0 112.841 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 1.001 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.88 125.15 52.49 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.733 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.3 mt -85.13 165.15 17.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.513 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.5 pt-20 -55.25 -29.94 59.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.609 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -91.32 15.6 11.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.357 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.77 3.33 79.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.341 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.591 ' HB3' HD12 ' A' ' 134' ' ' LEU . 3.3 tpt180 -61.31 97.58 0.07 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.343 0.572 . . . . 0.0 110.533 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -78.79 132.27 36.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' N ' HD23 ' A' ' 139' ' ' LEU . 75.1 mt -111.51 92.71 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.4 mttt -71.63 -28.49 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -80.23 -23.33 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.495 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.467 ' HG3' HD13 ' A' ' 140' ' ' LEU . 46.7 mm-40 -97.85 26.07 5.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.494 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -77.33 159.94 49.12 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.559 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 3.3 t -130.86 159.44 37.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 20.39 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.297 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.471 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -136.66 142.19 43.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.596 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.21 119.56 76.98 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.9 Cg_endo -73.71 106.58 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.046 1.831 . . . . 0.0 112.539 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -13.5 61.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.302 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.14 42.94 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.626 0.25 . . . . 0.0 111.554 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.56 161.11 56.41 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.83 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.518 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 57.7 Cg_endo -73.63 173.42 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.959 1.773 . . . . 0.0 112.673 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 130' ' ' PHE . 65.3 t -130.05 153.09 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.7 mt -112.84 97.55 6.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.7 t -82.73 134.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.452 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.56 85.98 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.78 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.509 ' CH2' HD11 ' A' ' 211' ' ' ILE . 68.0 m95 -147.1 110.82 4.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 0.0 111.607 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -101.38 -27.11 13.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.95 95.26 8.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.246 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.44 -20.91 47.07 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.983 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -40.7 98.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -34.41 71.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.449 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.001 HG23 HD11 ' A' ' 133' ' ' LEU . 47.6 mt -61.81 -51.95 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.622 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.1 60.02 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -69.46 -51.44 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.9 -52.43 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.958 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.01 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.23 -33.61 69.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.856 0.36 . . . . 0.0 110.334 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.89 97.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.346 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -64.94 -37.75 88.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.163 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.589 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.4 mp -67.88 -27.47 66.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.249 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.13 -19.47 60.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.513 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.49 -40.72 7.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.674 0.273 . . . . 0.0 111.551 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -71.04 157.1 91.05 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.474 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.657 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.0 Cg_exo -51.08 123.7 12.42 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 112.498 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -34.08 30.23 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.727 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.702 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -66.46 -42.21 87.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 110.357 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.765 ' HA ' HG22 ' A' ' 224' ' ' ILE . 49.1 t -58.96 -60.29 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.902 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -60.42 -25.02 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.47 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.93 -23.1 77.14 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.606 -0.806 . . . . 0.0 111.818 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.685 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.23 78.29 8.84 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 110.815 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 178.38 133.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.57 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 m -70.48 -61.64 1.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -154.86 152.32 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -102.76 135.21 41.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.433 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -107.75 114.89 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.045 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.473 ' CE2' ' CE3' ' A' ' 158' ' ' TRP . 0.6 OUTLIER -68.47 114.21 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -134.59 76.09 61.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 58.5 Cg_endo -72.21 157.68 53.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.415 2.077 . . . . 0.0 112.659 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.4 p -141.96 161.99 36.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.891 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -55.52 -25.64 38.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.9 -22.13 15.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.108 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -138.46 75.13 1.5 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.02 0.438 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.18 -21.22 21.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.757 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.18 39.26 2.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 111.08 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -87.91 122.92 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.4 mm -104.41 108.77 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.534 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -87.58 151.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 0.0 111.54 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.77 105.02 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.073 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.59 149.13 3.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.659 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -64.13 -22.64 67.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.15 -13.3 60.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.36 9.38 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.678 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -105.32 167.67 9.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.933 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -116.39 120.76 39.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 208' ' ' SER . 46.2 t -120.79 158.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 207' ' ' VAL . 90.7 p -122.29 148.97 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.125 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -164.27 -179.17 5.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.663 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.4 p -126.56 152.95 45.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.509 HD11 ' CH2' ' A' ' 158' ' ' TRP . 16.4 mt -68.54 -25.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.802 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -32.08 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.23 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -134.13 35.93 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.002 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.6 t80 -55.41 -49.39 72.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.443 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.84 -44.56 89.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.262 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.425 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 1.8 mmpt? -53.7 -50.61 65.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.993 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.536 HD12 HD13 ' A' ' 224' ' ' ILE . 3.6 mm? -79.42 -21.62 45.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.669 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.7 t -60.62 -33.68 73.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 0.0 110.436 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -78.75 4.72 13.04 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.137 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.428 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -100.19 99.17 8.9 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 122.238 -0.289 . . . . 0.0 110.257 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.26 -24.89 43.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.174 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -72.51 -49.15 34.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.765 HG22 ' HA ' ' A' ' 178' ' ' VAL . 49.8 mt -64.02 -53.46 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -56.01 -29.15 59.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.467 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.4 -29.0 14.23 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.59 -27.68 11.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.373 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.702 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.3 mt -78.27 -31.89 49.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.201 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.6 -41.68 53.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -91.25 -70.98 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.21 85.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.6 m -104.35 80.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.884 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -125.71 -175.68 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.66 -173.31 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.847 ' HB2' HD13 ' A' ' 134' ' ' LEU . 49.9 m95 -92.31 150.12 21.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.099 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ARG . . . . . 0.516 ' NH2' HG21 ' A' ' 121' ' ' ILE . 10.7 ttp180 -98.12 138.25 35.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.324 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.434 ' HG2' HD23 ' A' ' 134' ' ' LEU . 33.3 mtm180 -79.68 129.07 34.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.323 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.007 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.9 1.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.984 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.88 176.9 9.74 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.472 ' HB2' HG22 ' A' ' 154' ' ' VAL . 23.9 m-85 -139.13 173.81 11.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.696 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.6 t -134.25 116.63 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.466 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.4 110.43 15.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.009 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.405 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 10.3 t70 -169.01 145.19 3.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.26 39.4 22.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.846 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.27 30.62 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.569 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 90.9 m -151.93 142.78 22.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.466 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.6 m-85 -90.53 109.8 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.133 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -80.42 118.77 73.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.964 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.47 122.32 11.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.013 1.809 . . . . 0.0 112.351 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.91 HD11 HG23 ' A' ' 164' ' ' ILE . 1.3 mt -103.24 125.28 49.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.171 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.847 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.9 mt -82.35 166.39 19.5 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.2 pt-20 -56.68 -30.52 63.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -90.87 15.32 11.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.354 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.65 6.9 87.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.21 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.628 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.0 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.311 0.556 . . . . 0.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -81.01 117.91 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.76 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.488 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.8 mm? -102.19 97.34 7.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 22.8 mttp -72.38 -26.38 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -83.58 -21.15 32.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -100.42 24.31 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.38 164.3 54.63 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.783 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.54 156.53 42.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.525 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.9 28.16 3.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.8 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.33 139.37 25.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.618 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.25 118.55 54.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.917 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 64.8 Cg_endo -76.23 105.71 2.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.06 1.84 . . . . 0.0 112.668 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -67.61 -12.44 60.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -27.24 41.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.709 0.29 . . . . 0.0 111.501 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -143.17 160.05 53.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.925 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.9 Cg_endo -72.01 172.88 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.962 1.775 . . . . 0.0 112.743 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 123' ' ' TYR . 57.9 t -129.3 154.74 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.921 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.9 mt -114.15 97.82 6.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.478 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 77.7 t -83.34 135.11 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.58 86.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.733 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.576 ' CH2' HD11 ' A' ' 211' ' ' ILE . 72.2 m95 -149.05 111.85 4.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.418 . . . . 0.0 111.492 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -102.27 -25.35 13.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.599 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.43 96.24 7.88 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.895 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.8 -20.65 48.7 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.976 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.45 -40.68 97.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.33 -33.89 70.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.529 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.91 HG23 HD11 ' A' ' 133' ' ' LEU . 51.4 mt -62.38 -51.84 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.591 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.18 -29.7 58.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.9 mm-40 -69.53 -51.22 37.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.72 -52.48 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.789 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.007 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.7 -33.49 70.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.886 0.374 . . . . 0.0 110.241 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.56 -42.59 96.12 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.402 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -66.1 -38.86 89.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.648 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.1 mp -66.49 -26.24 67.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.3 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.63 59.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.572 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.03 -40.53 7.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.761 0.315 . . . . 0.0 111.461 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.746 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -72.41 156.82 90.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.362 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.654 ' O ' HD12 ' A' ' 174' ' ' LEU . 53.1 Cg_exo -50.61 124.48 13.49 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.561 2.174 . . . . 0.0 112.628 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.53 50.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.717 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.89 -40.54 91.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 110.315 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.845 ' HA ' HG22 ' A' ' 224' ' ' ILE . 55.9 t -60.13 -60.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.926 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.746 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.33 -24.48 66.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.381 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.4 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.0 -23.21 76.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.852 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.909 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -84.58 78.16 9.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.695 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 177.3 141.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.408 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.8 -50.01 11.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -163.68 153.06 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.505 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -104.25 133.9 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.135 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.6 m170 -106.82 112.51 25.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.029 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.444 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 73.1 t80 -67.53 102.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -125.81 77.48 70.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.048 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.444 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 43.1 Cg_endo -68.16 166.76 23.97 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.223 1.949 . . . . 0.0 112.322 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 p -141.35 173.54 11.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -27.3 68.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.015 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 193' ' ' TYR . 5.6 pt-20 -114.95 10.99 16.43 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 192' ' ' GLU . 71.6 m-85 -155.88 73.49 0.82 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -21.66 23.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.64 39.26 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.235 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.403 ' HB3' ' HA ' ' A' ' 189' ' ' PRO . 0.0 OUTLIER -85.8 112.66 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 209' ' ' ALA . 34.8 m -116.74 134.13 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 207' ' ' VAL . 22.5 mm -105.95 111.37 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.505 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -84.62 152.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.503 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -109.54 105.28 14.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.24 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.53 149.3 8.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -66.65 -22.35 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.97 -12.03 59.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.3 14.68 19.68 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.837 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -100.65 174.26 6.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.849 0.325 . . . . 0.0 110.511 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.41 120.58 27.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 0.0 110.963 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.491 ' HB ' HG22 ' A' ' 199' ' ' VAL . 15.2 t -117.22 160.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.459 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 207' ' ' VAL . 96.5 p -118.67 145.13 45.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.5 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -162.68 151.3 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.823 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.87 146.87 27.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.405 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' CH2' ' A' ' 158' ' ' TRP . 15.4 mt -58.8 -27.15 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 111.059 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -32.86 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.546 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -133.98 35.8 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.228 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -55.39 -50.41 69.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.154 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.49 88.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.77 -43.02 99.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.11 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.556 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 10.7 mmtt -51.94 -51.26 58.26 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.016 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -83.16 -16.56 46.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.958 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.9 t -62.48 -34.91 77.77 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.478 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.556 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 0.9 OUTLIER -81.5 8.12 10.3 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.89 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -101.99 99.31 11.92 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.29 -28.16 40.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.192 1.928 . . . . 0.0 112.175 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -66.64 -49.06 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.028 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.909 HG23 ' HB3' ' A' ' 181' ' ' ALA . 32.2 mt -65.76 -53.41 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -54.13 -29.83 46.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.514 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.48 -29.21 15.63 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.682 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.442 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.87 -28.06 14.8 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.717 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.9 mt -78.05 -31.06 50.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.31 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.535 ' O ' HG23 ' A' ' 232' ' ' VAL . 0.6 OUTLIER -67.0 -31.97 72.88 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 8.6 mtt85 -62.71 -33.5 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -113.93 84.68 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.536 ' O ' HG12 ' A' ' 232' ' ' VAL . 15.4 t -101.28 36.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.5 tttm . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.862 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.58 -77.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.712 0.291 . . . . 0.0 111.027 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -97.69 -177.36 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.82 ' HB2' HD13 ' A' ' 134' ' ' LEU . 32.2 m95 -129.05 153.8 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.55 128.81 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.54 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -69.51 126.74 30.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.035 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.023 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.68 -0.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.784 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.738 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.44 176.78 10.13 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.736 0.303 . . . . 0.0 110.984 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.437 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.5 m-85 -138.88 173.34 11.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 139' ' ' LEU . 18.9 t -133.71 119.43 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.91 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.15 110.95 16.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.191 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 13.4 t70 -162.09 137.73 7.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 59.16 42.93 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 53.96 26.87 6.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.599 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 145' ' ' THR . 92.2 m -143.49 141.95 30.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.97 0.414 . . . . 0.0 111.007 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.5 m-85 -91.63 110.0 21.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.37 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.712 ' HB2' HD21 ' A' ' 139' ' ' LEU . 12.0 m-30 -81.07 122.69 81.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.879 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.25 123.81 13.9 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.172 1.914 . . . . 0.0 112.684 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.925 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.73 125.19 50.7 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.914 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.9 mt -83.6 165.76 18.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.321 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.514 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.0 pt-20 -55.84 -30.21 61.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -90.87 14.87 12.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.411 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.28 4.15 83.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.33 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.587 ' HB3' HD12 ' A' ' 134' ' ' LEU . 19.6 tpp85 -61.21 97.6 0.07 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.333 0.566 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.712 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -83.79 117.39 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.068 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.91 97.65 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.8 mttp -69.96 -29.68 66.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.792 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -71.28 -22.61 61.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -101.8 24.53 9.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.505 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.07 162.2 52.52 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.439 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -128.35 156.49 43.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.849 0.357 . . . . 0.0 110.807 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 25.86 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.171 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.421 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.4 OUTLIER -142.93 139.43 30.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.605 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 117.99 53.95 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.3 105.96 2.14 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.114 1.876 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.8 t -67.41 -12.84 61.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.204 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.57 -27.3 51.39 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.39 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.12 164.01 38.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.9 Cg_endo -77.17 172.94 15.19 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.934 1.756 . . . . 0.0 112.445 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.6 t -129.57 154.88 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.067 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.567 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.0 mt -113.31 97.9 6.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.424 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.9 t -82.72 134.93 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.473 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.65 86.89 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.803 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.506 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -148.32 113.93 5.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 111.512 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -26.77 12.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.486 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.28 96.07 8.14 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.893 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.49 -20.95 47.64 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.026 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -40.7 98.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.49 69.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.497 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.925 HG23 HD11 ' A' ' 133' ' ' LEU . 50.0 mt -62.72 -52.37 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.48 47.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.238 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 7.0 mm-40 -68.73 -52.1 34.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.21 -52.83 64.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.023 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.99 -33.53 69.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.246 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.44 -42.63 97.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.306 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -64.68 -36.9 85.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.924 0.392 . . . . 0.0 110.107 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.628 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.1 mp -67.81 -27.74 66.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.072 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.65 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.583 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.59 -40.31 6.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.74 0.305 . . . . 0.0 111.726 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.781 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -71.38 156.97 90.94 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.66 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -51.42 124.38 14.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.624 2.216 . . . . 0.0 112.648 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.75 -35.65 32.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.852 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.692 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 110.259 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 224' ' ' ILE . 57.9 t -58.45 -55.58 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.768 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.781 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -68.45 -12.61 61.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.826 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 -12.69 58.42 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.575 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -93.63 78.05 4.31 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.093 0.447 . . . . 0.0 111.205 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.97 176.95 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 p -113.05 -46.22 3.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.88 0.372 . . . . 0.0 110.8 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -167.88 152.43 6.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.882 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -104.74 135.33 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.267 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.423 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 1.6 m80 -107.8 121.91 45.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -75.64 101.82 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -123.42 74.36 51.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.61 160.62 47.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.376 2.051 . . . . 0.0 112.564 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -139.09 163.44 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.985 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -53.96 -26.75 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.42 -18.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -134.09 79.38 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.952 0.406 . . . . 0.0 111.115 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.27 -21.14 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.699 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -114.14 38.28 3.07 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.777 0.322 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 113.89 20.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.58 132.93 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.65 111.26 33.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.63 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.521 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.5 m -85.0 153.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.467 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -109.09 109.93 21.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.255 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 149.27 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.402 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 3.8 p-10 -60.64 -24.37 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -85.37 7.03 23.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.13 -16.32 61.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.915 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.83 173.03 1.12 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -135.02 119.13 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.521 ' HB ' HG22 ' A' ' 199' ' ' VAL . 16.3 t -115.33 159.54 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.662 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 207' ' ' VAL . 89.3 p -119.28 149.14 42.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -163.59 -179.57 6.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -127.92 151.18 49.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.386 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.506 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.7 mt -64.94 -25.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.949 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -31.13 62.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.399 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.56 36.13 3.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.13 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 15.7 t80 -56.13 -50.72 70.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.013 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.3 97.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.411 ' HA ' ' HB2' ' A' ' 219' ' ' SER . 5.4 t70 -63.92 -47.64 79.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.042 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 21.8 mmtm -51.83 -51.82 53.79 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.672 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 224' ' ' ILE . 3.4 mm? -80.37 -21.51 42.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SER . . . . . 0.411 ' HB2' ' HA ' ' A' ' 216' ' ' ASP . 3.2 m -64.29 -27.74 69.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.753 0.311 . . . . 0.0 110.757 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -85.66 17.1 3.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.061 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.24 103.63 55.0 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.68 -24.46 35.08 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.143 1.895 . . . . 0.0 112.418 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -71.02 -49.69 42.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' A' ' 178' ' ' VAL . 41.5 mt -63.44 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.7 53.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -50.64 -28.36 8.71 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.56 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.564 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -52.03 -27.33 13.29 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.294 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.692 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 1.8 mt -77.03 -32.6 57.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.55 ' O ' HG12 ' A' ' 232' ' ' VAL . 0.8 OUTLIER -81.48 -30.82 33.21 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.083 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -59.91 -37.53 79.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -107.72 92.82 4.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 229' ' ' ASP . 10.7 p -168.97 140.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 26.0 pttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.884 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.52 163.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -127.4 -176.04 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.811 ' HB2' HD13 ' A' ' 134' ' ' LEU . 60.8 m95 -69.73 150.67 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 0.0 110.617 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -96.12 130.14 43.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -71.48 126.33 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.983 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.42 0.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.947 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.727 ' HB2' HD23 ' A' ' 171' ' ' LEU . . . -163.29 176.79 9.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 152' ' ' ALA . 58.2 m-85 -138.83 173.27 11.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.323 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.655 HG11 HD11 ' A' ' 139' ' ' LEU . 21.8 t -134.08 118.18 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.996 0.426 . . . . 0.0 111.044 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.1 109.4 14.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.961 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -158.73 139.27 12.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 40.96 23.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 55.08 31.13 15.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.332 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 145' ' ' THR . 84.8 m -147.69 144.02 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.994 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.3 m-85 -93.44 110.46 22.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.708 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.5 m-30 -82.8 127.09 71.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 28.3 Cg_exo -62.18 125.76 17.11 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.329 2.019 . . . . 0.0 112.746 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 1.049 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.8 124.97 50.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.795 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.6 mt -85.29 165.44 17.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.408 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.7 pt-20 -55.22 -30.46 60.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.49 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -91.56 15.82 11.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 76.85 7.74 86.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.321 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.61 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.89 96.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.332 0.566 . . . . 0.0 110.408 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.708 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -83.6 123.1 29.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.825 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.4 mt -107.77 96.56 6.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.9 mttp -70.98 -26.79 63.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.009 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -79.9 -23.06 42.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.577 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -98.02 25.51 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.515 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.71 159.35 52.14 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.418 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -127.09 156.39 41.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 27.32 3.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 139.61 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.74 117.95 55.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 64.7 Cg_endo -76.12 105.95 2.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.065 1.843 . . . . 0.0 112.643 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.4 t -67.82 -12.32 60.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.263 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -27.39 53.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.714 0.293 . . . . 0.0 111.271 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.646 ' HB3' ' HE1' ' A' ' 123' ' ' TYR . . . -143.34 160.66 50.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.859 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.9 Cg_endo -72.73 172.72 14.69 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.029 1.819 . . . . 0.0 112.678 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 123' ' ' TYR . 78.8 t -128.74 154.87 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.923 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.614 HD12 ' CD1' ' A' ' 133' ' ' LEU . 45.6 mt -113.62 97.72 6.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.546 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 60.5 t -83.6 132.52 31.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.622 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.8 82.77 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.874 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.543 ' CZ2' HD22 ' A' ' 155' ' ' LEU . 57.9 m95 -144.55 99.38 3.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.586 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -25.21 21.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -98.35 97.62 8.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.894 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.85 -20.88 50.05 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.969 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -40.22 96.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.45 70.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.488 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.049 HG23 HD11 ' A' ' 133' ' ' LEU . 47.1 mt -61.89 -51.72 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.403 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -56.28 -29.17 60.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.8 mm-40 -71.04 -50.01 38.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.103 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.501 ' HE2' HD21 ' A' ' 155' ' ' LEU . 1.2 mmm -57.65 -52.54 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.791 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.983 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -60.06 -33.53 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.172 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.24 94.16 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.501 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.74 -39.56 91.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.0 0.429 . . . . 0.0 109.982 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 122' ' ' ALA . 3.5 mp -66.83 -28.41 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.52 -19.89 60.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.734 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.77 -40.55 7.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 111.473 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.2 pp -72.25 156.28 90.71 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.579 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.674 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.0 Cg_exo -51.41 125.56 16.93 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.531 2.154 . . . . 0.0 112.429 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.1 53.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.823 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.715 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -61.49 -40.86 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.446 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.789 ' HA ' HG22 ' A' ' 224' ' ' ILE . 44.5 t -59.05 -60.05 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.729 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -62.61 -23.29 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.551 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -72.79 -24.82 75.38 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.782 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.792 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -82.36 78.06 9.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.775 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 177.16 153.33 0.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.465 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.05 -53.87 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.095 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.67 151.06 25.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.477 HG12 HG12 ' A' ' 199' ' ' VAL . 4.5 mt -106.27 134.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.397 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.3 m170 -106.38 127.47 53.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.24 112.55 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -135.0 78.04 54.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 163.22 32.96 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.351 2.034 . . . . 0.0 112.652 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -144.58 167.92 21.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -57.91 -24.15 56.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.22 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.69 -16.57 15.98 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -144.13 83.06 1.73 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -60.05 -20.5 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.626 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.29 34.32 4.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.71 0.291 . . . . 0.0 111.141 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.69 112.05 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.783 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.7 m -115.4 136.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.243 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.0 mm -106.91 109.75 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -86.45 155.63 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.743 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.04 105.79 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.982 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.55 149.11 6.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.918 0.389 . . . . 0.0 111.636 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -64.49 -23.44 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.918 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -77.58 -13.01 60.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.34 20.39 9.17 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.4 172.63 6.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -126.37 117.11 22.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 208' ' ' SER . 13.4 t -118.8 160.11 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 207' ' ' VAL . 59.7 p -121.47 146.75 46.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.36 -177.69 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.699 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -126.82 154.38 44.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.434 HD11 ' CH2' ' A' ' 158' ' ' TRP . 4.6 mt -69.31 -25.02 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.776 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -80.96 -28.64 35.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.286 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -132.28 35.5 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 171' ' ' LEU . 48.7 t80 -60.43 -50.51 73.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.98 -36.84 82.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.278 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -68.25 -45.68 72.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.1 mmpt? -53.77 -53.18 55.87 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.46 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.574 HD12 HD13 ' A' ' 224' ' ' ILE . 3.5 mm? -75.96 -24.95 55.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.818 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.4 m -61.12 -30.46 70.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.878 0.371 . . . . 0.0 110.407 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.66 5.57 12.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.046 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.77 101.72 34.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.56 -24.25 42.19 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.142 1.895 . . . . 0.0 112.326 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -71.1 -48.73 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.792 HG23 ' HB3' ' A' ' 181' ' ' ALA . 36.2 mt -64.86 -53.67 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -53.7 -29.32 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.636 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -52.53 -29.19 23.99 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.562 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.55 -27.65 11.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.115 0.483 . . . . 0.0 110.502 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.715 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 6.0 mt -77.86 -32.81 52.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.158 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.553 ' O ' HG22 ' A' ' 232' ' ' VAL . 1.3 m-20 -81.67 -30.54 32.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.875 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -24.22 67.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.404 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -55.08 -51.02 67.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.687 0.28 . . . . 0.0 111.425 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 229' ' ' ASP . 6.9 m -64.54 128.37 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.897 0.38 . . . . 0.0 111.098 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.968 -179.909 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 m -134.25 -48.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.38 -177.7 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.79 ' HB2' HD13 ' A' ' 134' ' ' LEU . 68.7 m95 -72.23 155.11 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -97.17 132.45 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.476 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -71.98 126.56 30.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.102 0.477 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.017 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.21 1.42 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.886 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.677 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.77 176.64 8.6 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.413 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.6 m-85 -139.88 173.0 11.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.443 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 139' ' ' LEU . 25.2 t -132.96 119.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.12 111.67 16.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.109 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 24.3 t0 -158.35 136.29 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.22 43.72 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.004 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 54.85 28.88 11.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.418 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 86.3 m -144.29 144.08 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.071 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.4 m-85 -94.61 110.4 22.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 111.04 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.717 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.1 m-30 -82.72 125.23 76.19 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.438 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.2 Cg_exo -59.66 126.96 22.0 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.348 2.032 . . . . 0.0 112.853 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.924 HD11 HG23 ' A' ' 164' ' ' ILE . 0.8 OUTLIER -109.47 124.82 51.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.703 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.9 mt -85.51 166.5 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.459 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.446 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.0 pt-20 -55.65 -30.68 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.651 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -91.08 15.34 11.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.477 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.404 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.45 3.88 83.46 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.326 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.603 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -60.76 97.93 0.06 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.264 0.532 . . . . 0.0 110.548 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.717 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.39 129.98 34.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.052 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.515 ' N ' HD23 ' A' ' 139' ' ' LEU . 24.5 mt -110.67 94.41 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.652 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 44.2 mttt -71.61 -28.95 64.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -80.12 -21.45 43.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.578 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.431 ' HG3' HD13 ' A' ' 140' ' ' LEU . 2.7 mm-40 -99.56 25.79 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.33 159.0 52.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.53 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -127.48 156.65 41.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.663 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.56 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.416 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -145.04 141.36 28.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.61 119.1 73.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.29 107.09 2.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.108 1.872 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.2 t -66.78 -13.34 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.286 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.52 -27.16 41.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.61 0.243 . . . . 0.0 111.512 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.82 162.81 48.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.925 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.4 Cg_endo -77.31 173.16 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.996 1.797 . . . . 0.0 112.627 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 130' ' ' PHE . 76.7 t -129.43 154.55 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.076 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.571 HD12 ' CD1' ' A' ' 133' ' ' LEU . 51.5 mt -114.17 97.77 6.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 0.0 110.561 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.8 t -82.41 134.84 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.84 87.04 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.878 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.502 ' CH2' HD11 ' A' ' 211' ' ' ILE . 67.4 m95 -146.97 116.62 7.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 111.545 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -106.68 -27.43 10.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.344 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.74 95.19 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.893 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.38 -20.91 46.56 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.03 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -40.64 97.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.13 -34.28 70.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.505 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.924 HG23 HD11 ' A' ' 133' ' ' LEU . 62.0 mt -62.13 -51.63 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.662 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.62 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.8 mm-40 -66.99 -50.46 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.64 -52.48 65.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.741 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.73 68.7 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.847 0.355 . . . . 0.0 110.268 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.98 98.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.366 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -66.84 -35.1 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.193 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.609 ' HB3' HD22 ' A' ' 179' ' ' LEU . 6.5 mp -70.59 -28.97 65.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.059 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.84 -18.13 62.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.68 -40.98 6.38 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -71.11 157.41 90.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.695 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.7 Cg_exo -51.21 123.88 12.88 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.629 2.219 . . . . 0.0 112.54 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.74 -36.31 35.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.988 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.681 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -64.05 -42.51 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.258 0.551 . . . . 0.0 110.309 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.782 ' HA ' HG22 ' A' ' 224' ' ' ILE . 78.5 t -58.78 -56.12 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.773 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -67.86 -13.64 62.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.766 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.88 -14.29 59.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.585 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.639 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.53 78.61 3.82 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 111.609 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.98 153.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.556 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.51 -49.64 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -167.55 156.82 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 153' ' ' PRO . 4.8 mt -104.79 135.48 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.406 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.427 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 13.1 m170 -106.14 127.78 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -80.12 111.63 16.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -133.62 73.55 72.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.854 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.19 160.02 51.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.285 1.99 . . . . 0.0 112.594 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.6 p -140.48 162.1 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -54.74 -25.86 30.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.368 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -102.43 -20.47 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -135.41 77.34 1.67 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.927 0.394 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -55.83 -22.21 23.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.767 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -113.05 39.51 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.314 . . . . 0.0 111.307 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.58 116.09 24.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.8 m -121.49 137.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.08 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 207' ' ' VAL . 19.1 mm -106.62 110.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.44 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.4 m -84.62 153.32 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.639 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.427 ' CE1' ' CD2' ' A' ' 186' ' ' HIS . 6.3 m-85 -111.42 107.37 16.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.449 ' SD ' HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -55.78 149.25 14.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.99 -24.05 66.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.882 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.3 m-20 -75.84 -13.28 60.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.21 20.3 9.31 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.787 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 51.7 m-85 -104.87 174.06 6.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -127.88 123.95 36.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.044 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 208' ' ' SER . 20.3 t -124.37 159.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 207' ' ' VAL . 79.4 p -118.92 144.91 46.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.99 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -163.09 149.68 12.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.68 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.25 147.15 24.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.582 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.502 HD11 ' CH2' ' A' ' 158' ' ' TRP . 14.4 mt -58.5 -27.48 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -32.87 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -130.16 35.8 4.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.074 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.8 -51.82 68.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.91 87.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.75 -42.67 99.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.0 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.415 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.3 mmpt? -52.31 -53.42 44.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.587 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -80.49 -21.22 42.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.973 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.8 t -60.03 -33.85 72.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.007 0.432 . . . . 0.0 110.447 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.75 3.87 15.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.128 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.36 99.87 14.1 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.25 -26.36 42.01 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.09 1.86 . . . . 0.0 112.126 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.538 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -67.17 -51.38 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.782 HG22 ' HA ' ' A' ' 178' ' ' VAL . 29.9 mt -64.2 -53.05 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -54.36 -29.26 47.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.596 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.69 -28.55 15.15 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.558 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.93 -27.48 13.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.103 0.477 . . . . 0.0 110.401 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.681 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.8 mt -77.14 -32.53 56.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.137 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.22 -57.51 8.31 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 56.82 26.42 11.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -144.78 -55.21 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.25 143.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 tptt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.915 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -71.31 -38.89 71.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.77 0.319 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 60.79 -178.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.846 ' HB2' HD13 ' A' ' 134' ' ' LEU . 44.0 m95 -94.48 148.57 22.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -99.72 132.84 44.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -72.06 127.81 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.016 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.9 0.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.949 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.707 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.6 176.75 10.06 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.094 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.483 ' HB2' HG22 ' A' ' 154' ' ' VAL . 28.4 m-85 -138.39 173.21 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.696 HG21 ' HG ' ' A' ' 139' ' ' LEU . 15.1 t -133.93 117.55 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.967 0.413 . . . . 0.0 111.101 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.477 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.59 114.42 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.277 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.449 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.4 t70 -169.09 142.01 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.771 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 59.34 41.14 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.497 . . . . 0.0 110.738 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.15 29.65 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.441 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 145' ' ' THR . 46.8 m -148.3 145.09 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.434 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.3 m-85 -95.52 110.53 22.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.701 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.715 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.9 m-85 -80.84 129.1 69.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.108 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 22.3 Cg_exo -64.73 123.92 12.4 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.167 1.911 . . . . 0.0 112.31 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.911 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -105.57 125.09 50.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.09 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.846 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.3 mt -84.11 167.09 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.197 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.4 pt-20 -55.75 -31.12 62.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.451 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.0 p30 -90.85 14.39 13.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.48 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 78.39 7.68 87.82 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.021 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.592 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.1 95.93 0.04 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.209 0.504 . . . . 0.0 110.27 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.715 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.2 118.62 23.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.017 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.4 mt -103.98 97.34 7.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.565 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 17.8 mttt -71.16 -25.67 62.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -80.71 -21.1 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.856 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -100.14 26.61 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.71 159.91 52.54 Favored Glycine 0 CA--C 1.506 -0.483 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.722 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.671 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -125.91 156.96 38.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.633 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 29.34 2.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.044 0.449 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.4 143.65 26.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.525 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.7 118.05 67.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.63 109.24 2.72 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.141 1.894 . . . . 0.0 112.54 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.4 t -67.39 -13.11 61.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.28 -27.26 53.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.43 162.56 46.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.868 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 68.0 Cg_endo -76.56 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.023 1.815 . . . . 0.0 112.682 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 123' ' ' TYR . 62.3 t -130.74 154.25 40.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.7 mt -113.61 97.57 6.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 0.0 110.587 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.5 t -82.26 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.474 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.89 89.42 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.611 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.0 m95 -147.36 97.48 2.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.721 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -93.61 7.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -131.27 93.02 3.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.427 0.156 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.877 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.86 -21.2 43.65 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.23 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -39.73 95.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.57 -33.56 62.7 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.788 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.911 HG23 HD11 ' A' ' 133' ' ' LEU . 62.6 mt -61.46 -52.05 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.919 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.93 -30.81 62.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.142 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.5 -51.52 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.188 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.31 -52.15 66.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.756 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.016 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.45 -33.63 69.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.872 0.367 . . . . 0.0 110.244 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.43 -41.82 97.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.38 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -66.15 -38.34 87.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.781 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.2 mp -66.34 -27.56 67.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.343 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.5 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.626 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -101.45 -41.06 6.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.645 0.259 . . . . 0.0 111.49 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.42 157.39 90.09 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.627 ' HB2' HG23 ' A' ' 178' ' ' VAL . 52.2 Cg_exo -50.13 129.26 24.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.529 2.153 . . . . 0.0 112.841 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.12 67.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.455 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.664 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.93 -37.1 86.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 110.399 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.706 ' HA ' HG22 ' A' ' 224' ' ' ILE . 55.6 t -61.82 -60.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.838 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -62.8 -23.89 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.451 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.96 -23.86 75.32 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.771 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -89.51 78.44 7.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.863 0.364 . . . . 0.0 110.688 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.62 131.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -59.27 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.26 155.43 32.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.415 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.6 m170 -107.31 118.85 37.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.24 115.0 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -138.7 77.47 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -69.14 162.08 43.23 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.0 p -139.27 161.43 37.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.05 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -25.5 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -103.34 -19.96 14.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.331 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -135.17 81.02 1.87 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -57.09 -21.24 30.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.617 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ASP . . . . . 0.422 ' OD2' HD12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -113.04 38.49 2.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.283 . . . . 0.0 111.044 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -85.2 115.73 23.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 209' ' ' ALA . 32.2 m -119.76 135.97 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.113 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 208' ' ' SER . 20.4 mm -105.33 111.38 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.52 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.84 155.38 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 111.694 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -114.45 99.78 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.956 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.501 ' HE3' HG21 ' A' ' 207' ' ' VAL . 7.5 tpp -54.18 149.33 9.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.489 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.82 -20.32 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.008 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 5.8 m-20 -76.02 -13.71 60.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.5 20.18 10.49 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.74 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 28.1 m-85 -111.52 155.93 22.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -109.3 118.77 37.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.501 HG21 ' HE3' ' A' ' 201' ' ' MET . 15.7 t -116.24 159.52 16.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 110.643 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 198' ' ' ILE . 51.4 p -121.64 143.68 49.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.791 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -162.67 150.15 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.43 146.57 24.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.523 HD11 ' CH2' ' A' ' 158' ' ' TRP . 17.9 mt -59.03 -28.15 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.097 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -31.58 69.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.586 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.23 36.11 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.139 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -55.46 -50.77 69.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.481 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.61 -48.27 82.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.976 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -63.07 -38.95 93.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.961 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -55.66 -53.48 56.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.965 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.515 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.6 mm? -78.61 -22.7 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.711 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.8 t -60.49 -34.1 73.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -72.08 -5.47 35.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.855 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.68 100.4 6.18 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.595 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 37.7 Cg_endo -66.4 -27.83 46.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.145 1.897 . . . . 0.0 112.105 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.27 80.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.706 HG22 ' HA ' ' A' ' 178' ' ' VAL . 24.8 mt -72.28 -54.93 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.61 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.198 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.78 -27.97 13.89 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.431 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.574 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.26 -27.91 10.44 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.376 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.664 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.9 mt -78.62 -32.77 47.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.221 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 20.45 18.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -127.39 -75.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 110.975 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -129.73 106.59 8.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.581 ' O ' HG12 ' A' ' 232' ' ' VAL . 15.8 t -101.57 31.23 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.007 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.864 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.2 m -69.33 112.89 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -146.63 -175.99 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.829 ' HB2' HD13 ' A' ' 134' ' ' LEU . 56.5 m95 -74.38 151.06 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.794 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 130.33 45.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.782 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -70.6 127.73 33.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.251 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.995 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.09 3.18 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.708 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.798 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.44 176.47 9.01 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.645 0.259 . . . . 0.0 110.894 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.457 ' HB2' HG22 ' A' ' 154' ' ' VAL . 18.9 m-85 -140.12 173.59 11.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.095 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.65 HG21 ' HG ' ' A' ' 139' ' ' LEU . 21.6 t -133.55 117.46 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.511 ' HD2' HG22 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -80.44 107.35 13.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.832 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.434 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.6 t0 -164.42 144.17 7.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.725 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.98 40.63 18.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.792 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.16 28.36 8.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 145' ' ' THR . 40.4 m -148.78 146.21 27.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.6 109.03 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.5 m-85 -81.15 129.95 64.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 19.5 Cg_exo -66.13 124.5 12.68 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.137 1.891 . . . . 0.0 112.287 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.922 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.84 124.77 50.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.861 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.5 mt -83.94 166.63 17.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.1 pt-20 -55.85 -30.35 61.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.41 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.52 15.77 11.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.497 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 75.5 9.64 84.6 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.123 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.609 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.96 96.39 0.07 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.244 0.522 . . . . 0.0 110.11 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.59 119.52 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.079 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.7 mt -105.02 97.63 7.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.439 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 40.8 mttt -72.03 -21.92 61.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -84.37 -21.68 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -100.76 29.2 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.498 0.189 . . . . 0.0 111.414 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.53 161.42 54.15 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -125.21 160.66 28.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.36 30.51 4.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.406 HG23 ' OG1' ' A' ' 145' ' ' THR . 0.0 OUTLIER -154.55 133.1 12.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.681 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.95 118.31 37.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.8 Cg_endo -73.1 111.78 3.36 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.985 1.79 . . . . 0.0 112.477 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -66.61 -13.9 61.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.32 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.24 -26.66 42.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.591 0.234 . . . . 0.0 111.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.86 159.25 47.49 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.2 Cg_endo -71.87 174.19 11.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.235 1.957 . . . . 0.0 112.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 123' ' ' TYR . 68.6 t -129.0 153.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.836 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.6 mt -112.87 98.58 7.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.565 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.511 HG22 ' HD2' ' A' ' 125' ' ' TYR . 59.5 t -82.81 135.32 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.475 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.63 86.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.6 m95 -148.11 115.73 6.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 111.468 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -106.26 -27.29 11.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.442 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -96.53 95.78 8.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.89 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.41 -20.96 47.01 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.084 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -40.3 96.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.46 68.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.659 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.922 ' CG2' HD11 ' A' ' 133' ' ' LEU . 58.1 mt -62.91 -52.34 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.625 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.38 57.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -68.94 -51.2 42.22 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.177 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.67 -52.54 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.995 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.02 -33.71 69.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.286 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.91 97.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.311 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.33 -37.7 87.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.388 . . . . 0.0 110.115 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.654 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.4 mp -67.75 -27.62 66.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.246 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.73 -19.27 60.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.534 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.04 -40.7 7.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.638 0.256 . . . . 0.0 111.573 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.68 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -72.18 157.58 89.07 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.518 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.646 ' O ' HD12 ' A' ' 174' ' ' LEU . 56.8 Cg_exo -50.27 124.45 13.01 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.594 2.196 . . . . 0.0 112.681 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.85 53.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.79 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.692 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -64.9 -40.06 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.0 110.3 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 224' ' ' ILE . 47.1 t -59.79 -60.21 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.907 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.68 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -62.79 -24.21 67.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.512 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.99 -21.91 77.64 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.145 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -88.66 78.53 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.069 0.461 . . . . 0.0 110.718 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.03 138.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.502 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.6 t -75.82 -57.27 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.044 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.2 153.9 28.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.073 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.18 136.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.398 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 19.3 m170 -108.53 125.54 51.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.768 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -77.58 108.88 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.982 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -129.42 77.96 76.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 67.9 Cg_endo -75.04 163.72 34.7 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.264 1.976 . . . . 0.0 112.827 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.4 p -142.4 164.11 31.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.828 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -54.49 -26.94 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.55 -19.17 14.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -135.87 77.46 1.66 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.13 -21.6 47.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.605 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -111.62 36.16 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.672 0.272 . . . . 0.0 111.337 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.726 ' NH1' HG23 ' A' ' 210' ' ' THR . 0.0 OUTLIER -85.56 114.43 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 209' ' ' ALA . 34.6 m -117.83 138.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -109.12 111.63 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.533 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -84.84 154.72 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -113.59 105.79 13.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.26 149.05 7.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.987 0.422 . . . . 0.0 111.57 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -66.95 -22.93 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.835 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.39 20.51 9.03 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.27 174.24 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -129.77 119.84 24.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 208' ' ' SER . 21.0 t -121.95 159.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 207' ' ' VAL . 94.4 p -119.59 147.34 44.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.02 150.45 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.7 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.726 HG23 ' NH1' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -101.06 147.59 26.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.432 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.0 mt -57.97 -27.23 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.641 0.258 . . . . 0.0 111.161 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -30.44 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.469 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.17 35.88 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.34 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.7 -49.62 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.88 -47.19 87.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.47 -42.42 99.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.054 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.411 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -52.05 -53.51 41.18 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.267 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.5 mm? -80.59 -21.69 41.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.918 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.2 t -59.82 -32.99 71.17 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.999 0.428 . . . . 0.0 110.35 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.81 5.26 14.07 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.037 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.4 100.35 18.15 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.5 -27.29 39.6 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.132 1.888 . . . . 0.0 112.189 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -66.47 -52.28 47.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.049 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.785 HG22 ' HA ' ' A' ' 178' ' ' VAL . 32.9 mt -63.5 -51.99 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.39 -29.84 50.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.491 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.46 -28.31 12.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.721 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.543 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.99 -28.75 17.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.252 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.692 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 5.0 mt -76.33 -32.11 58.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.083 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -26.18 68.57 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.199 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -97.09 28.61 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.346 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -106.32 -44.38 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.36 116.12 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.38 161.55 34.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.795 0.331 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.68 -179.59 7.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.04 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.792 ' HB2' HD13 ' A' ' 134' ' ' LEU . 66.8 m95 -69.76 155.09 41.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -99.89 130.53 46.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.572 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -68.62 127.41 32.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.07 0.462 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.015 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.94 0.29 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.834 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.661 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.46 176.78 9.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.488 ' HB2' HG22 ' A' ' 154' ' ' VAL . 33.9 m-85 -138.75 173.46 11.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.334 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.656 HG21 ' HG ' ' A' ' 139' ' ' LEU . 15.0 t -133.27 117.48 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.967 0.413 . . . . 0.0 111.025 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.52 110.7 16.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.148 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.441 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 15.9 t70 -169.15 144.23 3.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.53 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.001 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 53.86 28.65 8.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.679 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 145' ' ' THR . 88.6 m -149.58 141.86 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 14.1 m-85 -89.71 109.84 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.052 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.732 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.3 m-85 -80.99 123.93 81.72 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.967 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.43 124.24 14.72 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.206 1.937 . . . . 0.0 112.524 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.915 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.82 125.29 50.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.013 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.7 mt -84.14 166.7 17.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.179 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.7 pt-20 -56.28 -30.26 62.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.291 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -91.38 15.8 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.303 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 76.26 8.18 85.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.143 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.609 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.29 96.18 0.05 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.209 0.504 . . . . 0.0 110.243 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.59 112.88 21.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.853 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.18 98.21 7.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.595 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.4 mttp -69.0 -27.5 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.45 -22.39 60.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.603 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -101.13 23.77 10.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.619 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.17 164.24 52.58 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.733 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 129' ' ' THR . 4.0 t -130.26 158.82 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.953 0.406 . . . . 0.0 110.631 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.46 22.56 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.125 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.463 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -140.28 143.87 36.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 110.679 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.36 118.53 72.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.43 108.93 2.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.05 1.833 . . . . 0.0 112.608 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -67.07 -13.52 62.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.274 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.33 -27.54 52.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.667 0.27 . . . . 0.0 111.402 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.61 164.6 38.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.654 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 72.7 Cg_endo -78.73 172.72 14.65 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.893 1.729 . . . . 0.0 112.521 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 123' ' ' TYR . 60.1 t -129.37 153.57 38.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.939 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.611 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.4 mt -113.54 97.58 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.06 0.457 . . . . 0.0 110.569 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.2 t -83.44 134.6 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.2 85.78 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.724 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.505 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.64 110.28 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 111.536 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -101.22 -27.8 13.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.35 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.8 94.08 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.054 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.897 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.03 -21.0 44.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.154 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -39.9 95.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.25 -33.83 67.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.577 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.915 ' CG2' HD11 ' A' ' 133' ' ' LEU . 63.4 mt -62.03 -52.24 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.646 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.08 58.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.178 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 12.1 mm-40 -68.8 -50.42 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.94 -52.22 66.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.015 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.48 -33.7 68.27 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.946 0.403 . . . . 0.0 110.235 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.99 97.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.32 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.024 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.533 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.4 mp -69.23 -28.58 66.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.56 -18.43 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.547 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -102.62 -40.47 6.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 179' ' ' LEU . 1.9 pp -70.84 157.14 90.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.744 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.659 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.4 Cg_exo -51.3 124.09 13.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.575 2.183 . . . . 0.0 112.631 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.73 26.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.833 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.691 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.59 -43.35 89.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.14 0.495 . . . . 0.0 110.335 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 53.8 t -58.53 -55.9 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.757 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -67.69 -13.55 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.55 -14.54 59.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.519 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -93.62 78.37 4.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.965 0.383 . . . . 0.0 111.54 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.55 155.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.388 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 p -89.32 -48.6 7.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.57 156.1 9.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -105.88 134.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.151 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.456 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.2 m170 -109.12 118.52 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -69.07 110.0 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.424 ' HD3' HG12 ' A' ' 198' ' ' ILE . 1.0 OUTLIER -132.57 74.13 75.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.884 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.2 161.78 29.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.267 1.978 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -137.16 162.71 32.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -54.2 -26.37 27.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.369 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -104.41 -18.3 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.572 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.3 87.13 2.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -59.63 -19.56 49.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -115.52 36.05 4.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.741 0.305 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -78.94 108.33 12.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.706 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.9 133.06 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.424 HG12 ' HD3' ' A' ' 188' ' ' LYS . 30.9 mm -106.14 111.55 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.537 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.524 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -87.05 158.32 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.696 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.09 107.12 14.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.174 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.17 149.37 16.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.395 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -65.88 -21.92 66.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -77.07 -13.19 59.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.33 20.3 9.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.721 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -106.43 174.94 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.699 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.64 117.71 21.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 199' ' ' VAL . 12.1 t -113.42 160.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 207' ' ' VAL . 80.3 p -121.14 145.14 48.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.073 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.1 -178.71 7.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -128.73 154.66 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.369 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.505 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.9 mt -69.0 -22.34 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.975 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -32.05 47.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 111.321 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -134.21 35.77 3.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.963 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.2 t80 -56.8 -48.09 78.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -59.47 -48.07 83.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -62.78 -39.21 93.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.319 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.406 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 13.0 mmtt -56.93 -53.31 59.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.49 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.3 mm? -81.42 -21.35 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.19 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -64.11 -33.61 76.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.601 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -73.61 -2.74 24.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.385 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.36 110.22 43.27 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 122.263 -0.273 . . . . 0.0 110.848 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.28 -31.8 34.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.325 2.017 . . . . 0.0 112.38 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -70.55 -45.99 64.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.321 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 178' ' ' VAL . 35.9 mt -64.76 -55.32 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.158 0.504 . . . . 0.0 109.708 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.67 -29.16 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.319 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.33 -29.13 14.16 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.752 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.626 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.68 -27.5 11.85 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.691 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.2 mt -77.2 -33.11 56.34 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.014 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.74 19.14 14.16 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.653 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -53.86 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 111.033 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -143.28 96.87 2.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.65 139.94 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.882 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.95 69.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 0.0 110.859 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -129.72 177.43 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.808 ' HB2' HD13 ' A' ' 134' ' ' LEU . 54.3 m95 -70.47 152.0 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.962 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.59 134.62 38.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -76.78 126.71 31.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.712 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.0 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.62 0.72 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.995 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.69 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.96 176.89 9.7 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.624 ' HE1' ' HB3' ' A' ' 152' ' ' ALA . 55.6 m-85 -138.49 173.29 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.31 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.678 HG21 ' HG ' ' A' ' 139' ' ' LEU . 20.0 t -134.2 116.61 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 0.0 110.953 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.467 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.39 113.76 18.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.442 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.0 t70 -168.96 144.19 3.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.796 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.65 40.07 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 54.81 31.77 16.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.473 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 53.6 m -151.47 144.44 24.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 5.0 m-85 -93.55 110.12 21.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.3 m-85 -81.15 129.81 65.44 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.119 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.4 Cg_exo -65.09 124.91 13.71 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.189 1.926 . . . . 0.0 112.277 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.985 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.86 124.78 50.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.798 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.2 mt -84.95 165.63 17.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.373 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.2 pt-20 -55.31 -30.74 60.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.697 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -90.92 15.11 12.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.314 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 77.51 4.05 83.94 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.257 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.609 ' HB3' HD12 ' A' ' 134' ' ' LEU . 20.6 tpp180 -61.07 98.26 0.07 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.347 0.573 . . . . 0.0 110.476 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.3 126.97 31.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.079 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.497 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.9 mm? -106.53 94.24 5.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 12.5 mttp -70.97 -26.98 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.95 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -84.24 -20.75 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.795 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.09 24.58 6.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.527 0.204 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.31 160.43 53.17 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.825 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -126.72 157.21 39.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.599 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 27.72 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.29 140.5 25.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.483 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 117.65 53.29 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.439 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 65.0 Cg_endo -76.21 106.68 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.148 1.898 . . . . 0.0 112.75 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -67.99 -12.26 60.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.241 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.98 -27.22 54.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.759 0.314 . . . . 0.0 111.328 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.624 ' HB3' ' HE1' ' A' ' 123' ' ' TYR . . . -144.06 160.2 50.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.901 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.509 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.5 Cg_endo -71.97 174.18 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.021 1.814 . . . . 0.0 112.722 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 123' ' ' TYR . 63.6 t -130.43 155.56 41.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.944 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.3 mt -115.06 97.72 6.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.431 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.9 134.32 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.387 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.761 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.533 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.4 m95 -147.64 110.43 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 111.631 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -25.24 14.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.86 95.46 7.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.206 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.907 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.52 -20.85 47.42 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.057 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.39 -41.11 98.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.22 -34.82 73.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.441 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.985 HG23 HD11 ' A' ' 133' ' ' LEU . 54.5 mt -61.66 -51.68 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.585 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.409 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.33 -29.45 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.292 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.1 mm-40 -70.74 -50.64 33.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.381 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.453 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.97 -52.45 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.952 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.0 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.31 -33.64 67.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.41 98.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.25 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -65.41 -35.97 82.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.847 0.356 . . . . 0.0 110.344 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.662 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.0 mp -70.73 -27.88 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.89 -19.47 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.524 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.15 -40.69 7.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.481 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.81 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.7 157.2 89.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.375 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.658 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.0 Cg_exo -50.58 123.66 11.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.459 2.106 . . . . 0.0 112.51 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -33.91 39.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.638 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.687 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -66.47 -41.52 88.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.049 0.452 . . . . 0.0 110.404 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.675 ' HA ' HG22 ' A' ' 224' ' ' ILE . 53.6 t -59.53 -60.29 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.845 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.81 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.26 -24.32 66.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.64 -23.8 76.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.816 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -86.23 78.3 9.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 110.679 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.2 ptp 178.27 131.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 80.6 p -67.94 -55.4 12.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -161.48 155.64 22.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -104.54 136.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.436 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 25.1 m170 -107.19 122.19 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.87 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.544 ' HD1' HG12 ' A' ' 197' ' ' VAL . 9.2 t80 -75.0 109.77 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.811 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -129.37 72.37 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.03 154.77 57.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.439 2.092 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.4 p -140.89 166.9 23.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -26.27 60.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.291 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.75 -17.45 16.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.49 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.401 ' CB ' ' HB2' ' A' ' 196' ' ' ARG . 46.8 m-85 -143.89 76.78 1.53 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.951 0.405 . . . . 0.0 111.023 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.09 -19.77 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.74 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -113.87 37.09 3.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 111.146 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.401 ' HB2' ' CB ' ' A' ' 193' ' ' TYR . 6.4 ttt180 -87.53 116.94 25.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.025 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.544 HG12 ' HD1' ' A' ' 187' ' ' TYR . 28.1 m -120.59 133.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 208' ' ' SER . 23.4 mm -103.71 112.1 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.531 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -88.49 151.7 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.391 . . . . 0.0 111.517 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.58 103.78 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.99 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 13.2 tpp -56.25 149.38 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -67.17 -19.78 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.082 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -75.56 -13.51 60.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.05 20.21 10.02 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.772 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.76 167.84 10.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.736 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -119.14 120.7 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 208' ' ' SER . 22.7 t -118.91 159.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.618 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.577 ' HB3' HD12 ' A' ' 198' ' ' ILE . 6.9 p -118.53 148.77 42.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.911 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.2 150.78 9.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.48 147.55 25.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.526 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.533 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.6 mt -59.32 -25.88 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.187 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -29.48 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.2 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -133.96 35.51 3.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.73 -49.55 76.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.018 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.17 82.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.795 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -62.02 -41.23 97.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.11 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.436 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -52.88 -53.1 53.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.298 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.484 HD12 HD13 ' A' ' 224' ' ' ILE . 3.4 mm? -82.06 -20.8 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.151 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.0 t -61.59 -32.55 72.66 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.005 0.431 . . . . 0.0 110.445 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.84 3.4 14.46 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.502 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -103.1 100.39 17.19 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 38.6 Cg_endo -67.03 -26.63 43.13 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.121 1.881 . . . . 0.0 112.059 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -69.47 -41.58 76.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 178' ' ' VAL . 36.8 mt -71.62 -54.67 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -57.32 -29.06 63.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.159 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.22 -28.02 10.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.61 -28.04 13.01 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.293 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.687 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.9 mt -77.69 -32.38 52.99 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.184 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -26.95 39.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -28.82 55.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 111.458 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -62.95 -49.86 73.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 232' ' ' VAL . 11.9 m -95.49 82.05 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.1 ttpp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.861 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -55.86 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -176.33 -168.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.829 ' HB2' HD13 ' A' ' 134' ' ' LEU . 56.0 m95 -80.22 150.64 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.04 130.17 45.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HG2' HD23 ' A' ' 134' ' ' LEU . 52.1 mtt180 -69.75 127.67 33.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.61 1.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.77 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.678 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.66 176.7 9.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.714 0.292 . . . . 0.0 111.04 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.468 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.0 m-85 -139.72 173.77 11.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.629 HG21 ' CD1' ' A' ' 139' ' ' LEU . 16.6 t -133.59 117.17 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.42 15.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.291 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.435 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.8 t0 -169.28 145.17 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.52 40.9 23.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.97 29.92 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 145' ' ' THR . 89.7 m -151.47 142.52 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.425 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.5 m-85 -90.87 109.24 20.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.057 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.742 ' HB2' HD21 ' A' ' 139' ' ' LEU . 15.3 m-85 -79.05 122.74 84.8 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.45 122.11 10.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.13 1.887 . . . . 0.0 112.489 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.962 HD11 HG23 ' A' ' 164' ' ' ILE . 1.3 mt -103.87 125.03 50.0 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.791 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.2 mt -84.65 165.91 17.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.474 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HA ' HD12 ' A' ' 121' ' ' ILE . 4.8 pt-20 -55.72 -30.19 60.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.584 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.421 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.7 p-10 -90.61 14.68 12.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.396 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.27 3.82 82.75 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.583 -0.817 . . . . 0.0 113.254 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.578 ' HB3' HD12 ' A' ' 134' ' ' LEU . 16.1 tpp180 -60.6 97.36 0.05 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.276 0.56 . . . . 0.0 110.572 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.742 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -84.49 114.67 22.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.853 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.6 mt -105.07 97.69 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.717 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.2 mttt -69.76 -27.73 65.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -73.28 -23.26 60.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -101.48 25.36 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.547 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.02 163.0 54.08 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.512 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.28 156.12 42.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.661 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 28.43 3.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 138.33 24.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.72 118.36 47.44 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.407 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.5 Cg_endo -77.67 106.21 2.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.077 1.852 . . . . 0.0 112.794 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.0 t -68.0 -12.05 60.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -78.05 -27.26 48.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.59 160.14 48.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.951 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.0 Cg_endo -71.7 173.29 12.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.031 1.821 . . . . 0.0 112.763 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 123' ' ' TYR . 68.4 t -129.28 154.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.89 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.61 HD12 ' CD1' ' A' ' 133' ' ' LEU . 54.5 mt -112.94 98.33 7.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.128 0.49 . . . . 0.0 110.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.3 t -82.46 134.89 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.475 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.56 86.73 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.836 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.47 112.68 5.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.036 0.446 . . . . 0.0 111.446 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -26.84 12.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.409 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.68 95.82 8.19 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.914 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.49 -21.05 47.97 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.964 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.24 97.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.61 -34.18 69.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.524 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.962 HG23 HD11 ' A' ' 133' ' ' LEU . 40.3 mt -61.8 -52.05 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.498 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.97 -30.27 58.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 15.1 mm-40 -69.47 -50.78 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.338 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.459 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.34 -52.46 65.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.819 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.019 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.79 69.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 110.363 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.11 -40.29 96.95 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.197 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -66.64 -38.11 86.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.404 . . . . 0.0 110.273 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.732 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.9 mp -67.6 -28.13 67.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.363 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.24 -22.02 59.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.611 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -96.52 -40.75 8.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.283 . . . . 0.0 111.521 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.732 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -70.84 156.19 92.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.611 ' HB2' HG23 ' A' ' 178' ' ' VAL . 68.5 Cg_exo -49.31 129.86 23.49 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.651 2.234 . . . . 0.0 112.879 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.63 66.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.699 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.662 ' HB1' ' CB ' ' A' ' 227' ' ' ALA . . . -63.67 -37.48 87.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.49 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.756 ' HA ' HG22 ' A' ' 224' ' ' ILE . 52.1 t -60.86 -59.96 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.75 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.677 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -61.03 -23.82 65.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.384 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.59 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.27 -24.76 74.72 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.707 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.804 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -88.19 78.3 8.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.752 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 176.88 140.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.443 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -56.52 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.8 154.41 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 199' ' ' VAL . 4.5 mt -107.51 136.77 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.32 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.423 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.4 m170 -108.06 117.39 34.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 39.2 t80 -73.02 106.62 4.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.783 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -126.92 74.7 76.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 56.1 Cg_endo -70.41 158.16 56.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.26 1.973 . . . . 0.0 112.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.7 p -140.44 162.9 34.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -26.61 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -102.4 -20.4 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.22 76.61 1.61 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.32 -20.63 29.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.669 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.87 38.37 2.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 111.188 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -85.72 116.87 24.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.06 132.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.38 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.405 HG21 ' OE2' ' A' ' 206' ' ' GLU . 21.2 mm -105.77 110.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.477 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.526 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.6 m -85.02 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.0 111.61 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -116.06 106.48 13.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.07 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.82 149.33 11.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.483 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -66.14 -22.36 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.934 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.2 -12.02 59.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.26 20.33 9.26 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -103.14 174.18 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' GLU . . . . . 0.405 ' OE2' HG21 ' A' ' 198' ' ' ILE . 35.5 tt0 -129.38 116.4 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 199' ' ' VAL . 13.1 t -114.87 159.9 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.521 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.462 ' N ' HG12 ' A' ' 207' ' ' VAL . 85.0 p -121.02 145.33 47.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.11 -178.44 7.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.778 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.9 153.67 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.1 mt -67.77 -21.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.076 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.47 -35.3 58.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.709 0.29 . . . . 0.0 111.462 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -133.74 35.95 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -54.38 -48.18 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.61 -48.69 80.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -62.18 -38.7 90.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 19.7 mmtt -56.44 -51.04 69.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.392 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.411 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.4 mm? -79.66 -20.3 47.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.349 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.5 p -65.49 -36.85 85.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.962 0.411 . . . . 0.0 110.384 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -63.47 -14.93 55.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.795 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 111.21 23.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.535 -0.103 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.709 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 12.3 Cg_exo -70.3 -24.15 27.54 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.164 1.909 . . . . 0.0 112.459 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -80.23 -41.69 24.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.55 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.804 HG23 ' HB3' ' A' ' 181' ' ' ALA . 18.6 mt -68.78 -57.79 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.35 -29.4 58.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.325 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.81 -28.24 21.73 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.545 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.662 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.36 -28.03 11.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.368 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.646 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 6.2 mt -77.82 -33.51 52.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.01 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.92 21.61 11.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.438 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -40.95 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.318 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.94 -61.68 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.3 p -176.53 140.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.971 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.932 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.6 m -136.63 -170.77 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 61.14 -172.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.803 ' HB2' HD13 ' A' ' 134' ' ' LEU . 24.9 m95 -131.03 151.92 50.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.44 128.67 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.448 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm-85 -68.31 127.22 32.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.013 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.09 0.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.024 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.605 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.92 177.06 9.55 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.648 0.261 . . . . 0.0 111.042 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.438 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.4 m-85 -139.34 173.74 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.8 t -133.45 117.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 111.073 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.454 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.56 114.06 19.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.366 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.9 t70 -169.17 143.12 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 58.95 41.27 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.938 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 54.09 29.99 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.406 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 145' ' ' THR . 51.3 m -149.38 145.42 26.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 111.365 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.454 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.5 m-85 -95.97 110.92 23.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.735 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.2 m-85 -81.71 127.06 74.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 26.3 Cg_exo -62.45 124.81 14.91 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.191 1.927 . . . . 0.0 112.501 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.95 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -106.48 125.16 50.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.803 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.3 mt -85.35 164.6 17.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.417 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.6 pt-20 -54.94 -29.88 57.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -91.16 15.36 11.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 76.72 3.25 78.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.314 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.589 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.68 97.67 0.06 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.362 0.581 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -81.09 126.34 31.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.974 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.475 ' N ' HD23 ' A' ' 139' ' ' LEU . 18.2 mt -107.71 95.69 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.8 mttp -72.54 -25.51 61.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -82.64 -20.91 35.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.791 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -101.1 28.07 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 111.5 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.68 159.8 52.48 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.642 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 129' ' ' THR . 1.3 t -124.64 155.85 38.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.44 29.71 2.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.85 140.29 22.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 118.25 51.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.02 105.67 2.12 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.122 1.881 . . . . 0.0 112.78 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t -67.89 -12.2 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -78.51 -27.3 46.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.6 0.238 . . . . 0.0 111.316 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.44 159.92 49.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.866 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 53.2 Cg_endo -71.46 172.86 13.38 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.961 1.774 . . . . 0.0 112.6 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 123' ' ' TYR . 58.6 t -129.45 154.19 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.897 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.62 HD12 ' CD1' ' A' ' 133' ' ' LEU . 56.1 mt -113.17 97.84 6.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.422 . . . . 0.0 110.441 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 72.6 t -83.29 134.29 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.37 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.6 85.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.788 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.563 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -148.31 113.05 5.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 111.494 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.84 -26.01 12.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.464 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.93 95.37 7.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.208 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.59 -20.86 48.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.067 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.2 -40.43 97.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.73 -34.19 69.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.518 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.95 HG23 HD11 ' A' ' 133' ' ' LEU . 48.1 mt -61.42 -51.88 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.612 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.401 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.46 -31.2 61.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.26 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 9.7 mm-40 -67.9 -51.15 51.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.456 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.24 -52.0 67.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.81 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.013 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.47 -33.91 70.28 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.855 0.359 . . . . 0.0 110.252 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.42 96.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.333 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -67.05 -38.06 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 8.0 mp -68.06 -28.2 67.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.291 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.95 -18.75 60.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.701 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -101.18 -40.52 7.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 0.0 111.712 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -70.4 157.81 89.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.665 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.9 Cg_exo -50.88 124.23 13.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.542 2.161 . . . . 0.0 112.638 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.73 33.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.706 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.36 -40.65 93.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.17 0.51 . . . . 0.0 110.417 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.8 t -60.24 -60.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.998 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.757 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.2 pp -61.19 -25.52 67.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.39 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.449 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.84 -22.12 77.44 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.022 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.697 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.89 78.16 8.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.967 0.413 . . . . 0.0 110.913 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.6 ptp 177.92 140.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.543 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.91 -54.0 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.104 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 152.39 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 110.974 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.43 HG12 HG12 ' A' ' 199' ' ' VAL . 5.1 mt -102.97 135.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.384 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.428 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 21.3 m170 -108.05 114.71 28.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -72.14 100.74 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -123.54 79.36 54.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.72 165.93 31.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.35 2.034 . . . . 0.0 112.613 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 p -143.6 176.18 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -62.4 -25.58 68.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.81 5.14 18.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -156.58 78.01 0.92 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.911 0.386 . . . . 0.0 111.008 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -18.4 52.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.518 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.22 34.33 4.75 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.834 0.35 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -80.03 109.13 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.78 132.77 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.402 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.41 107.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.311 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.46 HG21 HD11 ' A' ' 218' ' ' LEU . 2.2 m -85.0 150.27 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.988 0.423 . . . . 0.0 111.653 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -109.08 109.2 20.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.985 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.81 148.96 9.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.416 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -66.16 -21.86 66.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.6 -10.58 59.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.27 20.52 9.09 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.713 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -100.66 174.25 6.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 110.825 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.03 122.08 29.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 208' ' ' SER . 38.6 t -125.76 158.68 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.478 ' N ' HG12 ' A' ' 207' ' ' VAL . 81.2 p -121.59 149.19 43.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.079 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.35 -177.14 5.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -129.24 153.75 47.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.563 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.4 mt -66.3 -22.43 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.022 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -32.51 57.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 111.381 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -134.16 35.82 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.408 ' CD1' HD23 ' A' ' 218' ' ' LEU . 12.3 t80 -57.3 -46.59 83.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.99 -48.68 79.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.645 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.47 -40.17 95.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -57.03 -52.99 63.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.6 mm? -77.3 -21.79 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.445 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 78.7 p -66.4 -33.5 75.84 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 110.361 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.86 -10.29 51.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.914 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.419 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -87.16 110.56 34.31 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 122.485 -0.134 . . . . 0.0 110.865 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.643 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 13.4 Cg_exo -69.83 -26.35 27.33 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.215 1.943 . . . . 0.0 112.343 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -76.38 -41.91 46.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 178' ' ' VAL . 19.7 mt -69.01 -56.83 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.295 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.5 -28.46 20.52 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.85 -27.55 13.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.1 0.476 . . . . 0.0 110.328 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.706 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.7 mt -78.42 -32.23 48.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.094 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.63 -17.4 57.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.757 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -53.89 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 111.45 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -147.21 -74.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.154 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 232' ' ' VAL . 18.1 t 64.45 33.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.978 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.865 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 p -159.8 132.58 6.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.35 -179.11 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.834 ' HB2' HD13 ' A' ' 134' ' ' LEU . 48.6 m95 -80.57 150.61 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -99.47 129.55 45.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -70.07 127.05 31.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.134 0.492 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.986 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.83 1.44 2.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.842 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.72 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.93 176.46 9.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 120.695 0.284 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.45 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 20.2 m-85 -140.15 173.85 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.635 HG21 ' CD1' ' A' ' 139' ' ' LEU . 18.7 t -132.7 117.64 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.883 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.424 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.96 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.26 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 38.9 t0 -169.25 143.77 3.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.781 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 59.98 40.46 18.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 53.92 27.58 7.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.586 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 145' ' ' THR . 89.6 m -147.87 142.47 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 154' ' ' VAL . 8.9 m-85 -91.1 109.94 21.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.73 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.4 m-85 -80.0 122.47 83.19 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.25 123.38 13.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.098 1.865 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.913 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -105.67 125.32 50.85 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.834 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.2 mt -84.95 166.11 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.339 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.1 pt-20 -55.7 -29.93 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.447 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.4 p-10 -90.34 13.99 14.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.345 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.53 4.18 84.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.17 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.579 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.9 tpt180 -60.15 97.6 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.18 0.514 . . . . 0.0 110.487 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.73 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.68 115.29 22.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.892 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.4 mt -105.29 98.05 7.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.51 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.2 mttt -70.34 -28.16 64.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.79 -22.35 59.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -101.54 25.08 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.82 53.44 Favored Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.603 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.5 156.02 42.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.42 139.67 25.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.519 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.37 119.14 50.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.45 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 61.5 Cg_endo -75.8 105.08 2.01 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.98 1.787 . . . . 0.0 112.765 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.6 t -67.64 -12.4 60.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.194 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.98 -26.91 39.77 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.663 0.268 . . . . 0.0 111.568 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.87 159.55 46.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 44.5 Cg_endo -70.74 173.66 11.52 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.06 1.84 . . . . 0.0 112.805 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 130' ' ' PHE . 77.7 t -129.06 154.44 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.023 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.587 HD12 ' CD1' ' A' ' 133' ' ' LEU . 58.7 mt -112.81 98.36 7.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.2 t -82.66 135.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.476 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.55 86.78 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.876 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.5 m95 -148.4 116.24 6.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.471 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -106.81 -26.53 11.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.459 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -97.41 95.56 7.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.4 -20.86 46.53 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.108 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -40.4 97.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.17 -33.28 67.57 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.621 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.913 HG23 HD11 ' A' ' 133' ' ' LEU . 53.1 mt -62.44 -51.86 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.678 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.71 -30.21 55.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.11 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 10.6 mm-40 -68.99 -51.11 42.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.348 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.836 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.986 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.59 -33.7 68.47 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.91 0.386 . . . . 0.0 110.383 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.64 96.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.478 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.1 -39.63 93.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.738 ' HA ' HD22 ' A' ' 174' ' ' LEU . 5.1 mp -66.17 -27.77 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.367 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.55 -19.42 60.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.667 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.86 -40.58 7.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.705 0.288 . . . . 0.0 111.633 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.738 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -70.37 157.31 90.29 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' A' ' 178' ' ' VAL . 72.9 Cg_exo -48.9 128.78 19.75 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.744 2.296 . . . . 0.0 112.92 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.54 67.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.552 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.703 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.4 -37.14 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 224' ' ' ILE . 44.9 t -61.45 -60.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.868 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.6 pp -62.56 -24.01 67.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -72.95 -24.44 75.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.628 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' A' ' 202' ' ' ASN . . . -90.32 78.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.26 137.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 p -80.27 -57.93 3.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.197 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.12 154.12 31.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.971 0.415 . . . . 0.0 111.145 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -106.06 136.84 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.6 m170 -108.22 123.27 48.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.724 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 55.1 t80 -77.67 107.82 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -131.35 76.4 75.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.744 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.406 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 50.2 Cg_endo -69.59 162.67 41.06 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.336 2.024 . . . . 0.0 112.609 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.3 p -140.86 163.37 33.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.9 mtp85 -55.89 -25.89 44.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 -20.64 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.283 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -136.8 82.48 1.94 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.71 -20.76 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.673 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -114.58 37.69 3.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 111.163 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -82.28 112.34 19.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.988 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.51 135.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -106.75 109.27 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.554 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.6 m -84.84 154.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.899 0.38 . . . . 0.0 111.654 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -114.5 101.36 9.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.957 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.436 ' HE3' HG21 ' A' ' 207' ' ' VAL . 7.8 tpp -53.87 149.33 8.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.596 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.502 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 11.5 p-10 -66.83 -20.08 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.041 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.76 -13.4 60.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 20.21 9.47 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -109.04 167.86 9.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.68 117.02 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.743 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 199' ' ' VAL . 9.3 t -113.85 160.39 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 207' ' ' VAL . 78.1 p -121.43 144.33 48.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.762 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -158.32 -177.36 6.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.8 152.35 47.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.321 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.5 mt -66.42 -24.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.913 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -29.8 51.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.695 0.283 . . . . 0.0 111.361 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -134.16 36.07 3.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.221 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.672 ' CE1' HD11 ' A' ' 171' ' ' LEU . 41.3 t80 -56.88 -50.03 73.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.845 0.355 . . . . 0.0 111.051 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -62.16 -42.49 99.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.81 -42.26 95.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.414 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 45.6 mmtt -57.08 -53.66 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.346 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.48 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -75.97 -24.0 55.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.5 m -62.8 -32.97 74.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 110.33 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -5.89 39.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.406 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -95.0 100.74 5.95 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.649 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 37.7 Cg_endo -65.86 -25.85 52.47 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.131 1.887 . . . . 0.0 111.97 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.3 -41.68 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 178' ' ' VAL . 27.3 mt -72.07 -54.88 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.19 -29.28 63.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.131 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.08 -28.31 10.21 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.436 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.59 -27.41 11.04 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.413 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.703 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.2 mt -78.67 -32.01 46.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.226 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.19 -28.72 65.06 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.26 -28.64 63.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.204 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.78 -55.08 2.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 233' ' ' LYS . 21.4 t -147.77 159.02 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.48 ' N ' HG12 ' A' ' 232' ' ' VAL . 9.3 mtmt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.01 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.7 p -83.26 133.86 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.06 -174.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.841 ' HB2' HD13 ' A' ' 134' ' ' LEU . 45.5 m95 -103.58 149.24 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.16 134.24 45.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.466 ' HG2' HD23 ' A' ' 134' ' ' LEU . 13.9 mtm-85 -73.4 127.46 32.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.136 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.009 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.12 -1.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.928 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.728 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -160.83 176.55 11.35 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 120.683 0.278 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.448 ' HB2' HG22 ' A' ' 154' ' ' VAL . 33.9 m-85 -138.62 173.05 12.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.503 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.651 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.6 t -133.88 120.17 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.927 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.08 109.77 14.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.977 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.418 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.3 t0 -161.38 138.56 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 58.39 42.73 20.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 54.11 28.75 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.625 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 145' ' ' THR . 94.9 m -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 111.103 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.1 m-85 -90.23 110.15 21.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.697 ' HB2' HD21 ' A' ' 139' ' ' LEU . 13.2 m-30 -81.3 118.23 71.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.999 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 10.8 Cg_endo -56.73 124.28 15.88 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.131 1.887 . . . . 0.0 112.563 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.926 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -106.24 125.35 50.89 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.117 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 118' ' ' TRP . 17.4 mt -81.67 167.98 18.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.058 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.6 pt-20 -57.28 -30.78 64.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.463 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.1 p30 -90.6 13.87 14.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.398 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.503 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 79.71 5.61 89.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.121 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.589 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -59.44 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 117.392 0.596 . . . . 0.0 110.23 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -81.33 118.66 22.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.491 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.9 mm? -103.74 96.77 6.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.755 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 37.9 mttt -71.84 -26.57 62.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -80.94 -23.74 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.526 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -98.28 22.68 9.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.642 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.2 163.27 54.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.549 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.712 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.53 156.38 43.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.586 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 26.12 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.42 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -143.57 139.67 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 118.11 59.89 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.86 106.7 2.3 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.07 1.847 . . . . 0.0 112.501 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.2 t -67.13 -13.24 61.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.74 -27.23 50.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.66 164.96 33.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.6 Cg_endo -78.49 173.33 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.051 1.834 . . . . 0.0 112.757 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.0 t -130.02 154.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.928 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 133' ' ' LEU . 67.5 mt -112.51 97.59 6.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.65 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.6 t -82.55 134.57 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.409 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.09 87.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.709 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.6 m95 -147.57 110.25 4.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 111.597 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -100.2 -25.91 14.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.507 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.43 95.39 7.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.915 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.44 -20.83 46.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.044 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.4 -40.56 97.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.88 -34.56 71.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.474 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.926 ' CG2' HD11 ' A' ' 133' ' ' LEU . 62.1 mt -61.99 -51.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.722 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.408 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.57 -29.79 59.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.188 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 27.3 mm-40 -69.25 -51.8 33.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.173 0.511 . . . . 0.0 110.25 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.47 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.42 -52.77 64.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.026 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.009 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.57 69.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.356 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.06 97.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.434 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.24 -38.48 87.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.913 0.387 . . . . 0.0 110.45 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.775 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.6 mp -64.81 -28.21 69.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.634 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -102.82 -40.84 6.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.698 0.285 . . . . 0.0 111.679 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.775 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -68.91 157.29 89.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.132 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.63 ' HB2' HG23 ' A' ' 178' ' ' VAL . 56.2 Cg_exo -49.85 129.79 25.27 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.696 2.264 . . . . 0.0 112.749 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.3 -38.89 66.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.654 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.05 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 110.314 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 175' ' ' PRO . 54.4 t -60.31 -57.07 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.679 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.4 pp -68.09 -13.19 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.29 -14.68 59.92 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.369 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.39 78.63 3.9 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.918 0.359 . . . . 0.0 111.724 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.35 176.82 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.702 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.9 m -116.55 -44.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -167.51 151.82 6.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -105.13 135.35 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.407 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -108.42 114.41 28.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 41.3 t80 -65.85 111.03 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.832 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -132.02 76.96 72.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 53.5 Cg_endo -70.31 160.66 48.77 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.0 p -140.17 161.46 37.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.04 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -54.73 -25.63 28.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.26 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.25 -21.82 14.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.247 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.448 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.7 m-85 -136.16 80.85 1.85 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.892 0.377 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.28 -21.13 32.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.562 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -112.89 38.09 2.91 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.448 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 3.4 ttm180 -85.89 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.8 m -120.0 138.7 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.23 111.09 34.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.794 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.607 HG12 HG12 ' A' ' 185' ' ' ILE . 2.9 m -86.53 152.89 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -110.55 100.58 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.535 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.3 tpp -55.8 149.34 14.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.479 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -67.51 -20.38 65.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.089 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -76.62 -13.54 60.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.18 20.15 10.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.781 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -112.24 156.54 22.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.899 0.38 . . . . 0.0 110.775 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -110.3 117.13 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.535 HG21 ' HE3' ' A' ' 201' ' ' MET . 41.2 t -114.04 159.18 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.648 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 207' ' ' VAL . 49.8 p -121.46 149.09 43.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.569 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -167.22 149.37 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.79 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.688 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.476 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.8 mt -58.83 -28.03 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.118 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -32.12 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -134.24 35.97 3.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.152 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.455 ' CD1' HD23 ' A' ' 218' ' ' LEU . 11.6 t80 -54.95 -50.22 69.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.516 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.84 -48.78 80.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 0.0 111.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -64.92 -32.81 74.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.155 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.409 ' CB ' ' HB1' ' A' ' 209' ' ' ALA . 1.9 mmpt? -61.67 -53.88 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.085 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.2 mm? -80.21 -23.67 40.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.4 t -63.29 -38.81 92.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 110.687 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -64.77 -14.38 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.684 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.74 111.39 25.75 Favored Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.567 -0.083 . . . . 0.0 110.828 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.743 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 15.3 Cg_exo -68.58 -25.56 34.59 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.259 1.972 . . . . 0.0 112.518 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -78.56 -40.88 33.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.564 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 178' ' ' VAL . 22.9 mt -70.07 -56.99 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.97 -29.04 62.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.212 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.743 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.17 -28.25 10.65 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.567 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.5 -27.7 11.37 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.214 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.654 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.4 mt -76.26 -34.22 59.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.007 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -97.49 17.32 17.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.686 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 54.64 24.66 5.67 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 59.32 84.14 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.043 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.72 150.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 11.5 tttp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.872 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 m -108.48 83.42 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 60.37 175.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.79 ' HB2' HD13 ' A' ' 134' ' ' LEU . 58.2 m95 -74.87 153.91 38.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.049 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -95.33 140.59 30.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.478 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -82.38 124.66 30.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 110.561 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.988 HD11 HG22 ' A' ' 168' ' ' THR . 0.1 OUTLIER -127.75 0.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.986 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.26 177.02 8.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.432 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 18.9 m-85 -140.46 173.09 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.338 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 139' ' ' LEU . 24.7 t -132.44 120.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.985 0.421 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.498 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.45 110.95 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.42 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.9 t70 -157.12 135.87 11.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 58.05 43.96 20.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.46 29.22 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.428 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 145' ' ' THR . 85.0 m -144.01 144.04 31.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.0 m-85 -95.27 110.62 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.488 . . . . 0.0 111.048 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.716 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.1 m-30 -83.29 124.25 76.22 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.185 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.546 ' HB2' HD12 ' A' ' 140' ' ' LEU . 31.4 Cg_exo -59.34 127.21 23.14 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.366 2.044 . . . . 0.0 112.82 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.994 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.44 124.78 51.6 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.817 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.6 mt -85.66 165.66 16.8 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.546 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 121' ' ' ILE . 9.3 pt-20 -55.38 -30.71 60.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -89.71 14.19 12.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 77.44 3.59 82.91 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.157 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.603 ' HB3' HD12 ' A' ' 134' ' ' LEU . 19.4 tpp180 -61.04 97.15 0.06 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.167 0.483 . . . . 0.0 110.589 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -78.15 129.63 35.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.863 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 132' ' ' PRO . 81.6 mt -108.06 92.38 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 21.2 mttp -72.64 -28.9 63.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.815 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.32 -21.08 42.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.472 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -101.64 28.02 5.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.505 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -76.31 159.42 50.2 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.384 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.33 157.56 40.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.952 0.406 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 25.67 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.4 OUTLIER -141.77 139.34 32.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.483 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.15 111.65 8.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.315 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.432 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 23.3 Cg_exo -63.65 100.41 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.475 2.117 . . . . 0.0 112.196 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -65.61 -14.92 62.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.346 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.64 -27.29 40.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.3 161.86 55.01 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.9 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.534 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 56.9 Cg_endo -73.97 172.9 14.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.751 1.634 . . . . 0.0 112.539 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.417 HG21 ' CD2' ' A' ' 130' ' ' PHE . 76.5 t -129.81 154.92 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.133 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.5 mt -114.09 97.69 6.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 0.0 110.492 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.68 133.81 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.459 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.45 85.53 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.809 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 68.6 m95 -147.7 115.46 6.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.966 0.413 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.19 -26.4 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.519 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.12 94.77 7.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.923 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.02 -21.26 45.0 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.096 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -39.97 96.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.75 67.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.556 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.994 HG23 HD11 ' A' ' 133' ' ' LEU . 39.6 mt -61.99 -51.76 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.638 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.418 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.62 -30.87 61.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 14.7 mm-40 -67.68 -50.77 56.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.172 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.446 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.77 -52.25 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.988 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.55 68.5 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.951 0.405 . . . . 0.0 110.321 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.2 97.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.37 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -64.14 -39.44 94.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.285 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.741 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.6 mp -66.14 -27.53 68.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.259 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.81 -19.87 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.61 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.36 -40.76 7.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 111.483 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.61 156.82 90.99 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.964 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.614 ' HB2' HG23 ' A' ' 178' ' ' VAL . 57.4 Cg_exo -49.78 129.52 24.3 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 112.864 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.58 -39.6 67.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.574 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.678 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -62.34 -37.4 85.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.097 0.475 . . . . 0.0 110.536 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.678 ' HA ' HG22 ' A' ' 224' ' ' ILE . 52.5 t -61.33 -60.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.72 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.667 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -61.86 -24.05 66.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.453 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.26 -24.41 75.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.631 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.563 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -90.19 78.16 6.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.768 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 178.59 138.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.554 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -80.2 -62.01 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.65 152.16 32.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 0.0 111.041 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.23 133.88 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.429 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 33.3 m170 -107.37 111.99 24.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.956 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -65.35 106.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -129.65 79.84 72.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.73 160.86 46.33 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.276 1.984 . . . . 0.0 112.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -138.56 162.58 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -54.75 -25.96 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.279 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -103.9 -18.7 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.515 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' TYR . . . . . 0.449 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.2 m-85 -136.6 83.44 2.0 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.905 0.383 . . . . 0.0 111.219 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.92 -20.58 38.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.544 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -114.13 38.46 3.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -82.81 117.7 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.78 133.05 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.517 HD12 ' HB3' ' A' ' 208' ' ' SER . 25.2 mm -104.09 107.98 23.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.341 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.542 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.55 152.4 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.68 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.93 100.77 9.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.013 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.42 ' HE3' HG21 ' A' ' 207' ' ' VAL . 10.2 tpp -54.81 149.5 11.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 111.492 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -65.95 -20.25 66.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.028 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.03 -13.54 60.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.33 20.11 11.53 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.74 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.23 162.64 14.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.666 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -112.44 120.79 42.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.685 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 208' ' ' SER . 39.6 t -118.25 158.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.687 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.517 ' HB3' HD12 ' A' ' 198' ' ' ILE . 44.4 p -121.95 149.44 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.44 -178.15 6.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.812 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -127.63 149.76 50.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.119 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.465 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.5 mt -64.6 -23.85 34.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.01 -31.22 56.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.445 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.25 35.98 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.1 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.427 ' CD1' HD23 ' A' ' 218' ' ' LEU . 13.0 t80 -55.75 -50.71 69.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.83 0.348 . . . . 0.0 111.032 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.57 -44.38 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.93 -41.46 97.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.43 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 57.2 mmtt -56.24 -53.37 57.96 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.016 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.427 HD23 ' CD1' ' A' ' 214' ' ' PHE . 3.3 mm? -76.64 -23.19 53.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -61.59 -34.34 75.45 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.072 0.463 . . . . 0.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -71.83 -5.55 35.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 99.96 5.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.573 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 37.4 Cg_endo -65.93 -28.24 50.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.171 1.914 . . . . 0.0 111.98 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.29 81.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.714 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.2 mt -72.13 -54.75 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.05 -29.43 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.81 -28.13 14.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.459 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.577 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.55 -27.87 12.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.27 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.678 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.6 mt -77.66 -33.21 53.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.8 19.86 11.89 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.649 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -85.95 -62.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.828 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -100.97 72.39 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.84 136.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.9 tptt . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.833 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -112.0 122.31 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 60.97 172.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.024 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.798 ' HB2' HD13 ' A' ' 134' ' ' LEU . 51.1 m95 -68.35 155.3 40.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.0 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 127.93 44.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -69.36 126.62 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.017 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.48 -0.16 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.969 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.06 176.68 9.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.963 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.449 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 18.9 m-85 -139.11 173.35 11.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.313 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.63 HG21 ' HG ' ' A' ' 139' ' ' LEU . 21.4 t -132.59 118.23 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.36 113.37 18.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.145 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 33.3 t0 -164.5 138.87 5.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.798 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.43 42.16 18.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 110.821 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.19 28.26 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.504 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 145' ' ' THR . 63.2 m -145.01 144.28 30.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.6 m-85 -95.16 110.58 22.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.718 ' HB2' HD21 ' A' ' 139' ' ' LEU . 12.3 m-30 -81.97 125.74 76.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.142 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.571 ' HB2' HD12 ' A' ' 140' ' ' LEU . 36.5 Cg_exo -61.29 126.1 18.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.293 1.995 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.949 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -108.14 125.04 51.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.793 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 118' ' ' TRP . 22.0 mt -85.27 166.13 16.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.384 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.9 pt-20 -55.44 -30.26 60.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.499 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -91.29 15.48 11.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.382 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.56 3.63 83.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.228 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.548 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.06 96.73 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.224 0.512 . . . . 0.0 110.581 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -82.24 122.3 27.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.077 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 132' ' ' PRO . 16.2 mt -104.5 96.64 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -72.76 -26.4 61.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -81.73 -22.9 37.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.696 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -97.55 27.25 4.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.383 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -75.26 159.08 51.34 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.801 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -126.01 155.54 41.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.684 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 29.6 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.756 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.55 22.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.43 119.05 56.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.1 Cg_endo -74.44 106.03 2.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.065 1.843 . . . . 0.0 112.68 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -67.28 -12.83 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.63 -27.23 40.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.653 0.263 . . . . 0.0 111.524 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.33 159.69 47.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 44.2 Cg_endo -70.86 174.28 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.115 1.877 . . . . 0.0 112.845 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' A' ' 130' ' ' PHE . 75.9 t -129.79 154.61 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.065 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.2 mt -113.75 97.76 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.016 0.436 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.22 134.42 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.438 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.18 86.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.811 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.7 m95 -148.23 113.95 5.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.031 0.443 . . . . 0.0 111.465 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -104.74 -25.38 12.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.589 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.88 95.04 7.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.227 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.885 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.43 -21.0 47.35 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.012 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -40.15 96.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.46 -33.77 67.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.606 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.949 HG23 HD11 ' A' ' 133' ' ' LEU . 56.2 mt -61.95 -51.9 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.709 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.8 mm-40 -67.57 -50.52 58.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.247 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.63 -52.21 66.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.856 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.07 -33.69 67.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.843 0.354 . . . . 0.0 110.439 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.38 -44.09 97.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.186 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.24 -38.21 88.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.255 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.779 ' HA ' HD22 ' A' ' 174' ' ' LEU . 6.5 mp -67.74 -28.7 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.245 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.6 -22.36 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.399 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.6 -41.15 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.709 0.29 . . . . 0.0 111.385 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.779 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.04 156.42 92.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.827 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' A' ' 178' ' ' VAL . 67.9 Cg_exo -49.38 128.53 20.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.621 2.214 . . . . 0.0 112.792 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.14 -40.41 67.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.684 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -61.9 -37.26 83.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.526 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.648 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.4 t -61.03 -60.03 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 171' ' ' LEU . 4.4 pp -62.15 -23.68 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.477 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.61 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -75.17 -22.59 76.05 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.978 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -90.84 78.32 6.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.85 132.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -58.29 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.14 153.33 25.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.51 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -101.66 135.71 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.438 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.419 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 8.0 m170 -108.68 114.69 28.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -69.29 113.48 6.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -133.73 71.85 74.23 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.94 159.52 51.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.299 2.0 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.4 p -139.59 161.21 38.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.101 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -52.93 -26.54 15.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -103.1 -21.46 13.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.27 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -132.79 76.81 1.71 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -21.68 23.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.652 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.55 39.55 2.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.884 0.374 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -86.3 118.31 25.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.06 133.78 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.8 mm -106.42 109.27 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.39 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.73 152.18 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 0.0 111.775 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -109.74 105.79 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.864 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.401 ' HE1' HD13 ' A' ' 224' ' ' ILE . 11.8 tpp -56.9 149.38 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -58.33 -22.81 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.28 -2.34 48.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.12 -15.22 60.71 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.972 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -66.48 164.87 15.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -119.61 121.38 39.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.675 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 208' ' ' SER . 35.7 t -119.48 159.15 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.786 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 207' ' ' VAL . 98.4 p -121.85 149.32 43.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.021 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.83 -177.49 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.79 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.23 154.61 44.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.4 mt -69.76 -21.69 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.097 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.07 -30.38 31.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -133.04 35.06 3.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.68 -47.87 81.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.66 -47.23 87.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.22 -38.56 91.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 1.4 mmpt? -57.86 -53.31 59.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.528 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.3 mm? -81.73 -20.11 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.382 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 26.1 t -64.92 -37.74 88.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.67 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -67.25 -10.68 53.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.065 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -81.32 111.7 27.06 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.451 -0.156 . . . . 0.0 110.808 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 14.5 Cg_exo -68.94 -27.11 30.88 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.233 1.955 . . . . 0.0 112.389 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -79.71 -44.75 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.575 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.648 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.1 mt -64.19 -56.95 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.98 -28.74 58.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.422 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.29 -28.8 12.91 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.706 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -52.19 -26.72 12.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.397 178.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.684 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 6.1 mt -76.76 -33.44 58.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.967 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.52 -59.23 5.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.21 25.23 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.6 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -130.89 36.58 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.2 m -109.8 77.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.894 -179.98 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 81.5 p -154.29 -73.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -98.79 -178.17 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.83 ' HB2' HD13 ' A' ' 134' ' ' LEU . 49.3 m95 -99.18 150.73 21.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 130.83 50.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -68.78 127.88 34.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.118 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.018 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.58 -0.2 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.007 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.65 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.5 176.82 9.37 Favored 'General case' 0 CA--C 1.523 -0.073 0 CA-C-O 120.655 0.265 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.443 ' HB2' HG22 ' A' ' 154' ' ' VAL . 26.8 m-85 -138.74 173.65 11.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.431 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.627 HG21 ' HG ' ' A' ' 139' ' ' LEU . 17.1 t -133.24 117.74 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.444 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.65 111.18 16.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.313 -179.382 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.2 t0 -169.34 144.5 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.37 40.31 21.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 53.96 29.08 9.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.65 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 145' ' ' THR . 85.2 m -150.11 142.19 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.7 m-85 -90.32 109.5 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.149 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.728 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.2 m-85 -79.86 123.28 83.85 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.095 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.19 123.72 13.74 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.181 1.921 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.926 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -106.29 125.11 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.0 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.83 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.6 mt -84.23 165.85 18.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.343 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.7 pt-20 -55.34 -30.45 60.29 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.48 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -91.3 15.1 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.276 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.425 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.36 7.13 86.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.292 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.595 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.55 95.63 0.04 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.322 0.561 . . . . 0.0 110.32 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.64 112.55 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.711 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.48 98.36 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 26.9 mttt -69.59 -26.39 64.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -74.3 -24.1 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.19 24.81 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.509 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.33 163.03 53.77 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.666 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.47 155.49 43.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 110.639 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.15 3.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.73 140.03 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 117.5 44.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 106.28 2.19 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.065 1.844 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -67.71 -12.47 60.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.267 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.46 -27.26 52.03 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.323 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.56 164.09 34.94 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.875 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.6 Cg_endo -76.02 173.56 14.29 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.913 1.742 . . . . 0.0 112.659 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 123' ' ' TYR . 57.9 t -130.24 153.71 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.951 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.589 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.1 mt -113.25 97.57 6.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -83.03 135.22 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.52 86.83 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.494 ' CH2' HD11 ' A' ' 211' ' ' ILE . 72.9 m95 -149.14 111.52 4.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.391 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -102.23 -26.08 13.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.566 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.85 95.09 7.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.397 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.897 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.17 -21.13 45.72 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.014 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.34 97.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -33.82 68.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.576 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.926 HG23 HD11 ' A' ' 133' ' ' LEU . 52.8 mt -61.85 -51.88 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.573 178.547 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.13 -27.99 49.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 29.5 mm-40 -72.08 -50.6 26.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 0.0 110.356 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.15 -52.33 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 179.661 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.018 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.55 -33.95 68.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.356 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.283 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -63.89 -38.42 91.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.162 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.763 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.3 mp -67.03 -28.32 68.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.22 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -19.27 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.544 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.26 -41.29 6.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 111.505 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.67 157.17 90.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.94 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.586 ' HB2' HG23 ' A' ' 178' ' ' VAL . 74.9 Cg_exo -49.16 128.3 19.44 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.35 67.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.552 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.704 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.16 -36.81 85.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.26 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 175' ' ' PRO . 41.7 t -61.45 -60.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.774 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.667 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.6 pp -62.17 -24.82 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.12 -23.75 77.06 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.727 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.446 ' HB1' ' OD1' ' A' ' 202' ' ' ASN . . . -90.43 78.34 6.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 110.746 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.25 130.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.7 m -70.15 -58.31 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.12 154.02 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.07 135.96 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.318 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.434 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.8 m170 -109.01 112.6 24.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.87 109.37 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -132.05 78.24 69.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.72 160.3 50.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.253 1.968 . . . . 0.0 112.417 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -139.23 162.36 35.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.28 -25.87 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -102.11 -20.07 14.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.505 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -136.38 81.29 1.87 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.66 -21.84 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.636 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.94 39.07 2.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -84.07 115.47 22.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.43 132.98 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.276 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.8 mm -104.89 108.73 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.487 HG12 HG12 ' A' ' 185' ' ' ILE . 2.4 m -86.14 154.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.69 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -111.96 102.15 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.507 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.6 tpp -56.71 149.26 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.213 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.446 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 3.9 p-10 -67.22 -19.92 65.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.36 -13.43 60.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.19 20.22 10.69 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.797 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -112.0 161.41 16.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.854 0.359 . . . . 0.0 110.691 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.69 120.6 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.806 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 201' ' ' MET . 27.4 t -118.2 158.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.444 . . . . 0.0 110.665 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 207' ' ' VAL . 52.4 p -121.88 149.14 43.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.157 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.06 -177.62 6.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.709 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -126.94 151.66 48.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.494 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.0 mt -65.95 -22.74 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -29.17 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.78 35.33 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.4 t80 -57.7 -51.43 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.16 -47.2 86.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.996 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.82 -38.69 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.42 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.503 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 53.4 mmtt -58.11 -53.41 58.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.497 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.1 mm? -82.12 -19.79 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.555 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.2 t -64.56 -39.85 94.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -10.65 55.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.851 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -77.21 111.63 18.1 Favored Pre-proline 0 CA--C 1.535 0.366 0 O-C-N 122.48 -0.138 . . . . 0.0 110.863 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 14.5 Cg_exo -68.92 -27.57 30.41 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.251 1.967 . . . . 0.0 112.376 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.6 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -81.13 -45.48 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.523 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 178' ' ' VAL . 24.9 mt -62.85 -57.18 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.01 0.434 . . . . 0.0 109.944 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.45 -29.05 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.356 178.396 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -50.9 -28.85 10.54 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 178.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.95 -27.54 13.57 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.086 0.469 . . . . 0.0 110.203 178.347 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.704 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.3 mt -73.9 -34.81 64.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.66 15.47 26.84 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.883 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -67.65 -33.63 75.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.001 0.429 . . . . 0.0 110.365 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -140.25 -67.58 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.356 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.83 179.63 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.927 -179.997 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 p 68.98 -62.82 0.39 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 111.394 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.11 -170.9 3.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.791 ' HB2' HD13 ' A' ' 134' ' ' LEU . 57.7 m95 -77.61 151.8 34.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -98.98 132.48 44.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -70.01 126.36 29.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.011 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.96 1.14 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.796 179.469 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.657 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.0 176.37 9.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.445 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.5 m-85 -139.23 173.64 11.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.334 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 139' ' ' LEU . 16.3 t -133.98 117.74 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.899 0.381 . . . . 0.0 110.922 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.461 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 113.16 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.14 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.435 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.8 t70 -167.19 139.54 3.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 59.23 42.13 19.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.21 0.529 . . . . 0.0 110.954 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 54.12 27.64 7.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.686 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 145' ' ' THR . 86.5 m -145.89 141.59 27.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.461 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.9 m-85 -91.93 109.44 20.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.228 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.5 m-30 -79.44 123.1 84.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.872 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.86 123.86 14.14 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.19 1.927 . . . . 0.0 112.678 -179.663 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.963 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -106.49 124.97 50.4 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.791 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.2 mt -85.18 166.27 16.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.378 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.3 pt-20 -55.64 -30.47 61.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -91.09 15.26 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.389 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.82 86.39 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.269 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.614 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.2 96.28 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.3 0.55 . . . . 0.0 110.36 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -86.71 113.46 22.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.88 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.2 mt -105.62 98.42 8.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 16.5 mttt -69.07 -28.59 66.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -72.39 -27.01 62.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.4 22.17 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.454 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 162.11 54.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.539 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.702 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.85 155.71 43.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.382 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 27.99 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.983 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 138.67 25.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.47 117.95 49.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.425 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 66.9 Cg_endo -76.44 105.79 2.14 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.117 1.878 . . . . 0.0 112.657 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.72 -12.59 60.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.58 -26.94 51.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.673 0.273 . . . . 0.0 111.358 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.5 163.93 36.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.823 -179.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.6 Cg_endo -75.87 172.77 15.66 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.891 1.727 . . . . 0.0 112.37 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 123' ' ' TYR . 58.3 t -128.9 153.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.618 HD12 ' CD1' ' A' ' 133' ' ' LEU . 58.3 mt -112.53 97.69 6.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.431 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.5 t -82.06 134.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.377 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.99 87.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.76 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.555 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.67 111.11 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.016 0.436 . . . . 0.0 111.438 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.21 -26.13 13.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.633 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -97.52 95.66 7.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.919 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.22 -21.23 46.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.1 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -40.06 96.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.57 -34.21 69.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.572 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.963 HG23 HD11 ' A' ' 133' ' ' LEU . 38.0 mt -61.85 -52.01 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.61 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.43 -28.98 57.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.24 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 6.1 mm-40 -70.89 -51.12 28.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.32 -52.29 66.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.885 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.011 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.91 -33.79 69.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.255 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.81 97.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.305 178.758 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -66.07 -37.39 85.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.248 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.765 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.1 mp -68.01 -29.65 68.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.86 -19.07 62.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.39 -41.07 6.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.751 0.31 . . . . 0.0 111.541 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.765 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.89 156.73 91.26 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 -179.593 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.654 ' HB2' HG23 ' A' ' 178' ' ' VAL . 53.2 Cg_exo -49.98 130.14 26.7 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 112.792 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.19 -39.78 63.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.652 ' HB1' ' CB ' ' A' ' 227' ' ' ALA . . . -62.94 -38.45 91.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 110.552 179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.766 ' HA ' HG22 ' A' ' 224' ' ' ILE . 58.1 t -59.6 -55.59 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.686 179.397 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.652 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -68.74 -12.61 61.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 178.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.69 -14.16 58.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.44 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.665 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.68 78.83 3.74 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.975 0.387 . . . . 0.0 111.593 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -178.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.554 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -121.31 -44.36 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -167.66 151.09 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.469 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -105.49 136.15 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.317 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.5 m170 -109.57 122.52 47.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.503 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -73.53 102.73 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.724 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -122.96 75.08 48.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.415 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 55.4 Cg_endo -70.62 161.04 47.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.335 2.023 . . . . 0.0 112.597 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.5 p -139.8 164.95 28.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.885 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -54.28 -27.86 38.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -104.28 -16.59 15.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.65 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -135.32 76.62 1.63 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.3 -21.28 33.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.711 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.76 38.37 2.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -85.77 117.8 24.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.008 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.88 133.67 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -104.53 110.58 31.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.497 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.3 m -84.99 156.26 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.686 -179.02 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.77 106.98 15.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.411 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.17 149.23 20.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -67.29 -21.57 65.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.014 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.433 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.9 m-20 -77.21 -13.08 60.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.19 20.35 9.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.617 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 32.9 m-85 -106.52 173.38 6.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.656 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -127.78 119.73 26.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 199' ' ' VAL . 18.6 t -116.77 159.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 207' ' ' VAL . 94.3 p -119.91 149.11 42.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.413 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.23 -179.11 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.808 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -129.93 150.01 51.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.314 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.555 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.3 mt -63.27 -24.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.156 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -35.96 64.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 0.0 111.553 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -131.95 36.15 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.093 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.456 ' CD1' HD23 ' A' ' 218' ' ' LEU . 15.2 t80 -54.84 -51.71 65.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.265 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.3 -43.01 92.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.7 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.44 -38.38 87.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.144 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.522 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 24.1 mmtm -58.94 -53.67 55.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.133 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.523 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.1 mm? -78.35 -22.12 48.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t -60.13 -47.98 83.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.227 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' HIS . . . . . 0.522 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 0.6 OUTLIER -62.57 -15.5 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.605 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -71.03 110.59 7.54 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.786 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 13.2 Cg_exo -69.98 -24.23 28.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -82.68 -40.84 20.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.613 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 178' ' ' VAL . 14.2 mt -69.72 -58.57 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.28 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.232 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.786 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.46 -28.45 20.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.506 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.652 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.61 -27.6 11.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.377 178.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.647 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.7 mt -79.53 -31.9 42.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.23 178.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.45 17.9 23.03 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.672 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.48 -32.51 58.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.62 -37.34 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.788 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.7 m -89.38 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.065 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.948 -179.947 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -95.51 128.53 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.832 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.3 -179.04 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.8 ' HB2' HD13 ' A' ' 134' ' ' LEU . 39.4 m95 -83.85 158.05 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 130.06 53.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.401 ' HG2' ' CD2' ' A' ' 134' ' ' LEU . 3.5 mtm180 -69.77 124.84 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.999 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.0 0.79 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.891 179.639 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.669 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -165.5 176.79 7.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.582 0.229 . . . . 0.0 110.869 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 24.2 m-85 -140.47 173.33 11.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.413 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.604 HG21 ' CD1' ' A' ' 139' ' ' LEU . 22.8 t -132.29 119.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.86 0.362 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.37 111.03 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.965 -179.526 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 43.8 t0 -156.74 134.74 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.796 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 58.52 44.21 18.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.058 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 54.74 27.59 9.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.552 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 87.0 m -142.12 144.0 33.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.4 m-85 -95.31 110.43 22.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.026 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HB2' HD21 ' A' ' 139' ' ' LEU . 9.7 m-30 -82.81 125.34 75.7 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 35.9 Cg_exo -60.23 127.51 23.3 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.218 1.946 . . . . 0.0 112.709 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 1.0 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -110.22 124.75 52.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.1 mt -86.37 165.85 16.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.41 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' A' ' 121' ' ' ILE . 8.8 pt-20 -55.12 -30.79 60.48 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.576 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.25 12.86 14.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 78.6 3.45 86.78 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.081 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.59 ' HB3' HD12 ' A' ' 134' ' ' LEU . 2.0 tpt180 -60.29 97.41 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.222 0.511 . . . . 0.0 110.436 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.45 125.87 30.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.494 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.8 mm? -104.0 92.64 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.586 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 11.3 mttm -71.69 -28.55 63.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.858 0.361 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -81.27 -22.9 38.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.405 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -97.27 24.42 6.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.524 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.03 159.22 53.46 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.272 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.93 157.77 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.911 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 26.22 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -142.41 139.89 31.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.498 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.7 111.67 8.95 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.307 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 22.3 Cg_exo -64.06 100.59 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.386 2.058 . . . . 0.0 112.146 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -65.75 -14.76 61.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.447 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 -27.27 40.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.5 162.91 48.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.934 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 57.6 Cg_endo -75.13 174.36 12.93 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.761 1.641 . . . . 0.0 112.64 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.405 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.5 t -130.78 155.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.087 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.3 mt -115.0 97.51 6.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.601 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 66.2 t -83.2 133.95 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.33 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.88 84.96 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.748 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.484 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.4 m95 -147.36 111.94 5.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.054 0.454 . . . . 0.0 111.508 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -102.13 -27.08 13.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -96.73 95.67 8.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.911 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.39 -21.06 47.24 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.037 178.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.62 98.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.737 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.78 -34.48 71.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 1.0 HG23 HD11 ' A' ' 133' ' ' LEU . 42.1 mt -61.95 -51.8 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.541 178.528 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.2 -29.62 58.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.264 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 16.3 mm-40 -70.14 -51.78 28.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.3 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.458 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.56 -52.54 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.044 179.917 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.999 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.86 -33.55 68.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.311 179.324 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.55 -42.36 97.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.205 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -65.79 -38.36 88.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.809 0.338 . . . . 0.0 110.311 179.003 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.817 ' HA ' HD22 ' A' ' 174' ' ' LEU . 8.0 mp -66.17 -27.22 67.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.397 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.43 -20.29 60.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.523 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -101.41 -41.11 6.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.817 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -68.57 156.94 89.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.615 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 178' ' ' VAL . 54.2 Cg_exo -50.15 124.93 13.75 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.64 2.227 . . . . 0.0 112.679 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.09 -38.42 65.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.591 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.724 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -62.5 -38.45 89.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.449 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.668 ' HA ' HG22 ' A' ' 224' ' ' ILE . 50.5 t -61.31 -60.21 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.794 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -62.07 -23.5 66.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.473 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.23 -24.87 74.59 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.588 178.798 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.18 78.37 7.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.29 134.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -159.53 153.68 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.421 . . . . 0.0 111.102 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -105.05 135.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.149 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.452 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.3 m170 -109.47 119.57 39.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.31 112.24 5.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.781 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 186' ' ' HIS . 1.1 mptp? -135.85 79.72 44.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.85 163.46 38.81 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.279 1.986 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -138.73 163.45 32.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -53.54 -27.07 23.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.63 -16.47 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.656 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -134.0 79.78 1.83 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -58.58 -19.93 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.612 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -114.11 36.52 3.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.74 0.305 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.8 116.36 22.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 110.776 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.08 133.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.402 HG12 ' HD3' ' A' ' 188' ' ' LYS . 33.2 mm -106.01 110.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.74 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.8 m -84.57 157.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.599 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -112.53 107.39 16.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.241 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' MET . . . . . 0.493 ' HE1' HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -56.25 149.29 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 111.309 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -60.58 -24.57 65.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.803 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -85.95 7.07 25.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -16.53 60.91 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.51 177.1 0.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.934 0.367 . . . . 0.0 110.792 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -140.88 115.23 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 199' ' ' VAL . 21.7 t -106.98 157.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 207' ' ' VAL . 83.3 p -121.93 142.78 49.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.123 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.56 -177.27 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.85 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.48 149.06 49.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.476 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.484 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.3 mt -61.21 -23.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.378 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -33.68 59.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -132.4 36.19 3.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.008 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 218' ' ' LEU . 11.9 t80 -58.12 -39.31 78.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.242 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -69.69 -48.79 58.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.186 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.29 -34.17 76.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.106 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -53.32 56.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.392 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -79.31 -22.9 43.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.4 m -64.32 -39.12 93.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.631 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -16.3 52.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.673 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 111.58 13.02 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 122.512 -0.117 . . . . 0.0 110.844 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 16.0 Cg_exo -67.98 -27.31 36.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.255 1.97 . . . . 0.0 112.381 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -80.14 -45.56 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 178' ' ' VAL . 34.6 mt -63.82 -56.28 17.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.066 0.46 . . . . 0.0 109.813 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -56.35 -28.3 58.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.457 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.2 -29.26 13.49 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.65 178.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.497 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.98 -27.33 12.99 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.041 0.448 . . . . 0.0 110.347 178.476 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.724 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.3 mt -76.99 -32.49 57.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.06 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.17 -31.06 65.59 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -72.5 -33.53 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.79 81.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.83 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.38 117.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.904 179.989 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.0 m -93.77 85.9 4.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.84 174.99 7.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.841 ' HB2' HD13 ' A' ' 134' ' ' LEU . 44.9 m95 -90.64 150.46 21.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -101.49 132.2 47.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.673 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.435 ' HG2' HD23 ' A' ' 134' ' ' LEU . 72.5 mtm180 -71.49 127.67 33.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 1.012 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.22 -1.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.875 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.3 177.06 9.94 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.025 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.435 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 23.5 m-85 -139.45 173.95 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.387 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.655 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.7 t -132.42 118.55 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.45 109.6 15.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 14.9 t70 -169.2 144.88 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.74 39.65 20.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.36 0.6 . . . . 0.0 110.804 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.92 29.2 9.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.506 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 145' ' ' THR . 90.8 m -150.59 143.0 24.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 111.294 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.431 ' CD2' HG21 ' A' ' 154' ' ' VAL . 7.1 m-85 -90.71 110.45 21.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.734 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.8 m-85 -80.47 118.55 72.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.04 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 11.2 Cg_endo -57.44 121.23 9.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.023 1.816 . . . . 0.0 112.422 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.901 HD11 HG23 ' A' ' 164' ' ' ILE . 1.4 mt -102.57 125.36 49.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.7 mt -82.98 165.48 19.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.516 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.0 pt-20 -56.03 -30.38 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.677 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.445 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 53.0 p-10 -89.89 13.92 13.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.93 86.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.171 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.586 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -61.65 97.34 0.07 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.13 0.491 . . . . 0.0 110.429 179.649 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.42 121.93 26.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.51 ' N ' HD22 ' A' ' 140' ' ' LEU . 3.2 mm? -104.33 96.6 6.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.586 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 5.0 mttt -72.71 -25.24 61.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.62 -20.86 30.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.737 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.15 23.35 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.19 163.8 54.5 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.615 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -126.68 155.28 42.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.825 0.345 . . . . 0.0 110.533 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 27.12 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.003 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.29 139.06 28.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.43 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.42 3.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.435 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 21.8 Cg_exo -64.54 98.05 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.482 2.122 . . . . 0.0 112.287 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -65.79 -14.49 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.339 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.634 0.254 . . . . 0.0 111.677 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.43 160.34 59.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.866 0.365 . . . . 0.0 111.936 -179.178 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -72.42 173.02 13.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.778 1.652 . . . . 0.0 112.668 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 130' ' ' PHE . 75.9 t -129.62 154.22 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.157 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.609 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.2 mt -112.92 97.96 6.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 110.551 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.36 135.04 25.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.2 87.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.859 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.477 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.3 m95 -148.22 114.9 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.082 0.468 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -105.39 -27.04 11.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.01 95.49 7.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.888 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.43 -20.84 46.65 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.014 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -41.06 98.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.788 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.03 71.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.463 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.901 HG23 HD11 ' A' ' 133' ' ' LEU . 55.3 mt -62.01 -52.08 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.559 178.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.53 -30.93 55.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.3 mm-40 -68.3 -51.0 49.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.223 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.445 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.0 -52.05 67.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.87 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 168' ' ' THR . . . . . 1.012 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.57 -33.73 68.47 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.877 0.37 . . . . 0.0 110.359 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.51 -43.65 97.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.246 178.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.55 -39.46 94.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.751 ' HA ' HD22 ' A' ' 174' ' ' LEU . 8.3 mp -66.93 -27.49 67.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.416 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.92 -22.25 58.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -96.94 -41.19 8.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.773 0.32 . . . . 0.0 111.506 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.751 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.09 155.55 93.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 -179.614 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.611 ' CB ' HD11 ' A' ' 228' ' ' LEU . 61.9 Cg_exo -49.89 129.82 25.5 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.632 2.222 . . . . 0.0 112.791 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.75 68.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.408 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.677 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.93 -37.01 85.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 110.4 179.576 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.759 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.2 t -61.66 -60.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.604 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.669 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -61.55 -24.49 66.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 178.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.47 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.91 -23.5 76.23 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.872 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.99 78.29 9.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.972 0.415 . . . . 0.0 110.865 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.39 163.65 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.372 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -103.83 -51.9 3.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.41 151.22 18.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 110.943 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -104.73 135.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.092 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.449 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 7.5 m170 -109.52 125.25 52.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 189' ' ' PRO . 14.0 t80 -75.49 107.37 7.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.526 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -133.24 70.83 77.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.959 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 187' ' ' TYR . 20.5 Cg_exo -65.82 162.75 33.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.339 2.026 . . . . 0.0 112.252 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.9 p -135.88 164.13 28.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -26.05 11.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.445 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -105.35 -20.21 13.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.416 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -129.41 82.05 2.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -16.57 25.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.045 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -121.1 37.22 4.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.645 0.26 . . . . 0.0 111.233 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.781 ' NH2' HG23 ' A' ' 210' ' ' THR . 3.8 ttm-85 -81.04 119.86 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.719 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.9 m -119.41 135.14 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 208' ' ' SER . 22.6 mm -105.0 110.78 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.483 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 185' ' ' ILE . 2.1 m -89.66 150.71 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.63 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -109.19 108.9 19.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.236 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.48 149.31 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.469 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -64.76 -22.52 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.939 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.67 -13.17 59.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.25 20.35 9.24 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -103.51 172.49 6.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.829 0.347 . . . . 0.0 110.863 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.36 120.05 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 208' ' ' SER . 13.9 t -121.8 160.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.457 ' N ' HG12 ' A' ' 207' ' ' VAL . 56.9 p -121.63 148.89 43.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -160.37 -179.26 7.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.72 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.781 HG23 ' NH2' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -125.59 151.52 46.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.359 179.781 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.459 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.1 mt -66.02 -25.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -79.14 -28.24 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.251 . . . . 0.0 111.403 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.05 35.77 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -57.89 -51.72 68.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.99 -42.01 97.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.511 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.95 -43.05 93.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.429 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 16.1 mmtm -55.03 -52.64 62.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.083 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.51 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.5 mm? -77.39 -22.84 51.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 21.6 t -60.55 -35.47 76.11 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.092 0.472 . . . . 0.0 110.406 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -72.06 -4.94 31.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.007 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 99.4 5.95 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 222' ' ' PRO . . . . . 0.522 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 37.4 Cg_endo -66.07 -27.07 50.0 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.156 1.904 . . . . 0.0 111.911 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -67.27 -45.12 77.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.783 HG23 ' HB3' ' A' ' 181' ' ' ALA . 38.3 mt -70.28 -53.51 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.636 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.53 60.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.315 178.376 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.24 -27.69 15.81 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.606 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.59 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.65 -27.75 12.41 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.134 0.493 . . . . 0.0 110.321 178.377 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.677 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 6.1 mt -78.54 -32.77 48.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.07 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.34 20.11 8.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.563 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.79 28.26 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.244 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -121.12 37.91 4.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.73 139.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.866 179.984 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -140.28 31.91 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 -175.04 4.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' TRP . . . . . 0.844 ' HB2' HD13 ' A' ' 134' ' ' LEU . 43.3 m95 -104.89 149.51 25.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.822 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -101.28 132.17 46.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -71.29 127.29 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.999 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.72 1.48 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.792 179.668 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.698 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.12 176.92 8.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 21.0 m-85 -139.82 173.43 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.226 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.68 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.7 t -132.92 118.58 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.57 111.25 16.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.9 t70 -169.09 145.4 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.79 40.86 22.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 54.1 30.62 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.518 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 145' ' ' THR . 41.6 m -152.0 146.42 25.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.424 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.03 109.18 20.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.657 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.0 m-85 -80.68 128.75 70.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.501 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.1 Cg_exo -64.16 125.33 14.98 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.162 1.908 . . . . 0.0 112.326 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.921 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.1 124.88 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.993 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' A' ' 118' ' ' TRP . 17.3 mt -84.07 166.91 17.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.171 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.2 pt-20 -55.72 -30.96 62.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.551 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 6.9 p30 -90.49 13.3 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.421 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.468 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 80.0 5.93 89.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.601 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.46 96.31 0.03 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 117.253 0.526 . . . . 0.0 110.401 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -80.89 124.15 28.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.184 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.501 ' N ' HD22 ' A' ' 140' ' ' LEU . 2.6 mm? -105.5 95.61 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.3 mtpt -72.33 -25.92 61.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.276 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -84.81 -21.14 30.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.695 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -99.31 25.7 6.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.553 0.216 . . . . 0.0 111.418 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -69.38 160.92 52.63 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.574 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -124.64 159.82 29.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.36 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.46 30.78 4.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.139 0.495 . . . . 0.0 109.714 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' THR . . . . . 0.464 HG23 ' OG1' ' A' ' 145' ' ' THR . 0.0 OUTLIER -154.25 129.62 9.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.483 -178.215 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.17 109.84 2.35 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.787 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.421 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 35.4 Cg_exo -61.19 105.85 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.225 1.95 . . . . 0.0 112.127 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.68 -15.62 61.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.481 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -81.53 -26.94 34.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.51 162.4 53.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.04 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.9 Cg_endo -76.5 173.69 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.99 1.793 . . . . 0.0 112.749 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.0 t -129.55 153.27 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.886 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 133' ' ' LEU . 56.5 mt -112.42 97.75 6.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.006 0.431 . . . . 0.0 110.638 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.8 t -82.43 134.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.514 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.74 86.91 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.722 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.8 m95 -148.41 112.93 5.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -103.42 -26.23 12.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.514 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -98.11 96.04 7.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.903 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.55 -20.97 48.14 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.028 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -40.46 97.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.96 -33.77 68.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.697 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.921 ' CG2' HD11 ' A' ' 133' ' ' LEU . 63.6 mt -62.28 -52.11 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.675 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.24 -30.41 59.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.187 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.7 mm-40 -67.9 -51.14 51.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 110.149 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.9 -52.47 65.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.757 179.609 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.999 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.3 -33.7 67.94 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.268 179.253 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.13 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -66.34 -34.76 78.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.37 . . . . 0.0 110.22 178.752 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.625 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.1 mp -71.79 -28.18 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -19.23 61.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.482 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.17 -40.24 8.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.8 0.334 . . . . 0.0 111.48 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.816 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -73.65 156.0 88.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.67 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.5 Cg_exo -51.41 124.7 14.77 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.02 36.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.925 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.72 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -64.93 -41.48 95.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 224' ' ' ILE . 48.3 t -59.17 -60.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.949 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 179' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -62.58 -24.35 67.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -22.48 77.66 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.101 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 181' ' ' ALA . . . . . 0.583 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.15 78.33 9.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.931 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.4 ptp 177.86 128.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 m -64.91 -48.78 72.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.47 153.92 8.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.984 0.421 . . . . 0.0 110.997 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -102.89 136.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.269 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.438 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -111.06 116.8 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.488 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -66.71 112.02 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.853 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -133.54 78.4 62.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 56.8 Cg_endo -71.38 162.11 43.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.306 2.004 . . . . 0.0 112.53 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.9 p -138.64 161.65 36.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.149 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ptt-85 -53.84 -24.83 17.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.376 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -104.99 -20.19 13.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.429 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -134.91 82.02 1.93 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.07 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.04 -19.34 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.659 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -113.17 35.85 3.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -82.91 115.89 21.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.788 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.92 134.53 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.3 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 207' ' ' VAL . 24.3 mm -105.63 110.6 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.622 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 199' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.28 153.89 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.452 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -111.5 100.57 9.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.207 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.8 tpp -55.85 149.42 14.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.505 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.467 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 3.8 p-10 -66.78 -20.17 65.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.039 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.83 -13.47 60.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.54 20.31 11.09 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.724 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -113.25 153.64 28.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 110.723 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.53 117.55 34.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.48 ' HB ' HG22 ' A' ' 199' ' ' VAL . 10.8 t -111.96 160.22 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.425 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 207' ' ' VAL . 88.0 p -121.57 146.36 47.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.005 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 209' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -158.18 179.5 9.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -125.19 152.94 43.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 211' ' ' ILE . . . . . 0.439 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.2 mt -68.37 -23.89 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.897 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -36.58 57.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.46 35.86 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.962 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.2 t80 -56.17 -45.95 79.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.127 -179.598 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.27 82.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -60.86 -41.47 95.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' LYS . . . . . 0.431 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -54.11 -52.35 61.29 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.648 179.713 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.4 mm? -83.34 -19.48 36.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 38.0 t -64.88 -30.72 71.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.942 0.401 . . . . 0.0 110.854 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -81.55 11.26 4.78 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.49 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -105.94 101.85 35.88 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.2 -35.02 87.62 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.241 1.961 . . . . 0.0 112.354 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.536 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -66.14 -44.83 83.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.224 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 178' ' ' VAL . 42.5 mt -65.58 -54.56 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.66 -29.37 59.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.383 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -50.97 -28.93 10.93 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.487 178.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 227' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -52.77 -25.22 10.6 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.491 178.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.72 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 1.2 mt -80.91 -30.08 35.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.405 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.1 -31.23 65.86 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.809 0.338 . . . . 0.0 111.078 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 74.55 -61.05 0.5 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.024 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -177.11 37.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.79 121.95 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.915 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.819 ' HB2' HD13 ' A' ' 134' ' ' LEU . 54.7 m95 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.787 0.327 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.03 129.61 48.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -68.65 127.51 33.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.095 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.0 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.89 1.18 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.848 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.21 177.02 8.67 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.664 0.268 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.453 ' HB2' HG22 ' A' ' 154' ' ' VAL . 25.1 m-85 -140.04 173.17 11.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.662 HG21 ' HG ' ' A' ' 139' ' ' LEU . 19.5 t -133.34 119.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.41 109.52 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.911 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -158.5 137.55 11.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 57.95 42.64 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.61 30.56 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.394 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 145' ' ' THR . 89.3 m -147.82 143.0 27.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 0.0 111.001 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.484 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.1 m-85 -92.36 110.25 21.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 110.678 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.7 ' HB2' HD21 ' A' ' 139' ' ' LEU . 11.8 m-30 -83.07 111.57 31.47 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.388 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 82.6 Cg_exo -47.14 126.11 11.1 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.546 2.164 . . . . 0.0 113.089 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.981 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.14 125.05 51.77 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.708 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.1 mt -84.31 166.04 17.78 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.9 pt-20 -55.45 -30.63 60.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.534 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -91.31 15.61 11.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.357 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.429 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.13 7.13 86.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.155 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.608 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -60.61 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.287 0.543 . . . . 0.0 110.213 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.15 119.95 23.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 140' ' ' LEU . 3.1 mm? -99.59 94.27 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 22.2 mttt -72.98 -29.43 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -82.2 -21.67 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.95 25.38 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.431 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.39 160.06 53.59 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.433 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.0 155.42 43.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.657 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.76 2.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.404 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -144.81 139.91 28.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.382 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.1 117.99 61.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.83 107.06 2.37 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.146 1.898 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.9 t -67.5 -12.85 61.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.74 -27.0 50.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.707 0.289 . . . . 0.0 111.397 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.1 162.83 45.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.868 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.4 Cg_endo -76.32 174.09 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.064 1.843 . . . . 0.0 112.733 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 130' ' ' PHE . 72.9 t -130.38 153.98 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.939 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.569 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.4 mt -113.04 97.88 6.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.13 0.49 . . . . 0.0 110.652 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.7 t -82.81 134.67 26.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.361 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.2 87.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.691 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.8 m95 -148.78 111.72 4.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 111.465 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.76 -26.67 13.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.528 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -97.52 96.18 8.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.301 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.906 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.19 -21.27 46.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.999 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.48 97.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.0 70.23 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.532 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.981 HG23 HD11 ' A' ' 133' ' ' LEU . 49.0 mt -62.57 -51.84 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.61 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.58 -27.93 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.384 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.5 mm-40 -71.29 -51.47 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 110.392 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.452 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.92 -52.34 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.955 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.0 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.63 -33.72 68.56 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.848 0.356 . . . . 0.0 110.352 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.98 97.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.159 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -63.51 -37.77 88.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.682 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.1 mp -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.068 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.02 -18.64 61.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.723 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -101.88 -40.49 6.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.685 0.279 . . . . 0.0 111.683 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.3 pp -71.16 156.93 91.23 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.774 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.679 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.9 Cg_exo -50.73 124.29 13.26 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.449 2.099 . . . . 0.0 112.466 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.54 -38.48 45.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.68 -41.24 98.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 110.593 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 51.9 t -59.71 -60.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.789 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.7 -24.03 66.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.542 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.513 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.81 -22.69 76.6 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.012 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.09 78.27 8.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 ptp 178.55 140.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 m -80.91 -53.88 6.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.3 150.67 20.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.198 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.527 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -102.52 135.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.292 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.2 m170 -109.56 118.8 37.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.769 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.447 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -70.28 110.5 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.955 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -133.01 78.34 65.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.423 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 60.8 Cg_endo -74.08 162.77 38.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.256 1.971 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.1 p -140.3 170.23 16.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -57.88 -25.35 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.306 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -104.85 -12.72 16.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.05 83.12 1.73 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 111.335 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.13 -19.08 61.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.546 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -112.42 33.71 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -81.5 115.17 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.66 133.43 63.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.221 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.6 mm -104.69 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -87.74 151.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.712 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -110.36 101.67 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.552 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.4 tpp -55.45 149.43 13.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.513 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -67.05 -20.58 65.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.055 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.79 -13.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.72 20.39 10.09 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.87 165.46 11.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 110.755 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.62 117.43 29.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 201' ' ' MET . 26.1 t -116.54 158.76 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 110.712 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 207' ' ' VAL . 54.2 p -121.79 149.3 43.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.0 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.32 -177.72 6.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -127.59 151.88 48.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.297 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.501 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -65.62 -24.23 34.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.964 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -76.46 -37.72 56.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.394 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -127.84 35.75 4.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.9 t80 -57.69 -42.23 83.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.801 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -64.12 -48.73 74.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.768 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.41 -37.33 86.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 13.9 mmtm -58.21 -53.13 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.532 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.477 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -82.99 -20.05 35.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.386 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.6 t -65.68 -36.61 84.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.061 0.457 . . . . 0.0 110.752 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -70.59 -7.73 46.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.069 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.411 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -80.2 112.16 28.21 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 122.356 -0.215 . . . . 0.0 110.786 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.3 -30.64 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.26 1.973 . . . . 0.0 112.542 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -77.37 -45.34 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.575 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.8 mt -63.04 -57.12 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.993 0.425 . . . . 0.0 109.935 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.423 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.513 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.825 ' HB2' HD13 ' A' ' 134' ' ' LEU . 55.6 m95 . . . . . 0 N--CA 1.456 -0.167 0 CA-C-O 120.881 0.372 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -98.59 131.87 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.663 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HG2' HD23 ' A' ' 134' ' ' LEU . 8.0 mtt85 -73.12 127.65 33.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.15 -0.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.768 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.687 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.03 176.76 10.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.67 0.272 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 22.6 m-85 -139.07 173.7 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.16 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.645 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.8 t -133.97 117.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.917 0.389 . . . . 0.0 110.858 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 111.45 16.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.097 -179.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 t70 -168.98 144.1 3.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.793 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 40.48 21.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.14 29.45 10.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.616 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 145' ' ' THR . 90.8 m -149.75 142.68 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.326 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.9 m-85 -91.41 109.38 20.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.172 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.734 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.8 m-85 -79.95 122.94 83.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.31 121.17 9.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.995 1.796 . . . . 0.0 112.372 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.916 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -101.18 125.28 47.79 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.076 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.5 mt -82.22 166.17 19.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.397 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.4 pt-20 -56.6 -30.06 62.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -90.86 15.32 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.445 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 76.73 4.32 81.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.158 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.591 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt85 -61.88 97.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 110.488 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.46 116.62 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.23 97.44 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.96 0.41 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 27.5 mttt -71.77 -26.02 62.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.12 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -77.26 -21.0 54.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -103.89 26.69 8.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.562 0.22 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.67 162.86 52.32 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.525 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.05 156.96 41.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.357 . . . . 0.0 110.613 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 26.72 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.401 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -145.83 140.37 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.446 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 118.78 56.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 67.3 Cg_endo -76.09 106.85 2.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.999 1.799 . . . . 0.0 112.678 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.5 t -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.199 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -26.95 47.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.726 0.298 . . . . 0.0 111.419 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.56 159.98 49.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 54.5 Cg_endo -71.52 172.92 13.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.046 1.83 . . . . 0.0 112.587 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.6 t -128.95 154.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.01 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.4 mt -112.93 97.79 6.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -82.36 135.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.492 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.62 88.18 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.782 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.9 m95 -148.46 110.66 4.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 111.549 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -100.98 -25.25 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.631 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -99.37 96.27 7.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.328 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.906 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.94 -20.78 50.34 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.952 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -40.41 97.16 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.31 -34.06 70.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.57 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.916 HG23 HD11 ' A' ' 133' ' ' LEU . 50.4 mt -61.99 -51.93 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.573 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.64 -29.18 51.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.28 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 60.2 mm-40 -71.08 -50.51 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.386 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.459 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.87 -52.52 65.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.771 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.026 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.56 -33.59 68.3 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 110.248 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.38 -42.72 97.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.181 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -64.33 -37.31 87.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.105 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.652 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -68.93 -27.26 65.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.314 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.15 -20.09 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.522 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -99.1 -40.55 7.95 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.694 0.283 . . . . 0.0 111.381 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.98 155.28 90.58 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.673 ' O ' HD12 ' A' ' 174' ' ' LEU . 54.2 Cg_exo -51.22 125.27 15.95 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.499 2.133 . . . . 0.0 112.443 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.95 -36.86 40.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.797 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.97 -41.17 97.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 110.355 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.772 ' HA ' HG22 ' A' ' 224' ' ' ILE . 40.3 t -59.46 -60.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.106 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.776 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.7 pp -61.44 -26.52 67.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.269 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.505 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.63 -22.01 78.83 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.97 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.855 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -82.05 78.07 8.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.911 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 176.88 154.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.1 t -91.98 -46.75 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.159 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -166.0 151.55 8.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -103.92 135.5 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.221 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 15.7 m170 -107.97 122.8 47.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 18.1 t80 -76.53 102.8 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.744 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -123.39 70.66 44.92 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.409 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 41.1 Cg_endo -67.96 160.07 50.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.35 2.034 . . . . 0.0 112.636 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.5 p -140.12 163.19 33.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.011 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -53.39 -27.33 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.51 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.97 -19.85 14.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -133.29 76.9 1.7 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.941 0.401 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.37 -21.05 33.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.59 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.57 37.88 3.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 111.237 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -83.91 112.76 20.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.836 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.59 132.85 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 207' ' ' VAL . 23.7 mm -104.72 108.14 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.425 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.496 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.15 151.82 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -108.75 109.8 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.12 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 149.16 7.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.48 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.59 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.3 p30 -61.4 -23.25 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.01 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.5 -13.22 59.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.819 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.94 20.35 9.41 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.792 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -101.28 173.09 6.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.823 0.344 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.57 120.52 36.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 208' ' ' SER . 40.8 t -121.23 159.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.479 ' N ' HG12 ' A' ' 207' ' ' VAL . 96.8 p -120.14 149.09 42.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.151 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -163.64 -179.34 6.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.576 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -128.24 155.06 45.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.431 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.501 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.8 mt -69.87 -23.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.753 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -31.82 57.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -134.1 35.85 3.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 13.1 t80 -56.88 -46.97 81.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.71 99.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.35 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.19 -45.83 89.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.141 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.5 mmpt? -53.34 -53.04 56.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.604 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.489 HD12 HD13 ' A' ' 224' ' ' ILE . 3.5 mm? -78.96 -22.43 45.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.079 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.6 m -64.67 -28.28 69.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.797 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.8 8.52 9.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.425 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -105.97 102.65 40.5 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.324 -0.235 . . . . 0.0 110.406 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.93 -34.31 71.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.177 1.918 . . . . 0.0 112.387 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -65.57 -45.19 84.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.855 HG23 ' HB3' ' A' ' 181' ' ' ALA . 31.7 mt -65.83 -54.76 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.51 178.579 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.787 ' HB2' HD13 ' A' ' 134' ' ' LEU . 66.5 m95 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.864 0.364 . . . . 0.0 110.961 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.6 ptt85 -99.53 132.32 44.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HG2' HD23 ' A' ' 134' ' ' LEU . 18.2 mtm180 -71.91 127.48 32.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.162 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.02 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.41 1.15 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.846 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.675 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.15 177.01 8.72 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 120.643 0.259 . . . . 0.0 111.092 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HB2' HG22 ' A' ' 154' ' ' VAL . 28.8 m-85 -140.08 173.78 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.663 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.6 t -133.54 117.37 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 111.002 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.46 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.49 112.57 17.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.27 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 27.8 t70 -169.18 142.21 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.769 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 41.22 20.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.161 0.505 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.12 28.09 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.672 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 145' ' ' THR . 82.1 m -147.61 142.32 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.317 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.6 m-85 -92.55 110.19 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.9 m-85 -79.96 119.35 76.37 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.922 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 11.8 Cg_endo -58.31 121.09 9.4 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.92 1.747 . . . . 0.0 112.351 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.919 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -102.04 125.74 48.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.15 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.787 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.7 mt -83.27 165.97 18.92 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.312 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' ' 121' ' ' ILE . 9.1 pt-20 -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.61 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -90.93 15.65 10.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.51 86.69 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.25 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.62 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -60.62 95.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.327 0.564 . . . . 0.0 110.243 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -81.03 117.29 21.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.7 mm? -100.77 96.78 7.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.2 mttt -73.25 -25.73 60.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.066 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -84.55 -21.17 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.686 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -100.83 25.47 7.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.649 0.261 . . . . 0.0 111.521 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.45 164.41 54.16 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.659 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -127.87 156.66 42.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 26.55 3.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.424 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -144.77 141.47 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.91 118.27 61.68 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 106.59 2.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.04 1.827 . . . . 0.0 112.567 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.48 -12.71 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.257 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.0 -27.42 48.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 111.367 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.97 161.44 53.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.851 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.8 Cg_endo -74.4 173.28 14.52 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.969 1.779 . . . . 0.0 112.517 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.3 t -129.91 154.47 40.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.9 mt -113.48 97.97 6.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.026 0.441 . . . . 0.0 110.529 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.9 t -83.88 135.17 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.326 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.46 85.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.69 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.537 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.6 m95 -148.57 116.45 6.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.074 0.464 . . . . 0.0 111.452 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.35 -25.68 11.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.464 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.06 95.52 7.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.919 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.28 -21.01 46.2 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.071 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.17 96.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.84 -33.59 68.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.589 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.919 HD12 ' HA2' ' A' ' 161' ' ' GLY . 43.5 mt -62.45 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.587 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.75 55.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.243 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.2 mm-40 -69.62 -50.43 44.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.234 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.73 -52.31 66.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.737 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.02 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.06 -33.76 69.38 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.911 0.386 . . . . 0.0 110.23 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -40.71 97.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.224 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -66.25 -37.37 85.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.247 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.568 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -69.02 -27.69 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.269 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.59 60.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.552 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.34 -40.44 7.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.309 . . . . 0.0 111.534 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.46 157.34 89.23 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.656 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.6 Cg_exo -50.76 124.01 12.73 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.494 2.129 . . . . 0.0 112.56 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.08 28.72 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.76 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.76 84.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.369 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.751 ' HA ' HG22 ' A' ' 224' ' ' ILE . 45.0 t -59.22 -59.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.8 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.2 pp -61.27 -25.24 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.46 -23.03 77.99 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.951 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.76 78.15 9.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.915 0.388 . . . . 0.0 110.715 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.84 138.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -78.9 -50.36 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -162.73 152.68 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.53 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.09 136.46 37.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.303 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 5.3 m170 -108.49 116.17 31.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 48.2 t80 -70.21 105.04 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -126.71 75.48 75.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 44.4 Cg_endo -68.43 160.55 48.67 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.232 1.955 . . . . 0.0 112.41 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.1 p -139.44 162.38 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -54.24 -26.24 27.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.36 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -103.22 -19.71 14.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.424 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.63 79.6 1.81 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.04 -21.43 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.55 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -113.42 38.59 2.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.678 0.275 . . . . 0.0 111.111 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.19 115.92 22.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.04 132.81 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.275 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.1 mm -105.34 111.69 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.628 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.5 m -86.62 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.55 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -112.2 105.19 13.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.022 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.24 149.09 7.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -67.24 -22.44 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.913 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.5 -10.72 59.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.39 9.15 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.622 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.75 176.17 5.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.853 0.358 . . . . 0.0 110.741 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.93 113.08 11.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 199' ' ' VAL . 15.0 t -109.84 159.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 207' ' ' VAL . 76.5 p -121.3 146.73 46.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.669 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.493 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.6 -179.74 7.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.2 147.66 51.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.326 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.537 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -58.82 -24.85 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.615 0.245 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.95 58.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.553 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -134.21 35.96 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.235 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.05 -50.97 71.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.753 0.311 . . . . 0.0 110.921 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.65 89.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.725 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.77 -41.04 99.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.146 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.493 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 26.7 mmtt -55.41 -53.45 56.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.217 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -77.8 -23.03 49.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.1 t -60.41 -34.26 73.68 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.092 0.472 . . . . 0.0 110.269 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -78.24 0.83 23.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.796 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.53 99.62 6.75 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.53 -20.08 47.9 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.105 1.87 . . . . 0.0 112.41 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.2 -52.27 12.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.152 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.787 HG23 ' HB3' ' A' ' 181' ' ' ALA . 23.5 mt -63.64 -53.04 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.449 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.495 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.801 ' HB2' HD13 ' A' ' 134' ' ' LEU . 61.3 m95 . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.906 0.384 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -95.12 145.81 24.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.519 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HG2' HD23 ' A' ' 134' ' ' LEU . 14.3 mtm180 -86.92 124.28 32.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 110.456 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 168' ' ' THR . 0.1 OUTLIER -126.98 -0.37 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.869 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.69 176.64 10.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HB2' HG22 ' A' ' 154' ' ' VAL . 19.8 m-85 -139.1 173.18 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.181 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.632 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.5 t -132.95 118.17 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.939 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.459 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.27 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 39.2 t0 -169.31 143.78 2.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.683 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 60.0 40.56 18.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 53.94 27.67 7.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.679 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 86.8 m -148.17 142.23 25.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.459 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 10.5 m-85 -90.41 109.75 20.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.5 m-85 -80.28 123.95 82.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.195 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.1 124.09 14.18 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.219 1.946 . . . . 0.0 112.569 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.923 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.3 125.31 50.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.312 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.3 mt -83.35 167.87 17.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.421 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.3 pt-20 -57.09 -30.87 64.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.5 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -90.94 15.28 11.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.374 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.452 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.24 7.86 86.91 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.091 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.624 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.07 96.76 0.05 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.28 0.54 . . . . 0.0 110.282 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.04 113.33 21.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.969 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.9 mt -104.54 97.93 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 32.6 mttt -69.57 -27.11 64.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.11 -22.09 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.693 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -102.28 25.31 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.483 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.87 163.73 52.63 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.693 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -127.72 156.22 42.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.55 27.08 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.947 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.77 140.03 26.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.568 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.2 118.56 51.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.38 105.4 2.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.068 1.846 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.9 t -67.61 -12.59 60.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.87 -26.94 44.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.492 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.69 163.44 38.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 59.9 Cg_endo -75.79 172.86 15.49 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.915 1.743 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 130' ' ' PHE . 74.9 t -128.96 154.17 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.214 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.57 HD12 ' CD1' ' A' ' 133' ' ' LEU . 61.7 mt -113.54 97.68 6.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.153 0.501 . . . . 0.0 110.614 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.2 t -83.03 134.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.352 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.748 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -147.9 113.89 5.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.1 0.476 . . . . 0.0 111.532 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -104.46 -25.64 12.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.518 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -98.79 95.69 7.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.243 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.878 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.58 -20.75 47.47 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.076 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -40.82 97.85 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.86 70.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.538 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.923 ' CG2' HD11 ' A' ' 133' ' ' LEU . 64.8 mt -62.54 -52.05 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -31.76 61.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.04 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 9.0 mm-40 -65.95 -52.08 52.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.057 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.61 -52.28 66.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.812 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.026 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.08 -33.65 69.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.41 97.73 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.321 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -65.62 -36.99 85.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.191 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.607 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -67.62 -28.23 67.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.2 -18.54 61.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.58 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -103.14 -40.93 6.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -70.3 157.41 90.02 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.666 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.4 Cg_exo -51.27 123.99 13.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.67 -35.74 32.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.97 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.7 -41.67 92.09 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.427 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.803 ' HA ' HG22 ' A' ' 224' ' ' ILE . 66.9 t -58.66 -55.86 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -68.68 -12.74 61.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.65 -12.95 58.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.53 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.67 78.34 3.74 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.991 0.395 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.14 170.14 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.5 m -103.86 -48.16 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -167.73 154.07 7.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.72 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.581 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -104.63 134.98 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.224 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -108.96 117.57 34.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -69.21 105.14 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.739 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -128.63 78.61 75.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.39 161.73 43.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.251 1.967 . . . . 0.0 112.479 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.6 p -136.93 163.49 30.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -54.59 -25.77 28.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.456 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.71 -17.11 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.421 ' HD1' HG21 ' A' ' 210' ' ' THR . 89.5 m-85 -135.16 81.92 1.92 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -58.86 -19.69 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.721 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -113.81 36.93 3.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -83.81 115.09 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.6 m -116.86 136.11 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 207' ' ' VAL . 25.4 mm -105.37 110.58 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.581 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.9 152.14 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.472 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.33 105.97 15.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -53.84 149.42 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.488 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -64.3 -21.62 66.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.22 -13.32 59.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.74 20.38 9.49 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.815 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.96 168.79 8.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.285 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -119.04 117.01 27.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 208' ' ' SER . 40.9 t -118.08 158.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.716 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 207' ' ' VAL . 77.3 p -121.76 147.35 46.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.65 147.89 7.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.421 HG21 ' HD1' ' A' ' 193' ' ' TYR . 0.9 OUTLIER -95.51 147.46 23.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.694 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.492 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.5 mt -59.59 -27.33 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.092 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.76 72.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.551 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -133.07 35.85 3.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.151 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -56.2 -43.88 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -63.87 -49.13 73.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.935 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -37.08 86.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.865 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.79 -53.91 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.502 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.4 mm? -83.17 -21.81 33.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.427 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 m -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 110.634 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -72.45 -4.61 31.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -90.54 110.68 42.86 Favored Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 122.276 -0.265 . . . . 0.0 110.803 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -66.41 -30.31 44.45 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.184 1.922 . . . . 0.0 112.393 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -73.92 -44.69 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.392 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.803 HG22 ' HA ' ' A' ' 178' ' ' VAL . 27.9 mt -64.56 -56.49 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 109.805 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.796 ' HB2' HD13 ' A' ' 134' ' ' LEU . 57.8 m95 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -101.36 130.38 47.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HG2' HD23 ' A' ' 134' ' ' LEU . 25.0 mtm180 -69.36 126.57 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.123 0.487 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.057 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.24 -1.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.787 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 171' ' ' LEU . . . -161.79 176.7 10.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.1 m-85 -138.09 173.6 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.641 HG21 ' HG ' ' A' ' 139' ' ' LEU . 13.5 t -134.24 119.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.414 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 109.46 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.999 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 37.3 t70 -161.31 138.05 8.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 58.59 42.62 20.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 54.17 28.42 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.546 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 145' ' ' THR . 89.8 m -145.66 141.97 28.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.424 ' CD2' HG21 ' A' ' 154' ' ' VAL . 8.2 m-85 -91.98 109.04 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.405 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.725 ' HB2' HD21 ' A' ' 139' ' ' LEU . 11.7 m-30 -79.73 123.03 84.14 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.784 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 123.89 14.05 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 112.642 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 164' ' ' ILE . 1.5 mt -105.89 125.01 50.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.946 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.7 mt -84.4 165.92 17.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.191 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 121' ' ' ILE . 4.8 pt-20 -55.47 -30.33 60.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.505 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.4 15.0 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.368 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.99 6.35 87.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.288 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.61 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.95 95.65 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.246 0.523 . . . . 0.0 110.358 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.725 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -86.1 112.98 21.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.876 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -102.74 98.08 8.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.625 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 17.1 mttp -69.8 -28.85 66.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -74.45 -23.71 58.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.78 25.54 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.451 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.08 162.88 52.94 Favored Glycine 0 CA--C 1.51 -0.246 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.479 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.7 155.3 44.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.794 0.331 . . . . 0.0 110.808 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 27.62 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.57 139.12 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.18 118.32 54.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.064 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -77.73 105.54 2.04 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.887 . . . . 0.0 112.726 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -67.88 -12.17 60.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.191 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -77.86 -27.17 49.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 111.386 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -143.83 160.01 51.66 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 47.5 Cg_endo -71.76 173.25 12.95 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.103 1.869 . . . . 0.0 112.71 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 123' ' ' TYR . 72.6 t -129.48 154.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.943 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.611 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.7 mt -112.95 97.99 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.9 t -83.04 134.96 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.33 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.75 85.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.842 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.562 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.1 m95 -148.93 112.7 5.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.41 -25.11 13.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.58 95.41 7.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.236 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.92 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.03 -21.46 45.71 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.085 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -40.06 96.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.67 67.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.6 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.946 HG23 HD11 ' A' ' 133' ' ' LEU . 43.7 mt -61.93 -51.74 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.573 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.09 58.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 1.6 mm-40 -68.81 -51.76 37.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.439 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -57.95 -51.74 68.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.734 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.057 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.65 -33.72 70.39 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.177 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.73 -41.55 95.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.167 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -65.04 -39.42 93.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.986 0.422 . . . . 0.0 110.03 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.608 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.1 mp -67.49 -28.56 67.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -20.49 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.691 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -99.64 -41.32 7.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.506 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.2 pp -70.12 157.66 89.31 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.66 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.4 Cg_exo -51.38 123.6 12.4 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.482 2.121 . . . . 0.0 112.539 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.53 18.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.58 -43.1 81.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.387 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 50.1 t -58.91 -59.88 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.866 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -60.6 -24.8 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.355 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.421 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.14 -23.27 76.41 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.981 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.857 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.33 78.15 9.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.918 0.39 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.31 157.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.507 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 74.0 m -100.8 -55.56 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.172 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.1 149.69 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 199' ' ' VAL . 4.6 mt -106.0 135.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.266 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.0 m170 -107.77 122.18 46.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -76.35 105.07 7.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.771 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -124.82 73.76 64.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.21 158.88 51.04 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.307 2.005 . . . . 0.0 112.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.6 p -143.71 167.11 23.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -25.8 59.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.294 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -100.95 -17.64 16.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.59 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -143.22 78.7 1.61 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 121.008 0.432 . . . . 0.0 111.146 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.42 -20.17 42.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.633 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.1 36.81 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -84.89 115.57 22.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.2 m -120.51 133.06 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 207' ' ' VAL . 21.6 mm -104.47 112.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 185' ' ' ILE . 3.1 m -89.04 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -110.82 103.73 12.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.969 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.572 ' SD ' HD11 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -50.29 149.03 3.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.652 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -64.76 -22.28 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.963 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -78.9 -13.33 59.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.42 9.32 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.709 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 27.5 m-85 -104.18 164.25 11.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.21 120.77 42.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 208' ' ' SER . 40.4 t -122.0 158.54 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.645 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 207' ' ' VAL . 39.3 p -121.93 149.21 43.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.91 -178.0 5.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -129.95 154.62 47.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.398 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.562 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -67.69 -21.88 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.123 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -30.28 30.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.5 35.04 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.43 ' CD1' HD23 ' A' ' 218' ' ' LEU . 12.6 t80 -59.13 -47.11 86.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.795 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.71 -46.27 90.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.16 -37.71 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -59.4 -53.4 58.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.457 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -79.72 -22.0 43.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.2 t -63.8 -40.56 96.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.382 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -64.5 -14.65 58.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.805 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.422 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -75.91 111.33 14.23 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.467 -0.093 . . . . 0.0 110.886 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -69.12 -25.76 31.23 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.273 1.982 . . . . 0.0 112.599 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.5 -40.77 25.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.578 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.857 HG23 ' HB3' ' A' ' 181' ' ' ALA . 17.3 mt -69.37 -58.27 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.436 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.216 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.809 ' HB2' HD13 ' A' ' 134' ' ' LEU . 51.8 m95 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.806 0.336 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.5 128.79 45.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.691 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.4 mtm-85 -68.08 127.8 34.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.025 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.53 1.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.84 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.84 176.62 8.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.65 0.262 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.435 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 23.1 m-85 -139.66 173.19 11.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.588 HG21 ' HG ' ' A' ' 139' ' ' LEU . 22.4 t -133.02 118.95 34.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.0 111.038 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.494 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.22 112.0 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.009 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.1 t70 -156.47 133.86 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 58.16 44.6 18.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.969 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 55.01 28.27 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.433 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 86.5 m -142.08 143.46 33.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.494 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.4 m-85 -95.63 110.7 22.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.721 ' HB2' HD21 ' A' ' 139' ' ' LEU . 9.2 m-30 -84.05 124.79 74.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.463 ' HB2' HD12 ' A' ' 140' ' ' LEU . 31.3 Cg_exo -59.61 127.3 23.2 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.295 1.997 . . . . 0.0 112.841 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 1.001 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.88 125.15 52.49 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.733 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.3 mt -85.13 165.15 17.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.513 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.5 pt-20 -55.25 -29.94 59.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.609 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -91.32 15.6 11.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.357 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.77 3.33 79.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.341 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.591 ' HB3' HD12 ' A' ' 134' ' ' LEU . 3.3 tpt180 -61.31 97.58 0.07 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.343 0.572 . . . . 0.0 110.533 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -78.79 132.27 36.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.58 ' N ' HD23 ' A' ' 139' ' ' LEU . 75.1 mt -111.51 92.71 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.4 mttt -71.63 -28.49 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -80.23 -23.33 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.495 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.467 ' HG3' HD13 ' A' ' 140' ' ' LEU . 46.7 mm-40 -97.85 26.07 5.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.494 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -77.33 159.94 49.12 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.559 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 3.3 t -130.86 159.44 37.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 20.39 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.297 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.471 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -136.66 142.19 43.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.596 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.21 119.56 76.98 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.9 Cg_endo -73.71 106.58 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.046 1.831 . . . . 0.0 112.539 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -13.5 61.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.302 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.14 42.94 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.626 0.25 . . . . 0.0 111.554 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.56 161.11 56.41 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.83 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.518 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 57.7 Cg_endo -73.63 173.42 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.959 1.773 . . . . 0.0 112.673 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 130' ' ' PHE . 65.3 t -130.05 153.09 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.7 mt -112.84 97.55 6.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.7 t -82.73 134.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.452 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.56 85.98 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.78 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.509 ' CH2' HD11 ' A' ' 211' ' ' ILE . 68.0 m95 -147.1 110.82 4.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 0.0 111.607 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -101.38 -27.11 13.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.95 95.26 8.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.246 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.44 -20.91 47.07 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.983 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -40.7 98.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -34.41 71.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.449 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.001 HG23 HD11 ' A' ' 133' ' ' LEU . 47.6 mt -61.81 -51.95 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.622 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.1 60.02 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -69.46 -51.44 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.9 -52.43 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.958 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.01 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.23 -33.61 69.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.856 0.36 . . . . 0.0 110.334 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.89 97.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.346 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -64.94 -37.75 88.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.163 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.589 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.4 mp -67.88 -27.47 66.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.249 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.13 -19.47 60.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.513 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.49 -40.72 7.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.674 0.273 . . . . 0.0 111.551 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -71.04 157.1 91.05 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.474 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.657 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.0 Cg_exo -51.08 123.7 12.42 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 112.498 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -34.08 30.23 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.727 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.21 87.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 110.357 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.765 ' HA ' HG22 ' A' ' 224' ' ' ILE . 49.1 t -58.96 -60.29 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.902 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -60.42 -25.02 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.47 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.93 -23.1 77.14 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.606 -0.806 . . . . 0.0 111.818 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.685 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.23 78.29 8.84 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 110.815 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 178.38 133.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.57 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 m -70.48 -61.64 1.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -154.86 152.32 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -102.76 135.21 41.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.433 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -107.75 114.89 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.045 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.473 ' CE2' ' CE3' ' A' ' 158' ' ' TRP . 0.6 OUTLIER -68.47 114.21 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -134.59 76.09 61.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 58.5 Cg_endo -72.21 157.68 53.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.415 2.077 . . . . 0.0 112.659 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.4 p -141.96 161.99 36.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.891 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -55.52 -25.64 38.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.9 -22.13 15.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.108 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -138.46 75.13 1.5 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.02 0.438 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.18 -21.22 21.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.757 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.18 39.26 2.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 111.08 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -87.91 122.92 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.4 mm -104.41 108.77 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.534 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -87.58 151.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 0.0 111.54 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.77 105.02 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.073 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.59 149.13 3.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.659 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -64.13 -22.64 67.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.15 -13.3 60.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.36 9.38 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.678 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -105.32 167.67 9.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.933 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -116.39 120.76 39.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 208' ' ' SER . 46.2 t -120.79 158.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 207' ' ' VAL . 90.7 p -122.29 148.97 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.125 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -164.27 -179.17 5.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.663 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.4 p -126.56 152.95 45.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.509 HD11 ' CH2' ' A' ' 158' ' ' TRP . 16.4 mt -68.54 -25.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.802 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -32.08 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.23 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -134.13 35.93 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.002 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.6 t80 -55.41 -49.39 72.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.443 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.84 -44.56 89.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.262 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.425 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 1.8 mmpt? -53.7 -50.61 65.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.993 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.536 HD12 HD13 ' A' ' 224' ' ' ILE . 3.6 mm? -79.42 -21.62 45.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.669 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.7 t -60.62 -33.68 73.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 0.0 110.436 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -78.75 4.72 13.04 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.137 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.428 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -100.19 99.17 8.9 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 122.238 -0.289 . . . . 0.0 110.257 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.26 -24.89 43.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.174 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -72.51 -49.15 34.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.765 HG22 ' HA ' ' A' ' 178' ' ' VAL . 49.8 mt -64.02 -53.46 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.467 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.847 ' HB2' HD13 ' A' ' 134' ' ' LEU . 49.9 m95 . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.921 0.391 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . 0.516 ' NH2' HG21 ' A' ' 121' ' ' ILE . 10.7 ttp180 -98.12 138.25 35.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.324 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.434 ' HG2' HD23 ' A' ' 134' ' ' LEU . 33.3 mtm180 -79.68 129.07 34.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.323 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.007 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.9 1.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.984 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.88 176.9 9.74 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.472 ' HB2' HG22 ' A' ' 154' ' ' VAL . 23.9 m-85 -139.13 173.81 11.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.696 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.6 t -134.25 116.63 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.466 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.4 110.43 15.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.009 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.405 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 10.3 t70 -169.01 145.19 3.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.26 39.4 22.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.846 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.27 30.62 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.569 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 90.9 m -151.93 142.78 22.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.466 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.6 m-85 -90.53 109.8 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.133 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -80.42 118.77 73.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.964 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.47 122.32 11.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.013 1.809 . . . . 0.0 112.351 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.91 HD11 HG23 ' A' ' 164' ' ' ILE . 1.3 mt -103.24 125.28 49.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.171 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.847 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.9 mt -82.35 166.39 19.5 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.2 pt-20 -56.68 -30.52 63.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -90.87 15.32 11.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.354 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.65 6.9 87.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.21 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.628 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.0 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.311 0.556 . . . . 0.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -81.01 117.91 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.76 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.8 mm? -102.19 97.34 7.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 22.8 mttp -72.38 -26.38 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -83.58 -21.15 32.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -100.42 24.31 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.38 164.3 54.63 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.783 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.54 156.53 42.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.525 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.9 28.16 3.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.8 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.33 139.37 25.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.618 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.25 118.55 54.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.917 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 64.8 Cg_endo -76.23 105.71 2.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.06 1.84 . . . . 0.0 112.668 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -67.61 -12.44 60.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -27.24 41.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.709 0.29 . . . . 0.0 111.501 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -143.17 160.05 53.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.925 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.9 Cg_endo -72.01 172.88 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.962 1.775 . . . . 0.0 112.743 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 123' ' ' TYR . 57.9 t -129.3 154.74 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.921 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.9 mt -114.15 97.82 6.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.478 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 77.7 t -83.34 135.11 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.58 86.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.733 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.576 ' CH2' HD11 ' A' ' 211' ' ' ILE . 72.2 m95 -149.05 111.85 4.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.418 . . . . 0.0 111.492 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -102.27 -25.35 13.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.599 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.43 96.24 7.88 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.895 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.8 -20.65 48.7 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.976 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.45 -40.68 97.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.33 -33.89 70.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.529 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.91 HG23 HD11 ' A' ' 133' ' ' LEU . 51.4 mt -62.38 -51.84 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.591 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.18 -29.7 58.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.9 mm-40 -69.53 -51.22 37.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.72 -52.48 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.789 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.007 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.7 -33.49 70.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.886 0.374 . . . . 0.0 110.241 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.56 -42.59 96.12 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.402 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -66.1 -38.86 89.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.648 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.1 mp -66.49 -26.24 67.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.3 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.63 59.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.572 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.03 -40.53 7.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.761 0.315 . . . . 0.0 111.461 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.746 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -72.41 156.82 90.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.362 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.654 ' O ' HD12 ' A' ' 174' ' ' LEU . 53.1 Cg_exo -50.61 124.48 13.49 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.561 2.174 . . . . 0.0 112.628 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.53 50.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.89 -40.54 91.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 110.315 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.845 ' HA ' HG22 ' A' ' 224' ' ' ILE . 55.9 t -60.13 -60.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.926 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.746 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.33 -24.48 66.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.381 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.4 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.0 -23.21 76.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.852 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.909 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -84.58 78.16 9.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.695 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 177.3 141.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.408 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.8 -50.01 11.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -163.68 153.06 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.505 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -104.25 133.9 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.135 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.6 m170 -106.82 112.51 25.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.029 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.444 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 73.1 t80 -67.53 102.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -125.81 77.48 70.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.048 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.444 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 43.1 Cg_endo -68.16 166.76 23.97 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.223 1.949 . . . . 0.0 112.322 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 p -141.35 173.54 11.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -27.3 68.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.015 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 193' ' ' TYR . 5.6 pt-20 -114.95 10.99 16.43 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 192' ' ' GLU . 71.6 m-85 -155.88 73.49 0.82 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -21.66 23.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.64 39.26 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.235 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.403 ' HB3' ' HA ' ' A' ' 189' ' ' PRO . 0.0 OUTLIER -85.8 112.66 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 209' ' ' ALA . 34.8 m -116.74 134.13 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 207' ' ' VAL . 22.5 mm -105.95 111.37 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.505 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -84.62 152.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.503 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -109.54 105.28 14.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.24 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.53 149.3 8.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -66.65 -22.35 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.97 -12.03 59.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.3 14.68 19.68 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.837 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -100.65 174.26 6.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.849 0.325 . . . . 0.0 110.511 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.41 120.58 27.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 0.0 110.963 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.491 ' HB ' HG22 ' A' ' 199' ' ' VAL . 15.2 t -117.22 160.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.459 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 207' ' ' VAL . 96.5 p -118.67 145.13 45.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.5 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -162.68 151.3 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.823 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.87 146.87 27.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.405 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' CH2' ' A' ' 158' ' ' TRP . 15.4 mt -58.8 -27.15 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 111.059 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -32.86 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.546 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -133.98 35.8 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.228 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -55.39 -50.41 69.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.154 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.49 88.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.77 -43.02 99.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.11 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.411 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 10.7 mmtt -51.94 -51.26 58.26 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.016 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -83.16 -16.56 46.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.958 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.9 t -62.48 -34.91 77.77 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.478 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 1.7 p-80 -81.5 8.12 10.3 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -101.99 99.31 11.92 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.29 -28.16 40.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.192 1.928 . . . . 0.0 112.175 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.64 -49.06 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.028 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.909 HG23 ' HB3' ' A' ' 181' ' ' ALA . 32.2 mt -65.76 -53.41 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.514 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.82 ' HB2' HD13 ' A' ' 134' ' ' LEU . 32.2 m95 . . . . . 0 N--CA 1.457 -0.116 0 CA-C-O 120.845 0.355 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.55 128.81 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.54 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -69.51 126.74 30.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.035 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.023 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.68 -0.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.784 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.738 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.44 176.78 10.13 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.736 0.303 . . . . 0.0 110.984 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.437 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.5 m-85 -138.88 173.34 11.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 139' ' ' LEU . 18.9 t -133.71 119.43 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.91 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.15 110.95 16.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.191 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 13.4 t70 -162.09 137.73 7.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 59.16 42.93 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 53.96 26.87 6.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.599 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 145' ' ' THR . 92.2 m -143.49 141.95 30.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.97 0.414 . . . . 0.0 111.007 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.5 m-85 -91.63 110.0 21.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.37 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.712 ' HB2' HD21 ' A' ' 139' ' ' LEU . 12.0 m-30 -81.07 122.69 81.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.879 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.25 123.81 13.9 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.172 1.914 . . . . 0.0 112.684 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.925 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.73 125.19 50.7 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.914 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.9 mt -83.6 165.76 18.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.321 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.514 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.0 pt-20 -55.84 -30.21 61.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -90.87 14.87 12.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.411 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.28 4.15 83.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.33 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.587 ' HB3' HD12 ' A' ' 134' ' ' LEU . 19.6 tpp85 -61.21 97.6 0.07 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.333 0.566 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.712 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -83.79 117.39 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.068 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.91 97.65 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.8 mttp -69.96 -29.68 66.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.792 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -71.28 -22.61 61.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -101.8 24.53 9.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.505 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.07 162.2 52.52 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.439 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -128.35 156.49 43.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.849 0.357 . . . . 0.0 110.807 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 25.86 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.171 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.421 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.4 OUTLIER -142.93 139.43 30.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.605 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 117.99 53.95 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.3 105.96 2.14 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.114 1.876 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.8 t -67.41 -12.84 61.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.204 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.57 -27.3 51.39 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.39 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.12 164.01 38.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.9 Cg_endo -77.17 172.94 15.19 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.934 1.756 . . . . 0.0 112.445 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.6 t -129.57 154.88 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.067 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.567 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.0 mt -113.31 97.9 6.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.424 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.9 t -82.72 134.93 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.473 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.65 86.89 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.803 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.506 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -148.32 113.93 5.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 111.512 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -26.77 12.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.486 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.28 96.07 8.14 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.893 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.49 -20.95 47.64 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.026 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -40.7 98.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.49 69.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.497 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.925 HG23 HD11 ' A' ' 133' ' ' LEU . 50.0 mt -62.72 -52.37 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.48 47.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.238 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 7.0 mm-40 -68.73 -52.1 34.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.21 -52.83 64.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.023 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.99 -33.53 69.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.246 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.44 -42.63 97.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.306 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -64.68 -36.9 85.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.924 0.392 . . . . 0.0 110.107 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.628 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.1 mp -67.81 -27.74 66.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.072 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.65 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.583 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.59 -40.31 6.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.74 0.305 . . . . 0.0 111.726 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.781 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -71.38 156.97 90.94 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.66 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -51.42 124.38 14.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.624 2.216 . . . . 0.0 112.648 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.75 -35.65 32.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.852 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 110.259 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 224' ' ' ILE . 57.9 t -58.45 -55.58 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.768 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.781 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -68.45 -12.61 61.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.826 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 -12.69 58.42 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.575 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -93.63 78.05 4.31 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.093 0.447 . . . . 0.0 111.205 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.97 176.95 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 p -113.05 -46.22 3.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.88 0.372 . . . . 0.0 110.8 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -167.88 152.43 6.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.882 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -104.74 135.33 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.267 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.423 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 8.2 m170 -107.8 121.91 45.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -75.64 101.82 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -123.42 74.36 51.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.61 160.62 47.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.376 2.051 . . . . 0.0 112.564 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -139.09 163.44 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.985 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -53.96 -26.75 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.42 -18.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -134.09 79.38 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.952 0.406 . . . . 0.0 111.115 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.27 -21.14 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.699 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -114.14 38.28 3.07 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.777 0.322 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 113.89 20.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.58 132.93 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.65 111.26 33.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.63 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.521 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.5 m -85.0 153.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.467 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -109.09 109.93 21.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.255 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 149.27 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.553 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.3 p30 -60.64 -24.37 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -85.37 7.03 23.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.13 -16.32 61.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.915 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.83 173.03 1.12 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -135.02 119.13 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.521 ' HB ' HG22 ' A' ' 199' ' ' VAL . 16.3 t -115.33 159.54 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.662 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 207' ' ' VAL . 89.3 p -119.28 149.14 42.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -163.59 -179.57 6.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -127.92 151.18 49.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.386 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.506 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.7 mt -64.94 -25.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.949 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -31.13 62.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.399 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.56 36.13 3.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.13 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 15.7 t80 -56.13 -50.72 70.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.013 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.3 97.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.411 ' HA ' ' HB2' ' A' ' 219' ' ' SER . 5.4 t70 -63.92 -47.64 79.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.042 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 21.8 mmtm -51.83 -51.82 53.79 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.672 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 224' ' ' ILE . 3.4 mm? -80.37 -21.51 42.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . 0.411 ' HB2' ' HA ' ' A' ' 216' ' ' ASP . 3.2 m -64.29 -27.74 69.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.753 0.311 . . . . 0.0 110.757 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -85.66 17.1 3.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.061 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.24 103.63 55.0 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.68 -24.46 35.08 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.143 1.895 . . . . 0.0 112.418 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.02 -49.69 42.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.159 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' A' ' 178' ' ' VAL . 41.5 mt -63.44 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 178.669 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.811 ' HB2' HD13 ' A' ' 134' ' ' LEU . 60.8 m95 . . . . . 0 CA--C 1.523 -0.092 0 CA-C-O 120.904 0.383 . . . . 0.0 110.617 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -96.12 130.14 43.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -71.48 126.33 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.983 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.42 0.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.947 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.727 ' HB2' HD23 ' A' ' 171' ' ' LEU . . . -163.29 176.79 9.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 152' ' ' ALA . 58.2 m-85 -138.83 173.27 11.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.323 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.655 HG11 HD11 ' A' ' 139' ' ' LEU . 21.8 t -134.08 118.18 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.996 0.426 . . . . 0.0 111.044 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.1 109.4 14.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.961 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -158.73 139.27 12.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 40.96 23.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 55.08 31.13 15.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.332 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 145' ' ' THR . 84.8 m -147.69 144.02 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.994 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.3 m-85 -93.44 110.46 22.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.708 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.5 m-30 -82.8 127.09 71.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 28.3 Cg_exo -62.18 125.76 17.11 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.329 2.019 . . . . 0.0 112.746 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 1.049 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.8 124.97 50.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.795 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.6 mt -85.29 165.44 17.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.408 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.7 pt-20 -55.22 -30.46 60.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.49 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -91.56 15.82 11.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 76.85 7.74 86.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.321 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.61 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.89 96.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.332 0.566 . . . . 0.0 110.408 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.708 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -83.6 123.1 29.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.825 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.4 mt -107.77 96.56 6.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.9 mttp -70.98 -26.79 63.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.009 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -79.9 -23.06 42.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.577 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -98.02 25.51 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.515 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.71 159.35 52.14 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.418 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -127.09 156.39 41.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 27.32 3.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 139.61 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.74 117.95 55.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 64.7 Cg_endo -76.12 105.95 2.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.065 1.843 . . . . 0.0 112.643 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.4 t -67.82 -12.32 60.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.263 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -27.39 53.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.714 0.293 . . . . 0.0 111.271 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.646 ' HB3' ' HE1' ' A' ' 123' ' ' TYR . . . -143.34 160.66 50.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.859 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.9 Cg_endo -72.73 172.72 14.69 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.029 1.819 . . . . 0.0 112.678 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 123' ' ' TYR . 78.8 t -128.74 154.87 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.923 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.614 HD12 ' CD1' ' A' ' 133' ' ' LEU . 45.6 mt -113.62 97.72 6.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.546 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 60.5 t -83.6 132.52 31.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.622 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.8 82.77 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.874 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.543 ' CZ2' HD22 ' A' ' 155' ' ' LEU . 57.9 m95 -144.55 99.38 3.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.586 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -25.21 21.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -98.35 97.62 8.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.894 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.85 -20.88 50.05 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.969 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -40.22 96.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.45 70.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.488 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.049 HG23 HD11 ' A' ' 133' ' ' LEU . 47.1 mt -61.89 -51.72 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.403 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -56.28 -29.17 60.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.8 mm-40 -71.04 -50.01 38.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.103 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.501 ' HE2' HD21 ' A' ' 155' ' ' LEU . 1.2 mmm -57.65 -52.54 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.791 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.983 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -60.06 -33.53 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.172 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.24 94.16 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.501 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.74 -39.56 91.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.0 0.429 . . . . 0.0 109.982 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 122' ' ' ALA . 3.5 mp -66.83 -28.41 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.52 -19.89 60.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.734 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.77 -40.55 7.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 111.473 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.2 pp -72.25 156.28 90.71 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.579 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.674 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.0 Cg_exo -51.41 125.56 16.93 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.531 2.154 . . . . 0.0 112.429 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.1 53.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.823 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.49 -40.86 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.446 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.789 ' HA ' HG22 ' A' ' 224' ' ' ILE . 44.5 t -59.05 -60.05 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.729 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -62.61 -23.29 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.551 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -72.79 -24.82 75.38 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.782 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.792 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -82.36 78.06 9.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.775 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 177.16 153.33 0.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.465 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.05 -53.87 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.095 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.67 151.06 25.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.477 HG12 HG12 ' A' ' 199' ' ' VAL . 4.5 mt -106.27 134.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.397 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.3 m170 -106.38 127.47 53.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.24 112.55 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -135.0 78.04 54.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 163.22 32.96 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.351 2.034 . . . . 0.0 112.652 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -144.58 167.92 21.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -57.91 -24.15 56.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.22 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.69 -16.57 15.98 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -144.13 83.06 1.73 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -60.05 -20.5 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.626 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.29 34.32 4.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.71 0.291 . . . . 0.0 111.141 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.69 112.05 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.783 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.7 m -115.4 136.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.243 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.0 mm -106.91 109.75 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -86.45 155.63 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.743 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.04 105.79 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.982 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.55 149.11 6.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.918 0.389 . . . . 0.0 111.636 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -64.49 -23.44 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.918 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -77.58 -13.01 60.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.34 20.39 9.17 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.4 172.63 6.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -126.37 117.11 22.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 208' ' ' SER . 13.4 t -118.8 160.11 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 207' ' ' VAL . 59.7 p -121.47 146.75 46.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.36 -177.69 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.699 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -126.82 154.38 44.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.434 HD11 ' CH2' ' A' ' 158' ' ' TRP . 4.6 mt -69.31 -25.02 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.776 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -80.96 -28.64 35.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.286 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -132.28 35.5 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 171' ' ' LEU . 48.7 t80 -60.43 -50.51 73.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.98 -36.84 82.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.278 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -68.25 -45.68 72.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.1 mmpt? -53.77 -53.18 55.87 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.46 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.574 HD12 HD13 ' A' ' 224' ' ' ILE . 3.5 mm? -75.96 -24.95 55.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.818 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.4 m -61.12 -30.46 70.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.878 0.371 . . . . 0.0 110.407 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.66 5.57 12.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.046 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.77 101.72 34.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.56 -24.25 42.19 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.142 1.895 . . . . 0.0 112.326 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.1 -48.73 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.792 HG23 ' HB3' ' A' ' 181' ' ' ALA . 36.2 mt -64.86 -53.67 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.636 178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.79 ' HB2' HD13 ' A' ' 134' ' ' LEU . 68.7 m95 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -97.17 132.45 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.476 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -71.98 126.56 30.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.102 0.477 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.017 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.21 1.42 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.886 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.677 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.77 176.64 8.6 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.413 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.6 m-85 -139.88 173.0 11.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.443 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 139' ' ' LEU . 25.2 t -132.96 119.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.12 111.67 16.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.109 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 24.3 t0 -158.35 136.29 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.22 43.72 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.004 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 54.85 28.88 11.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.418 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 86.3 m -144.29 144.08 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.071 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.4 m-85 -94.61 110.4 22.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 111.04 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.717 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.1 m-30 -82.72 125.23 76.19 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.438 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.2 Cg_exo -59.66 126.96 22.0 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.348 2.032 . . . . 0.0 112.853 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.924 HD11 HG23 ' A' ' 164' ' ' ILE . 0.8 OUTLIER -109.47 124.82 51.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.703 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.9 mt -85.51 166.5 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.459 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.446 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.0 pt-20 -55.65 -30.68 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.651 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -91.08 15.34 11.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.477 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.404 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.45 3.88 83.46 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.326 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.603 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -60.76 97.93 0.06 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.264 0.532 . . . . 0.0 110.548 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.717 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.39 129.98 34.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.052 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.515 ' N ' HD23 ' A' ' 139' ' ' LEU . 24.5 mt -110.67 94.41 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.652 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 44.2 mttt -71.61 -28.95 64.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -80.12 -21.45 43.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.578 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.431 ' HG3' HD13 ' A' ' 140' ' ' LEU . 2.7 mm-40 -99.56 25.79 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.33 159.0 52.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.53 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -127.48 156.65 41.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.663 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.56 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.416 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -145.04 141.36 28.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.61 119.1 73.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.29 107.09 2.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.108 1.872 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.2 t -66.78 -13.34 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.286 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.52 -27.16 41.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.61 0.243 . . . . 0.0 111.512 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.82 162.81 48.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.925 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.4 Cg_endo -77.31 173.16 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.996 1.797 . . . . 0.0 112.627 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 130' ' ' PHE . 76.7 t -129.43 154.55 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.076 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.571 HD12 ' CD1' ' A' ' 133' ' ' LEU . 51.5 mt -114.17 97.77 6.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 0.0 110.561 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.8 t -82.41 134.84 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.84 87.04 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.878 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.502 ' CH2' HD11 ' A' ' 211' ' ' ILE . 67.4 m95 -146.97 116.62 7.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 111.545 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -106.68 -27.43 10.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.344 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.74 95.19 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.893 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.38 -20.91 46.56 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.03 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -40.64 97.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.13 -34.28 70.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.505 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.924 HG23 HD11 ' A' ' 133' ' ' LEU . 62.0 mt -62.13 -51.63 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.662 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.62 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.8 mm-40 -66.99 -50.46 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.64 -52.48 65.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.741 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.73 68.7 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.847 0.355 . . . . 0.0 110.268 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.98 98.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.366 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -66.84 -35.1 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.193 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.609 ' HB3' HD22 ' A' ' 179' ' ' LEU . 6.5 mp -70.59 -28.97 65.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.059 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.84 -18.13 62.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.68 -40.98 6.38 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -71.11 157.41 90.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.695 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.7 Cg_exo -51.21 123.88 12.88 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.629 2.219 . . . . 0.0 112.54 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.74 -36.31 35.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.988 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.51 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.258 0.551 . . . . 0.0 110.309 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.782 ' HA ' HG22 ' A' ' 224' ' ' ILE . 78.5 t -58.78 -56.12 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.773 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -67.86 -13.64 62.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.766 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.88 -14.29 59.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.585 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.639 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.53 78.61 3.82 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 111.609 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.98 153.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.556 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.51 -49.64 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -167.55 156.82 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 153' ' ' PRO . 4.8 mt -104.79 135.48 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.406 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.427 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 13.1 m170 -106.14 127.78 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -80.12 111.63 16.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -133.62 73.55 72.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.854 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.19 160.02 51.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.285 1.99 . . . . 0.0 112.594 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.6 p -140.48 162.1 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -54.74 -25.86 30.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.368 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -102.43 -20.47 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -135.41 77.34 1.67 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.927 0.394 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -55.83 -22.21 23.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.767 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -113.05 39.51 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.314 . . . . 0.0 111.307 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.58 116.09 24.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.8 m -121.49 137.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.08 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 207' ' ' VAL . 19.1 mm -106.62 110.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.44 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.4 m -84.62 153.32 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.639 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.427 ' CE1' ' CD2' ' A' ' 186' ' ' HIS . 6.3 m-85 -111.42 107.37 16.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.449 ' SD ' HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -55.78 149.25 14.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.99 -24.05 66.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.882 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.3 m-20 -75.84 -13.28 60.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.21 20.3 9.31 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.787 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 51.7 m-85 -104.87 174.06 6.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -127.88 123.95 36.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.044 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 208' ' ' SER . 20.3 t -124.37 159.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 207' ' ' VAL . 79.4 p -118.92 144.91 46.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.99 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -163.09 149.68 12.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.68 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.25 147.15 24.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.582 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.502 HD11 ' CH2' ' A' ' 158' ' ' TRP . 14.4 mt -58.5 -27.48 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -32.87 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -130.16 35.8 4.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.074 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.8 -51.82 68.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.91 87.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.75 -42.67 99.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.0 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.415 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.3 mmpt? -52.31 -53.42 44.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.587 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -80.49 -21.22 42.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.973 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.8 t -60.03 -33.85 72.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.007 0.432 . . . . 0.0 110.447 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.75 3.87 15.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.128 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.36 99.87 14.1 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.25 -26.36 42.01 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.09 1.86 . . . . 0.0 112.126 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.17 -51.38 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.782 HG22 ' HA ' ' A' ' 178' ' ' VAL . 29.9 mt -64.2 -53.05 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.596 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.846 ' HB2' HD13 ' A' ' 134' ' ' LEU . 44.0 m95 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.894 0.378 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -99.72 132.84 44.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -72.06 127.81 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.016 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.9 0.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.949 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.707 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.6 176.75 10.06 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.094 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.483 ' HB2' HG22 ' A' ' 154' ' ' VAL . 28.4 m-85 -138.39 173.21 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.696 HG21 ' HG ' ' A' ' 139' ' ' LEU . 15.1 t -133.93 117.55 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.967 0.413 . . . . 0.0 111.101 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.477 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.59 114.42 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.277 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.449 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.4 t70 -169.09 142.01 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.771 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 59.34 41.14 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.497 . . . . 0.0 110.738 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.15 29.65 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.441 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 145' ' ' THR . 46.8 m -148.3 145.09 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.434 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.3 m-85 -95.52 110.53 22.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.701 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.715 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.9 m-85 -80.84 129.1 69.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.108 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 22.3 Cg_exo -64.73 123.92 12.4 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.167 1.911 . . . . 0.0 112.31 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.911 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -105.57 125.09 50.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.09 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.846 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.3 mt -84.11 167.09 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.197 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.4 pt-20 -55.75 -31.12 62.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.451 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.0 p30 -90.85 14.39 13.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.48 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 78.39 7.68 87.82 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.021 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.592 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.1 95.93 0.04 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.209 0.504 . . . . 0.0 110.27 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.715 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.2 118.62 23.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.017 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.4 mt -103.98 97.34 7.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.565 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 17.8 mttt -71.16 -25.67 62.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -80.71 -21.1 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.856 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -100.14 26.61 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.71 159.91 52.54 Favored Glycine 0 CA--C 1.506 -0.483 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.722 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.671 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -125.91 156.96 38.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.633 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 29.34 2.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.044 0.449 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.4 143.65 26.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.525 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.7 118.05 67.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.63 109.24 2.72 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.141 1.894 . . . . 0.0 112.54 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.4 t -67.39 -13.11 61.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.28 -27.26 53.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.43 162.56 46.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.868 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 68.0 Cg_endo -76.56 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.023 1.815 . . . . 0.0 112.682 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 123' ' ' TYR . 62.3 t -130.74 154.25 40.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.7 mt -113.61 97.57 6.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 0.0 110.587 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.5 t -82.26 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.474 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.89 89.42 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.611 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.0 m95 -147.36 97.48 2.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.721 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -93.61 7.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -131.27 93.02 3.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.427 0.156 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.877 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.86 -21.2 43.65 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.23 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -39.73 95.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.57 -33.56 62.7 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.788 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.911 HG23 HD11 ' A' ' 133' ' ' LEU . 62.6 mt -61.46 -52.05 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.919 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.93 -30.81 62.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.142 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.5 -51.52 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.188 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.31 -52.15 66.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.756 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.016 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.45 -33.63 69.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.872 0.367 . . . . 0.0 110.244 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.43 -41.82 97.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.38 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -66.15 -38.34 87.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.781 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.2 mp -66.34 -27.56 67.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.343 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.5 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.626 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -101.45 -41.06 6.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.645 0.259 . . . . 0.0 111.49 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.42 157.39 90.09 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.627 ' HB2' HG23 ' A' ' 178' ' ' VAL . 52.2 Cg_exo -50.13 129.26 24.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.529 2.153 . . . . 0.0 112.841 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.12 67.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.455 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.1 86.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 110.399 179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.706 ' HA ' HG22 ' A' ' 224' ' ' ILE . 55.6 t -61.82 -60.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.838 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -62.8 -23.89 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.451 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.96 -23.86 75.32 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.771 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -89.51 78.44 7.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.863 0.364 . . . . 0.0 110.688 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.62 131.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -59.27 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.26 155.43 32.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.415 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.6 m170 -107.31 118.85 37.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.24 115.0 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -138.7 77.47 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -69.14 162.08 43.23 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.0 p -139.27 161.43 37.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.05 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -25.5 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -103.34 -19.96 14.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.331 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -135.17 81.02 1.87 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -57.09 -21.24 30.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.617 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . 0.422 ' OD2' HD12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -113.04 38.49 2.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.283 . . . . 0.0 111.044 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -85.2 115.73 23.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 209' ' ' ALA . 32.2 m -119.76 135.97 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.113 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 208' ' ' SER . 20.4 mm -105.33 111.38 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.52 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.84 155.38 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 111.694 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -114.45 99.78 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.956 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.501 ' HE3' HG21 ' A' ' 207' ' ' VAL . 7.5 tpp -54.18 149.33 9.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.489 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.82 -20.32 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.008 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 5.8 m-20 -76.02 -13.71 60.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.5 20.18 10.49 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.74 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 28.1 m-85 -111.52 155.93 22.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -109.3 118.77 37.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.501 HG21 ' HE3' ' A' ' 201' ' ' MET . 15.7 t -116.24 159.52 16.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 110.643 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 198' ' ' ILE . 51.4 p -121.64 143.68 49.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.791 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -162.67 150.15 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.43 146.57 24.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.523 HD11 ' CH2' ' A' ' 158' ' ' TRP . 17.9 mt -59.03 -28.15 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.097 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -31.58 69.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.586 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.23 36.11 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.139 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -55.46 -50.77 69.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.481 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.61 -48.27 82.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.976 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -63.07 -38.95 93.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.961 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -55.66 -53.48 56.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.965 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.515 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.6 mm? -78.61 -22.7 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.711 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.8 t -60.49 -34.1 73.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -72.08 -5.47 35.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.855 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.68 100.4 6.18 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.4 -27.83 46.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.145 1.897 . . . . 0.0 112.105 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.27 80.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.706 HG22 ' HA ' ' A' ' 178' ' ' VAL . 24.8 mt -72.28 -54.93 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.198 178.191 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.829 ' HB2' HD13 ' A' ' 134' ' ' LEU . 56.5 m95 . . . . . 0 C--O 1.23 0.059 0 CA-C-O 120.822 0.344 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 130.33 45.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.782 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -70.6 127.73 33.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.251 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.995 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.09 3.18 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.708 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.798 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.44 176.47 9.01 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.645 0.259 . . . . 0.0 110.894 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.457 ' HB2' HG22 ' A' ' 154' ' ' VAL . 18.9 m-85 -140.12 173.59 11.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.095 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.65 HG21 ' HG ' ' A' ' 139' ' ' LEU . 21.6 t -133.55 117.46 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.511 ' HD2' HG22 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -80.44 107.35 13.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.832 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.434 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.6 t0 -164.42 144.17 7.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.725 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.98 40.63 18.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.792 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.16 28.36 8.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 145' ' ' THR . 40.4 m -148.78 146.21 27.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.6 109.03 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.5 m-85 -81.15 129.95 64.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 19.5 Cg_exo -66.13 124.5 12.68 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.137 1.891 . . . . 0.0 112.287 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.922 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.84 124.77 50.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.861 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.5 mt -83.94 166.63 17.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.1 pt-20 -55.85 -30.35 61.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.41 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.52 15.77 11.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.497 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 75.5 9.64 84.6 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.123 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.609 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.96 96.39 0.07 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.244 0.522 . . . . 0.0 110.11 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.59 119.52 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.079 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.7 mt -105.02 97.63 7.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.439 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 40.8 mttt -72.03 -21.92 61.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -84.37 -21.68 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -100.76 29.2 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.498 0.189 . . . . 0.0 111.414 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.53 161.42 54.15 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -125.21 160.66 28.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.36 30.51 4.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.406 HG23 ' OG1' ' A' ' 145' ' ' THR . 0.0 OUTLIER -154.55 133.1 12.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.681 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.95 118.31 37.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.8 Cg_endo -73.1 111.78 3.36 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.985 1.79 . . . . 0.0 112.477 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -66.61 -13.9 61.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.32 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.24 -26.66 42.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.591 0.234 . . . . 0.0 111.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.86 159.25 47.49 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.2 Cg_endo -71.87 174.19 11.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.235 1.957 . . . . 0.0 112.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 123' ' ' TYR . 68.6 t -129.0 153.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.836 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.6 mt -112.87 98.58 7.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.565 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.511 HG22 ' HD2' ' A' ' 125' ' ' TYR . 59.5 t -82.81 135.32 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.475 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.63 86.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.6 m95 -148.11 115.73 6.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 111.468 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -106.26 -27.29 11.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.442 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -96.53 95.78 8.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.89 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.41 -20.96 47.01 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.084 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -40.3 96.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.46 68.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.659 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.922 ' CG2' HD11 ' A' ' 133' ' ' LEU . 58.1 mt -62.91 -52.34 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.625 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.38 57.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -68.94 -51.2 42.22 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.177 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.67 -52.54 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.995 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.02 -33.71 69.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.286 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.91 97.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.311 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.33 -37.7 87.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.388 . . . . 0.0 110.115 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.654 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.4 mp -67.75 -27.62 66.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.246 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.73 -19.27 60.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.534 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.04 -40.7 7.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.638 0.256 . . . . 0.0 111.573 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.68 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -72.18 157.58 89.07 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.518 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.646 ' O ' HD12 ' A' ' 174' ' ' LEU . 56.8 Cg_exo -50.27 124.45 13.01 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.594 2.196 . . . . 0.0 112.681 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.85 53.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.79 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.06 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.0 110.3 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 224' ' ' ILE . 47.1 t -59.79 -60.21 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.907 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.68 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -62.79 -24.21 67.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.512 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.99 -21.91 77.64 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.145 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -88.66 78.53 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.069 0.461 . . . . 0.0 110.718 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.03 138.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.502 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.6 t -75.82 -57.27 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.044 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.2 153.9 28.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.073 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.18 136.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.398 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.42 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 19.3 m170 -108.53 125.54 51.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.768 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -77.58 108.88 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.982 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -129.42 77.96 76.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 67.9 Cg_endo -75.04 163.72 34.7 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.264 1.976 . . . . 0.0 112.827 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.4 p -142.4 164.11 31.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.828 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -54.49 -26.94 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.55 -19.17 14.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -135.87 77.46 1.66 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.13 -21.6 47.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.605 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -111.62 36.16 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.672 0.272 . . . . 0.0 111.337 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.726 ' NH1' HG23 ' A' ' 210' ' ' THR . 0.0 OUTLIER -85.56 114.43 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 209' ' ' ALA . 34.6 m -117.83 138.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -109.12 111.63 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.533 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -84.84 154.72 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -113.59 105.79 13.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.26 149.05 7.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.987 0.422 . . . . 0.0 111.57 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -66.95 -22.93 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.835 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.39 20.51 9.03 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.27 174.24 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -129.77 119.84 24.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 208' ' ' SER . 21.0 t -121.95 159.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 207' ' ' VAL . 94.4 p -119.59 147.34 44.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.02 150.45 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.7 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.726 HG23 ' NH1' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -101.06 147.59 26.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.432 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.0 mt -57.97 -27.23 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.641 0.258 . . . . 0.0 111.161 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -30.44 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.469 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.17 35.88 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.34 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.7 -49.62 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.88 -47.19 87.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.47 -42.42 99.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.054 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.411 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -52.05 -53.51 41.18 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.267 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.5 mm? -80.59 -21.69 41.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.918 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.2 t -59.82 -32.99 71.17 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.999 0.428 . . . . 0.0 110.35 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.81 5.26 14.07 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.037 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.4 100.35 18.15 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.5 -27.29 39.6 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.132 1.888 . . . . 0.0 112.189 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.47 -52.28 47.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.049 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.785 HG22 ' HA ' ' A' ' 178' ' ' VAL . 32.9 mt -63.5 -51.99 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.491 178.582 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.792 ' HB2' HD13 ' A' ' 134' ' ' LEU . 66.8 m95 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.898 0.38 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -99.89 130.53 46.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.572 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -68.62 127.41 32.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.07 0.462 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.015 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.94 0.29 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.834 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.661 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.46 176.78 9.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.488 ' HB2' HG22 ' A' ' 154' ' ' VAL . 33.9 m-85 -138.75 173.46 11.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.334 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.656 HG21 ' HG ' ' A' ' 139' ' ' LEU . 15.0 t -133.27 117.48 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.967 0.413 . . . . 0.0 111.025 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.52 110.7 16.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.148 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.441 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 15.9 t70 -169.15 144.23 3.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.53 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.001 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 53.86 28.65 8.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.679 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 145' ' ' THR . 88.6 m -149.58 141.86 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 14.1 m-85 -89.71 109.84 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.052 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.732 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.3 m-85 -80.99 123.93 81.72 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.967 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.43 124.24 14.72 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.206 1.937 . . . . 0.0 112.524 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.915 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.82 125.29 50.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.013 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.7 mt -84.14 166.7 17.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.179 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.7 pt-20 -56.28 -30.26 62.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.291 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -91.38 15.8 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.303 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 76.26 8.18 85.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.143 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.609 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.29 96.18 0.05 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.209 0.504 . . . . 0.0 110.243 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.59 112.88 21.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.853 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.18 98.21 7.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.595 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.4 mttp -69.0 -27.5 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.45 -22.39 60.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.603 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -101.13 23.77 10.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.619 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.17 164.24 52.58 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.733 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 129' ' ' THR . 4.0 t -130.26 158.82 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.953 0.406 . . . . 0.0 110.631 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.46 22.56 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.125 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.463 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -140.28 143.87 36.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 110.679 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.36 118.53 72.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.43 108.93 2.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.05 1.833 . . . . 0.0 112.608 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -67.07 -13.52 62.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.274 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.33 -27.54 52.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.667 0.27 . . . . 0.0 111.402 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.61 164.6 38.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.654 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 72.7 Cg_endo -78.73 172.72 14.65 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.893 1.729 . . . . 0.0 112.521 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 123' ' ' TYR . 60.1 t -129.37 153.57 38.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.939 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.611 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.4 mt -113.54 97.58 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.06 0.457 . . . . 0.0 110.569 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.2 t -83.44 134.6 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.2 85.78 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.724 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.505 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.64 110.28 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 111.536 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -101.22 -27.8 13.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.35 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.8 94.08 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.054 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.897 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.03 -21.0 44.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.154 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -39.9 95.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.25 -33.83 67.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.577 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.915 ' CG2' HD11 ' A' ' 133' ' ' LEU . 63.4 mt -62.03 -52.24 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.646 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.08 58.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.178 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 12.1 mm-40 -68.8 -50.42 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.94 -52.22 66.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.015 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.48 -33.7 68.27 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.946 0.403 . . . . 0.0 110.235 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.99 97.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.32 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.024 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.533 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.4 mp -69.23 -28.58 66.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.56 -18.43 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.547 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -102.62 -40.47 6.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 179' ' ' LEU . 1.9 pp -70.84 157.14 90.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.744 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.659 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.4 Cg_exo -51.3 124.09 13.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.575 2.183 . . . . 0.0 112.631 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.73 26.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.833 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -43.35 89.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.14 0.495 . . . . 0.0 110.335 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 53.8 t -58.53 -55.9 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.757 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -67.69 -13.55 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.55 -14.54 59.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.519 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -93.62 78.37 4.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.965 0.383 . . . . 0.0 111.54 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.55 155.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.388 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 p -89.32 -48.6 7.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.57 156.1 9.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -105.88 134.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.151 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.456 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.2 m170 -109.12 118.52 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -69.07 110.0 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.424 ' HD3' HG12 ' A' ' 198' ' ' ILE . 1.0 OUTLIER -132.57 74.13 75.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.884 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.2 161.78 29.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.267 1.978 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -137.16 162.71 32.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -54.2 -26.37 27.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.369 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -104.41 -18.3 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.572 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.3 87.13 2.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -59.63 -19.56 49.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -115.52 36.05 4.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.741 0.305 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -78.94 108.33 12.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.706 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.9 133.06 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.424 HG12 ' HD3' ' A' ' 188' ' ' LYS . 30.9 mm -106.14 111.55 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.537 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.524 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -87.05 158.32 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.696 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.09 107.12 14.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.174 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.17 149.37 16.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.395 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -65.88 -21.92 66.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -77.07 -13.19 59.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.33 20.3 9.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.721 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -106.43 174.94 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.699 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.64 117.71 21.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 199' ' ' VAL . 12.1 t -113.42 160.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 207' ' ' VAL . 80.3 p -121.14 145.14 48.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.073 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.1 -178.71 7.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -128.73 154.66 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.369 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.505 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.9 mt -69.0 -22.34 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.975 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -32.05 47.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 111.321 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -134.21 35.77 3.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.963 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.2 t80 -56.8 -48.09 78.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -59.47 -48.07 83.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -62.78 -39.21 93.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.319 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.406 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 13.0 mmtt -56.93 -53.31 59.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.49 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.3 mm? -81.42 -21.35 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.19 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -64.11 -33.61 76.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.601 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -73.61 -2.74 24.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.385 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.36 110.22 43.27 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 122.263 -0.273 . . . . 0.0 110.848 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.28 -31.8 34.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.325 2.017 . . . . 0.0 112.38 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -70.55 -45.99 64.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.321 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 178' ' ' VAL . 35.9 mt -64.76 -55.32 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.158 0.504 . . . . 0.0 109.708 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.319 178.53 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.808 ' HB2' HD13 ' A' ' 134' ' ' LEU . 54.3 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.923 0.392 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.59 134.62 38.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -76.78 126.71 31.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.712 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.0 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.62 0.72 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.995 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.69 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.96 176.89 9.7 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.624 ' HE1' ' HB3' ' A' ' 152' ' ' ALA . 55.6 m-85 -138.49 173.29 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.31 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.678 HG21 ' HG ' ' A' ' 139' ' ' LEU . 20.0 t -134.2 116.61 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 0.0 110.953 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.467 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.39 113.76 18.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.442 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.0 t70 -168.96 144.19 3.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.796 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.65 40.07 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 54.81 31.77 16.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.473 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 53.6 m -151.47 144.44 24.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 5.0 m-85 -93.55 110.12 21.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.3 m-85 -81.15 129.81 65.44 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.119 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.4 Cg_exo -65.09 124.91 13.71 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.189 1.926 . . . . 0.0 112.277 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.985 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.86 124.78 50.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.798 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.2 mt -84.95 165.63 17.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.373 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.2 pt-20 -55.31 -30.74 60.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.697 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -90.92 15.11 12.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.314 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 77.51 4.05 83.94 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.257 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.609 ' HB3' HD12 ' A' ' 134' ' ' LEU . 20.6 tpp180 -61.07 98.26 0.07 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.347 0.573 . . . . 0.0 110.476 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.3 126.97 31.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.079 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.9 mm? -106.53 94.24 5.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 12.5 mttp -70.97 -26.98 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.95 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -84.24 -20.75 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.795 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.09 24.58 6.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.527 0.204 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.31 160.43 53.17 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.825 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -126.72 157.21 39.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.599 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 27.72 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.29 140.5 25.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.483 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 117.65 53.29 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.439 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 65.0 Cg_endo -76.21 106.68 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.148 1.898 . . . . 0.0 112.75 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -67.99 -12.26 60.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.241 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.98 -27.22 54.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.759 0.314 . . . . 0.0 111.328 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.624 ' HB3' ' HE1' ' A' ' 123' ' ' TYR . . . -144.06 160.2 50.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.901 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.509 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.5 Cg_endo -71.97 174.18 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.021 1.814 . . . . 0.0 112.722 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 123' ' ' TYR . 63.6 t -130.43 155.56 41.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.944 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.3 mt -115.06 97.72 6.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.431 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.9 134.32 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.387 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.761 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.533 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.4 m95 -147.64 110.43 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 111.631 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -25.24 14.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.86 95.46 7.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.206 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.907 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.52 -20.85 47.42 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.057 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.39 -41.11 98.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.22 -34.82 73.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.441 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.985 HG23 HD11 ' A' ' 133' ' ' LEU . 54.5 mt -61.66 -51.68 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.585 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.409 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.33 -29.45 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.292 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.1 mm-40 -70.74 -50.64 33.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.381 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.453 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.97 -52.45 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.952 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.0 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.31 -33.64 67.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.41 98.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.25 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -65.41 -35.97 82.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.847 0.356 . . . . 0.0 110.344 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.662 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.0 mp -70.73 -27.88 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.89 -19.47 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.524 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.15 -40.69 7.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.481 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.81 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.7 157.2 89.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.375 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.658 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.0 Cg_exo -50.58 123.66 11.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.459 2.106 . . . . 0.0 112.51 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -33.91 39.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.638 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.47 -41.52 88.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.049 0.452 . . . . 0.0 110.404 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.675 ' HA ' HG22 ' A' ' 224' ' ' ILE . 53.6 t -59.53 -60.29 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.845 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.81 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.26 -24.32 66.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.64 -23.8 76.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.816 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -86.23 78.3 9.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 110.679 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.2 ptp 178.27 131.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 80.6 p -67.94 -55.4 12.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -161.48 155.64 22.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -104.54 136.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.436 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 25.1 m170 -107.19 122.19 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.87 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.544 ' HD1' HG12 ' A' ' 197' ' ' VAL . 9.2 t80 -75.0 109.77 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.811 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -129.37 72.37 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.03 154.77 57.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.439 2.092 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.4 p -140.89 166.9 23.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -26.27 60.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.291 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.75 -17.45 16.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.49 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.401 ' CB ' ' HB2' ' A' ' 196' ' ' ARG . 46.8 m-85 -143.89 76.78 1.53 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.951 0.405 . . . . 0.0 111.023 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.09 -19.77 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.74 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -113.87 37.09 3.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 111.146 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.401 ' HB2' ' CB ' ' A' ' 193' ' ' TYR . 6.4 ttt180 -87.53 116.94 25.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.025 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.544 HG12 ' HD1' ' A' ' 187' ' ' TYR . 28.1 m -120.59 133.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 208' ' ' SER . 23.4 mm -103.71 112.1 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.531 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -88.49 151.7 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.391 . . . . 0.0 111.517 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.58 103.78 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.99 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 13.2 tpp -56.25 149.38 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -67.17 -19.78 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.082 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -75.56 -13.51 60.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.05 20.21 10.02 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.772 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.76 167.84 10.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.736 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -119.14 120.7 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 208' ' ' SER . 22.7 t -118.91 159.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.618 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.577 ' HB3' HD12 ' A' ' 198' ' ' ILE . 6.9 p -118.53 148.77 42.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.911 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.2 150.78 9.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.48 147.55 25.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.526 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.533 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.6 mt -59.32 -25.88 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.187 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -29.48 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.2 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -133.96 35.51 3.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.73 -49.55 76.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.018 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.17 82.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.795 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -62.02 -41.23 97.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.11 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.436 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -52.88 -53.1 53.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.298 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.484 HD12 HD13 ' A' ' 224' ' ' ILE . 3.4 mm? -82.06 -20.8 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.151 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.0 t -61.59 -32.55 72.66 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.005 0.431 . . . . 0.0 110.445 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.84 3.4 14.46 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.502 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -103.1 100.39 17.19 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.03 -26.63 43.13 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.121 1.881 . . . . 0.0 112.059 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.47 -41.58 76.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 178' ' ' VAL . 36.8 mt -71.62 -54.67 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.159 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.829 ' HB2' HD13 ' A' ' 134' ' ' LEU . 56.0 m95 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.799 0.333 . . . . 0.0 110.918 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.04 130.17 45.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HG2' HD23 ' A' ' 134' ' ' LEU . 52.1 mtt180 -69.75 127.67 33.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.61 1.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.77 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.678 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.66 176.7 9.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.714 0.292 . . . . 0.0 111.04 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.468 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.0 m-85 -139.72 173.77 11.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.629 HG21 ' CD1' ' A' ' 139' ' ' LEU . 16.6 t -133.59 117.17 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.42 15.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.291 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.435 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.8 t0 -169.28 145.17 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.52 40.9 23.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.97 29.92 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 145' ' ' THR . 89.7 m -151.47 142.52 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.425 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.5 m-85 -90.87 109.24 20.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.057 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.742 ' HB2' HD21 ' A' ' 139' ' ' LEU . 15.3 m-85 -79.05 122.74 84.8 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.45 122.11 10.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.13 1.887 . . . . 0.0 112.489 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.962 HD11 HG23 ' A' ' 164' ' ' ILE . 1.3 mt -103.87 125.03 50.0 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.791 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.2 mt -84.65 165.91 17.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.474 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HA ' HD12 ' A' ' 121' ' ' ILE . 4.8 pt-20 -55.72 -30.19 60.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.584 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.421 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.7 p-10 -90.61 14.68 12.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.396 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.27 3.82 82.75 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.583 -0.817 . . . . 0.0 113.254 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.578 ' HB3' HD12 ' A' ' 134' ' ' LEU . 16.1 tpp180 -60.6 97.36 0.05 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.276 0.56 . . . . 0.0 110.572 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.742 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -84.49 114.67 22.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.853 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.6 mt -105.07 97.69 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.717 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.2 mttt -69.76 -27.73 65.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -73.28 -23.26 60.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -101.48 25.36 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.547 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.02 163.0 54.08 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.512 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.28 156.12 42.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.661 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 28.43 3.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 138.33 24.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.72 118.36 47.44 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.407 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.5 Cg_endo -77.67 106.21 2.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.077 1.852 . . . . 0.0 112.794 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.0 t -68.0 -12.05 60.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -78.05 -27.26 48.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.59 160.14 48.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.951 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.0 Cg_endo -71.7 173.29 12.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.031 1.821 . . . . 0.0 112.763 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 123' ' ' TYR . 68.4 t -129.28 154.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.89 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.61 HD12 ' CD1' ' A' ' 133' ' ' LEU . 54.5 mt -112.94 98.33 7.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.128 0.49 . . . . 0.0 110.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.3 t -82.46 134.89 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.475 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.56 86.73 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.836 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.47 112.68 5.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.036 0.446 . . . . 0.0 111.446 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -26.84 12.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.409 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.68 95.82 8.19 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.914 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.49 -21.05 47.97 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.964 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.24 97.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.61 -34.18 69.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.524 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.962 HG23 HD11 ' A' ' 133' ' ' LEU . 40.3 mt -61.8 -52.05 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.498 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.97 -30.27 58.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 15.1 mm-40 -69.47 -50.78 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.338 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.459 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.34 -52.46 65.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.819 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.019 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.79 69.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 110.363 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.11 -40.29 96.95 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.197 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -66.64 -38.11 86.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.404 . . . . 0.0 110.273 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.732 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.9 mp -67.6 -28.13 67.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.363 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.24 -22.02 59.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.611 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -96.52 -40.75 8.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.283 . . . . 0.0 111.521 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.732 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -70.84 156.19 92.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.611 ' HB2' HG23 ' A' ' 178' ' ' VAL . 68.5 Cg_exo -49.31 129.86 23.49 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.651 2.234 . . . . 0.0 112.879 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.63 66.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.699 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.67 -37.48 87.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.49 . . . . 0.0 110.414 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.756 ' HA ' HG22 ' A' ' 224' ' ' ILE . 52.1 t -60.86 -59.96 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.75 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.677 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -61.03 -23.82 65.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.384 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.59 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.27 -24.76 74.72 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.707 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.804 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -88.19 78.3 8.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.752 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 176.88 140.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.443 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -56.52 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.8 154.41 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 199' ' ' VAL . 4.5 mt -107.51 136.77 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.32 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.423 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.4 m170 -108.06 117.39 34.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 39.2 t80 -73.02 106.62 4.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.783 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -126.92 74.7 76.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 56.1 Cg_endo -70.41 158.16 56.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.26 1.973 . . . . 0.0 112.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.7 p -140.44 162.9 34.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -26.61 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -102.4 -20.4 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.22 76.61 1.61 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.32 -20.63 29.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.669 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.87 38.37 2.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 111.188 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -85.72 116.87 24.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.06 132.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.38 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.405 HG21 ' OE2' ' A' ' 206' ' ' GLU . 21.2 mm -105.77 110.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.477 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.526 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.6 m -85.02 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.0 111.61 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -116.06 106.48 13.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.07 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.82 149.33 11.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.483 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.465 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.6 p30 -66.14 -22.36 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.934 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.2 -12.02 59.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.26 20.33 9.26 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -103.14 174.18 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . 0.405 ' OE2' HG21 ' A' ' 198' ' ' ILE . 35.5 tt0 -129.38 116.4 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 199' ' ' VAL . 13.1 t -114.87 159.9 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.521 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.462 ' N ' HG12 ' A' ' 207' ' ' VAL . 85.0 p -121.02 145.33 47.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.11 -178.44 7.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.778 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.9 153.67 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.1 mt -67.77 -21.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.076 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.47 -35.3 58.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.709 0.29 . . . . 0.0 111.462 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -133.74 35.95 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -54.38 -48.18 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.61 -48.69 80.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -62.18 -38.7 90.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 19.7 mmtt -56.44 -51.04 69.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.392 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.411 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.4 mm? -79.66 -20.3 47.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.349 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.5 p -65.49 -36.85 85.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.962 0.411 . . . . 0.0 110.384 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -63.47 -14.93 55.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.795 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 111.21 23.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.535 -0.103 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.3 -24.15 27.54 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.164 1.909 . . . . 0.0 112.459 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.23 -41.69 24.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.55 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.804 HG23 ' HB3' ' A' ' 181' ' ' ALA . 18.6 mt -68.78 -57.79 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.325 178.23 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.803 ' HB2' HD13 ' A' ' 134' ' ' LEU . 24.9 m95 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.894 0.378 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.44 128.67 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.448 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm-85 -68.31 127.22 32.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.013 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.09 0.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.024 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.605 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.92 177.06 9.55 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.648 0.261 . . . . 0.0 111.042 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.438 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.4 m-85 -139.34 173.74 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.665 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.8 t -133.45 117.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 111.073 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.454 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.56 114.06 19.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.366 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.9 t70 -169.17 143.12 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 58.95 41.27 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.938 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 54.09 29.99 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.406 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 145' ' ' THR . 51.3 m -149.38 145.42 26.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 111.365 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.454 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.5 m-85 -95.97 110.92 23.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.735 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.2 m-85 -81.71 127.06 74.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 26.3 Cg_exo -62.45 124.81 14.91 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.191 1.927 . . . . 0.0 112.501 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.95 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -106.48 125.16 50.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.803 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.3 mt -85.35 164.6 17.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.417 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.6 pt-20 -54.94 -29.88 57.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -91.16 15.36 11.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 76.72 3.25 78.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.314 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.589 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.68 97.67 0.06 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.362 0.581 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -81.09 126.34 31.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.974 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.475 ' N ' HD23 ' A' ' 139' ' ' LEU . 18.2 mt -107.71 95.69 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.8 mttp -72.54 -25.51 61.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -82.64 -20.91 35.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.791 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -101.1 28.07 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 111.5 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.68 159.8 52.48 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.642 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 129' ' ' THR . 1.3 t -124.64 155.85 38.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.44 29.71 2.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.85 140.29 22.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 118.25 51.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.02 105.67 2.12 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.122 1.881 . . . . 0.0 112.78 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t -67.89 -12.2 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -78.51 -27.3 46.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.6 0.238 . . . . 0.0 111.316 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.44 159.92 49.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.866 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 53.2 Cg_endo -71.46 172.86 13.38 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.961 1.774 . . . . 0.0 112.6 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 123' ' ' TYR . 58.6 t -129.45 154.19 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.897 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.62 HD12 ' CD1' ' A' ' 133' ' ' LEU . 56.1 mt -113.17 97.84 6.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.422 . . . . 0.0 110.441 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 72.6 t -83.29 134.29 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.37 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.6 85.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.788 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.563 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -148.31 113.05 5.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 111.494 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.84 -26.01 12.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.464 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.93 95.37 7.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.208 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.59 -20.86 48.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.067 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.2 -40.43 97.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.73 -34.19 69.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.518 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.95 HG23 HD11 ' A' ' 133' ' ' LEU . 48.1 mt -61.42 -51.88 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.612 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.401 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.46 -31.2 61.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.26 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 9.7 mm-40 -67.9 -51.15 51.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.456 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.24 -52.0 67.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.81 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.013 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.47 -33.91 70.28 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.855 0.359 . . . . 0.0 110.252 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.42 96.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.333 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -67.05 -38.06 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 8.0 mp -68.06 -28.2 67.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.291 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.95 -18.75 60.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.701 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -101.18 -40.52 7.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 0.0 111.712 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -70.4 157.81 89.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.665 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.9 Cg_exo -50.88 124.23 13.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.542 2.161 . . . . 0.0 112.638 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.73 33.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.65 93.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.17 0.51 . . . . 0.0 110.417 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.8 t -60.24 -60.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.998 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.757 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.2 pp -61.19 -25.52 67.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.39 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.449 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.84 -22.12 77.44 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.022 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.697 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.89 78.16 8.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.967 0.413 . . . . 0.0 110.913 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.6 ptp 177.92 140.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.543 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.91 -54.0 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.104 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 152.39 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 110.974 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.43 HG12 HG12 ' A' ' 199' ' ' VAL . 5.1 mt -102.97 135.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.384 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.428 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 21.3 m170 -108.05 114.71 28.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -72.14 100.74 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -123.54 79.36 54.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.72 165.93 31.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.35 2.034 . . . . 0.0 112.613 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 p -143.6 176.18 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -62.4 -25.58 68.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.81 5.14 18.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -156.58 78.01 0.92 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.911 0.386 . . . . 0.0 111.008 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -18.4 52.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.518 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.22 34.33 4.75 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.834 0.35 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -80.03 109.13 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.78 132.77 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.402 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.41 107.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.311 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.46 HG21 HD11 ' A' ' 218' ' ' LEU . 2.2 m -85.0 150.27 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.988 0.423 . . . . 0.0 111.653 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -109.08 109.2 20.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.985 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.81 148.96 9.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.416 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -66.16 -21.86 66.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.6 -10.58 59.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.27 20.52 9.09 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.713 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -100.66 174.25 6.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 110.825 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.03 122.08 29.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 208' ' ' SER . 38.6 t -125.76 158.68 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.478 ' N ' HG12 ' A' ' 207' ' ' VAL . 81.2 p -121.59 149.19 43.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.079 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.35 -177.14 5.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -129.24 153.75 47.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.563 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.4 mt -66.3 -22.43 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.022 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -32.51 57.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 111.381 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -134.16 35.82 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.408 ' CD1' HD23 ' A' ' 218' ' ' LEU . 12.3 t80 -57.3 -46.59 83.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.99 -48.68 79.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.645 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.47 -40.17 95.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -57.03 -52.99 63.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.6 mm? -77.3 -21.79 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.445 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 78.7 p -66.4 -33.5 75.84 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 110.361 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.86 -10.29 51.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.914 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.419 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -87.16 110.56 34.31 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 122.485 -0.134 . . . . 0.0 110.865 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.83 -26.35 27.33 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.215 1.943 . . . . 0.0 112.343 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -76.38 -41.91 46.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 178' ' ' VAL . 19.7 mt -69.01 -56.83 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.295 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.834 ' HB2' HD13 ' A' ' 134' ' ' LEU . 48.6 m95 . . . . . 0 N--CA 1.456 -0.145 0 CA-C-O 120.763 0.316 . . . . 0.0 110.78 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -99.47 129.55 45.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -70.07 127.05 31.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.134 0.492 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.986 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.83 1.44 2.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.842 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.72 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.93 176.46 9.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 120.695 0.284 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.45 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 20.2 m-85 -140.15 173.85 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.635 HG21 ' CD1' ' A' ' 139' ' ' LEU . 18.7 t -132.7 117.64 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.883 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.424 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.96 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.26 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 38.9 t0 -169.25 143.77 3.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.781 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 59.98 40.46 18.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 53.92 27.58 7.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.586 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 145' ' ' THR . 89.6 m -147.87 142.47 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 154' ' ' VAL . 8.9 m-85 -91.1 109.94 21.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.73 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.4 m-85 -80.0 122.47 83.19 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.25 123.38 13.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.098 1.865 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.913 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -105.67 125.32 50.85 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.834 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.2 mt -84.95 166.11 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.339 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.1 pt-20 -55.7 -29.93 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.447 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.4 p-10 -90.34 13.99 14.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.345 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.53 4.18 84.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.17 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.579 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.9 tpt180 -60.15 97.6 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.18 0.514 . . . . 0.0 110.487 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.73 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.68 115.29 22.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.892 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.4 mt -105.29 98.05 7.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.51 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.2 mttt -70.34 -28.16 64.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.79 -22.35 59.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -101.54 25.08 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.82 53.44 Favored Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.603 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.5 156.02 42.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.42 139.67 25.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.519 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.37 119.14 50.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.45 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 61.5 Cg_endo -75.8 105.08 2.01 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.98 1.787 . . . . 0.0 112.765 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.6 t -67.64 -12.4 60.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.194 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.98 -26.91 39.77 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.663 0.268 . . . . 0.0 111.568 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.87 159.55 46.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 44.5 Cg_endo -70.74 173.66 11.52 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.06 1.84 . . . . 0.0 112.805 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 130' ' ' PHE . 77.7 t -129.06 154.44 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.023 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.587 HD12 ' CD1' ' A' ' 133' ' ' LEU . 58.7 mt -112.81 98.36 7.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.2 t -82.66 135.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.476 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.55 86.78 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.876 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.5 m95 -148.4 116.24 6.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.471 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -106.81 -26.53 11.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.459 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -97.41 95.56 7.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.4 -20.86 46.53 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.108 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -40.4 97.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.17 -33.28 67.57 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.621 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.913 HG23 HD11 ' A' ' 133' ' ' LEU . 53.1 mt -62.44 -51.86 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.678 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.71 -30.21 55.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.11 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 10.6 mm-40 -68.99 -51.11 42.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.348 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.836 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.986 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.59 -33.7 68.47 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.91 0.386 . . . . 0.0 110.383 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.64 96.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.478 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.1 -39.63 93.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.738 ' HA ' HD22 ' A' ' 174' ' ' LEU . 5.1 mp -66.17 -27.77 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.367 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.55 -19.42 60.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.667 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.86 -40.58 7.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.705 0.288 . . . . 0.0 111.633 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.738 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -70.37 157.31 90.29 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' A' ' 178' ' ' VAL . 72.9 Cg_exo -48.9 128.78 19.75 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.744 2.296 . . . . 0.0 112.92 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.54 67.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.552 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.4 -37.14 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 0.0 110.327 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 224' ' ' ILE . 44.9 t -61.45 -60.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.868 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.6 pp -62.56 -24.01 67.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -72.95 -24.44 75.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.628 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' A' ' 202' ' ' ASN . . . -90.32 78.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.26 137.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 p -80.27 -57.93 3.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.197 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.12 154.12 31.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.971 0.415 . . . . 0.0 111.145 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -106.06 136.84 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.6 m170 -108.22 123.27 48.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.724 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 55.1 t80 -77.67 107.82 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -131.35 76.4 75.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.744 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.406 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 50.2 Cg_endo -69.59 162.67 41.06 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.336 2.024 . . . . 0.0 112.609 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.3 p -140.86 163.37 33.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.9 mtp85 -55.89 -25.89 44.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 -20.64 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.283 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -136.8 82.48 1.94 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.71 -20.76 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.673 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -114.58 37.69 3.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 111.163 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -82.28 112.34 19.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.988 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.51 135.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -106.75 109.27 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.554 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.6 m -84.84 154.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.899 0.38 . . . . 0.0 111.654 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -114.5 101.36 9.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.957 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.436 ' HE3' HG21 ' A' ' 207' ' ' VAL . 7.8 tpp -53.87 149.33 8.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.596 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.502 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 11.5 p-10 -66.83 -20.08 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.041 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.76 -13.4 60.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 20.21 9.47 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -109.04 167.86 9.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.68 117.02 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.743 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 199' ' ' VAL . 9.3 t -113.85 160.39 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 207' ' ' VAL . 78.1 p -121.43 144.33 48.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.762 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -158.32 -177.36 6.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.8 152.35 47.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.321 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.5 mt -66.42 -24.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.913 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -29.8 51.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.695 0.283 . . . . 0.0 111.361 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -134.16 36.07 3.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.221 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.672 ' CE1' HD11 ' A' ' 171' ' ' LEU . 41.3 t80 -56.88 -50.03 73.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.845 0.355 . . . . 0.0 111.051 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -62.16 -42.49 99.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.81 -42.26 95.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.414 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 45.6 mmtt -57.08 -53.66 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.346 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.48 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -75.97 -24.0 55.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.5 m -62.8 -32.97 74.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 110.33 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -5.89 39.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.406 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -95.0 100.74 5.95 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -65.86 -25.85 52.47 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.131 1.887 . . . . 0.0 111.97 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.3 -41.68 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 178' ' ' VAL . 27.3 mt -72.07 -54.88 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.446 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.131 178.133 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.841 ' HB2' HD13 ' A' ' 134' ' ' LEU . 45.5 m95 . . . . . 0 N--CA 1.456 -0.146 0 CA-C-O 120.791 0.329 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.16 134.24 45.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.466 ' HG2' HD23 ' A' ' 134' ' ' LEU . 13.9 mtm-85 -73.4 127.46 32.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.136 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.009 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.12 -1.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.928 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.728 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -160.83 176.55 11.35 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 120.683 0.278 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.448 ' HB2' HG22 ' A' ' 154' ' ' VAL . 33.9 m-85 -138.62 173.05 12.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.503 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.651 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.6 t -133.88 120.17 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.927 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.08 109.77 14.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.977 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.418 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.3 t0 -161.38 138.56 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 58.39 42.73 20.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 54.11 28.75 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.625 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 145' ' ' THR . 94.9 m -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 111.103 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.1 m-85 -90.23 110.15 21.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.697 ' HB2' HD21 ' A' ' 139' ' ' LEU . 13.2 m-30 -81.3 118.23 71.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.999 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 10.8 Cg_endo -56.73 124.28 15.88 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.131 1.887 . . . . 0.0 112.563 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.926 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -106.24 125.35 50.89 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.117 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 118' ' ' TRP . 17.4 mt -81.67 167.98 18.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.058 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.6 pt-20 -57.28 -30.78 64.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.463 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.1 p30 -90.6 13.87 14.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.398 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.503 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 79.71 5.61 89.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.121 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.589 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -59.44 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 117.392 0.596 . . . . 0.0 110.23 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -81.33 118.66 22.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.9 mm? -103.74 96.77 6.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.755 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 37.9 mttt -71.84 -26.57 62.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -80.94 -23.74 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.526 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -98.28 22.68 9.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.642 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.2 163.27 54.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.549 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.712 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.53 156.38 43.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.586 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 26.12 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.42 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -143.57 139.67 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 118.11 59.89 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.86 106.7 2.3 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.07 1.847 . . . . 0.0 112.501 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.2 t -67.13 -13.24 61.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.74 -27.23 50.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.66 164.96 33.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.6 Cg_endo -78.49 173.33 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.051 1.834 . . . . 0.0 112.757 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.0 t -130.02 154.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.928 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 133' ' ' LEU . 67.5 mt -112.51 97.59 6.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.65 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.6 t -82.55 134.57 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.409 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.09 87.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.709 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.6 m95 -147.57 110.25 4.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 111.597 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -100.2 -25.91 14.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.507 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.43 95.39 7.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.915 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.44 -20.83 46.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.044 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.4 -40.56 97.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.88 -34.56 71.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.474 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.926 ' CG2' HD11 ' A' ' 133' ' ' LEU . 62.1 mt -61.99 -51.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.722 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.408 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.57 -29.79 59.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.188 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 27.3 mm-40 -69.25 -51.8 33.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.173 0.511 . . . . 0.0 110.25 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.47 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.42 -52.77 64.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.026 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.009 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.57 69.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.356 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.06 97.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.434 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.24 -38.48 87.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.913 0.387 . . . . 0.0 110.45 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.775 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.6 mp -64.81 -28.21 69.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.634 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -102.82 -40.84 6.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.698 0.285 . . . . 0.0 111.679 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.775 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -68.91 157.29 89.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.132 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.63 ' HB2' HG23 ' A' ' 178' ' ' VAL . 56.2 Cg_exo -49.85 129.79 25.27 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.696 2.264 . . . . 0.0 112.749 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.3 -38.89 66.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 110.314 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 175' ' ' PRO . 54.4 t -60.31 -57.07 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.679 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.4 pp -68.09 -13.19 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.29 -14.68 59.92 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.369 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.39 78.63 3.9 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.918 0.359 . . . . 0.0 111.724 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.35 176.82 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.702 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.9 m -116.55 -44.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -167.51 151.82 6.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -105.13 135.35 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.407 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -108.42 114.41 28.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 41.3 t80 -65.85 111.03 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.832 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -132.02 76.96 72.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 53.5 Cg_endo -70.31 160.66 48.77 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.0 p -140.17 161.46 37.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.04 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -54.73 -25.63 28.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.26 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.25 -21.82 14.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.247 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.448 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.7 m-85 -136.16 80.85 1.85 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.892 0.377 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.28 -21.13 32.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.562 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -112.89 38.09 2.91 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.448 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 3.4 ttm180 -85.89 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.8 m -120.0 138.7 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.23 111.09 34.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.794 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.607 HG12 HG12 ' A' ' 185' ' ' ILE . 2.9 m -86.53 152.89 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -110.55 100.58 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.535 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.3 tpp -55.8 149.34 14.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.479 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -67.51 -20.38 65.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.089 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -76.62 -13.54 60.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.18 20.15 10.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.781 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -112.24 156.54 22.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.899 0.38 . . . . 0.0 110.775 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -110.3 117.13 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.535 HG21 ' HE3' ' A' ' 201' ' ' MET . 41.2 t -114.04 159.18 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.648 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 207' ' ' VAL . 49.8 p -121.46 149.09 43.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.569 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -167.22 149.37 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.79 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.688 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.476 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.8 mt -58.83 -28.03 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.118 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -32.12 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -134.24 35.97 3.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.152 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.455 ' CD1' HD23 ' A' ' 218' ' ' LEU . 11.6 t80 -54.95 -50.22 69.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.516 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.84 -48.78 80.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 0.0 111.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -64.92 -32.81 74.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.155 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.409 ' CB ' ' HB1' ' A' ' 209' ' ' ALA . 1.9 mmpt? -61.67 -53.88 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.085 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.2 mm? -80.21 -23.67 40.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.4 t -63.29 -38.81 92.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 110.687 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -64.77 -14.38 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.684 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.74 111.39 25.75 Favored Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.567 -0.083 . . . . 0.0 110.828 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -68.58 -25.56 34.59 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.259 1.972 . . . . 0.0 112.518 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.88 33.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.564 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 178' ' ' VAL . 22.9 mt -70.07 -56.99 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.212 178.099 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.79 ' HB2' HD13 ' A' ' 134' ' ' LEU . 58.2 m95 . . . . . 0 CA--C 1.521 -0.136 0 CA-C-O 120.947 0.403 . . . . 0.0 111.049 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -95.33 140.59 30.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.478 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -82.38 124.66 30.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 110.561 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.988 HD11 HG22 ' A' ' 168' ' ' THR . 0.1 OUTLIER -127.75 0.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.986 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.26 177.02 8.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.432 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 18.9 m-85 -140.46 173.09 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.338 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 139' ' ' LEU . 24.7 t -132.44 120.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.985 0.421 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.498 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.45 110.95 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.42 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.9 t70 -157.12 135.87 11.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 58.05 43.96 20.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.46 29.22 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.428 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 145' ' ' THR . 85.0 m -144.01 144.04 31.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.0 m-85 -95.27 110.62 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.488 . . . . 0.0 111.048 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.716 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.1 m-30 -83.29 124.25 76.22 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.185 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.546 ' HB2' HD12 ' A' ' 140' ' ' LEU . 31.4 Cg_exo -59.34 127.21 23.14 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.366 2.044 . . . . 0.0 112.82 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.994 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.44 124.78 51.6 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.817 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.6 mt -85.66 165.66 16.8 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.546 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 121' ' ' ILE . 9.3 pt-20 -55.38 -30.71 60.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -89.71 14.19 12.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 77.44 3.59 82.91 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.157 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.603 ' HB3' HD12 ' A' ' 134' ' ' LEU . 19.4 tpp180 -61.04 97.15 0.06 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.167 0.483 . . . . 0.0 110.589 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -78.15 129.63 35.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.863 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 132' ' ' PRO . 81.6 mt -108.06 92.38 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 21.2 mttp -72.64 -28.9 63.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.815 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.32 -21.08 42.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.472 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -101.64 28.02 5.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.505 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -76.31 159.42 50.2 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.384 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.33 157.56 40.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.952 0.406 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 25.67 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.4 OUTLIER -141.77 139.34 32.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.483 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.15 111.65 8.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.315 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.432 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 23.3 Cg_exo -63.65 100.41 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.475 2.117 . . . . 0.0 112.196 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -65.61 -14.92 62.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.346 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.64 -27.29 40.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.3 161.86 55.01 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.9 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.534 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 56.9 Cg_endo -73.97 172.9 14.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.751 1.634 . . . . 0.0 112.539 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.417 HG21 ' CD2' ' A' ' 130' ' ' PHE . 76.5 t -129.81 154.92 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.133 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.5 mt -114.09 97.69 6.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 0.0 110.492 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.68 133.81 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.459 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.45 85.53 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.809 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 68.6 m95 -147.7 115.46 6.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.966 0.413 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.19 -26.4 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.519 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.12 94.77 7.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.923 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.02 -21.26 45.0 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.096 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -39.97 96.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.75 67.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.556 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.994 HG23 HD11 ' A' ' 133' ' ' LEU . 39.6 mt -61.99 -51.76 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.638 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.418 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.62 -30.87 61.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 14.7 mm-40 -67.68 -50.77 56.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.172 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.446 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.77 -52.25 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.988 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.55 68.5 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.951 0.405 . . . . 0.0 110.321 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.2 97.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.37 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -64.14 -39.44 94.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.285 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.741 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.6 mp -66.14 -27.53 68.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.259 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.81 -19.87 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.61 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.36 -40.76 7.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 111.483 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.61 156.82 90.99 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.964 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.614 ' HB2' HG23 ' A' ' 178' ' ' VAL . 57.4 Cg_exo -49.78 129.52 24.3 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 112.864 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.58 -39.6 67.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.574 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.34 -37.4 85.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.097 0.475 . . . . 0.0 110.536 179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.678 ' HA ' HG22 ' A' ' 224' ' ' ILE . 52.5 t -61.33 -60.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.72 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.667 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -61.86 -24.05 66.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.453 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.26 -24.41 75.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.631 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.563 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -90.19 78.16 6.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.768 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 178.59 138.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.554 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -80.2 -62.01 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.65 152.16 32.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 0.0 111.041 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.23 133.88 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.429 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 33.3 m170 -107.37 111.99 24.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.956 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -65.35 106.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -129.65 79.84 72.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.73 160.86 46.33 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.276 1.984 . . . . 0.0 112.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -138.56 162.58 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -54.75 -25.96 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.279 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -103.9 -18.7 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.515 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . 0.449 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.2 m-85 -136.6 83.44 2.0 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.905 0.383 . . . . 0.0 111.219 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.92 -20.58 38.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.544 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -114.13 38.46 3.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -82.81 117.7 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.78 133.05 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.517 HD12 ' HB3' ' A' ' 208' ' ' SER . 25.2 mm -104.09 107.98 23.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.341 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.542 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.55 152.4 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.68 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.93 100.77 9.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.013 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.42 ' HE3' HG21 ' A' ' 207' ' ' VAL . 10.2 tpp -54.81 149.5 11.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 111.492 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -65.95 -20.25 66.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.028 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.03 -13.54 60.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.33 20.11 11.53 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.74 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.23 162.64 14.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.666 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -112.44 120.79 42.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.685 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 208' ' ' SER . 39.6 t -118.25 158.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.687 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.517 ' HB3' HD12 ' A' ' 198' ' ' ILE . 44.4 p -121.95 149.44 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.44 -178.15 6.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.812 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -127.63 149.76 50.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.119 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.465 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.5 mt -64.6 -23.85 34.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.01 -31.22 56.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.445 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.25 35.98 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.1 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.427 ' CD1' HD23 ' A' ' 218' ' ' LEU . 13.0 t80 -55.75 -50.71 69.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.83 0.348 . . . . 0.0 111.032 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.57 -44.38 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.93 -41.46 97.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.43 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 57.2 mmtt -56.24 -53.37 57.96 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.016 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.427 HD23 ' CD1' ' A' ' 214' ' ' PHE . 3.3 mm? -76.64 -23.19 53.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -61.59 -34.34 75.45 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.072 0.463 . . . . 0.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -71.83 -5.55 35.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 99.96 5.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.93 -28.24 50.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.171 1.914 . . . . 0.0 111.98 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.29 81.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.714 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.2 mt -72.13 -54.75 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.281 178.156 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.798 ' HB2' HD13 ' A' ' 134' ' ' LEU . 51.1 m95 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.801 0.334 . . . . 0.0 111.0 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 127.93 44.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -69.36 126.62 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.017 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.48 -0.16 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.969 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.06 176.68 9.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.963 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.449 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 18.9 m-85 -139.11 173.35 11.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.313 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.63 HG21 ' HG ' ' A' ' 139' ' ' LEU . 21.4 t -132.59 118.23 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.36 113.37 18.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.145 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 33.3 t0 -164.5 138.87 5.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.798 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.43 42.16 18.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 110.821 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.19 28.26 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.504 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 145' ' ' THR . 63.2 m -145.01 144.28 30.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.6 m-85 -95.16 110.58 22.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.718 ' HB2' HD21 ' A' ' 139' ' ' LEU . 12.3 m-30 -81.97 125.74 76.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.142 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.571 ' HB2' HD12 ' A' ' 140' ' ' LEU . 36.5 Cg_exo -61.29 126.1 18.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.293 1.995 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.949 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -108.14 125.04 51.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.793 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 118' ' ' TRP . 22.0 mt -85.27 166.13 16.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.384 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.9 pt-20 -55.44 -30.26 60.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.499 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -91.29 15.48 11.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.382 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.56 3.63 83.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.228 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.548 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.06 96.73 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.224 0.512 . . . . 0.0 110.581 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -82.24 122.3 27.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.077 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 132' ' ' PRO . 16.2 mt -104.5 96.64 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -72.76 -26.4 61.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -81.73 -22.9 37.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.696 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -97.55 27.25 4.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.383 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -75.26 159.08 51.34 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.801 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -126.01 155.54 41.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.684 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 29.6 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.756 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.55 22.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.43 119.05 56.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.1 Cg_endo -74.44 106.03 2.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.065 1.843 . . . . 0.0 112.68 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -67.28 -12.83 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.63 -27.23 40.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.653 0.263 . . . . 0.0 111.524 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.33 159.69 47.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 44.2 Cg_endo -70.86 174.28 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.115 1.877 . . . . 0.0 112.845 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' A' ' 130' ' ' PHE . 75.9 t -129.79 154.61 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.065 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.2 mt -113.75 97.76 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.016 0.436 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.22 134.42 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.438 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.18 86.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.811 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.7 m95 -148.23 113.95 5.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.031 0.443 . . . . 0.0 111.465 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -104.74 -25.38 12.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.589 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.88 95.04 7.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.227 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.885 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.43 -21.0 47.35 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.012 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -40.15 96.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.46 -33.77 67.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.606 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.949 HG23 HD11 ' A' ' 133' ' ' LEU . 56.2 mt -61.95 -51.9 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.709 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.8 mm-40 -67.57 -50.52 58.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.247 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.63 -52.21 66.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.856 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.07 -33.69 67.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.843 0.354 . . . . 0.0 110.439 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.38 -44.09 97.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.186 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.24 -38.21 88.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.255 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.779 ' HA ' HD22 ' A' ' 174' ' ' LEU . 6.5 mp -67.74 -28.7 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.245 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.6 -22.36 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.399 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.6 -41.15 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.709 0.29 . . . . 0.0 111.385 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.779 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.04 156.42 92.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.827 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' A' ' 178' ' ' VAL . 67.9 Cg_exo -49.38 128.53 20.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.621 2.214 . . . . 0.0 112.792 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.14 -40.41 67.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.9 -37.26 83.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.526 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.648 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.4 t -61.03 -60.03 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 171' ' ' LEU . 4.4 pp -62.15 -23.68 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.477 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.61 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -75.17 -22.59 76.05 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.978 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -90.84 78.32 6.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.85 132.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -58.29 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.14 153.33 25.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.51 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -101.66 135.71 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.438 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.419 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 8.0 m170 -108.68 114.69 28.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -69.29 113.48 6.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -133.73 71.85 74.23 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.94 159.52 51.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.299 2.0 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.4 p -139.59 161.21 38.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.101 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -52.93 -26.54 15.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -103.1 -21.46 13.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.27 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -132.79 76.81 1.71 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -21.68 23.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.652 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.55 39.55 2.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.884 0.374 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -86.3 118.31 25.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.06 133.78 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.8 mm -106.42 109.27 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.39 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.73 152.18 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 0.0 111.775 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -109.74 105.79 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.864 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.401 ' HE1' HD13 ' A' ' 224' ' ' ILE . 11.8 tpp -56.9 149.38 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -58.33 -22.81 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.28 -2.34 48.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.12 -15.22 60.71 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.972 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -66.48 164.87 15.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -119.61 121.38 39.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.675 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 208' ' ' SER . 35.7 t -119.48 159.15 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.786 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 207' ' ' VAL . 98.4 p -121.85 149.32 43.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.021 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.83 -177.49 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.79 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.23 154.61 44.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.4 mt -69.76 -21.69 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.097 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.07 -30.38 31.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -133.04 35.06 3.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.68 -47.87 81.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.66 -47.23 87.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.22 -38.56 91.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 1.4 mmpt? -57.86 -53.31 59.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.528 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.3 mm? -81.73 -20.11 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.382 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 26.1 t -64.92 -37.74 88.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.67 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -67.25 -10.68 53.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.065 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -81.32 111.7 27.06 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.451 -0.156 . . . . 0.0 110.808 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.94 -27.11 30.88 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.233 1.955 . . . . 0.0 112.389 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -79.71 -44.75 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.575 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.648 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.1 mt -64.19 -56.95 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.383 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.422 178.426 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.83 ' HB2' HD13 ' A' ' 134' ' ' LEU . 49.3 m95 . . . . . 0 N--CA 1.454 -0.231 0 CA-C-O 120.784 0.326 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 130.83 50.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -68.78 127.88 34.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.118 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.018 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.58 -0.2 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.007 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.65 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.5 176.82 9.37 Favored 'General case' 0 CA--C 1.523 -0.073 0 CA-C-O 120.655 0.265 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.443 ' HB2' HG22 ' A' ' 154' ' ' VAL . 26.8 m-85 -138.74 173.65 11.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.431 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.627 HG21 ' HG ' ' A' ' 139' ' ' LEU . 17.1 t -133.24 117.74 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.444 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.65 111.18 16.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.313 -179.382 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.2 t0 -169.34 144.5 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.37 40.31 21.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 53.96 29.08 9.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.65 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 145' ' ' THR . 85.2 m -150.11 142.19 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.7 m-85 -90.32 109.5 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.149 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.728 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.2 m-85 -79.86 123.28 83.85 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.095 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.19 123.72 13.74 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.181 1.921 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.926 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -106.29 125.11 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.0 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.83 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.6 mt -84.23 165.85 18.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.343 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.7 pt-20 -55.34 -30.45 60.29 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.48 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -91.3 15.1 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.276 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.425 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.36 7.13 86.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.292 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.595 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.55 95.63 0.04 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.322 0.561 . . . . 0.0 110.32 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.64 112.55 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.711 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.48 98.36 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 26.9 mttt -69.59 -26.39 64.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -74.3 -24.1 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.19 24.81 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.509 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.33 163.03 53.77 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.666 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.47 155.49 43.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 110.639 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.15 3.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.73 140.03 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 117.5 44.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 106.28 2.19 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.065 1.844 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -67.71 -12.47 60.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.267 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.46 -27.26 52.03 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.323 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.56 164.09 34.94 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.875 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.6 Cg_endo -76.02 173.56 14.29 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.913 1.742 . . . . 0.0 112.659 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 123' ' ' TYR . 57.9 t -130.24 153.71 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.951 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.589 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.1 mt -113.25 97.57 6.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -83.03 135.22 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.52 86.83 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.494 ' CH2' HD11 ' A' ' 211' ' ' ILE . 72.9 m95 -149.14 111.52 4.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.391 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -102.23 -26.08 13.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.566 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.85 95.09 7.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.397 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.897 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.17 -21.13 45.72 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.014 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.34 97.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -33.82 68.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.576 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.926 HG23 HD11 ' A' ' 133' ' ' LEU . 52.8 mt -61.85 -51.88 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.573 178.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.13 -27.99 49.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 29.5 mm-40 -72.08 -50.6 26.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 0.0 110.356 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.15 -52.33 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 179.661 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.018 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.55 -33.95 68.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.356 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.283 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -63.89 -38.42 91.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.162 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.763 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.3 mp -67.03 -28.32 68.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.22 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -19.27 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.544 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.26 -41.29 6.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 111.505 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.67 157.17 90.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.94 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.586 ' HB2' HG23 ' A' ' 178' ' ' VAL . 74.9 Cg_exo -49.16 128.3 19.44 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.35 67.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.552 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.16 -36.81 85.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.26 179.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 175' ' ' PRO . 41.7 t -61.45 -60.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.774 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.667 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.6 pp -62.17 -24.82 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.12 -23.75 77.06 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.727 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.594 ' HB1' ' ND2' ' A' ' 202' ' ' ASN . . . -90.43 78.34 6.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 110.746 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.25 130.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.7 m -70.15 -58.31 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.12 154.02 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.07 135.96 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.318 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.434 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.8 m170 -109.01 112.6 24.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.87 109.37 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -132.05 78.24 69.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.72 160.3 50.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.253 1.968 . . . . 0.0 112.417 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -139.23 162.36 35.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.28 -25.87 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -102.11 -20.07 14.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.505 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -136.38 81.29 1.87 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.66 -21.84 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.636 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.94 39.07 2.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -84.07 115.47 22.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.43 132.98 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.276 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.8 mm -104.89 108.73 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.487 HG12 HG12 ' A' ' 185' ' ' ILE . 2.4 m -86.14 154.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.69 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -111.96 102.15 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.507 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.6 tpp -56.71 149.26 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.213 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.594 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.4 p30 -67.22 -19.92 65.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.36 -13.43 60.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.19 20.22 10.69 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.797 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -112.0 161.41 16.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.854 0.359 . . . . 0.0 110.691 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.69 120.6 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.806 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 201' ' ' MET . 27.4 t -118.2 158.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.444 . . . . 0.0 110.665 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 207' ' ' VAL . 52.4 p -121.88 149.14 43.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.157 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.06 -177.62 6.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.709 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -126.94 151.66 48.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.494 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.0 mt -65.95 -22.74 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -29.17 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.78 35.33 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.4 t80 -57.7 -51.43 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.16 -47.2 86.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.996 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.82 -38.69 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.42 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.503 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 53.4 mmtt -58.11 -53.41 58.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.497 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.1 mm? -82.12 -19.79 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.555 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.2 t -64.56 -39.85 94.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -10.65 55.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.851 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.415 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -77.21 111.63 18.1 Favored Pre-proline 0 CA--C 1.535 0.366 0 O-C-N 122.48 -0.138 . . . . 0.0 110.863 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.92 -27.57 30.41 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.251 1.967 . . . . 0.0 112.376 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -81.13 -45.48 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.523 -179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 178' ' ' VAL . 24.9 mt -62.85 -57.18 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.01 0.434 . . . . 0.0 109.944 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.356 178.396 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.791 ' HB2' HD13 ' A' ' 134' ' ' LEU . 57.7 m95 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.894 0.378 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -98.98 132.48 44.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -70.01 126.36 29.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.011 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.96 1.14 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.796 179.469 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.657 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.0 176.37 9.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.445 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.5 m-85 -139.23 173.64 11.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.334 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 139' ' ' LEU . 16.3 t -133.98 117.74 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.899 0.381 . . . . 0.0 110.922 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.461 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 113.16 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.14 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.435 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.8 t70 -167.19 139.54 3.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 59.23 42.13 19.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.21 0.529 . . . . 0.0 110.954 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 54.12 27.64 7.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.686 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 145' ' ' THR . 86.5 m -145.89 141.59 27.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.461 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.9 m-85 -91.93 109.44 20.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.228 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.5 m-30 -79.44 123.1 84.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.872 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.86 123.86 14.14 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.19 1.927 . . . . 0.0 112.678 -179.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.963 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -106.49 124.97 50.4 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.791 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.2 mt -85.18 166.27 16.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.378 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.3 pt-20 -55.64 -30.47 61.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -91.09 15.26 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.389 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.82 86.39 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.269 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.614 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.2 96.28 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.3 0.55 . . . . 0.0 110.36 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -86.71 113.46 22.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.88 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.2 mt -105.62 98.42 8.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.431 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 16.5 mttt -69.07 -28.59 66.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -72.39 -27.01 62.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.4 22.17 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.454 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 162.11 54.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.539 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.702 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.85 155.71 43.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.382 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 27.99 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.983 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 138.67 25.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.47 117.95 49.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.425 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 66.9 Cg_endo -76.44 105.79 2.14 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.117 1.878 . . . . 0.0 112.657 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.72 -12.59 60.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.58 -26.94 51.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.673 0.273 . . . . 0.0 111.358 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.5 163.93 36.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.823 -179.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.6 Cg_endo -75.87 172.77 15.66 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.891 1.727 . . . . 0.0 112.37 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 123' ' ' TYR . 58.3 t -128.9 153.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.618 HD12 ' CD1' ' A' ' 133' ' ' LEU . 58.3 mt -112.53 97.69 6.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.431 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.5 t -82.06 134.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.377 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.99 87.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.76 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.555 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.67 111.11 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.016 0.436 . . . . 0.0 111.438 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.21 -26.13 13.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.633 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -97.52 95.66 7.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.919 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.22 -21.23 46.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.1 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -40.06 96.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.57 -34.21 69.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.572 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.963 HG23 HD11 ' A' ' 133' ' ' LEU . 38.0 mt -61.85 -52.01 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.61 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.43 -28.98 57.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.24 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 6.1 mm-40 -70.89 -51.12 28.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.32 -52.29 66.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.885 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.011 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.91 -33.79 69.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.255 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.81 97.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.305 178.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -66.07 -37.39 85.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.248 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.765 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.1 mp -68.01 -29.65 68.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.86 -19.07 62.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.39 -41.07 6.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.751 0.31 . . . . 0.0 111.541 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.765 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.89 156.73 91.26 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 -179.593 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.654 ' HB2' HG23 ' A' ' 178' ' ' VAL . 53.2 Cg_exo -49.98 130.14 26.7 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 112.792 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.19 -39.78 63.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.94 -38.45 91.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 110.552 179.672 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.766 ' HA ' HG22 ' A' ' 224' ' ' ILE . 58.1 t -59.6 -55.59 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.686 179.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.652 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -68.74 -12.61 61.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 178.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.69 -14.16 58.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.44 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.665 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.68 78.83 3.74 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.975 0.387 . . . . 0.0 111.593 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -178.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.554 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -121.31 -44.36 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -167.66 151.09 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.469 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -105.49 136.15 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.317 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.5 m170 -109.57 122.52 47.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.503 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -73.53 102.73 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.724 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -122.96 75.08 48.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.415 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 55.4 Cg_endo -70.62 161.04 47.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.335 2.023 . . . . 0.0 112.597 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.5 p -139.8 164.95 28.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.885 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -54.28 -27.86 38.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -104.28 -16.59 15.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.65 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -135.32 76.62 1.63 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.3 -21.28 33.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.711 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.76 38.37 2.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -85.77 117.8 24.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.008 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.88 133.67 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -104.53 110.58 31.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.497 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.3 m -84.99 156.26 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.686 -179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.77 106.98 15.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.411 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.17 149.23 20.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -67.29 -21.57 65.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.014 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.433 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.9 m-20 -77.21 -13.08 60.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.19 20.35 9.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.617 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 32.9 m-85 -106.52 173.38 6.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.656 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -127.78 119.73 26.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 199' ' ' VAL . 18.6 t -116.77 159.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 207' ' ' VAL . 94.3 p -119.91 149.11 42.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.413 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.23 -179.11 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.808 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -129.93 150.01 51.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.314 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.555 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.3 mt -63.27 -24.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.156 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -35.96 64.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 0.0 111.553 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -131.95 36.15 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.093 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.456 ' CD1' HD23 ' A' ' 218' ' ' LEU . 15.2 t80 -54.84 -51.71 65.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.265 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.3 -43.01 92.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.7 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.44 -38.38 87.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.144 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 24.1 mmtm -58.94 -53.67 55.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.133 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.523 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.1 mm? -78.35 -22.12 48.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t -60.13 -47.98 83.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.227 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . 0.418 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 1.5 p-80 -62.57 -15.5 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -71.03 110.59 7.54 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.98 -24.23 28.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.426 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -82.68 -40.84 20.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.613 -179.342 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 178' ' ' VAL . 14.2 mt -69.72 -58.57 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.232 178.173 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.8 ' HB2' HD13 ' A' ' 134' ' ' LEU . 39.4 m95 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.885 0.374 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 130.06 53.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.401 ' HG2' ' CD2' ' A' ' 134' ' ' LEU . 3.5 mtm180 -69.77 124.84 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.999 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.0 0.79 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.891 179.639 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.669 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -165.5 176.79 7.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.582 0.229 . . . . 0.0 110.869 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 24.2 m-85 -140.47 173.33 11.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.413 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.604 HG21 ' CD1' ' A' ' 139' ' ' LEU . 22.8 t -132.29 119.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.86 0.362 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.37 111.03 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.965 -179.526 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 43.8 t0 -156.74 134.74 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.796 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 58.52 44.21 18.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.058 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 54.74 27.59 9.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.552 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 87.0 m -142.12 144.0 33.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.4 m-85 -95.31 110.43 22.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.026 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HB2' HD21 ' A' ' 139' ' ' LEU . 9.7 m-30 -82.81 125.34 75.7 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 35.9 Cg_exo -60.23 127.51 23.3 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.218 1.946 . . . . 0.0 112.709 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 1.0 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -110.22 124.75 52.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.1 mt -86.37 165.85 16.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.41 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' A' ' 121' ' ' ILE . 8.8 pt-20 -55.12 -30.79 60.48 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.576 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.25 12.86 14.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 78.6 3.45 86.78 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.081 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.59 ' HB3' HD12 ' A' ' 134' ' ' LEU . 2.0 tpt180 -60.29 97.41 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.222 0.511 . . . . 0.0 110.436 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.45 125.87 30.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.8 mm? -104.0 92.64 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.586 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 11.3 mttm -71.69 -28.55 63.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.858 0.361 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -81.27 -22.9 38.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.405 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -97.27 24.42 6.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.524 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.03 159.22 53.46 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.272 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.93 157.77 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.911 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 26.22 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -142.41 139.89 31.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.498 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.7 111.67 8.95 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.307 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 22.3 Cg_exo -64.06 100.59 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.386 2.058 . . . . 0.0 112.146 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -65.75 -14.76 61.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.447 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 -27.27 40.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.5 162.91 48.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.934 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 57.6 Cg_endo -75.13 174.36 12.93 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.761 1.641 . . . . 0.0 112.64 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.405 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.5 t -130.78 155.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.087 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.3 mt -115.0 97.51 6.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.601 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 66.2 t -83.2 133.95 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.33 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.88 84.96 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.748 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.484 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.4 m95 -147.36 111.94 5.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.054 0.454 . . . . 0.0 111.508 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -102.13 -27.08 13.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -96.73 95.67 8.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.911 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.39 -21.06 47.24 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.037 178.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.62 98.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.78 -34.48 71.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 1.0 HG23 HD11 ' A' ' 133' ' ' LEU . 42.1 mt -61.95 -51.8 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.541 178.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.405 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.2 -29.62 58.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.264 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 16.3 mm-40 -70.14 -51.78 28.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.3 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.458 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.56 -52.54 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.044 179.917 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.999 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.86 -33.55 68.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.311 179.324 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.55 -42.36 97.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.205 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -65.79 -38.36 88.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.809 0.338 . . . . 0.0 110.311 179.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.817 ' HA ' HD22 ' A' ' 174' ' ' LEU . 8.0 mp -66.17 -27.22 67.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.397 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.43 -20.29 60.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.523 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -101.41 -41.11 6.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.817 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -68.57 156.94 89.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 178' ' ' VAL . 54.2 Cg_exo -50.15 124.93 13.75 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.64 2.227 . . . . 0.0 112.679 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.09 -38.42 65.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.591 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.45 89.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.449 179.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.668 ' HA ' HG22 ' A' ' 224' ' ' ILE . 50.5 t -61.31 -60.21 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.794 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -62.07 -23.5 66.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.473 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.23 -24.87 74.59 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.588 178.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.18 78.37 7.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.29 134.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -159.53 153.68 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.421 . . . . 0.0 111.102 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -105.05 135.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.149 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.452 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.3 m170 -109.47 119.57 39.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.31 112.24 5.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.781 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 186' ' ' HIS . 1.1 mptp? -135.85 79.72 44.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.85 163.46 38.81 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.279 1.986 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -138.73 163.45 32.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -53.54 -27.07 23.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.63 -16.47 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.656 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -134.0 79.78 1.83 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -58.58 -19.93 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.612 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -114.11 36.52 3.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.74 0.305 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.8 116.36 22.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 110.776 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.08 133.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.402 HG12 ' HD3' ' A' ' 188' ' ' LYS . 33.2 mm -106.01 110.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.74 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.8 m -84.57 157.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.599 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -112.53 107.39 16.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.241 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . 0.493 ' HE1' HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -56.25 149.29 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 111.309 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -60.58 -24.57 65.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.803 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -85.95 7.07 25.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -16.53 60.91 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.51 177.1 0.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.934 0.367 . . . . 0.0 110.792 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -140.88 115.23 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 199' ' ' VAL . 21.7 t -106.98 157.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 207' ' ' VAL . 83.3 p -121.93 142.78 49.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.123 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.56 -177.27 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.85 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.48 149.06 49.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.476 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.484 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.3 mt -61.21 -23.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.378 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -33.68 59.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -132.4 36.19 3.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.008 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 218' ' ' LEU . 11.9 t80 -58.12 -39.31 78.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.242 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -69.69 -48.79 58.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.186 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.29 -34.17 76.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.106 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -53.32 56.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.392 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -79.31 -22.9 43.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.4 m -64.32 -39.12 93.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.631 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -16.3 52.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.673 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 111.58 13.02 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 122.512 -0.117 . . . . 0.0 110.844 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -67.98 -27.31 36.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.255 1.97 . . . . 0.0 112.381 -179.822 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -80.14 -45.56 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 178' ' ' VAL . 34.6 mt -63.82 -56.28 17.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.066 0.46 . . . . 0.0 109.813 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.457 178.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.841 ' HB2' HD13 ' A' ' 134' ' ' LEU . 44.9 m95 . . . . . 0 N--CA 1.455 -0.179 0 CA-C-O 120.779 0.323 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -101.49 132.2 47.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.673 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.435 ' HG2' HD23 ' A' ' 134' ' ' LEU . 72.5 mtm180 -71.49 127.67 33.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 1.012 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.22 -1.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.875 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.3 177.06 9.94 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.025 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.435 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 23.5 m-85 -139.45 173.95 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.387 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.655 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.7 t -132.42 118.55 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.45 109.6 15.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 14.9 t70 -169.2 144.88 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.74 39.65 20.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.36 0.6 . . . . 0.0 110.804 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.92 29.2 9.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.506 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 145' ' ' THR . 90.8 m -150.59 143.0 24.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 111.294 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . 0.431 ' CD2' HG21 ' A' ' 154' ' ' VAL . 7.1 m-85 -90.71 110.45 21.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.734 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.8 m-85 -80.47 118.55 72.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.04 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 11.2 Cg_endo -57.44 121.23 9.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.023 1.816 . . . . 0.0 112.422 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.901 HD11 HG23 ' A' ' 164' ' ' ILE . 1.4 mt -102.57 125.36 49.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.7 mt -82.98 165.48 19.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.516 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.0 pt-20 -56.03 -30.38 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.677 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.445 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 53.0 p-10 -89.89 13.92 13.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.93 86.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.171 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.586 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -61.65 97.34 0.07 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.13 0.491 . . . . 0.0 110.429 179.649 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.42 121.93 26.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 140' ' ' LEU . 3.2 mm? -104.33 96.6 6.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.586 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 5.0 mttt -72.71 -25.24 61.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.62 -20.86 30.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.737 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.15 23.35 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.19 163.8 54.5 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.615 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -126.68 155.28 42.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.825 0.345 . . . . 0.0 110.533 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 27.12 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.003 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.29 139.06 28.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.43 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.42 3.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.435 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 21.8 Cg_exo -64.54 98.05 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.482 2.122 . . . . 0.0 112.287 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -65.79 -14.49 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.339 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.634 0.254 . . . . 0.0 111.677 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.43 160.34 59.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.866 0.365 . . . . 0.0 111.936 -179.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -72.42 173.02 13.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.778 1.652 . . . . 0.0 112.668 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 130' ' ' PHE . 75.9 t -129.62 154.22 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.157 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.609 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.2 mt -112.92 97.96 6.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 110.551 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.36 135.04 25.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.2 87.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.859 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.477 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.3 m95 -148.22 114.9 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.082 0.468 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -105.39 -27.04 11.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.01 95.49 7.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.888 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.43 -20.84 46.65 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.014 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -41.06 98.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.03 71.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.463 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.901 HG23 HD11 ' A' ' 133' ' ' LEU . 55.3 mt -62.01 -52.08 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.559 178.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.53 -30.93 55.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.3 mm-40 -68.3 -51.0 49.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.223 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.445 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.0 -52.05 67.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.87 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 1.012 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.57 -33.73 68.47 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.877 0.37 . . . . 0.0 110.359 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.51 -43.65 97.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.246 178.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.55 -39.46 94.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.751 ' HA ' HD22 ' A' ' 174' ' ' LEU . 8.3 mp -66.93 -27.49 67.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.416 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.92 -22.25 58.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -96.94 -41.19 8.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.773 0.32 . . . . 0.0 111.506 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.751 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.09 155.55 93.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 -179.614 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.575 ' HB2' HG23 ' A' ' 178' ' ' VAL . 61.9 Cg_exo -49.89 129.82 25.5 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.632 2.222 . . . . 0.0 112.791 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.75 68.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.408 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.01 85.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 110.4 179.576 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.759 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.2 t -61.66 -60.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.604 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.669 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -61.55 -24.49 66.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 178.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.47 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.91 -23.5 76.23 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.872 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.99 78.29 9.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.972 0.415 . . . . 0.0 110.865 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.39 163.65 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.372 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -103.83 -51.9 3.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.41 151.22 18.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 110.943 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -104.73 135.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.092 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.449 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 7.5 m170 -109.52 125.25 52.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 189' ' ' PRO . 14.0 t80 -75.49 107.37 7.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.526 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -133.24 70.83 77.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.959 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 187' ' ' TYR . 20.5 Cg_exo -65.82 162.75 33.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.339 2.026 . . . . 0.0 112.252 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.9 p -135.88 164.13 28.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -26.05 11.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.445 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -105.35 -20.21 13.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.416 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -129.41 82.05 2.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -16.57 25.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.045 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -121.1 37.22 4.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.645 0.26 . . . . 0.0 111.233 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . 0.781 ' NH2' HG23 ' A' ' 210' ' ' THR . 3.8 ttm-85 -81.04 119.86 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.719 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.9 m -119.41 135.14 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 208' ' ' SER . 22.6 mm -105.0 110.78 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.483 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 185' ' ' ILE . 2.1 m -89.66 150.71 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.63 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -109.19 108.9 19.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.236 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.48 149.31 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.469 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -64.76 -22.52 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.939 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.67 -13.17 59.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.25 20.35 9.24 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -103.51 172.49 6.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.829 0.347 . . . . 0.0 110.863 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.36 120.05 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 208' ' ' SER . 13.9 t -121.8 160.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.457 ' N ' HG12 ' A' ' 207' ' ' VAL . 56.9 p -121.63 148.89 43.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -160.37 -179.26 7.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.72 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.781 HG23 ' NH2' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -125.59 151.52 46.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.359 179.781 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.459 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.1 mt -66.02 -25.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -79.14 -28.24 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.251 . . . . 0.0 111.403 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.05 35.77 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -57.89 -51.72 68.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.99 -42.01 97.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.511 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.95 -43.05 93.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.429 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 16.1 mmtm -55.03 -52.64 62.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.083 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.51 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.5 mm? -77.39 -22.84 51.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 21.6 t -60.55 -35.47 76.11 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.092 0.472 . . . . 0.0 110.406 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -72.06 -4.94 31.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.007 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 99.4 5.95 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -66.07 -27.07 50.0 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.156 1.904 . . . . 0.0 111.911 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.27 -45.12 77.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.783 HG23 ' HB3' ' A' ' 181' ' ' ALA . 38.3 mt -70.28 -53.51 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.315 178.376 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' TRP . . . . . 0.844 ' HB2' HD13 ' A' ' 134' ' ' LEU . 43.3 m95 . . . . . 0 N--CA 1.456 -0.134 0 CA-C-O 120.846 0.355 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -101.28 132.17 46.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -71.29 127.29 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.999 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.72 1.48 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.792 179.668 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.698 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.12 176.92 8.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 21.0 m-85 -139.82 173.43 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.226 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.68 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.7 t -132.92 118.58 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.57 111.25 16.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.9 t70 -169.09 145.4 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.79 40.86 22.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 54.1 30.62 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.518 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 145' ' ' THR . 41.6 m -152.0 146.42 25.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.424 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.03 109.18 20.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.657 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.0 m-85 -80.68 128.75 70.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.501 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.1 Cg_exo -64.16 125.33 14.98 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.162 1.908 . . . . 0.0 112.326 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.921 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.1 124.88 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.993 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' A' ' 118' ' ' TRP . 17.3 mt -84.07 166.91 17.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.171 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.2 pt-20 -55.72 -30.96 62.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.551 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 6.9 p30 -90.49 13.3 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.421 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.468 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 80.0 5.93 89.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.601 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.46 96.31 0.03 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 117.253 0.526 . . . . 0.0 110.401 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -80.89 124.15 28.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.184 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.6 mm? -105.5 95.61 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.3 mtpt -72.33 -25.92 61.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.276 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -84.81 -21.14 30.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.695 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -99.31 25.7 6.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.553 0.216 . . . . 0.0 111.418 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -69.38 160.92 52.63 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.574 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -124.64 159.82 29.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.36 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.46 30.78 4.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.139 0.495 . . . . 0.0 109.714 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' THR . . . . . 0.464 HG23 ' OG1' ' A' ' 145' ' ' THR . 0.0 OUTLIER -154.25 129.62 9.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.483 -178.215 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.17 109.84 2.35 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.787 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.421 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 35.4 Cg_exo -61.19 105.85 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.225 1.95 . . . . 0.0 112.127 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.68 -15.62 61.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.481 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -81.53 -26.94 34.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.51 162.4 53.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.9 Cg_endo -76.5 173.69 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.99 1.793 . . . . 0.0 112.749 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.0 t -129.55 153.27 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.886 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 133' ' ' LEU . 56.5 mt -112.42 97.75 6.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.006 0.431 . . . . 0.0 110.638 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.8 t -82.43 134.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.514 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.74 86.91 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.722 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.8 m95 -148.41 112.93 5.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -103.42 -26.23 12.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.514 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -98.11 96.04 7.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.903 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.55 -20.97 48.14 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.028 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -40.46 97.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.96 -33.77 68.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.697 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.921 ' CG2' HD11 ' A' ' 133' ' ' LEU . 63.6 mt -62.28 -52.11 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.675 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.24 -30.41 59.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.187 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.7 mm-40 -67.9 -51.14 51.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 110.149 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.9 -52.47 65.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.757 179.609 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.999 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.3 -33.7 67.94 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.268 179.253 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.13 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -66.34 -34.76 78.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.37 . . . . 0.0 110.22 178.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.625 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.1 mp -71.79 -28.18 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -19.23 61.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.482 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.17 -40.24 8.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.8 0.334 . . . . 0.0 111.48 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.816 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -73.65 156.0 88.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 175' ' ' PRO . . . . . 0.67 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.5 Cg_exo -51.41 124.7 14.77 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.02 36.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.925 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.48 95.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 179.601 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 224' ' ' ILE . 48.3 t -59.17 -60.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.949 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -62.58 -24.35 67.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -22.48 77.66 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.101 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . 0.613 ' HB1' ' ND2' ' A' ' 202' ' ' ASN . . . -85.15 78.33 9.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.931 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.4 ptp 177.86 128.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 m -64.91 -48.78 72.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.47 153.92 8.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.984 0.421 . . . . 0.0 110.997 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -102.89 136.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.269 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 186' ' ' HIS . . . . . 0.438 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -111.06 116.8 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.488 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -66.71 112.02 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.853 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -133.54 78.4 62.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 56.8 Cg_endo -71.38 162.11 43.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.306 2.004 . . . . 0.0 112.53 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.9 p -138.64 161.65 36.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.149 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ptt-85 -53.84 -24.83 17.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.376 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -104.99 -20.19 13.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.429 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -134.91 82.02 1.93 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.07 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.04 -19.34 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.659 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -113.17 35.85 3.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -82.91 115.89 21.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.788 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.92 134.53 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.3 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 207' ' ' VAL . 24.3 mm -105.63 110.6 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.622 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.28 153.89 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.452 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -111.5 100.57 9.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.207 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.8 tpp -55.85 149.42 14.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.505 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.613 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.4 p30 -66.78 -20.17 65.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.039 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.83 -13.47 60.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.54 20.31 11.09 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.724 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -113.25 153.64 28.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 110.723 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.53 117.55 34.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' VAL . . . . . 0.48 ' HB ' HG22 ' A' ' 199' ' ' VAL . 10.8 t -111.96 160.22 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.425 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 207' ' ' VAL . 88.0 p -121.57 146.36 47.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.005 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -158.18 179.5 9.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -125.19 152.94 43.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' ILE . . . . . 0.439 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.2 mt -68.37 -23.89 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.897 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -36.58 57.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.46 35.86 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.962 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.2 t80 -56.17 -45.95 79.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.127 -179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.27 82.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -60.86 -41.47 95.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . 0.431 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -54.11 -52.35 61.29 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.648 179.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.4 mm? -83.34 -19.48 36.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 38.0 t -64.88 -30.72 71.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.942 0.401 . . . . 0.0 110.854 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -81.55 11.26 4.78 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' TYR . . . . . 0.49 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -105.94 101.85 35.88 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.2 -35.02 87.62 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.241 1.961 . . . . 0.0 112.354 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -66.14 -44.83 83.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.224 -179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 178' ' ' VAL . 42.5 mt -65.58 -54.56 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.383 178.701 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.559 -0.216 . . . . 0.0 112.559 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -83.4 162.98 20.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.856 0.36 . . . . 0.0 110.801 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.73 173.22 17.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.961 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.819 ' HB2' HD13 ' A' ' 134' ' ' LEU . 54.7 m95 -87.67 153.01 21.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.956 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.03 129.61 48.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.8 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.8 mtm180 -68.65 127.51 33.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.095 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.0 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.89 1.18 2.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.848 179.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.703 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.21 177.02 8.67 Favored 'General case' 0 CA--C 1.522 -0.124 0 CA-C-O 120.664 0.268 . . . . 0.0 110.837 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.453 ' HB2' HG22 ' A' ' 154' ' ' VAL . 25.1 m-85 -140.04 173.17 11.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.423 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.662 HG21 ' HG ' ' A' ' 139' ' ' LEU . 19.5 t -133.34 119.95 37.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.05 0.452 . . . . 0.0 111.09 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.484 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.41 109.52 14.98 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.911 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -158.5 137.55 11.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.723 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? 57.95 42.64 22.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.071 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.61 30.56 13.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.394 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 145' ' ' THR . 89.3 m -147.82 143.0 27.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.884 0.373 . . . . 0.0 111.001 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.484 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.1 m-85 -92.36 110.25 21.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.209 0.528 . . . . 0.0 110.678 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.7 ' HB2' HD21 ' A' ' 139' ' ' LEU . 11.8 m-30 -83.07 111.57 31.47 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.388 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 82.6 Cg_exo -47.14 126.11 11.1 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.546 2.164 . . . . 0.0 113.089 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.981 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.14 125.05 51.77 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.708 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.819 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.1 mt -84.31 166.04 17.78 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.471 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.461 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.9 pt-20 -55.45 -30.63 60.89 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.534 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 19.6 p-10 -91.31 15.61 11.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.357 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.429 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.13 7.13 86.71 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.155 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.608 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -60.61 95.39 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 117.287 0.543 . . . . 0.0 110.213 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.15 119.95 23.62 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.112 -179.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 140' ' ' LEU . 3.1 mm? -99.59 94.27 6.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.646 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 22.2 mttt -72.98 -29.43 63.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.802 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.9 mt-30 -82.2 -21.67 36.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.43 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -98.95 25.38 6.72 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.715 -0.22 . . . . 0.0 111.431 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.441 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.39 160.06 53.59 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.433 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.711 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.0 155.42 43.23 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.501 -0.35 . . . . 0.0 110.657 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.76 2.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.974 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.404 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -144.81 139.91 28.08 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.382 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -71.1 117.99 61.57 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.041 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -76.83 107.06 2.37 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.146 1.898 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.9 t -67.5 -12.85 61.31 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.257 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -77.74 -27.0 50.32 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 120.707 0.289 . . . . 0.0 111.397 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.561 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.1 162.83 45.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.823 0.344 . . . . 0.0 111.868 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.561 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 60.4 Cg_endo -76.32 174.09 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 122.064 1.843 . . . . 0.0 112.733 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 130' ' ' PHE . 72.9 t -130.38 153.98 39.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.524 -0.762 . . . . 0.0 109.939 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.569 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.4 mt -113.04 97.88 6.8 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.13 0.49 . . . . 0.0 110.652 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.7 t -82.81 134.67 26.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.361 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.2 87.13 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.691 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.8 m95 -148.78 111.72 4.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.96 0.409 . . . . 0.0 111.465 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.76 -26.67 13.4 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.528 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -97.52 96.18 8.14 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.301 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.906 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.19 -21.27 46.35 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.999 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.9 -40.48 97.69 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.3 -34.0 70.23 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.532 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.981 HG23 HD11 ' A' ' 133' ' ' LEU . 49.0 mt -62.57 -51.84 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-N 115.837 -0.62 . . . . 0.0 109.61 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.406 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.58 -27.93 52.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.384 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.5 mm-40 -71.29 -51.47 24.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.183 0.516 . . . . 0.0 110.392 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.452 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.92 -52.34 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.955 179.737 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.0 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.63 -33.72 68.56 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.848 0.356 . . . . 0.0 110.352 179.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.49 -42.98 97.87 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.159 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -63.51 -37.77 88.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.923 0.392 . . . . 0.0 110.047 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.682 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.1 mp -67.99 -28.08 67.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.068 179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.02 -18.64 61.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.723 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -101.88 -40.49 6.89 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.685 0.279 . . . . 0.0 111.683 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.789 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.3 pp -71.16 156.93 91.23 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.774 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.679 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.9 Cg_exo -50.73 124.29 13.26 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.449 2.099 . . . . 0.0 112.466 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.54 -38.48 45.05 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.833 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.703 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -62.68 -41.24 98.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.052 0.453 . . . . 0.0 110.593 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 51.9 t -59.71 -60.24 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.96 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.789 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.7 -24.03 66.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.542 178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.513 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.81 -22.69 76.6 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.012 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.09 78.27 8.95 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-O 120.979 0.419 . . . . 0.0 110.727 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.4 ptp 178.55 140.2 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.434 -179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.6 m -80.91 -53.88 6.06 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.231 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -159.3 150.67 20.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.198 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.527 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -102.52 135.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.292 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.2 m170 -109.56 118.8 37.54 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.769 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.447 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -70.28 110.5 5.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.955 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -133.01 78.34 65.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.699 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.423 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 60.8 Cg_endo -74.08 162.77 38.22 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.256 1.971 . . . . 0.0 112.504 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.1 p -140.3 170.23 16.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.839 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -57.88 -25.35 60.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.306 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -104.85 -12.72 16.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -144.05 83.12 1.73 Allowed 'General case' 0 C--O 1.231 0.131 0 CA-C-O 120.897 0.38 . . . . 0.0 111.335 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -61.13 -19.08 61.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.546 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -112.42 33.71 4.76 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.677 0.275 . . . . 0.0 110.959 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 tpt180 -81.5 115.17 20.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.839 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.66 133.43 63.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.221 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.6 mm -104.69 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.386 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.527 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -87.74 151.92 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.712 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -110.36 101.67 10.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.043 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.552 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.4 tpp -55.45 149.43 13.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.513 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 42.7 p-10 -67.05 -20.58 65.86 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.055 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -75.79 -13.46 60.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.72 20.39 10.09 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.867 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -109.87 165.46 11.69 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.907 0.384 . . . . 0.0 110.755 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -117.62 117.43 29.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.711 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.552 HG21 ' HE3' ' A' ' 201' ' ' MET . 26.1 t -116.54 158.76 16.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.895 0.378 . . . . 0.0 110.712 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 207' ' ' VAL . 54.2 p -121.79 149.3 43.51 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.0 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.32 -177.72 6.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.64 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.412 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -127.59 151.88 48.35 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.297 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.501 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -65.62 -24.23 34.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.964 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -76.46 -37.72 56.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.669 0.271 . . . . 0.0 111.394 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 10.3 mt-30 -127.84 35.75 4.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.957 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.412 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.9 t80 -57.69 -42.23 83.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.801 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -64.12 -48.73 74.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.768 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -63.41 -37.33 86.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.286 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 13.9 mmtm -58.21 -53.13 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.532 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.477 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -82.99 -20.05 35.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.386 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.6 t -65.68 -36.61 84.14 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.061 0.457 . . . . 0.0 110.752 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -70.59 -7.73 46.32 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.069 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.411 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -80.2 112.16 28.21 Favored Pre-proline 0 CA--C 1.534 0.352 0 O-C-N 122.356 -0.215 . . . . 0.0 110.786 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 17.0 Cg_exo -67.3 -30.64 36.79 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.26 1.973 . . . . 0.0 112.542 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.59 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -77.37 -45.34 26.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.575 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.8 mt -63.04 -57.12 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.993 0.425 . . . . 0.0 109.935 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.423 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -55.01 -28.57 53.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.513 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.98 -29.04 18.9 Favored 'General case' 0 C--O 1.231 0.104 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.774 178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.566 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -52.36 -28.48 19.69 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 121.093 0.473 . . . . 0.0 110.285 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.703 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.4 mt -76.62 -31.29 57.33 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.097 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -73.4 -34.45 65.52 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.984 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -77.6 -49.45 14.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.973 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -78.08 76.98 4.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.851 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.3 t -77.96 133.44 30.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.127 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.3 ttmm . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.281 -0.866 . . . . 0.0 110.854 -179.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.49 -0.244 . . . . 0.0 112.49 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.4 114.11 4.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.721 0.296 . . . . 0.0 110.871 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -174.36 -174.81 0.9 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.904 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.825 ' HB2' HD13 ' A' ' 134' ' ' LEU . 55.6 m95 -108.51 152.97 24.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.005 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.0 tmt_? -98.59 131.87 44.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.663 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.446 ' HG2' HD23 ' A' ' 134' ' ' LEU . 8.0 mtt85 -73.12 127.65 33.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.15 -0.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.507 -0.769 . . . . 0.0 111.768 179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.687 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.03 176.76 10.4 Favored 'General case' 0 N--CA 1.457 -0.123 0 CA-C-O 120.67 0.272 . . . . 0.0 110.926 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.446 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 22.6 m-85 -139.07 173.7 11.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.16 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.645 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.8 t -133.97 117.3 25.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.917 0.389 . . . . 0.0 110.858 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.472 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 111.45 16.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.097 -179.498 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.432 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.0 t70 -168.98 144.1 3.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.793 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.18 40.48 21.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.96 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.14 29.45 10.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.616 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 145' ' ' THR . 90.8 m -149.75 142.68 24.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.877 0.37 . . . . 0.0 111.326 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.472 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.9 m-85 -91.41 109.38 20.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.172 178.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.734 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.8 m-85 -79.95 122.94 83.79 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.916 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -62.31 121.17 9.06 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.995 1.796 . . . . 0.0 112.372 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.916 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -101.18 125.28 47.79 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.076 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.825 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.5 mt -82.22 166.17 19.82 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.397 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.537 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.4 pt-20 -56.6 -30.06 62.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.642 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -90.86 15.32 11.52 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.445 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 76.73 4.32 81.42 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.158 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.591 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.3 tpt85 -61.88 97.13 0.07 Allowed 'General case' 0 N--CA 1.454 -0.261 0 CA-C-O 121.206 0.527 . . . . 0.0 110.488 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.46 116.62 20.61 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.808 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.2 mt -103.23 97.44 7.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.96 0.41 . . . . 0.0 110.718 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 27.5 mttt -71.77 -26.02 62.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.12 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -77.26 -21.0 54.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -103.89 26.69 8.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.562 0.22 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.67 162.86 52.32 Favored Glycine 0 CA--C 1.509 -0.301 0 C-N-CA 120.384 -0.912 . . . . 0.0 112.525 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.69 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.05 156.96 41.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.851 0.357 . . . . 0.0 110.613 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.56 26.72 3.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.942 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.401 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -145.83 140.37 27.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.446 -179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.3 118.78 56.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.02 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 67.3 Cg_endo -76.09 106.85 2.34 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.999 1.799 . . . . 0.0 112.678 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.5 t -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.199 179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.2 -26.95 47.73 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.726 0.298 . . . . 0.0 111.419 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.56 159.98 49.4 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 54.5 Cg_endo -71.52 172.92 13.32 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.046 1.83 . . . . 0.0 112.587 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.439 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.6 t -128.95 154.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.01 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.4 mt -112.93 97.79 6.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.489 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -82.36 135.33 25.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.492 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.62 88.18 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.782 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.501 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.9 m95 -148.46 110.66 4.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.963 0.411 . . . . 0.0 111.549 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.4 mtmm -100.98 -25.25 14.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.631 179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -99.37 96.27 7.6 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.328 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.906 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.94 -20.78 50.34 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.072 -1.061 . . . . 0.0 111.952 178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.38 -40.41 97.16 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.31 -34.06 70.23 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 114.667 -1.152 . . . . 0.0 109.57 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.916 HG23 HD11 ' A' ' 133' ' ' LEU . 50.4 mt -61.99 -51.93 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.573 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.64 -29.18 51.56 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.28 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 60.2 mm-40 -71.08 -50.51 33.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.386 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.459 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.87 -52.52 65.08 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.771 179.771 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.026 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.56 -33.59 68.3 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.831 0.348 . . . . 0.0 110.248 179.244 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.38 -42.72 97.59 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.634 -0.794 . . . . 0.0 111.181 178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -64.33 -37.31 87.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.954 0.407 . . . . 0.0 110.105 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.652 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -68.93 -27.26 65.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.314 179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.15 -20.09 60.34 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.522 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -99.1 -40.55 7.95 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.694 0.283 . . . . 0.0 111.381 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.776 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.98 155.28 90.58 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.456 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.673 ' O ' HD12 ' A' ' 174' ' ' LEU . 54.2 Cg_exo -51.22 125.27 15.95 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.499 2.133 . . . . 0.0 112.443 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.95 -36.86 40.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.797 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.714 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.97 -41.17 97.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.054 0.454 . . . . 0.0 110.355 179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.772 ' HA ' HG22 ' A' ' 224' ' ' ILE . 40.3 t -59.46 -60.24 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.106 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.776 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.7 pp -61.44 -26.52 67.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.269 178.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.505 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.63 -22.01 78.83 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.649 -0.786 . . . . 0.0 111.97 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.855 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -82.05 78.07 8.78 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.88 0.372 . . . . 0.0 110.911 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 176.88 154.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.54 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 15.1 t -91.98 -46.75 7.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.159 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -166.0 151.55 8.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.933 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.496 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -103.92 135.5 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.221 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 15.7 m170 -107.97 122.8 47.58 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.409 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 18.1 t80 -76.53 102.8 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.744 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -123.39 70.66 44.92 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.699 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.409 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 41.1 Cg_endo -67.96 160.07 50.13 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.35 2.034 . . . . 0.0 112.636 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.5 p -140.12 163.19 33.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.011 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.0 ptp85 -53.39 -27.33 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.51 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.97 -19.85 14.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.448 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -133.29 76.9 1.7 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.941 0.401 . . . . 0.0 110.936 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -57.37 -21.05 33.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.59 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -113.57 37.88 3.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.669 0.271 . . . . 0.0 111.237 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -83.91 112.76 20.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.836 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.0 m -116.59 132.85 65.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.248 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 207' ' ' VAL . 23.7 mm -104.72 108.14 24.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.425 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.496 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.15 151.82 3.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.973 0.416 . . . . 0.0 111.624 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -108.75 109.8 21.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.12 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.29 149.16 7.61 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.48 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.59 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.3 p30 -61.4 -23.25 65.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.01 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -78.5 -13.22 59.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.819 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.94 20.35 9.41 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.792 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -101.28 173.09 6.61 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.823 0.344 . . . . 0.0 110.779 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -120.57 120.52 36.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 208' ' ' SER . 40.8 t -121.23 159.15 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.479 ' N ' HG12 ' A' ' 207' ' ' VAL . 96.8 p -120.14 149.09 42.79 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.151 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -163.64 -179.34 6.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.576 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.0 OUTLIER -128.24 155.06 45.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.431 179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.501 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.8 mt -69.87 -23.79 25.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.881 -0.327 . . . . 0.0 110.753 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.73 -31.82 57.39 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 111.238 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -134.1 35.85 3.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.02 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 13.1 t80 -56.88 -46.97 81.49 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.885 0.374 . . . . 0.0 110.88 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.86 -42.71 99.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.35 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -63.19 -45.83 89.92 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.141 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.5 mmpt? -53.34 -53.04 56.8 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.604 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.489 HD12 HD13 ' A' ' 224' ' ' ILE . 3.5 mm? -78.96 -22.43 45.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.079 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.6 m -64.67 -28.28 69.49 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.752 0.311 . . . . 0.0 110.797 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -81.8 8.52 9.95 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.193 0.442 . . . . 0.0 112.193 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.425 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -105.97 102.65 40.5 Favored Pre-proline 0 CA--C 1.534 0.35 0 O-C-N 122.324 -0.235 . . . . 0.0 110.406 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -62.93 -34.31 71.78 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.177 1.918 . . . . 0.0 112.387 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.514 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -65.57 -45.19 84.26 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.232 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.855 HG23 ' HB3' ' A' ' 181' ' ' ALA . 31.7 mt -65.83 -54.76 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.31 -29.32 47.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.51 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.81 -28.68 16.43 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.799 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.573 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.95 -28.41 16.55 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-O 121.019 0.437 . . . . 0.0 110.325 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.714 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 5.3 mt -77.23 -31.74 55.32 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.09 178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -69.43 -22.47 63.67 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.444 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.9 tpp180 -53.76 -28.84 36.96 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.714 0.292 . . . . 0.0 111.424 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 17.3 t30 -67.31 -40.68 86.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.784 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.86 121.47 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.178 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.9 tttm . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.209 -0.9 . . . . 0.0 110.9 179.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.147 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 t -147.76 95.38 2.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.828 0.347 . . . . 0.0 110.827 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -116.8 -177.01 3.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.917 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.787 ' HB2' HD13 ' A' ' 134' ' ' LEU . 66.5 m95 -74.76 154.31 38.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.961 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.6 ptt85 -99.53 132.32 44.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.8 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HG2' HD23 ' A' ' 134' ' ' LEU . 18.2 mtm180 -71.91 127.48 32.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.162 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.02 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.41 1.15 2.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.846 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.675 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.15 177.01 8.72 Favored 'General case' 0 C--O 1.227 -0.099 0 CA-C-O 120.643 0.259 . . . . 0.0 111.092 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HB2' HG22 ' A' ' 154' ' ' VAL . 28.8 m-85 -140.08 173.78 11.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.393 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.663 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.6 t -133.54 117.37 27.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.886 0.374 . . . . 0.0 111.002 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.46 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.49 112.57 17.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.27 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.438 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 27.8 t70 -169.18 142.21 2.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.769 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.34 41.22 20.11 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.161 0.505 . . . . 0.0 110.946 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.12 28.09 8.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.672 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.692 HG23 ' O ' ' A' ' 145' ' ' THR . 82.1 m -147.61 142.32 26.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.956 0.408 . . . . 0.0 111.317 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.46 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 9.6 m-85 -92.55 110.19 21.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.15 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.9 m-85 -79.96 119.35 76.37 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.922 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 11.8 Cg_endo -58.31 121.09 9.4 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.92 1.747 . . . . 0.0 112.351 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.919 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -102.04 125.74 48.81 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.15 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.787 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.7 mt -83.27 165.97 18.92 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.312 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' HA ' HD12 ' A' ' 121' ' ' ILE . 9.1 pt-20 -56.17 -30.69 62.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.61 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -90.93 15.65 10.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.437 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.48 6.51 86.69 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.606 -0.807 . . . . 0.0 113.25 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.62 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -60.62 95.22 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.18 0 CA-C-N 117.327 0.564 . . . . 0.0 110.243 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -81.03 117.29 21.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.822 -179.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.482 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.7 mm? -100.77 96.78 7.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.613 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 6.2 mttt -73.25 -25.73 60.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.066 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -84.55 -21.17 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.686 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -100.83 25.47 7.92 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.649 0.261 . . . . 0.0 111.521 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.45 164.41 54.16 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.659 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.692 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -127.87 156.66 42.22 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.82 0.343 . . . . 0.0 110.588 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.44 26.55 3.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.909 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.424 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -144.77 141.47 29.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.604 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.91 118.27 61.68 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.948 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.25 106.59 2.26 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.04 1.827 . . . . 0.0 112.567 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.9 t -67.48 -12.71 60.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.257 179.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -78.0 -27.42 48.98 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.689 0.28 . . . . 0.0 111.367 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.524 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.97 161.44 53.74 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.851 -179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.524 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.8 Cg_endo -74.4 173.28 14.52 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 121.969 1.779 . . . . 0.0 112.517 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.3 t -129.91 154.47 40.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.899 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.9 mt -113.48 97.97 6.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.026 0.441 . . . . 0.0 110.529 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.439 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.9 t -83.88 135.17 25.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.326 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.46 85.38 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.69 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.537 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.6 m95 -148.57 116.45 6.35 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.074 0.464 . . . . 0.0 111.452 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.35 -25.68 11.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.464 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -98.06 95.52 7.51 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.111 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.919 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.28 -21.01 46.2 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.041 -1.076 . . . . 0.0 112.071 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.28 -40.17 96.63 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 177.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.84 -33.59 68.58 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.589 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.919 HD12 ' HA2' ' A' ' 161' ' ' GLY . 43.5 mt -62.45 -51.89 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.587 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.83 -29.75 55.73 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.243 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.2 mm-40 -69.62 -50.43 44.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.234 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.73 -52.31 66.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.737 179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.02 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.06 -33.76 69.38 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.911 0.386 . . . . 0.0 110.23 179.346 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.18 -40.71 97.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.549 -0.834 . . . . 0.0 111.224 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -66.25 -37.37 85.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.995 0.426 . . . . 0.0 110.247 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.568 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -69.02 -27.69 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.269 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.01 -19.59 60.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.552 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -99.34 -40.44 7.91 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.748 0.309 . . . . 0.0 111.534 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.46 157.34 89.23 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.472 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.656 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.6 Cg_exo -50.76 124.01 12.73 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.494 2.129 . . . . 0.0 112.56 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.4 -33.08 28.72 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.76 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.716 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -67.42 -41.76 84.31 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.132 0.491 . . . . 0.0 110.369 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.751 ' HA ' HG22 ' A' ' 224' ' ' ILE . 45.0 t -59.22 -59.95 3.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.8 -0.637 . . . . 0.0 109.857 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.8 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.2 pp -61.27 -25.24 66.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.412 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.419 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.46 -23.03 77.99 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.951 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.76 78.15 9.62 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.915 0.388 . . . . 0.0 110.715 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.84 138.73 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.524 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -78.9 -50.36 11.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.139 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -162.73 152.68 16.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.02 0.438 . . . . 0.0 111.019 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.53 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.09 136.46 37.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.303 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.439 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 5.3 m170 -108.49 116.17 31.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.989 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 48.2 t80 -70.21 105.04 2.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.696 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 19.7 mttm -126.71 75.48 75.11 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.819 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 44.4 Cg_endo -68.43 160.55 48.67 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.232 1.955 . . . . 0.0 112.41 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.1 p -139.44 162.38 35.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.852 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -54.24 -26.24 27.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.36 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -103.22 -19.71 14.4 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.424 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -134.63 79.6 1.81 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.857 0.361 . . . . 0.0 111.106 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.04 -21.43 31.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.55 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -113.42 38.59 2.85 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.678 0.275 . . . . 0.0 111.111 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.19 115.92 22.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 27.3 m -120.04 132.81 68.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.275 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.1 mm -105.34 111.69 35.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.628 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.535 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.5 m -86.62 152.76 3.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.55 -179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -112.2 105.19 13.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.022 178.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.24 149.09 7.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.924 0.392 . . . . 0.0 111.562 -179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -67.24 -22.44 65.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.913 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -78.5 -10.72 59.82 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.37 20.39 9.15 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.622 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -104.75 176.17 5.25 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.853 0.358 . . . . 0.0 110.741 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -134.93 113.08 11.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.908 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.535 ' HB ' HG22 ' A' ' 199' ' ' VAL . 15.0 t -109.84 159.59 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.436 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 207' ' ' VAL . 76.5 p -121.3 146.73 46.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.669 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.493 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.6 -179.74 7.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.2 147.66 51.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.326 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.537 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -58.82 -24.85 27.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.615 0.245 . . . . 0.0 111.417 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.01 -30.95 58.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.721 0.296 . . . . 0.0 111.553 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -134.21 35.96 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.235 -179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -57.05 -50.97 71.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.753 0.311 . . . . 0.0 110.921 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.65 89.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.725 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -62.77 -41.04 99.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.146 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.493 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 26.7 mmtt -55.41 -53.45 56.12 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.217 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.63 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -77.8 -23.03 49.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.727 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.1 t -60.41 -34.26 73.68 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 121.092 0.472 . . . . 0.0 110.269 179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -78.24 0.83 23.67 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.796 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.53 99.62 6.75 Favored Pre-proline 0 CA--C 1.532 0.27 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.53 -20.08 47.9 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.105 1.87 . . . . 0.0 112.41 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.545 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -74.2 -52.27 12.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.152 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.787 HG23 ' HB3' ' A' ' 181' ' ' ALA . 23.5 mt -63.64 -53.04 49.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.449 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -54.38 -29.43 48.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.495 178.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.46 -28.45 13.17 Favored 'General case' 0 C--N 1.339 0.115 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.567 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.66 -27.32 11.19 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.384 178.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.716 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.2 mt -79.55 -31.68 42.01 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.223 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -108.82 26.44 10.58 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.269 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -55.87 -57.76 10.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.342 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -176.48 -40.01 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.029 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.9 t 65.51 119.61 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.025 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.798 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.619 -0.193 . . . . 0.0 112.619 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.3 m -91.47 147.95 22.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.758 0.313 . . . . 0.0 110.926 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -135.34 179.97 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.801 ' HB2' HD13 ' A' ' 134' ' ' LEU . 61.3 m95 -96.93 154.96 16.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.161 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -95.12 145.81 24.74 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.519 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.43 ' HG2' HD23 ' A' ' 134' ' ' LEU . 14.3 mtm180 -86.92 124.28 32.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.065 0.46 . . . . 0.0 110.456 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.026 HD11 HG22 ' A' ' 168' ' ' THR . 0.1 OUTLIER -126.98 -0.37 4.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.869 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.69 176.64 10.12 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.174 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.401 ' HB2' HG22 ' A' ' 154' ' ' VAL . 19.8 m-85 -139.1 173.18 11.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.181 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.632 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.5 t -132.95 118.17 32.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.938 0.399 . . . . 0.0 110.939 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.459 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.41 111.32 16.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.27 -179.336 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 39.2 t0 -169.31 143.78 2.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.683 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 35.2 mtt180 60.0 40.56 18.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.953 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 53.94 27.67 7.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.679 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 86.8 m -148.17 142.23 25.98 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.877 0.37 . . . . 0.0 111.312 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.459 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 10.5 m-85 -90.41 109.75 20.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.977 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.5 m-85 -80.28 123.95 82.84 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.195 -179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -61.1 124.09 14.18 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.219 1.946 . . . . 0.0 112.569 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.923 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.3 125.31 50.84 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-N 115.426 -0.807 . . . . 0.0 111.312 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.801 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.3 mt -83.35 167.87 17.15 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.421 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.3 pt-20 -57.09 -30.87 64.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.5 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -90.94 15.28 11.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.374 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.452 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.24 7.86 86.91 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.594 -0.812 . . . . 0.0 113.091 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.624 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.07 96.76 0.05 Allowed 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.28 0.54 . . . . 0.0 110.282 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.04 113.33 21.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.969 -179.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 64.9 mt -104.54 97.93 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.554 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 32.6 mttt -69.57 -27.11 64.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.968 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.11 -22.09 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.693 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.7 mm-40 -102.28 25.31 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.642 -0.253 . . . . 0.0 111.483 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.87 163.73 52.63 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.489 -0.863 . . . . 0.0 112.693 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -127.72 156.22 42.75 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.936 0.398 . . . . 0.0 110.675 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.55 27.08 3.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.947 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.77 140.03 26.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.568 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.2 118.56 51.04 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.942 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.38 105.4 2.07 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.068 1.846 . . . . 0.0 112.755 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 42.9 t -67.61 -12.59 60.76 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.15 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.87 -26.94 44.02 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-O 120.698 0.285 . . . . 0.0 111.492 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.57 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.69 163.44 38.59 Favored Pre-proline 0 C--N 1.328 -0.342 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 59.9 Cg_endo -75.79 172.86 15.49 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 121.915 1.743 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.418 HG21 ' CD2' ' A' ' 130' ' ' PHE . 74.9 t -128.96 154.17 39.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.214 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.57 HD12 ' CD1' ' A' ' 133' ' ' LEU . 61.7 mt -113.54 97.68 6.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.153 0.501 . . . . 0.0 110.614 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.2 t -83.03 134.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.352 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.53 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.748 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.492 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -147.9 113.89 5.8 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.1 0.476 . . . . 0.0 111.532 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -104.46 -25.64 12.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.518 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -98.79 95.69 7.38 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.243 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.878 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.58 -20.75 47.47 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.204 -0.998 . . . . 0.0 112.076 178.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.63 -40.82 97.85 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.86 70.0 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.538 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.923 ' CG2' HD11 ' A' ' 133' ' ' LEU . 64.8 mt -62.54 -52.05 64.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.69 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.31 -31.76 61.92 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.04 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 9.0 mm-40 -65.95 -52.08 52.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.057 179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.474 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.61 -52.28 66.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.812 179.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.026 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.08 -33.65 69.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.015 0.436 . . . . 0.0 110.222 179.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.58 -42.41 97.73 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.644 -0.788 . . . . 0.0 111.321 178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -65.62 -36.99 85.31 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.892 0.377 . . . . 0.0 110.191 178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.607 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.7 mp -67.62 -28.23 67.56 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.2 -18.54 61.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.58 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -103.14 -40.93 6.25 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.724 0.297 . . . . 0.0 111.74 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.779 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -70.3 157.41 90.02 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.68 -179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.666 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.4 Cg_exo -51.27 123.99 13.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.561 2.174 . . . . 0.0 112.462 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.67 -35.74 32.35 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.97 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.654 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.7 -41.67 92.09 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.061 0.458 . . . . 0.0 110.427 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.803 ' HA ' HG22 ' A' ' 224' ' ' ILE . 66.9 t -58.66 -55.86 20.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.652 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.779 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -68.68 -12.74 61.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.835 178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -91.65 -12.95 58.84 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.53 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.436 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.67 78.34 3.74 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 116.991 0.395 . . . . 0.0 111.408 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -177.14 170.14 2.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.495 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 3.5 m -103.86 -48.16 4.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 0.0 110.684 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -167.73 154.07 7.77 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.72 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.581 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -104.63 134.98 44.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.224 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.442 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -108.96 117.57 34.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -69.21 105.14 2.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.739 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.0 mttm -128.63 78.61 75.68 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.782 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.39 161.73 43.62 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.251 1.967 . . . . 0.0 112.479 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.6 p -136.93 163.49 30.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.952 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.5 ptp180 -54.59 -25.77 28.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.456 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.71 -17.11 14.49 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.587 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.421 ' HD1' HG21 ' A' ' 210' ' ' THR . 89.5 m-85 -135.16 81.92 1.92 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-O 120.921 0.391 . . . . 0.0 111.198 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -58.86 -19.69 44.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.721 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -113.81 36.93 3.44 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.817 0.341 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 16.6 ttt-85 -83.81 115.09 22.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.013 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.6 m -116.86 136.11 55.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.914 179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 207' ' ' VAL . 25.4 mm -105.37 110.58 31.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.581 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.9 152.14 3.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.472 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -109.33 105.97 15.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.221 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.434 ' SD ' HD11 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -53.84 149.42 8.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.488 -179.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.6 p30 -64.3 -21.62 66.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.22 -13.32 59.77 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.74 20.38 9.49 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.815 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -102.96 168.79 8.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.7 0.285 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -119.04 117.01 27.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.475 HG12 ' N ' ' A' ' 208' ' ' SER . 40.9 t -118.08 158.68 18.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.716 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 207' ' ' VAL . 77.3 p -121.76 147.35 46.04 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.967 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.65 147.89 7.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.89 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.421 HG21 ' HD1' ' A' ' 193' ' ' TYR . 0.9 OUTLIER -95.51 147.46 23.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.694 179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.492 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.5 mt -59.59 -27.33 37.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.092 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -33.76 72.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.551 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -133.07 35.85 3.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.151 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -56.2 -43.88 78.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.174 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -63.87 -49.13 73.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.935 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.27 -37.08 86.23 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.865 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -56.79 -53.91 52.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.502 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.405 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.4 mm? -83.17 -21.81 33.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.427 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 m -65.58 -30.85 71.64 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.834 0.35 . . . . 0.0 110.634 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -72.45 -4.61 31.32 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.42 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -90.54 110.68 42.86 Favored Pre-proline 0 CA--C 1.534 0.337 0 O-C-N 122.276 -0.265 . . . . 0.0 110.803 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.47 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 18.3 Cg_exo -66.41 -30.31 44.45 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.184 1.922 . . . . 0.0 112.393 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -73.92 -44.69 54.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.392 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.803 HG22 ' HA ' ' A' ' 178' ' ' VAL . 27.9 mt -64.56 -56.49 15.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.088 0.47 . . . . 0.0 109.805 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.425 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -56.31 -28.83 60.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.332 178.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.31 -29.1 13.92 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.634 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.579 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.64 -27.4 11.28 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.388 178.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.654 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.4 mt -78.29 -32.18 49.28 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.157 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -76.8 -37.11 56.37 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.033 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.9 mtp85 -66.27 -75.32 0.09 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.894 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -96.9 78.8 2.86 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.6 p -90.59 141.27 14.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.068 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 29.1 mmtt . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.949 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.27 -37.54 60.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.734 0.302 . . . . 0.0 110.831 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.42 -171.45 2.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.917 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.796 ' HB2' HD13 ' A' ' 134' ' ' LEU . 57.8 m95 -78.29 153.87 31.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 5.9 ttt180 -101.36 130.38 47.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.618 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.404 ' HG2' HD23 ' A' ' 134' ' ' LEU . 25.0 mtm180 -69.36 126.57 30.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.123 0.487 . . . . 0.0 111.079 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.057 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.24 -1.22 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.787 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 171' ' ' LEU . . . -161.79 176.7 10.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-O 120.784 0.326 . . . . 0.0 111.097 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.456 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.1 m-85 -138.09 173.6 11.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.186 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.641 HG21 ' HG ' ' A' ' 139' ' ' LEU . 13.5 t -134.24 119.1 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 120.87 0.367 . . . . 0.0 110.958 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.414 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 109.46 14.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.999 -179.56 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 37.3 t70 -161.31 138.05 8.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.853 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 58.59 42.62 20.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.011 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 54.17 28.42 9.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.546 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 145' ' ' THR . 89.8 m -145.66 141.97 28.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.424 ' CD2' HG21 ' A' ' 154' ' ' VAL . 8.2 m-85 -91.98 109.04 20.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.405 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.725 ' HB2' HD21 ' A' ' 139' ' ' LEU . 11.7 m-30 -79.73 123.03 84.14 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.784 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.33 123.89 14.05 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.184 1.923 . . . . 0.0 112.642 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.946 HD11 HG23 ' A' ' 164' ' ' ILE . 1.5 mt -105.89 125.01 50.48 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.946 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.796 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.7 mt -84.4 165.92 17.78 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.191 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.5 ' HA ' HD12 ' A' ' 121' ' ' ILE . 4.8 pt-20 -55.47 -30.33 60.39 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.505 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.0 p-10 -91.4 15.0 13.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.368 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.402 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.99 6.35 87.33 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.661 -0.781 . . . . 0.0 113.288 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.61 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.95 95.65 0.03 OUTLIER 'General case' 0 C--O 1.232 0.15 0 CA-C-N 117.246 0.523 . . . . 0.0 110.358 179.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.725 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -86.1 112.98 21.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.876 -179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 15.7 mt -102.74 98.08 8.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.625 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.433 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 17.1 mttp -69.8 -28.85 66.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.77 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -74.45 -23.71 58.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.439 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -99.78 25.54 7.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.451 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.08 162.88 52.94 Favored Glycine 0 CA--C 1.51 -0.246 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.479 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.703 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.7 155.3 44.19 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.794 0.331 . . . . 0.0 110.808 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.03 27.62 3.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.979 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.57 139.12 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.512 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.18 118.32 54.86 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.064 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.412 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.8 Cg_endo -77.73 105.54 2.04 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.131 1.887 . . . . 0.0 112.726 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 4.8 t -67.88 -12.17 60.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.191 179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -77.86 -27.17 49.73 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.649 0.261 . . . . 0.0 111.386 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -143.83 160.01 51.66 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 47.5 Cg_endo -71.76 173.25 12.95 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.103 1.869 . . . . 0.0 112.71 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' HB2' ' A' ' 123' ' ' TYR . 72.6 t -129.48 154.54 40.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.943 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.611 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.7 mt -112.95 97.99 6.88 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.073 0.464 . . . . 0.0 110.617 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.9 t -83.04 134.96 25.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.33 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.75 85.99 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.842 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.562 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.1 m95 -148.93 112.7 5.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.986 0.422 . . . . 0.0 111.427 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -103.41 -25.11 13.39 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.609 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -98.58 95.41 7.26 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.236 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.92 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.03 -21.46 45.71 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.085 178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.91 -40.06 96.43 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.26 -33.67 67.65 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 114.702 -1.136 . . . . 0.0 109.6 178.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.946 HG23 HD11 ' A' ' 133' ' ' LEU . 43.7 mt -61.93 -51.74 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.573 178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.09 -30.09 58.95 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.252 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 1.6 mm-40 -68.81 -51.76 37.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.246 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.439 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -57.95 -51.74 68.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.734 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.057 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.65 -33.72 70.39 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.177 179.375 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.73 -41.55 95.92 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.167 178.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -65.04 -39.42 93.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.986 0.422 . . . . 0.0 110.03 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.608 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.1 mp -67.49 -28.56 67.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.29 -20.49 60.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.691 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -99.64 -41.32 7.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.745 0.307 . . . . 0.0 111.506 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.784 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.2 pp -70.12 157.66 89.31 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.465 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.66 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.4 Cg_exo -51.38 123.6 12.4 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.482 2.121 . . . . 0.0 112.539 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.01 -31.53 18.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.532 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.662 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -67.58 -43.1 81.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.387 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 50.1 t -58.91 -59.88 3.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.866 179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.784 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -60.6 -24.8 65.75 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.355 178.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.421 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.14 -23.27 76.41 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.981 179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.857 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.33 78.15 9.82 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.918 0.39 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.31 157.26 0.44 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.507 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 74.0 m -100.8 -55.56 2.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.172 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -154.1 149.69 27.39 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.125 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 199' ' ' VAL . 4.6 mt -106.0 135.91 42.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.266 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.0 m170 -107.77 122.18 46.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.836 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 17.5 t80 -76.35 105.07 7.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.771 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -124.82 73.76 64.08 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.874 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.21 158.88 51.04 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 122.307 2.005 . . . . 0.0 112.549 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.6 p -143.71 167.11 23.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.981 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.27 -25.8 59.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.294 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -100.95 -17.64 16.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.59 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -143.22 78.7 1.61 Allowed 'General case' 0 C--O 1.23 0.078 0 CA-C-O 121.008 0.432 . . . . 0.0 111.146 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -58.42 -20.17 42.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.633 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -113.1 36.81 3.36 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.759 0.314 . . . . 0.0 111.055 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -84.89 115.57 22.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.866 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.2 m -120.51 133.06 68.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.225 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 207' ' ' VAL . 21.6 mm -104.47 112.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.459 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.593 HG12 HG12 ' A' ' 185' ' ' ILE . 3.1 m -89.04 153.17 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.027 0.441 . . . . 0.0 111.779 -178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -110.82 103.73 12.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.969 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.572 ' SD ' HD11 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -50.29 149.03 3.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.652 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 29.1 p-10 -64.76 -22.28 66.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.963 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.417 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 0.8 OUTLIER -78.9 -13.33 59.86 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 111.817 0.303 . . . . 0.0 111.817 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.42 9.32 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.709 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 27.5 m-85 -104.18 164.25 11.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.884 0.373 . . . . 0.0 110.769 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -112.21 120.77 42.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.749 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 208' ' ' SER . 40.4 t -122.0 158.54 25.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.645 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.463 ' N ' HG12 ' A' ' 207' ' ' VAL . 39.3 p -121.93 149.21 43.76 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.091 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.91 -178.0 5.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.89 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -129.95 154.62 47.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.398 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.562 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.7 mt -67.69 -21.88 27.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.123 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.25 -30.28 30.81 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.817 0.342 . . . . 0.0 110.84 -179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -132.5 35.04 3.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.987 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.43 ' CD1' HD23 ' A' ' 218' ' ' LEU . 12.6 t80 -59.13 -47.11 86.5 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.795 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.71 -46.27 90.4 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.669 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -65.16 -37.71 88.25 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.273 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.6 mmpt? -59.4 -53.4 58.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.457 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.473 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -79.72 -22.0 43.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.294 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 18.2 t -63.8 -40.56 96.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.903 0.382 . . . . 0.0 110.772 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 9.9 m80 -64.5 -14.65 58.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.805 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.422 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -75.91 111.33 14.23 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.467 -0.093 . . . . 0.0 110.886 -179.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.753 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 14.8 Cg_exo -69.12 -25.76 31.23 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.273 1.982 . . . . 0.0 112.599 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -80.5 -40.77 25.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.578 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.857 HG23 ' HB3' ' A' ' 181' ' ' ALA . 17.3 mt -69.37 -58.27 6.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.436 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -55.83 -29.12 59.29 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.216 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.753 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.49 -28.23 19.55 Favored 'General case' 0 C--N 1.338 0.093 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.561 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.414 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.72 -27.31 11.49 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.408 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.662 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.5 mt -79.97 -31.96 39.85 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.132 178.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -98.28 18.99 15.07 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.521 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -91.13 -31.74 16.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.952 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -73.08 -38.25 66.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.946 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 232' ' ' VAL . 17.5 t 61.51 31.85 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.902 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 28.5 mttt . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.192 -0.908 . . . . 0.0 110.851 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 N-CA-C 112.414 -0.274 . . . . 0.0 112.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.0 m 60.21 80.66 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 0.0 110.894 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 -153.29 -176.76 5.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.943 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.809 ' HB2' HD13 ' A' ' 134' ' ' LEU . 51.8 m95 -79.82 151.09 30.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.5 128.79 45.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.691 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.4 mtm-85 -68.08 127.8 34.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.025 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.01 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.53 1.74 2.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.84 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.84 176.62 8.57 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-O 120.65 0.262 . . . . 0.0 110.863 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.435 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 23.1 m-85 -139.66 173.19 11.79 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.508 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.588 HG21 ' HG ' ' A' ' 139' ' ' LEU . 22.4 t -133.02 118.95 34.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.0 111.038 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.494 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.22 112.0 17.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.009 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.425 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.1 t70 -156.47 133.86 10.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.843 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 58.16 44.6 18.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.969 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 55.01 28.27 10.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.433 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 86.5 m -142.08 143.46 33.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.963 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.494 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.4 m-85 -95.63 110.7 22.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.058 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.721 ' HB2' HD21 ' A' ' 139' ' ' LEU . 9.2 m-30 -84.05 124.79 74.01 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.463 ' HB2' HD12 ' A' ' 140' ' ' LEU . 31.3 Cg_exo -59.61 127.3 23.2 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.295 1.997 . . . . 0.0 112.841 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 1.001 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.88 125.15 52.49 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.733 179.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.809 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.3 mt -85.13 165.15 17.69 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.513 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.5 pt-20 -55.25 -29.94 59.08 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.609 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -91.32 15.6 11.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.357 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 76.77 3.33 79.44 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.341 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.591 ' HB3' HD12 ' A' ' 134' ' ' LEU . 3.3 tpt180 -61.31 97.58 0.07 Allowed 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 117.343 0.572 . . . . 0.0 110.533 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -78.79 132.27 36.83 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.001 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.58 ' N ' HD23 ' A' ' 139' ' ' LEU . 75.1 mt -111.51 92.71 4.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.665 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.442 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.4 mttt -71.63 -28.49 63.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -80.23 -23.33 40.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.495 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.467 ' HG3' HD13 ' A' ' 140' ' ' LEU . 46.7 mm-40 -97.85 26.07 5.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.494 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -77.33 159.94 49.12 Favored Glycine 0 CA--C 1.507 -0.418 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.559 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 3.3 t -130.86 159.44 37.38 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.329 -0.435 . . . . 0.0 110.72 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 20.39 5.69 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.297 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.471 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.3 OUTLIER -136.66 142.19 43.19 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.921 0.391 . . . . 0.0 110.596 -179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.21 119.56 76.98 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.767 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.435 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.9 Cg_endo -73.71 106.58 2.22 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.046 1.831 . . . . 0.0 112.539 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.7 t -66.74 -13.5 61.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.302 179.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.09 -27.14 42.94 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.626 0.25 . . . . 0.0 111.554 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.518 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.56 161.11 56.41 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-O 120.818 0.342 . . . . 0.0 111.83 -179.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.518 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 57.7 Cg_endo -73.63 173.42 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.959 1.773 . . . . 0.0 112.673 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.424 HG21 ' CD2' ' A' ' 130' ' ' PHE . 65.3 t -130.05 153.09 38.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.982 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.7 mt -112.84 97.55 6.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.484 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.7 t -82.73 134.08 27.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.452 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.56 85.98 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.78 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.509 ' CH2' HD11 ' A' ' 211' ' ' ILE . 68.0 m95 -147.1 110.82 4.97 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.003 0.43 . . . . 0.0 111.607 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -101.38 -27.11 13.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.295 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.95 95.26 8.11 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.246 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.44 -20.91 47.07 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.983 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.01 -40.7 98.55 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.99 -34.41 71.35 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 114.666 -1.152 . . . . 0.0 109.449 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.001 HG23 HD11 ' A' ' 133' ' ' LEU . 47.6 mt -61.81 -51.95 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.622 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.5 -30.1 60.02 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.214 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -69.46 -51.44 36.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.46 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.465 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.9 -52.43 65.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.958 179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.01 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.23 -33.61 69.51 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-O 120.856 0.36 . . . . 0.0 110.334 179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.97 -42.89 97.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.346 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -64.94 -37.75 88.68 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.859 0.362 . . . . 0.0 110.163 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.589 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.4 mp -67.88 -27.47 66.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.249 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.13 -19.47 60.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.513 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -100.49 -40.72 7.3 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.674 0.273 . . . . 0.0 111.551 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.822 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -71.04 157.1 91.05 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.474 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.657 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.0 Cg_exo -51.08 123.7 12.42 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.473 2.115 . . . . 0.0 112.498 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.19 -34.08 30.23 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.727 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.702 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -66.46 -42.21 87.9 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.024 0.44 . . . . 0.0 110.357 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.765 ' HA ' HG22 ' A' ' 224' ' ' ILE . 49.1 t -58.96 -60.29 2.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.902 179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.822 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -60.42 -25.02 65.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.47 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.448 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.93 -23.1 77.14 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.606 -0.806 . . . . 0.0 111.818 179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.685 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.23 78.29 8.84 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 120.934 0.397 . . . . 0.0 110.815 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 178.38 133.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.57 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.8 m -70.48 -61.64 1.69 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -154.86 152.32 29.64 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.534 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -102.76 135.21 41.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.351 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.433 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -107.75 114.89 29.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.045 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.473 ' CE2' ' CE3' ' A' ' 158' ' ' TRP . 0.6 OUTLIER -68.47 114.21 6.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.711 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.9 mttm -134.59 76.09 61.77 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.825 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 58.5 Cg_endo -72.21 157.68 53.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.415 2.077 . . . . 0.0 112.659 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.4 p -141.96 161.99 36.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.891 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -55.52 -25.64 38.59 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.216 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -99.9 -22.13 15.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.108 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -138.46 75.13 1.5 Allowed 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 121.02 0.438 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -56.18 -21.22 21.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.757 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -113.18 39.26 2.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.786 0.327 . . . . 0.0 111.08 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -87.91 122.92 32.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.964 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.7 m -123.99 132.99 70.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.209 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.4 mm -104.41 108.77 25.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.501 179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.534 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -87.58 151.53 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.93 0.395 . . . . 0.0 111.54 -179.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -110.77 105.02 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.073 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.59 149.13 3.39 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.659 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -64.13 -22.64 67.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.939 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -76.15 -13.3 60.2 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.99 20.36 9.38 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.678 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -105.32 167.67 9.58 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.857 0.36 . . . . 0.0 110.933 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -116.39 120.76 39.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.644 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 208' ' ' SER . 46.2 t -120.79 158.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.64 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 207' ' ' VAL . 90.7 p -122.29 148.97 44.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.125 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.425 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -164.27 -179.17 5.92 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.663 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.4 p -126.56 152.95 45.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.509 HD11 ' CH2' ' A' ' 158' ' ' TRP . 16.4 mt -68.54 -25.42 30.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.802 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -32.08 64.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.791 0.329 . . . . 0.0 111.23 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -134.13 35.93 3.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.002 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.6 t80 -55.41 -49.39 72.49 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.003 -179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.27 -42.11 99.05 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.443 179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -64.84 -44.56 89.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.262 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.425 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 1.8 mmpt? -53.7 -50.61 65.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.993 179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.536 HD12 HD13 ' A' ' 224' ' ' ILE . 3.6 mm? -79.42 -21.62 45.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.669 179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.7 t -60.62 -33.68 73.12 Favored 'General case' 0 CA--C 1.521 -0.16 0 CA-C-O 121.056 0.455 . . . . 0.0 110.436 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -78.75 4.72 13.04 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.677 -0.692 . . . . 0.0 112.137 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.428 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -100.19 99.17 8.9 Favored Pre-proline 0 CA--C 1.531 0.238 0 O-C-N 122.238 -0.289 . . . . 0.0 110.257 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.26 -24.89 43.29 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.117 1.878 . . . . 0.0 112.174 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.554 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -72.51 -49.15 34.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.765 HG22 ' HA ' ' A' ' 178' ' ' VAL . 49.8 mt -64.02 -53.46 43.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.414 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -56.01 -29.15 59.93 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.467 178.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.554 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.4 -29.0 14.23 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.566 178.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.59 -27.68 11.87 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.373 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.702 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.3 mt -78.27 -31.89 49.26 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.201 178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -75.6 -41.68 53.82 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.019 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 39.9 mtt180 -91.25 -70.98 0.66 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.985 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -61.21 85.25 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.882 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.6 m -104.35 80.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 76.4 tttt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.277 -0.868 . . . . 0.0 110.884 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.519 -0.233 . . . . 0.0 112.519 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.2 m -125.71 -175.68 3.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.761 0.315 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.66 -173.31 3.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.847 ' HB2' HD13 ' A' ' 134' ' ' LEU . 49.9 m95 -92.31 150.12 21.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.099 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . 0.516 ' NH2' HG21 ' A' ' 121' ' ' ILE . 10.7 ttp180 -98.12 138.25 35.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.324 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.434 ' HG2' HD23 ' A' ' 134' ' ' LEU . 33.3 mtm180 -79.68 129.07 34.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.323 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.007 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.9 1.29 2.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.984 179.4 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.88 176.9 9.74 Favored 'General case' 0 CA--C 1.522 -0.11 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.238 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.472 ' HB2' HG22 ' A' ' 154' ' ' VAL . 23.9 m-85 -139.13 173.81 11.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.291 179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.696 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.6 t -134.25 116.63 22.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.976 0.417 . . . . 0.0 110.87 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.466 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.4 110.43 15.84 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.009 -179.424 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.405 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 10.3 t70 -169.01 145.19 3.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.703 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 59.26 39.4 22.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.158 0.504 . . . . 0.0 110.846 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.27 30.62 12.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.569 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 90.9 m -151.93 142.78 22.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.873 0.368 . . . . 0.0 111.288 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.466 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.6 m-85 -90.53 109.8 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.133 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.1 m-85 -80.42 118.77 73.96 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.964 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.47 122.32 11.58 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.013 1.809 . . . . 0.0 112.351 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.91 HD11 HG23 ' A' ' 164' ' ' ILE . 1.3 mt -103.24 125.28 49.83 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.171 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.847 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.9 mt -82.35 166.39 19.5 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.284 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.507 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.2 pt-20 -56.68 -30.52 63.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.498 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -90.87 15.32 11.55 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.354 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.419 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.65 6.9 87.19 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.628 -0.796 . . . . 0.0 113.21 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.628 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.0 95.99 0.04 OUTLIER 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.311 0.556 . . . . 0.0 110.344 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -81.01 117.91 22.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.76 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.8 mm? -102.19 97.34 7.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.595 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.434 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 22.8 mttp -72.38 -26.38 61.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.127 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -83.58 -21.15 32.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.906 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 60.8 mm-40 -100.42 24.31 9.05 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.605 0.224 . . . . 0.0 111.605 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.38 164.3 54.63 Favored Glycine 0 CA--C 1.508 -0.363 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.783 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.54 156.53 42.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.34 . . . . 0.0 110.525 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.9 28.16 3.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.8 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.33 139.37 25.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.618 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.25 118.55 54.21 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.917 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.461 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 64.8 Cg_endo -76.23 105.71 2.13 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.06 1.84 . . . . 0.0 112.668 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.3 t -67.61 -12.44 60.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.158 179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.45 -27.24 41.63 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.709 0.29 . . . . 0.0 111.501 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -143.17 160.05 53.6 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 120.825 -0.35 . . . . 0.0 111.925 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.9 Cg_endo -72.01 172.88 13.78 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 121.962 1.775 . . . . 0.0 112.743 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 123' ' ' TYR . 57.9 t -129.3 154.74 40.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.921 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.9 mt -114.15 97.82 6.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.478 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 77.7 t -83.34 135.11 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.287 -179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.58 86.63 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.733 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.576 ' CH2' HD11 ' A' ' 211' ' ' ILE . 72.2 m95 -149.05 111.85 4.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.979 0.418 . . . . 0.0 111.492 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -102.27 -25.35 13.71 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.599 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -98.43 96.24 7.88 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.319 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.895 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.8 -20.65 48.7 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.119 -1.038 . . . . 0.0 111.976 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.45 -40.68 97.79 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 177.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.33 -33.89 70.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.529 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.91 HG23 HD11 ' A' ' 133' ' ' LEU . 51.4 mt -62.38 -51.84 67.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.591 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.18 -29.7 58.41 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.9 mm-40 -69.53 -51.22 37.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.072 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.467 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.72 -52.48 65.53 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.789 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.007 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.7 -33.49 70.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.886 0.374 . . . . 0.0 110.241 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -58.56 -42.59 96.12 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.402 178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -66.1 -38.86 89.28 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.381 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.648 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.1 mp -66.49 -26.24 67.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.3 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -75.26 -20.63 59.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.572 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -99.03 -40.53 7.99 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.761 0.315 . . . . 0.0 111.461 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.746 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -72.41 156.82 90.01 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.362 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.654 ' O ' HD12 ' A' ' 174' ' ' LEU . 53.1 Cg_exo -50.61 124.48 13.49 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.561 2.174 . . . . 0.0 112.628 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.53 50.18 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.65 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.717 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.89 -40.54 91.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.143 0.497 . . . . 0.0 110.315 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.845 ' HA ' HG22 ' A' ' 224' ' ' ILE . 55.9 t -60.13 -60.26 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.926 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.746 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.33 -24.48 66.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.381 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.4 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.0 -23.21 76.77 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.69 -0.767 . . . . 0.0 111.852 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.909 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -84.58 78.16 9.9 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-O 120.898 0.38 . . . . 0.0 110.695 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.3 ptp 177.3 141.46 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.408 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.8 -50.01 11.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.171 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -163.68 153.06 14.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.016 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.505 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -104.25 133.9 47.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.135 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.6 m170 -106.82 112.51 25.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.029 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.444 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 73.1 t80 -67.53 102.94 1.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.696 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 16.6 mttm -125.81 77.48 70.2 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.048 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.444 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 43.1 Cg_endo -68.16 166.76 23.97 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.223 1.949 . . . . 0.0 112.322 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 20.2 p -141.35 173.54 11.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.096 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.93 -27.3 68.11 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.015 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 193' ' ' TYR . 5.6 pt-20 -114.95 10.99 16.43 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 192' ' ' GLU . 71.6 m-85 -155.88 73.49 0.82 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.011 0.434 . . . . 0.0 110.86 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.13 -21.66 23.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.731 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -113.64 39.26 2.7 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.821 0.343 . . . . 0.0 111.235 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.403 ' HB3' ' HA ' ' A' ' 189' ' ' PRO . 0.0 OUTLIER -85.8 112.66 21.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.841 0.353 . . . . 0.0 110.836 179.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 209' ' ' ALA . 34.8 m -116.74 134.13 61.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.278 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 207' ' ' VAL . 22.5 mm -105.95 111.37 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.649 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.505 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -84.62 152.28 3.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.503 -179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -109.54 105.28 14.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.24 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.53 149.3 8.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.6 m-20 -66.65 -22.35 66.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.97 -12.03 59.95 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.3 14.68 19.68 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.837 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -100.65 174.26 6.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.849 0.325 . . . . 0.0 110.511 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.41 120.58 27.21 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.894 0.378 . . . . 0.0 110.963 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.491 ' HB ' HG22 ' A' ' 199' ' ' VAL . 15.2 t -117.22 160.12 16.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.459 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 207' ' ' VAL . 96.5 p -118.67 145.13 45.73 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.5 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -162.68 151.3 14.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.823 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.87 146.87 27.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.405 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.576 HD11 ' CH2' ' A' ' 158' ' ' TRP . 15.4 mt -58.8 -27.15 34.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.662 0.268 . . . . 0.0 111.059 179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.55 -32.86 70.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.546 -179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -133.98 35.8 3.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.228 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -55.39 -50.41 69.8 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.154 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.35 -46.49 88.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 110.744 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -62.77 -43.02 99.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.11 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.411 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 10.7 mmtt -51.94 -51.26 58.26 Favored 'General case' 0 N--CA 1.461 0.088 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.016 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.651 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -83.16 -16.56 46.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.958 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 39.9 t -62.48 -34.91 77.77 Favored 'General case' 0 CA--C 1.522 -0.123 0 CA-C-O 120.869 0.366 . . . . 0.0 110.478 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.403 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 1.7 p-80 -81.5 8.12 10.3 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.404 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -101.99 99.31 11.92 Favored Pre-proline 0 N--CA 1.455 -0.222 0 N-CA-C 110.089 -0.338 . . . . 0.0 110.089 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.29 -28.16 40.08 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 122.192 1.928 . . . . 0.0 112.175 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -66.64 -49.06 67.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.028 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.909 HG23 ' HB3' ' A' ' 181' ' ' ALA . 32.2 mt -65.76 -53.41 38.82 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.488 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -54.13 -29.83 46.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.232 -0.895 . . . . 0.0 110.514 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.511 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.48 -29.21 15.63 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.682 179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.442 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.87 -28.06 14.8 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.376 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.717 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.9 mt -78.05 -31.06 50.15 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.31 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.535 ' O ' HG23 ' A' ' 232' ' ' VAL . 0.6 OUTLIER -67.0 -31.97 72.88 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.855 -179.964 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 8.6 mtt85 -62.71 -33.5 75.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.89 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -113.93 84.68 2.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 232' ' ' VAL . 15.4 t -101.28 36.6 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.96 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 34.5 tttm . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.862 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.212 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 64.58 -77.85 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.712 0.291 . . . . 0.0 111.027 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -97.69 -177.36 3.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.82 ' HB2' HD13 ' A' ' 134' ' ' LEU . 32.2 m95 -129.05 153.8 47.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.957 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -101.55 128.81 47.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.54 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.8 mtm-85 -69.51 126.74 30.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.035 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.023 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.68 -0.15 3.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.784 179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.738 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.44 176.78 10.13 Favored 'General case' 0 CA--C 1.522 -0.105 0 CA-C-O 120.736 0.303 . . . . 0.0 110.984 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.437 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.5 m-85 -138.88 173.34 11.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.349 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.624 HG21 ' CD1' ' A' ' 139' ' ' LEU . 18.9 t -133.71 119.43 33.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.927 0.394 . . . . 0.0 110.91 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.492 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.15 110.95 16.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.191 -179.267 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.422 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 13.4 t70 -162.09 137.73 7.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.87 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 59.16 42.93 17.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.992 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 53.96 26.87 6.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.599 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 145' ' ' THR . 92.2 m -143.49 141.95 30.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.97 0.414 . . . . 0.0 111.007 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.492 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.5 m-85 -91.63 110.0 21.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.37 179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.712 ' HB2' HD21 ' A' ' 139' ' ' LEU . 12.0 m-30 -81.07 122.69 81.93 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.879 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -60.25 123.81 13.9 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 122.172 1.914 . . . . 0.0 112.684 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.925 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.73 125.19 50.7 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.914 -179.772 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.9 mt -83.6 165.76 18.76 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.321 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.514 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.0 pt-20 -55.84 -30.21 61.07 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.629 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -90.87 14.87 12.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.411 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.28 4.15 83.44 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.33 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.587 ' HB3' HD12 ' A' ' 134' ' ' LEU . 19.6 tpp85 -61.21 97.6 0.07 Allowed 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 117.333 0.566 . . . . 0.0 110.482 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.712 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -83.79 117.39 23.24 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.068 -179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 30.6 mt -106.91 97.65 7.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.9 0.381 . . . . 0.0 110.543 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 31.8 mttp -69.96 -29.68 66.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.792 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -71.28 -22.61 61.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.447 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -101.8 24.53 9.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.505 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -76.07 162.2 52.52 Favored Glycine 0 CA--C 1.509 -0.296 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.439 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -128.35 156.49 43.02 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.849 0.357 . . . . 0.0 110.807 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.09 25.86 3.54 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.171 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.421 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.4 OUTLIER -142.93 139.43 30.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.605 -179.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.96 117.99 53.95 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.031 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.3 105.96 2.14 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.114 1.876 . . . . 0.0 112.579 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 40.8 t -67.41 -12.84 61.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.204 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.57 -27.3 51.39 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 120.707 0.289 . . . . 0.0 111.39 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.593 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.12 164.01 38.5 Favored Pre-proline 0 C--N 1.327 -0.394 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.593 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 61.9 Cg_endo -77.17 172.94 15.19 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.934 1.756 . . . . 0.0 112.445 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.452 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.6 t -129.57 154.88 40.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.067 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.567 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.0 mt -113.31 97.9 6.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.424 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.9 t -82.72 134.93 25.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.473 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.65 86.89 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 115.826 -0.624 . . . . 0.0 112.803 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.506 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -148.32 113.93 5.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.969 0.414 . . . . 0.0 111.512 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.21 -26.77 12.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.486 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -97.28 96.07 8.14 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.202 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.893 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.49 -20.95 47.64 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.117 -1.04 . . . . 0.0 112.026 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.3 -40.7 98.07 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.34 -33.49 69.65 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.497 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.925 HG23 HD11 ' A' ' 133' ' ' LEU . 50.0 mt -62.72 -52.37 60.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.02 -30.48 47.72 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.238 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 7.0 mm-40 -68.73 -52.1 34.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.348 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.46 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.21 -52.83 64.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.775 179.65 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.023 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.99 -33.53 69.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.246 179.293 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.44 -42.63 97.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.306 178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.4 mm100 -64.68 -36.9 85.78 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.924 0.392 . . . . 0.0 110.107 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.628 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 7.1 mp -67.81 -27.74 66.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.072 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.52 -18.65 61.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.583 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -102.59 -40.31 6.7 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.74 0.305 . . . . 0.0 111.726 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.781 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -71.38 156.97 90.94 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.771 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.66 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.8 Cg_exo -51.42 124.38 14.09 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.624 2.216 . . . . 0.0 112.648 179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.75 -35.65 32.65 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.852 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.692 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -64.88 -42.88 94.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.174 0.512 . . . . 0.0 110.259 179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.786 ' HA ' HG22 ' A' ' 224' ' ' ILE . 57.9 t -58.45 -55.58 21.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.768 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.781 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -68.45 -12.61 61.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.826 178.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -92.22 -12.69 58.42 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.575 179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.633 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -93.63 78.05 4.31 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 117.093 0.447 . . . . 0.0 111.205 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -176.97 176.95 1.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.314 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.6 p -113.05 -46.22 3.12 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.88 0.372 . . . . 0.0 110.8 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -167.88 152.43 6.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.882 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -104.74 135.33 43.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.267 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.423 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 8.2 m170 -107.8 121.91 45.69 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.928 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.2 t80 -75.64 101.82 5.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.776 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.6 mttm -123.42 74.36 51.94 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.799 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -67.61 160.62 47.23 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.376 2.051 . . . . 0.0 112.564 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.2 p -139.09 163.44 32.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.985 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -53.96 -26.75 27.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.42 -18.26 14.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.552 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -134.09 79.38 1.81 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.952 0.406 . . . . 0.0 111.115 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -57.27 -21.14 32.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.699 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -114.14 38.28 3.07 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.777 0.322 . . . . 0.0 111.154 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -82.67 113.89 20.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.784 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.2 m -118.58 132.93 67.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.251 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.4 mm -104.65 111.26 33.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.63 179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.521 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.5 m -85.0 153.13 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.467 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -109.09 109.93 21.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.255 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.33 149.27 20.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.198 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.553 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.3 p30 -60.64 -24.37 65.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.903 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -85.37 7.03 23.97 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 95.13 -16.32 61.57 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.915 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -61.83 173.03 1.12 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.86 0.362 . . . . 0.0 110.791 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -135.02 119.13 17.56 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.725 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.521 ' HB ' HG22 ' A' ' 199' ' ' VAL . 16.3 t -115.33 159.54 15.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.662 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.465 ' N ' HG12 ' A' ' 207' ' ' VAL . 89.3 p -119.28 149.14 42.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.852 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -163.59 -179.57 6.53 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -127.92 151.18 49.41 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.386 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.506 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.7 mt -64.94 -25.89 38.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.949 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.05 -31.13 62.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.399 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -134.56 36.13 3.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.13 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.402 ' N ' ' O ' ' A' ' 210' ' ' THR . 15.7 t80 -56.13 -50.72 70.29 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.013 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -61.52 -41.3 97.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.411 ' HA ' ' HB2' ' A' ' 219' ' ' SER . 5.4 t70 -63.92 -47.64 79.74 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.042 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 21.8 mmtm -51.83 -51.82 53.79 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.672 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.557 HD12 HD13 ' A' ' 224' ' ' ILE . 3.4 mm? -80.37 -21.51 42.3 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.141 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . 0.411 ' HB2' ' HA ' ' A' ' 216' ' ' ASP . 3.2 m -64.29 -27.74 69.24 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 120.753 0.311 . . . . 0.0 110.757 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 57.1 m170 -85.66 17.1 3.47 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.318 -0.401 . . . . 0.0 112.061 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.24 103.63 55.0 Favored Pre-proline 0 CA--C 1.533 0.294 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.68 -24.46 35.08 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.143 1.895 . . . . 0.0 112.418 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.543 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -71.02 -49.69 42.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.159 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.786 HG22 ' HA ' ' A' ' 178' ' ' VAL . 41.5 mt -63.44 -52.97 51.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.65 -29.7 53.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.6 178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -50.64 -28.36 8.71 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.56 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.564 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -52.03 -27.33 13.29 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.294 178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.692 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 1.8 mt -77.03 -32.6 57.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.078 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.55 ' O ' HG12 ' A' ' 232' ' ' VAL . 0.8 OUTLIER -81.48 -30.82 33.21 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.083 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -59.91 -37.53 79.73 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.082 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 34.2 p-10 -107.72 92.82 4.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.55 HG12 ' O ' ' A' ' 229' ' ' ASP . 10.7 p -168.97 140.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 26.0 pttt . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.884 179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.52 163.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.92 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -127.4 -176.04 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.737 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.811 ' HB2' HD13 ' A' ' 134' ' ' LEU . 60.8 m95 -69.73 150.67 46.69 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.904 0.383 . . . . 0.0 110.617 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 17.1 ptt180 -96.12 130.14 43.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.036 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 9.3 mtm-85 -71.48 126.33 29.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.655 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.983 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.42 0.91 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.947 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.727 ' HB2' HD23 ' A' ' 171' ' ' LEU . . . -163.29 176.79 9.56 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.086 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 152' ' ' ALA . 58.2 m-85 -138.83 173.27 11.74 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.323 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.655 HG11 HD11 ' A' ' 139' ' ' LEU . 21.8 t -134.08 118.18 27.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.996 0.426 . . . . 0.0 111.044 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.51 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.1 109.4 14.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.961 -179.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -158.73 139.27 12.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.781 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.52 40.96 23.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.909 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 55.08 31.13 15.62 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.332 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 145' ' ' THR . 84.8 m -147.69 144.02 28.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.994 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.51 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.3 m-85 -93.44 110.46 22.03 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.708 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.5 m-30 -82.8 127.09 71.3 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.418 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 28.3 Cg_exo -62.18 125.76 17.11 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 122.329 2.019 . . . . 0.0 112.746 -179.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 1.049 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.8 124.97 50.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.795 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.811 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.6 mt -85.29 165.44 17.31 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.408 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.475 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.7 pt-20 -55.22 -30.46 60.04 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.49 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -91.56 15.82 11.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.293 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.403 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 76.85 7.74 86.36 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.72 -0.752 . . . . 0.0 113.321 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.61 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.89 96.99 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 117.332 0.566 . . . . 0.0 110.408 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.708 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -83.6 123.1 29.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.825 -179.901 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 23.4 mt -107.77 96.56 6.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.76 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.445 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 15.9 mttp -70.98 -26.79 63.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.009 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -79.9 -23.06 42.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.577 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -98.02 25.51 6.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.515 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.418 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.71 159.35 52.14 Favored Glycine 0 CA--C 1.507 -0.412 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.418 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -127.09 156.39 41.79 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.711 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.46 27.32 3.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.99 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -145.78 139.61 26.56 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.625 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.74 117.95 55.95 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CD1' ' A' ' 123' ' ' TYR . 64.7 Cg_endo -76.12 105.95 2.17 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 122.065 1.843 . . . . 0.0 112.643 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.4 t -67.82 -12.32 60.37 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.263 179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -77.21 -27.39 53.47 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.714 0.293 . . . . 0.0 111.271 179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.646 ' HB3' ' HE1' ' A' ' 123' ' ' TYR . . . -143.34 160.66 50.92 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.859 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.514 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.9 Cg_endo -72.73 172.72 14.69 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.029 1.819 . . . . 0.0 112.678 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' A' ' 123' ' ' TYR . 78.8 t -128.74 154.87 40.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.923 179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.614 HD12 ' CD1' ' A' ' 133' ' ' LEU . 45.6 mt -113.62 97.72 6.61 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.546 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 60.5 t -83.6 132.52 31.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.622 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 62.8 82.77 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.874 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.543 ' CZ2' HD22 ' A' ' 155' ' ' LEU . 57.9 m95 -144.55 99.38 3.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.887 0.375 . . . . 0.0 111.586 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.92 -25.21 21.07 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.489 178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -98.35 97.62 8.96 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.373 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.894 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.85 -20.88 50.05 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.079 -1.057 . . . . 0.0 111.969 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.18 -40.22 96.9 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.37 -34.45 70.45 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.661 -1.154 . . . . 0.0 109.488 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.049 HG23 HD11 ' A' ' 133' ' ' LEU . 47.1 mt -61.89 -51.72 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.666 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.403 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -56.28 -29.17 60.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.8 mm-40 -71.04 -50.01 38.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.156 0.503 . . . . 0.0 110.103 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.501 ' HE2' HD21 ' A' ' 155' ' ' LEU . 1.2 mmm -57.65 -52.54 65.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.791 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.983 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -60.06 -33.53 72.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.172 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -57.67 -42.24 94.16 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.501 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -65.74 -39.56 91.25 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.0 0.429 . . . . 0.0 109.982 178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.727 HD23 ' HB2' ' A' ' 122' ' ' ALA . 3.5 mp -66.83 -28.41 68.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.52 -19.89 60.18 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.734 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.77 -40.55 7.68 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.659 0.266 . . . . 0.0 111.473 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.729 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.2 pp -72.25 156.28 90.71 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.579 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.674 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.0 Cg_exo -51.41 125.56 16.93 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.531 2.154 . . . . 0.0 112.429 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.7 -40.1 53.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.823 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.715 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -61.49 -40.86 96.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.116 0.484 . . . . 0.0 110.446 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.789 ' HA ' HG22 ' A' ' 224' ' ' ILE . 44.5 t -59.05 -60.05 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.093 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.729 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -62.61 -23.29 66.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.551 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -72.79 -24.82 75.38 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.626 -0.797 . . . . 0.0 111.782 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.792 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -82.36 78.06 9.06 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 120.948 0.404 . . . . 0.0 110.775 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 177.16 153.33 0.23 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.465 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.05 -53.87 3.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.095 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.67 151.06 25.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.034 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.477 HG12 HG12 ' A' ' 199' ' ' VAL . 4.5 mt -106.27 134.15 48.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.397 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.3 m170 -106.38 127.47 53.3 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.885 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.24 112.55 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -135.0 78.04 54.69 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.23 163.22 32.96 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 122.351 2.034 . . . . 0.0 112.652 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 6.8 p -144.58 167.92 21.39 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.933 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -57.91 -24.15 56.53 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.22 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -102.69 -16.57 15.98 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.642 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -144.13 83.06 1.73 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.942 0.401 . . . . 0.0 111.268 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -60.05 -20.5 58.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.626 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -112.29 34.32 4.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.71 0.291 . . . . 0.0 111.141 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -81.69 112.05 18.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.783 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.7 m -115.4 136.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.243 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.0 mm -106.91 109.75 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.441 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.477 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -86.45 155.63 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.85 0.357 . . . . 0.0 111.743 -178.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -114.04 105.79 13.64 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.982 178.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.55 149.11 6.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.918 0.389 . . . . 0.0 111.636 -179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -64.49 -23.44 67.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.918 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -77.58 -13.01 60.02 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.874 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.34 20.39 9.17 Favored Glycine 0 C--N 1.335 0.48 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.665 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -102.4 172.63 6.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.863 0.363 . . . . 0.0 110.822 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -126.37 117.11 22.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.812 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 208' ' ' SER . 13.4 t -118.8 160.11 18.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.546 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.455 ' N ' HG12 ' A' ' 207' ' ' VAL . 59.7 p -121.47 146.75 46.59 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.36 -177.69 6.62 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.699 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -126.82 154.38 44.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.54 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.434 HD11 ' CH2' ' A' ' 158' ' ' TRP . 4.6 mt -69.31 -25.02 28.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.776 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -80.96 -28.64 35.59 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.286 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -132.28 35.5 3.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.991 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 171' ' ' LEU . 48.7 t80 -60.43 -50.51 73.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.546 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.98 -36.84 82.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.278 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -68.25 -45.68 72.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.831 178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.1 mmpt? -53.77 -53.18 55.87 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.46 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.574 HD12 HD13 ' A' ' 224' ' ' ILE . 3.5 mm? -75.96 -24.95 55.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.818 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.4 m -61.12 -30.46 70.38 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.878 0.371 . . . . 0.0 110.407 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -79.66 5.57 12.91 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 116.065 -0.516 . . . . 0.0 112.046 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.77 101.72 34.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.56 -24.25 42.19 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.142 1.895 . . . . 0.0 112.326 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -71.1 -48.73 50.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.215 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.792 HG23 ' HB3' ' A' ' 181' ' ' ALA . 36.2 mt -64.86 -53.67 39.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.424 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -53.7 -29.32 38.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.636 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -52.53 -29.19 23.99 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.785 179.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.562 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.55 -27.65 11.51 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-O 121.115 0.483 . . . . 0.0 110.502 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.715 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 6.0 mt -77.86 -32.81 52.24 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.158 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.553 ' O ' HG22 ' A' ' 232' ' ' VAL . 1.3 m-20 -81.67 -30.54 32.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.875 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -63.56 -24.22 67.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.404 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -55.08 -51.02 67.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.687 0.28 . . . . 0.0 111.425 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 229' ' ' ASP . 6.9 m -64.54 128.37 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.897 0.38 . . . . 0.0 111.098 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.267 -0.873 . . . . 0.0 110.968 -179.909 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.3 m -134.25 -48.66 0.78 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.866 0.365 . . . . 0.0 110.938 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -156.38 -177.7 6.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.79 ' HB2' HD13 ' A' ' 134' ' ' LEU . 68.7 m95 -72.23 155.11 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.96 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -97.17 132.45 42.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.476 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mtt85 -71.98 126.56 30.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.102 0.477 . . . . 0.0 111.028 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.017 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.21 1.42 2.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.886 179.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.677 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.77 176.64 8.6 Favored 'General case' 0 CA--C 1.522 -0.132 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.413 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.6 m-85 -139.88 173.0 11.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.443 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.617 HG11 HD11 ' A' ' 139' ' ' LEU . 25.2 t -132.96 119.36 36.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.977 0.418 . . . . 0.0 110.905 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.481 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.12 111.67 16.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.109 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.421 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 24.3 t0 -158.35 136.29 10.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.22 43.72 19.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.004 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 54.85 28.88 11.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.418 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 86.3 m -144.29 144.08 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.845 0.355 . . . . 0.0 111.071 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.481 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.4 m-85 -94.61 110.4 22.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.138 0.494 . . . . 0.0 111.04 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.717 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.1 m-30 -82.72 125.23 76.19 Favored Pre-proline 0 CA--C 1.536 0.431 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.438 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 31.2 Cg_exo -59.66 126.96 22.0 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.348 2.032 . . . . 0.0 112.853 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.924 HD11 HG23 ' A' ' 164' ' ' ILE . 0.8 OUTLIER -109.47 124.82 51.69 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.703 179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.9 mt -85.51 166.5 16.24 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.459 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.446 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.0 pt-20 -55.65 -30.68 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.651 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 29.5 p-10 -91.08 15.34 11.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.477 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.404 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.45 3.88 83.46 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.326 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.603 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.8 OUTLIER -60.76 97.93 0.06 Allowed 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 117.264 0.532 . . . . 0.0 110.548 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.717 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.39 129.98 34.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.052 -179.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.515 ' N ' HD23 ' A' ' 139' ' ' LEU . 24.5 mt -110.67 94.41 4.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.652 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 44.2 mttt -71.61 -28.95 64.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.961 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -80.12 -21.45 43.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.578 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.431 ' HG3' HD13 ' A' ' 140' ' ' LEU . 2.7 mm-40 -99.56 25.79 6.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.673 -0.239 . . . . 0.0 111.483 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.33 159.0 52.23 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.53 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -127.48 156.65 41.8 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.415 -0.392 . . . . 0.0 110.663 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.87 27.56 3.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.871 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.416 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -145.04 141.36 28.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.52 -179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -72.61 119.1 73.32 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.997 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -76.29 107.09 2.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.108 1.872 . . . . 0.0 112.592 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.2 t -66.78 -13.34 61.35 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.286 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -79.52 -27.16 41.39 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 120.61 0.243 . . . . 0.0 111.512 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.563 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.82 162.81 48.7 Favored Pre-proline 0 C--N 1.327 -0.377 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.925 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.563 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.4 Cg_endo -77.31 173.16 14.76 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 121.996 1.797 . . . . 0.0 112.627 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.444 HG21 ' CD2' ' A' ' 130' ' ' PHE . 76.7 t -129.43 154.55 40.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.076 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.571 HD12 ' CD1' ' A' ' 133' ' ' LEU . 51.5 mt -114.17 97.77 6.55 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 0.0 110.561 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.8 t -82.41 134.84 26.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.552 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.84 87.04 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.878 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.502 ' CH2' HD11 ' A' ' 211' ' ' ILE . 67.4 m95 -146.97 116.62 7.12 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.993 0.425 . . . . 0.0 111.545 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 10.3 mttp -106.68 -27.43 10.82 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.344 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -96.74 95.19 7.74 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.142 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.893 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.38 -20.91 46.56 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.125 -1.036 . . . . 0.0 112.03 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.43 -40.64 97.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 177.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.13 -34.28 70.9 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.505 178.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.924 HG23 HD11 ' A' ' 133' ' ' LEU . 62.0 mt -62.13 -51.63 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.662 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.48 -31.62 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.8 mm-40 -66.99 -50.46 62.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.278 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.472 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.64 -52.48 65.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.741 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.73 68.7 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.847 0.355 . . . . 0.0 110.268 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.98 98.19 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.366 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 44.4 mm-40 -66.84 -35.1 79.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.949 0.404 . . . . 0.0 110.193 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.609 ' HB3' HD22 ' A' ' 179' ' ' LEU . 6.5 mp -70.59 -28.97 65.28 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.059 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -70.84 -18.13 62.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.518 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -102.68 -40.98 6.38 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.773 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -71.11 157.41 90.32 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.695 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 174' ' ' LEU . 50.7 Cg_exo -51.21 123.88 12.88 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.629 2.219 . . . . 0.0 112.54 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.74 -36.31 35.87 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.988 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.681 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -64.05 -42.51 97.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.258 0.551 . . . . 0.0 110.309 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.782 ' HA ' HG22 ' A' ' 224' ' ' ILE . 78.5 t -58.78 -56.12 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.711 179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.773 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -67.86 -13.64 62.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.766 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.88 -14.29 59.62 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.585 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.639 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.53 78.61 3.82 Favored 'General case' 0 CA--C 1.528 0.113 0 CA-C-O 120.828 0.347 . . . . 0.0 111.609 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.98 153.67 0.52 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.556 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.51 -49.64 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.762 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -167.55 156.82 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 153' ' ' PRO . 4.8 mt -104.79 135.48 42.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.406 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.427 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 13.1 m170 -106.14 127.78 53.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.734 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -80.12 111.63 16.66 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.854 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 21.6 mttt -133.62 73.55 72.24 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.854 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -69.19 160.02 51.51 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 122.285 1.99 . . . . 0.0 112.594 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 26.6 p -140.48 162.1 36.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.006 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.4 ptp85 -54.74 -25.86 30.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.368 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -102.43 -20.47 14.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.323 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -135.41 77.34 1.67 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 120.927 0.394 . . . . 0.0 110.934 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -55.83 -22.21 23.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.767 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -113.05 39.51 2.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.76 0.314 . . . . 0.0 111.307 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -86.58 116.09 24.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.953 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.499 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.8 m -121.49 137.2 55.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.08 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 207' ' ' VAL . 19.1 mm -106.62 110.99 33.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.775 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.44 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.4 m -84.62 153.32 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.639 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.427 ' CE1' ' CD2' ' A' ' 186' ' ' HIS . 6.3 m-85 -111.42 107.37 16.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.18 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.449 ' SD ' HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -55.78 149.25 14.92 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.296 -179.471 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -65.99 -24.05 66.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.882 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.3 m-20 -75.84 -13.28 60.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.809 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.21 20.3 9.31 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.787 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 51.7 m-85 -104.87 174.06 6.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.764 0.316 . . . . 0.0 110.645 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -127.88 123.95 36.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.044 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 208' ' ' SER . 20.3 t -124.37 159.69 29.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.609 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 207' ' ' VAL . 79.4 p -118.92 144.91 46.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.99 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.499 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -163.09 149.68 12.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.68 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -98.25 147.15 24.92 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.582 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.502 HD11 ' CH2' ' A' ' 158' ' ' TRP . 14.4 mt -58.5 -27.48 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.195 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -32.87 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.74 0.305 . . . . 0.0 111.383 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -130.16 35.8 4.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.074 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.8 -51.82 68.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.818 0.342 . . . . 0.0 110.938 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -59.34 -46.91 87.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.857 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.75 -42.67 99.79 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.0 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.415 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 2.3 mmpt? -52.31 -53.42 44.57 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.228 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.587 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -80.49 -21.22 42.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.973 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.8 t -60.03 -33.85 72.58 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.007 0.432 . . . . 0.0 110.447 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -78.75 3.87 15.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.128 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -102.36 99.87 14.1 Favored Pre-proline 0 CA--C 1.532 0.263 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -67.25 -26.36 42.01 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.09 1.86 . . . . 0.0 112.126 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.538 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -67.17 -51.38 54.45 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.944 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.782 HG22 ' HA ' ' A' ' 178' ' ' VAL . 29.9 mt -64.2 -53.05 48.25 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.471 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -54.36 -29.26 47.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.596 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.69 -28.55 15.15 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.584 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.558 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.93 -27.48 13.2 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.103 0.477 . . . . 0.0 110.401 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.681 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.8 mt -77.14 -32.53 56.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.137 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -65.22 -57.51 8.31 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 13.7 ttp180 56.82 26.42 11.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.415 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -144.78 -55.21 0.33 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.036 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.9 t -76.25 143.49 13.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 7.5 tptt . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.915 -179.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.235 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.2 m -71.31 -38.89 71.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.77 0.319 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 60.79 -178.43 0.11 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.846 ' HB2' HD13 ' A' ' 134' ' ' LEU . 44.0 m95 -94.48 148.57 22.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.893 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -99.72 132.84 44.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.797 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mtt85 -72.06 127.81 33.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.016 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.9 0.16 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.949 179.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.707 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.6 176.75 10.06 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.094 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.483 ' HB2' HG22 ' A' ' 154' ' ' VAL . 28.4 m-85 -138.39 173.21 11.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.364 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.696 HG21 ' HG ' ' A' ' 139' ' ' LEU . 15.1 t -133.93 117.55 26.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.967 0.413 . . . . 0.0 111.101 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.477 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.59 114.42 19.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.277 -179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.449 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.4 t70 -169.09 142.01 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.771 179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.4 ttt85 59.34 41.14 20.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.145 0.497 . . . . 0.0 110.738 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 54.15 29.65 10.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.441 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.671 HG23 ' O ' ' A' ' 145' ' ' THR . 46.8 m -148.3 145.09 28.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.318 . . . . 0.0 111.434 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.477 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.3 m-85 -95.52 110.53 22.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.701 179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.715 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.9 m-85 -80.84 129.1 69.28 Favored Pre-proline 0 C--N 1.325 -0.499 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.108 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.417 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 22.3 Cg_exo -64.73 123.92 12.4 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.167 1.911 . . . . 0.0 112.31 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.911 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -105.57 125.09 50.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.09 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.846 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.3 mt -84.11 167.09 17.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.197 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.4 pt-20 -55.75 -31.12 62.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.622 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.451 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.0 p30 -90.85 14.39 13.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.386 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.48 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 78.39 7.68 87.82 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.603 -0.808 . . . . 0.0 113.021 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.592 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.1 95.93 0.04 OUTLIER 'General case' 0 C--O 1.232 0.16 0 CA-C-N 117.209 0.504 . . . . 0.0 110.27 179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.715 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.2 118.62 23.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.017 -179.372 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 35.4 mt -103.98 97.34 7.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.565 179.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 17.8 mttt -71.16 -25.67 62.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.209 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -80.71 -21.1 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.856 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -100.14 26.61 6.31 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.553 0.205 . . . . 0.0 111.553 -179.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.417 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.71 159.91 52.54 Favored Glycine 0 CA--C 1.506 -0.483 0 C-N-CA 120.415 -0.898 . . . . 0.0 112.722 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.671 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -125.91 156.96 38.87 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.278 -0.461 . . . . 0.0 110.633 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.45 29.34 2.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.044 0.449 . . . . 0.0 110.649 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.4 143.65 26.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.525 -179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.7 118.05 67.11 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.63 109.24 2.72 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.141 1.894 . . . . 0.0 112.54 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.4 t -67.39 -13.11 61.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.215 179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.28 -27.26 53.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.694 0.283 . . . . 0.0 111.388 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.551 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -141.43 162.56 46.63 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.868 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.551 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 68.0 Cg_endo -76.56 174.17 13.27 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.023 1.815 . . . . 0.0 112.682 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.483 HG22 ' HB2' ' A' ' 123' ' ' TYR . 62.3 t -130.74 154.25 40.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.797 179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.7 mt -113.61 97.57 6.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.079 0.466 . . . . 0.0 110.587 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.43 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.5 t -82.26 134.47 26.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.474 -179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 57.89 89.42 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.611 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.523 ' CH2' HD11 ' A' ' 211' ' ' ILE . 71.0 m95 -147.36 97.48 2.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.963 0.411 . . . . 0.0 111.721 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -93.61 7.42 44.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.321 178.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -131.27 93.02 3.28 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.427 0.156 . . . . 0.0 110.978 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.877 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -57.86 -21.2 43.65 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.198 -1.001 . . . . 0.0 112.23 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.47 -39.73 95.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -74.57 -33.56 62.7 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 114.748 -1.115 . . . . 0.0 109.788 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.911 HG23 HD11 ' A' ' 133' ' ' LEU . 62.6 mt -61.46 -52.05 65.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.919 178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.93 -30.81 62.23 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.142 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.4 mm-40 -67.5 -51.52 50.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.188 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.31 -52.15 66.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.756 179.561 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.016 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.45 -33.63 69.95 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.872 0.367 . . . . 0.0 110.244 179.224 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.43 -41.82 97.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.38 178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -66.15 -38.34 87.88 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.873 0.368 . . . . 0.0 110.277 179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.781 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.2 mp -66.34 -27.56 67.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.343 179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.11 -19.5 60.57 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.626 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -101.45 -41.06 6.78 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.645 0.259 . . . . 0.0 111.49 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.781 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.42 157.39 90.09 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.005 -179.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.627 ' HB2' HG23 ' A' ' 178' ' ' VAL . 52.2 Cg_exo -50.13 129.26 24.7 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.529 2.153 . . . . 0.0 112.841 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.69 -37.12 67.93 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.455 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.664 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.93 -37.1 86.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 110.399 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.706 ' HA ' HG22 ' A' ' 224' ' ' ILE . 55.6 t -61.82 -60.22 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.838 179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.661 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -62.8 -23.89 67.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.451 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.96 -23.86 75.32 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.771 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.559 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -89.51 78.44 7.09 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.863 0.364 . . . . 0.0 110.688 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.9 ptp 177.62 131.06 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.62 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.88 -59.27 3.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.034 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.26 155.43 32.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.042 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -106.32 135.0 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.415 179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.43 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 6.6 m170 -107.31 118.85 37.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.813 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -70.24 115.0 8.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.5 mttm -138.7 77.47 33.17 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -69.14 162.08 43.23 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.279 1.986 . . . . 0.0 112.555 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 29.0 p -139.27 161.43 37.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.05 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -54.65 -25.5 27.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.365 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -103.34 -19.96 14.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.331 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -135.17 81.02 1.87 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.858 0.361 . . . . 0.0 110.982 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -57.09 -21.24 30.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.617 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . 0.422 ' OD2' HD12 ' A' ' 211' ' ' ILE . 0.7 OUTLIER -113.04 38.49 2.81 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.693 0.283 . . . . 0.0 111.044 -179.796 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -85.2 115.73 23.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.001 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 209' ' ' ALA . 32.2 m -119.76 135.97 58.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.113 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 208' ' ' SER . 20.4 mm -105.33 111.38 34.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.77 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.52 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.84 155.38 3.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.855 0.359 . . . . 0.0 111.694 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -114.45 99.78 7.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.956 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.501 ' HE3' HG21 ' A' ' 207' ' ' VAL . 7.5 tpp -54.18 149.33 9.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.983 0.42 . . . . 0.0 111.489 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -66.82 -20.32 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.008 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.428 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 5.8 m-20 -76.02 -13.71 60.23 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.5 20.18 10.49 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.74 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.428 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 28.1 m-85 -111.52 155.93 22.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.824 0.345 . . . . 0.0 110.709 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -109.3 118.77 37.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.83 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.501 HG21 ' HE3' ' A' ' 201' ' ' MET . 15.7 t -116.24 159.52 16.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.947 0.403 . . . . 0.0 110.643 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.52 ' HB3' HD12 ' A' ' 198' ' ' ILE . 51.4 p -121.64 143.68 49.19 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.791 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.505 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -162.67 150.15 13.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -96.43 146.57 24.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.845 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.523 HD11 ' CH2' ' A' ' 158' ' ' TRP . 17.9 mt -59.03 -28.15 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.097 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.92 -31.58 69.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.586 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -134.23 36.11 3.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.139 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -55.46 -50.77 69.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.481 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.61 -48.27 82.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.976 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -63.07 -38.95 93.24 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.961 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -55.66 -53.48 56.01 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.965 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.515 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.6 mm? -78.61 -22.7 46.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.711 179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.8 t -60.49 -34.1 73.58 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.118 0.485 . . . . 0.0 110.261 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 62.9 m170 -72.08 -5.47 35.52 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.855 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.68 100.4 6.18 Favored Pre-proline 0 N--CA 1.453 -0.288 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.595 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 37.7 Cg_endo -66.4 -27.83 46.94 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.145 1.897 . . . . 0.0 112.105 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.27 80.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.852 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.706 HG22 ' HA ' ' A' ' 178' ' ' VAL . 24.8 mt -72.28 -54.93 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 178.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.61 60.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.198 178.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.78 -27.97 13.89 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.431 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.574 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.26 -27.91 10.44 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.376 178.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.664 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.9 mt -78.62 -32.77 47.61 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.221 178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.14 20.45 18.93 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.502 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 30.8 mtt-85 -127.39 -75.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.835 0.35 . . . . 0.0 110.975 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -129.73 106.59 8.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.97 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 232' ' ' VAL . 15.8 t -101.57 31.23 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.007 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 25.0 tttt . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.864 179.985 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.131 0 N-CA-C 112.501 -0.239 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 41.2 m -69.33 112.89 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.87 0.367 . . . . 0.0 110.881 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -146.63 -175.99 5.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.829 ' HB2' HD13 ' A' ' 134' ' ' LEU . 56.5 m95 -74.38 151.06 39.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.794 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.31 130.33 45.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.782 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 15.3 mtm180 -70.6 127.73 33.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.251 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.995 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -130.09 3.18 2.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.708 179.425 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.798 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.44 176.47 9.01 Favored 'General case' 0 C--N 1.338 0.099 0 CA-C-O 120.645 0.259 . . . . 0.0 110.894 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.457 ' HB2' HG22 ' A' ' 154' ' ' VAL . 18.9 m-85 -140.12 173.59 11.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.095 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.65 HG21 ' HG ' ' A' ' 139' ' ' LEU . 21.6 t -133.55 117.46 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.004 0.43 . . . . 0.0 111.38 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.511 ' HD2' HG22 ' A' ' 156' ' ' VAL . 0.1 OUTLIER -80.44 107.35 13.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.832 -179.752 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.434 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.6 t0 -164.42 144.17 7.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.725 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.98 40.63 18.62 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.792 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.16 28.36 8.92 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.581 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 145' ' ' THR . 40.4 m -148.78 146.21 27.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.897 0.38 . . . . 0.0 111.408 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -93.6 109.03 20.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.641 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.5 m-85 -81.15 129.95 64.86 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.167 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 19.5 Cg_exo -66.13 124.5 12.68 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.137 1.891 . . . . 0.0 112.287 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.922 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.84 124.77 50.11 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.861 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.5 mt -83.94 166.63 17.67 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.234 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.1 pt-20 -55.85 -30.35 61.33 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.41 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 21.1 p-10 -91.52 15.77 11.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.497 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 75.5 9.64 84.6 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.679 -0.772 . . . . 0.0 113.123 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.609 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.96 96.39 0.07 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 117.244 0.522 . . . . 0.0 110.11 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -83.59 119.52 24.83 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.079 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 51.7 mt -105.02 97.63 7.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.632 179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.439 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 40.8 mttt -72.03 -21.92 61.47 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.519 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -84.37 -21.68 30.78 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.3 mm-40 -100.76 29.2 4.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.498 0.189 . . . . 0.0 111.414 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.53 161.42 54.15 Favored Glycine 0 CA--C 1.509 -0.343 0 C-N-CA 120.549 -0.834 . . . . 0.0 112.857 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -125.21 160.66 28.66 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.356 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.36 30.51 4.53 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.406 HG23 ' OG1' ' A' ' 145' ' ' THR . 0.0 OUTLIER -154.55 133.1 12.03 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.681 -178.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -61.95 118.31 37.64 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.355 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.446 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 58.8 Cg_endo -73.1 111.78 3.36 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 121.985 1.79 . . . . 0.0 112.477 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 t -66.61 -13.9 61.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.32 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -79.24 -26.66 42.43 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 120.591 0.234 . . . . 0.0 111.606 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.495 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.86 159.25 47.49 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.495 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.2 Cg_endo -71.87 174.19 11.58 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.235 1.957 . . . . 0.0 112.902 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.457 HG22 ' HB2' ' A' ' 123' ' ' TYR . 68.6 t -129.0 153.87 39.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.836 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.6 mt -112.87 98.58 7.28 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.565 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.511 HG22 ' HD2' ' A' ' 125' ' ' TYR . 59.5 t -82.81 135.32 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.475 -179.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.63 86.46 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.807 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.6 m95 -148.11 115.73 6.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.005 0.431 . . . . 0.0 111.468 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 7.6 tttt -106.26 -27.29 11.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.442 179.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -96.53 95.78 8.23 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.077 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.89 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.41 -20.96 47.01 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.084 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.71 -40.3 96.43 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.534 -0.914 . . . . 0.0 108.534 177.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.04 -33.46 68.03 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.737 -1.12 . . . . 0.0 109.659 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.922 ' CG2' HD11 ' A' ' 133' ' ' LEU . 58.1 mt -62.91 -52.34 60.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.625 178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.0 -29.38 57.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.163 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.413 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.3 mm-40 -68.94 -51.2 42.22 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.177 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.462 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.67 -52.54 65.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.678 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.995 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.02 -33.71 69.26 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.937 0.398 . . . . 0.0 110.286 179.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.7 -41.91 97.68 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.662 -0.78 . . . . 0.0 111.311 178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -65.33 -37.7 87.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.916 0.388 . . . . 0.0 110.115 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.654 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.4 mp -67.75 -27.62 66.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.246 179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.73 -19.27 60.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.534 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -101.04 -40.7 7.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.638 0.256 . . . . 0.0 111.573 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.68 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.0 pp -72.18 157.58 89.07 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.518 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.646 ' O ' HD12 ' A' ' 174' ' ' LEU . 56.8 Cg_exo -50.27 124.45 13.01 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.594 2.196 . . . . 0.0 112.681 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.85 53.23 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.79 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.692 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -64.9 -40.06 94.51 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.094 0.473 . . . . 0.0 110.3 179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.785 ' HA ' HG22 ' A' ' 224' ' ' ILE . 47.1 t -59.79 -60.21 2.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.907 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.68 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -62.79 -24.21 67.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.512 178.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.416 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.99 -21.91 77.64 Favored Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.145 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.736 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -88.66 78.53 7.71 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 121.069 0.461 . . . . 0.0 110.718 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.03 138.42 0.08 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.502 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.6 t -75.82 -57.27 3.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.044 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -157.2 153.9 28.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.073 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.533 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.18 136.03 39.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.398 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.42 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 19.3 m170 -108.53 125.54 51.92 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.768 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -77.58 108.88 11.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.982 -179.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -129.42 77.96 76.51 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.507 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 67.9 Cg_endo -75.04 163.72 34.7 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.264 1.976 . . . . 0.0 112.827 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.4 p -142.4 164.11 31.03 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.828 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 -54.49 -26.94 34.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.358 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -102.55 -19.17 14.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.449 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -135.87 77.46 1.66 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.879 0.371 . . . . 0.0 111.087 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -58.13 -21.6 47.34 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.605 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -111.62 36.16 3.37 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.672 0.272 . . . . 0.0 111.337 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.726 ' NH1' HG23 ' A' ' 210' ' ' THR . 0.0 OUTLIER -85.56 114.43 22.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.84 0.353 . . . . 0.0 110.937 179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 209' ' ' ALA . 34.6 m -117.83 138.38 48.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.036 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 22.7 mm -109.12 111.63 36.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.533 HG12 HG12 ' A' ' 185' ' ' ILE . 2.6 m -84.84 154.72 3.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.399 . . . . 0.0 111.675 -179.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -113.59 105.79 13.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.26 149.05 7.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.987 0.422 . . . . 0.0 111.57 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 38.3 p30 -66.95 -22.93 65.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.936 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -79.25 -11.58 59.95 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.835 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.39 20.51 9.03 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.809 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -103.27 174.24 5.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.849 0.357 . . . . 0.0 110.849 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -129.77 119.84 24.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 208' ' ' SER . 21.0 t -121.95 159.35 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.654 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 207' ' ' VAL . 94.4 p -119.59 147.34 44.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.801 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.519 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.02 150.45 9.61 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.7 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.726 HG23 ' NH1' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -101.06 147.59 26.04 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.432 179.79 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.0 mt -57.97 -27.23 30.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.641 0.258 . . . . 0.0 111.161 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.37 -30.44 63.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.469 -179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -134.17 35.88 3.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.34 -179.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.7 -49.62 75.93 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.805 0.336 . . . . 0.0 110.972 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.88 -47.19 87.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.687 179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -62.47 -42.42 99.46 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.054 179.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.411 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -52.05 -53.51 41.18 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.267 179.287 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.565 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.5 mm? -80.59 -21.69 41.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.918 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 35.2 t -59.82 -32.99 71.17 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.999 0.428 . . . . 0.0 110.35 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -79.81 5.26 14.07 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.847 -0.615 . . . . 0.0 112.037 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.4 100.35 18.15 Favored Pre-proline 0 CA--C 1.532 0.273 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.5 -27.29 39.6 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.132 1.888 . . . . 0.0 112.189 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.541 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -66.47 -52.28 47.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.049 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.785 HG22 ' HA ' ' A' ' 178' ' ' VAL . 32.9 mt -63.5 -51.99 63.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.286 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 178.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -54.39 -29.84 50.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.491 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.46 -28.31 12.82 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.721 178.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.543 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.99 -28.75 17.93 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.252 178.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.692 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 5.0 mt -76.33 -32.11 58.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.083 178.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.6 -26.18 68.57 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.199 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -97.09 28.61 3.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.346 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -106.32 -44.38 4.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.915 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.4 m -112.36 116.12 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.192 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.416 -0.274 . . . . 0.0 112.416 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -134.38 161.55 34.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.795 0.331 . . . . 0.0 110.809 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -152.68 -179.59 7.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.04 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.792 ' HB2' HD13 ' A' ' 134' ' ' LEU . 66.8 m95 -69.76 155.09 41.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.048 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -99.89 130.53 46.08 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.572 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 41.9 mtt85 -68.62 127.41 32.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.07 0.462 . . . . 0.0 111.004 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.015 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.94 0.29 2.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.834 179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.661 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.46 176.78 9.44 Favored 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 120.824 0.345 . . . . 0.0 111.107 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.488 ' HB2' HG22 ' A' ' 154' ' ' VAL . 33.9 m-85 -138.75 173.46 11.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.334 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.656 HG21 ' HG ' ' A' ' 139' ' ' LEU . 15.0 t -133.27 117.48 28.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.967 0.413 . . . . 0.0 111.025 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.475 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.52 110.7 16.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.148 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.441 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 15.9 t70 -169.15 144.23 3.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.757 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.38 40.53 20.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.001 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 53.86 28.65 8.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.679 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 145' ' ' THR . 88.6 m -149.58 141.86 24.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.964 0.411 . . . . 0.0 111.247 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.475 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 14.1 m-85 -89.71 109.84 20.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.052 178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.732 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.3 m-85 -80.99 123.93 81.72 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.967 -179.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -60.43 124.24 14.72 Favored 'Trans proline' 0 C--N 1.353 0.788 0 C-N-CA 122.206 1.937 . . . . 0.0 112.524 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.915 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.2 mt -106.82 125.29 50.81 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.013 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.792 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.7 mt -84.14 166.7 17.4 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.179 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.453 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.7 pt-20 -56.28 -30.26 62.26 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.291 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.6 p-10 -91.38 15.8 11.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.303 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 76.26 8.18 85.27 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.143 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.609 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -61.29 96.18 0.05 Allowed 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 117.209 0.504 . . . . 0.0 110.243 179.766 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.732 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -85.59 112.88 21.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.853 -179.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 68.2 mt -105.18 98.21 7.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.595 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 7.4 mttp -69.0 -27.5 65.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -73.45 -22.39 60.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.603 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.4 mm-40 -101.13 23.77 10.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.619 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -77.17 164.24 52.58 Favored Glycine 0 CA--C 1.508 -0.38 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.733 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 129' ' ' THR . 4.0 t -130.26 158.82 38.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.953 0.406 . . . . 0.0 110.631 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.46 22.56 4.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.125 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.463 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -140.28 143.87 36.13 Favored 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.902 0.382 . . . . 0.0 110.679 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.36 118.53 72.08 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.745 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -76.43 108.93 2.77 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.05 1.833 . . . . 0.0 112.608 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -67.07 -13.52 62.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.274 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -77.33 -27.54 52.82 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.667 0.27 . . . . 0.0 111.402 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.604 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.61 164.6 38.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.654 -179.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.604 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 72.7 Cg_endo -78.73 172.72 14.65 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.893 1.729 . . . . 0.0 112.521 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.488 HG22 ' HB2' ' A' ' 123' ' ' TYR . 60.1 t -129.37 153.57 38.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.939 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.611 HD12 ' CD1' ' A' ' 133' ' ' LEU . 60.4 mt -113.54 97.58 6.53 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.06 0.457 . . . . 0.0 110.569 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 64.2 t -83.44 134.6 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.325 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.2 85.78 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.888 -0.673 . . . . 0.0 112.724 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.505 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.64 110.28 4.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.949 0.404 . . . . 0.0 111.536 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.8 mttt -101.22 -27.8 13.01 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.35 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -94.8 94.08 7.86 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.054 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.897 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.03 -21.0 44.28 Favored Glycine 0 C--N 1.334 0.456 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.154 179.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.43 -39.9 95.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.25 -33.83 67.8 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.68 -1.145 . . . . 0.0 109.577 178.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.915 ' CG2' HD11 ' A' ' 133' ' ' LEU . 63.4 mt -62.03 -52.24 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.646 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.04 -30.08 58.82 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.178 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.426 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 12.1 mm-40 -68.8 -50.42 50.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.232 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.455 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.94 -52.22 66.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.672 179.583 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.015 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.48 -33.7 68.27 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.946 0.403 . . . . 0.0 110.235 179.22 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.99 97.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.584 -0.817 . . . . 0.0 111.32 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -63.3 -37.01 85.6 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.024 178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.533 ' HB3' HD22 ' A' ' 179' ' ' LEU . 7.4 mp -69.23 -28.58 66.47 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.984 179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.56 -18.43 62.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.547 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -102.62 -40.47 6.62 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 179' ' ' LEU . 1.9 pp -70.84 157.14 90.93 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.744 -179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.659 ' O ' HD12 ' A' ' 174' ' ' LEU . 51.4 Cg_exo -51.3 124.09 13.38 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.575 2.183 . . . . 0.0 112.631 179.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.48 -34.73 26.05 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.833 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.691 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.59 -43.35 89.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.14 0.495 . . . . 0.0 110.335 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.835 ' HA ' HG22 ' A' ' 224' ' ' ILE . 53.8 t -58.53 -55.9 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.757 179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -67.69 -13.55 62.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.666 178.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.55 -14.54 59.74 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.519 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.664 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -93.62 78.37 4.31 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.965 0.383 . . . . 0.0 111.54 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.55 155.61 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.388 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 p -89.32 -48.6 7.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.94 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -167.57 156.1 9.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.116 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.524 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -105.88 134.0 48.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.151 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.456 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.2 m170 -109.12 118.52 36.96 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.434 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 37.7 t80 -69.07 110.0 4.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.902 -179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.424 ' HD3' HG12 ' A' ' 198' ' ' ILE . 1.0 OUTLIER -132.57 74.13 75.58 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.884 179.905 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.2 161.78 29.07 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.267 1.978 . . . . 0.0 112.238 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -137.16 162.71 32.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.03 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 9.2 ptt180 -54.2 -26.37 27.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.369 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -104.41 -18.3 14.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.572 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -134.3 87.13 2.33 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.865 0.364 . . . . 0.0 111.187 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -59.63 -19.56 49.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -115.52 36.05 4.13 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.741 0.305 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 3.0 ttt85 -78.94 108.33 12.34 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.905 0.383 . . . . 0.0 110.706 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 19.2 m -111.9 133.06 58.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.195 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.424 HG12 ' HD3' ' A' ' 188' ' ' LYS . 30.9 mm -106.14 111.55 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.537 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.524 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -87.05 158.32 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.696 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -115.09 107.12 14.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.174 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.17 149.37 16.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 0.0 111.395 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 15.7 m-20 -65.88 -21.92 66.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.993 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -77.07 -13.19 59.99 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.33 20.3 9.24 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.721 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -106.43 174.94 5.67 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.699 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -128.64 117.71 21.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.021 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.51 ' HB ' HG22 ' A' ' 199' ' ' VAL . 12.1 t -113.42 160.54 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.489 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 207' ' ' VAL . 80.3 p -121.14 145.14 48.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.073 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.406 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.1 -178.71 7.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.714 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.407 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -128.73 154.66 46.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.369 179.669 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.505 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.9 mt -69.0 -22.34 26.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.975 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.56 -32.05 47.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.698 0.285 . . . . 0.0 111.321 -179.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -134.21 35.77 3.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.963 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.407 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.2 t80 -56.8 -48.09 78.74 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.155 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -59.47 -48.07 83.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -62.78 -39.21 93.5 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.319 179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.406 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 13.0 mmtt -56.93 -53.31 59.44 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.49 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.449 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.3 mm? -81.42 -21.35 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.19 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -64.11 -33.61 76.16 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.033 0.444 . . . . 0.0 110.601 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.6 m80 -73.61 -2.74 24.22 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.385 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -92.36 110.22 43.27 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 122.263 -0.273 . . . . 0.0 110.848 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.28 -31.8 34.59 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.325 2.017 . . . . 0.0 112.38 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -70.55 -45.99 64.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.321 -179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.835 HG22 ' HA ' ' A' ' 178' ' ' VAL . 35.9 mt -64.76 -55.32 21.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-O 121.158 0.504 . . . . 0.0 109.708 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.67 -29.16 58.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.319 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.33 -29.13 14.16 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.752 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.626 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.68 -27.5 11.85 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.334 178.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.691 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.2 mt -77.2 -33.11 56.34 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.014 178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -97.74 19.14 14.16 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.653 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.66 -53.86 4.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.957 0.408 . . . . 0.0 111.033 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -143.28 96.87 2.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.952 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 7.7 m -105.65 139.94 25.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.002 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.882 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.514 -0.235 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 59.95 69.65 0.69 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.008 0.433 . . . . 0.0 110.859 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -129.72 177.43 7.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.918 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.808 ' HB2' HD13 ' A' ' 134' ' ' LEU . 54.3 m95 -70.47 152.0 44.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.962 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.59 134.62 38.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.508 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -76.78 126.71 31.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.712 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.0 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.62 0.72 2.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.995 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.69 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.96 176.89 9.7 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.098 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.624 ' HE1' ' HB3' ' A' ' 152' ' ' ALA . 55.6 m-85 -138.49 173.29 11.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.31 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.678 HG21 ' HG ' ' A' ' 139' ' ' LEU . 20.0 t -134.2 116.61 23.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.933 0.397 . . . . 0.0 110.953 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.467 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.39 113.76 18.81 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.12 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.442 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.0 t70 -168.96 144.19 3.26 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.796 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 58.65 40.07 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.208 0.528 . . . . 0.0 110.795 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 54.81 31.77 16.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.473 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 145' ' ' THR . 53.6 m -151.47 144.44 24.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.857 0.361 . . . . 0.0 111.37 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.467 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 5.0 m-85 -93.55 110.12 21.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.675 179.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.3 m-85 -81.15 129.81 65.44 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.119 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 21.4 Cg_exo -65.09 124.91 13.71 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.189 1.926 . . . . 0.0 112.277 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.985 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -105.86 124.78 50.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.798 179.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.808 HD13 ' HB2' ' A' ' 118' ' ' TRP . 21.2 mt -84.95 165.63 17.45 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.373 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.486 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.2 pt-20 -55.31 -30.74 60.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.697 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -90.92 15.11 12.01 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.314 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.409 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 77.51 4.05 83.94 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.257 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.609 ' HB3' HD12 ' A' ' 134' ' ' LEU . 20.6 tpp180 -61.07 98.26 0.07 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.347 0.573 . . . . 0.0 110.476 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.729 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -80.3 126.97 31.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.386 -0.825 . . . . 0.0 111.079 -179.45 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.9 mm? -106.53 94.24 5.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.618 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.437 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 12.5 mttp -70.97 -26.98 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.95 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -84.24 -20.75 31.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.795 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -98.09 24.58 6.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.527 0.204 . . . . 0.0 111.507 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.31 160.43 53.17 Favored Glycine 0 CA--C 1.507 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.825 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.691 ' O ' HG23 ' A' ' 129' ' ' THR . 1.5 t -126.72 157.21 39.69 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.599 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 27.72 3.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.866 179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -147.29 140.5 25.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.483 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.83 117.65 53.29 Favored Pre-proline 0 C--N 1.327 -0.402 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.888 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.439 ' CG ' ' CD1' ' A' ' 123' ' ' TYR . 65.0 Cg_endo -76.21 106.68 2.31 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 122.148 1.898 . . . . 0.0 112.75 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 7.8 t -67.99 -12.26 60.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.241 179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -76.98 -27.22 54.65 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 120.759 0.314 . . . . 0.0 111.328 179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.624 ' HB3' ' HE1' ' A' ' 123' ' ' TYR . . . -144.06 160.2 50.25 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.901 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.509 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.5 Cg_endo -71.97 174.18 11.67 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.021 1.814 . . . . 0.0 112.722 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.506 HG22 ' HB2' ' A' ' 123' ' ' TYR . 63.6 t -130.43 155.56 41.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.944 179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.3 mt -115.06 97.72 6.38 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.006 0.431 . . . . 0.0 110.533 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.9 134.32 27.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.387 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.34 86.18 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.761 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.533 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.4 m95 -147.64 110.43 4.73 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.056 0.455 . . . . 0.0 111.631 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.88 -25.24 14.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.488 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -97.86 95.46 7.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.206 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.907 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.52 -20.85 47.42 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.104 -1.046 . . . . 0.0 112.057 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.39 -41.11 98.75 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 177.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.22 -34.82 73.36 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.441 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.985 HG23 HD11 ' A' ' 133' ' ' LEU . 54.5 mt -61.66 -51.68 69.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.585 178.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.409 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.33 -29.45 58.34 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.292 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.422 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 4.1 mm-40 -70.74 -50.64 33.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.381 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.453 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.97 -52.45 65.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.952 179.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.0 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.31 -33.64 67.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.881 0.372 . . . . 0.0 110.339 179.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.23 -42.41 98.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.25 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -65.41 -35.97 82.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.847 0.356 . . . . 0.0 110.344 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.662 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.0 mp -70.73 -27.88 64.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.89 -19.47 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.524 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -99.15 -40.69 7.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.708 0.289 . . . . 0.0 111.481 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.81 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -72.7 157.2 89.24 Favored Pre-proline 0 CA--C 1.533 0.3 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.375 -179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.658 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.0 Cg_exo -50.58 123.66 11.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 122.459 2.106 . . . . 0.0 112.51 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -51.96 -33.91 39.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.638 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.687 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -66.47 -41.52 88.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.049 0.452 . . . . 0.0 110.404 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.675 ' HA ' HG22 ' A' ' 224' ' ' ILE . 53.6 t -59.53 -60.29 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.845 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.81 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.3 pp -61.26 -24.32 66.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.496 178.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -73.64 -23.8 76.03 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.669 -0.777 . . . . 0.0 111.816 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.418 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -86.23 78.3 9.37 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 110.679 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.2 ptp 178.27 131.76 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.622 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 80.6 p -67.94 -55.4 12.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -161.48 155.64 22.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.531 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -104.54 136.05 39.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.374 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.436 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 25.1 m170 -107.19 122.19 46.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.87 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.544 ' HD1' HG12 ' A' ' 197' ' ' VAL . 9.2 t80 -75.0 109.77 8.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.811 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttm -129.37 72.37 81.97 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.853 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.03 154.77 57.67 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.439 2.092 . . . . 0.0 112.446 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 7.4 p -140.89 166.9 23.5 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.106 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -26.27 60.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.291 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -100.75 -17.45 16.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.49 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.401 ' CB ' ' HB2' ' A' ' 196' ' ' ARG . 46.8 m-85 -143.89 76.78 1.53 Allowed 'General case' 0 C--O 1.231 0.122 0 CA-C-O 120.951 0.405 . . . . 0.0 111.023 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -58.09 -19.77 34.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.74 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -113.87 37.09 3.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.778 0.323 . . . . 0.0 111.146 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.401 ' HB2' ' CB ' ' A' ' 193' ' ' TYR . 6.4 ttt180 -87.53 116.94 25.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.025 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.544 HG12 ' HD1' ' A' ' 187' ' ' TYR . 28.1 m -120.59 133.35 67.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.108 179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 208' ' ' SER . 23.4 mm -103.71 112.1 35.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.607 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.531 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -88.49 151.7 3.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.92 0.391 . . . . 0.0 111.517 -179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -110.58 103.78 12.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.99 179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 13.2 tpp -56.25 149.38 16.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.441 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 40.1 p30 -67.17 -19.78 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.082 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 34.4 m-20 -75.56 -13.51 60.36 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.05 20.21 10.02 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.772 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -111.76 167.84 10.04 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.866 0.365 . . . . 0.0 110.736 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 51.3 tt0 -119.14 120.7 37.88 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.906 179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.484 HG12 ' N ' ' A' ' 208' ' ' SER . 22.7 t -118.91 159.16 19.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.618 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.577 ' HB3' HD12 ' A' ' 198' ' ' ILE . 6.9 p -118.53 148.77 42.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.911 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.476 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -165.2 150.78 9.54 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.671 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -100.48 147.55 25.76 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.526 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.533 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.6 mt -59.32 -25.88 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.187 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.7 -29.48 58.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 111.2 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -133.96 35.51 3.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.241 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -57.73 -49.55 76.17 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.787 0.327 . . . . 0.0 111.018 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.01 -48.17 82.82 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.795 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -62.02 -41.23 97.86 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.11 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.436 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -52.88 -53.1 53.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.298 179.455 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.484 HD12 HD13 ' A' ' 224' ' ' ILE . 3.4 mm? -82.06 -20.8 37.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.151 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 40.0 t -61.59 -32.55 72.66 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.005 0.431 . . . . 0.0 110.445 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -77.84 3.4 14.46 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.334 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.502 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -103.1 100.39 17.19 Favored Pre-proline 0 CA--C 1.531 0.215 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.582 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 38.6 Cg_endo -67.03 -26.63 43.13 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.121 1.881 . . . . 0.0 112.059 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.4 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -69.47 -41.58 76.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.825 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.675 HG22 ' HA ' ' A' ' 178' ' ' VAL . 36.8 mt -71.62 -54.67 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.468 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -57.32 -29.06 63.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.159 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.22 -28.02 10.42 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.412 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . . . . . . . . . . . -51.61 -28.04 13.01 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.293 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.687 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.9 mt -77.69 -32.38 52.99 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.184 178.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.98 -26.95 39.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.173 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.21 -28.82 55.77 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.789 0.328 . . . . 0.0 111.458 -179.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 -62.95 -49.86 73.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.935 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 232' ' ' VAL . 11.9 m -95.49 82.05 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 15.1 ttpp . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.861 -179.97 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.75 -55.86 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.798 0.332 . . . . 0.0 110.879 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -176.33 -168.9 0.27 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.829 ' HB2' HD13 ' A' ' 134' ' ' LEU . 56.0 m95 -80.22 150.64 30.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.918 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.04 130.17 45.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.444 ' HG2' HD23 ' A' ' 134' ' ' LEU . 52.1 mtt180 -69.75 127.67 33.75 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.019 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.61 1.27 3.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.77 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.678 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.66 176.7 9.37 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-O 120.714 0.292 . . . . 0.0 111.04 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.468 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.0 m-85 -139.72 173.77 11.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.248 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.629 HG21 ' CD1' ' A' ' 139' ' ' LEU . 16.6 t -133.59 117.17 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.953 0.406 . . . . 0.0 110.895 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.425 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.42 15.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.291 -179.354 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.435 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.8 t0 -169.28 145.17 3.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.783 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.52 40.9 23.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.97 29.92 10.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.74 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.688 HG23 ' O ' ' A' ' 145' ' ' THR . 89.7 m -151.47 142.52 23.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.961 0.41 . . . . 0.0 111.324 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.425 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.5 m-85 -90.87 109.24 20.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.057 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.742 ' HB2' HD21 ' A' ' 139' ' ' LEU . 15.3 m-85 -79.05 122.74 84.8 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -60.45 122.11 10.8 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.13 1.887 . . . . 0.0 112.489 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.962 HD11 HG23 ' A' ' 164' ' ' ILE . 1.3 mt -103.87 125.03 50.0 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.791 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.829 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.2 mt -84.65 165.91 17.53 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.474 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.488 ' HA ' HD12 ' A' ' 121' ' ' ILE . 4.8 pt-20 -55.72 -30.19 60.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.584 -179.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.421 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.7 p-10 -90.61 14.68 12.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.396 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.27 3.82 82.75 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.583 -0.817 . . . . 0.0 113.254 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.578 ' HB3' HD12 ' A' ' 134' ' ' LEU . 16.1 tpp180 -60.6 97.36 0.05 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 121.276 0.56 . . . . 0.0 110.572 179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.742 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -84.49 114.67 22.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.853 -179.622 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 56.6 mt -105.07 97.69 7.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.717 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 4.2 mttt -69.76 -27.73 65.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -73.28 -23.26 60.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.617 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -101.48 25.36 8.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.547 -179.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.02 163.0 54.08 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.512 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.688 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.28 156.12 42.42 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.661 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.93 28.43 3.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.64 138.33 24.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.543 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -64.72 118.36 47.44 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.407 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 72.5 Cg_endo -77.67 106.21 2.16 Favored 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.077 1.852 . . . . 0.0 112.794 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.0 t -68.0 -12.05 60.05 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.228 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -78.05 -27.26 48.69 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.757 0.313 . . . . 0.0 111.312 179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.59 160.14 48.77 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.951 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.0 Cg_endo -71.7 173.29 12.85 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.031 1.821 . . . . 0.0 112.763 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 123' ' ' TYR . 68.4 t -129.28 154.56 40.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.89 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.61 HD12 ' CD1' ' A' ' 133' ' ' LEU . 54.5 mt -112.94 98.33 7.1 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.128 0.49 . . . . 0.0 110.528 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.423 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.3 t -82.46 134.89 25.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.475 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.56 86.73 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 115.782 -0.645 . . . . 0.0 112.836 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.515 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.47 112.68 5.23 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.036 0.446 . . . . 0.0 111.446 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.96 -26.84 12.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.409 179.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.68 95.82 8.19 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.251 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.914 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.49 -21.05 47.97 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.189 -1.005 . . . . 0.0 111.964 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.24 97.06 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 177.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.61 -34.18 69.63 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 114.583 -1.19 . . . . 0.0 109.524 178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.962 HG23 HD11 ' A' ' 133' ' ' LEU . 40.3 mt -61.8 -52.05 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.498 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.97 -30.27 58.68 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.267 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 15.1 mm-40 -69.47 -50.78 42.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.338 179.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.459 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.34 -52.46 65.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.819 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.019 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.79 69.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.832 0.349 . . . . 0.0 110.363 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.11 -40.29 96.95 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.197 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 8.1 mm-40 -66.64 -38.11 86.21 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.947 0.404 . . . . 0.0 110.273 178.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.732 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.9 mp -67.6 -28.13 67.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.363 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.24 -22.02 59.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.611 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -96.52 -40.75 8.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.693 0.283 . . . . 0.0 111.521 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.732 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -70.84 156.19 92.34 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.978 -179.531 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.611 ' HB2' HG23 ' A' ' 178' ' ' VAL . 68.5 Cg_exo -49.31 129.86 23.49 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.651 2.234 . . . . 0.0 112.879 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.54 -38.63 66.83 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.699 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.662 ' HB1' ' CB ' ' A' ' 227' ' ' ALA . . . -63.67 -37.48 87.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.128 0.49 . . . . 0.0 110.414 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.756 ' HA ' HG22 ' A' ' 224' ' ' ILE . 52.1 t -60.86 -59.96 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.75 179.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.677 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -61.03 -23.82 65.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.384 178.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.59 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.27 -24.76 74.72 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.707 179.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.804 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -88.19 78.3 8.11 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.902 0.382 . . . . 0.0 110.752 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 176.88 140.42 0.07 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.443 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 33.2 t -84.06 -56.52 3.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.17 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -154.8 154.41 32.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.021 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.522 HG12 HG12 ' A' ' 199' ' ' VAL . 4.5 mt -107.51 136.77 41.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.32 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.423 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.4 m170 -108.06 117.39 34.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.949 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.408 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 39.2 t80 -73.02 106.62 4.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.783 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 15.6 mttm -126.92 74.7 76.36 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.824 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.408 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 56.1 Cg_endo -70.41 158.16 56.95 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 122.26 1.973 . . . . 0.0 112.552 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 22.7 p -140.44 162.9 34.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.104 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.16 -26.61 28.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.33 179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -102.4 -20.4 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.385 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -136.22 76.61 1.61 Allowed 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.976 0.417 . . . . 0.0 111.0 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -57.32 -20.63 29.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.669 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -113.87 38.37 2.99 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.851 0.358 . . . . 0.0 111.188 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -85.72 116.87 24.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.922 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 28.1 m -121.06 132.87 69.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.38 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.405 HG21 ' OE2' ' A' ' 206' ' ' GLU . 21.2 mm -105.77 110.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.477 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.526 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.6 m -85.02 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.932 0.396 . . . . 0.0 111.61 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -116.06 106.48 13.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.07 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.82 149.33 11.49 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.483 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.465 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.6 p30 -66.14 -22.36 66.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.934 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -79.2 -12.02 59.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.26 20.33 9.26 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.763 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -103.14 174.18 5.98 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.899 0.38 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . 0.405 ' OE2' HG21 ' A' ' 198' ' ' ILE . 35.5 tt0 -129.38 116.4 18.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.928 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.526 ' HB ' HG22 ' A' ' 199' ' ' VAL . 13.1 t -114.87 159.9 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.521 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.462 ' N ' HG12 ' A' ' 207' ' ' VAL . 85.0 p -121.02 145.33 47.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.066 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.423 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -159.11 -178.44 7.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.778 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.9 153.67 47.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.313 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.515 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.1 mt -67.77 -21.84 27.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.076 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.47 -35.3 58.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.709 0.29 . . . . 0.0 111.462 -179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -133.74 35.95 3.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.788 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -54.38 -48.18 71.83 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.264 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.515 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.61 -48.69 80.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.933 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -62.18 -38.7 90.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.394 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.423 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 19.7 mmtt -56.44 -51.04 69.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.392 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.411 ' HB3' ' CG1' ' A' ' 178' ' ' VAL . 3.4 mm? -79.66 -20.3 47.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.349 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.5 p -65.49 -36.85 85.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.962 0.411 . . . . 0.0 110.384 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -63.47 -14.93 55.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.795 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.44 111.21 23.26 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.535 -0.103 . . . . 0.0 110.922 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.709 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 12.3 Cg_exo -70.3 -24.15 27.54 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.164 1.909 . . . . 0.0 112.459 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -80.23 -41.69 24.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.55 -179.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.804 HG23 ' HB3' ' A' ' 181' ' ' ALA . 18.6 mt -68.78 -57.79 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.35 -29.4 58.28 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.325 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.81 -28.24 21.73 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.545 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.662 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.36 -28.03 11.37 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.368 178.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.646 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 6.2 mt -77.82 -33.51 52.4 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.01 178.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.92 21.61 11.35 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.438 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -90.45 -40.95 11.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.769 0.318 . . . . 0.0 110.937 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.94 -61.68 1.4 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.3 p -176.53 140.75 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.971 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 26.8 mtpt . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.932 -179.991 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.6 m -136.63 -170.77 2.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 61.14 -172.16 0.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.78 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.803 ' HB2' HD13 ' A' ' 134' ' ' LEU . 24.9 m95 -131.03 151.92 50.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.038 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.44 128.67 46.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.448 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 26.9 mtm-85 -68.31 127.22 32.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.099 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.013 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.09 0.17 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.024 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.605 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.92 177.06 9.55 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.648 0.261 . . . . 0.0 111.042 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.438 ' HB2' HG22 ' A' ' 154' ' ' VAL . 24.4 m-85 -139.34 173.74 11.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.305 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.665 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.8 t -133.45 117.21 26.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.966 0.412 . . . . 0.0 111.073 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.454 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.56 114.06 19.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.366 -179.374 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.44 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 17.9 t70 -169.17 143.12 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.85 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 58.95 41.27 21.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.938 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 54.09 29.99 11.23 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.406 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.675 HG23 ' O ' ' A' ' 145' ' ' THR . 51.3 m -149.38 145.42 26.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.823 0.344 . . . . 0.0 111.365 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.454 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.5 m-85 -95.97 110.92 23.06 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.809 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.735 ' HB2' HD21 ' A' ' 139' ' ' LEU . 17.2 m-85 -81.71 127.06 74.05 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.248 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.423 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 26.3 Cg_exo -62.45 124.81 14.91 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.191 1.927 . . . . 0.0 112.501 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.95 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -106.48 125.16 50.65 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.794 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.803 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.3 mt -85.35 164.6 17.87 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.417 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.447 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.6 pt-20 -54.94 -29.88 57.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.515 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.8 p-10 -91.16 15.36 11.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.388 179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 76.72 3.25 78.88 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.65 -0.786 . . . . 0.0 113.314 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.589 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.68 97.67 0.06 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.362 0.581 . . . . 0.0 110.485 179.667 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.735 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -81.09 126.34 31.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.974 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.475 ' N ' HD23 ' A' ' 139' ' ' LEU . 18.2 mt -107.71 95.69 5.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.633 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.427 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.8 mttp -72.54 -25.51 61.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.252 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -82.64 -20.91 35.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.791 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -101.1 28.07 5.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.652 0.263 . . . . 0.0 111.5 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.423 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -74.68 159.8 52.48 Favored Glycine 0 CA--C 1.508 -0.368 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.642 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.675 ' O ' HG23 ' A' ' 129' ' ' THR . 1.3 t -124.64 155.85 38.48 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.287 -0.456 . . . . 0.0 110.626 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.44 29.71 2.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -149.85 140.29 22.4 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.23 118.25 51.21 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.02 105.67 2.12 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 122.122 1.881 . . . . 0.0 112.78 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 t -67.89 -12.2 60.2 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.224 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 65.5 m-20 -78.51 -27.3 46.06 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 120.6 0.238 . . . . 0.0 111.316 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.502 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -144.44 159.92 49.99 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 120.909 0.385 . . . . 0.0 111.866 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.502 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 53.2 Cg_endo -71.46 172.86 13.38 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.961 1.774 . . . . 0.0 112.6 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.438 HG22 ' HB2' ' A' ' 123' ' ' TYR . 58.6 t -129.45 154.19 39.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.897 179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.62 HD12 ' CD1' ' A' ' 133' ' ' LEU . 56.1 mt -113.17 97.84 6.75 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.985 0.422 . . . . 0.0 110.441 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 72.6 t -83.29 134.29 27.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.37 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.6 85.36 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.816 -0.629 . . . . 0.0 112.788 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.563 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.2 m95 -148.31 113.05 5.39 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.971 0.415 . . . . 0.0 111.494 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.84 -26.01 12.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.464 178.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.93 95.37 7.78 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.208 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.902 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.59 -20.86 48.05 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.1 -1.048 . . . . 0.0 112.067 178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.2 -40.43 97.46 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.73 -34.19 69.34 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.518 178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.95 HG23 HD11 ' A' ' 133' ' ' LEU . 48.1 mt -61.42 -51.88 67.7 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.612 178.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.401 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.46 -31.2 61.76 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.26 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.421 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 9.7 mm-40 -67.9 -51.15 51.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.209 179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.456 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.24 -52.0 67.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.81 179.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.013 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.47 -33.91 70.28 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.855 0.359 . . . . 0.0 110.252 179.4 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.71 -40.42 96.52 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.529 -0.843 . . . . 0.0 111.333 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 45.2 mm-40 -67.05 -38.06 85.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.883 0.373 . . . . 0.0 110.18 178.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.568 ' CD2' ' HB2' ' A' ' 122' ' ' ALA . 8.0 mp -68.06 -28.2 67.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.291 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.95 -18.75 60.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.701 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -101.18 -40.52 7.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.728 0.299 . . . . 0.0 111.712 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.757 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -70.4 157.81 89.13 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.723 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.665 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.9 Cg_exo -50.88 124.23 13.3 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.542 2.161 . . . . 0.0 112.638 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.78 -35.73 33.41 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.928 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.706 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.36 -40.65 93.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.17 0.51 . . . . 0.0 110.417 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.715 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.8 t -60.24 -60.03 3.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.998 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.757 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.2 pp -61.19 -25.52 67.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.39 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.449 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -74.84 -22.12 77.44 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.022 179.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.697 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -87.89 78.16 8.37 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.967 0.413 . . . . 0.0 110.913 179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.6 ptp 177.92 140.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.543 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.91 -54.0 6.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.104 -179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.63 152.39 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.075 0.464 . . . . 0.0 110.974 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.43 HG12 HG12 ' A' ' 199' ' ' VAL . 5.1 mt -102.97 135.81 38.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.384 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.428 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 21.3 m170 -108.05 114.71 28.83 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.885 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -72.14 100.74 2.62 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.859 179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 12.8 mtmm -123.54 79.36 54.85 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.82 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.72 165.93 31.37 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.35 2.034 . . . . 0.0 112.613 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 8.7 p -143.6 176.18 9.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.808 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -62.4 -25.58 68.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.369 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -111.81 5.14 18.87 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -156.58 78.01 0.92 Allowed 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.911 0.386 . . . . 0.0 111.008 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.62 -18.4 52.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.518 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -114.22 34.33 4.75 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.834 0.35 . . . . 0.0 111.037 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.3 ttt180 -80.03 109.13 14.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.836 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.5 m -111.78 132.77 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.003 0.43 . . . . 0.0 111.402 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 24.6 mm -105.41 107.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.311 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.46 HG21 HD11 ' A' ' 218' ' ' LEU . 2.2 m -85.0 150.27 4.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.988 0.423 . . . . 0.0 111.653 -178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -109.08 109.2 20.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.985 179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.81 148.96 9.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.416 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.0 p-10 -66.16 -21.86 66.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.6 -10.58 59.39 Favored 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.27 20.52 9.09 Favored Glycine 0 C--N 1.333 0.415 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.713 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -100.66 174.25 6.15 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 110.825 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -129.03 122.08 29.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.859 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.478 HG12 ' N ' ' A' ' 208' ' ' SER . 38.6 t -125.76 158.68 34.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.754 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.478 ' N ' HG12 ' A' ' 207' ' ' VAL . 81.2 p -121.59 149.19 43.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.079 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -163.35 -177.14 5.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.726 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.8 p -129.24 153.75 47.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.408 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.563 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.4 mt -66.3 -22.43 30.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.022 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.92 -32.51 57.43 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.749 0.309 . . . . 0.0 111.381 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -134.16 35.82 3.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.088 -179.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.408 ' CD1' HD23 ' A' ' 218' ' ' LEU . 12.3 t80 -57.3 -46.59 83.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.936 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 174' ' ' LEU . . . -61.99 -48.68 79.27 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.645 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -62.47 -40.17 95.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.131 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 22.0 mmtm -57.03 -52.99 63.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.619 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.476 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.6 mm? -77.3 -21.79 52.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.445 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 78.7 p -66.4 -33.5 75.84 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.957 0.408 . . . . 0.0 110.361 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -67.86 -10.29 51.82 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.914 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.419 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -87.16 110.56 34.31 Favored Pre-proline 0 CA--C 1.534 0.365 0 O-C-N 122.485 -0.134 . . . . 0.0 110.865 -179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.643 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 13.4 Cg_exo -69.83 -26.35 27.33 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 122.215 1.943 . . . . 0.0 112.343 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -76.38 -41.91 46.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.459 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.715 HG22 ' HA ' ' A' ' 178' ' ' VAL . 19.7 mt -69.01 -56.83 10.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.42 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -55.57 -29.03 58.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.295 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.643 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.5 -28.46 20.52 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.565 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.476 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.85 -27.55 13.0 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-O 121.1 0.476 . . . . 0.0 110.328 178.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.706 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.7 mt -78.42 -32.23 48.58 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.094 178.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -77.63 -17.4 57.79 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.757 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.6 mtp180 -53.89 -78.33 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 111.45 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 19.8 m-80 -147.21 -74.29 0.2 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.154 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.576 HG12 ' O ' ' A' ' 232' ' ' VAL . 18.1 t 64.45 33.08 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.978 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.7 mtpp . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.865 -179.949 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.2 p -159.8 132.58 6.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.85 0.357 . . . . 0.0 110.871 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -112.35 -179.11 3.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.834 ' HB2' HD13 ' A' ' 134' ' ' LEU . 48.6 m95 -80.57 150.61 29.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.78 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -99.47 129.55 45.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.76 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 74.8 mtm180 -70.07 127.05 31.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.134 0.492 . . . . 0.0 110.88 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.986 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.83 1.44 2.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.842 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.72 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.93 176.46 9.4 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-O 120.695 0.284 . . . . 0.0 110.893 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.45 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 20.2 m-85 -140.15 173.85 11.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.141 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.635 HG21 ' CD1' ' A' ' 139' ' ' LEU . 18.7 t -132.7 117.64 31.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.98 0.419 . . . . 0.0 110.883 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.424 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.38 110.96 16.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.26 -179.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 38.9 t0 -169.25 143.77 3.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.781 179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 mmt180 59.98 40.46 18.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.959 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 53.92 27.58 7.48 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.586 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.689 HG23 ' O ' ' A' ' 145' ' ' THR . 89.6 m -147.87 142.47 26.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.447 ' CD2' HG21 ' A' ' 154' ' ' VAL . 8.9 m-85 -91.1 109.94 21.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.186 178.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.73 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.4 m-85 -80.0 122.47 83.19 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.912 -179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -60.25 123.38 13.01 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.098 1.865 . . . . 0.0 112.502 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.913 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -105.67 125.32 50.85 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.028 -179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.834 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.2 mt -84.95 166.11 17.05 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.339 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.1 pt-20 -55.7 -29.93 60.26 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.629 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.447 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 52.4 p-10 -90.34 13.99 14.0 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.345 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.406 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.53 4.18 84.21 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.588 -0.815 . . . . 0.0 113.17 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.579 ' HB3' HD12 ' A' ' 134' ' ' LEU . 1.9 tpt180 -60.15 97.6 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.18 0.514 . . . . 0.0 110.487 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.73 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.68 115.29 22.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.892 -179.632 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 44.4 mt -105.29 98.05 7.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.51 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.438 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 24.2 mttt -70.34 -28.16 64.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.944 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -73.79 -22.35 59.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.603 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 54.2 mm-40 -101.54 25.08 8.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.667 -0.242 . . . . 0.0 111.497 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.55 162.82 53.44 Favored Glycine 0 CA--C 1.508 -0.378 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.603 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.689 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.5 156.02 42.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.856 0.36 . . . . 0.0 110.6 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.19 3.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.42 139.67 25.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.519 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -63.37 119.14 50.55 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.45 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 61.5 Cg_endo -75.8 105.08 2.01 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 121.98 1.787 . . . . 0.0 112.765 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.6 t -67.64 -12.4 60.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.194 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -79.98 -26.91 39.77 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 120.663 0.268 . . . . 0.0 111.568 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.87 159.55 46.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 112.121 0.415 . . . . 0.0 112.121 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 44.5 Cg_endo -70.74 173.66 11.52 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.06 1.84 . . . . 0.0 112.805 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' A' ' 130' ' ' PHE . 77.7 t -129.06 154.44 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.023 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.587 HD12 ' CD1' ' A' ' 133' ' ' LEU . 58.7 mt -112.81 98.36 7.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.514 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.2 t -82.66 135.1 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.476 -179.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.55 86.78 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.876 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.5 m95 -148.4 116.24 6.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.052 0.453 . . . . 0.0 111.471 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 5.1 tttt -106.81 -26.53 11.22 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.459 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -97.41 95.56 7.75 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.22 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.891 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.4 -20.86 46.53 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.114 -1.041 . . . . 0.0 112.108 178.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.41 -40.4 97.1 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 177.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.17 -33.28 67.57 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.634 -1.167 . . . . 0.0 109.621 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.913 HG23 HD11 ' A' ' 133' ' ' LEU . 53.1 mt -62.44 -51.86 67.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.678 178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.71 -30.21 55.3 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.11 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.425 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 10.6 mm-40 -68.99 -51.11 42.81 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.348 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.4 -52.03 67.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.836 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.986 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.59 -33.7 68.47 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.91 0.386 . . . . 0.0 110.383 179.458 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.82 -44.64 96.85 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.478 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -62.1 -39.63 93.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.914 0.388 . . . . 0.0 110.375 179.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.738 ' HA ' HD22 ' A' ' 174' ' ' LEU . 5.1 mp -66.17 -27.77 68.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.367 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.55 -19.42 60.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.667 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -100.86 -40.58 7.22 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.705 0.288 . . . . 0.0 111.633 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.738 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -70.37 157.31 90.29 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.124 -179.42 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' A' ' 178' ' ' VAL . 72.9 Cg_exo -48.9 128.78 19.75 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.744 2.296 . . . . 0.0 112.92 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.98 -38.54 67.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.552 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.703 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.4 -37.14 86.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.953 0.406 . . . . 0.0 110.327 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.619 ' HA ' HG22 ' A' ' 224' ' ' ILE . 44.9 t -61.45 -60.09 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.868 179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.6 pp -62.56 -24.01 67.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.518 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -72.95 -24.44 75.98 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.628 179.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.502 ' HB1' ' OD1' ' A' ' 202' ' ' ASN . . . -90.32 78.5 6.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 120.866 0.365 . . . . 0.0 110.668 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.26 137.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.616 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 7.0 p -80.27 -57.93 3.38 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.197 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -155.12 154.12 31.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.971 0.415 . . . . 0.0 111.145 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.464 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -106.06 136.84 38.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 12.6 m170 -108.22 123.27 48.51 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.724 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.406 ' CE2' ' HG3' ' A' ' 189' ' ' PRO . 55.1 t80 -77.67 107.82 10.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.769 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.9 mtmm -131.35 76.4 75.83 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.744 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.406 ' HG3' ' CE2' ' A' ' 187' ' ' TYR . 50.2 Cg_endo -69.59 162.67 41.06 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.336 2.024 . . . . 0.0 112.609 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 21.3 p -140.86 163.37 33.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 13.9 mtp85 -55.89 -25.89 44.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.122 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -100.57 -20.64 15.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.283 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -136.8 82.48 1.94 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.903 0.382 . . . . 0.0 111.18 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.71 -20.76 36.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.673 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 14.2 p30 -114.58 37.69 3.33 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 111.163 -179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 6.6 ttt85 -82.28 112.34 19.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.988 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 30.4 m -116.51 135.82 55.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.252 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -106.75 109.27 27.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.554 179.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.523 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.6 m -84.84 154.98 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.899 0.38 . . . . 0.0 111.654 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -114.5 101.36 9.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.957 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.436 ' HE3' HG21 ' A' ' 207' ' ' VAL . 7.8 tpp -53.87 149.33 8.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 111.596 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.502 ' OD1' ' HB1' ' A' ' 181' ' ' ALA . 11.5 p-10 -66.83 -20.08 65.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.041 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -76.76 -13.4 60.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.06 20.21 9.47 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -109.04 167.86 9.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.855 0.36 . . . . 0.0 110.782 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -122.68 117.02 24.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.743 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.523 ' HB ' HG22 ' A' ' 199' ' ' VAL . 9.3 t -113.85 160.39 13.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.991 0.424 . . . . 0.0 110.655 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 207' ' ' VAL . 78.1 p -121.43 144.33 48.74 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.762 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.414 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -158.32 -177.36 6.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.8 152.35 47.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.321 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.5 mt -66.42 -24.75 33.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.913 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.68 -29.8 51.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.695 0.283 . . . . 0.0 111.361 -179.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -134.16 36.07 3.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.221 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.672 ' CE1' HD11 ' A' ' 171' ' ' LEU . 41.3 t80 -56.88 -50.03 73.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.845 0.355 . . . . 0.0 111.051 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.48 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -62.16 -42.49 99.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.481 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -64.81 -42.26 95.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.039 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.414 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 45.6 mmtt -57.08 -53.66 55.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.346 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.48 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.3 mm? -75.97 -24.0 55.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.756 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.5 m -62.8 -32.97 74.26 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.023 0.44 . . . . 0.0 110.33 179.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.45 -5.89 39.84 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.627 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.406 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -95.0 100.74 5.95 Favored Pre-proline 0 N--CA 1.454 -0.259 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.649 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 37.7 Cg_endo -65.86 -25.85 52.47 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.131 1.887 . . . . 0.0 111.97 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -71.3 -41.68 69.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.933 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 178' ' ' VAL . 27.3 mt -72.07 -54.88 15.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.449 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -57.19 -29.28 63.56 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.131 178.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.08 -28.31 10.21 Favored 'General case' 0 C--N 1.339 0.124 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.465 178.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.436 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.59 -27.41 11.04 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.413 178.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.703 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 2.2 mt -78.67 -32.01 46.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.226 178.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -58.19 -28.72 65.06 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.222 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.26 -28.64 63.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.204 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -108.78 -55.08 2.44 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.005 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 233' ' ' LYS . 21.4 t -147.77 159.02 8.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.187 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.48 ' N ' HG12 ' A' ' 232' ' ' VAL . 9.3 mtmt . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.344 -0.836 . . . . 0.0 111.01 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.7 p -83.26 133.86 34.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.933 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.06 -174.93 0.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.81 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.841 ' HB2' HD13 ' A' ' 134' ' ' LEU . 45.5 m95 -103.58 149.24 25.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.973 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.16 134.24 45.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.466 ' HG2' HD23 ' A' ' 134' ' ' LEU . 13.9 mtm-85 -73.4 127.46 32.76 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.136 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.009 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.12 -1.34 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.928 179.595 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.728 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -160.83 176.55 11.35 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-O 120.683 0.278 . . . . 0.0 111.058 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.448 ' HB2' HG22 ' A' ' 154' ' ' VAL . 33.9 m-85 -138.62 173.05 12.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.503 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.651 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.6 t -133.88 120.17 35.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.896 0.379 . . . . 0.0 110.927 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.483 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.2 OUTLIER -80.08 109.77 14.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.977 -179.495 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.418 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.3 t0 -161.38 138.56 8.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.923 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.9 mmt180 58.39 42.73 20.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.09 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 54.11 28.75 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.625 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.712 HG23 ' O ' ' A' ' 145' ' ' THR . 94.9 m -146.57 141.79 27.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.906 0.384 . . . . 0.0 111.103 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.483 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 11.1 m-85 -90.23 110.15 21.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.255 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.697 ' HB2' HD21 ' A' ' 139' ' ' LEU . 13.2 m-30 -81.3 118.23 71.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.999 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.404 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 10.8 Cg_endo -56.73 124.28 15.88 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.131 1.887 . . . . 0.0 112.563 -179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.926 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.1 mt -106.24 125.35 50.89 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.117 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 118' ' ' TRP . 17.4 mt -81.67 167.98 18.6 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.058 179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.6 pt-20 -57.28 -30.78 64.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.463 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.454 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 7.1 p30 -90.6 13.87 14.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.398 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.503 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 79.71 5.61 89.33 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.641 -0.79 . . . . 0.0 113.121 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.589 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.2 OUTLIER -59.44 95.52 0.03 OUTLIER 'General case' 0 N--CA 1.457 -0.09 0 CA-C-N 117.392 0.596 . . . . 0.0 110.23 179.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.697 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -81.33 118.66 22.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.026 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.491 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.9 mm? -103.74 96.77 6.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.755 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.42 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 37.9 mttt -71.84 -26.57 62.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.89 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -80.94 -23.74 38.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.526 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -98.28 22.68 9.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.642 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.2 163.27 54.49 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.549 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.712 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.53 156.38 43.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.881 0.372 . . . . 0.0 110.586 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.02 26.12 3.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.42 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -143.57 139.67 29.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.576 -179.775 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -69.75 118.11 59.89 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.085 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.86 106.7 2.3 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 122.07 1.847 . . . . 0.0 112.501 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.2 t -67.13 -13.24 61.76 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.228 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -77.74 -27.23 50.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.658 0.266 . . . . 0.0 111.417 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.612 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.66 164.96 33.15 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 111.998 0.37 . . . . 0.0 111.998 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.612 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 67.6 Cg_endo -78.49 173.33 13.9 Favored 'Trans proline' 0 N--CA 1.457 -0.624 0 C-N-CA 122.051 1.834 . . . . 0.0 112.757 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.46 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.0 t -130.02 154.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.928 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.52 HD12 ' CD1' ' A' ' 133' ' ' LEU . 67.5 mt -112.51 97.59 6.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.65 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 57.6 t -82.55 134.57 26.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.409 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.09 87.62 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.709 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 69.6 m95 -147.57 110.25 4.69 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.941 0.401 . . . . 0.0 111.597 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 3.9 mtmp? -100.2 -25.91 14.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.507 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -98.43 95.39 7.3 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.288 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.915 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.44 -20.83 46.75 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.044 178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.4 -40.56 97.54 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.88 -34.56 71.73 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 114.627 -1.17 . . . . 0.0 109.474 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.926 ' CG2' HD11 ' A' ' 133' ' ' LEU . 62.1 mt -61.99 -51.97 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.278 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.722 178.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.408 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.57 -29.79 59.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.188 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 27.3 mm-40 -69.25 -51.8 33.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.173 0.511 . . . . 0.0 110.25 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.47 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.42 -52.77 64.24 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.026 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.009 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -58.1 -33.57 69.24 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.808 0.337 . . . . 0.0 110.356 179.366 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.35 -42.06 97.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.434 178.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -66.24 -38.48 87.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.913 0.387 . . . . 0.0 110.45 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.775 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.6 mp -64.81 -28.21 69.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.25 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.75 -19.23 61.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.634 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -102.82 -40.84 6.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.698 0.285 . . . . 0.0 111.679 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.775 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -68.91 157.29 89.4 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.132 -179.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.63 ' HB2' HG23 ' A' ' 178' ' ' VAL . 56.2 Cg_exo -49.85 129.79 25.27 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.696 2.264 . . . . 0.0 112.749 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.3 -38.89 66.45 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.654 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.05 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.05 0.452 . . . . 0.0 110.314 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 175' ' ' PRO . 54.4 t -60.31 -57.07 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.727 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.679 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.4 pp -68.09 -13.19 62.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.79 178.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -89.29 -14.68 59.92 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.369 178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -94.39 78.63 3.9 Favored 'General case' 0 CA--C 1.528 0.097 0 CA-C-N 116.918 0.359 . . . . 0.0 111.724 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -179.35 176.82 0.81 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.702 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 14.9 m -116.55 -44.96 2.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -167.51 151.82 6.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.902 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.607 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -105.13 135.35 43.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.407 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.416 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.7 m170 -108.42 114.41 28.23 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.909 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.429 ' CD2' ' HD3' ' A' ' 189' ' ' PRO . 41.3 t80 -65.85 111.03 3.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.832 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.7 mttm -132.02 76.96 72.63 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.429 ' HD3' ' CD2' ' A' ' 187' ' ' TYR . 53.5 Cg_endo -70.31 160.66 48.77 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.542 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 25.0 p -140.17 161.46 37.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.04 179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 12.1 mtp85 -54.73 -25.63 28.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.26 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.25 -21.82 14.8 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.247 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.448 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.7 m-85 -136.16 80.85 1.85 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.892 0.377 . . . . 0.0 111.045 -179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -57.28 -21.13 32.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.562 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -112.89 38.09 2.91 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 111.182 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.448 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 3.4 ttm180 -85.89 117.89 25.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.901 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.569 HG22 ' O ' ' A' ' 209' ' ' ALA . 35.8 m -120.0 138.7 49.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.8 mm -108.23 111.09 34.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.794 179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.607 HG12 HG12 ' A' ' 185' ' ' ILE . 2.9 m -86.53 152.89 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.911 0.386 . . . . 0.0 111.645 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -110.55 100.58 9.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.156 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.535 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.3 tpp -55.8 149.34 14.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.479 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.5 p-10 -67.51 -20.38 65.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.089 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -76.62 -13.54 60.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 105.18 20.15 10.0 Favored Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.491 -0.861 . . . . 0.0 112.781 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -112.24 156.54 22.2 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.899 0.38 . . . . 0.0 110.775 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -110.3 117.13 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.535 HG21 ' HE3' ' A' ' 201' ' ' MET . 41.2 t -114.04 159.18 14.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.648 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.48 ' N ' HG12 ' A' ' 207' ' ' VAL . 49.8 p -121.46 149.09 43.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.569 ' O ' HG22 ' A' ' 197' ' ' VAL . . . -167.22 149.37 5.99 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.918 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -95.79 146.47 24.51 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.688 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.476 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.8 mt -58.83 -28.03 36.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.118 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -32.12 71.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.506 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -134.24 35.97 3.23 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.152 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.455 ' CD1' HD23 ' A' ' 218' ' ' LEU . 11.6 t80 -54.95 -50.22 69.44 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.516 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.84 -48.78 80.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.809 0.337 . . . . 0.0 111.195 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -64.92 -32.81 74.7 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.155 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.409 ' CB ' ' HB1' ' A' ' 209' ' ' ALA . 1.9 mmpt? -61.67 -53.88 50.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.085 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.463 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.2 mm? -80.21 -23.67 40.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 30.4 t -63.29 -38.81 92.63 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.971 0.415 . . . . 0.0 110.687 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -64.77 -14.38 58.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.684 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -81.74 111.39 25.75 Favored Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.567 -0.083 . . . . 0.0 110.828 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.743 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 15.3 Cg_exo -68.58 -25.56 34.59 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 122.259 1.972 . . . . 0.0 112.518 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -78.56 -40.88 33.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.564 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.602 HG22 ' HA ' ' A' ' 178' ' ' VAL . 22.9 mt -70.07 -56.99 9.34 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.39 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.97 -29.04 62.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.212 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.743 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.17 -28.25 10.65 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.535 178.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.567 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.5 -27.7 11.37 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.132 0.491 . . . . 0.0 110.214 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.654 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.4 mt -76.26 -34.22 59.14 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.007 178.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -97.49 17.32 17.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.686 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.4 tpp180 54.64 24.66 5.67 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 120.734 0.302 . . . . 0.0 111.64 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 59.32 84.14 0.12 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.851 0.358 . . . . 0.0 111.043 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 10.2 p -89.72 150.41 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.033 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 11.5 tttp . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.872 -179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 2.6 m -108.48 83.42 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.84 0.352 . . . . 0.0 110.922 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 60.37 175.77 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.977 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.79 ' HB2' HD13 ' A' ' 134' ' ' LEU . 58.2 m95 -74.87 153.91 38.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.049 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 4.4 ptm180 -95.33 140.59 30.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.478 179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 11.4 mtm-85 -82.38 124.66 30.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.958 0.409 . . . . 0.0 110.561 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.988 HD11 HG22 ' A' ' 168' ' ' THR . 0.1 OUTLIER -127.75 0.71 3.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.986 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.691 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.26 177.02 8.64 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.925 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.432 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 18.9 m-85 -140.46 173.09 11.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.338 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 139' ' ' LEU . 24.7 t -132.44 120.31 42.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.985 0.421 . . . . 0.0 111.079 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.498 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.45 110.95 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.999 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.42 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 9.9 t70 -157.12 135.87 11.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 ttp180 58.05 43.96 20.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.03 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 54.46 29.22 10.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.428 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.698 HG23 ' O ' ' A' ' 145' ' ' THR . 85.0 m -144.01 144.04 31.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.908 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.498 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.0 m-85 -95.27 110.62 22.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.126 0.488 . . . . 0.0 111.048 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.716 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.1 m-30 -83.29 124.25 76.22 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.185 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.546 ' HB2' HD12 ' A' ' 140' ' ' LEU . 31.4 Cg_exo -59.34 127.21 23.14 Favored 'Trans proline' 0 C--N 1.354 0.862 0 C-N-CA 122.366 2.044 . . . . 0.0 112.82 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.994 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -109.44 124.78 51.6 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.817 179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' TRP . 20.6 mt -85.66 165.66 16.8 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.546 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.508 ' HA ' HD12 ' A' ' 121' ' ' ILE . 9.3 pt-20 -55.38 -30.71 60.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.594 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -89.71 14.19 12.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.422 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 77.44 3.59 82.91 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.572 -0.823 . . . . 0.0 113.157 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.603 ' HB3' HD12 ' A' ' 134' ' ' LEU . 19.4 tpp180 -61.04 97.15 0.06 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.167 0.483 . . . . 0.0 110.589 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -78.15 129.63 35.39 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.863 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.546 HD12 ' HB2' ' A' ' 132' ' ' PRO . 81.6 mt -108.06 92.38 4.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.756 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.444 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 21.2 mttp -72.64 -28.9 63.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.815 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.32 -21.08 42.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.472 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -101.64 28.02 5.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.505 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -76.31 159.42 50.2 Favored Glycine 0 CA--C 1.509 -0.34 0 C-N-CA 120.3 -0.953 . . . . 0.0 112.384 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.698 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.33 157.56 40.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.952 0.406 . . . . 0.0 110.827 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.19 25.67 3.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.135 179.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.4 OUTLIER -141.77 139.34 32.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.483 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.15 111.65 8.49 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.315 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.432 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 23.3 Cg_exo -63.65 100.41 0.28 Allowed 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 122.475 2.117 . . . . 0.0 112.196 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.4 t -65.61 -14.92 62.15 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.346 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -79.64 -27.29 40.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.534 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.3 161.86 55.01 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.9 -179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.534 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 56.9 Cg_endo -73.97 172.9 14.98 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 121.751 1.634 . . . . 0.0 112.539 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.417 HG21 ' CD2' ' A' ' 130' ' ' PHE . 76.5 t -129.81 154.92 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.133 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 57.5 mt -114.09 97.69 6.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.11 0.481 . . . . 0.0 110.492 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.429 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 75.9 t -82.68 133.81 28.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.459 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.45 85.53 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.809 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 68.6 m95 -147.7 115.46 6.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.966 0.413 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -106.19 -26.4 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.519 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -97.12 94.77 7.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.17 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.923 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.02 -21.26 45.0 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.164 -1.017 . . . . 0.0 112.096 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.06 -39.97 96.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.75 67.69 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.556 178.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.994 HG23 HD11 ' A' ' 133' ' ' LEU . 39.6 mt -61.99 -51.76 68.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.638 178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.418 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.62 -30.87 61.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.223 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 14.7 mm-40 -67.68 -50.77 56.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.172 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.446 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.77 -52.25 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.778 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.988 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.7 -33.55 68.5 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-O 120.951 0.405 . . . . 0.0 110.321 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.54 -43.2 97.78 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.37 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -64.14 -39.44 94.03 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.844 0.354 . . . . 0.0 110.285 178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.741 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.6 mp -66.14 -27.53 68.1 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.259 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.81 -19.87 60.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.61 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -100.36 -40.76 7.33 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.754 0.311 . . . . 0.0 111.483 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.741 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.61 156.82 90.99 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.964 -179.51 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.614 ' HB2' HG23 ' A' ' 178' ' ' VAL . 57.4 Cg_exo -49.78 129.52 24.3 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.643 2.229 . . . . 0.0 112.864 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.58 -39.6 67.95 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.574 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.678 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -62.34 -37.4 85.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.097 0.475 . . . . 0.0 110.536 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.678 ' HA ' HG22 ' A' ' 224' ' ' ILE . 52.5 t -61.33 -60.05 3.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.72 179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.667 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -61.86 -24.05 66.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.453 178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.585 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.26 -24.41 75.47 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.631 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.563 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -90.19 78.16 6.62 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.876 0.369 . . . . 0.0 110.768 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.8 ptp 178.59 138.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.554 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 1.4 m -80.2 -62.01 1.81 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.102 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.65 152.16 32.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.007 0.432 . . . . 0.0 111.041 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.542 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.23 133.88 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.197 179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.429 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 33.3 m170 -107.37 111.99 24.59 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.956 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -65.35 106.85 1.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.808 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -129.65 79.84 72.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.798 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.73 160.86 46.33 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.276 1.984 . . . . 0.0 112.355 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -138.56 162.58 34.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -54.75 -25.96 31.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.279 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -103.9 -18.7 14.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.515 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . 0.449 ' CD2' ' NH1' ' A' ' 196' ' ' ARG . 92.2 m-85 -136.6 83.44 2.0 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-O 120.905 0.383 . . . . 0.0 111.219 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.92 -20.58 38.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.544 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -114.13 38.46 3.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.449 ' NH1' ' CD2' ' A' ' 193' ' ' TYR . 0.0 OUTLIER -82.81 117.7 22.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.81 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 16.6 m -117.78 133.05 65.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.328 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.517 HD12 ' HB3' ' A' ' 208' ' ' SER . 25.2 mm -104.09 107.98 23.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.341 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.542 HG12 HG12 ' A' ' 185' ' ' ILE . 2.7 m -86.55 152.4 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.68 -178.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -110.93 100.77 9.42 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.013 179.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.42 ' HE3' HG21 ' A' ' 207' ' ' VAL . 10.2 tpp -54.81 149.5 11.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.012 0.434 . . . . 0.0 111.492 -179.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -65.95 -20.25 66.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.028 179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -75.03 -13.54 60.51 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.33 20.11 11.53 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.74 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.23 162.64 14.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.821 0.343 . . . . 0.0 110.666 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 58.3 tt0 -112.44 120.79 42.85 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.685 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 208' ' ' SER . 39.6 t -118.25 158.48 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.687 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.517 ' HB3' HD12 ' A' ' 198' ' ' ILE . 44.4 p -121.95 149.44 43.45 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.006 -179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.43 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.44 -178.15 6.44 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.812 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -127.63 149.76 50.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.119 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.465 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.5 mt -64.6 -23.85 34.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.01 -31.22 56.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.668 0.271 . . . . 0.0 111.445 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -134.25 35.98 3.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.1 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.427 ' CD1' HD23 ' A' ' 218' ' ' LEU . 13.0 t80 -55.75 -50.71 69.66 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.83 0.348 . . . . 0.0 111.032 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.57 -44.38 96.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.586 179.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.93 -41.46 97.63 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.182 179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.43 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 57.2 mmtt -56.24 -53.37 57.96 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.016 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.427 HD23 ' CD1' ' A' ' 214' ' ' PHE . 3.3 mm? -76.64 -23.19 53.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.814 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.9 t -61.59 -34.34 75.45 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.072 0.463 . . . . 0.0 110.332 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 14.8 m80 -71.83 -5.55 35.17 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.931 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -95.62 99.96 5.51 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.573 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 37.4 Cg_endo -65.93 -28.24 50.34 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.171 1.914 . . . . 0.0 111.98 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -67.86 -42.29 81.54 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.714 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.2 mt -72.13 -54.75 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.05 -29.43 60.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.281 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.573 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -51.81 -28.13 14.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.459 178.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.577 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.55 -27.87 12.16 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.27 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.678 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.6 mt -77.66 -33.21 53.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.095 178.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.8 19.86 11.89 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.649 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 4.6 tpm_? -85.95 -62.61 1.48 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.846 0.355 . . . . 0.0 110.828 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 24.5 t30 -100.97 72.39 1.48 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.718 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 11.6 p -167.84 136.83 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.035 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.9 tptt . . . . . 0 C--O 1.249 1.026 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.833 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -112.0 122.31 47.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.798 0.332 . . . . 0.0 110.973 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 60.97 172.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.024 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.798 ' HB2' HD13 ' A' ' 134' ' ' LEU . 51.1 m95 -68.35 155.3 40.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.0 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.68 127.93 44.77 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.66 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 55.5 mtm180 -69.36 126.62 30.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.06 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.017 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.48 -0.16 3.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.969 179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.662 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.06 176.68 9.84 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.963 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.449 ' CG ' ' HG3' ' A' ' 149' ' ' PRO . 18.9 m-85 -139.11 173.35 11.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.313 179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.63 HG21 ' HG ' ' A' ' 139' ' ' LEU . 21.4 t -132.59 118.23 34.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.915 0.388 . . . . 0.0 110.994 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.485 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.36 113.37 18.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.145 -179.375 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 33.3 t0 -164.5 138.87 5.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.798 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.43 42.16 18.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.108 0.48 . . . . 0.0 110.821 -179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 54.19 28.26 8.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.504 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.672 HG23 ' O ' ' A' ' 145' ' ' THR . 63.2 m -145.01 144.28 30.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.912 0.387 . . . . 0.0 111.101 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.485 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 7.6 m-85 -95.16 110.58 22.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.718 ' HB2' HD21 ' A' ' 139' ' ' LEU . 12.3 m-30 -81.97 125.74 76.73 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.142 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.571 ' HB2' HD12 ' A' ' 140' ' ' LEU . 36.5 Cg_exo -61.29 126.1 18.51 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.293 1.995 . . . . 0.0 112.72 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.949 HD11 HG23 ' A' ' 164' ' ' ILE . 1.0 OUTLIER -108.14 125.04 51.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.793 179.878 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.798 HD13 ' HB2' ' A' ' 118' ' ' TRP . 22.0 mt -85.27 166.13 16.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.384 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.487 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.9 pt-20 -55.44 -30.26 60.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.499 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.2 p-10 -91.29 15.48 11.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.382 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.412 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.56 3.63 83.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.6 -0.809 . . . . 0.0 113.228 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.548 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -58.06 96.73 0.03 OUTLIER 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.224 0.512 . . . . 0.0 110.581 179.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.718 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.0 OUTLIER -82.24 122.3 27.75 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.077 -179.592 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' A' ' 132' ' ' PRO . 16.2 mt -104.5 96.64 6.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.58 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -72.76 -26.4 61.53 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.119 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -81.73 -22.9 37.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.696 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -97.55 27.25 4.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.383 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.428 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -75.26 159.08 51.34 Favored Glycine 0 CA--C 1.507 -0.435 0 C-N-CA 120.466 -0.873 . . . . 0.0 112.801 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.672 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -126.01 155.54 41.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.3 -0.45 . . . . 0.0 110.684 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.63 29.6 2.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.756 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.93 139.55 22.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.607 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -65.43 119.05 56.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 60.1 Cg_endo -74.44 106.03 2.16 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.065 1.843 . . . . 0.0 112.68 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.4 t -67.28 -12.83 61.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.253 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.63 -27.23 40.96 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 120.653 0.263 . . . . 0.0 111.524 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -145.33 159.69 47.89 Favored Pre-proline 0 C--N 1.328 -0.36 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.506 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 44.2 Cg_endo -70.86 174.28 10.7 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.115 1.877 . . . . 0.0 112.845 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.448 HG21 ' CD2' ' A' ' 130' ' ' PHE . 75.9 t -129.79 154.61 40.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.065 179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.576 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.2 mt -113.75 97.76 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.016 0.436 . . . . 0.0 110.571 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.22 134.42 27.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.438 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.18 86.44 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.811 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.481 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.7 m95 -148.23 113.95 5.7 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.031 0.443 . . . . 0.0 111.465 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -104.74 -25.38 12.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.589 179.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -97.88 95.04 7.24 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.227 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.885 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.43 -21.0 47.35 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.012 178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.23 -40.15 96.64 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -72.46 -33.77 67.27 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.606 178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.949 HG23 HD11 ' A' ' 133' ' ' LEU . 56.2 mt -61.95 -51.9 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.709 178.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.28 -31.22 61.42 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.429 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 5.8 mm-40 -67.57 -50.52 58.06 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.247 179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.63 -52.21 66.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.856 179.57 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.017 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.07 -33.69 67.53 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.843 0.354 . . . . 0.0 110.439 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.38 -44.09 97.97 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.186 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.24 -38.21 88.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.839 0.352 . . . . 0.0 110.255 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.779 ' HA ' HD22 ' A' ' 174' ' ' LEU . 6.5 mp -67.74 -28.7 67.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.245 179.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.6 -22.36 60.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.399 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -97.6 -41.15 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.709 0.29 . . . . 0.0 111.385 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.779 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.04 156.42 92.03 Favored Pre-proline 0 CA--C 1.539 0.532 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.827 -179.681 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' A' ' 178' ' ' VAL . 67.9 Cg_exo -49.38 128.53 20.58 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.621 2.214 . . . . 0.0 112.792 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.14 -40.41 67.39 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.482 179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.684 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -61.9 -37.26 83.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.941 0.4 . . . . 0.0 110.526 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.648 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.4 t -61.03 -60.03 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.631 HD22 ' HB3' ' A' ' 171' ' ' LEU . 4.4 pp -62.15 -23.68 66.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.477 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.61 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -75.17 -22.59 76.05 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.978 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.435 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -90.84 78.32 6.1 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.871 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 177.85 132.33 0.07 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.653 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -58.29 4.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.023 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -158.14 153.33 25.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.062 0.458 . . . . 0.0 110.959 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.51 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -101.66 135.71 37.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.438 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.419 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 8.0 m170 -108.68 114.69 28.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.859 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -69.29 113.48 6.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.78 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -133.73 71.85 74.23 Favored Pre-proline 0 CA--C 1.533 0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.796 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.94 159.52 51.44 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.299 2.0 . . . . 0.0 112.513 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.4 p -139.59 161.21 38.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.101 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -52.93 -26.54 15.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.477 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -103.1 -21.46 13.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.27 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -132.79 76.81 1.71 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.972 0.415 . . . . 0.0 110.902 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.1 -21.68 23.69 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.652 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -113.55 39.55 2.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.884 0.374 . . . . 0.0 111.207 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -86.3 118.31 25.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.822 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 15.6 m -121.06 133.78 66.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.391 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 19.8 mm -106.42 109.27 27.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.39 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.51 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.73 152.18 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.97 0.414 . . . . 0.0 111.775 -178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -109.74 105.79 15.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.864 178.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.401 ' HE1' HD13 ' A' ' 224' ' ' ILE . 11.8 tpp -56.9 149.38 18.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.838 0.351 . . . . 0.0 111.348 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -58.33 -22.81 54.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.912 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -81.28 -2.34 48.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 99.12 -15.22 60.71 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.972 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -66.48 164.87 15.51 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.878 0.37 . . . . 0.0 111.049 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -119.61 121.38 39.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.675 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.477 HG12 ' N ' ' A' ' 208' ' ' SER . 35.7 t -119.48 159.15 20.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.984 0.421 . . . . 0.0 110.786 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.477 ' N ' HG12 ' A' ' 207' ' ' VAL . 98.4 p -121.85 149.32 43.54 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.021 -179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.418 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.83 -177.49 5.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.79 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -127.23 154.61 44.63 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.589 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.481 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.4 mt -69.76 -21.69 24.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.097 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -82.07 -30.38 31.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.784 0.326 . . . . 0.0 110.873 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -133.04 35.06 3.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 -179.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -57.68 -47.87 81.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.66 -47.23 87.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -63.22 -38.56 91.66 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.397 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 1.4 mmpt? -57.86 -53.31 59.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.528 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.442 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.3 mm? -81.73 -20.11 40.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.382 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 26.1 t -64.92 -37.74 88.65 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.022 0.439 . . . . 0.0 110.67 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -67.25 -10.68 53.13 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.065 -179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.2 OUTLIER -81.32 111.7 27.06 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 122.451 -0.156 . . . . 0.0 110.808 -179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.511 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 14.5 Cg_exo -68.94 -27.11 30.88 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.233 1.955 . . . . 0.0 112.389 -179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.56 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -79.71 -44.75 20.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.575 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.648 HG22 ' HA ' ' A' ' 178' ' ' VAL . 25.1 mt -64.19 -56.95 13.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.98 -28.74 58.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.422 178.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.29 -28.8 12.91 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.706 178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -52.19 -26.72 12.25 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-O 121.024 0.44 . . . . 0.0 110.397 178.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.684 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 6.1 mt -76.76 -33.44 58.08 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.967 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.52 -59.23 5.24 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.893 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.21 25.23 5.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.6 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -130.89 36.58 3.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 4.2 m -109.8 77.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.224 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.27 -0.871 . . . . 0.0 110.894 -179.98 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 81.5 p -154.29 -73.51 0.12 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.868 0.366 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -98.79 -178.17 3.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.941 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.83 ' HB2' HD13 ' A' ' 134' ' ' LEU . 49.3 m95 -99.18 150.73 21.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.887 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.89 130.83 50.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.593 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.8 mtm-85 -68.78 127.88 34.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.121 0.486 . . . . 0.0 111.118 -179.687 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.018 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.58 -0.2 2.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.007 179.605 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.65 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -163.5 176.82 9.37 Favored 'General case' 0 CA--C 1.523 -0.073 0 CA-C-O 120.655 0.265 . . . . 0.0 111.18 -179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.443 ' HB2' HG22 ' A' ' 154' ' ' VAL . 26.8 m-85 -138.74 173.65 11.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.431 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.627 HG21 ' HG ' ' A' ' 139' ' ' LEU . 17.1 t -133.24 117.74 29.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.9 0.381 . . . . 0.0 111.045 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.444 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.65 111.18 16.85 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.313 -179.382 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.439 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 41.2 t0 -169.34 144.5 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.709 179.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 59.37 40.31 21.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.874 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 53.96 29.08 9.44 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.65 179.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.697 HG23 ' O ' ' A' ' 145' ' ' THR . 85.2 m -150.11 142.19 24.0 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.904 0.383 . . . . 0.0 111.182 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.444 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.7 m-85 -90.32 109.5 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.149 178.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.728 ' HB2' HD21 ' A' ' 139' ' ' LEU . 16.2 m-85 -79.86 123.28 83.85 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.095 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.19 123.72 13.74 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.181 1.921 . . . . 0.0 112.458 -179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.926 HD11 HG23 ' A' ' 164' ' ' ILE . 1.1 mt -106.29 125.11 50.59 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.0 -179.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.83 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.6 mt -84.23 165.85 18.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.343 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.7 pt-20 -55.34 -30.45 60.29 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.48 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -91.3 15.1 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.276 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.425 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 77.36 7.13 86.95 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.292 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.595 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.55 95.63 0.04 OUTLIER 'General case' 0 C--O 1.234 0.248 0 CA-C-N 117.322 0.561 . . . . 0.0 110.32 179.765 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -84.64 112.55 20.55 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.711 -179.707 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 54.4 mt -104.48 98.36 8.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.44 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 26.9 mttt -69.59 -26.39 64.43 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.044 -179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -74.3 -24.1 59.18 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.623 -179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -100.19 24.81 8.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.509 -179.743 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -75.33 163.03 53.77 Favored Glycine 0 C--N 1.333 0.365 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.666 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.697 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -127.47 155.49 43.63 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.854 0.359 . . . . 0.0 110.639 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 28.15 3.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.854 179.344 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -146.73 140.03 25.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.591 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.55 117.5 44.91 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.009 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.47 106.28 2.19 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 122.065 1.844 . . . . 0.0 112.649 -179.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.9 t -67.71 -12.47 60.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.267 179.118 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -77.46 -27.26 52.03 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.716 0.293 . . . . 0.0 111.323 179.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.587 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.56 164.09 34.94 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.875 -179.245 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.587 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.6 Cg_endo -76.02 173.56 14.29 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 121.913 1.742 . . . . 0.0 112.659 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 123' ' ' TYR . 57.9 t -130.24 153.71 39.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.951 179.338 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.589 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.1 mt -113.25 97.57 6.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.102 0.477 . . . . 0.0 110.556 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.434 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 62.6 t -83.03 135.22 25.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.628 -0.715 . . . . 0.0 111.276 -179.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 60.52 86.83 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.626 179.882 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.494 ' CH2' HD11 ' A' ' 211' ' ' ILE . 72.9 m95 -149.14 111.52 4.71 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.966 0.412 . . . . 0.0 111.391 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -102.23 -26.08 13.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.566 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -97.85 95.09 7.28 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.397 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.897 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.17 -21.13 45.72 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.241 -0.98 . . . . 0.0 112.014 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.22 -40.34 97.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 177.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.82 -33.82 68.81 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.7 -1.136 . . . . 0.0 109.576 178.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.926 HG23 HD11 ' A' ' 133' ' ' LEU . 52.8 mt -61.85 -51.88 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.573 178.547 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.407 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.13 -27.99 49.36 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.383 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.43 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 29.5 mm-40 -72.08 -50.6 26.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.175 0.512 . . . . 0.0 110.356 179.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.15 -52.33 66.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.868 179.661 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.018 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.55 -33.95 68.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.837 0.351 . . . . 0.0 110.342 179.356 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.46 -43.05 97.81 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.594 -0.812 . . . . 0.0 111.283 178.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -63.89 -38.42 91.01 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.872 0.368 . . . . 0.0 110.162 178.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.763 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.3 mp -67.03 -28.32 68.12 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.22 179.64 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -73.86 -19.27 60.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.544 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -101.26 -41.29 6.76 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 111.505 -179.579 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.763 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.67 157.17 90.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.94 -179.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.586 ' HB2' HG23 ' A' ' 178' ' ' VAL . 74.9 Cg_exo -49.16 128.3 19.44 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.639 2.226 . . . . 0.0 112.747 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.67 -36.35 67.0 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.552 -179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.704 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -65.16 -36.81 85.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.26 179.473 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.586 HG23 ' HB2' ' A' ' 175' ' ' PRO . 41.7 t -61.45 -60.15 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.774 179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.667 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.6 pp -62.17 -24.82 67.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.349 178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.431 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.12 -23.75 77.06 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.727 179.13 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.594 ' HB1' ' ND2' ' A' ' 202' ' ' ASN . . . -90.43 78.34 6.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.833 0.349 . . . . 0.0 110.746 179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.7 ptp 178.25 130.93 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.673 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 20.7 m -70.15 -58.31 3.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.13 -179.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -157.12 154.02 28.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.015 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.487 HG12 HG12 ' A' ' 199' ' ' VAL . 5.0 mt -104.07 135.96 39.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.318 179.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.434 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 17.8 m170 -109.01 112.6 24.88 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.881 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -67.87 109.37 3.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.799 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.6 mttm -132.05 78.24 69.72 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.805 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.72 160.3 50.13 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.253 1.968 . . . . 0.0 112.417 -179.833 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.1 p -139.23 162.36 35.18 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.042 179.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.28 -25.87 36.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.142 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -102.11 -20.07 14.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.505 179.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -136.38 81.29 1.87 Allowed 'General case' 0 C--N 1.334 -0.081 0 CA-C-O 120.952 0.406 . . . . 0.0 111.093 -179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -56.66 -21.84 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.636 -179.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.94 39.07 2.8 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.758 0.313 . . . . 0.0 111.154 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -84.07 115.47 22.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.955 179.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.43 132.98 65.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.276 179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 23.8 mm -104.89 108.73 25.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.628 179.698 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.487 HG12 HG12 ' A' ' 185' ' ' ILE . 2.4 m -86.14 154.08 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.69 -178.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -111.96 102.15 10.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.221 179.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.507 ' HE3' HG21 ' A' ' 207' ' ' VAL . 6.6 tpp -56.71 149.26 18.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.213 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.594 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.4 p30 -67.22 -19.92 65.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.112 179.561 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -75.36 -13.43 60.41 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 104.19 20.22 10.69 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.797 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -112.0 161.41 16.48 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.854 0.359 . . . . 0.0 110.691 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.69 120.6 41.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.806 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.507 HG21 ' HE3' ' A' ' 201' ' ' MET . 27.4 t -118.2 158.8 18.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.031 0.444 . . . . 0.0 110.665 179.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.481 ' N ' HG12 ' A' ' 207' ' ' VAL . 52.4 p -121.88 149.14 43.81 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.157 -179.577 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.503 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -161.06 -177.62 6.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.709 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.401 ' O ' ' N ' ' A' ' 214' ' ' PHE . 0.9 OUTLIER -126.94 151.66 48.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.551 179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.494 HD11 ' CH2' ' A' ' 158' ' ' TRP . 11.0 mt -65.95 -22.74 30.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.145 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -29.17 36.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.872 0.368 . . . . 0.0 110.934 -179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.78 35.33 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.941 -179.05 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.401 ' N ' ' O ' ' A' ' 210' ' ' THR . 11.4 t80 -57.7 -51.43 69.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.962 -179.555 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.472 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.16 -47.2 86.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.996 179.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -62.82 -38.69 91.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.42 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.503 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 53.4 mmtt -58.11 -53.41 58.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.497 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.1 mm? -82.12 -19.79 39.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.555 -179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 25.2 t -64.56 -39.85 94.5 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.867 0.365 . . . . 0.0 110.626 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -68.0 -10.65 55.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.851 179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.415 ' CD1' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -77.21 111.63 18.1 Favored Pre-proline 0 CA--C 1.535 0.366 0 O-C-N 122.48 -0.138 . . . . 0.0 110.863 -179.859 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 14.5 Cg_exo -68.92 -27.57 30.41 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.251 1.967 . . . . 0.0 112.376 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.6 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -81.13 -45.48 16.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.523 -179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 178' ' ' VAL . 24.9 mt -62.85 -57.18 13.2 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 CA-C-O 121.01 0.434 . . . . 0.0 109.944 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.45 -29.05 57.96 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.356 178.396 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -50.9 -28.85 10.54 Favored 'General case' 0 CA--C 1.522 -0.101 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.721 178.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -51.95 -27.54 13.57 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 121.086 0.469 . . . . 0.0 110.203 178.347 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.704 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.3 mt -73.9 -34.81 64.54 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.92 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.66 15.47 26.84 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.883 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -67.65 -33.63 75.32 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.001 0.429 . . . . 0.0 110.365 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -140.25 -67.58 0.43 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.356 179.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 1.4 m -149.83 179.63 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.0 179.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.927 -179.997 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.5 p 68.98 -62.82 0.39 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 122.265 0.226 . . . . 0.0 111.394 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.11 -170.9 3.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.801 0.334 . . . . 0.0 110.953 -179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.791 ' HB2' HD13 ' A' ' 134' ' ' LEU . 57.7 m95 -77.61 151.8 34.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.934 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -98.98 132.48 44.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.533 179.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 8.3 mtm180 -70.01 126.36 29.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.849 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.011 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -127.96 1.14 3.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.796 179.469 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.657 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.0 176.37 9.43 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.798 0.332 . . . . 0.0 110.963 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.445 ' HB2' HG22 ' A' ' 154' ' ' VAL . 27.5 m-85 -139.23 173.64 11.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.334 179.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.646 HG21 ' CD1' ' A' ' 139' ' ' LEU . 16.3 t -133.98 117.74 26.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.899 0.381 . . . . 0.0 110.922 179.887 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.461 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.33 113.16 18.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.14 -179.303 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.435 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 34.8 t70 -167.19 139.54 3.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.854 179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 59.23 42.13 19.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.21 0.529 . . . . 0.0 110.954 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 54.12 27.64 7.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.686 179.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.702 HG23 ' O ' ' A' ' 145' ' ' THR . 86.5 m -145.89 141.59 27.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.992 0.425 . . . . 0.0 111.067 179.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.461 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 8.9 m-85 -91.93 109.44 20.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.228 179.035 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.727 ' HB2' HD21 ' A' ' 139' ' ' LEU . 10.5 m-30 -79.44 123.1 84.52 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.872 -179.625 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.86 123.86 14.14 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 122.19 1.927 . . . . 0.0 112.678 -179.663 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.963 HD11 HG23 ' A' ' 164' ' ' ILE . 1.2 mt -106.49 124.97 50.4 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.834 -179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.791 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.2 mt -85.18 166.27 16.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.378 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.456 ' HA ' HD12 ' A' ' 121' ' ' ILE . 6.3 pt-20 -55.64 -30.47 61.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.471 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -91.09 15.26 12.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.389 179.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.03 6.82 86.39 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.269 179.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.614 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -60.2 96.28 0.04 OUTLIER 'General case' 0 C--O 1.232 0.184 0 CA-C-N 117.3 0.55 . . . . 0.0 110.36 179.74 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.9 OUTLIER -86.71 113.46 22.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.88 -179.683 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 22.2 mt -105.62 98.42 8.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.604 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.431 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 16.5 mttt -69.07 -28.59 66.66 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.717 179.849 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -72.39 -27.01 62.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.139 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -95.4 22.17 7.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.454 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -74.17 162.11 54.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.539 179.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.702 ' O ' HG23 ' A' ' 129' ' ' THR . 1.6 t -127.85 155.71 43.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.901 0.382 . . . . 0.0 110.617 -179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.82 27.99 2.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.983 179.306 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.8 138.67 25.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.471 -179.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -66.47 117.95 49.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.063 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.425 ' HG3' ' CG ' ' A' ' 123' ' ' TYR . 66.9 Cg_endo -76.44 105.79 2.14 Favored 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.117 1.878 . . . . 0.0 112.657 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 10.8 t -67.72 -12.59 60.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.235 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -77.58 -26.94 51.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.673 0.273 . . . . 0.0 111.358 179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -142.5 163.93 36.04 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.823 -179.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.581 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 58.6 Cg_endo -75.87 172.77 15.66 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 121.891 1.727 . . . . 0.0 112.37 179.901 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.445 HG22 ' HB2' ' A' ' 123' ' ' TYR . 58.3 t -128.9 153.65 38.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.927 179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.618 HD12 ' CD1' ' A' ' 133' ' ' LEU . 58.3 mt -112.53 97.69 6.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.431 -179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.432 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.5 t -82.06 134.98 25.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.377 -179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 58.99 87.79 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.76 179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.555 ' CH2' HD11 ' A' ' 211' ' ' ILE . 70.9 m95 -148.67 111.11 4.7 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.016 0.436 . . . . 0.0 111.438 179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -101.21 -26.13 13.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.633 179.303 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -97.52 95.66 7.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.863 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.919 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.22 -21.23 46.43 Favored Glycine 0 C--N 1.334 0.443 0 C-N-CA 120.038 -1.077 . . . . 0.0 112.1 178.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -40.06 96.56 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 177.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.57 -34.21 69.74 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.572 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.963 HG23 HD11 ' A' ' 133' ' ' LEU . 38.0 mt -61.85 -52.01 65.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 CA-C-N 115.833 -0.622 . . . . 0.0 109.61 178.694 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -55.43 -28.98 57.65 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.24 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 6.1 mm-40 -70.89 -51.12 28.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.37 179.519 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.457 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.32 -52.29 66.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.885 179.671 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.011 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.91 -33.79 69.14 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.873 0.368 . . . . 0.0 110.312 179.255 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.81 97.7 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.564 -0.826 . . . . 0.0 111.305 178.758 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 38.3 mm-40 -66.07 -37.39 85.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.248 179.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.765 ' HA ' HD22 ' A' ' 174' ' ' LEU . 7.1 mp -68.01 -29.65 68.71 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.176 179.638 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -71.86 -19.07 62.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.689 -179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -101.39 -41.07 6.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.751 0.31 . . . . 0.0 111.541 -179.488 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.765 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -69.89 156.73 91.26 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.939 -179.593 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.654 ' HB2' HG23 ' A' ' 178' ' ' VAL . 53.2 Cg_exo -49.98 130.14 26.7 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.648 2.232 . . . . 0.0 112.792 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.19 -39.78 63.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.653 179.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.652 ' HB1' ' CB ' ' A' ' 227' ' ' ALA . . . -62.94 -38.45 91.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.084 0.469 . . . . 0.0 110.552 179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.766 ' HA ' HG22 ' A' ' 224' ' ' ILE . 58.1 t -59.6 -55.59 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.686 179.397 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.652 ' HB3' HD21 ' A' ' 174' ' ' LEU . 4.5 pp -68.74 -12.61 61.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.811 178.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -90.69 -14.16 58.58 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.44 178.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.665 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -94.68 78.83 3.74 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.975 0.387 . . . . 0.0 111.593 -179.64 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -178.9 -178.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.554 179.604 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 37.8 t -121.31 -44.36 2.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.059 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -167.66 151.09 6.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.109 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.469 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -105.49 136.15 40.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.317 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.432 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 11.5 m170 -109.57 122.52 47.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 -179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.503 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.4 OUTLIER -73.53 102.73 3.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.724 179.87 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -122.96 75.08 48.77 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.718 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.415 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 55.4 Cg_endo -70.62 161.04 47.45 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.335 2.023 . . . . 0.0 112.597 -179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 27.5 p -139.8 164.95 28.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.885 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -54.28 -27.86 38.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.405 179.907 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -104.28 -16.59 15.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.65 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -135.32 76.62 1.63 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.884 0.373 . . . . 0.0 111.164 -179.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -57.3 -21.28 33.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.711 179.977 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -112.76 38.37 2.81 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 17.0 ttt180 -85.77 117.8 24.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.008 179.878 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 26.9 m -119.88 133.67 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.212 -179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . . . . . . . . . 21.1 mm -104.53 110.58 31.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.586 179.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.497 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.3 m -84.99 156.26 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 0.0 111.686 -179.02 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -112.77 106.98 15.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.411 179.249 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.17 149.23 20.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.87 0.366 . . . . 0.0 111.213 -179.573 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 39.6 p30 -67.29 -21.57 65.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.014 179.465 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.433 ' HB3' ' CE2' ' A' ' 205' ' ' TYR . 9.9 m-20 -77.21 -13.08 60.0 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.19 20.35 9.28 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.617 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.433 ' CE2' ' HB3' ' A' ' 203' ' ' ASP . 32.9 m-85 -106.52 173.38 6.35 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.656 179.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -127.78 119.73 26.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.891 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.497 ' HB ' HG22 ' A' ' 199' ' ' VAL . 18.6 t -116.77 159.36 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.701 179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.476 ' N ' HG12 ' A' ' 207' ' ' VAL . 94.3 p -119.91 149.11 42.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.895 -179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.413 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -162.23 -179.11 6.8 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.808 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.402 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.2 p -129.93 150.01 51.41 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.314 179.641 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.555 HD11 ' CH2' ' A' ' 158' ' ' TRP . 13.3 mt -63.27 -24.29 35.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.156 179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -35.96 64.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.645 0.26 . . . . 0.0 111.553 -179.486 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -131.95 36.15 3.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.838 0.351 . . . . 0.0 111.093 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.456 ' CD1' HD23 ' A' ' 218' ' ' LEU . 15.2 t80 -54.84 -51.71 65.03 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.265 -179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.51 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -59.3 -43.01 92.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.7 179.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.44 -38.38 87.25 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.144 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.418 ' O ' ' CE1' ' A' ' 220' ' ' HIS . 24.1 mmtm -58.94 -53.67 55.82 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.133 179.614 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.523 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.1 mm? -78.35 -22.12 48.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.039 179.741 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 11.6 t -60.13 -47.98 83.63 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.227 -179.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . 0.418 ' CE1' ' O ' ' A' ' 217' ' ' LYS . 1.5 p-80 -62.57 -15.5 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.412 ' CG ' HG13 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -71.03 110.59 7.54 Favored Pre-proline 0 CA--C 1.534 0.348 0 N-CA-C 110.447 -0.205 . . . . 0.0 110.447 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.786 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 13.2 Cg_exo -69.98 -24.23 28.92 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.435 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -82.68 -40.84 20.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.596 -0.274 . . . . 0.0 111.613 -179.342 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 178' ' ' VAL . 14.2 mt -69.72 -58.57 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.222 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.32 -29.28 57.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.232 178.173 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.786 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.46 -28.45 20.26 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.506 178.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.652 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.61 -27.6 11.76 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.377 178.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.647 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 4.7 mt -79.53 -31.9 42.17 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.23 178.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.45 17.9 23.03 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.672 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -76.48 -32.51 58.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.893 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -69.62 -37.34 76.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.788 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.7 m -89.38 153.58 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.065 -179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 17.3 mttt . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.189 -0.91 . . . . 0.0 110.948 -179.947 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.1 t -95.51 128.53 42.44 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.83 0.348 . . . . 0.0 110.832 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -118.3 -179.04 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.946 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.8 ' HB2' HD13 ' A' ' 134' ' ' LEU . 39.4 m95 -83.85 158.05 21.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.932 179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.36 130.06 53.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.465 179.728 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.401 ' HG2' ' CD2' ' A' ' 134' ' ' LEU . 3.5 mtm180 -69.77 124.84 25.03 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.781 179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.999 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -129.0 0.79 2.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.891 179.639 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.669 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -165.5 176.79 7.9 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-O 120.582 0.229 . . . . 0.0 110.869 179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.449 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 24.2 m-85 -140.47 173.33 11.61 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.413 179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.604 HG21 ' CD1' ' A' ' 139' ' ' LEU . 22.8 t -132.29 119.69 40.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.86 0.362 . . . . 0.0 111.116 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.486 ' CE2' ' CE2' ' A' ' 130' ' ' PHE . 0.1 OUTLIER -80.37 111.03 16.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.965 -179.526 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.423 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 43.8 t0 -156.74 134.74 11.1 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.796 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.4 mmt85 58.52 44.21 18.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.058 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 54.74 27.59 9.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.552 179.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.699 HG23 ' O ' ' A' ' 145' ' ' THR . 87.0 m -142.12 144.0 33.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.842 0.353 . . . . 0.0 110.948 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.486 ' CE2' ' CE2' ' A' ' 125' ' ' TYR . 6.4 m-85 -95.31 110.43 22.44 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.039 0.447 . . . . 0.0 111.026 179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HB2' HD21 ' A' ' 139' ' ' LEU . 9.7 m-30 -82.81 125.34 75.7 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.907 179.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 35.9 Cg_exo -60.23 127.51 23.3 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.218 1.946 . . . . 0.0 112.709 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 1.0 HD11 HG23 ' A' ' 164' ' ' ILE . 0.9 OUTLIER -110.22 124.75 52.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.639 179.76 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.8 HD13 ' HB2' ' A' ' 118' ' ' TRP . 19.1 mt -86.37 165.85 16.05 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.41 -179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.441 ' HA ' HD12 ' A' ' 121' ' ' ILE . 8.8 pt-20 -55.12 -30.79 60.48 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.576 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . . . . . . . . . 14.4 p-10 -89.25 12.86 14.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.405 ' HA3' ' HA ' ' A' ' 165' ' ' ALA . . . 78.6 3.45 86.78 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.59 -0.814 . . . . 0.0 113.081 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.59 ' HB3' HD12 ' A' ' 134' ' ' LEU . 2.0 tpt180 -60.29 97.41 0.05 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.222 0.511 . . . . 0.0 110.436 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.45 125.87 30.48 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 -179.496 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.8 mm? -104.0 92.64 4.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.586 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.436 ' HA ' ' CG ' ' A' ' 131' ' ' PHE . 11.3 mttm -71.69 -28.55 63.79 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.858 0.361 . . . . 0.0 110.696 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -81.27 -22.9 38.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.405 179.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -97.27 24.42 6.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.524 -179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -73.03 159.22 53.46 Favored Glycine 0 CA--C 1.507 -0.415 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.272 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.699 ' O ' HG23 ' A' ' 129' ' ' THR . 1.7 t -128.93 157.77 40.67 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.911 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.66 26.22 3.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.961 179.598 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.444 HG22 ' OG1' ' A' ' 145' ' ' THR . 0.5 OUTLIER -142.41 139.89 31.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.498 179.958 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.7 111.67 8.95 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.307 -179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.449 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 22.3 Cg_exo -64.06 100.59 0.31 Allowed 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.386 2.058 . . . . 0.0 112.146 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t -65.75 -14.76 61.95 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.447 179.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -79.8 -27.27 40.33 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -139.5 162.91 48.8 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.934 -179.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 57.6 Cg_endo -75.13 174.36 12.93 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 121.761 1.641 . . . . 0.0 112.64 -179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.405 HG21 ' CD2' ' A' ' 130' ' ' PHE . 73.5 t -130.78 155.46 41.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.087 179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.562 HD12 ' CD1' ' A' ' 133' ' ' LEU . 62.3 mt -115.0 97.51 6.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.114 0.483 . . . . 0.0 110.601 -179.77 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 66.2 t -83.2 133.95 27.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.33 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 61.88 84.96 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.748 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.484 ' CH2' HD11 ' A' ' 211' ' ' ILE . 69.4 m95 -147.36 111.94 5.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.054 0.454 . . . . 0.0 111.508 179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.7 mttt -102.13 -27.08 13.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.508 179.167 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -96.73 95.67 8.07 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.227 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.911 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.39 -21.06 47.24 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 120.112 -1.042 . . . . 0.0 112.037 178.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -40.62 98.17 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 177.737 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.78 -34.48 71.85 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.491 178.417 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 1.0 HG23 HD11 ' A' ' 133' ' ' LEU . 42.1 mt -61.95 -51.8 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.541 178.528 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.405 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.2 -29.62 58.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.264 179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.424 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 16.3 mm-40 -70.14 -51.78 28.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.3 179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.458 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -58.56 -52.54 65.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.044 179.917 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.999 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.86 -33.55 68.8 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.858 0.361 . . . . 0.0 110.311 179.324 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.55 -42.36 97.67 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.205 178.753 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.6 mm100 -65.79 -38.36 88.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.809 0.338 . . . . 0.0 110.311 179.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.817 ' HA ' HD22 ' A' ' 174' ' ' LEU . 8.0 mp -66.17 -27.22 67.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.397 179.562 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.43 -20.29 60.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.523 179.948 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -101.41 -41.11 6.78 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.76 0.314 . . . . 0.0 111.466 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.817 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -68.57 156.94 89.64 Favored Pre-proline 0 CA--C 1.538 0.519 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.126 -179.615 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.577 ' HB2' HG23 ' A' ' 178' ' ' VAL . 54.2 Cg_exo -50.15 124.93 13.75 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.64 2.227 . . . . 0.0 112.679 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.09 -38.42 65.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.591 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.724 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -62.5 -38.45 89.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.045 0.45 . . . . 0.0 110.449 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.668 ' HA ' HG22 ' A' ' 224' ' ' ILE . 50.5 t -61.31 -60.21 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.866 179.555 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.794 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -62.07 -23.5 66.54 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.473 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.23 -24.87 74.59 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.588 178.798 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -89.18 78.37 7.35 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 120.865 0.364 . . . . 0.0 110.866 179.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.0 ptp 178.29 134.44 0.08 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.498 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 -54.16 7.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.109 -179.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -159.53 153.68 23.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.985 0.421 . . . . 0.0 111.102 -179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.593 HG12 HG12 ' A' ' 199' ' ' VAL . 4.9 mt -105.05 135.09 44.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.149 179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.452 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 14.3 m170 -109.47 119.57 39.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.507 -179.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -68.31 112.24 5.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.781 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.409 ' HD2' ' HB3' ' A' ' 186' ' ' HIS . 1.1 mptp? -135.85 79.72 44.88 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.85 163.46 38.81 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.279 1.986 . . . . 0.0 112.575 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.0 p -138.73 163.45 32.12 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.957 179.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 5.8 ptt180 -53.54 -27.07 23.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.509 -179.912 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -106.63 -16.47 14.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.656 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -134.0 79.78 1.83 Allowed 'General case' 0 C--N 1.334 -0.093 0 CA-C-O 120.946 0.403 . . . . 0.0 111.009 -179.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -58.58 -19.93 42.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.612 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -114.11 36.52 3.67 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.74 0.305 . . . . 0.0 111.161 -179.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.8 116.36 22.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.898 0.38 . . . . 0.0 110.776 179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 23.7 m -118.08 133.8 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.402 HG12 ' HD3' ' A' ' 188' ' ' LYS . 33.2 mm -106.01 110.2 30.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.74 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.594 HG22 ' HB ' ' A' ' 207' ' ' VAL . 2.8 m -84.57 157.02 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.599 -179.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -112.53 107.39 16.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.241 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . 0.493 ' HE1' HG21 ' A' ' 207' ' ' VAL . 0.0 OUTLIER -56.25 149.29 16.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.947 0.403 . . . . 0.0 111.309 -179.491 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -60.58 -24.57 65.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.803 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -85.95 7.07 25.71 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 96.35 -16.53 60.91 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.91 -179.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -62.51 177.1 0.55 Allowed 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.934 0.367 . . . . 0.0 110.792 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -140.88 115.23 9.36 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.594 ' HB ' HG22 ' A' ' 199' ' ' VAL . 21.7 t -106.98 157.47 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.57 179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 207' ' ' VAL . 83.3 p -121.93 142.78 49.94 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.123 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.56 -177.27 6.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.85 179.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -126.48 149.06 49.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.476 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.484 HD11 ' CH2' ' A' ' 158' ' ' TRP . 12.3 mt -61.21 -23.85 31.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.378 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -33.68 59.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.756 0.312 . . . . 0.0 111.172 -179.3 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -132.4 36.19 3.61 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.008 -178.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.423 ' O ' HD23 ' A' ' 218' ' ' LEU . 11.9 t80 -58.12 -39.31 78.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.242 -179.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.482 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -69.69 -48.79 58.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.186 -179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -67.29 -34.17 76.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.171 0.51 . . . . 0.0 110.106 179.312 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.26 -53.32 56.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.392 179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.428 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.4 mm? -79.31 -22.9 43.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.076 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 3.4 m -64.32 -39.12 93.27 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.928 0.394 . . . . 0.0 110.631 179.814 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -62.19 -16.3 52.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.673 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.97 111.58 13.02 Favored Pre-proline 0 CA--C 1.534 0.36 0 O-C-N 122.512 -0.117 . . . . 0.0 110.844 -179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 16.0 Cg_exo -67.98 -27.31 36.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.255 1.97 . . . . 0.0 112.381 -179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.583 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -80.14 -45.56 17.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.463 -179.674 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.668 HG22 ' HA ' ' A' ' 178' ' ' VAL . 34.6 mt -63.82 -56.28 17.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.066 0.46 . . . . 0.0 109.813 179.446 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . 0.43 ' HA ' HG22 ' A' ' 178' ' ' VAL . . . -56.35 -28.3 58.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.457 178.535 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -51.2 -29.26 13.49 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.65 178.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.497 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.98 -27.33 12.99 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 121.041 0.448 . . . . 0.0 110.347 178.476 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.724 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 3.3 mt -76.99 -32.49 57.25 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.06 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.17 -31.06 65.59 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.879 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -72.5 -33.53 66.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.942 -179.899 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -70.79 81.87 0.63 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.83 -179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.6 t -116.38 117.1 54.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.141 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.904 179.989 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.208 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 3.0 m -93.77 85.9 4.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 110.922 -179.965 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -124.84 174.99 7.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 -179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.841 ' HB2' HD13 ' A' ' 134' ' ' LEU . 44.9 m95 -90.64 150.46 21.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.934 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 11.3 ttt85 -101.49 132.2 47.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.673 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.435 ' HG2' HD23 ' A' ' 134' ' ' LEU . 72.5 mtm180 -71.49 127.67 33.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 -179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 1.012 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.22 -1.34 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.875 179.423 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.63 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -162.3 177.06 9.94 Favored 'General case' 0 CA--C 1.522 -0.115 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.025 179.965 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.435 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 23.5 m-85 -139.45 173.95 11.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.387 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.655 HG21 ' HG ' ' A' ' 139' ' ' LEU . 16.7 t -132.42 118.55 35.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.997 0.427 . . . . 0.0 110.947 179.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.45 109.6 15.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.177 -179.469 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.415 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 14.9 t70 -169.2 144.88 3.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.801 179.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 59.74 39.65 20.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.36 0.6 . . . . 0.0 110.804 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 53.92 29.2 9.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.506 179.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 145' ' ' THR . 90.8 m -150.59 143.0 24.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.909 0.385 . . . . 0.0 111.294 -179.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.431 ' CD2' HG21 ' A' ' 154' ' ' VAL . 7.1 m-85 -90.71 110.45 21.63 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.162 178.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.734 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.8 m-85 -80.47 118.55 72.92 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.04 -179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.409 ' HG2' ' HB2' ' A' ' 140' ' ' LEU . 11.2 Cg_endo -57.44 121.23 9.68 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.023 1.816 . . . . 0.0 112.422 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.901 HD11 HG23 ' A' ' 164' ' ' ILE . 1.4 mt -102.57 125.36 49.27 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.086 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.841 HD13 ' HB2' ' A' ' 118' ' ' TRP . 18.7 mt -82.98 165.48 19.63 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.287 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.516 ' HA ' HD12 ' A' ' 121' ' ' ILE . 7.0 pt-20 -56.03 -30.38 61.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.677 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.445 ' ND2' ' CE2' ' A' ' 118' ' ' TRP . 53.0 p-10 -89.89 13.92 13.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.463 179.877 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.4 3.93 86.55 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.585 -0.817 . . . . 0.0 113.171 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.586 ' HB3' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -61.65 97.34 0.07 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 121.13 0.491 . . . . 0.0 110.429 179.649 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.734 HD21 ' HB2' ' A' ' 131' ' ' PHE . 1.1 tt -80.42 121.93 26.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.033 -179.472 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 140' ' ' LEU . 3.2 mm? -104.33 96.6 6.74 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.586 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 5.0 mttt -72.71 -25.24 61.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.203 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -84.62 -20.86 30.71 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.737 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.15 23.35 10.1 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 -179.698 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -72.19 163.8 54.5 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.615 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.705 ' O ' HG23 ' A' ' 129' ' ' THR . 1.8 t -126.68 155.28 42.88 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.825 0.345 . . . . 0.0 110.533 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.39 27.12 3.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.003 179.589 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -144.29 139.06 28.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.43 -179.774 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -62.95 110.42 3.46 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.102 -179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.435 ' HG2' ' CG ' ' A' ' 123' ' ' TYR . 21.8 Cg_exo -64.54 98.05 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.482 2.122 . . . . 0.0 112.287 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.5 t -65.79 -14.49 61.47 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.339 179.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -80.59 -27.36 37.43 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.634 0.254 . . . . 0.0 111.677 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -140.43 160.34 59.86 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.866 0.365 . . . . 0.0 111.936 -179.178 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.511 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 55.7 Cg_endo -72.42 173.02 13.84 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 121.778 1.652 . . . . 0.0 112.668 -179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.431 HG21 ' CD2' ' A' ' 130' ' ' PHE . 75.9 t -129.62 154.22 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.157 179.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.609 HD12 ' CD1' ' A' ' 133' ' ' LEU . 59.2 mt -112.92 97.96 6.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.094 0.473 . . . . 0.0 110.551 -179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 61.8 t -82.36 135.04 25.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.489 -179.445 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.2 87.07 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.859 179.784 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.477 ' CD1' ' HB3' ' A' ' 155' ' ' LEU . 70.3 m95 -148.22 114.9 6.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.082 0.468 . . . . 0.0 111.546 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -105.39 -27.04 11.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.316 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.01 95.49 7.84 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.116 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.888 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.43 -20.84 46.65 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.187 -1.006 . . . . 0.0 112.014 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -63.32 -41.06 98.88 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 177.788 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -70.72 -34.03 71.47 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.463 178.383 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.901 HG23 HD11 ' A' ' 133' ' ' LEU . 55.3 mt -62.01 -52.08 64.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.559 178.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -54.53 -30.93 55.26 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.193 179.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.423 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 2.3 mm-40 -68.3 -51.0 49.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.223 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.445 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.0 -52.05 67.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.87 179.53 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 1.012 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.57 -33.73 68.47 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.877 0.37 . . . . 0.0 110.359 179.393 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.51 -43.65 97.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.246 178.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 25.0 mm100 -63.55 -39.46 94.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.885 0.374 . . . . 0.0 110.261 178.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.751 ' HA ' HD22 ' A' ' 174' ' ' LEU . 8.3 mp -66.93 -27.49 67.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.416 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -74.92 -22.25 58.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.575 -179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -96.94 -41.19 8.53 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.773 0.32 . . . . 0.0 111.506 -179.756 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.751 HD22 ' HA ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -71.09 155.55 93.08 Favored Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.959 -179.614 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.611 ' CB ' HD11 ' A' ' 228' ' ' LEU . 61.9 Cg_exo -49.89 129.82 25.5 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.632 2.222 . . . . 0.0 112.791 -179.756 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.43 -37.75 68.1 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.408 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.677 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -63.93 -37.01 85.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.063 0.459 . . . . 0.0 110.4 179.576 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.759 ' HA ' HG22 ' A' ' 224' ' ' ILE . 42.2 t -61.66 -60.2 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.604 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.669 HD23 ' CD2' ' A' ' 174' ' ' LEU . 4.6 pp -61.55 -24.49 66.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.392 178.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.47 ' N ' HD12 ' A' ' 179' ' ' LEU . . . -73.91 -23.5 76.23 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.872 179.221 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.783 ' HB3' HG23 ' A' ' 224' ' ' ILE . . . -85.99 78.29 9.48 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-O 120.972 0.415 . . . . 0.0 110.865 179.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 9.2 ptp 178.39 163.65 0.72 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.372 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 49.9 m -103.83 -51.9 3.08 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.802 0.334 . . . . 0.0 111.124 -179.771 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -160.41 151.22 18.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.983 0.42 . . . . 0.0 110.943 -179.765 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.429 HG12 HG12 ' A' ' 199' ' ' VAL . 4.7 mt -104.73 135.9 40.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.092 179.528 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.449 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 7.5 m170 -109.52 125.25 52.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.048 -179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.45 ' CZ ' ' HG3' ' A' ' 189' ' ' PRO . 14.0 t80 -75.49 107.37 7.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.526 179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 5.4 mttt -133.24 70.83 77.42 Favored Pre-proline 0 CA--C 1.532 0.261 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.959 -179.783 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.45 ' HG3' ' CZ ' ' A' ' 187' ' ' TYR . 20.5 Cg_exo -65.82 162.75 33.45 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.339 2.026 . . . . 0.0 112.252 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 30.9 p -135.88 164.13 28.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.853 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -52.44 -26.05 11.69 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.445 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -105.35 -20.21 13.56 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.416 179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -129.41 82.05 2.06 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.982 0.42 . . . . 0.0 111.09 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -59.55 -16.57 25.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.932 -0.577 . . . . 0.0 112.045 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -121.1 37.22 4.38 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.645 0.26 . . . . 0.0 111.233 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.781 ' NH2' HG23 ' A' ' 210' ' ' THR . 3.8 ttm-85 -81.04 119.86 24.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.719 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 14.9 m -119.41 135.14 60.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.503 -179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 208' ' ' SER . 22.6 mm -105.0 110.78 31.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.483 179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 185' ' ' ILE . 2.1 m -89.66 150.71 3.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.63 -178.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -109.19 108.9 19.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.236 179.072 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.48 149.31 10.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.469 -179.465 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -64.76 -22.52 67.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.939 179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -77.67 -13.17 59.98 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 179.937 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 106.25 20.35 9.24 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.704 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -103.51 172.49 6.78 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.829 0.347 . . . . 0.0 110.863 179.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -124.36 120.05 31.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.915 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.457 HG12 ' N ' ' A' ' 208' ' ' SER . 13.9 t -121.8 160.14 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.581 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.457 ' N ' HG12 ' A' ' 207' ' ' VAL . 56.9 p -121.63 148.89 43.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.926 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.429 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -160.37 -179.26 7.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.72 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.781 HG23 ' NH2' ' A' ' 196' ' ' ARG . 0.9 OUTLIER -125.59 151.52 46.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.359 179.781 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.459 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.1 mt -66.02 -25.05 35.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.885 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 2.1 ptm180 -79.14 -28.24 42.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.626 0.251 . . . . 0.0 111.403 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 18.0 mt-30 -134.05 35.77 3.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.723 0.297 . . . . 0.0 111.168 -179.762 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -57.89 -51.72 68.44 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.854 0.359 . . . . 0.0 110.923 -179.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . 0.484 ' HB1' ' HB2' ' A' ' 174' ' ' LEU . . . -60.99 -42.01 97.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.511 179.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -64.95 -43.05 93.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.152 179.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.429 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 16.1 mmtm -55.03 -52.64 62.52 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.083 179.389 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.51 HD12 ' CD1' ' A' ' 224' ' ' ILE . 3.5 mm? -77.39 -22.84 51.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.753 179.343 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 21.6 t -60.55 -35.47 76.11 Favored 'General case' 0 CA--C 1.521 -0.14 0 CA-C-O 121.092 0.472 . . . . 0.0 110.406 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -72.06 -4.94 31.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.007 179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.1 99.4 5.95 Favored Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.264 -0.273 . . . . 0.0 110.264 179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . 0.522 ' O ' ' HB2' ' A' ' 226' ' ' ALA . 37.4 Cg_endo -66.07 -27.07 50.0 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.156 1.904 . . . . 0.0 111.911 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.415 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -67.27 -45.12 77.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.9 179.824 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.783 HG23 ' HB3' ' A' ' 181' ' ' ALA . 38.3 mt -70.28 -53.51 22.78 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.388 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.636 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -56.1 -29.53 60.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.315 178.376 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.522 ' HB2' ' O ' ' A' ' 222' ' ' PRO . . . -52.24 -27.69 15.81 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.606 178.696 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.59 ' CB ' ' HB1' ' A' ' 177' ' ' ALA . . . -51.65 -27.75 12.41 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-O 121.134 0.493 . . . . 0.0 110.321 178.377 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.677 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 6.1 mt -78.54 -32.77 48.05 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.07 178.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -94.34 20.11 8.66 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.563 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -96.79 28.26 3.55 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.74 0.305 . . . . 0.0 111.244 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -121.12 37.91 4.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.917 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 20.2 t -146.73 139.46 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.099 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 2.9 mtmp? . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.866 179.984 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.4 m -140.28 31.91 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.0 110.915 179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.99 -175.04 4.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.871 -179.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' TRP . . . . . 0.844 ' HB2' HD13 ' A' ' 134' ' ' LEU . 43.3 m95 -104.89 149.51 25.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.822 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? -101.28 132.17 46.94 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.1 mtt85 -71.29 127.29 32.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.999 HD11 HG22 ' A' ' 168' ' ' THR . 0.0 OUTLIER -128.72 1.48 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.792 179.668 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.698 ' HB3' HG23 ' A' ' 168' ' ' THR . . . -164.12 176.92 8.83 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-O 120.682 0.277 . . . . 0.0 110.889 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.421 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 21.0 m-85 -139.82 173.43 11.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.226 179.79 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.68 HG21 ' HG ' ' A' ' 139' ' ' LEU . 18.7 t -132.92 118.58 33.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.997 0.427 . . . . 0.0 111.309 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.57 111.25 16.82 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.921 -179.784 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.43 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 18.9 t70 -169.09 145.4 3.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 58.79 40.86 22.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.887 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 54.1 30.62 12.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.518 179.71 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 145' ' ' THR . 41.6 m -152.0 146.42 25.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.897 0.379 . . . . 0.0 111.424 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.03 109.18 20.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.657 179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.713 ' HB2' HD21 ' A' ' 139' ' ' LEU . 18.0 m-85 -80.68 128.75 70.93 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.501 -179.563 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' HA2' ' A' ' 144' ' ' GLY . 23.1 Cg_exo -64.16 125.33 14.98 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.162 1.908 . . . . 0.0 112.326 179.805 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.921 HD11 ' CG2' ' A' ' 164' ' ' ILE . 1.0 OUTLIER -107.1 124.88 50.33 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.993 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.844 HD13 ' HB2' ' A' ' 118' ' ' TRP . 17.3 mt -84.07 166.91 17.3 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.171 179.735 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.45 ' HA ' HD12 ' A' ' 121' ' ' ILE . 5.2 pt-20 -55.72 -30.96 62.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.551 -179.725 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' ASN . . . . . 0.459 ' ND2' ' CG ' ' A' ' 118' ' ' TRP . 6.9 p30 -90.49 13.3 16.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.421 179.78 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.468 ' HA2' HD22 ' A' ' 133' ' ' LEU . . . 80.0 5.93 89.35 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.108 -179.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.601 ' CB ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -59.46 96.31 0.03 OUTLIER 'General case' 0 C--O 1.231 0.088 0 CA-C-N 117.253 0.526 . . . . 0.0 110.401 179.781 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.713 HD21 ' HB2' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -80.89 124.15 28.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.184 -179.484 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 140' ' ' LEU . 2.6 mm? -105.5 95.61 5.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.581 179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . 0.435 ' HA ' ' CD1' ' A' ' 131' ' ' PHE . 15.3 mtpt -72.33 -25.92 61.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.276 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -84.81 -21.14 30.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.695 -179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -99.31 25.7 6.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.553 0.216 . . . . 0.0 111.418 -179.744 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.435 ' HA2' ' HD3' ' A' ' 132' ' ' PRO . . . -69.38 160.92 52.63 Favored Glycine 0 CA--C 1.506 -0.501 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.574 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.676 ' O ' HG23 ' A' ' 129' ' ' THR . 1.4 t -124.64 159.82 29.88 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.937 0.399 . . . . 0.0 110.36 179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.46 30.78 4.4 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.139 0.495 . . . . 0.0 109.714 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . 0.464 HG23 ' OG1' ' A' ' 145' ' ' THR . 0.0 OUTLIER -154.25 129.62 9.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.483 -178.215 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.17 109.84 2.35 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.787 179.945 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.421 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 35.4 Cg_exo -61.19 105.85 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.225 1.95 . . . . 0.0 112.127 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.2 t -64.68 -15.62 61.64 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.481 179.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -81.53 -26.94 34.67 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.942 0.349 . . . . 0.0 111.942 -179.633 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.553 ' HB1' ' HD2' ' A' ' 153' ' ' PRO . . . -138.51 162.4 53.42 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.04 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . 0.553 ' HD2' ' HB1' ' A' ' 152' ' ' ALA . 65.9 Cg_endo -76.5 173.69 14.06 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 121.99 1.793 . . . . 0.0 112.749 -179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 123' ' ' TYR . 61.0 t -129.55 153.27 38.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.886 179.082 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.59 HD12 ' CD1' ' A' ' 133' ' ' LEU . 56.5 mt -112.42 97.75 6.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.006 0.431 . . . . 0.0 110.638 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 186' ' ' HIS . 58.8 t -82.43 134.92 25.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.514 -179.46 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 59.74 86.91 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.722 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.488 ' CZ3' ' CE2' ' A' ' 187' ' ' TYR . 70.8 m95 -148.41 112.93 5.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.017 0.437 . . . . 0.0 111.492 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -103.42 -26.23 12.97 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.514 179.222 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -98.11 96.04 7.85 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.237 -179.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.903 ' HA2' HD12 ' A' ' 164' ' ' ILE . . . -58.55 -20.97 48.14 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.096 -1.049 . . . . 0.0 112.028 178.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.4 -40.46 97.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 177.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -71.96 -33.77 68.45 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.649 -1.159 . . . . 0.0 109.697 178.582 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.921 ' CG2' HD11 ' A' ' 133' ' ' LEU . 63.6 mt -62.28 -52.11 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.675 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.4 ' HA ' ' HA3' ' A' ' 137' ' ' GLY . . . -55.24 -30.41 59.97 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.187 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 211' ' ' ILE . 3.7 mm-40 -67.9 -51.14 51.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.261 0.553 . . . . 0.0 110.149 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.454 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -59.9 -52.47 65.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.757 179.609 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.999 HG22 HD11 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -57.3 -33.7 67.94 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.268 179.253 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.72 97.13 Favored Glycine 0 N--CA 1.451 -0.367 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 178.587 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 170' ' ' GLN . . . . . . . . . . . . . 58.0 mm-40 -66.34 -34.76 78.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.37 . . . . 0.0 110.22 178.752 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.625 ' HB3' HD22 ' A' ' 179' ' ' LEU . 8.1 mp -71.79 -28.18 63.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.165 179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -72.29 -19.23 61.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.482 179.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -99.17 -40.24 8.08 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.8 0.334 . . . . 0.0 111.48 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.816 HD11 ' HB3' ' A' ' 179' ' ' LEU . 2.1 pp -73.65 156.0 88.79 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.594 -179.596 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.67 ' O ' HD12 ' A' ' 174' ' ' LEU . 52.5 Cg_exo -51.41 124.7 14.77 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.486 2.124 . . . . 0.0 112.441 179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -50.92 -36.02 36.29 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.925 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.72 ' HB3' ' CD2' ' A' ' 228' ' ' LEU . . . -64.93 -41.48 95.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.06 0.457 . . . . 0.0 110.352 179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.81 ' HA ' HG22 ' A' ' 224' ' ' ILE . 48.3 t -59.17 -60.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.949 179.356 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 174' ' ' LEU . 4.4 pp -62.58 -24.35 67.5 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.513 178.962 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -74.19 -22.48 77.66 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.101 179.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . 0.613 ' HB1' ' ND2' ' A' ' 202' ' ' ASN . . . -85.15 78.33 9.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.923 0.392 . . . . 0.0 110.931 179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 182' ' ' MET . . . . . . . . . . . . . 10.4 ptp 177.86 128.73 0.05 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.618 179.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 183' ' ' SER . . . . . . . . . . . . . 2.2 m -64.91 -48.78 72.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.132 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -167.47 153.92 8.04 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.984 0.421 . . . . 0.0 110.997 -179.7 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.503 HG12 HG12 ' A' ' 199' ' ' VAL . 4.8 mt -102.89 136.22 36.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.269 179.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.438 ' HA ' ' HB ' ' A' ' 156' ' ' VAL . 9.0 m170 -111.06 116.8 31.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 -179.708 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.488 ' CE2' ' CZ3' ' A' ' 158' ' ' TRP . 0.3 OUTLIER -66.71 112.02 3.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.853 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -133.54 78.4 62.47 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.598 179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' PRO . . . . . 0.417 ' HD3' ' CD1' ' A' ' 187' ' ' TYR . 56.8 Cg_endo -71.38 162.11 43.43 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.306 2.004 . . . . 0.0 112.53 -179.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 28.9 p -138.64 161.65 36.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.149 179.758 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' ARG . . . . . . . . . . . . . 3.3 ptt-85 -53.84 -24.83 17.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.376 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -104.99 -20.19 13.61 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.429 179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -134.91 82.02 1.93 Allowed 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.927 0.394 . . . . 0.0 111.07 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.04 -19.34 43.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.659 179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -113.17 35.85 3.78 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.753 0.311 . . . . 0.0 111.125 -179.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 11.7 ttt180 -82.91 115.89 21.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.788 179.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 18.6 m -116.92 134.53 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.3 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 207' ' ' VAL . 24.3 mm -105.63 110.6 31.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.622 179.605 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . 0.503 HG12 HG12 ' A' ' 185' ' ' ILE . 2.5 m -86.28 153.89 3.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.452 -179.145 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -111.5 100.57 9.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.207 179.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' MET . . . . . . . . . . . . . 12.8 tpp -55.85 149.42 14.88 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.505 -179.482 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.613 ' ND2' ' HB1' ' A' ' 181' ' ' ALA . 8.4 p30 -66.78 -20.17 65.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.039 179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -75.83 -13.47 60.28 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . . . . . . . . . . . 103.54 20.31 11.09 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.724 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -113.25 153.64 28.06 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.78 0.324 . . . . 0.0 110.723 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -106.53 117.55 34.33 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.48 ' HB ' HG22 ' A' ' 199' ' ' VAL . 10.8 t -111.96 160.22 11.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.976 0.417 . . . . 0.0 110.425 179.697 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.451 ' N ' HG12 ' A' ' 207' ' ' VAL . 88.0 p -121.57 146.36 47.03 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.005 -179.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . 0.431 ' HB1' ' HG3' ' A' ' 217' ' ' LYS . . . -158.18 179.5 9.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.694 179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 214' ' ' PHE . 1.1 p -125.19 152.94 43.84 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.333 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' ILE . . . . . 0.439 HD11 ' CH2' ' A' ' 158' ' ' TRP . 10.2 mt -68.37 -23.89 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 120.989 -0.284 . . . . 0.0 110.897 179.819 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.55 -36.58 57.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.786 0.327 . . . . 0.0 111.322 -179.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -129.46 35.86 4.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.962 -179.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 210' ' ' THR . 12.2 t80 -56.17 -45.95 79.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.127 -179.598 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -60.54 -48.27 82.52 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 179.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -60.86 -41.47 95.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.455 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . 0.431 ' HG3' ' HB1' ' A' ' 209' ' ' ALA . 0.0 OUTLIER -54.11 -52.35 61.29 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.648 179.713 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 218' ' ' LEU . 3.4 mm? -83.34 -19.48 36.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.295 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 38.0 t -64.88 -30.72 71.74 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 120.942 0.401 . . . . 0.0 110.854 179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -81.55 11.26 4.78 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 -179.884 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.49 ' CB ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -105.94 101.85 35.88 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 179.573 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -61.2 -35.02 87.62 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.241 1.961 . . . . 0.0 112.354 -179.577 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.536 ' O ' ' HB3' ' A' ' 226' ' ' ALA . . . -66.14 -44.83 83.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.224 -179.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.81 HG22 ' HA ' ' A' ' 178' ' ' VAL . 42.5 mt -65.58 -54.56 26.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -55.66 -29.37 59.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.383 178.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.536 ' HB3' ' O ' ' A' ' 223' ' ' ALA . . . -50.97 -28.93 10.93 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.487 178.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' ALA . . . . . 0.465 ' HB3' ' HB1' ' A' ' 177' ' ' ALA . . . -52.77 -25.22 10.6 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.491 178.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.72 ' CD2' ' HB3' ' A' ' 177' ' ' ALA . 1.2 mt -80.91 -30.08 35.47 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.405 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.1 -31.23 65.86 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.809 0.338 . . . . 0.0 111.078 -179.645 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' ARG . . . . . . . . . . . . . 13.3 tpt180 74.55 -61.05 0.5 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.024 -179.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -177.11 37.7 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' VAL . . . . . . . . . . . . . 21.4 t -118.79 121.95 68.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.112 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 8.7 mttp . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.182 -0.914 . . . . 0.0 110.915 -179.993 . . . . . . . . 0 0 . 1 stop_ save_